1	Annu	NNP	PERSON	Annu	_	0	SENT_1	[p1l307t1443r330b1524],
2	.	.	O	.	_	0	SENT_1	[p1l307t1443r330b1524],

1	Rev.	NNP	O	Rev.	nn	2	SENT_2	[p1l307t1373r330b1432],
2	Med	NNP	O	Med	_	0	SENT_2	[p1l307t1295r330b1362],
3	.	.	O	.	_	0	SENT_2	[p1l307t1295r330b1362],

1	1997482353-374	CD	NUMBER	1997482353-374	_	0	SENT_3	[p1l307t1050r331b1281],
2	.	.	O	.	_	0	SENT_3	[p1l307t1050r331b1281],

1	Downloaded	VBN	O	download	_	0	SENT_4	[p1l307t869r330b1039],
2	from	IN	O	from	_	0	SENT_4	[p1l307t796r330b860],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_4	[p1l307t451r337b775],
4	by	IN	O	by	_	0	SENT_4	[p1l340t1457r371b1489],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_4	[p1l340t1308r371b1447],
6	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l340t1269r364b1298],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_4	[p1l340t1122r364b1262],
8	-	:	O	-	_	0	SENT_4	[p1l354t1104r357b1112],
9	Madison	NNP	O	Madison	prep_by	1	SENT_4	[p1l340t978r364b1094],
10	on	IN	O	on	_	0	SENT_4	[p1l348t936r364b968],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_4	[p1l340t802r364b926],
12	.	.	O	.	_	0	SENT_4	[p1l340t802r364b926],

1	For	IN	O	for	_	0	SENT_5	[p1l341t734r364b780],
2	personal	JJ	O	personal	amod	3	SENT_5	[p1l340t615r371b727],
3	use	NN	O	use	pobj	1	SENT_5	[p1l348t562r364b606],
4	only	RB	O	only	advmod	3	SENT_5	[p1l340t487r371b552],
5	.	.	O	.	_	0	SENT_5	[p1l340t487r371b552],

1	Rev.	NNP	O	Rev.	nn	2	SENT_6	[p1l309t3581r332b3641],
2	Med	NNP	O	Med	_	0	SENT_6	[p1l309t3504r332b3571],
3	.	.	O	.	_	0	SENT_6	[p1l309t3504r332b3571],

1	l997	NN	O	l997	_	0	SENT_7	[p1l309t3283r333b3491],
2	.48:353	CD	NUMBER	.48:353	num	1	SENT_7	[p1l309t3283r333b3491],
3	-37	CD	NUMBER	-37	number	4	SENT_7	[p1l309t3283r333b3491],
4	4	CD	NUMBER	4	num	1	SENT_7	[p1l309t3198r332b3220],
5	.	.	O	.	_	0	SENT_7	[p1l309t3198r332b3220],

1	Downloaded	VBN	O	download	_	0	SENT_8	[p1l309t3017r332b3187],
2	from	IN	O	from	_	0	SENT_8	[p1l309t2944r332b3008],
3	www.annualreviews.org	NN	O	www.annualreviews.org	nn	4	SENT_8	[p1l309t2610r339b2935],
4	Jniversity	NN	O	jniversity	prep_from	1	SENT_8	[p1l342t3517r373b3642],
5	of	IN	O	of	_	0	SENT_8	[p1l342t3479r366b3507],
6	Wisconsin	NNP	LOCATION	Wisconsin	nn	11	SENT_8	[p1l342t3331r366b3472],
7	-	:	O	-	_	0	SENT_8	[p1l356t3313r359b3321],
8	l	NN	O	l	dep	11	SENT_8	[p1l343t3283r365b3303],
9	\	CD	NUMBER	\	num	8	SENT_8	[p1l343t3283r365b3303],
10	/	:	O	/	punct	8	SENT_8	[p1l343t3283r365b3303],
11	Iadison	NN	O	iadison	prep_of	4	SENT_8	[p1l342t3126r366b3222],
12	on	IN	O	on	_	0	SENT_8	[p1l350t3084r366b3116],
13	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_8	[p1l342t2950r366b3075],
14	.	.	O	.	_	0	SENT_8	[p1l342t2950r366b3075],

1	For	IN	O	for	_	0	SENT_9	[p1l343t2893r366b2940],
2	personal	JJ	O	personal	amod	3	SENT_9	[p1l342t2773r373b2885],
3	use	NN	O	use	pobj	1	SENT_9	[p1l350t2720r366b2764],
4	only	RB	O	only	advmod	3	SENT_9	[p1l342t2646r373b2711],
5	.	.	O	.	_	0	SENT_9	[p1l342t2646r373b2711],

1	Annu	NNP	PERSON	Annu	_	0	SENT_10	[p1l545t81r612b102],
2	.	.	O	.	_	0	SENT_10	[p1l545t81r612b102],

1	Rev.	NNP	O	Rev.	nn	2	SENT_11	[p1l622t82r670b102],
2	Med	NNP	O	Med	_	0	SENT_11	[p1l680t81r736b102],
3	.	.	O	.	_	0	SENT_11	[p1l680t81r736b102],

1	1997	CD	DATE	1997	_	0	SENT_12	[p1l748t81r809b102],
2	.	.	O	.	_	0	SENT_12	[p1l748t81r809b102],

1	48353-74	CD	NUMBER	48353-74	num	2	SENT_13	[p1l818t81r944b102],
2	Copyright	NN	O	copyright	_	0	SENT_13	[p1l548t114r665b140],
3	©	CD	NUMBER	©	num	4	SENT_13	[p1l672t115r692b135],
4	1997	CD	DATE	1997	dep	2	SENT_13	[p1l702t114r759b135],
5	by	IN	O	by	_	0	SENT_13	[p1l766t114r793b140],
6	Annual	JJ	ORGANIZATION	annual	amod	7	SENT_13	[p1l799t114r885b135],
7	Reviews	NNPS	ORGANIZATION	Reviews	prep_by	4	SENT_13	[p1l891t115r985b135],
8	Inc.	NNP	ORGANIZATION	Inc.	dep	4	SENT_13	[p1l992t115r1034b135],
9	.	.	O	.	_	0	SENT_13	[p1l992t115r1034b135],

1	All	DT	O	all	det	2	SENT_14	[p1l1043t114r1079b135],
2	rights	NNS	O	rights	nsubj	3	SENT_14	[p1l1087t114r1153b140],
3	reserved	VBD	O	reserve	_	0	SENT_14	[p1l1161t114r1260b135],

1	THE	DT	O	the	_	0	SENT_15	[p1l548t216r697b269],
2	DEVELOPMENT	NNP	O	DEVELOPMENT	dep	1	SENT_15	[p1l713t215r1282b270],
3	AND	CC	O	and	rcmod	2	SENT_15	[p1l1297t215r1462b270],

1	CLINICAL	NNP	O	CLINICAL	nn	2	SENT_16	[p1l549t312r905b367],
2	UTILITY	NNP	O	UTILITY	_	0	SENT_16	[p1l920t313r1221b367],
3	OF	IN	O	of	_	0	SENT_16	[p1l1238t312r1334b367],
4	THE	DT	O	the	det	5	SENT_16	[p1l1352t313r1501b366],
5	TAXANE	NN	O	taxane	prep_of	2	SENT_16	[p1l1519t312r1829b367],

1	CLASS	NN	O	class	_	0	SENT_17	[p1l549t409r783b464],
2	OF	IN	O	of	_	0	SENT_17	[p1l804t409r901b464],
3	ANTIMICROTUBULE	NN	O	antimicrotubule	prep_of	1	SENT_17	[p1l917t409r1657b464],

1	CHEMOTHERAPY	NN	MISC	chemotherapy	nn	2	SENT_18	[p1l549t507r1181b562],
2	AGENTS	NNS	O	agent	_	0	SENT_18	[p1l1193t507r1492b562],

1	Eric	NNP	PERSON	Eric	nn	3	SENT_19	[p1l547t669r632b702],
2	K.	NNP	PERSON	K.	nn	3	SENT_19	[p1l645t669r685b702],
3	Rowinsky	NNP	PERSON	Rowinsky	_	0	SENT_19	[p1l702t667r901b712],
4	,	,	O	,	_	0	SENT_19	[p1l702t667r901b712],
5	MD	NNP	ORGANIZATION	MD	nn	7	SENT_19	[p1l918t669r995b702],
6	Cancer	NNP	ORGANIZATION	Cancer	nn	7	SENT_19	[p1l548t735r653b761],
7	Therapy	NN	ORGANIZATION	therapy	appos	3	SENT_19	[p1l662t735r786b769],
8	and	CC	ORGANIZATION	and	_	0	SENT_19	[p1l797t735r850b761],
9	Research	NNP	ORGANIZATION	Research	nn	15	SENT_19	[p1l860t735r997b761],
10	Center	NNP	ORGANIZATION	Center	nn	15	SENT_19	[p1l1007t735r1113b766],
11	,	,	O	,	_	0	SENT_19	[p1l1007t735r1113b766],
12	Institute	NNP	ORGANIZATION	Institute	appos	15	SENT_19	[p1l1125t735r1246b761],
13	for	IN	ORGANIZATION	for	amod	15	SENT_19	[p1l1257t735r1300b761],
14	Drug	NNP	ORGANIZATION	Drug	nn	15	SENT_19	[p1l1310t736r1386b769],
15	Development	NNP	ORGANIZATION	Development	appos	3	SENT_19	[p1l1396t735r1605b769],
16	,	,	O	,	_	0	SENT_19	[p1l1396t735r1605b769],
17	8122	CD	NUMBER	8122	num	19	SENT_19	[p1l1618t735r1690b761],
18	Datapoint	NNP	LOCATION	Datapoint	nn	19	SENT_19	[p1l1701t735r1848b769],
19	Drive	NNP	LOCATION	Drive	appos	3	SENT_19	[p1l547t792r639b822],
20	,	,	O	,	_	0	SENT_19	[p1l547t792r639b822],
21	Suite	NNP	O	Suite	appos	3	SENT_19	[p1l652t792r726b818],
22	700	CD	NUMBER	700	num	21	SENT_19	[p1l737t792r800b823],
23	,	,	O	,	_	0	SENT_19	[p1l737t792r800b823],
24	San	NNP	LOCATION	San	nn	25	SENT_19	[p1l812t792r866b818],
25	Antonio	NNP	LOCATION	Antonio	appos	3	SENT_19	[p1l877t792r1006b822],
26	,	,	O	,	_	0	SENT_19	[p1l877t792r1006b822],
27	Texas	NNP	LOCATION	Texas	appos	3	SENT_19	[p1l1017t792r1105b818],
28	78229	CD	NUMBER	78229	num	27	SENT_19	[p1l1116t792r1208b818],

1	KEY	JJ	O	key	amod	2	SENT_20	[p1l548t887r615b909],
2	WORDS	NNS	O	word	_	0	SENT_20	[p1l623t886r749b910],
3	:	:	O	:	_	0	SENT_20	[p1l623t886r749b910],
4	paclitaxel	NN	O	paclitaxel	nn	16	SENT_20	[p1l772t886r908b917],
5	,	,	O	,	_	0	SENT_20	[p1l772t886r908b917],
6	docetaxel	NN	O	docetaxel	dep	16	SENT_20	[p1l927t886r1062b914],
7	,	,	O	,	_	0	SENT_20	[p1l927t886r1062b914],
8	Taxol	NN	O	taxol	dep	16	SENT_20	[p1l1081t886r1165b914],
9	,	,	O	,	_	0	SENT_20	[p1l1081t886r1165b914],
10	Taxotere	NNP	O	Taxotere	dep	16	SENT_20	[p1l1184t887r1309b914],
11	,	,	O	,	_	0	SENT_20	[p1l1184t887r1309b914],
12	microtubules	NNS	O	microtubule	dep	16	SENT_20	[p1l1327t886r1505b914],
13	,	,	O	,	_	0	SENT_20	[p1l1327t886r1505b914],
14	pharmacology	NN	O	pharmacology	dep	16	SENT_20	[p1l1524t886r1719b917],
15	,	,	O	,	_	0	SENT_20	[p1l1524t886r1719b917],
16	toxicity	NN	O	toxicity	dep	2	SENT_20	[p1l1738t886r1845b917],
17	,	,	O	,	_	0	SENT_20	[p1l1738t886r1845b917],

1	breast	NN	O	breast	nn	2	SENT_21	[p1l772t926r851b950],
2	cancer	NN	O	cancer	_	0	SENT_21	[p1l860t933r953b954],
3	,	,	O	,	_	0	SENT_21	[p1l860t933r953b954],
4	ovarian	JJ	O	ovarian	amod	5	SENT_21	[p1l963t926r1061b950],
5	cancer	NN	O	cancer	appos	2	SENT_21	[p1l1070t933r1163b954],
6	,	,	O	,	_	0	SENT_21	[p1l1070t933r1163b954],
7	lung	NN	O	lung	nn	8	SENT_21	[p1l1173t926r1230b957],
8	cancer	NN	O	cancer	appos	2	SENT_21	[p1l1240t933r1326b950],

1	ABSTRACT	NN	O	abstract	_	0	SENT_22	[p1l1132t1044r1311b1072],

1	The	DT	O	the	det	3	SENT_23	[p1l597t1101r654b1127],
2	taxane	NN	O	taxane	nn	3	SENT_23	[p1l672t1105r769b1127],
3	class	NN	O	class	nsubj	13	SENT_23	[p1l787t1101r857b1127],
4	of	IN	O	of	_	0	SENT_23	[p1l877t1100r909b1127],
5	antimicrotubule	JJ	O	antimicrotubule	amod	7	SENT_23	[p1l926t1101r1160b1127],
6	anticancer	JJ	O	anticancer	amod	7	SENT_23	[p1l1179t1101r1332b1127],
7	agents	NNS	O	agent	prep_of	3	SENT_23	[p1l1350t1105r1443b1135],
8	is	VBZ	O	be	cop	13	SENT_23	[p1l1462t1101r1485b1127],
9	perhaps	RB	O	perhaps	advmod	13	SENT_23	[p1l1504t1101r1619b1135],
10	the	DT	O	the	det	13	SENT_23	[p1l1638t1101r1682b1127],
11	most	RBS	O	most	advmod	12	SENT_23	[p1l1701t1105r1772b1127],
12	important	JJ	O	important	amod	13	SENT_23	[p1l597t1147r742b1181],
13	addition	NN	O	addition	_	0	SENT_23	[p1l751t1147r872b1173],
14	to	TO	O	to	_	0	SENT_23	[p1l880t1151r908b1173],
15	the	DT	O	the	det	17	SENT_23	[p1l917t1147r962b1173],
16	chemotherapeutic	JJ	O	chemotherapeutic	amod	17	SENT_23	[p1l971t1147r1235b1181],
17	armamentarium	NN	O	armamentarium	prep_to	13	SENT_23	[p1l1245t1147r1480b1173],
18	against	IN	O	against	_	0	SENT_23	[p1l1489t1147r1593b1181],
19	cancer	NN	O	cancer	prep_against	17	SENT_23	[p1l1602t1155r1698b1173],
20	over	IN	O	over	_	0	SENT_23	[p1l1707t1155r1773b1173],
21	the	DT	DATE	the	det	24	SENT_23	[p1l597t1192r642b1219],
22	past	JJ	DATE	past	amod	24	SENT_23	[p1l654t1196r715b1226],
23	several	JJ	DATE	several	amod	24	SENT_23	[p1l728t1192r832b1219],
24	decades	NNS	DATE	decade	prep_over	19	SENT_23	[p1l845t1192r970b1219],
25	.	.	O	.	_	0	SENT_23	[p1l845t1192r970b1219],

1	After	IN	O	after	_	0	SENT_24	[p1l985t1192r1063b1219],
2	only	RB	O	only	advmod	5	SENT_24	[p1l1076t1192r1141b1226],
3	a	DT	O	a	det	5	SENT_24	[p1l1155t1201r1170b1219],
4	brief	JJ	O	brief	amod	5	SENT_24	[p1l1182t1192r1255b1219],
5	period	NN	O	period	prep_after	47	SENT_24	[p1l1265t1192r1368b1227],
6	,	,	O	,	_	0	SENT_24	[p1l1265t1192r1368b1227],
7	the	DT	O	the	det	8	SENT_24	[p1l1382t1192r1427b1219],
8	taxanes	NNS	O	taxane	nsubj	12	SENT_24	[p1l1440t1196r1550b1219],
9	have	VBP	O	have	aux	12	SENT_24	[p1l1563t1192r1633b1219],
10	not	RB	O	not	neg	12	SENT_24	[p1l1646t1197r1694b1219],
11	only	RB	O	only	advmod	12	SENT_24	[p1l1706t1192r1771b1226],
12	demonstrated	VBD	O	demonstrate	parataxis	47	SENT_24	[p1l597t1238r798b1265],
13	a	DT	O	a	det	15	SENT_24	[p1l817t1247r833b1265],
14	unique	JJ	O	unique	amod	15	SENT_24	[p1l851t1238r952b1272],
15	ability	NN	O	ability	dobj	12	SENT_24	[p1l972t1238r1065b1272],
16	to	TO	O	to	aux	17	SENT_24	[p1l1085t1242r1112b1265],
17	palliate	VB	O	palliate	xcomp	12	SENT_24	[p1l1131t1238r1240b1272],
18	the	DT	O	the	det	19	SENT_24	[p1l1259t1238r1303b1265],
19	symptoms	NNS	O	symptom	dobj	17	SENT_24	[p1l1324t1242r1475b1272],
20	of	IN	O	of	_	0	SENT_24	[p1l1494t1238r1527b1265],
21	many	JJ	O	many	amod	22	SENT_24	[p1l1543t1247r1625b1272],
22	types	NNS	O	type	prep_of	19	SENT_24	[p1l1644t1242r1722b1272],
23	of	IN	O	of	_	0	SENT_24	[p1l1742t1238r1774b1265],
24	advanced	JJ	O	advanced	amod	25	SENT_24	[p1l598t1284r738b1311],
25	cancers	NNS	O	cancer	prep_of	22	SENT_24	[p1l755t1292r874b1315],
26	,	,	O	,	_	0	SENT_24	[p1l755t1292r874b1315],
27	including	VBG	O	include	_	0	SENT_24	[p1l893t1284r1033b1318],
28	carcinoma	NN	O	carcinoma	prep_including	19	SENT_24	[p1l1051t1284r1206b1310],
29	of	IN	O	of	_	0	SENT_24	[p1l1223t1284r1255b1310],
30	the	DT	O	the	det	31	SENT_24	[p1l1270t1284r1315b1310],
31	ovary	NN	O	ovary	prep_of	28	SENT_24	[p1l1332t1292r1425b1318],
32	,	,	O	,	_	0	SENT_24	[p1l1332t1292r1425b1318],
33	lung	NN	O	lung	prep_of	28	SENT_24	[p1l1443t1284r1517b1318],
34	,	,	O	,	_	0	SENT_24	[p1l1443t1284r1517b1318],
35	head	NN	O	head	prep_of	28	SENT_24	[p1l1536t1284r1606b1310],
36	and	CC	O	and	_	0	SENT_24	[p1l1624t1284r1676b1310],
37	neck	NN	O	neck	prep_of	28	SENT_24	[p1l1693t1284r1771b1315],
38	,	,	O	,	_	0	SENT_24	[p1l1693t1284r1771b1315],
39	bladder	NN	O	bladder	conj_and	31	SENT_24	[p1l596t1330r716b1361],
40	,	,	O	,	_	0	SENT_24	[p1l596t1330r716b1361],
41	and	CC	O	and	_	0	SENT_24	[p1l728t1330r781b1356],
42	esophagus	NN	O	esophagus	conj_and	31	SENT_24	[p1l790t1330r953b1364],
43	,	,	O	,	_	0	SENT_24	[p1l790t1330r953b1364],
44	they	PRP	O	they	nsubj	47	SENT_24	[p1l963t1330r1026b1364],
45	have	VBP	O	have	aux	47	SENT_24	[p1l1036t1330r1105b1356],
46	also	RB	O	also	advmod	47	SENT_24	[p1l1115t1330r1173b1356],
47	demonstrated	VBN	O	demonstrate	_	0	SENT_24	[p1l1183t1330r1383b1356],
48	effectiveness	NN	O	effectiveness	dobj	47	SENT_24	[p1l1393t1330r1586b1356],
49	in	IN	O	in	_	0	SENT_24	[p1l1595t1330r1624b1356],
50	the	DT	O	the	det	52	SENT_24	[p1l1633t1330r1677b1356],
51	initial	JJ	O	initial	amod	52	SENT_24	[p1l1686t1330r1772b1356],
52	therapy	NN	O	therapy	prep_in	47	SENT_24	[p1l597t1376r708b1410],
53	of	IN	O	of	_	0	SENT_24	[p1l720t1376r752b1402],
54	earlier	JJR	O	earlier	amod	55	SENT_24	[p1l761t1376r855b1402],
55	stages	NNS	O	stage	prep_of	52	SENT_24	[p1l866t1380r954b1410],
56	of	IN	O	of	_	0	SENT_24	[p1l966t1376r998b1402],
57	cancer	NN	O	cancer	prep_of	55	SENT_24	[p1l1006t1384r1111b1407],
58	,	,	O	,	_	0	SENT_24	[p1l1006t1384r1111b1407],
59	a	DT	O	a	det	60	SENT_24	[p1l1123t1384r1139b1402],
60	setting	NN	O	setting	appos	57	SENT_24	[p1l1149t1376r1246b1410],
61	in	IN	O	in	_	0	SENT_24	[p1l1257t1376r1285b1402],
62	which	WDT	O	which	rel	67	SENT_24	[p1l1296t1376r1386b1402],
63	any	DT	O	any	det	65	SENT_24	[p1l1397t1384r1449b1410],
64	new	JJ	O	new	amod	65	SENT_24	[p1l1460t1384r1521b1402],
65	therapy	NN	O	therapy	nsubj	67	SENT_24	[p1l1532t1376r1643b1410],
66	is	VBZ	O	be	cop	67	SENT_24	[p1l1653t1376r1677b1402],
67	likely	JJ	O	likely	rcmod	60	SENT_24	[p1l1688t1376r1771b1410],
68	to	TO	O	to	aux	69	SENT_24	[p1l597t1426r625b1448],
69	make	VB	O	make	xcomp	67	SENT_24	[p1l633t1422r713b1448],
70	its	PRP$	O	its	poss	72	SENT_24	[p1l721t1422r754b1448],
71	greatest	JJS	O	greatest	amod	72	SENT_24	[p1l763t1426r879b1456],
72	impact	NN	O	impact	dobj	69	SENT_24	[p1l886t1422r994b1456],
73	.	.	O	.	_	0	SENT_24	[p1l886t1422r994b1456],

1	The	DT	O	the	det	2	SENT_25	[p1l1003t1422r1061b1448],
2	challenge	NN	O	challenge	nsubj	6	SENT_25	[p1l1069t1422r1210b1456],
3	now	RB	DATE	now	advmod	4	SENT_25	[p1l1218t1430r1281b1448],
4	facing	VBG	O	face	partmod	2	SENT_25	[p1l1289t1422r1381b1456],
5	investigators	NNS	O	investigator	dobj	4	SENT_25	[p1l1389t1422r1578b1456],
6	is	VBZ	O	be	_	0	SENT_25	[p1l1587t1422r1610b1448],
7	to	TO	O	to	aux	8	SENT_25	[p1l1618t1426r1646b1448],
8	develop	VB	O	develop	xcomp	6	SENT_25	[p1l1654t1422r1771b1456],
9	strategies	NNS	O	strategy	nsubj	11	SENT_25	[p1l598t1468r736b1502],
10	to	TO	O	to	aux	11	SENT_25	[p1l747t1472r775b1494],
11	maximize	VB	O	maximize	xcomp	8	SENT_25	[p1l785t1468r931b1494],
12	therapeutic	JJ	O	therapeutic	amod	13	SENT_25	[p1l941t1468r1106b1502],
13	benefits	NNS	O	benefit	dobj	11	SENT_25	[p1l1116t1468r1233b1494],
14	with	IN	O	with	_	0	SENT_25	[p1l1245t1468r1309b1494],
15	the	DT	O	the	det	16	SENT_25	[p1l1319t1468r1364b1494],
16	taxanes	NNS	O	taxane	prep_with	11	SENT_25	[p1l1374t1472r1485b1494],
17	in	IN	O	in	_	0	SENT_25	[p1l1495t1468r1524b1494],
18	the	DT	O	the	det	20	SENT_25	[p1l1534t1468r1578b1494],
19	early	JJ	O	early	amod	20	SENT_25	[p1l1589t1468r1662b1502],
20	stages	NNS	O	stage	prep_in	16	SENT_25	[p1l1673t1472r1770b1502],
21	,	,	O	,	_	0	SENT_25	[p1l1673t1472r1770b1502],
22	as	RB	O	as	_	0	SENT_25	[p1l598t1522r626b1540],
23	well	RB	O	well	_	0	SENT_25	[p1l643t1514r706b1540],
24	as	IN	O	as	_	0	SENT_25	[p1l722t1522r751b1540],
25	the	DT	O	the	det	27	SENT_25	[p1l767t1514r811b1540],
26	advanced	JJ	O	advanced	amod	27	SENT_25	[p1l828t1514r968b1540],
27	stages	NNS	O	stage	prep_in	16	SENT_25	[p1l984t1518r1081b1548],
28	,	,	O	,	_	0	SENT_25	[p1l984t1518r1081b1548],
29	of	IN	O	of	_	0	SENT_25	[p1l1098t1514r1130b1540],
30	many	JJ	O	many	amod	31	SENT_25	[p1l1143t1522r1225b1548],
31	cancers	NNS	O	cancer	prep_of	20	SENT_25	[p1l1241t1522r1359b1540],
32	.	.	O	.	_	0	SENT_25	[p1l1241t1522r1359b1540],

1	This	DT	O	this	det	2	SENT_26	[p1l1377t1514r1441b1540],
2	review	NN	O	review	nsubj	3	SENT_26	[p1l1457t1514r1558b1540],
3	describes	VBZ	O	describe	_	0	SENT_26	[p1l1574t1514r1711b1540],
4	the	DT	O	the	det	6	SENT_26	[p1l1727t1514r1772b1540],
5	preclinical	JJ	O	preclinical	amod	6	SENT_26	[p1l596t1560r754b1594],
6	features	NNS	O	feature	dobj	3	SENT_26	[p1l770t1560r886b1586],
7	and	CC	O	and	_	0	SENT_26	[p1l904t1560r957b1586],
8	clinical	JJ	O	clinical	amod	9	SENT_26	[p1l973t1560r1081b1586],
9	results	NNS	O	result	dobj	3	SENT_26	[p1l1098t1560r1194b1586],
10	of	IN	O	of	_	0	SENT_26	[p1l1211t1560r1244b1586],
11	the	DT	O	the	det	14	SENT_26	[p1l1257t1560r1302b1586],
12	two	CD	NUMBER	two	num	14	SENT_26	[p1l1318t1564r1373b1586],
13	major	JJ	O	major	amod	14	SENT_26	[p1l1389t1560r1476b1594],
14	taxanes	NNS	O	taxane	prep_of	9	SENT_26	[p1l1491t1564r1610b1591],
15	,	,	O	,	_	0	SENT_26	[p1l1491t1564r1610b1591],
16	paclitaxel	NN	O	paclitaxel	nn	19	SENT_26	[p1l1628t1560r1772b1594],
17	(	CD	NUMBER	(	num	19	SENT_26	[p1l598t1599r733b1631],
18	Taxol	NN	O	taxol	nn	19	SENT_26	[p1l598t1599r733b1631],
19	®	NN	O	®	prep_of	9	SENT_26	[p1l598t1599r733b1631],
20	,	,	O	,	_	0	SENT_26	[p1l598t1599r733b1631],
21	Bristol-Myers	NNP	O	Bristol-Myers	nn	23	SENT_26	[p1l751t1599r959b1633],
22	Squibb	NNP	O	Squibb	nn	23	SENT_26	[p1l979t1599r1094b1633],
23	)	NN	O	)	conj_and	14	SENT_26	[p1l979t1599r1094b1633],
24	and	CC	O	and	_	0	SENT_26	[p1l1113t1599r1166b1625],
25	docetaxel	NN	O	docetaxel	nn	28	SENT_26	[p1l1183t1599r1325b1625],
26	(	CD	NUMBER	(	num	28	SENT_26	[p1l1343t1599r1523b1631],
27	Taxotere	NNP	MISC	Taxotere	nn	28	SENT_26	[p1l1343t1599r1523b1631],
28	®	NNP	O	®	conj_and	14	SENT_26	[p1l1343t1599r1523b1631],
29	,	,	O	,	_	0	SENT_26	[p1l1343t1599r1523b1631],
30	Rhone-Poulenc	NNP	PERSON	Rhone-Poulenc	nn	32	SENT_26	[p1l1541t1599r1770b1625],
31	Rhorer	NNP	PERSON	Rhorer	nn	32	SENT_26	[p1l597t1636r720b1668],
32	)	NN	O	)	appos	28	SENT_26	[p1l597t1636r720b1668],
33	.	.	O	.	_	0	SENT_26	[p1l597t1636r720b1668],

1	HISTORY	NN	O	history	_	0	SENT_27	[p1l547t1716r758b1751],
2	AND	CC	O	and	cc	3	SENT_27	[p1l768t1716r874b1751],
3	CHEMISTRY	NN	O	chemistry	dep	1	SENT_27	[p1l888t1716r1171b1751],

1	The	DT	O	the	det	3	SENT_28	[p1l547t1801r610b1831],
2	prototypic	JJ	O	prototypic	amod	3	SENT_28	[p1l622t1801r791b1839],
3	taxane	NN	O	taxane	nsubjpass	8	SENT_28	[p1l804t1806r920b1836],
4	,	,	O	,	_	0	SENT_28	[p1l804t1806r920b1836],
5	paclitaxel	NN	O	paclitaxel	appos	3	SENT_28	[p1l933t1801r1102b1839],
6	,	,	O	,	_	0	SENT_28	[p1l933t1801r1102b1839],
7	was	VBD	O	be	auxpass	8	SENT_28	[p1l1115t1810r1177b1831],
8	discovered	VBN	O	discover	_	0	SENT_28	[p1l1191t1801r1369b1831],
9	as	IN	O	as	_	0	SENT_28	[p1l1381t1810r1413b1831],
10	part	NN	O	part	prep_as	8	SENT_28	[p1l1425t1806r1490b1839],
11	of	IN	O	of	_	0	SENT_28	[p1l1502t1801r1537b1831],
12	a	DT	O	a	det	16	SENT_28	[p1l1547t1810r1564b1831],
13	National	NNP	ORGANIZATION	National	nn	16	SENT_28	[p1l1576t1801r1717b1831],
14	Cancer	NNP	ORGANIZATION	Cancer	nn	16	SENT_28	[p1l1730t1801r1846b1831],
15	Institute	NNP	ORGANIZATION	Institute	nn	16	SENT_28	[p1l547t1851r682b1881],
16	program	NN	O	program	prep_of	10	SENT_28	[p1l697t1860r837b1889],
17	in	IN	O	in	_	0	SENT_28	[p1l851t1851r883b1880],
18	which	WDT	O	which	rel	25	SENT_28	[p1l898t1851r998b1881],
19	extracts	NNS	O	extract	nsubjpass	25	SENT_28	[p1l1013t1856r1139b1881],
20	of	IN	O	of	_	0	SENT_28	[p1l1156t1851r1192b1881],
21	thousands	NNS	O	thousand	prep_of	19	SENT_28	[p1l1204t1851r1367b1881],
22	of	IN	O	of	_	0	SENT_28	[p1l1384t1851r1420b1881],
23	plants	NNS	O	plant	prep_of	21	SENT_28	[p1l1432t1851r1529b1889],
24	were	VBD	O	be	auxpass	25	SENT_28	[p1l1546t1860r1625b1881],
25	screened	VBN	O	screen	rcmod	16	SENT_28	[p1l1641t1851r1784b1881],
26	for	IN	O	for	prep	25	SENT_28	[p1l1798t1851r1846b1881],

1	354	CD	NUMBER	354	num	2	SENT_29	[p1l550t2040r604b2066],
2	ROWINSKY	NN	O	rowinsky	_	0	SENT_29	[p1l643t2040r843b2066],

1	anticancer	JJ	O	anticancer	amod	2	SENT_30	[p1l550t2124r719b2154],
2	activity	NN	O	activity	_	0	SENT_30	[p1l734t2124r856b2162],
3	(	CD	NUMBER	(	number	4	SENT_30	[p1l873t2125r928b2160],
4	1	CD	NUMBER	1	dep	2	SENT_30	[p1l873t2125r928b2160],
5	)	NN	O	)	dep	4	SENT_30	[p1l873t2125r928b2160],
6	.	.	O	.	_	0	SENT_30	[p1l873t2125r928b2160],

1	Paclitaxel	NN	O	paclitaxel	nsubjpass	4	SENT_31	[p1l945t2124r1108b2154],
2	was	VBD	O	be	auxpass	4	SENT_31	[p1l1123t2133r1185b2154],
3	initially	RB	O	initially	advmod	4	SENT_31	[p1l1202t2124r1330b2162],
4	supplied	VBN	O	supply	_	0	SENT_31	[p1l1347t2124r1485b2162],
5	from	IN	O	from	_	0	SENT_31	[p1l1501t2124r1581b2154],
6	the	DT	O	the	det	7	SENT_31	[p1l1597t2124r1646b2154],
7	bark	NN	O	bark	prep_from	4	SENT_31	[p1l1661t2124r1735b2154],
8	of	IN	O	of	_	0	SENT_31	[p1l1750t2124r1786b2154],
9	the	DT	O	the	det	12	SENT_31	[p1l1799t2124r1848b2154],
10	scarce	JJ	O	scarce	amod	12	SENT_31	[p1l551t2183r651b2204],
11	Pacific	NNP	LOCATION	Pacific	nn	12	SENT_31	[p1l662t2174r775b2204],
12	yew	NN	O	yew	prep_of	7	SENT_31	[p1l786t2183r862b2212],
13	,	,	O	,	_	0	SENT_31	[p1l786t2183r862b2212],
14	T	NN	O	t	nn	16	SENT_31	[p1l876t2175r900b2203],
15	axus	NN	O	axus	nn	16	SENT_31	[p1l898t2184r972b2204],
16	brevifolia	NN	O	brevifolium	appos	12	SENT_31	[p1l983t2174r1152b2212],
17	,	,	O	,	_	0	SENT_31	[p1l983t2174r1152b2212],
18	which	WDT	O	which	nsubj	19	SENT_31	[p1l1165t2174r1265b2204],
19	had	VBD	O	have	rcmod	12	SENT_31	[p1l1275t2174r1334b2204],
20	deleterious	JJ	O	deleterious	amod	23	SENT_31	[p1l1345t2174r1524b2204],
21	long	JJ	O	long	amod	23	SENT_31	[p1l1537t2174r1700b2212],
22	—	NN	O	—	nn	23	SENT_31	[p1l1537t2174r1700b2212],
23	term	NN	O	term	dobj	19	SENT_31	[p1l1537t2174r1700b2212],
24	environmental	JJ	O	environmental	amod	25	SENT_31	[p1l1711t2174r1847b2204, p1l549t2224r661b2253],
25	implications	NNS	O	implication	dep	23	SENT_31	[p1l683t2224r895b2262],
26	.	.	O	.	_	0	SENT_31	[p1l683t2224r895b2262],

1	However	RB	O	however	advmod	41	SENT_32	[p1l920t2225r1079b2259],
2	,	,	O	,	_	0	SENT_32	[p1l920t2225r1079b2259],
3	alternate	JJ	O	alternate	amod	4	SENT_32	[p1l1104t2224r1245b2253],
4	sources	NNS	O	source	nsubj	41	SENT_32	[p1l1268t2233r1399b2259],
5	,	,	O	,	_	0	SENT_32	[p1l1268t2233r1399b2259],
6	particularly	RB	O	particularly	advmod	10	SENT_32	[p1l1422t2224r1612b2262],
7	an	DT	O	a	det	10	SENT_32	[p1l1636t2233r1673b2253],
8	approved	VBN	O	approve	amod	10	SENT_32	[p1l1696t2224r1849b2262],
9	semisynthetic	JJ	O	semisynthetic	amod	10	SENT_32	[p1l551t2274r775b2312],
10	process	NN	O	process	appos	4	SENT_32	[p1l788t2283r910b2312],
11	using	VBG	O	use	partmod	10	SENT_32	[p1l924t2274r1013b2312],
12	a	DT	O	a	det	15	SENT_32	[p1l1026t2283r1043b2304],
13	readily	RB	O	readily	advmod	14	SENT_32	[p1l1055t2274r1169b2312],
14	available	JJ	O	available	amod	15	SENT_32	[p1l1182t2274r1329b2304],
15	precursor	NN	O	precursor	dobj	11	SENT_32	[p1l1341t2283r1506b2312],
16	,	,	O	,	_	0	SENT_32	[p1l1341t2283r1506b2312],
17	10	CD	NUMBER	10	num	19	SENT_32	[p1l1523t2274r1849b2312],
18	—	NN	O	—	nn	19	SENT_32	[p1l1523t2274r1849b2312],
19	deacetylbaccatin	NN	O	deacetylbaccatin	appos	10	SENT_32	[p1l1523t2274r1849b2312],
20	III	CD	NUMBER	iii	dep	19	SENT_32	[p1l549t2325r598b2359],
21	,	,	O	,	_	0	SENT_32	[p1l549t2325r598b2359],
22	derived	VBN	O	derive	partmod	19	SENT_32	[p1l622t2324r745b2354],
23	from	IN	O	from	_	0	SENT_32	[p1l766t2324r846b2354],
24	the	DT	O	the	det	25	SENT_32	[p1l868t2324r917b2354],
25	needles	NNS	O	needle	prep_from	22	SENT_32	[p1l939t2324r1061b2354],
26	of	IN	O	of	_	0	SENT_32	[p1l1084t2324r1120b2354],
27	more	JJR	O	more	amod	30	SENT_32	[p1l1139t2333r1223b2354],
28	abundant	JJ	O	abundant	amod	30	SENT_32	[p1l1245t2324r1396b2354],
29	yew	NN	O	yew	nn	30	SENT_32	[p1l1417t2333r1485b2362],
30	species	NNS	O	species	prep_of	25	SENT_32	[p1l1508t2324r1624b2362],
31	such	JJ	O	such	_	0	SENT_32	[p1l1649t2324r1722b2354],
32	as	IN	O	as	_	0	SENT_32	[p1l1745t2333r1776b2354],
33	the	DT	O	the	det	37	SENT_32	[p1l1799t2324r1848b2354],
34	European	JJ	MISC	european	amod	37	SENT_32	[p1l549t2375r707b2412],
35	yew	NN	O	yew	nn	37	SENT_32	[p1l719t2383r787b2412],
36	Taxus	NN	MISC	taxus	nn	37	SENT_32	[p1l802t2375r898b2404],
37	baccata	NN	O	bacca	prep_such_as	30	SENT_32	[p1l911t2374r1050b2409],
38	,	,	O	,	_	0	SENT_32	[p1l911t2374r1050b2409],
39	is	VBZ	O	be	aux	41	SENT_32	[p1l1064t2374r1090b2403],
40	currently	RB	DATE	currently	advmod	41	SENT_32	[p1l1104t2374r1252b2412],
41	meeting	VBG	O	meet	_	0	SENT_32	[p1l1265t2374r1397b2412],
42	commercial	JJ	O	commercial	amod	43	SENT_32	[p1l1410t2374r1604b2403],
43	demands	NNS	O	demand	dobj	41	SENT_32	[p1l1616t2374r1770b2403],
44	.	.	O	.	_	0	SENT_32	[p1l1616t2374r1770b2403],

1	Docetaxel	NNP	O	Docetaxel	nsubjpass	3	SENT_33	[p1l1785t2375r1847b2403, p1l549t2424r665b2454],
2	is	VBZ	O	be	auxpass	3	SENT_33	[p1l691t2424r717b2454],
3	derived	VBN	O	derive	_	0	SENT_33	[p1l745t2424r868b2454],
4	semisynthetically	RB	O	semisynthetically	advmod	3	SENT_33	[p1l895t2424r1183b2462],
5	from	IN	O	from	_	0	SENT_33	[p1l1209t2424r1289b2454],
6	10	CD	NUMBER	10	number	7	SENT_33	[p1l1319t2424r1645b2462],
7	—	CD	NUMBER	—	prep_from	3	SENT_33	[p1l1319t2424r1645b2462],
8	deacetylbaccatin	NN	O	deacetylbaccatin	dep	7	SENT_33	[p1l1319t2424r1645b2462],
9	III	CD	NUMBER	iii	num	8	SENT_33	[p1l1670t2425r1711b2453],
10	and	CC	O	and	_	0	SENT_33	[p1l1738t2424r1796b2454],
11	is	VBZ	O	be	cop	14	SENT_33	[p1l1822t2424r1847b2454],
12	slightly	RB	O	slightly	advmod	14	SENT_33	[p1l551t2474r672b2512],
13	more	RBR	O	more	advmod	14	SENT_33	[p1l692t2483r776b2504],
14	water	NN	O	water	conj_and	3	SENT_33	[p1l796t2479r888b2504],
15	soluble	JJ	O	soluble	amod	14	SENT_33	[p1l908t2474r1025b2504],
16	than	IN	O	than	mark	21	SENT_33	[p1l1045t2474r1116b2504],
17	paclitaxel	NN	O	paclitaxel	nsubj	21	SENT_33	[p1l1135t2474r1295b2512],
18	is	VBZ	O	be	cop	21	SENT_33	[p1l1314t2474r1340b2504],
19	(	NN	O	(	nn	21	SENT_33	[p1l1362t2474r1416b2510],
20	2	CD	NUMBER	2	num	21	SENT_33	[p1l1362t2474r1416b2510],
21	)	NN	O	)	advcl	3	SENT_33	[p1l1362t2474r1416b2510],
22	.	.	O	.	_	0	SENT_33	[p1l1362t2474r1416b2510],

1	Both	DT	O	both	preconj	2	SENT_34	[p1l1438t2474r1517b2504],
2	paclitaxel	NN	O	paclitaxel	nsubj	5	SENT_34	[p1l1536t2474r1697b2512],
3	and	CC	O	and	_	0	SENT_34	[p1l1717t2474r1775b2504],
4	docetaxel	NN	O	docetaxel	conj_and	2	SENT_34	[p1l1795t2474r1847b2504, p1l550t2524r665b2553],
5	consist	VBP	O	consist	_	0	SENT_34	[p1l677t2524r791b2553],
6	of	IN	O	of	_	0	SENT_34	[p1l803t2524r839b2553],
7	a	DT	O	a	det	10	SENT_34	[p1l849t2533r866b2553],
8	complex	JJ	O	complex	amod	10	SENT_34	[p1l877t2524r1018b2562],
9	taxane	NN	O	taxane	nn	10	SENT_34	[p1l1030t2529r1137b2553],
10	ring	NN	O	ring	prep_of	5	SENT_34	[p1l1148t2524r1214b2562],
11	linked	VBN	O	link	partmod	10	SENT_34	[p1l1226t2524r1329b2553],
12	to	TO	O	to	_	0	SENT_34	[p1l1340t2529r1371b2553],
13	an	DT	O	a	det	14	SENT_34	[p1l1384t2533r1421b2553],
14	ester	NN	O	ester	prep_to	11	SENT_34	[p1l1433t2529r1510b2553],
15	at	IN	O	at	_	0	SENT_34	[p1l1522t2529r1550b2553],
16	the	DT	O	the	det	18	SENT_34	[p1l1561t2524r1611b2553],
17	C-13	NN	MISC	c-13	nn	18	SENT_34	[p1l1623t2524r1702b2554],
18	position	NN	O	position	prep_at	14	SENT_34	[p1l1715t2524r1849b2562],
19	(	CD	NUMBER	(	num	20	SENT_34	[p1l550t2574r670b2612],
20	Figure	NN	O	figure	tmod	11	SENT_34	[p1l550t2574r670b2612],
21	1	CD	NUMBER	1	num	22	SENT_34	[p1l687t2574r724b2610],
22	)	NN	O	)	dep	20	SENT_34	[p1l687t2574r724b2610],
23	.	.	O	.	_	0	SENT_34	[p1l687t2574r724b2610],

1	The	DT	O	the	det	2	SENT_35	[p1l739t2574r802b2603],
2	moieties	NNS	O	moiety	nsubj	17	SENT_35	[p1l815t2574r953b2603],
3	at	IN	O	at	_	0	SENT_35	[p1l968t2579r996b2603],
4	the	DT	O	the	det	6	SENT_35	[p1l1008t2574r1058b2603],
5	C-2	NN	O	c-2	nn	6	SENT_35	[p1l1071t2572r1142b2603],
6	’	NN	O	’	prep_at	2	SENT_35	[p1l1071t2572r1142b2603],
7	and	CC	O	and	_	0	SENT_35	[p1l1156t2574r1215b2603],
8	C-3	NN	O	c-3	nsubj	17	SENT_35	[p1l1227t2572r1298b2603],
9	’	CD	NUMBER	’	num	10	SENT_35	[p1l1227t2572r1298b2603],
10	positions	NNS	O	position	dep	8	SENT_35	[p1l1310t2574r1458b2612],
11	on	IN	O	on	_	0	SENT_35	[p1l1473t2583r1513b2603],
12	the	DT	O	the	det	15	SENT_35	[p1l1525t2574r1574b2603],
13	C-13	NN	MISC	c-13	nn	15	SENT_35	[p1l1588t2574r1667b2603],
14	side	NN	O	side	nn	15	SENT_35	[p1l1683t2574r1747b2603],
15	chain	NN	O	chain	prep_on	10	SENT_35	[p1l1760t2574r1849b2603],
16	are	VBP	O	be	cop	17	SENT_35	[p1l550t2634r598b2653],
17	essential	JJ	O	essential	_	0	SENT_35	[p1l610t2624r751b2653],
18	for	IN	O	for	_	0	SENT_35	[p1l763t2624r811b2653],
19	their	PRP$	O	they	poss	21	SENT_35	[p1l821t2624r897b2653],
20	antimicrotubule	JJ	O	antimicrotubule	amod	21	SENT_35	[p1l908t2624r1168b2653],
21	activity	NN	O	activity	prep_for	17	SENT_35	[p1l1180t2624r1311b2662],
22	.	.	O	.	_	0	SENT_35	[p1l1180t2624r1311b2662],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_36	[p1l549t2741r878b2776],
2	OF	IN	O	of	_	0	SENT_36	[p1l894t2741r956b2776],
3	ACTION	NNP	O	ACTION	prep_of	1	SENT_36	[p1l968t2741r1155b2776],
4	AND	CC	O	and	_	0	SENT_36	[p1l1167t2741r1273b2776],
5	RESISTANCE	NN	O	resistance	prep_of	1	SENT_36	[p1l1286t2741r1583b2776],

1	The	DT	O	the	det	3	SENT_37	[p1l549t2832r612b2861],
2	binding	NN	O	binding	nn	3	SENT_37	[p1l624t2832r749b2870],
3	site	NN	O	site	nsubj	10	SENT_37	[p1l762t2832r817b2861],
4	for	IN	O	for	_	0	SENT_37	[p1l828t2832r876b2861],
5	the	DT	O	the	det	6	SENT_37	[p1l886t2832r935b2861],
6	taxanes	NNS	O	taxane	prep_for	3	SENT_37	[p1l947t2836r1069b2861],
7	on	IN	O	on	_	0	SENT_37	[p1l1081t2841r1121b2861],
8	microtubules	NNS	O	microtubule	prep_on	6	SENT_37	[p1l1133t2832r1347b2861],
9	is	VBZ	O	be	cop	10	SENT_37	[p1l1359t2832r1384b2861],
10	distinct	JJ	O	distinct	_	0	SENT_37	[p1l1397t2832r1518b2861],
11	from	IN	O	from	_	0	SENT_37	[p1l1528t2832r1608b2861],
12	those	DT	O	those	prep_from	10	SENT_37	[p1l1619t2832r1705b2861],
13	of	IN	O	of	_	0	SENT_37	[p1l1717t2832r1753b2861],
14	GTP	NN	O	gtp	prep_of	12	SENT_37	[p1l1761t2832r1847b2866],
15	,	,	O	,	_	0	SENT_37	[p1l1761t2832r1847b2866],
16	colchicine	NN	O	colchicine	attr	10	SENT_37	[p1l550t2882r727b2916],
17	,	,	O	,	_	0	SENT_37	[p1l550t2882r727b2916],
18	podophyllotoxin	NN	O	podophyllotoxin	conj_and	16	SENT_37	[p1l742t2882r1024b2920],
19	,	,	O	,	_	0	SENT_37	[p1l742t2882r1024b2920],
20	and	CC	O	and	_	0	SENT_37	[p1l1041t2882r1099b2911],
21	vinblastine	NN	O	vinblastine	attr	10	SENT_37	[p1l1113t2882r1302b2911],
22	.	.	O	.	_	0	SENT_37	[p1l1113t2882r1302b2911],

1	Paclitaxel	NN	O	paclitaxel	nsubj	2	SENT_38	[p1l1318t2882r1480b2911],
2	binds	VBZ	O	bind	_	0	SENT_38	[p1l1493t2882r1581b2911],
3	to	TO	O	to	_	0	SENT_38	[p1l1597t2886r1627b2911],
4	the	DT	O	the	det	5	SENT_38	[p1l1642t2882r1691b2911],
5	N	NN	O	n	prep_to	2	SENT_38	[p1l1705t2882r1847b2911],
6	—	NN	O	—	dobj	2	SENT_38	[p1l1705t2882r1847b2911],
7	termi	FW	O	termi	nn	6	SENT_38	[p1l1705t2882r1847b2911],
8	—	FW	O	—	nn	6	SENT_38	[p1l1705t2882r1847b2911],
9	nal	FW	O	nal	dep	6	SENT_38	[p1l549t2932r598b2961],
10	31	CD	NUMBER	31	num	12	SENT_38	[p1l612t2932r648b2961],
11	amino	NN	O	amino	nn	12	SENT_38	[p1l664t2932r766b2961],
12	acids	NNS	O	acid	nsubj	20	SENT_38	[p1l779t2932r862b2961],
13	of	IN	O	of	_	0	SENT_38	[p1l875t2932r911b2961],
14	the	DT	O	the	det	16	SENT_38	[p1l920t2932r970b2961],
15	beta-tubulin	NN	O	beta-tubulin	nn	16	SENT_38	[p1l982t2932r1181b2961],
16	subunit	NN	O	subunit	prep_of	12	SENT_38	[p1l1195t2932r1315b2961],
17	of	IN	O	of	_	0	SENT_38	[p1l1328t2932r1363b2961],
18	tubulin	NN	O	tubulin	nn	19	SENT_38	[p1l1373t2932r1489b2961],
19	polymers	NNS	O	polymer	prep_of	16	SENT_38	[p1l1501t2932r1654b2970],
20	(	VBP	O	(	rcmod	6	SENT_38	[p1l1669t2932r1723b2968],
21	3	CD	NUMBER	3	num	22	SENT_38	[p1l1669t2932r1723b2968],
22	)	NN	O	)	dobj	20	SENT_38	[p1l1669t2932r1723b2968],
23	.	.	O	.	_	0	SENT_38	[p1l1669t2932r1723b2968],

1	Unlike	IN	O	unlike	_	0	SENT_39	[p1l1737t2932r1848b2961],
2	the	DT	O	the	det	4	SENT_39	[p1l549t2982r598b3011],
3	vinca	NN	O	vinca	nn	4	SENT_39	[p1l610t2982r699b3011],
4	alkaloids	NNS	O	alkaloid	prep_unlike	7	SENT_39	[p1l711t2982r867b3016],
5	,	,	O	,	_	0	SENT_39	[p1l711t2982r867b3016],
6	which	WDT	O	which	nsubj	18	SENT_39	[p1l881t2982r981b3011],
7	prevent	VBP	O	prevent	_	0	SENT_39	[p1l992t2986r1116b3019],
8	microtubule	NN	O	microtubule	nn	9	SENT_39	[p1l1127t2982r1326b3011],
9	assembly	NN	O	assembly	dobj	7	SENT_39	[p1l1338t2982r1499b3019],
10	,	,	O	,	_	0	SENT_39	[p1l1338t2982r1499b3019],
11	the	DT	O	the	det	13	SENT_39	[p1l1512t2982r1561b3011],
12	taxanes	JJ	O	taxanes	amod	13	SENT_39	[p1l1573t2986r1695b3011],
13	decrease	NN	O	decrease	appos	9	SENT_39	[p1l1708t2982r1848b3011],
14	the	DT	O	the	det	16	SENT_39	[p1l549t3032r598b3061],
15	lag	NN	O	lag	nn	16	SENT_39	[p1l616t3032r665b3070],
16	time	NN	O	time	dep	13	SENT_39	[p1l683t3032r755b3061],
17	and	CC	O	and	_	0	SENT_39	[p1l773t3032r832b3061],
18	shift	VB	O	shift	conj_and	7	SENT_39	[p1l850t3032r922b3061],
19	the	DT	O	the	det	21	SENT_39	[p1l938t3032r988b3061],
20	dynamic	JJ	O	dynamic	amod	21	SENT_39	[p1l1006t3032r1146b3069],
21	equilibrium	NN	O	equilibrium	dobj	18	SENT_39	[p1l1165t3032r1357b3070],
22	between	IN	O	between	_	0	SENT_39	[p1l1373t3032r1510b3061],
23	tubulin	NN	O	tubulin	nn	24	SENT_39	[p1l1527t3032r1644b3061],
24	dimers	NNS	O	dimer	prep_between	21	SENT_39	[p1l1661t3032r1772b3061],
25	and	CC	O	and	_	0	SENT_39	[p1l1791t3032r1849b3061],
26	microtubules	NNS	O	microtubule	prep_between	21	SENT_39	[p1l549t3082r763b3111],
27	toward	IN	O	toward	_	0	SENT_39	[p1l788t3082r903b3111],
28	polymerization	NN	O	polymerization	prep_toward	18	SENT_39	[p1l926t3082r1185b3120],
29	,	,	O	,	_	0	SENT_39	[p1l926t3082r1185b3120],
30	thereby	RB	O	thereby	advmod	31	SENT_39	[p1l1210t3082r1332b3120],
31	stabilizing	VBG	O	stabilize	partmod	18	SENT_39	[p1l1358t3082r1528b3120],
32	microtubules	NNS	O	microtubule	nsubj	35	SENT_39	[p1l1552t3082r1766b3111],
33	(	CD	NUMBER	(	number	34	SENT_39	[p1l1792t3082r1846b3118],
34	4	CD	NUMBER	4	num	35	SENT_39	[p1l1792t3082r1846b3118],
35	)	NN	O	)	xcomp	31	SENT_39	[p1l1792t3082r1846b3118],
36	.	.	O	.	_	0	SENT_39	[p1l1792t3082r1846b3118],

1	These	DT	O	these	det	2	SENT_40	[p1l549t3132r647b3161],
2	effects	NNS	O	effect	nsubj	3	SENT_40	[p1l662t3132r770b3161],
3	occur	VBP	O	occur	_	0	SENT_40	[p1l787t3141r878b3161],
4	even	RB	O	even	advmod	3	SENT_40	[p1l892t3141r969b3161],
5	in	IN	O	in	_	0	SENT_40	[p1l983t3132r1014b3160],
6	the	DT	O	the	det	7	SENT_40	[p1l1029t3132r1079b3161],
7	absence	NN	O	absence	prep_in	3	SENT_40	[p1l1095t3132r1223b3161],
8	of	IN	O	of	_	0	SENT_40	[p1l1239t3132r1275b3161],
9	GTP	NN	O	gtp	prep_of	7	SENT_40	[p1l1287t3132r1376b3161],
10	-	:	O	-	_	0	SENT_40	[p1l1287t3132r1376b3161],
11	and	CC	O	and	_	0	SENT_40	[p1l1393t3132r1451b3161],
12	microtubule	JJ	O	microtubule	amod	13	SENT_40	[p1l1466t3132r1849b3161],
13	—	NN	O	—	nsubj	14	SENT_40	[p1l1466t3132r1849b3161],
14	associated	VBN	O	associate	conj_and	3	SENT_40	[p1l1466t3132r1849b3161],
15	proteins	NNS	O	protein	dobj	14	SENT_40	[p1l549t3182r690b3220],
16	,	,	O	,	_	0	SENT_40	[p1l549t3182r690b3220],
17	which	WDT	O	which	nsubj	20	SENT_40	[p1l704t3182r803b3211],
18	are	VBP	O	be	cop	20	SENT_40	[p1l816t3191r864b3211],
19	usually	RB	O	usually	advmod	20	SENT_40	[p1l875t3182r993b3219],
20	essential	JJ	O	essential	rcmod	15	SENT_40	[p1l1006t3182r1147b3211],
21	for	IN	O	for	_	0	SENT_40	[p1l1158t3182r1206b3211],
22	this	DT	O	this	det	23	SENT_40	[p1l1217t3182r1275b3211],
23	function	NN	O	function	prep_for	20	SENT_40	[p1l1287t3182r1432b3211],
24	.	.	O	.	_	0	SENT_40	[p1l1287t3182r1432b3211],

1	Docetaxel	NNP	O	Docetaxel	nsubj	2	SENT_41	[p1l1445t3182r1612b3211],
2	has	VBZ	O	have	_	0	SENT_41	[p1l1623t3182r1676b3211],
3	a	DT	O	a	det	8	SENT_41	[p1l1690t3191r1707b3211],
4	1.9	CD	NUMBER	1.9	number	5	SENT_41	[p1l1721t3182r1849b3211],
5	—	CD	NUMBER	—	num	6	SENT_41	[p1l1721t3182r1849b3211],
6	fold	NN	O	fold	npadvmod	7	SENT_41	[p1l1721t3182r1849b3211],
7	higher	JJR	O	higher	amod	8	SENT_41	[p1l549t3293r655b3331],
8	affinity	NN	O	affinity	dobj	2	SENT_41	[p1l666t3293r786b3331],
9	for	IN	O	for	_	0	SENT_41	[p1l798t3293r846b3322],
10	the	DT	O	the	det	11	SENT_41	[p1l855t3293r904b3322],
11	site	NN	O	site	prep_for	2	SENT_41	[p1l917t3293r972b3322],
12	than	IN	O	than	mark	14	SENT_41	[p1l984t3293r1054b3322],
13	paclitaxel	NN	O	paclitaxel	nsubj	14	SENT_41	[p1l1064t3293r1224b3331],
14	does	VBZ	O	do	advcl	2	SENT_41	[p1l1236t3293r1310b3322],
15	and	CC	O	and	_	0	SENT_41	[p1l1321t3293r1380b3322],
16	it	PRP	O	it	nsubj	17	SENT_41	[p1l1390t3293r1412b3322],
17	induces	VBZ	O	induce	conj_and	2	SENT_41	[p1l1423t3293r1548b3322],
18	tubulin	NN	O	tubulin	nn	19	SENT_41	[p1l1559t3293r1675b3322],
19	polymerization	NN	O	polymerization	dobj	17	SENT_41	[p1l1686t3293r1847b3331, p1l550t3343r649b3372],
20	at	IN	O	at	_	0	SENT_41	[p1l662t3348r690b3372],
21	a	DT	O	a	det	22	SENT_41	[p1l702t3352r719b3372],
22	2	CD	NUMBER	2	prep_at	17	SENT_41	[p1l731t3343r862b3372],
23	.	.	O	.	_	0	SENT_41	[p1l731t3343r862b3372],

1	l	NN	O	l	nn	3	SENT_42	[p1l731t3343r862b3372],
2	—	CD	NUMBER	—	num	3	SENT_42	[p1l731t3343r862b3372],
3	fold	NN	O	fold	_	0	SENT_42	[p1l731t3343r862b3372],
4	lower	JJR	O	lower	amod	7	SENT_42	[p1l873t3343r967b3372],
5	critical	JJ	O	critical	amod	7	SENT_42	[p1l978t3343r1091b3372],
6	tubulin	NN	O	tubulin	nn	7	SENT_42	[p1l1103t3343r1219b3372],
7	concentration	NN	O	concentration	dep	3	SENT_42	[p1l1231t3343r1455b3372],
8	(	CD	NUMBER	(	number	9	SENT_42	[p1l1468t3343r1522b3379],
9	5	CD	NUMBER	5	num	10	SENT_42	[p1l1468t3343r1522b3379],
10	)	NN	O	)	dep	7	SENT_42	[p1l1468t3343r1522b3379],
11	.	.	O	.	_	0	SENT_42	[p1l1468t3343r1522b3379],

1	The	DT	O	the	det	3	SENT_43	[p1l1535t3343r1599b3372],
2	initial	JJ	O	initial	amod	3	SENT_43	[p1l1610t3343r1706b3372],
3	slope	NN	O	slope	nsubj	16	SENT_43	[p1l1718t3343r1803b3381],
4	of	IN	O	of	_	0	SENT_43	[p1l1816t3343r1851b3372],
5	the	DT	O	the	det	7	SENT_43	[p1l549t3393r599b3422],
6	assembly	NN	O	assembly	nn	7	SENT_43	[p1l616t3393r767b3431],
7	reaction	NN	O	reaction	prep_of	3	SENT_43	[p1l783t3393r916b3422],
8	and	CC	O	and	_	0	SENT_43	[p1l933t3393r991b3422],
9	the	DT	O	the	det	10	SENT_43	[p1l1007t3393r1056b3422],
10	amount	NN	O	amount	prep_of	3	SENT_43	[p1l1073t3397r1196b3422],
11	of	IN	O	of	_	0	SENT_43	[p1l1212t3393r1248b3422],
12	polymer	NN	O	polymer	prep_of	10	SENT_43	[p1l1260t3393r1399b3431],
13	formed	VBN	O	form	partmod	12	SENT_43	[p1l1414t3393r1533b3422],
14	is	VBZ	O	be	cop	16	SENT_43	[p1l1548t3393r1574b3422],
15	also	RB	O	also	advmod	16	SENT_43	[p1l1591t3393r1656b3422],
16	greater	JJR	O	greater	_	0	SENT_43	[p1l1672t3397r1787b3431],
17	for	IN	O	for	_	0	SENT_43	[p1l1801t3393r1849b3422],
18	docetaxel	NN	O	docetaxel	prep_for	16	SENT_43	[p1l550t3444r715b3473],
19	.	.	O	.	_	0	SENT_43	[p1l550t3444r715b3473],

1	In	IN	O	in	_	0	SENT_44	[p1l731t3444r764b3473],
2	addition	NN	O	addition	prep_in	7	SENT_44	[p1l779t3444r922b3478],
3	,	,	O	,	_	0	SENT_44	[p1l779t3444r922b3478],
4	docetaxel	NN	O	docetaxel	nsubj	7	SENT_44	[p1l938t3444r1094b3473],
5	is	VBZ	O	be	cop	7	SENT_44	[p1l1109t3444r1134b3473],
6	more	RBR	O	more	advmod	7	SENT_44	[p1l1149t3453r1233b3473],
7	potent	JJ	O	potent	_	0	SENT_44	[p1l1247t3448r1350b3482],
8	than	IN	O	than	mark	10	SENT_44	[p1l1364t3444r1434b3473],
9	paclitaxel	NN	O	paclitaxel	nsubj	10	SENT_44	[p1l1448t3444r1608b3482],
10	is	VBZ	O	be	dep	7	SENT_44	[p1l1621t3444r1647b3473],
11	at	IN	O	at	_	0	SENT_44	[p1l1663t3448r1691b3473],
12	inducing	VBG	O	induce	prepc_at	10	SENT_44	[p1l1705t3444r1848b3482],
13	cytotoxicity	NN	O	cytotoxicity	dobj	12	SENT_44	[p1l550t3493r746b3531],
14	in	FW	O	in	nn	15	SENT_44	[p1l764t3493r796b3522],
15	vitro	FW	O	vitro	advmod	12	SENT_44	[p1l814t3493r891b3522],
16	and	CC	O	and	_	0	SENT_44	[p1l911t3493r969b3522],
17	in	IN	O	in	mark	20	SENT_44	[p1l987t3493r1019b3522],
18	tumor	NN	O	tumor	nn	19	SENT_44	[p1l1037t3498r1136b3522],
19	xenografts	NNS	O	xenograft	nsubj	20	SENT_44	[p1l1153t3493r1326b3531],
20	(	VBP	O	(	conj_and	10	SENT_44	[p1l1347t3493r1401b3529],
21	6	CD	NUMBER	6	num	22	SENT_44	[p1l1347t3493r1401b3529],
22	)	NN	O	)	dobj	20	SENT_44	[p1l1347t3493r1401b3529],
23	.	.	O	.	_	0	SENT_44	[p1l1347t3493r1401b3529],

1	These	DT	O	these	det	2	SENT_45	[p1l1421t3493r1519b3522],
2	differences	NNS	O	difference	nsubj	5	SENT_45	[p1l1537t3493r1719b3522],
3	do	VBP	O	do	aux	5	SENT_45	[p1l1738t3493r1778b3522],
4	not	RB	O	not	neg	5	SENT_45	[p1l1797t3498r1849b3522],
5	imply	VB	O	imply	_	0	SENT_45	[p1l549t3542r645b3580],
6	that	IN	O	that	complm	8	SENT_45	[p1l661t3542r722b3571],
7	docetaxel	NN	O	docetaxel	nsubj	8	SENT_45	[p1l737t3542r895b3571],
8	has	VBZ	O	have	ccomp	5	SENT_45	[p1l909t3542r963b3571],
9	a	DT	O	a	det	12	SENT_45	[p1l980t3552r997b3571],
10	greater	JJR	O	greater	amod	12	SENT_45	[p1l1012t3547r1126b3580],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_45	[p1l1141t3542r1323b3580],
12	index	NN	O	index	dobj	8	SENT_45	[p1l1338t3542r1429b3571],
13	because	IN	O	because	mark	18	SENT_45	[p1l1444t3543r1575b3571],
14	greater	JJR	O	greater	amod	15	SENT_45	[p1l1590t3547r1704b3580],
15	potency	NN	O	potency	nsubj	18	SENT_45	[p1l1718t3547r1848b3580],
16	may	MD	O	may	aux	18	SENT_45	[p1l549t3602r619b3630],
17	also	RB	O	also	advmod	18	SENT_45	[p1l633t3593r697b3622],
18	portend	VB	O	portend	dep	12	SENT_45	[p1l711t3593r837b3630],
19	greater	JJR	O	greater	amod	20	SENT_45	[p1l850t3597r964b3630],
20	toxicity	NN	O	toxicity	dobj	18	SENT_45	[p1l976t3592r1111b3630],
21	,	,	O	,	_	0	SENT_45	[p1l976t3592r1111b3630],
22	and	CC	O	and	_	0	SENT_45	[p1l1126t3593r1184b3622],
23	pharmacologic	JJ	O	pharmacologic	amod	24	SENT_45	[p1l1196t3592r1441b3630],
24	differences	NNS	O	difference	conj_and	12	SENT_45	[p1l1455t3592r1636b3622],
25	between	IN	O	between	_	0	SENT_45	[p1l1649t3593r1786b3622],
26	the	DT	O	the	prep_between	24	SENT_45	[p1l1799t3593r1848b3622],

1	Annu	NNP	PERSON	Annu	_	0	SENT_46	[p2l309t28r332b108],
2	.	.	O	.	_	0	SENT_46	[p2l309t28r332b108],

1	w.annualreviews.org	NN	O	w.annualreviews.org	nn	3	SENT_47	[p2l309t3527r339b3803],
2	personal	JJ	O	personal	amod	3	SENT_47	[p2l342t3690r373b3802],
3	use	NN	O	use	nsubj	4	SENT_47	[p2l350t3637r366b3681],
4	only	RB	O	only	_	0	SENT_47	[p2l342t3563r373b3628],
5	.	.	O	.	_	0	SENT_47	[p2l342t3563r373b3628],

1	by	IN	O	by	dep	3	SENT_48	[p2l342t18r373b74],
2	[	CD	NUMBER	[	pobj	1	SENT_48	[p2l342t18r373b74],
3	Annu	NNP	PERSON	Annu	_	0	SENT_48	[p2l310t2255r333b2335],
4	.	.	O	.	_	0	SENT_48	[p2l310t2255r333b2335],

1	Rev.	NNP	O	Rev.	nn	2	SENT_49	[p2l310t2185r333b2244],
2	M	NNP	O	M	nsubj	3	SENT_49	[p2l310t2137r333b2166],
3	ed	VBD	O	ed	_	0	SENT_49	[p2l310t2085r333b2121],
4	.	.	O	.	_	0	SENT_49	[p2l310t2085r333b2121],

1	1997482353-374	CD	NUMBER	1997482353-374	_	0	SENT_50	[p2l310t1839r334b2071],
2	.	.	O	.	_	0	SENT_50	[p2l310t1839r334b2071],

1	Downloaded	VBN	O	download	_	0	SENT_51	[p2l310t1659r333b1829],
2	from	IN	O	from	_	0	SENT_51	[p2l310t1585r333b1650],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_51	[p2l310t1251r340b1576],
4	by	IN	O	by	_	0	SENT_51	[p2l343t2269r374b2301],
5	Unive	NNP	PERSON	Unive	nn	7	SENT_51	[p2l343t2179r367b2259],
6	rsi	NN	O	rsus	nn	7	SENT_51	[p2l343t2137r367b2170],
7	ty	NN	O	ty	prep_by	1	SENT_51	[p2l347t2097r374b2122],
8	of	IN	O	of	_	0	SENT_51	[p2l343t2059r367b2088],
9	Wisconsin	NNP	LOCATION	Wisconsin	prep_of	7	SENT_51	[p2l343t1912r367b2052],
10	-	:	O	-	_	0	SENT_51	[p2l357t1893r360b1902],
11	Madison	NNP	O	Madison	dep	1	SENT_51	[p2l343t1767r367b1884],
12	on	IN	O	on	_	0	SENT_51	[p2l351t1726r367b1758],
13	01/05/14	NN	DATE	01/05/14	prep_on	11	SENT_51	[p2l343t1599r367b1716],
14	For	IN	O	for	_	0	SENT_51	[p2l344t1535r367b1582],
15	personal	JJ	O	personal	amod	16	SENT_51	[p2l343t1415r374b1527],
16	use	NN	O	use	prep_for	21	SENT_51	[p2l351t1362r367b1406],
17	only	RB	O	only	advmod	18	SENT_51	[p2l343t1294r374b1352],
18	agents	NNS	O	agent	nsubjpass	21	SENT_51	[p2l550t23r653b56],
19	must	MD	O	must	aux	21	SENT_51	[p2l665t23r746b48],
20	be	VB	O	be	auxpass	21	SENT_51	[p2l756t18r794b48],
21	considered	VBN	O	consider	rcmod	13	SENT_51	[p2l806t18r992b48],
22	.	.	O	.	_	0	SENT_51	[p2l806t18r992b48],

1	The	DT	O	the	det	2	SENT_52	[p2l599t74r662b103],
2	taxanes	NNS	O	taxane	nsubj	3	SENT_52	[p2l675t78r798b103],
3	inhibit	VBP	O	inhibit	_	0	SENT_52	[p2l812t74r919b103],
4	cell	NN	O	cell	nn	5	SENT_52	[p2l932t74r991b103],
5	proliferation	NN	O	proliferation	dobj	3	SENT_52	[p2l1003t74r1209b111],
6	by	IN	O	by	_	0	SENT_52	[p2l1222t74r1262b111],
7	inducing	VBG	O	induce	prepc_by	3	SENT_52	[p2l1276t74r1419b111],
8	a	DT	O	a	det	11	SENT_52	[p2l1433t83r1450b103],
9	sustained	JJ	O	sustained	amod	11	SENT_52	[p2l1464t74r1616b103],
10	mitotic	JJ	O	mitotic	amod	11	SENT_52	[p2l1628t74r1744b103],
11	block	NN	O	block	dobj	7	SENT_52	[p2l1757t74r1849b103],
12	at	IN	O	at	_	0	SENT_52	[p2l550t128r579b152],
13	the	DT	O	the	det	15	SENT_52	[p2l594t123r644b152],
14	metaphase/anaphase	NN	O	metaphase/anaphase	nn	15	SENT_52	[p2l660t123r997b161],
15	boundary	NN	O	boundary	prep_at	11	SENT_52	[p2l1013t123r1178b161],
16	,	,	O	,	_	0	SENT_52	[p2l1013t123r1178b161],
17	as	RB	O	as	_	0	SENT_52	[p2l1197t132r1228b152],
18	well	RB	O	well	_	0	SENT_52	[p2l1246t123r1316b152],
19	as	IN	O	as	_	0	SENT_52	[p2l1334t132r1365b152],
20	formation	NN	O	formation	dobj	7	SENT_52	[p2l1383t123r1545b152],
21	of	IN	O	of	_	0	SENT_52	[p2l1562t123r1598b152],
22	an	DT	O	a	det	25	SENT_52	[p2l1612t132r1650b152],
23	incomplete	JJ	O	incomplete	amod	25	SENT_52	[p2l1666t123r1849b161],
24	metaphase	NN	O	metaphase	nn	25	SENT_52	[p2l549t173r723b211],
25	plate	NN	O	plate	prep_of	20	SENT_52	[p2l742t173r821b211],
26	of	IN	O	of	_	0	SENT_52	[p2l841t173r877b203],
27	chromosomes	NNS	O	chromosome	prep_of	25	SENT_52	[p2l894t173r1122b203],
28	and	CC	O	and	_	0	SENT_52	[p2l1143t173r1201b203],
29	an	DT	O	a	det	31	SENT_52	[p2l1221t182r1258b203],
30	abnormal	JJ	O	abnormal	amod	31	SENT_52	[p2l1278t173r1433b203],
31	organization	NN	O	organization	prep_of	20	SENT_52	[p2l1452t173r1658b211],
32	of	IN	O	of	_	0	SENT_52	[p2l1677t173r1713b203],
33	spindle	NN	O	spindle	nn	34	SENT_52	[p2l1731t173r1848b211],
34	microtubules	NNS	O	microtubule	prep_of	31	SENT_52	[p2l549t223r773b258],
35	,	,	O	,	_	0	SENT_52	[p2l549t223r773b258],
36	which	WDT	O	which	nsubj	37	SENT_52	[p2l790t223r891b253],
37	occur	VBP	O	occur	rcmod	34	SENT_52	[p2l906t232r997b253],
38	at	IN	O	at	_	0	SENT_52	[p2l1012t228r1041b253],
39	much	RB	O	much	advmod	40	SENT_52	[p2l1056t223r1147b253],
40	lower	JJR	O	lower	amod	42	SENT_52	[p2l1162t223r1256b253],
41	drug	NN	O	drug	nn	42	SENT_52	[p2l1271t223r1345b261],
42	concentrations	NNS	O	concentration	prep_at	37	SENT_52	[p2l1361t223r1600b253],
43	than	IN	O	than	_	0	SENT_52	[p2l1616t223r1687b253],
44	those	DT	O	those	prep_than	37	SENT_52	[p2l1702t223r1788b253],
45	required	VBN	O	require	partmod	44	SENT_52	[p2l1803t232r1847b253, p2l550t273r654b311],
46	to	TO	O	to	aux	47	SENT_52	[p2l666t278r697b302],
47	increase	VB	O	increase	xcomp	45	SENT_52	[p2l709t273r844b302],
48	microtubule	JJ	O	microtubule	amod	52	SENT_52	[p2l855t273r1054b302],
49	mass	NN	O	mass	nn	52	SENT_52	[p2l1066t282r1147b302],
50	(	NN	O	(	nn	52	SENT_52	[p2l1161t273r1215b309],
51	7	CD	NUMBER	7	num	52	SENT_52	[p2l1161t273r1215b309],
52	)	NN	O	)	dobj	47	SENT_52	[p2l1161t273r1215b309],
53	.	.	O	.	_	0	SENT_52	[p2l1161t273r1215b309],

1	Aberrant	JJ	O	aberrant	amod	3	SENT_53	[p2l1229t273r1376b302],
2	mitotic	JJ	O	mitotic	amod	3	SENT_53	[p2l1387t273r1503b302],
3	spindles	NNS	O	spindle	nsubj	13	SENT_53	[p2l1516t273r1649b311],
4	and	CC	O	and	_	0	SENT_53	[p2l1662t273r1721b302],
5	mitotic	JJ	O	mitotic	amod	6	SENT_53	[p2l1732t273r1848b302],
6	block	NN	O	block	conj_and	3	SENT_53	[p2l549t323r641b353],
7	due	JJ	O	due	_	0	SENT_53	[p2l660t323r719b353],
8	to	TO	O	to	_	0	SENT_53	[p2l739t328r769b353],
9	stabilization	NN	O	stabilization	prep_due_to	6	SENT_53	[p2l791t323r991b353],
10	of	IN	O	of	_	0	SENT_53	[p2l1011t323r1047b353],
11	microtubule	NN	O	microtubule	nn	12	SENT_53	[p2l1064t323r1263b353],
12	dynamics	NNS	O	dynamics	prep_of	9	SENT_53	[p2l1283t323r1439b361],
13	results	VBZ	O	result	_	0	SENT_53	[p2l1460t323r1567b353],
14	from	IN	O	from	_	0	SENT_53	[p2l1587t323r1667b353],
15	inhibitory	JJ	O	inhibitory	amod	17	SENT_53	[p2l1686t323r1848b361],
16	drug	NN	O	drug	nn	17	SENT_53	[p2l550t373r624b411],
17	effects	NNS	O	effect	prep_from	13	SENT_53	[p2l639t373r747b403],
18	on	IN	O	on	_	0	SENT_53	[p2l763t382r803b403],
19	intrinsic	JJ	O	intrinsic	amod	21	SENT_53	[p2l818t373r952b403],
20	microtubule	NN	O	microtubule	nn	21	SENT_53	[p2l968t373r1167b403],
21	processes	NNS	O	process	prep_on	17	SENT_53	[p2l1181t382r1338b411],
22	involving	VBG	O	involve	_	0	SENT_53	[p2l1353t373r1511b411],
23	the	DT	O	the	det	24	SENT_53	[p2l1526t373r1575b403],
24	equilibrium	NN	O	equilibrium	prep_involving	21	SENT_53	[p2l1590t373r1783b411],
25	between	IN	O	between	_	0	SENT_53	[p2l1796t373r1847b403, p2l549t428r647b452],
26	tubular	JJ	O	tubular	amod	27	SENT_53	[p2l658t423r775b452],
27	dimers	NNS	O	dimer	prep_between	24	SENT_53	[p2l786t423r896b452],
28	and	CC	O	and	_	0	SENT_53	[p2l909t423r967b452],
29	microtuble	JJ	O	microtuble	amod	30	SENT_53	[p2l978t423r1156b452],
30	polymers	NNS	O	polymer	prep_involving	21	SENT_53	[p2l1166t423r1319b461],
31	such	JJ	O	such	_	0	SENT_53	[p2l1333t423r1407b452],
32	as	IN	O	as	_	0	SENT_53	[p2l1419t432r1450b452],
33	dynamic	JJ	O	dynamic	amod	34	SENT_53	[p2l1462t423r1603b461],
34	instability	NN	O	instability	prep_such_as	30	SENT_53	[p2l1614t423r1778b461],
35	and	CC	O	and	_	0	SENT_53	[p2l1790t423r1849b452],
36	treadmilling	NN	O	treadmilling	conj_and	34	SENT_53	[p2l549t473r759b511],
37	.	.	O	.	_	0	SENT_53	[p2l549t473r759b511],

1	After	IN	O	after	_	0	SENT_54	[p2l774t473r861b503],
2	the	DT	O	the	det	3	SENT_54	[p2l873t473r923b503],
3	disruption	NN	O	disruption	nsubj	9	SENT_54	[p2l936t473r1103b511],
4	of	IN	O	of	_	0	SENT_54	[p2l1117t473r1152b503],
5	microtubules	NNS	O	microtubule	prep_of	3	SENT_54	[p2l1162t473r1387b508],
6	,	,	O	,	_	0	SENT_54	[p2l1162t473r1387b508],
7	particularly	RB	O	particularly	advmod	5	SENT_54	[p2l1400t473r1590b511],
8	those	DT	O	those	dep	5	SENT_54	[p2l1603t473r1689b503],
9	comprising	VBG	O	comprise	prepc_after	25	SENT_54	[p2l1703t473r1847b511, p2l549t523r601b561],
10	the	DT	O	the	det	13	SENT_54	[p2l613t523r662b553],
11	mitotic	JJ	O	mitotic	amod	13	SENT_54	[p2l672t523r788b553],
12	spindle	NN	O	spindle	nn	13	SENT_54	[p2l802t523r919b561],
13	apparatus	NN	O	apparatus	dobj	9	SENT_54	[p2l930t528r1096b561],
14	,	,	O	,	_	0	SENT_54	[p2l930t528r1096b561],
15	the	DT	O	the	det	17	SENT_54	[p2l1108t523r1157b553],
16	precise	JJ	O	precise	amod	17	SENT_54	[p2l1168t523r1284b561],
17	means	NNS	O	means	nsubj	25	SENT_54	[p2l1295t532r1399b553],
18	by	IN	O	by	_	0	SENT_54	[p2l1410t523r1451b561],
19	which	WDT	O	which	rel	22	SENT_54	[p2l1462t523r1562b553],
20	cell	NN	O	cell	nn	21	SENT_54	[p2l1573t523r1631b553],
21	death	NN	O	death	nsubj	22	SENT_54	[p2l1643t523r1731b553],
22	occurs	VBZ	O	occur	rcmod	17	SENT_54	[p2l1742t532r1848b553],
23	are	VBP	O	be	cop	25	SENT_54	[p2l550t582r598b602],
24	not	RB	O	not	neg	25	SENT_54	[p2l610t578r662b602],
25	clear	JJ	O	clear	_	0	SENT_54	[p2l673t573r760b602],
26	.	.	O	.	_	0	SENT_54	[p2l673t573r760b602],

1	However	RB	O	however	advmod	18	SENT_55	[p2l773t574r932b608],
2	,	,	O	,	_	0	SENT_55	[p2l773t574r932b608],
3	morphologic	JJ	O	morphologic	amod	4	SENT_55	[p2l945t573r1155b611],
4	features	NNS	O	feature	nsubjpass	18	SENT_55	[p2l1167t573r1296b602],
5	and	CC	O	and	_	0	SENT_55	[p2l1308t573r1366b602],
6	DNA	NN	MISC	dna	nn	8	SENT_55	[p2l1377t573r1466b602],
7	fragmentation	NN	O	fragmentation	nn	8	SENT_55	[p2l1477t573r1708b611],
8	patterns	NNS	O	pattern	conj_and	4	SENT_55	[p2l1718t577r1848b611],
9	characteristic	JJ	O	characteristic	amod	4	SENT_55	[p2l550t623r768b653],
10	of	IN	O	of	_	0	SENT_55	[p2l780t623r816b653],
11	programmed	VBN	O	program	amod	13	SENT_55	[p2l824t623r1036b661],
12	cell	NN	O	cell	nn	13	SENT_55	[p2l1047t623r1105b653],
13	death	NN	O	death	prep_of	9	SENT_55	[p2l1117t623r1206b653],
14	or	CC	O	or	_	0	SENT_55	[p2l1217t632r1251b653],
15	apoptosis	NN	O	apoptosis	conj_or	13	SENT_55	[p2l1262t623r1416b661],
16	have	VBP	O	have	aux	18	SENT_55	[p2l1428t623r1505b653],
17	been	VBN	O	be	auxpass	18	SENT_55	[p2l1516t623r1594b653],
18	documented	VBN	O	document	_	0	SENT_55	[p2l1606t623r1807b653],
19	in	IN	O	in	_	0	SENT_55	[p2l1818t623r1849b652],
20	THE	DT	O	the	det	21	SENT_55	[p2l1492t681r1564b707],
21	TAXANES	NN	O	taxane	prep_in	18	SENT_55	[p2l1574t680r1746b707],
22	355	CD	NUMBER	355	num	21	SENT_55	[p2l1795t680r1848b707],

1	tumor	NN	O	tumor	nn	2	SENT_56	[p2l550t770r649b795],
2	cells	NNS	O	cell	_	0	SENT_56	[p2l661t765r734b795],
3	after	IN	O	after	_	0	SENT_56	[p2l748t765r823b795],
4	taxane	NN	O	taxane	nn	6	SENT_56	[p2l834t770r941b795],
5	treatment	NN	O	treatment	nn	6	SENT_56	[p2l953t770r1109b795],
6	(	NN	O	(	prep_after	2	SENT_56	[p2l1122t766r1176b801],
7	7	CD	NUMBER	7	num	8	SENT_56	[p2l1122t766r1176b801],
8	)	NN	O	)	dep	6	SENT_56	[p2l1122t766r1176b801],
9	.	.	O	.	_	0	SENT_56	[p2l1122t766r1176b801],

1	These	DT	O	these	det	3	SENT_57	[p2l1190t765r1288b795],
2	apoptotic	JJ	O	apoptotic	amod	3	SENT_57	[p2l1301t765r1453b803],
3	effects	NNS	O	effect	nsubjpass	6	SENT_57	[p2l1466t765r1574b795],
4	have	VBP	O	have	aux	6	SENT_57	[p2l1587t765r1664b795],
5	been	VBN	O	be	auxpass	6	SENT_57	[p2l1676t765r1753b795],
6	associated	VBN	O	associate	ccomp	33	SENT_57	[p2l1766t774r1848b795, p2l551t815r648b845],
7	with	IN	O	with	_	0	SENT_57	[p2l664t815r737b845],
8	phosphorylation	NN	O	phosphorylation	prep_with	6	SENT_57	[p2l753t815r1022b853],
9	of	IN	O	of	_	0	SENT_57	[p2l1038t815r1074b845],
10	bcl	NN	O	bcl	nn	11	SENT_57	[p2l1087t815r1180b850],
11	—	NN	O	—	prep_of	8	SENT_57	[p2l1087t815r1180b850],
12	2	CD	NUMBER	2	num	11	SENT_57	[p2l1087t815r1180b850],
13	,	,	O	,	_	0	SENT_57	[p2l1087t815r1180b850],
14	an	DT	O	a	det	16	SENT_57	[p2l1198t824r1235b845],
15	antiapoptotic	JJ	O	antiapoptotic	amod	16	SENT_57	[p2l1252t815r1466b853],
16	protein	NN	O	protein	nsubj	33	SENT_57	[p2l1482t815r1607b853],
17	,	,	O	,	_	0	SENT_57	[p2l1482t815r1607b853],
18	resulting	VBG	O	result	partmod	33	SENT_57	[p2l1624t815r1768b853],
19	in	IN	O	in	_	0	SENT_57	[p2l1785t815r1816b844],
20	a	DT	O	a	det	21	SENT_57	[p2l1833t824r1850b845],
21	disruption	NN	O	disruption	prep_in	18	SENT_57	[p2l551t865r717b903],
22	of	IN	O	of	_	0	SENT_57	[p2l729t865r765b894],
23	the	DT	O	the	det	24	SENT_57	[p2l774t865r823b894],
24	balance	NN	O	balance	prep_of	21	SENT_57	[p2l834t865r960b894],
25	between	IN	O	between	_	0	SENT_57	[p2l970t865r1108b894],
26	the	DT	O	the	det	27	SENT_57	[p2l1119t865r1168b894],
27	dimerization	NN	O	dimerization	prep_between	24	SENT_57	[p2l1181t865r1388b894],
28	of	IN	O	of	_	0	SENT_57	[p2l1399t865r1435b894],
29	bcl	NN	O	bcl	nn	32	SENT_57	[p2l1444t865r1494b894],
30	and	CC	O	and	_	0	SENT_57	[p2l1505t865r1563b894],
31	bax	NN	O	bax	nn	32	SENT_57	[p2l1575t865r1634b894],
32	proteins	NNS	O	protein	prep_of	27	SENT_57	[p2l1644t865r1776b903],
33	(	VBP	O	(	_	0	SENT_57	[p2l1789t865r1844b901],
34	8	CD	NUMBER	8	number	35	SENT_57	[p2l1789t865r1844b901],
35	)	CD	NUMBER	)	dobj	33	SENT_57	[p2l1789t865r1844b901],
36	.	.	O	.	_	0	SENT_57	[p2l1789t865r1844b901],

1	Both	DT	O	both	preconj	2	SENT_58	[p2l600t915r680b945],
2	paclitaxel	NN	O	paclitaxel	nsubjpass	8	SENT_58	[p2l695t915r855b953],
3	and	CC	O	and	_	0	SENT_58	[p2l871t915r929b945],
4	docetaxel	NN	O	docetaxel	conj_and	2	SENT_58	[p2l944t915r1102b945],
5	have	VBP	O	have	aux	8	SENT_58	[p2l1116t915r1194b945],
6	also	RB	O	also	advmod	8	SENT_58	[p2l1210t915r1274b945],
7	been	VBN	O	be	auxpass	8	SENT_58	[p2l1290t915r1367b945],
8	shown	VBN	O	show	_	0	SENT_58	[p2l1384t915r1489b945],
9	to	TO	O	to	aux	10	SENT_58	[p2l1505t920r1536b945],
10	enhance	VB	O	enhance	xcomp	8	SENT_58	[p2l1552t915r1686b945],
11	the	DT	O	the	det	13	SENT_58	[p2l1701t915r1751b945],
12	cytotoxic	JJ	O	cytotoxic	amod	13	SENT_58	[p2l1766t920r1849b953, p2l550t965r631b995],
13	effects	NNS	O	effect	dobj	10	SENT_58	[p2l648t965r756b995],
14	of	IN	O	of	_	0	SENT_58	[p2l773t965r809b995],
15	ionizing	VBG	O	ionize	prepc_of	13	SENT_58	[p2l821t965r956b1003],
16	radiation	NN	O	radiation	dobj	15	SENT_58	[p2l971t965r1118b995],
17	in	FW	O	in	nn	18	SENT_58	[p2l1133t965r1164b994],
18	vitro	FW	O	vitro	advmod	15	SENT_58	[p2l1180t965r1257b995],
19	at	IN	O	at	_	0	SENT_58	[p2l1273t970r1302b995],
20	clinically	RB	O	clinically	advmod	21	SENT_58	[p2l1317t965r1470b1003],
21	achievable	JJ	O	achievable	amod	22	SENT_58	[p2l1486t965r1661b995],
22	concentrations	NNS	O	concentration	prep_at	15	SENT_58	[p2l1676t970r1848b995, p2l550t1015r639b1050],
23	,	,	O	,	_	0	SENT_58	[p2l1676t970r1848b995, p2l550t1015r639b1050],
24	which	WDT	O	which	nsubj	27	SENT_58	[p2l655t1015r755b1044],
25	may	MD	O	may	aux	27	SENT_58	[p2l770t1024r840b1053],
26	be	VB	O	be	cop	27	SENT_58	[p2l855t1015r893b1044],
27	due	JJ	O	due	rcmod	22	SENT_58	[p2l908t1015r966b1044],
28	to	TO	O	to	_	0	SENT_58	[p2l981t1019r1012b1044],
29	the	DT	O	the	det	30	SENT_58	[p2l1027t1015r1076b1044],
30	inhibition	NN	O	inhibition	prep_to	27	SENT_58	[p2l1091t1015r1251b1044],
31	of	IN	O	of	_	0	SENT_58	[p2l1266t1015r1302b1044],
32	cell	NN	O	cell	nn	35	SENT_58	[p2l1314t1015r1473b1053],
33	—	NN	O	—	nn	35	SENT_58	[p2l1314t1015r1473b1053],
34	cycle	NN	O	cycle	nn	35	SENT_58	[p2l1314t1015r1473b1053],
35	progression	NN	O	progression	prep_of	30	SENT_58	[p2l1487t1015r1679b1053],
36	in	IN	O	in	_	0	SENT_58	[p2l1694t1015r1725b1044],
37	the	DT	O	the	det	41	SENT_58	[p2l1740t1015r1789b1044],
38	G2	NN	O	g2	nn	41	SENT_58	[p2l1805t1015r1849b1056],
39	and	CC	O	and	_	0	SENT_58	[p2l551t1065r609b1095],
40	M	NN	O	m	nn	41	SENT_58	[p2l620t1066r656b1094],
41	phases	NNS	O	phase	prep_in	27	SENT_58	[p2l667t1065r786b1103],
42	,	,	O	,	_	0	SENT_58	[p2l667t1065r786b1103],
43	the	DT	O	the	det	46	SENT_58	[p2l799t1065r848b1095],
44	most	RBS	O	most	advmod	45	SENT_58	[p2l859t1070r939b1095],
45	radiosensitive	JJ	O	radiosensitive	amod	46	SENT_58	[p2l950t1065r1179b1095],
46	phases	NNS	O	phase	appos	41	SENT_58	[p2l1190t1065r1299b1103],
47	of	IN	O	of	_	0	SENT_58	[p2l1312t1065r1348b1095],
48	the	DT	O	the	det	50	SENT_58	[p2l1356t1065r1405b1095],
49	cell	NN	O	cell	nn	50	SENT_58	[p2l1417t1065r1476b1095],
50	cycle	NN	O	cycle	prep_of	46	SENT_58	[p2l1487t1065r1573b1103],
51	(	CD	NUMBER	(	number	52	SENT_58	[p2l1586t1065r1640b1101],
52	9	CD	NUMBER	9	num	53	SENT_58	[p2l1586t1065r1640b1101],
53	)	NN	O	)	dep	46	SENT_58	[p2l1586t1065r1640b1101],
54	.	.	O	.	_	0	SENT_58	[p2l1586t1065r1640b1101],

1	Two	CD	NUMBER	two	num	2	SENT_59	[p2l600t1116r674b1145],
2	mechanisms	NNS	O	mechanism	nsubjpass	13	SENT_59	[p2l690t1115r893b1145],
3	of	IN	O	of	_	0	SENT_59	[p2l910t1115r945b1145],
4	acquired	VBN	O	acquire	amod	5	SENT_59	[p2l959t1115r1100b1153],
5	resistance	NN	O	resistance	prep_of	2	SENT_59	[p2l1114t1115r1277b1145],
6	to	TO	O	to	_	0	SENT_59	[p2l1292t1120r1323b1145],
7	the	DT	O	the	det	8	SENT_59	[p2l1339t1115r1388b1145],
8	taxanes	NNS	O	taxane	prep_to	5	SENT_59	[p2l1403t1120r1525b1145],
9	in	FW	O	in	nn	10	SENT_59	[p2l1542t1115r1573b1144],
10	vitro	FW	O	vitro	dep	8	SENT_59	[p2l1588t1115r1665b1145],
11	have	VBP	O	have	aux	13	SENT_59	[p2l1680t1115r1757b1145],
12	been	VBN	O	be	auxpass	13	SENT_59	[p2l1772t1115r1850b1145],
13	described	VBN	O	describe	_	0	SENT_59	[p2l551t1165r716b1194],
14	.	.	O	.	_	0	SENT_59	[p2l551t1165r716b1194],

1	First	RB	ORDINAL	first	advmod	5	SENT_60	[p2l732t1165r816b1200],
2	,	,	O	,	_	0	SENT_60	[p2l732t1165r816b1200],
3	some	DT	O	some	det	4	SENT_60	[p2l832t1174r917b1194],
4	tumors	NNS	O	tumor	nsubj	5	SENT_60	[p2l932t1170r1045b1194],
5	contain	VBP	O	contain	_	0	SENT_60	[p2l1060t1165r1181b1194],
6	alpha	NN	O	alpha	dep	5	SENT_60	[p2l1196t1165r1296b1203],
7	—	NN	O	—	dep	6	SENT_60	[p2l1196t1165r1296b1203],
8	and	CC	O	and	_	0	SENT_60	[p2l1312t1165r1370b1194],
9	beta	NN	O	beta	dep	6	SENT_60	[p2l1383t1165r1591b1200],
10	—	CD	NUMBER	—	num	11	SENT_60	[p2l1383t1165r1591b1200],
11	tubulin	NN	O	tubulin	tmod	7	SENT_60	[p2l1383t1165r1591b1200],
12	,	,	O	,	_	0	SENT_60	[p2l1383t1165r1591b1200],
13	which	WDT	O	which	nsubj	14	SENT_60	[p2l1607t1165r1707b1194],
14	have	VBP	O	have	rcmod	11	SENT_60	[p2l1721t1165r1798b1194],
15	an	DT	O	a	det	17	SENT_60	[p2l1812t1174r1850b1194],
16	impaired	JJ	O	impaired	amod	17	SENT_60	[p2l550t1215r697b1253],
17	capacity	NN	O	capacity	dobj	14	SENT_60	[p2l708t1215r845b1253],
18	to	TO	O	to	aux	19	SENT_60	[p2l857t1220r887b1244],
19	polymerize	VB	O	polymerize	infmod	17	SENT_60	[p2l900t1215r1085b1253],
20	into	IN	O	into	_	0	SENT_60	[p2l1097t1215r1160b1244],
21	microtubules	NNS	O	microtubule	prep_into	19	SENT_60	[p2l1173t1215r1387b1244],
22	and	CC	O	and	_	0	SENT_60	[p2l1401t1215r1459b1244],
23	an	DT	O	a	det	26	SENT_60	[p2l1471t1224r1509b1244],
24	inherently	RB	O	inherently	advmod	25	SENT_60	[p2l1521t1215r1687b1253],
25	slow	JJ	O	slow	amod	26	SENT_60	[p2l1701t1215r1776b1244],
26	rate	NN	O	rate	prep_into	19	SENT_60	[p2l1788t1220r1849b1244],

1	A	DT	O	a	_	0	SENT_61	[p2l662t1341r717b1403],

1	uumz	NN	O	uumz	_	0	SENT_62	[p2l942t1563r968b1667],

1	B	NN	O	b	nn	2	SENT_63	[p2l675t2231r726b2291],
2	o	NN	O	o	_	0	SENT_63	[p2l941t2246r972b2278],

1	(	NN	O	(	nn	2	SENT_64	[p2l666t2346r863b2387],
2	Cl-l3	NN	O	cl-l3	_	0	SENT_64	[p2l666t2346r863b2387],
3	)	CD	NUMBER	)	num	4	SENT_64	[p2l666t2346r863b2387],
4	3C	NN	O	3c	dep	2	SENT_64	[p2l666t2346r863b2387],
5	—	CD	NUMBER	—	num	6	SENT_64	[p2l666t2346r863b2387],
6	O	NN	O	o	dep	2	SENT_64	[p2l873t2347r904b2378],

1	umnz	NN	O	umnz	nn	2	SENT_65	[p2l1014t2345r1040b2446],
2	I	NN	O	i	_	0	SENT_65	[p2l1043t2345r1070b2375],

1	Figure	NNP	O	Figure	nn	3	SENT_66	[p2l550t2852r639b2882],
2	1	CD	NUMBER	1	num	3	SENT_66	[p2l649t2852r662b2875],
3	Structures	NNS	O	structure	_	0	SENT_66	[p2l696t2852r828b2875],
4	of	IN	O	of	_	0	SENT_66	[p2l838t2852r867b2875],
5	the	DT	O	the	det	6	SENT_66	[p2l873t2852r913b2875],
6	taxanes	NNS	O	taxane	prep_of	3	SENT_66	[p2l922t2855r1028b2875],
7	:	:	O	:	_	0	SENT_66	[p2l922t2855r1028b2875],
8	(	CD	NUMBER	(	dep	3	SENT_66	[p2l1040t2852r1079b2880],
9	A	DT	O	a	det	11	SENT_66	[p2l1040t2852r1079b2880],
10	)	NN	O	)	nn	11	SENT_66	[p2l1040t2852r1079b2880],
11	paclitaxel	NN	O	paclitaxel	dep	8	SENT_66	[p2l1089t2852r1217b2882],
12	and	CC	O	and	_	0	SENT_66	[p2l1226t2852r1273b2875],
13	(	NN	O	(	nn	14	SENT_66	[p2l1282t2852r1322b2880],
14	B	NN	O	b	conj_and	11	SENT_66	[p2l1282t2852r1322b2880],
15	)	CD	NUMBER	)	num	16	SENT_66	[p2l1282t2852r1322b2880],
16	docetaxel	NN	O	docetaxel	dep	8	SENT_66	[p2l1332t2852r1464b2875],
17	.	.	O	.	_	0	SENT_66	[p2l1332t2852r1464b2875],

1	356	CD	NUMBER	356	num	2	SENT_67	[p2l550t2957r604b2983],
2	ROWINSKY	NN	O	rowinsky	_	0	SENT_67	[p2l643t2957r843b2983],

1	of	IN	O	of	_	0	SENT_68	[p2l550t3041r585b3071],
2	microtubule	NN	O	microtubule	prep_of	10	SENT_68	[p2l596t3041r794b3071],
3	assembly	NN	O	assembly	nsubj	10	SENT_68	[p2l808t3041r960b3079],
4	in	IN	O	in	_	0	SENT_68	[p2l974t3041r1005b3070],
5	the	DT	O	the	det	6	SENT_68	[p2l1018t3041r1067b3071],
6	absence	NN	O	absence	prep_in	3	SENT_68	[p2l1081t3041r1210b3071],
7	of	IN	O	of	_	0	SENT_68	[p2l1224t3041r1259b3071],
8	the	DT	O	the	det	9	SENT_68	[p2l1270t3041r1319b3071],
9	taxanes	NNS	O	taxane	prep_of	6	SENT_68	[p2l1332t3046r1454b3071],
10	(	VBP	O	(	_	0	SENT_68	[p2l1469t3041r1544b3077],
11	10	CD	NUMBER	10	number	12	SENT_68	[p2l1469t3041r1544b3077],
12	)	CD	NUMBER	)	dobj	10	SENT_68	[p2l1469t3041r1544b3077],
13	.	.	O	.	_	0	SENT_68	[p2l1469t3041r1544b3077],

1	A	DT	DURATION	a	det	3	SENT_69	[p2l1559t3042r1588b3070],
2	second	JJ	DURATION	second	amod	3	SENT_69	[p2l1602t3041r1715b3071],
3	mechanism	NN	O	mechanism	nsubj	25	SENT_69	[p2l1727t3041r1847b3071, p2l549t3091r637b3126],
4	,	,	O	,	_	0	SENT_69	[p2l1727t3041r1847b3071, p2l549t3091r637b3126],
5	multi	NNS	O	multus	nsubj	6	SENT_69	[p2l654t3091r830b3129],
6	—	VBP	O	—	parataxis	25	SENT_69	[p2l654t3091r830b3129],
7	drug	NN	O	drug	nn	8	SENT_69	[p2l654t3091r830b3129],
8	resistance	NN	O	resistance	nsubj	11	SENT_69	[p2l846t3091r1008b3121],
9	(	CD	NUMBER	(	num	11	SENT_69	[p2l1025t3092r1143b3127],
10	MDR	NN	ORGANIZATION	mdr	nn	11	SENT_69	[p2l1025t3092r1143b3127],
11	)	NN	O	)	xcomp	6	SENT_69	[p2l1025t3092r1143b3127],
12	that	WDT	O	that	nsubj	13	SENT_69	[p2l1160t3091r1222b3121],
13	involves	VBZ	O	involve	rcmod	11	SENT_69	[p2l1236t3091r1375b3121],
14	amplification	NN	O	amplification	dobj	13	SENT_69	[p2l1392t3091r1611b3129],
15	of	IN	O	of	_	0	SENT_69	[p2l1626t3091r1662b3121],
16	membrane	NN	O	membrane	nn	17	SENT_69	[p2l1674t3091r1848b3121],
17	phosphoglycoproteins	NNS	O	phosphoglycoprotein	prep_of	14	SENT_69	[p2l549t3141r913b3179],
18	that	WDT	O	that	nsubj	19	SENT_69	[p2l935t3141r996b3170],
19	function	VBP	O	function	rcmod	14	SENT_69	[p2l1016t3141r1153b3170],
20	as	IN	O	as	_	0	SENT_69	[p2l1175t3150r1206b3170],
21	drug	NN	O	drug	nn	23	SENT_69	[p2l1228t3141r1302b3179],
22	efﬂux	NN	O	efﬂux	nn	23	SENT_69	[p2l1324t3141r1421b3170],
23	pumps	NNS	O	pump	prep_as	19	SENT_69	[p2l1441t3150r1560b3179],
24	,	,	O	,	_	0	SENT_69	[p2l1441t3150r1560b3179],
25	confers	VBZ	O	confer	_	0	SENT_69	[p2l1582t3141r1701b3170],
26	varying	VBG	O	vary	amod	27	SENT_69	[p2l1723t3141r1847b3179],
27	degrees	NNS	O	degree	nsubj	40	SENT_69	[p2l550t3191r674b3229],
28	of	IN	O	of	_	0	SENT_69	[p2l688t3191r724b3221],
29	cross	JJ	O	cross	amod	31	SENT_69	[p2l734t3191r995b3221],
30	—	NN	O	—	nn	31	SENT_69	[p2l734t3191r995b3221],
31	resistance	NN	O	resistance	prep_of	27	SENT_69	[p2l734t3191r995b3221],
32	to	TO	O	to	_	0	SENT_69	[p2l1007t3196r1038b3221],
33	diverse	JJ	O	diverse	amod	36	SENT_69	[p2l1052t3191r1179b3226],
34	,	,	O	,	_	0	SENT_69	[p2l1052t3191r1179b3226],
35	structurally	RB	O	structurally	advmod	36	SENT_69	[p2l1194t3191r1380b3229],
36	bulky	JJ	O	bulky	amod	39	SENT_69	[p2l1392t3191r1486b3229],
37	natural	JJ	O	natural	amod	39	SENT_69	[p2l1499t3191r1613b3221],
38	product	NN	O	product	nn	39	SENT_69	[p2l1625t3191r1752b3229],
39	cytotoxins	NNS	O	cytotoxin	prep_to	31	SENT_69	[p2l1765t3196r1847b3229, p2l549t3241r648b3271],
40	(	VBP	O	(	ccomp	25	SENT_69	[p2l662t3241r737b3277],
41	11	CD	NUMBER	11	num	42	SENT_69	[p2l662t3241r737b3277],
42	)	CD	NUMBER	)	dobj	40	SENT_69	[p2l662t3241r737b3277],
43	.	.	O	.	_	0	SENT_69	[p2l662t3241r737b3277],

1	MDR	NN	O	mdr	nsubjpass	4	SENT_70	[p2l749t3242r843b3270],
2	can	MD	O	can	aux	4	SENT_70	[p2l854t3250r910b3271],
3	be	VB	O	be	auxpass	4	SENT_70	[p2l921t3241r959b3271],
4	reversed	VBN	O	reverse	_	0	SENT_70	[p2l969t3241r1109b3271],
5	by	IN	O	by	_	0	SENT_70	[p2l1119t3241r1160b3279],
6	many	JJ	O	many	amod	7	SENT_70	[p2l1171t3250r1261b3279],
7	types	NNS	O	type	agent	4	SENT_70	[p2l1273t3246r1358b3279],
8	of	IN	O	of	_	0	SENT_70	[p2l1371t3241r1406b3271],
9	agents	NNS	O	agent	prep_of	7	SENT_70	[p2l1415t3246r1528b3279],
10	,	,	O	,	_	0	SENT_70	[p2l1415t3246r1528b3279],
11	including	VBG	O	include	_	0	SENT_70	[p2l1540t3241r1695b3279],
12	the	DT	O	the	det	14	SENT_70	[p2l1706t3241r1755b3271],
13	main	JJ	O	main	amod	14	SENT_70	[p2l1766t3241r1848b3271],
14	components	NNS	O	component	prep_including	4	SENT_70	[p2l550t3296r747b3329],
15	of	IN	O	of	_	0	SENT_70	[p2l762t3291r797b3320],
16	the	DT	O	the	det	18	SENT_70	[p2l807t3291r856b3320],
17	formulation	NN	O	formulation	nn	18	SENT_70	[p2l869t3291r1064b3320],
18	vehicles	NNS	O	vehicle	prep_of	14	SENT_70	[p2l1076t3291r1209b3320],
19	of	IN	O	of	_	0	SENT_70	[p2l1223t3291r1259b3320],
20	both	DT	O	both	preconj	21	SENT_70	[p2l1267t3291r1341b3320],
21	paclitaxel	NN	O	paclitaxel	prep_of	18	SENT_70	[p2l1353t3291r1513b3329],
22	and	CC	O	and	_	0	SENT_70	[p2l1526t3291r1584b3320],
23	docetaxel	NN	O	docetaxel	conj_and	21	SENT_70	[p2l1596t3291r1762b3326],
24	,	,	O	,	_	0	SENT_70	[p2l1596t3291r1762b3326],
25	Cremophor	NNP	O	Cremophor	nn	26	SENT_70	[p2l1776t3291r1847b3321, p2l549t3341r678b3379],
26	EL	NNP	O	EL	appos	21	SENT_70	[p2l698t3342r747b3370],
27	(	CD	NUMBER	(	num	26	SENT_70	[p2l769t3341r1069b3379],
28	polyoxyethylated	VBN	O	polyoxyethylate	partmod	26	SENT_70	[p2l769t3341r1069b3379],
29	castor	NN	O	castor	nn	31	SENT_70	[p2l1089t3346r1188b3371],
30	oil	NN	O	oil	nn	31	SENT_70	[p2l1208t3341r1263b3377],
31	)	NN	O	)	nsubj	36	SENT_70	[p2l1208t3341r1263b3377],
32	and	CC	O	and	_	0	SENT_70	[p2l1285t3341r1343b3371],
33	Tween	NNP	ORGANIZATION	Tween	nsubj	36	SENT_70	[p2l1364t3342r1475b3371],
34	80	CD	NUMBER	80	number	35	SENT_70	[p2l1497t3341r1536b3371],
35	(	CD	NUMBER	(	num	36	SENT_70	[p2l1558t3341r1763b3379],
36	polysorbate	NN	O	polysorbate	xcomp	28	SENT_70	[p2l1558t3341r1763b3379],
37	80	CD	NUMBER	80	number	38	SENT_70	[p2l1785t3341r1846b3377],
38	)	CD	NUMBER	)	amod	36	SENT_70	[p2l1785t3341r1846b3377],
39	,	,	O	,	_	0	SENT_70	[p2l1785t3341r1846b3377],
40	respectively	RB	O	respectively	dep	42	SENT_70	[p2l549t3391r748b3429],
41	(	CD	NUMBER	(	num	42	SENT_70	[p2l761t3391r822b3427],
42	12	CD	NUMBER	12	dep	38	SENT_70	[p2l761t3391r822b3427],
43	,	,	O	,	_	0	SENT_70	[p2l761t3391r822b3427],
44	13	CD	NUMBER	13	num	45	SENT_70	[p2l839t3391r898b3427],
45	)	NN	O	)	appos	42	SENT_70	[p2l839t3391r898b3427],
46	.	.	O	.	_	0	SENT_70	[p2l839t3391r898b3427],

1	The	DT	O	the	det	3	SENT_71	[p2l911t3391r974b3421],
2	clinical	JJ	O	clinical	amod	3	SENT_71	[p2l986t3391r1107b3421],
3	relevance	NN	O	relevance	nsubjpass	11	SENT_71	[p2l1117t3391r1275b3421],
4	of	IN	O	of	_	0	SENT_71	[p2l1287t3391r1323b3421],
5	these	DT	O	these	det	6	SENT_71	[p2l1332t3391r1416b3421],
6	mechanisms	NNS	O	mechanism	prep_of	3	SENT_71	[p2l1426t3391r1629b3421],
7	of	IN	O	of	_	0	SENT_71	[p2l1642t3391r1678b3421],
8	resistance	NN	O	resistance	prep_of	6	SENT_71	[p2l1686t3391r1848b3421],
9	is	VBZ	O	be	auxpass	11	SENT_71	[p2l549t3441r575b3470],
10	not	RB	O	not	neg	11	SENT_71	[p2l588t3446r640b3470],
11	known	VBN	O	know	_	0	SENT_71	[p2l652t3441r773b3476],
12	,	,	O	,	_	0	SENT_71	[p2l652t3441r773b3476],
13	but	CC	O	but	_	0	SENT_71	[p2l786t3441r839b3470],
14	the	DT	O	the	det	16	SENT_71	[p2l851t3441r900b3470],
15	early	JJ	O	early	amod	16	SENT_71	[p2l913t3441r994b3479],
16	results	NNS	O	result	nsubj	22	SENT_71	[p2l1006t3441r1113b3470],
17	of	IN	O	of	_	0	SENT_71	[p2l1127t3441r1162b3470],
18	studies	NNS	O	study	prep_of	16	SENT_71	[p2l1173t3441r1285b3470],
19	in	IN	O	in	_	0	SENT_71	[p2l1298t3441r1330b3470],
20	breast	NN	O	breast	nn	21	SENT_71	[p2l1341t3441r1440b3470],
21	cancer	NN	O	cancer	prep_in	18	SENT_71	[p2l1452t3450r1559b3470],
22	suggest	VBP	O	suggest	conj_but	11	SENT_71	[p2l1571t3445r1694b3479],
23	a	DT	O	a	det	24	SENT_71	[p2l1707t3450r1724b3470],
24	lack	NN	O	lack	dobj	22	SENT_71	[p2l1735t3441r1804b3470],
25	of	IN	O	of	_	0	SENT_71	[p2l1815t3441r1851b3470],
26	complete	JJ	O	complete	amod	29	SENT_71	[p2l550t3491r700b3529],
27	cross	NN	O	cross	nn	29	SENT_71	[p2l715t3491r975b3520],
28	—	NN	O	—	nn	29	SENT_71	[p2l715t3491r975b3520],
29	resistance	NN	O	resistance	prep_of	24	SENT_71	[p2l715t3491r975b3520],
30	between	IN	O	between	_	0	SENT_71	[p2l990t3491r1127b3520],
31	the	DT	O	the	det	32	SENT_71	[p2l1142t3491r1191b3520],
32	taxanes	NNS	O	taxane	prep_between	29	SENT_71	[p2l1206t3496r1328b3520],
33	and	CC	O	and	_	0	SENT_71	[p2l1344t3491r1403b3520],
34	anthracyclines	NNS	O	anthracycline	conj_and	32	SENT_71	[p2l1418t3491r1654b3529],
35	that	WDT	O	that	nsubjpass	39	SENT_71	[p2l1670t3491r1731b3520],
36	would	MD	O	would	aux	39	SENT_71	[p2l1745t3491r1848b3520],
37	not	RB	O	not	neg	39	SENT_71	[p2l549t3546r602b3570],
38	be	VB	O	be	auxpass	39	SENT_71	[p2l620t3541r658b3571],
39	expected	VBN	O	expect	rcmod	32	SENT_71	[p2l678t3541r824b3579],
40	if	IN	O	if	mark	45	SENT_71	[p2l843t3541r870b3570],
41	MDR	NN	ORGANIZATION	mdr	nsubj	45	SENT_71	[p2l886t3542r980b3570],
42	is	VBZ	O	be	cop	45	SENT_71	[p2l999t3541r1025b3571],
43	an	DT	O	a	det	45	SENT_71	[p2l1046t3551r1084b3570],
44	important	JJ	O	important	amod	45	SENT_71	[p2l1103t3541r1263b3579],
45	mechanism	NN	O	mechanism	advcl	39	SENT_71	[p2l1282t3541r1470b3570],
46	of	IN	O	of	_	0	SENT_71	[p2l1489t3541r1525b3570],
47	resistance	NN	O	resistance	prep_of	45	SENT_71	[p2l1541t3541r1703b3571],
48	for	IN	O	for	_	0	SENT_71	[p2l1723t3541r1770b3570],
49	this	DT	O	this	det	54	SENT_71	[p2l1789t3541r1847b3570],
50	particular	JJ	O	particular	amod	54	SENT_71	[p2l549t3591r708b3629],
51	tumor	NN	O	tumor	nn	54	SENT_71	[p2l723t3596r821b3620],
52	(	NN	O	(	nn	54	SENT_71	[p2l838t3592r913b3627],
53	14	CD	NUMBER	14	num	54	SENT_71	[p2l838t3592r913b3627],
54	)	NN	O	)	prep_for	47	SENT_71	[p2l838t3592r913b3627],
55	.	.	O	.	_	0	SENT_71	[p2l838t3592r913b3627],

1	Taxane	NN	O	taxane	nn	2	SENT_72	[p2l931t3592r1052b3620],
2	resistance	NN	O	resistance	nsubjpass	6	SENT_72	[p2l1068t3591r1230b3620],
3	has	VBZ	O	have	aux	6	SENT_72	[p2l1246t3591r1299b3620],
4	also	RB	O	also	advmod	6	SENT_72	[p2l1317t3591r1381b3620],
5	been	VBN	O	be	auxpass	6	SENT_72	[p2l1398t3591r1475b3620],
6	related	VBN	O	relate	ccomp	15	SENT_72	[p2l1491t3591r1603b3620],
7	to	TO	O	to	_	0	SENT_72	[p2l1618t3596r1649b3620],
8	differential	JJ	O	differential	amod	9	SENT_72	[p2l1666t3591r1848b3620],
9	expression	NN	O	expression	prep_to	6	SENT_72	[p2l550t3641r725b3679],
10	of	IN	O	of	_	0	SENT_72	[p2l741t3641r777b3670],
11	various	JJ	O	various	amod	13	SENT_72	[p2l790t3641r910b3670],
12	tubulin	NN	O	tubulin	nn	13	SENT_72	[p2l926t3641r1043b3670],
13	isotypes	NNS	O	isotype	prep_of	9	SENT_72	[p2l1058t3641r1201b3679],
14	,	,	O	,	_	0	SENT_72	[p2l1058t3641r1201b3679],
15	decreased	VBD	O	decrease	_	0	SENT_72	[p2l1219t3641r1381b3670],
16	microtubule	NN	O	microtubule	nn	18	SENT_72	[p2l1395t3641r1594b3670],
17	bundle	NN	O	bundle	nn	18	SENT_72	[p2l1609t3641r1721b3670],
18	forrna	NN	O	forrna	dobj	15	SENT_72	[p2l1737t3641r1847b3670],
19	—	CD	NUMBER	—	num	20	SENT_72	[p2l1737t3641r1847b3670],
20	tion	NN	O	tion	nsubj	15	SENT_72	[p2l549t3691r621b3725],
21	,	,	O	,	_	0	SENT_72	[p2l549t3691r621b3725],
22	decreased	VBD	O	decrease	ccomp	15	SENT_72	[p2l634t3691r796b3720],
23	expression	NN	O	expression	dobj	22	SENT_72	[p2l806t3691r982b3728],
24	of	IN	O	of	_	0	SENT_72	[p2l994t3691r1030b3720],
25	bcl-2	NN	O	bcl-2	prep_of	23	SENT_72	[p2l1038t3691r1130b3725],
26	,	,	O	,	_	0	SENT_72	[p2l1038t3691r1130b3725],
27	and	CC	O	and	_	0	SENT_72	[p2l1143t3691r1202b3720],
28	other	JJ	O	other	amod	29	SENT_72	[p2l1213t3691r1298b3720],
29	mechanisms	NNS	O	mechanism	conj_and	23	SENT_72	[p2l1307t3691r1510b3720],
30	that	WDT	O	that	nsubj	32	SENT_72	[p2l1521t3691r1583b3720],
31	are	VBP	O	be	cop	32	SENT_72	[p2l1595t3700r1643b3720],
32	unrelated	JJ	O	unrelated	rcmod	29	SENT_72	[p2l1653t3691r1807b3720],
33	to	TO	O	to	_	0	SENT_72	[p2l1817t3695r1847b3720],
34	MDR	NN	O	mdr	prep_to	32	SENT_72	[p2l549t3741r643b3769],
35	(	CD	NUMBER	(	number	36	SENT_72	[p2l655t3741r696b3776],
36	8	CD	NUMBER	8	dep	34	SENT_72	[p2l655t3741r696b3776],
37	,	,	O	,	_	0	SENT_72	[p2l655t3741r696b3776],
38	15-17	CD	NUMBER	15-17	num	39	SENT_72	[p2l713t3740r834b3776],
39	)	NN	O	)	appos	34	SENT_72	[p2l713t3740r834b3776],
40	.	.	O	.	_	0	SENT_72	[p2l713t3740r834b3776],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_73	[p3l550t64r780b99],
2	RESULTS	NNS	O	result	_	0	SENT_73	[p3l792t64r1000b99],

1	Pharmacology	NN	O	pharmacology	_	0	SENT_74	[p3l549t163r842b208],

1	Paclitaxel	NN	O	paclitaxel	nsubj	4	SENT_75	[p3l549t243r711b272],
2	and	CC	O	and	_	0	SENT_75	[p3l731t243r789b272],
3	docetaxel	NN	O	docetaxel	conj_and	1	SENT_75	[p3l809t243r966b272],
4	share	VBP	O	share	_	0	SENT_75	[p3l986t243r1071b272],
5	the	DT	O	the	dobj	4	SENT_75	[p3l1090t243r1139b272],
6	following	VBG	O	follow	_	0	SENT_75	[p3l1158t243r1318b281],
7	pharinacologic	JJ	O	pharinacologic	amod	8	SENT_75	[p3l1337t243r1582b281],
8	characteristics	NNS	O	characteristic	prep_following	5	SENT_75	[p3l1602t243r1846b272],
9	:	:	O	:	_	0	SENT_75	[p3l1602t243r1846b272],
10	large	JJ	O	large	amod	11	SENT_75	[p3l549t293r631b331],
11	volumes	NNS	O	volume	conj_and	5	SENT_75	[p3l644t293r783b323],
12	of	IN	O	of	_	0	SENT_75	[p3l798t293r834b322],
13	distribution	NN	O	distribution	prep_of	11	SENT_75	[p3l845t293r1044b328],
14	,	,	O	,	_	0	SENT_75	[p3l845t293r1044b328],
15	rapid	JJ	O	rapid	amod	16	SENT_75	[p3l1058t293r1143b331],
16	uptake	NN	O	uptake	conj_and	5	SENT_75	[p3l1156t293r1265b331],
17	by	IN	O	by	_	0	SENT_75	[p3l1278t293r1319b331],
18	most	JJS	O	most	amod	19	SENT_75	[p3l1333t298r1413b323],
19	tissues	NNS	O	tissue	prep_by	16	SENT_75	[p3l1426t293r1544b328],
20	,	,	O	,	_	0	SENT_75	[p3l1426t293r1544b328],
21	long	RB	O	long	advmod	5	SENT_75	[p3l1560t293r1632b331],
22	half-lives	NNS	O	half-life	dep	5	SENT_75	[p3l1646t293r1800b323],
23	of	IN	O	of	_	0	SENT_75	[p3l1815t293r1851b322],
24	elimination	NN	O	elimination	prep_of	22	SENT_75	[p3l550t343r746b378],
25	,	,	O	,	_	0	SENT_75	[p3l550t343r746b378],
26	and	CC	O	and	_	0	SENT_75	[p3l758t343r817b372],
27	substantial	JJ	O	substantial	amod	29	SENT_75	[p3l828t343r1003b372],
28	hepatic	JJ	O	hepatic	amod	29	SENT_75	[p3l1013t343r1131b381],
29	disposition	NN	O	disposition	dobj	4	SENT_75	[p3l1143t343r1332b381],
30	.	.	O	.	_	0	SENT_75	[p3l1143t343r1332b381],

1	The	DT	O	the	det	4	SENT_76	[p3l1344t343r1407b372],
2	pertinent	JJ	O	pertinent	amod	4	SENT_76	[p3l1417t343r1564b381],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_76	[p3l1573t343r1848b381],
4	parameters	NNS	O	parameter	nsubjpass	9	SENT_76	[p3l549t398r729b431],
5	of	IN	O	of	_	0	SENT_76	[p3l742t393r777b422],
6	both	DT	O	both	det	7	SENT_76	[p3l785t393r859b422],
7	agents	NNS	O	agent	prep_of	4	SENT_76	[p3l870t398r973b431],
8	are	VBP	O	be	auxpass	9	SENT_76	[p3l986t402r1035b423],
9	summarized	VBN	O	summarize	_	0	SENT_76	[p3l1048t393r1248b423],
10	in	IN	O	in	_	0	SENT_76	[p3l1258t393r1290b422],
11	Table	NNP	O	Table	prep_in	9	SENT_76	[p3l1301t393r1394b423],
12	1	CD	NUMBER	1	num	11	SENT_76	[p3l1410t394r1433b422],
13	.	.	O	.	_	0	SENT_76	[p3l1410t394r1433b422],

1	PACLITAXEL	NN	O	paclitaxel	nsubj	8	SENT_77	[p3l549t518r753b542],
2	The	DT	O	the	det	4	SENT_77	[p3l792t513r855b542],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_77	[p3l870t513r1145b550],
4	behavior	NN	O	behavior	dep	1	SENT_77	[p3l1161t513r1306b542],
5	of	IN	O	of	_	0	SENT_77	[p3l1321t513r1357b542],
6	paclitaxel	NN	O	paclitaxel	prep_of	1	SENT_77	[p3l1370t513r1530b550],
7	appeared	VBD	O	appear	cop	8	SENT_77	[p3l1546t513r1694b550],
8	linear	JJ	O	linear	_	0	SENT_77	[p3l1709t513r1803b542],
9	in	IN	O	in	_	0	SENT_77	[p3l1817t513r1848b541],
10	early	JJ	O	early	amod	11	SENT_77	[p3l550t562r631b600],
11	studies	NNS	O	study	prep_in	8	SENT_77	[p3l652t562r764b591],
12	of	IN	O	of	_	0	SENT_77	[p3l785t562r821b591],
13	prolonged	JJ	O	prolonged	amod	14	SENT_77	[p3l838t562r1006b600],
14	schedules	NNS	O	schedule	prep_of	11	SENT_77	[p3l1026t562r1194b596],
15	,	,	O	,	_	0	SENT_77	[p3l1026t562r1194b596],
16	but	CC	O	but	_	0	SENT_77	[p3l1214t562r1267b591],
17	clearance	NN	O	clearance	nsubjpass	20	SENT_77	[p3l1287t562r1442b591],
18	has	VBZ	O	have	aux	20	SENT_77	[p3l1461t562r1514b591],
19	been	VBN	O	be	auxpass	20	SENT_77	[p3l1534t562r1612b591],
20	shown	VBN	O	show	conj_but	8	SENT_77	[p3l1633t562r1739b591],
21	to	TO	O	to	aux	23	SENT_77	[p3l1759t567r1790b591],
22	be	VB	O	be	cop	23	SENT_77	[p3l1809t562r1848b591],
23	nonlinear	JJ	O	nonlinear	xcomp	20	SENT_77	[p3l549t611r705b640],
24	or	CC	O	or	_	0	SENT_77	[p3l725t620r758b640],
25	saturable	JJ	O	saturable	xcomp	20	SENT_77	[p3l779t611r934b645],
26	,	,	O	,	_	0	SENT_77	[p3l779t611r934b645],
27	particularly	RB	O	particularly	acomp	20	SENT_77	[p3l955t611r1144b649],
28	on	IN	O	on	_	0	SENT_77	[p3l1165t620r1204b640],
29	shorter	JJR	O	shorter	amod	30	SENT_77	[p3l1226t611r1339b640],
30	schedules	NNS	O	schedule	prep_on	27	SENT_77	[p3l1359t611r1526b645],
31	,	,	O	,	_	0	SENT_77	[p3l1359t611r1526b645],
32	with	IN	O	with	_	0	SENT_77	[p3l1548t611r1620b640],
33	both	DT	O	both	preconj	35	SENT_77	[p3l1639t611r1712b640],
34	plasma	NN	O	plasma	nn	35	SENT_77	[p3l1731t611r1849b649],
35	concentrations	NNS	O	concentration	nsubj	39	SENT_77	[p3l550t661r789b690],
36	and	CC	O	and	_	0	SENT_77	[p3l799t661r858b690],
37	drug	NN	O	drug	nn	38	SENT_77	[p3l866t661r940b699],
38	exposure	NN	O	exposure	conj_and	35	SENT_77	[p3l950t670r1098b699],
39	increasing	VBG	O	increase	prepc_with	20	SENT_77	[p3l1107t661r1276b699],
40	disproportionately	RB	O	disproportionately	advmod	39	SENT_77	[p3l1286t661r1588b699],
41	with	IN	O	with	_	0	SENT_77	[p3l1598t661r1670b690],
42	increasing	VBG	O	increase	prepc_with	39	SENT_77	[p3l1679t661r1848b699],
43	doses	NNS	O	dose	iobj	42	SENT_77	[p3l550t711r639b741],
44	(	CD	NUMBER	(	number	45	SENT_77	[p3l658t711r732b747],
45	18	CD	NUMBER	18	num	46	SENT_77	[p3l658t711r732b747],
46	)	NN	O	)	dobj	42	SENT_77	[p3l658t711r732b747],
47	.	.	O	.	_	0	SENT_77	[p3l658t711r732b747],

1	Plasma	NN	O	plasma	nn	2	SENT_78	[p3l750t711r870b741],
2	levels	NNS	O	level	nsubj	7	SENT_78	[p3l885t711r980b741],
3	that	WDT	O	that	nsubjpass	5	SENT_78	[p3l997t711r1058b741],
4	are	VBP	O	be	auxpass	5	SENT_78	[p3l1074t720r1123b741],
5	achieved	VBN	O	achieve	rcmod	2	SENT_78	[p3l1140t711r1285b741],
6	are	VBP	O	be	cop	7	SENT_78	[p3l1302t720r1350b741],
7	capable	JJ	O	capable	_	0	SENT_78	[p3l1366t711r1491b749],
8	of	IN	O	of	_	0	SENT_78	[p3l1507t711r1543b741],
9	inducing	VBG	O	induce	prepc_of	7	SENT_78	[p3l1556t711r1700b749],
10	relevant	JJ	O	relevant	amod	11	SENT_78	[p3l1716t711r1849b741],
11	effects	NNS	O	effect	dobj	9	SENT_78	[p3l550t761r657b791],
12	in	FW	O	in	nn	13	SENT_78	[p3l670t761r702b790],
13	vitro	FW	O	vitro	advmod	9	SENT_78	[p3l714t761r799b791],
14	.	.	O	.	_	0	SENT_78	[p3l714t761r799b791],

1	Despite	IN	O	despite	_	0	SENT_79	[p3l813t761r939b799],
2	extensive	JJ	O	extensive	amod	5	SENT_79	[p3l952t761r1107b791],
3	plasma	NN	O	plasma	nn	5	SENT_79	[p3l1118t762r1236b799],
4	protein	NN	O	protein	nn	5	SENT_79	[p3l1247t761r1364b799],
5	binding	NN	O	binding	prep_despite	10	SENT_79	[p3l1375t761r1510b799],
6	,	,	O	,	_	0	SENT_79	[p3l1375t761r1510b799],
7	paclitaxel	NN	O	paclitaxel	nsubjpass	10	SENT_79	[p3l1524t761r1684b799],
8	is	VBZ	O	be	auxpass	10	SENT_79	[p3l1695t761r1721b791],
9	readily	RB	O	readily	advmod	10	SENT_79	[p3l1734t761r1848b799],
10	cleared	VBN	O	clear	_	0	SENT_79	[p3l550t811r668b841],
11	from	IN	O	from	_	0	SENT_79	[p3l676t811r756b841],
12	plasma	NN	O	plasma	prep_from	10	SENT_79	[p3l763t811r888b849],
13	.	.	O	.	_	0	SENT_79	[p3l763t811r888b849],

1	The	DT	O	the	det	2	SENT_80	[p3l899t811r962b841],
2	volume	NN	O	volume	nsubj	6	SENT_80	[p3l971t811r1095b841],
3	of	IN	O	of	_	0	SENT_80	[p3l1104t811r1139b841],
4	distribution	NN	O	distribution	prep_of	2	SENT_80	[p3l1146t811r1336b841],
5	is	VBZ	O	be	cop	6	SENT_80	[p3l1344t811r1370b841],
6	large	JJ	O	large	_	0	SENT_80	[p3l1380t811r1471b849],
7	,	,	O	,	_	0	SENT_80	[p3l1380t811r1471b849],
8	most	RBS	O	most	advmod	6	SENT_80	[p3l1481t816r1561b841],
9	likely	RB	O	likely	advmod	6	SENT_80	[p3l1569t811r1662b849],
10	due	JJ	O	due	_	0	SENT_80	[p3l1671t811r1729b841],
11	to	TO	O	to	_	0	SENT_80	[p3l1738t816r1769b841],
12	avid	JJ	O	avid	amod	14	SENT_80	[p3l1779t811r1848b841],
13	drug	NN	O	drug	nn	14	SENT_80	[p3l550t861r624b899],
14	binding	NN	O	binding	prep_due_to	6	SENT_80	[p3l636t861r762b899],
15	to	TO	O	to	_	0	SENT_80	[p3l775t866r805b891],
16	tubulin	NN	O	tubulin	prep_to	6	SENT_80	[p3l819t861r944b896],
17	,	,	O	,	_	0	SENT_80	[p3l819t861r944b896],
18	which	WDT	O	which	nsubj	20	SENT_80	[p3l958t861r1058b891],
19	is	VBZ	O	be	cop	20	SENT_80	[p3l1071t861r1096b891],
20	ubiquitious	JJ	O	ubiquitious	rcmod	16	SENT_80	[p3l1110t861r1304b899],
21	.	.	O	.	_	0	SENT_80	[p3l1110t861r1304b899],

1	Renal	JJ	MISC	renal	amod	2	SENT_81	[p3l1318t861r1414b891],
2	clearance	NN	O	clearance	nsubj	4	SENT_81	[p3l1426t861r1581b891],
3	is	VBZ	O	be	cop	4	SENT_81	[p3l1593t861r1618b891],
4	insignificant	JJ	O	insignificant	_	0	SENT_81	[p3l1632t861r1847b899],
5	,	,	O	,	_	0	SENT_81	[p3l1632t861r1847b899],
6	whereas	IN	O	whereas	mark	26	SENT_81	[p3l549t911r683b940],
7	hepatic	JJ	O	hepatic	amod	9	SENT_81	[p3l694t911r812b949],
8	P	NN	O	p	nn	9	SENT_81	[p3l823t911r920b941],
9	—	NN	O	—	nsubj	26	SENT_81	[p3l823t911r920b941],
10	450	CD	NUMBER	450	num	12	SENT_81	[p3l823t911r920b941],
11	mixed	JJ	O	mixed	amod	12	SENT_81	[p3l931t911r1034b940],
12	function	NN	O	function	dep	9	SENT_81	[p3l1045t911r1182b940],
13	oxidative	JJ	O	oxidative	amod	14	SENT_81	[p3l1192t911r1345b940],
14	metabolism	NN	O	metabolism	dep	9	SENT_81	[p3l1355t911r1556b946],
15	,	,	O	,	_	0	SENT_81	[p3l1355t911r1556b946],
16	biliary	JJ	O	biliary	amod	17	SENT_81	[p3l1567t911r1674b949],
17	excretion	NN	O	excretion	dep	9	SENT_81	[p3l1685t911r1846b946],
18	,	,	O	,	_	0	SENT_81	[p3l1685t911r1846b946],
19	fecal	JJ	O	fecal	amod	20	SENT_81	[p3l549t961r628b991],
20	elimination	NN	O	elimination	dep	9	SENT_81	[p3l643t961r839b996],
21	,	,	O	,	_	0	SENT_81	[p3l643t961r839b996],
22	and	CC	O	and	_	0	SENT_81	[p3l856t961r914b991],
23	tissue	NN	O	tissue	nn	24	SENT_81	[p3l929t961r1022b991],
24	binding	NN	O	binding	conj_and	14	SENT_81	[p3l1036t961r1162b999],
25	are	VBP	O	be	cop	26	SENT_81	[p3l1178t970r1226b991],
26	responsible	JJ	O	responsible	advcl	4	SENT_81	[p3l1240t961r1428b999],
27	for	IN	O	for	_	0	SENT_81	[p3l1443t961r1491b991],
28	the	DT	O	the	det	29	SENT_81	[p3l1505t961r1554b991],
29	bulk	NN	O	bulk	prep_for	26	SENT_81	[p3l1568t961r1642b991],
30	of	IN	O	of	_	0	SENT_81	[p3l1657t961r1692b991],
31	systemic	JJ	O	systemic	amod	32	SENT_81	[p3l1705t961r1847b999],
32	clearance	NN	O	clearance	prep_of	29	SENT_81	[p3l550t1011r704b1041],
33	(	CD	NUMBER	(	number	34	SENT_81	[p3l715t1011r789b1047],
34	18	CD	NUMBER	18	num	35	SENT_81	[p3l715t1011r789b1047],
35	)	NN	O	)	dep	32	SENT_81	[p3l715t1011r789b1047],
36	.	.	O	.	_	0	SENT_81	[p3l715t1011r789b1047],

1	In	IN	O	in	_	0	SENT_82	[p3l801t1012r835b1040],
2	animals	NNS	O	animal	prep_in	6	SENT_82	[p3l845t1011r981b1046],
3	,	,	O	,	_	0	SENT_82	[p3l845t1011r981b1046],
4	paclitaxel	NN	O	paclitaxel	nsubjpass	6	SENT_82	[p3l991t1011r1152b1049],
5	is	VBZ	O	be	auxpass	6	SENT_82	[p3l1161t1011r1187b1041],
6	distributed	VBN	O	distribute	_	0	SENT_82	[p3l1198t1011r1374b1041],
7	to	TO	O	to	_	0	SENT_82	[p3l1383t1016r1414b1041],
8	all	DT	O	all	det	9	SENT_82	[p3l1425t1011r1464b1041],
9	tissues	NNS	O	tissue	prep_to	6	SENT_82	[p3l1474t1011r1582b1041],
10	except	IN	O	except	_	0	SENT_82	[p3l1593t1016r1700b1049],
11	classical	JJ	O	classical	amod	14	SENT_82	[p3l1709t1011r1848b1041],
12	tumor	NN	O	tumor	nn	14	SENT_82	[p3l549t1065r648b1090],
13	sanctuary	NN	O	sanctuary	nn	14	SENT_82	[p3l660t1065r816b1099],
14	sites	NNS	O	site	prep_except	9	SENT_82	[p3l829t1061r899b1090],
15	such	JJ	O	such	_	0	SENT_82	[p3l912t1061r986b1090],
16	as	IN	O	as	_	0	SENT_82	[p3l998t1070r1030b1090],
17	testes	NNS	O	testis	prep_such_as	14	SENT_82	[p3l1042t1065r1132b1090],
18	and	CC	O	and	_	0	SENT_82	[p3l1145t1061r1203b1090],
19	the	DT	O	the	det	22	SENT_82	[p3l1215t1061r1264b1090],
20	central	JJ	O	central	amod	22	SENT_82	[p3l1276t1061r1387b1090],
21	nervous	JJ	O	nervous	amod	22	SENT_82	[p3l1398t1070r1527b1090],
22	system	NN	O	system	prep_such_as	14	SENT_82	[p3l1541t1065r1661b1099],
23	.	.	O	.	_	0	SENT_82	[p3l1541t1065r1661b1099],

1	As	IN	O	as	mark	17	SENT_83	[p3l599t1112r643b1141],
2	part	NN	O	part	nsubjpass	17	SENT_83	[p3l660t1117r724b1150],
3	of	IN	O	of	_	0	SENT_83	[p3l741t1112r776b1141],
4	the	DT	O	the	det	5	SENT_83	[p3l790t1112r839b1141],
5	effort	NN	O	effort	prep_of	2	SENT_83	[p3l856t1112r947b1141],
6	to	TO	O	to	aux	7	SENT_83	[p3l963t1117r993b1141],
7	combine	VB	O	combine	infmod	5	SENT_83	[p3l1010t1112r1152b1141],
8	paclitaxel	NN	O	paclitaxel	dobj	7	SENT_83	[p3l1167t1112r1328b1150],
9	with	IN	O	with	_	0	SENT_83	[p3l1344t1112r1416b1141],
10	cisplatin	NN	O	cisplatin	prep_with	7	SENT_83	[p3l1433t1112r1572b1150],
11	after	IN	O	after	_	0	SENT_83	[p3l1589t1112r1664b1141],
12	prominent	JJ	O	prominent	amod	15	SENT_83	[p3l1678t1112r1849b1150],
13	single	JJ	O	single	amod	15	SENT_83	[p3l551t1162r647b1200],
14	agent	NN	O	agent	nn	15	SENT_83	[p3l662t1167r750b1200],
15	activity	NN	O	activity	prep_after	7	SENT_83	[p3l765t1162r887b1200],
16	was	VBD	O	be	auxpass	17	SENT_83	[p3l901t1171r963b1192],
17	noted	VBN	O	note	advcl	32	SENT_83	[p3l978t1162r1069b1192],
18	in	IN	O	in	_	0	SENT_83	[p3l1083t1162r1114b1191],
19	advanced	JJ	O	advanced	amod	21	SENT_83	[p3l1129t1162r1284b1192],
20	ovarian	JJ	O	ovarian	amod	21	SENT_83	[p3l1298t1162r1421b1192],
21	cancer	NN	O	cancer	prep_in	17	SENT_83	[p3l1435t1171r1550b1197],
22	,	,	O	,	_	0	SENT_83	[p3l1435t1171r1550b1197],
23	the	DT	O	the	det	24	SENT_83	[p3l1565t1162r1614b1192],
24	possibility	NN	O	possibility	nsubjpass	32	SENT_83	[p3l1628t1162r1800b1200],
25	of	IN	O	of	_	0	SENT_83	[p3l1815t1162r1851b1192],
26	sequence	NN	O	sequence	nn	30	SENT_83	[p3l551t1212r892b1250],
27	—	NN	O	—	nn	30	SENT_83	[p3l551t1212r892b1250],
28	dependent	JJ	O	dependent	amod	30	SENT_83	[p3l551t1212r892b1250],
29	drug	NN	O	drug	nn	30	SENT_83	[p3l914t1212r989b1250],
30	interactions	NNS	O	interaction	prep_of	24	SENT_83	[p3l1011t1212r1205b1242],
31	was	VBD	O	be	auxpass	32	SENT_83	[p3l1228t1221r1290b1242],
32	studied	VBN	O	study	_	0	SENT_83	[p3l1315t1212r1434b1242],
33	(	CD	NUMBER	(	number	34	SENT_83	[p3l1457t1212r1532b1248],
34	19	CD	NUMBER	19	num	35	SENT_83	[p3l1457t1212r1532b1248],
35	)	NN	O	)	dobj	32	SENT_83	[p3l1457t1212r1532b1248],
36	.	.	O	.	_	0	SENT_83	[p3l1457t1212r1532b1248],

1	Neutropenia	NN	PERSON	neutropenia	nsubjpass	3	SENT_84	[p3l1556t1212r1763b1250],
2	was	VBD	O	be	auxpass	3	SENT_84	[p3l1784t1221r1847b1242],
3	shown	VBN	O	show	_	0	SENT_84	[p3l551t1262r656b1292],
4	to	TO	O	to	aux	7	SENT_84	[p3l673t1267r703b1291],
5	be	VB	O	be	cop	7	SENT_84	[p3l719t1262r758b1291],
6	most	RBS	O	most	advmod	7	SENT_84	[p3l774t1266r854b1291],
7	severe	JJ	O	severe	xcomp	3	SENT_84	[p3l871t1271r974b1291],
8	when	WRB	O	when	advmod	11	SENT_84	[p3l990t1262r1079b1291],
9	cisplatin	NN	O	cisplatin	nsubjpass	11	SENT_84	[p3l1095t1262r1234b1300],
10	was	VBD	O	be	auxpass	11	SENT_84	[p3l1250t1271r1312b1292],
11	administered	VBN	O	administer	ccomp	7	SENT_84	[p3l1330t1262r1543b1291],
12	before	IN	O	before	_	0	SENT_84	[p3l1557t1262r1662b1291],
13	paclitaxel	NN	O	paclitaxel	prep_before	11	SENT_84	[p3l1678t1262r1847b1300],
14	,	,	O	,	_	0	SENT_84	[p3l1678t1262r1847b1300],
15	which	WDT	O	which	nsubj	18	SENT_84	[p3l549t1312r649b1342],
16	may	MD	O	may	aux	18	SENT_84	[p3l662t1321r732b1350],
17	be	VB	O	be	cop	18	SENT_84	[p3l745t1312r783b1342],
18	due	JJ	O	due	rcmod	13	SENT_84	[p3l796t1312r854b1342],
19	to	TO	O	to	_	0	SENT_84	[p3l868t1317r898b1342],
20	a	DT	O	a	det	21	SENT_84	[p3l912t1321r929b1342],
21	reduction	NN	O	reduction	prep_to	18	SENT_84	[p3l941t1312r1097b1342],
22	in	IN	O	in	_	0	SENT_84	[p3l1109t1312r1141b1341],
23	paclitaxel	NN	O	paclitaxel	poss	25	SENT_84	[p3l1153t1312r1342b1350],
24	’s	POS	O	’s	_	0	SENT_84	[p3l1153t1312r1342b1350],
25	clearance	NN	O	clearance	prep_in	21	SENT_84	[p3l1356t1312r1520b1347],
26	,	,	O	,	_	0	SENT_84	[p3l1356t1312r1520b1347],
27	possibly	RB	O	possibly	advmod	28	SENT_84	[p3l1533t1312r1670b1350],
28	caused	VBN	O	cause	partmod	25	SENT_84	[p3l1684t1312r1795b1342],
29	by	IN	O	by	_	0	SENT_84	[p3l1807t1312r1848b1350],
30	THE	DT	O	the	det	31	SENT_84	[p3l1491t1370r1563b1396],
31	TAXANES	NN	O	taxane	agent	28	SENT_84	[p3l1573t1369r1745b1396],
32	357	CD	NUMBER	357	num	31	SENT_84	[p3l1794t1369r1847b1396],

1	Annu	NNP	PERSON	Annu	_	0	SENT_85	[p3l309t717r332b797],
2	.	.	O	.	_	0	SENT_85	[p3l309t717r332b797],

1	Rev.	NNP	O	Rev.	nn	2	SENT_86	[p3l309t646r332b706],
2	Med	NNP	O	Med	_	0	SENT_86	[p3l309t569r332b636],
3	.	.	O	.	_	0	SENT_86	[p3l309t569r332b636],

1	1997.48	CD	NUMBER	1997.48	_	0	SENT_87	[p3l309t444r333b556],
2	:	:	O	:	_	0	SENT_87	[p3l309t444r333b556],
3	353-374	CD	NUMBER	353-374	dep	1	SENT_87	[p3l309t318r332b434],
4	.	.	O	.	_	0	SENT_87	[p3l309t318r332b434],

1	Downloaded	VBN	O	download	_	0	SENT_88	[p3l309t137r332b307],
2	from	IN	O	from	_	0	SENT_88	[p3l309t63r332b128],
3	ww	NN	O	ww	prep_from	1	SENT_88	[p3l317t7r332b54],
4	by	IN	O	by	_	0	SENT_88	[p3l342t730r373b763],
5	University	NNP	ORGANIZATION	University	prep_by	3	SENT_88	[p3l343t582r373b721],
6	of	IN	ORGANIZATION	of	_	0	SENT_88	[p3l342t544r366b572],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_88	[p3l343t390r366b537],
8	-	:	O	-	_	0	SENT_88	[p3l356t372r359b381],
9	Madison	NNP	O	Madison	parataxis	1	SENT_88	[p3l342t246r366b362],
10	on	IN	O	on	dep	9	SENT_88	[p3l350t204r366b236],
11	01/05/14	NN	DATE	01/05/14	pobj	10	SENT_88	[p3l342t77r366b194],
12	For	IN	O	for	dep	9	SENT_88	[p3l343t12r366b59],
13	the	DT	O	the	det	15	SENT_88	[p3l549t1454r599b1484],
14	modulating	JJ	O	modulating	amod	15	SENT_88	[p3l614t1454r802b1492],
15	effects	NNS	O	effect	pobj	12	SENT_88	[p3l818t1454r926b1484],
16	of	IN	O	of	_	0	SENT_88	[p3l942t1454r978b1484],
17	cisplatin	NN	O	cisplatin	prep_of	15	SENT_88	[p3l991t1454r1130b1492],
18	on	IN	O	on	_	0	SENT_88	[p3l1146t1463r1186b1484],
19	cytochrome	NN	O	cytochrome	nn	23	SENT_88	[p3l1201t1454r1395b1492],
20	P	NN	O	p	nn	23	SENT_88	[p3l1410t1454r1508b1484],
21	—	CD	NUMBER	—	number	22	SENT_88	[p3l1410t1454r1508b1484],
22	450	CD	NUMBER	450	num	23	SENT_88	[p3l1410t1454r1508b1484],
23	enzymes	NNS	O	enzyme	prep_on	17	SENT_88	[p3l1524t1463r1676b1492],
24	.	.	O	.	_	0	SENT_88	[p3l1524t1463r1676b1492],

1	Since	IN	O	since	mark	15	SENT_89	[p3l1694t1454r1784b1484],
2	the	DT	O	the	det	5	SENT_89	[p3l1799t1454r1848b1484],
3	least	JJS	O	least	amod	5	SENT_89	[p3l549t1504r625b1534],
4	toxic	JJ	O	toxic	amod	5	SENT_89	[p3l636t1504r717b1534],
5	sequence	NN	O	sequence	nsubj	15	SENT_89	[p3l731t1513r889b1542],
6	,	,	O	,	_	0	SENT_89	[p3l731t1513r889b1542],
7	paclitaxel	NN	O	paclitaxel	appos	5	SENT_89	[p3l902t1504r1062b1542],
8	followed	VBN	O	follow	partmod	7	SENT_89	[p3l1074t1504r1220b1534],
9	by	IN	O	by	_	0	SENT_89	[p3l1232t1504r1272b1542],
10	cisplatin	NN	O	cisplatin	agent	8	SENT_89	[p3l1285t1504r1433b1542],
11	,	,	O	,	_	0	SENT_89	[p3l1285t1504r1433b1542],
12	was	VBD	O	be	cop	15	SENT_89	[p3l1447t1513r1509b1534],
13	also	RB	O	also	advmod	15	SENT_89	[p3l1523t1504r1587b1534],
14	more	RBR	O	more	advmod	15	SENT_89	[p3l1600t1513r1684b1534],
15	cytotoxic	JJ	O	cytotoxic	advcl	28	SENT_89	[p3l1696t1504r1848b1542],
16	to	TO	O	to	_	0	SENT_89	[p3l549t1559r580b1583],
17	tumor	NN	O	tumor	nn	18	SENT_89	[p3l593t1559r692b1583],
18	cells	NNS	O	cell	prep_to	15	SENT_89	[p3l704t1554r778b1583],
19	in	FW	O	in	prep	18	SENT_89	[p3l791t1554r822b1583],
20	vitro	FW	O	vitro	nn	21	SENT_89	[p3l835t1554r911b1583],
21	(	FW	O	(	pobj	19	SENT_89	[p3l926t1554r1001b1590],
22	20	CD	NUMBER	20	num	23	SENT_89	[p3l926t1554r1001b1590],
23	)	NN	O	)	dep	21	SENT_89	[p3l926t1554r1001b1590],
24	,	,	O	,	_	0	SENT_89	[p3l926t1554r1001b1590],
25	it	PRP	O	it	nsubjpass	28	SENT_89	[p3l1015t1554r1038b1583],
26	was	VBD	O	be	auxpass	28	SENT_89	[p3l1050t1563r1112b1583],
27	specifically	RB	O	specifically	advmod	28	SENT_89	[p3l1127t1554r1315b1592],
28	selected	VBN	O	select	_	0	SENT_89	[p3l1329t1554r1461b1583],
29	for	IN	O	for	mark	33	SENT_89	[p3l1472t1554r1520b1583],
30	subsequent	JJ	O	subsequent	amod	32	SENT_89	[p3l1534t1554r1716b1592],
31	clinical	JJ	O	clinical	amod	32	SENT_89	[p3l1728t1554r1849b1583],
32	studies	NNS	O	study	nsubj	33	SENT_89	[p3l551t1604r662b1634],
33	(	VBP	O	(	advcl	28	SENT_89	[p3l679t1604r754b1640],
34	21	CD	NUMBER	21	num	35	SENT_89	[p3l679t1604r754b1640],
35	)	CD	NUMBER	)	dobj	33	SENT_89	[p3l679t1604r754b1640],
36	.	.	O	.	_	0	SENT_89	[p3l679t1604r754b1640],

1	Sequence	NN	O	sequence	nn	4	SENT_90	[p3l772t1604r1113b1642],
2	—	NN	O	—	nn	4	SENT_90	[p3l772t1604r1113b1642],
3	dependent	JJ	O	dependent	amod	4	SENT_90	[p3l772t1604r1113b1642],
4	effects	NNS	O	effect	nsubjpass	7	SENT_90	[p3l1127t1604r1235b1634],
5	have	VBP	O	have	aux	7	SENT_90	[p3l1250t1604r1327b1634],
6	been	VBN	O	be	auxpass	7	SENT_90	[p3l1341t1604r1419b1634],
7	described	VBN	O	describe	_	0	SENT_90	[p3l1433t1604r1591b1634],
8	with	IN	O	with	_	0	SENT_90	[p3l1605t1604r1678b1634],
9	the	DT	O	the	det	12	SENT_90	[p3l1692t1604r1741b1634],
10	paclitaxel	NN	O	paclitaxel	nn	12	SENT_90	[p3l1755t1604r1847b1642, p3l549t1654r843b1684],
11	—	NN	O	—	nn	12	SENT_90	[p3l1755t1604r1847b1642, p3l549t1654r843b1684],
12	doxorubicin	NN	O	doxorubicin	prep_with	7	SENT_90	[p3l1755t1604r1847b1642, p3l549t1654r843b1684],
13	(	CD	NUMBER	(	num	15	SENT_90	[p3l866t1655r962b1690],
14	more	JJR	O	more	amod	15	SENT_90	[p3l866t1655r962b1690],
15	toxicity	NN	O	toxicity	dep	7	SENT_90	[p3l984t1654r1109b1692],
16	and	CC	O	and	_	0	SENT_90	[p3l1132t1654r1190b1684],
17	reduced	VBD	O	reduce	conj_and	7	SENT_90	[p3l1211t1654r1342b1684],
18	doxorubicin	NN	O	doxorubicin	nn	19	SENT_90	[p3l1364t1654r1562b1684],
19	clearance	NN	O	clearance	dobj	17	SENT_90	[p3l1584t1654r1739b1684],
20	when	WRB	O	when	advmod	22	SENT_90	[p3l1761t1654r1850b1684],
21	paclitaxel	NN	O	paclitaxel	nsubj	22	SENT_90	[p3l549t1704r709b1742],
22	preceeds	VBZ	O	preceed	advcl	17	SENT_90	[p3l726t1704r869b1742],
23	doxorubicin	NN	O	doxorubicin	nn	24	SENT_90	[p3l889t1704r1100b1740],
24	)	NN	O	)	nsubj	30	SENT_90	[p3l889t1704r1100b1740],
25	and	CC	O	and	_	0	SENT_90	[p3l1120t1704r1179b1733],
26	paclitaxel	NN	O	paclitaxel	nn	29	SENT_90	[p3l1196t1704r1680b1742],
27	—	CD	NUMBER	—	num	29	SENT_90	[p3l1196t1704r1680b1742],
28	cyclophosphamide	NN	O	cyclophosphamide	nn	29	SENT_90	[p3l1196t1704r1680b1742],
29	regimens	NNS	O	regimen	nsubj	30	SENT_90	[p3l1697t1704r1848b1742],
30	(	VBP	O	(	ccomp	22	SENT_90	[p3l551t1755r647b1790],
31	more	JJR	O	more	amod	32	SENT_90	[p3l551t1755r647b1790],
32	toxicity	NN	O	toxicity	dobj	30	SENT_90	[p3l664t1754r789b1792],
33	when	WRB	O	when	advmod	35	SENT_90	[p3l806t1754r895b1784],
34	paclitaxel	NN	O	paclitaxel	nsubj	35	SENT_90	[p3l911t1754r1071b1792],
35	preceeds	VBZ	O	preceed	advcl	30	SENT_90	[p3l1087t1754r1230b1792],
36	cyclophosphamide	NN	O	cyclophosphamide	nn	37	SENT_90	[p3l1248t1754r1570b1792],
37	)	NN	O	)	dobj	35	SENT_90	[p3l1248t1754r1570b1792],
38	(	CD	NUMBER	(	num	39	SENT_90	[p3l1589t1754r1651b1790],
39	22	CD	NUMBER	22	tmod	35	SENT_90	[p3l1589t1754r1651b1790],
40	,	,	O	,	_	0	SENT_90	[p3l1589t1754r1651b1790],
41	23	CD	NUMBER	23	num	42	SENT_90	[p3l1670t1754r1732b1790],
42	)	NN	O	)	appos	39	SENT_90	[p3l1670t1754r1732b1790],
43	.	.	O	.	_	0	SENT_90	[p3l1670t1754r1732b1790],

1	These	DT	O	these	det	2	SENT_91	[p3l1751t1754r1848b1784],
2	effects	NNS	O	effect	nsubjpass	5	SENT_91	[p3l550t1804r658b1834],
3	have	VBP	O	have	aux	5	SENT_91	[p3l674t1804r752b1834],
4	been	VBN	O	be	auxpass	5	SENT_91	[p3l768t1804r846b1834],
5	noted	VBN	O	note	_	0	SENT_91	[p3l862t1804r953b1834],
6	only	RB	O	only	advmod	5	SENT_91	[p3l970t1804r1042b1842],
7	with	IN	O	with	_	0	SENT_91	[p3l1059t1804r1131b1834],
8	prolonged	JJ	O	prolonged	amod	11	SENT_91	[p3l1147t1804r1315b1842],
9	(	NN	O	(	nn	11	SENT_91	[p3l1333t1804r1385b1840],
10	24	CD	NUMBER	24	num	11	SENT_91	[p3l1333t1804r1385b1840],
11	h	NN	O	h	prep_with	5	SENT_91	[p3l1402t1804r1434b1840],
12	)	CD	NUMBER	)	num	13	SENT_91	[p3l1402t1804r1434b1840],
13	schedules	NNS	O	schedule	dobj	5	SENT_91	[p3l1454t1804r1611b1834],
14	of	IN	O	of	_	0	SENT_91	[p3l1629t1804r1665b1834],
15	paclitaxel	NN	O	paclitaxel	prep_of	13	SENT_91	[p3l1678t1804r1847b1842],
16	.	.	O	.	_	0	SENT_91	[p3l1678t1804r1847b1842],

1	Sequence	NN	O	sequence	nn	2	SENT_92	[p3l550t1854r891b1892],
2	—	NN	O	—	nsubjpass	9	SENT_92	[p3l550t1854r891b1892],
3	dependent	JJ	O	dependent	amod	5	SENT_92	[p3l550t1854r891b1892],
4	cytotoxic	JJ	O	cytotoxic	amod	5	SENT_92	[p3l909t1854r1061b1892],
5	effects	NNS	O	effect	dep	2	SENT_92	[p3l1081t1854r1189b1883],
6	have	VBP	O	have	aux	9	SENT_92	[p3l1208t1854r1285b1883],
7	also	RB	O	also	advmod	9	SENT_92	[p3l1305t1854r1370b1883],
8	been	VBN	O	be	auxpass	9	SENT_92	[p3l1388t1854r1466b1883],
9	observed	VBN	O	observe	_	0	SENT_92	[p3l1485t1854r1633b1883],
10	in	FW	O	in	nn	11	SENT_92	[p3l1651t1854r1683b1883],
11	vitro	FW	O	vitro	advmod	9	SENT_92	[p3l1701t1854r1778b1883],
12	between	IN	O	between	_	0	SENT_92	[p3l1796t1854r1847b1883, p3l549t1909r647b1933],
13	paclitaxel	NN	O	paclitaxel	prep_between	9	SENT_92	[p3l666t1904r826b1942],
14	and	CC	O	and	_	0	SENT_92	[p3l847t1904r905b1933],
15	melphalan	NN	O	melphalan	prep_between	9	SENT_92	[p3l925t1904r1105b1942],
16	,	,	O	,	_	0	SENT_92	[p3l925t1904r1105b1942],
17	etoposide	NN	O	etoposide	prep_between	9	SENT_92	[p3l1126t1904r1293b1942],
18	,	,	O	,	_	0	SENT_92	[p3l1126t1904r1293b1942],
19	5	CD	NUMBER	5	num	21	SENT_92	[p3l1314t1904r1531b1938],
20	—	NN	O	—	nn	21	SENT_92	[p3l1314t1904r1531b1938],
21	ﬂuoruracil	NN	O	ﬂuoruracil	conj_and	13	SENT_92	[p3l1314t1904r1531b1938],
22	,	,	O	,	_	0	SENT_92	[p3l1314t1904r1531b1938],
23	estramustine	NN	O	estramustine	conj_and	13	SENT_92	[p3l1552t1904r1769b1939],
24	,	,	O	,	_	0	SENT_92	[p3l1552t1904r1769b1939],
25	and	CC	O	and	_	0	SENT_92	[p3l1791t1904r1849b1933],
26	gallium	NN	O	gallium	nn	27	SENT_92	[p3l550t1954r675b1992],
27	nitrate	NN	O	nitrate	conj_and	13	SENT_92	[p3l686t1954r799b1984],
28	.	.	O	.	_	0	SENT_92	[p3l686t1954r799b1984],

1	Other	JJ	O	other	amod	4	SENT_93	[p3l600t2004r693b2034],
2	intriguing	JJ	O	intriguing	amod	4	SENT_93	[p3l709t2004r870b2042],
3	drug	NN	O	drug	nn	4	SENT_93	[p3l887t2004r961b2042],
4	interactions	NNS	O	interaction	nsubjpass	8	SENT_93	[p3l977t2004r1169b2033],
5	have	VBP	O	have	aux	8	SENT_93	[p3l1185t2004r1262b2034],
6	also	RB	O	also	advmod	8	SENT_93	[p3l1279t2004r1343b2033],
7	been	VBN	O	be	auxpass	8	SENT_93	[p3l1359t2004r1437b2033],
8	observed	VBN	O	observe	_	0	SENT_93	[p3l1453t2004r1609b2034],
9	.	.	O	.	_	0	SENT_93	[p3l1453t2004r1609b2034],

1	For	IN	O	for	_	0	SENT_94	[p3l1627t2005r1684b2033],
2	example	NN	O	example	prep_for	10	SENT_94	[p3l1699t2004r1847b2042],
3	,	,	O	,	_	0	SENT_94	[p3l1699t2004r1847b2042],
4	the	DT	O	the	det	5	SENT_94	[p3l549t2054r599b2083],
5	combination	NN	O	combination	nsubj	10	SENT_94	[p3l618t2054r824b2083],
6	of	IN	O	of	_	0	SENT_94	[p3l844t2054r880b2083],
7	paclitaxel	NN	O	paclitaxel	prep_of	5	SENT_94	[p3l896t2054r1056b2092],
8	and	CC	O	and	_	0	SENT_94	[p3l1075t2054r1134b2083],
9	carboplatin	NN	O	carboplatin	prep_of	5	SENT_94	[p3l1153t2054r1338b2092],
10	seems	VBZ	O	seem	_	0	SENT_94	[p3l1358t2063r1456b2083],
11	to	TO	O	to	aux	12	SENT_94	[p3l1476t2059r1506b2083],
12	produce	VB	O	produce	xcomp	10	SENT_94	[p3l1526t2054r1658b2092],
13	equivalent	JJ	O	equivalent	amod	14	SENT_94	[p3l1678t2054r1849b2092],
14	neutropenia	NN	O	neutropenia	dobj	12	SENT_94	[p3l549t2104r744b2141],
15	and	CC	O	and	_	0	SENT_94	[p3l762t2104r820b2133],
16	less	JJR	O	less	amod	17	SENT_94	[p3l838t2104r898b2133],
17	thrombocytopenia	NN	O	thrombocytopenia	dobj	12	SENT_94	[p3l917t2104r1219b2141],
18	than	IN	O	than	_	0	SENT_94	[p3l1236t2104r1306b2133],
19	either	CC	O	either	preconj	20	SENT_94	[p3l1324t2104r1418b2133],
20	carboplatin	NN	O	carboplatin	prep_than	12	SENT_94	[p3l1435t2104r1620b2141],
21	or	CC	O	or	_	0	SENT_94	[p3l1638t2113r1672b2133],
22	paclitaxel	NN	O	paclitaxel	prep_than	12	SENT_94	[p3l1689t2104r1849b2141],
23	alone	RB	O	alone	advmod	22	SENT_94	[p3l550t2154r638b2183],
24	(	RB	O	(	advmod	12	SENT_94	[p3l654t2154r729b2189],
25	24	CD	NUMBER	24	num	26	SENT_94	[p3l654t2154r729b2189],
26	)	NN	O	)	dobj	12	SENT_94	[p3l654t2154r729b2189],
27	.	.	O	.	_	0	SENT_94	[p3l654t2154r729b2189],

1	Less	RBR	O	less	amod	2	SENT_95	[p3l745t2154r819b2183],
2	toxicity	NN	O	toxicity	nsubjpass	9	SENT_95	[p3l835t2154r960b2191],
3	and	CC	O	and	_	0	SENT_95	[p3l975t2154r1033b2183],
4	greater	JJR	O	greater	amod	5	SENT_95	[p3l1048t2158r1163b2191],
5	efficacy	NN	O	efficacy	conj_and	2	SENT_95	[p3l1176t2154r1308b2191],
6	have	VBP	O	have	aux	9	SENT_95	[p3l1322t2154r1399b2183],
7	also	RB	O	also	advmod	9	SENT_95	[p3l1414t2154r1479b2183],
8	been	VBN	O	be	auxpass	9	SENT_95	[p3l1493t2154r1571b2183],
9	noted	VBN	O	note	_	0	SENT_95	[p3l1586t2154r1677b2183],
10	in	IN	O	in	_	0	SENT_95	[p3l1691t2154r1722b2182],
11	animal	JJ	O	animal	amod	13	SENT_95	[p3l1738t2154r1848b2183],
12	tumor	NN	O	tumor	nn	13	SENT_95	[p3l549t2208r648b2233],
13	models	NNS	O	model	prep_in	9	SENT_95	[p3l665t2204r783b2233],
14	following	VBG	O	follow	_	0	SENT_95	[p3l802t2204r961b2241],
15	treatment	NN	O	treatment	prep_following	13	SENT_95	[p3l979t2208r1136b2233],
16	with	IN	O	with	_	0	SENT_95	[p3l1153t2204r1225b2233],
17	the	DT	O	the	det	18	SENT_95	[p3l1243t2204r1292b2233],
18	combination	NN	O	combination	prep_with	15	SENT_95	[p3l1311t2204r1516b2233],
19	of	IN	O	of	_	0	SENT_95	[p3l1534t2204r1570b2233],
20	vinorelbine	NN	O	vinorelbine	prep_of	18	SENT_95	[p3l1585t2204r1772b2233],
21	and	CC	O	and	_	0	SENT_95	[p3l1791t2204r1849b2233],
22	either	CC	O	either	preconj	23	SENT_95	[p3l550t2254r643b2283],
23	paclitaxel	NN	O	paclitaxel	conj_and	18	SENT_95	[p3l659t2254r819b2292],
24	or	CC	O	or	_	0	SENT_95	[p3l836t2263r870b2283],
25	docetaxel	NN	O	docetaxel	conj_and	18	SENT_95	[p3l887t2254r1044b2283],
26	compared	VBN	O	compare	_	0	SENT_95	[p3l1061t2254r1223b2292],
27	with	IN	O	with	prepc_compared_with	9	SENT_95	[p3l1240t2254r1312b2283],
28	any	DT	O	any	pobj	9	SENT_95	[p3l1330t2263r1388b2292],
29	of	IN	O	of	_	0	SENT_95	[p3l1406t2254r1441b2283],
30	these	DT	O	these	det	31	SENT_95	[p3l1456t2254r1540b2283],
31	agents	NNS	O	agent	prep_of	28	SENT_95	[p3l1557t2258r1660b2292],
32	alone	RB	O	alone	advmod	31	SENT_95	[p3l1679t2254r1767b2283],
33	(	RB	O	(	advmod	28	SENT_95	[p3l1785t2254r1847b2290],
34	25	CD	NUMBER	25	dep	28	SENT_95	[p3l1785t2254r1847b2290],
35	,	,	O	,	_	0	SENT_95	[p3l1785t2254r1847b2290],
36	26	CD	NUMBER	26	num	37	SENT_95	[p3l550t2304r612b2340],
37	)	NN	O	)	appos	34	SENT_95	[p3l550t2304r612b2340],
38	.	.	O	.	_	0	SENT_95	[p3l550t2304r612b2340],

1	Table	NNP	O	Table	_	0	SENT_96	[p3l558t2510r637b2533],
2	1	CD	NUMBER	1	num	1	SENT_96	[p3l648t2509r661b2533],
3	Summary	NNP	O	Summary	dep	1	SENT_96	[p3l694t2510r821b2540],
4	of	IN	O	of	_	0	SENT_96	[p3l831t2510r859b2533],
5	the	DT	O	the	det	7	SENT_96	[p3l866t2510r905b2533],
6	pharmacologic	JJ	O	pharmacologic	amod	7	SENT_96	[p3l914t2510r1110b2540],
7	characteristics	NNS	O	characteristic	prep_of	3	SENT_96	[p3l1120t2510r1307b2533],
8	of	IN	O	of	_	0	SENT_96	[p3l1317t2510r1346b2533],
9	paclitaxel	NN	O	paclitaxel	prep_of	7	SENT_96	[p3l1352t2510r1480b2540],
10	and	CC	O	and	_	0	SENT_96	[p3l1490t2510r1536b2533],
11	docetaxela	NN	O	docetaxelum	prep_of	7	SENT_96	[p3l1545t2505r1682b2533],

1	-374	CD	NUMBER	-374	_	0	SENT_97	[p3l309t2537r332b2603],
2	.	.	O	.	_	0	SENT_97	[p3l309t2537r332b2603],

1	Downlo	NNP	PERSON	Downlo	nsubj	2	SENT_98	[p3l309t2419r332b2526],
2	aded	VBD	O	ade	_	0	SENT_98	[p3l309t2347r332b2409],
3	from	IN	O	from	_	0	SENT_98	[p3l309t2273r332b2338],
4	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	2	SENT_98	[p3l309t1940r339b2264],
5	-	:	O	-	_	0	SENT_98	[p3l356t2591r359b2600],
6	Madison	NNP	O	Madison	dep	4	SENT_98	[p3l342t2465r366b2581],
7	on	IN	O	on	dep	6	SENT_98	[p3l350t2423r366b2455],
8	01/05/14	NN	DATE	01/05/14	pobj	7	SENT_98	[p3l342t2287r366b2405],
9	For	IN	O	for	dep	6	SENT_98	[p3l343t2223r366b2270],
10	personal	JJ	O	personal	amod	11	SENT_98	[p3l342t2103r373b2215],
11	use	NN	O	use	pobj	9	SENT_98	[p3l350t2050r366b2094],
12	only	RB	O	only	advmod	2	SENT_98	[p3l342t1983r373b2041],

1	Characteristic	JJ	O	characteristic	amod	3	SENT_99	[p3l557t2569r740b2593],
2	Paclitaxel	NN	O	paclitaxel	nn	3	SENT_99	[p3l991t2569r1120b2592],
3	Docetaxel	NN	O	docetaxel	_	0	SENT_99	[p3l1425t2569r1558b2592],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_100	[p3l806t2643r1517b2717],
2	behavior	NN	O	behavior	_	0	SENT_100	[p3l1547t2643r1920b2718],

1	:	:	O	:	_	0	SENT_101	[p3l31t2803r82b2816],
2	353	CD	NUMBER	353	num	3	SENT_101	[p3l7t2614r83b2764],
3	iscor	NN	O	iscor	_	0	SENT_101	[p3l137t2800r189b2999],
4	isin	NN	O	isin	dep	3	SENT_101	[p3l114t2623r189b2773],

1	Optimal	JJ	O	optimal	amod	3	SENT_102	[p3l807t2819r1153b2916],
2	linear	JJ	O	linear	amod	3	SENT_102	[p3l1181t2819r1422b2893],
3	model	NN	O	model	_	0	SENT_102	[p3l1449t2819r1712b2893],

1	Elimination	NN	O	elimination	nn	2	SENT_103	[p3l805t2968r1305b3043],
2	half-life	NN	O	half-life	_	0	SENT_103	[p3l1332t2968r1672b3043],

1	2	CD	NUMBER	2	num	2	SENT_104	[p3l907t3089r954b3163],
2	compartments	NNS	O	compartment	_	0	SENT_104	[p3l984t3100r1583b3186],
3	3	CD	NUMBER	3	num	4	SENT_104	[p3l907t3210r950b3285],
4	compartments	NNS	O	compartment	dep	2	SENT_104	[p3l985t3221r1583b3306],

1	Med	NNP	O	Med	_	0	SENT_105	[p3l7t3206r81b3422],
2	.	.	O	.	_	0	SENT_105	[p3l7t3206r81b3422],

1	1997.48	CD	NUMBER	1997.48	_	0	SENT_106	[p3l7t2830r83b3161],

1	rsity	NN	O	rsity	_	0	SENT_107	[p3l114t3246r212b3435],
2	of	IN	O	of	_	0	SENT_107	[p3l114t3123r189b3215],
3	W	NN	O	w	prep_of	1	SENT_107	[p3l116t3001r189b3102],

1	Volume	NN	O	volume	_	0	SENT_108	[p3l806t3359r1147b3435],
2	of	IN	O	of	dep	1	SENT_108	[p3l1177t3359r1269b3434],
3	distribution	NN	O	distribution	pobj	2	SENT_108	[p3l1292t3359r1778b3434],
4	at	IN	O	at	dep	1	SENT_108	[p3l1807t3370r1881b3434],

1	A	DT	O	a	det	2	SENT_109	[p4l7t465r81b539],
2	nnu	NN	O	nnu	_	0	SENT_109	[p4l31t253r81b433],
3	.	.	O	.	_	0	SENT_109	[p4l31t253r81b433],

1	Rev.	NNP	O	Rev.	_	0	SENT_110	[p4l9t27r82b218],

1	by	IN	O	by	_	0	SENT_111	[p4l114t296r212b401],
2	Unive	NNP	O	Unive	nn	4	SENT_111	[p4l114t8r189b266],
3	steady	JJ	O	steady	amod	4	SENT_111	[p4l1007t50r1271b147],
4	state	NN	O	state	pobj	1	SENT_111	[p4l1306t61r1493b124],

1	Peak	JJ	O	peak	amod	3	SENT_112	[p4l805t200r1014b275],
2	plasma	NN	O	plasma	nn	3	SENT_112	[p4l1039t200r1342b297],
3	concentrations	NNS	O	concentration	_	0	SENT_112	[p4l1371t199r1984b275],

1	Plasma	NN	O	plasma	_	0	SENT_113	[p4l806t775r1115b851],
2	protein	NN	O	protein	nn	5	SENT_113	[p4l1140t775r1440b873],
3	binding	NN	O	binding	nn	5	SENT_113	[p4l1467t775r1788b873],
4	Tissue	NN	O	tissue	nn	5	SENT_113	[p4l806t908r1081b984],
5	distribution	NN	O	distribution	dep	1	SENT_113	[p4l1113t908r1598b984],

1	Systemic	JJ	O	systemic	amod	4	SENT_114	[p4l809t1178r1194b1276],
2	clearance	NN	O	clearance	nn	4	SENT_114	[p4l1224t1178r1622b1254],
3	Renal	JJ	MISC	renal	amod	4	SENT_114	[p4l805t1311r1054b1387],
4	clearance	NN	O	clearance	_	0	SENT_114	[p4l1081t1311r1482b1387],
5	Hepatic	JJ	O	hepatic	amod	7	SENT_114	[p4l806t1445r1133b1543],
6	clearance	NN	O	clearance	nn	7	SENT_114	[p4l1164t1445r1565b1520],
7	Nature	NN	O	nature	dep	4	SENT_114	[p4l805t1581r1092b1654],
8	of	IN	O	of	_	0	SENT_114	[p4l1124t1578r1216b1653],
9	hepatic	JJ	O	hepatic	amod	10	SENT_114	[p4l1237t1578r1540b1676],
10	disposition	NN	O	disposition	prep_of	7	SENT_114	[p4l1572t1578r2036b1676],

1	Drug	NN	O	drug	nn	2	SENT_115	[p4l805t1921r1023b2016],
2	interactions	NNS	O	interaction	_	0	SENT_115	[p4l1052t1918r1542b1993],

1	Nonlinear	JJ	O	nonlinear	_	0	SENT_116	[p4l43t2207r369b2264],
2	2-3	CD	NUMBER	2-3	num	3	SENT_116	[p4l45t2310r160b2368],
3	compartments	NNS	O	compartment	dep	1	SENT_116	[p4l187t2319r643b2384],

1	~	NN	O	~	nn	4	SENT_117	[p4l45t2517r124b2573],
2	7	CD	NUMBER	7	num	4	SENT_117	[p4l45t2517r124b2573],
3	h	NN	O	h	nn	4	SENT_117	[p4l148t2516r188b2573],
4	~	NN	O	~	_	0	SENT_117	[p4l45t2608r167b2666],
5	20	CD	NUMBER	20	num	6	SENT_117	[p4l45t2608r167b2666],
6	h	NN	O	h	dep	4	SENT_117	[p4l189t2608r229b2665],
7	Large	JJ	O	large	dep	4	SENT_117	[p4l43t2723r250b2796],
8	,	,	O	,	_	0	SENT_117	[p4l43t2723r250b2796],
9	~	NN	O	~	nn	11	SENT_117	[p4l277t2722r438b2780],
10	182	CD	NUMBER	182	num	11	SENT_117	[p4l277t2722r438b2780],
11	liters/m2	NN	O	liters/m2	appos	7	SENT_117	[p4l461t2705r736b2780],

1	Linear	JJ	O	linear	_	0	SENT_118	[p4l1110t2207r1323b2264],
2	2-3	CD	NUMBER	2-3	num	3	SENT_118	[p4l1112t2310r1227b2368],
3	compartments	NNS	O	compartment	dep	1	SENT_118	[p4l1253t2319r1710b2384],

1	~	NN	O	~	_	0	SENT_119	[p4l1112t2516r1295b2573],
2	12h	CD	NUMBER	12h	num	3	SENT_119	[p4l1112t2516r1295b2573],
3	~	NN	O	~	dep	1	SENT_119	[p4l1112t2608r1230b2666],
4	13	CD	NUMBER	13	num	5	SENT_119	[p4l1112t2608r1230b2666],
5	h	NN	O	h	npadvmod	6	SENT_119	[p4l1256t2608r1295b2665],
6	Large	JJ	O	large	amod	3	SENT_119	[p4l1109t2724r1316b2797],
7	,	,	O	,	_	0	SENT_119	[p4l1109t2724r1316b2797],
8	~	NN	O	~	nn	10	SENT_119	[p4l1343t2723r1464b2780],
9	74	CD	NUMBER	74	num	10	SENT_119	[p4l1343t2723r1464b2780],
10	liters/m2	NN	O	liters/m2	appos	3	SENT_119	[p4l1487t2705r1762b2780],

1	~	NN	O	~	nn	4	SENT_120	[p4l45t2937r123b2995],
2	5	CD	NUMBER	5	num	4	SENT_120	[p4l45t2937r123b2995],
3	uM	NN	O	um	nn	4	SENT_120	[p4l150t2939r266b3012],
4	(	NN	O	(	dep	14	SENT_120	[p4l291t2937r432b3008],
5	175	CD	NUMBER	175	num	6	SENT_120	[p4l291t2937r432b3008],
6	mg/m2	NN	O	mg/m2	dep	4	SENT_120	[p4l457t2920r675b3012],
7	over	IN	O	over	_	0	SENT_120	[p4l699t2956r843b2995],
8	3	CD	NUMBER	3	prep_over	6	SENT_120	[p4l865t2938r898b2995],
9	h	NN	O	h	dep	14	SENT_120	[p4l924t2937r988b3008],
10	)	CD	NUMBER	)	num	9	SENT_120	[p4l924t2937r988b3008],
11	~	NN	O	~	nn	14	SENT_120	[p4l1112t2938r1189b2995],
12	3	CD	NUMBER	3	num	14	SENT_120	[p4l1112t2938r1189b2995],
13	uM	NN	O	um	nn	14	SENT_120	[p4l1217t2939r1332b3011],
14	(	NN	O	(	dep	19	SENT_120	[p4l1358t2938r1502b3007],
15	100	CD	NUMBER	100	num	16	SENT_120	[p4l1358t2938r1502b3007],
16	mg/m2	NN	O	mg/m2	dep	14	SENT_120	[p4l1524t2920r1742b3012],
17	over	IN	O	over	_	0	SENT_120	[p4l1765t2956r1909b2995],
18	1	CD	NUMBER	1	prep_over	16	SENT_120	[p4l1937t2938r1961b2994],
19	h	NN	O	h	dep	24	SENT_120	[p4l1990t2938r2054b3008],
20	)	CD	NUMBER	)	num	19	SENT_120	[p4l1990t2938r2054b3008],
21	~	NN	O	~	nn	24	SENT_120	[p4l45t3037r167b3095],
22	10	CD	NUMBER	10	num	24	SENT_120	[p4l45t3037r167b3095],
23	uM	NN	O	um	nn	24	SENT_120	[p4l191t3038r306b3111],
24	(	NN	O	(	dep	32	SENT_120	[p4l332t3037r476b3108],
25	250	CD	NUMBER	250	num	26	SENT_120	[p4l332t3037r476b3108],
26	mg/m2	NN	O	mg/m2	dep	24	SENT_120	[p4l498t3020r716b3111],
27	over	IN	O	over	_	0	SENT_120	[p4l739t3056r883b3095],
28	3	CD	NUMBER	3	num	29	SENT_120	[p4l905t3038r938b3095],
29	h	NN	O	h	prep_over	26	SENT_120	[p4l964t3037r1028b3108],
30	)	CD	NUMBER	)	num	32	SENT_120	[p4l964t3037r1028b3108],
31	~	NN	O	~	nn	32	SENT_120	[p4l46t3138r184b3196],
32	O.	NNP	O	O.	dep	38	SENT_120	[p4l46t3138r184b3196],
33	5	CD	NUMBER	5	number	34	SENT_120	[p4l46t3138r184b3196],
34	[	CD	NUMBER	[	dep	32	SENT_120	[p4l211t3140r327b3212],
35	AM	NNP	O	AM	nn	36	SENT_120	[p4l211t3140r327b3212],
36	(	NN	O	(	dep	34	SENT_120	[p4l352t3138r492b3209],
37	175	CD	NUMBER	175	num	38	SENT_120	[p4l352t3138r492b3209],
38	mg/m2	NN	O	mg/m2	_	0	SENT_120	[p4l519t3121r736b3212],

1	over	IN	O	over	dep	4	SENT_121	[p4l120t3247r263b3287],
2	24	CD	NUMBER	24	num	3	SENT_121	[p4l284t3230r362b3286],
3	h	NN	O	h	pobj	1	SENT_121	[p4l385t3229r449b3300],
4	)	CD	NUMBER	)	_	0	SENT_121	[p4l385t3229r449b3300],

1	>	JJR	O	>	_	0	SENT_122	[p4l44t3330r235b3389],
2	95	CD	PERCENT	95	num	3	SENT_122	[p4l44t3330r235b3389],
3	%	NN	PERCENT	%	npadvmod	4	SENT_122	[p4l44t3330r235b3389],
4	>	JJR	O	>	dep	1	SENT_122	[p4l1112t3331r1302b3389],
5	90	CD	PERCENT	90	num	6	SENT_122	[p4l1112t3331r1302b3389],
6	%	NN	PERCENT	%	npadvmod	7	SENT_122	[p4l1112t3331r1302b3389],
7	Extensive	JJ	O	extensive	dep	4	SENT_122	[p4l43t3431r362b3489],
8	except	IN	O	except	_	0	SENT_122	[p4l386t3440r597b3505],
9	CNS	NN	O	cn	prep_except	7	SENT_122	[p4l618t3432r771b3489],
10	and	CC	O	and	_	0	SENT_122	[p4l798t3431r913b3489],
11	Extensive	JJ	O	extensive	dep	1	SENT_122	[p4l1109t3431r1428b3489],
12	except	IN	O	except	_	0	SENT_122	[p4l1452t3440r1662b3505],
13	CNS	NN	O	cn	prep_except	11	SENT_122	[p4l1684t3432r1837b3489],

1	testes	NNS	O	testis	_	0	SENT_123	[p4l119t3530r295b3579],

1	~	NN	O	~	nn	4	SENT_124	[p4l45t3635r208b3693],
2	350	CD	NUMBER	350	num	4	SENT_124	[p4l45t3635r208b3693],
3	ml/min/m2	NN	O	ml/min/m2	nn	4	SENT_124	[p4l230t3618r577b3693],
4	~	NN	O	~	dep	13	SENT_124	[p4l1112t3636r1274b3693],
5	300	CD	NUMBER	300	num	7	SENT_124	[p4l1112t3636r1274b3693],
6	ml/min/m2	NN	O	ml/min/m2	nn	7	SENT_124	[p4l1296t3618r1644b3693],
7	Minor	NNP	O	Minor	dep	4	SENT_124	[p4l43t3737r262b3805],
8	,	,	O	,	_	0	SENT_124	[p4l43t3737r262b3805],
9	<	JJR	O	<	appos	7	SENT_124	[p4l288t3737r559b3795],
10	5	CD	NUMBER	5	num	11	SENT_124	[p4l288t3737r559b3795],
11	—	NN	O	—	dep	13	SENT_124	[p4l288t3737r559b3795],
12	l0	CD	PERCENT	l0	num	13	SENT_124	[p4l288t3737r559b3795],
13	%	NN	PERCENT	%	dep	18	SENT_124	[p4l288t3737r559b3795],
14	Minor	NNP	O	Minor	dep	13	SENT_124	[p4l1110t3737r1329b3805],
15	,	,	O	,	_	0	SENT_124	[p4l1110t3737r1329b3805],
16	<	JJR	O	<	appos	14	SENT_124	[p4l1355t3737r1626b3795],
17	5	CD	NUMBER	5	num	18	SENT_124	[p4l1355t3737r1626b3795],
18	—	NN	O	—	dep	20	SENT_124	[p4l1355t3737r1626b3795],
19	l0	CD	PERCENT	l0	num	20	SENT_124	[p4l1355t3737r1626b3795],
20	%	NN	PERCENT	%	_	0	SENT_124	[p4l1355t3737r1626b3795],

1	Significant	JJ	O	significant	_	0	SENT_125	[p5l45t26r416b101],
2	,	,	O	,	_	0	SENT_125	[p5l45t26r416b101],
3	70-80	CD	PERCENT	70-80	num	4	SENT_125	[p5l441t27r706b84],
4	%	NN	PERCENT	%	appos	1	SENT_125	[p5l441t27r706b84],
5	in	IN	O	in	_	0	SENT_125	[p5l732t26r794b83],
6	feces	NNS	O	fece	prep_in	4	SENT_125	[p5l815t26r979b84],
7	Significant	JJ	O	significant	dep	1	SENT_125	[p5l1113t26r1482b100],
8	,	,	O	,	_	0	SENT_125	[p5l1113t26r1482b100],
9	70-80	CD	PERCENT	70-80	num	10	SENT_125	[p5l1508t27r1773b84],
10	%	NN	PERCENT	%	appos	7	SENT_125	[p5l1508t27r1773b84],
11	in	IN	O	in	_	0	SENT_125	[p5l1799t26r1861b83],
12	feces	NNS	O	fece	prep_in	10	SENT_125	[p5l1882t26r2046b84],

1	Inactivation	NN	O	inactivation	_	0	SENT_126	[p5l44t127r446b195],
2	,	,	O	,	_	0	SENT_126	[p5l44t127r446b195],
3	hydroxylation	NN	O	hydroxylation	nn	7	SENT_126	[p5l471t127r942b201],
4	,	,	O	,	_	0	SENT_126	[p5l471t127r942b201],
5	Inactivation	NN	O	inactivation	dep	7	SENT_126	[p5l1110t127r1512b195],
6	,	,	O	,	_	0	SENT_126	[p5l1110t127r1512b195],
7	oxidation	NN	O	oxidation	dep	1	SENT_126	[p5l1539t127r1860b195],
8	,	,	O	,	_	0	SENT_126	[p5l1539t127r1860b195],

1	cytochrome	NN	O	cytochrome	nn	2	SENT_127	[p5l119t218r501b292],
2	P450	NN	O	p450	_	0	SENT_127	[p5l523t218r706b286],
3	,	,	O	,	_	0	SENT_127	[p5l523t218r706b286],
4	primarily	RB	O	primarily	dep	6	SENT_127	[p5l730t218r1031b293],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_127	[p5l1186t218r1567b292],
6	P450	NN	O	p450	dep	2	SENT_127	[p5l1589t218r1773b286],
7	,	,	O	,	_	0	SENT_127	[p5l1589t218r1773b286],
8	primarily	RB	O	primarily	advmod	10	SENT_127	[p5l1797t218r2098b292],
9	CYP3A	NN	O	cyp3a	nn	10	SENT_127	[p5l120t310r375b367],
10	CYP3A	NN	O	cyp3a	appos	6	SENT_127	[p5l1186t310r1442b367],

1	P450	NN	O	p450	nn	2	SENT_128	[p5l43t410r209b468],
2	inducers	NNS	O	inducer	_	0	SENT_128	[p5l231t410r503b468],
3	and	CC	O	and	_	0	SENT_128	[p5l530t410r645b468],
4	inhibitors	NNS	O	inhibitor	conj_and	2	SENT_128	[p5l665t410r972b468],
5	P450	NN	O	p450	nn	6	SENT_128	[p5l1111t410r1277b468],
6	inducers	NNS	O	inducer	dep	2	SENT_128	[p5l1299t410r1571b468],
7	and	CC	O	and	_	0	SENT_128	[p5l1598t410r1713b468],
8	inhibitors	NNS	O	inhibitor	dep	2	SENT_128	[p5l1733t410r2040b468],
9	aFrom	NN	O	afrom	nn	10	SENT_128	[p5l656t504r738b533],
10	References	NNS	O	reference	dep	2	SENT_128	[p5l746t509r893b533],
11	18	CD	NUMBER	18	dep	10	SENT_128	[p5l905t509r941b537],
12	,	,	O	,	_	0	SENT_128	[p5l905t509r941b537],
13	27	CD	NUMBER	27	num	11	SENT_128	[p5l952t509r991b537],
14	,	,	O	,	_	0	SENT_128	[p5l952t509r991b537],
15	and	CC	NUMBER	and	_	0	SENT_128	[p5l1002t509r1049b533],
16	48	CD	NUMBER	48	dep	10	SENT_128	[p5l1057t509r1096b533],
17	.	.	O	.	_	0	SENT_128	[p5l1057t509r1096b533],

1	CNS	NNS	O	cn	_	0	SENT_129	[p5l1107t509r1177b537],
2	,	,	O	,	_	0	SENT_129	[p5l1107t509r1177b537],
3	Central	NNP	O	Central	nn	5	SENT_129	[p5l1188t509r1284b533],
4	nervous	JJ	O	nervous	amod	5	SENT_129	[p5l1293t517r1396b533],
5	system	NN	O	system	appos	1	SENT_129	[p5l1407t513r1504b540],
6	.	.	O	.	_	0	SENT_129	[p5l1407t513r1504b540],

1	358	CD	NUMBER	358	num	2	SENT_130	[p5l551t615r604b641],
2	ROWINSKY	NN	O	rowinsky	_	0	SENT_130	[p5l644t615r844b641],

1	DOCETAXEL	NNP	O	DOCETAXEL	nn	4	SENT_131	[p5l550t705r748b729],
2	The	NNP	O	The	nn	4	SENT_131	[p5l787t699r851b729],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_131	[p5l870t699r1145b737],
4	behavior	NN	O	behavior	nsubj	10	SENT_131	[p5l1165t699r1310b729],
5	of	IN	O	of	_	0	SENT_131	[p5l1330t699r1365b729],
6	docetaxel	NN	O	docetaxel	prep_of	4	SENT_131	[p5l1383t699r1540b729],
7	at	IN	O	at	_	0	SENT_131	[p5l1561t704r1589b729],
8	relevant	JJ	O	relevant	amod	9	SENT_131	[p5l1608t699r1741b729],
9	doseschedules	NNS	O	doseschedule	prep_at	6	SENT_131	[p5l1761t699r1848b729, p5l551t749r709b779],
10	(	VBP	O	(	_	0	SENT_131	[p5l725t749r820b785],
11	<	JJR	O	<	acomp	10	SENT_131	[p5l725t749r820b785],
12	115	CD	NUMBER	115	num	13	SENT_131	[p5l725t749r820b785],
13	mg/I112	NN	O	mg/i112	nsubj	19	SENT_131	[p5l835t738r947b787],
14	over	IN	O	over	_	0	SENT_131	[p5l962t759r1034b779],
15	1	CD	NUMBER	1	num	17	SENT_131	[p5l1051t750r1063b778],
16	h	NN	O	h	nn	17	SENT_131	[p5l1080t749r1112b785],
17	)	NN	O	)	prep_over	13	SENT_131	[p5l1080t749r1112b785],
18	is	VBZ	O	be	cop	19	SENT_131	[p5l1126t749r1152b779],
19	linear	JJ	O	linear	ccomp	11	SENT_131	[p5l1167t749r1269b784],
20	,	,	O	,	_	0	SENT_131	[p5l1167t749r1269b784],
21	and	CC	O	and	_	0	SENT_131	[p5l1284t749r1342b779],
22	plasma	NN	O	plasma	nn	23	SENT_131	[p5l1355t749r1472b787],
23	disposition	NN	O	disposition	nsubj	25	SENT_131	[p5l1485t749r1666b787],
24	is	VBZ	O	be	cop	25	SENT_131	[p5l1679t749r1705b779],
25	triexponential	JJ	O	triexponential	conj_and	10	SENT_131	[p5l1719t749r1848b787, p5l550t799r662b829],
26	(	NN	O	(	tmod	25	SENT_131	[p5l682t799r743b835],
27	27	CD	NUMBER	27	num	26	SENT_131	[p5l682t799r743b835],
28	,	,	O	,	_	0	SENT_131	[p5l682t799r743b835],
29	28	CD	NUMBER	28	num	30	SENT_131	[p5l764t799r826b835],
30	)	NN	O	)	appos	26	SENT_131	[p5l764t799r826b835],
31	.	.	O	.	_	0	SENT_131	[p5l764t799r826b835],

1	Like	IN	O	like	_	0	SENT_132	[p5l846t799r921b829],
2	paclitaxel	NN	O	paclitaxel	prep_like	6	SENT_132	[p5l939t799r1108b837],
3	,	,	O	,	_	0	SENT_132	[p5l939t799r1108b837],
4	docetaxel	NN	O	docetaxel	nsubj	6	SENT_132	[p5l1128t799r1285b829],
5	avidly	RB	O	avidly	advmod	6	SENT_132	[p5l1304t799r1406b837],
6	binds	VBZ	O	bind	_	0	SENT_132	[p5l1424t799r1512b829],
7	to	TO	O	to	_	0	SENT_132	[p5l1532t804r1563b829],
8	plasma	NN	O	plasma	nn	9	SENT_132	[p5l1581t799r1699b837],
9	proteins	NNS	O	protein	prep_to	6	SENT_132	[p5l1716t799r1848b837],
10	(	VBP	O	(	dep	9	SENT_132	[p5l551t849r685b885],
11	>	JJR	O	>	acomp	10	SENT_132	[p5l551t849r685b885],
12	90	CD	PERCENT	90	num	13	SENT_132	[p5l551t849r685b885],
13	%	NN	PERCENT	%	dep	11	SENT_132	[p5l551t849r685b885],
14	)	CD	NUMBER	)	dep	13	SENT_132	[p5l551t849r685b885],
15	,	,	O	,	_	0	SENT_132	[p5l551t849r685b885],
16	peak	JJ	O	peak	amod	18	SENT_132	[p5l698t849r776b887],
17	plasma	NN	O	plasma	nn	18	SENT_132	[p5l787t849r904b887],
18	concentrations	NNS	O	concentration	nsubj	19	SENT_132	[p5l916t849r1156b879],
19	exceed	VBP	O	exceed	dep	6	SENT_132	[p5l1169t849r1283b879],
20	levels	NNS	O	level	dobj	19	SENT_132	[p5l1294t849r1389b879],
21	that	WDT	O	that	nsubj	22	SENT_132	[p5l1402t849r1463b879],
22	induce	VBP	O	induce	rcmod	20	SENT_132	[p5l1475t849r1584b879],
23	relevant	JJ	O	relevant	amod	24	SENT_132	[p5l1595t849r1729b879],
24	effects	NNS	O	effect	dobj	22	SENT_132	[p5l1740t849r1848b879],
25	in	FW	O	in	nn	26	SENT_132	[p5l550t899r581b928],
26	vitro	FW	O	vitro	advmod	22	SENT_132	[p5l595t899r680b933],
27	,	,	O	,	_	0	SENT_132	[p5l595t899r680b933],
28	and	CC	O	and	_	0	SENT_132	[p5l696t899r754b928],
29	tissue	NN	O	tissue	nn	30	SENT_132	[p5l767t899r860b928],
30	distribution	NN	O	distribution	nsubj	33	SENT_132	[p5l875t899r1064b928],
31	is	VBZ	O	be	cop	33	SENT_132	[p5l1077t899r1103b928],
32	extensive	JJ	O	extensive	amod	33	SENT_132	[p5l1118t899r1273b928],
33	(	NN	O	(	conj_and	6	SENT_132	[p5l1287t899r1362b935],
34	27	CD	NUMBER	27	num	35	SENT_132	[p5l1287t899r1362b935],
35	)	NN	O	)	dep	33	SENT_132	[p5l1287t899r1362b935],
36	.	.	O	.	_	0	SENT_132	[p5l1287t899r1362b935],

1	Fecal	JJ	O	fecal	amod	3	SENT_133	[p5l1377t899r1466b928],
2	excretion	NN	O	excretion	nn	3	SENT_133	[p5l1479t899r1632b928],
3	accounts	NNS	O	account	_	0	SENT_133	[p5l1646t904r1788b928],
4	for	IN	O	for	_	0	SENT_133	[p5l1802t899r1850b928],
5	70	CD	PERCENT	70	num	6	SENT_133	[p5l550t948r720b978],
6	%	NN	PERCENT	%	prep_for	3	SENT_133	[p5l550t948r720b978],
7	.	.	O	.	_	0	SENT_133	[p5l550t948r720b978],

1	—	NN	O	—	_	0	SENT_134	[p5l550t948r720b978],
2	.	.	O	.	_	0	SENT_134	[p5l550t948r720b978],

1	80	CD	PERCENT	80	num	2	SENT_135	[p5l550t948r720b978],
2	%	NN	PERCENT	%	_	0	SENT_135	[p5l550t948r720b978],
3	of	IN	O	of	_	0	SENT_135	[p5l731t948r767b977],
4	total	JJ	O	total	amod	6	SENT_135	[p5l772t948r845b977],
5	drug	NN	O	drug	nn	6	SENT_135	[p5l854t948r928b986],
6	disposition	NN	O	disposition	prep_of	2	SENT_135	[p5l937t948r1118b986],
7	in	IN	O	in	_	0	SENT_135	[p5l1126t948r1157b977],
8	animals	NNS	O	animal	prep_in	2	SENT_135	[p5l1166t948r1302b983],
9	,	,	O	,	_	0	SENT_135	[p5l1166t948r1302b983],
10	whereas	IN	O	whereas	mark	13	SENT_135	[p5l1312t948r1445b977],
11	renal	JJ	O	renal	amod	13	SENT_135	[p5l1454t948r1536b977],
12	excretion	NN	O	excretion	nn	13	SENT_135	[p5l1544t948r1697b977],
13	accounts	NNS	O	account	dep	8	SENT_135	[p5l1706t953r1848b977],
14	for	IN	O	for	_	0	SENT_135	[p5l550t998r598b1028],
15	<	JJR	O	<	prep_for	13	SENT_135	[p5l620t998r726b1028],
16	lo	CD	PERCENT	lo	num	17	SENT_135	[p5l620t998r726b1028],
17	%	NN	PERCENT	%	dep	15	SENT_135	[p5l620t998r726b1028],
18	.	.	O	.	_	0	SENT_135	[p5l620t998r726b1028],

1	Docetaxel	NNP	O	Docetaxel	nsubjpass	3	SENT_136	[p5l749t998r916b1028],
2	is	VBZ	O	be	auxpass	3	SENT_136	[p5l937t998r963b1028],
3	metabolized	VBN	O	metabolize	_	0	SENT_136	[p5l986t998r1188b1028],
4	by	IN	O	by	_	0	SENT_136	[p5l1208t998r1249b1036],
5	hepatic	JJ	O	hepatic	amod	7	SENT_136	[p5l1271t998r1389b1036],
6	cytochrome	NN	O	cytochrome	nn	7	SENT_136	[p5l1411t998r1605b1036],
7	P	NN	O	p	agent	3	SENT_136	[p5l1627t998r1725b1028],
8	—	CD	NUMBER	—	number	9	SENT_136	[p5l1627t998r1725b1028],
9	450	CD	NUMBER	450	num	12	SENT_136	[p5l1627t998r1725b1028],
10	mixed	JJ	O	mixed	amod	12	SENT_136	[p5l1747t998r1849b1028],
11	function	NN	O	function	nn	12	SENT_136	[p5l550t1048r687b1078],
12	enzymes	NNS	O	enzyme	nsubj	13	SENT_136	[p5l700t1057r842b1086],
13	(	VBP	O	(	rcmod	7	SENT_136	[p5l857t1048r932b1084],
14	29	CD	NUMBER	29	num	15	SENT_136	[p5l857t1048r932b1084],
15	)	CD	NUMBER	)	dobj	13	SENT_136	[p5l857t1048r932b1084],
16	.	.	O	.	_	0	SENT_136	[p5l857t1048r932b1084],

1	Except	IN	O	except	_	0	SENT_137	[p5l946t1049r1061b1086],
2	for	IN	O	for	_	0	SENT_137	[p5l1073t1048r1121b1078],
3	the	DT	O	the	det	4	SENT_137	[p5l1133t1048r1182b1078],
4	combination	NN	O	combination	prep_except_for	32	SENT_137	[p5l1195t1048r1401b1078],
5	of	IN	O	of	_	0	SENT_137	[p5l1413t1048r1449b1078],
6	docetaxel	NN	O	docetaxel	prep_of	4	SENT_137	[p5l1460t1048r1616b1078],
7	and	CC	O	and	_	0	SENT_137	[p5l1629t1048r1688b1078],
8	cisplatin	NN	O	cisplatin	prep_of	4	SENT_137	[p5l1700t1048r1847b1086],
9	,	,	O	,	_	0	SENT_137	[p5l1700t1048r1847b1086],
10	which	WDT	O	which	nsubjpass	13	SENT_137	[p5l550t1098r650b1127],
11	is	VBZ	O	be	auxpass	13	SENT_137	[p5l660t1098r686b1127],
12	not	RB	O	not	neg	13	SENT_137	[p5l697t1102r750b1127],
13	associated	VBN	O	associate	rcmod	4	SENT_137	[p5l760t1098r929b1127],
14	with	IN	O	with	_	0	SENT_137	[p5l939t1098r1011b1127],
15	sequence	NN	O	sequence	nn	16	SENT_137	[p5l1023t1107r1172b1136],
16	dependence	NN	O	dependence	prep_with	13	SENT_137	[p5l1182t1098r1385b1136],
17	,	,	O	,	_	0	SENT_137	[p5l1182t1098r1385b1136],
18	sequence	NN	O	sequence	nn	21	SENT_137	[p5l1397t1098r1731b1136],
19	—	NN	O	—	nn	21	SENT_137	[p5l1397t1098r1731b1136],
20	dependent	JJ	O	dependent	amod	21	SENT_137	[p5l1397t1098r1731b1136],
21	effects	NNS	O	effect	nsubjpass	32	SENT_137	[p5l1740t1098r1848b1127],
22	between	IN	O	between	_	0	SENT_137	[p5l549t1148r687b1177],
23	docetaxel	NN	O	docetaxel	nn	27	SENT_137	[p5l699t1148r856b1177],
24	and	CC	O	and	_	0	SENT_137	[p5l868t1148r926b1177],
25	other	JJ	O	other	conj_and	23	SENT_137	[p5l938t1148r1022b1177],
26	cytotoxic	JJ	O	cytotoxic	amod	27	SENT_137	[p5l1033t1148r1186b1186],
27	agents	NNS	O	agent	prep_between	21	SENT_137	[p5l1198t1153r1301b1186],
28	have	VBP	O	have	aux	32	SENT_137	[p5l1314t1148r1391b1177],
29	not	RB	O	not	neg	32	SENT_137	[p5l1402t1153r1455b1177],
30	been	VBN	O	be	auxpass	32	SENT_137	[p5l1465t1148r1543b1177],
31	thoroughly	RB	O	thoroughly	advmod	32	SENT_137	[p5l1554t1148r1735b1186],
32	evaluated	VBN	O	evaluate	_	0	SENT_137	[p5l1747t1148r1848b1177, p5l551t1198r627b1233],
33	,	,	O	,	_	0	SENT_137	[p5l1747t1148r1848b1177, p5l551t1198r627b1233],
34	though	IN	O	though	mark	58	SENT_137	[p5l644t1198r758b1236],
35	the	DT	O	the	det	36	SENT_137	[p5l775t1198r824b1227],
36	potential	NN	O	potential	nsubjpass	58	SENT_137	[p5l840t1198r984b1236],
37	for	IN	O	for	_	0	SENT_137	[p5l1001t1198r1048b1227],
38	interactions	NNS	O	interaction	prep_for	36	SENT_137	[p5l1064t1198r1255b1227],
39	with	IN	O	with	_	0	SENT_137	[p5l1272t1198r1345b1228],
40	drugs	NNS	O	drug	prep_with	38	SENT_137	[p5l1362t1198r1451b1236],
41	that	WDT	O	that	nsubj	42	SENT_137	[p5l1469t1198r1530b1227],
42	affect	VBP	O	affect	rcmod	40	SENT_137	[p5l1547t1198r1640b1227],
43	cytochrome	NN	O	cytochrome	nn	44	SENT_137	[p5l1655t1198r1849b1236],
44	P	NN	O	p	nsubj	47	SENT_137	[p5l550t1248r648b1278],
45	—	CD	NUMBER	—	number	46	SENT_137	[p5l550t1248r648b1278],
46	450	CD	NUMBER	450	num	47	SENT_137	[p5l550t1248r648b1278],
47	enzymes	NNS	O	enzyme	xcomp	42	SENT_137	[p5l661t1258r813b1286],
48	,	,	O	,	_	0	SENT_137	[p5l661t1258r813b1286],
49	as	RB	O	as	_	0	SENT_137	[p5l828t1258r859b1277],
50	well	RB	O	well	_	0	SENT_137	[p5l873t1248r943b1278],
51	as	IN	O	as	_	0	SENT_137	[p5l957t1258r988b1277],
52	other	JJ	O	other	amod	54	SENT_137	[p5l1003t1248r1087b1277],
53	chemotherapy	NN	O	chemotherapy	nn	54	SENT_137	[p5l1099t1248r1331b1286],
54	agents	NNS	O	agent	xcomp	42	SENT_137	[p5l1345t1253r1458b1286],
55	,	,	O	,	_	0	SENT_137	[p5l1345t1253r1458b1286],
56	has	VBZ	O	have	aux	58	SENT_137	[p5l1471t1248r1525b1278],
57	been	VBN	O	be	auxpass	58	SENT_137	[p5l1537t1248r1615b1277],
58	demonstrated	VBN	O	demonstrate	advcl	32	SENT_137	[p5l1628t1248r1849b1277],
59	in	FW	O	in	prep	58	SENT_137	[p5l550t1298r581b1327],
60	vitro	FW	O	vitro	nn	61	SENT_137	[p5l593t1298r669b1327],
61	(	FW	O	(	pobj	59	SENT_137	[p5l682t1298r757b1334],
62	29	CD	NUMBER	29	num	63	SENT_137	[p5l682t1298r757b1334],
63	)	NN	O	)	dep	61	SENT_137	[p5l682t1298r757b1334],
64	.	.	O	.	_	0	SENT_137	[p5l682t1298r757b1334],

1	Administration	NNP	O	Administration	_	0	SENT_138	[p5l547t1396r855b1436],
2	,	,	O	,	_	0	SENT_138	[p5l547t1396r855b1436],
3	Dose	NNP	O	Dose	conj_and	1	SENT_138	[p5l873t1397r983b1436],
4	,	,	O	,	_	0	SENT_138	[p5l873t1397r983b1436],
5	and	CC	O	and	_	0	SENT_138	[p5l1002t1396r1078b1431],
6	Schedule	NN	O	schedule	conj_and	1	SENT_138	[p5l1089t1396r1267b1431],

1	PACLITAXEL	NN	O	paclitaxel	nsubj	13	SENT_139	[p5l550t1514r754b1537],
2	The	DT	O	the	det	5	SENT_139	[p5l793t1508r856b1537],
3	most	RBS	O	most	advmod	4	SENT_139	[p5l873t1512r953b1537],
4	important	JJ	O	important	amod	5	SENT_139	[p5l970t1508r1130b1546],
5	issues	NNS	O	issue	dep	1	SENT_139	[p5l1147t1508r1244b1537],
6	regarding	VBG	O	regard	partmod	1	SENT_139	[p5l1261t1508r1419b1546],
7	the	DT	O	the	det	8	SENT_139	[p5l1436t1508r1485b1537],
8	use	NN	O	use	dobj	6	SENT_139	[p5l1502t1517r1556b1537],
9	of	IN	O	of	_	0	SENT_139	[p5l1574t1508r1610b1537],
10	paclitaxel	NN	O	paclitaxel	prep_of	8	SENT_139	[p5l1623t1508r1783b1546],
11	are	VBP	O	be	cop	13	SENT_139	[p5l1801t1517r1849b1537],
12	optimal	JJ	O	optimal	amod	13	SENT_139	[p5l551t1558r675b1596],
13	dosing	NN	O	dosing	_	0	SENT_139	[p5l696t1558r805b1596],
14	and	CC	O	and	_	0	SENT_139	[p5l826t1558r884b1587],
15	scheduling	NN	O	scheduling	conj_and	13	SENT_139	[p5l905t1558r1090b1596],
16	.	.	O	.	_	0	SENT_139	[p5l905t1558r1090b1596],

1	The	DT	O	the	det	2	SENT_140	[p5l1112t1558r1175b1587],
2	duration	NN	O	duration	nsubj	18	SENT_140	[p5l1196t1558r1332b1587],
3	of	IN	O	of	_	0	SENT_140	[p5l1353t1558r1388b1587],
4	treatment	NN	O	treatment	prep_of	2	SENT_140	[p5l1405t1562r1570b1592],
5	,	,	O	,	_	0	SENT_140	[p5l1405t1562r1570b1592],
6	particularly	RB	O	particularly	advmod	8	SENT_140	[p5l1590t1558r1779b1596],
7	the	DT	O	the	det	8	SENT_140	[p5l1800t1558r1849b1587],
8	duration	NN	O	duration	appos	2	SENT_140	[p5l551t1608r687b1637],
9	of	IN	O	of	_	0	SENT_140	[p5l699t1608r735b1637],
10	drug	NN	O	drug	nn	11	SENT_140	[p5l744t1608r818b1646],
11	exposure	NN	O	exposure	prep_of	8	SENT_140	[p5l830t1617r978b1646],
12	above	IN	O	above	_	0	SENT_140	[p5l991t1608r1087b1637],
13	a	DT	O	a	det	16	SENT_140	[p5l1100t1617r1118b1637],
14	relevant	JJ	O	relevant	amod	16	SENT_140	[p5l1128t1608r1261b1637],
15	threshold	NN	O	threshold	nn	16	SENT_140	[p5l1271t1608r1425b1637],
16	concentration	NN	O	concentration	prep_above	11	SENT_140	[p5l1436t1608r1669b1642],
17	,	,	O	,	_	0	SENT_140	[p5l1436t1608r1669b1642],
18	appears	VBZ	O	appear	_	0	SENT_140	[p5l1682t1617r1806b1646],
19	to	TO	O	to	aux	26	SENT_140	[p5l1818t1612r1849b1637],
20	be	VB	O	be	cop	26	SENT_140	[p5l550t1658r588b1687],
21	the	DT	O	the	det	26	SENT_140	[p5l606t1658r655b1687],
22	most	RBS	O	most	advmod	23	SENT_140	[p5l673t1663r753b1687],
23	important	JJ	O	important	amod	26	SENT_140	[p5l770t1658r931b1696],
24	factor	NN	O	factor	nn	26	SENT_140	[p5l947t1658r1044b1687],
25	inﬂuencing	NN	O	inﬂuencing	nn	26	SENT_140	[p5l1060t1658r1247b1696],
26	cytotoxicity	NN	O	cytotoxicity	xcomp	18	SENT_140	[p5l1265t1658r1462b1696],
27	in	FW	O	in	prep	26	SENT_140	[p5l1479t1658r1510b1687],
28	vitro	FW	O	vitro	nn	29	SENT_140	[p5l1528t1658r1604b1687],
29	(	FW	O	(	amod	30	SENT_140	[p5l1623t1658r1685b1694],
30	18	CD	NUMBER	18	pobj	27	SENT_140	[p5l1623t1658r1685b1694],
31	,	,	O	,	_	0	SENT_140	[p5l1623t1658r1685b1694],
32	24	CD	NUMBER	24	num	33	SENT_140	[p5l1704t1658r1766b1694],
33	)	NN	O	)	appos	30	SENT_140	[p5l1704t1658r1766b1694],
34	.	.	O	.	_	0	SENT_140	[p5l1704t1658r1766b1694],

1	The	DT	O	the	det	3	SENT_141	[p5l1786t1658r1849b1687],
2	clinical	JJ	O	clinical	amod	3	SENT_141	[p5l551t1708r671b1737],
3	development	NN	O	development	nsubjpass	8	SENT_141	[p5l681t1708r894b1746],
4	of	IN	O	of	_	0	SENT_141	[p5l904t1708r939b1737],
5	paclitaxel	NN	O	paclitaxel	prep_of	3	SENT_141	[p5l946t1708r1106b1746],
6	was	VBD	O	be	auxpass	8	SENT_141	[p5l1116t1717r1178b1737],
7	initially	RB	O	initially	advmod	8	SENT_141	[p5l1189t1708r1316b1746],
8	limited	VBN	O	limit	dep	22	SENT_141	[p5l1326t1708r1443b1737],
9	to	TO	O	to	_	0	SENT_141	[p5l1452t1712r1482b1737],
10	the	DT	O	the	det	12	SENT_141	[p5l1493t1708r1542b1737],
11	24-h	JJ	O	24-h	amod	12	SENT_141	[p5l1553t1708r1627b1737],
12	schedule	NN	O	schedule	prep_to	8	SENT_141	[p5l1638t1708r1780b1737],
13	due	JJ	O	due	_	0	SENT_141	[p5l1791t1708r1849b1737],
14	to	TO	O	to	_	0	SENT_141	[p5l550t1763r581b1787],
15	the	DT	O	the	det	17	SENT_141	[p5l591t1758r641b1787],
16	high	JJ	O	high	amod	17	SENT_141	[p5l651t1758r724b1796],
17	rate	NN	O	rate	prep_due_to	8	SENT_141	[p5l733t1763r794b1787],
18	of	IN	O	of	_	0	SENT_141	[p5l805t1758r841b1787],
19	major	JJ	O	major	amod	21	SENT_141	[p5l848t1758r944b1796],
20	hypersensitivity	NN	O	hypersensitivity	nn	21	SENT_141	[p5l953t1758r1217b1796],
21	reactions	NNS	O	reaction	prep_of	17	SENT_141	[p5l1227t1758r1374b1787],
22	(	VBP	O	(	_	0	SENT_141	[p5l1387t1758r1491b1794],
23	HSR	NN	O	hsr	nn	24	SENT_141	[p5l1387t1758r1491b1794],
24	)	NN	O	)	dobj	22	SENT_141	[p5l1387t1758r1491b1794],
25	in	IN	O	in	_	0	SENT_141	[p5l1503t1758r1534b1787],
26	studies	NNS	O	study	prep_in	22	SENT_141	[p5l1545t1758r1657b1787],
27	using	VBG	O	use	partmod	26	SENT_141	[p5l1668t1758r1756b1796],
28	short	JJ	O	short	amod	29	SENT_141	[p5l1768t1758r1849b1787],
29	schedules	NNS	O	schedule	dobj	27	SENT_141	[p5l552t1808r709b1837],
30	without	IN	O	without	_	0	SENT_141	[p5l720t1808r846b1837],
31	premedication	NN	O	premedication	nn	32	SENT_141	[p5l855t1808r1091b1846],
32	(	NN	O	(	prep_without	27	SENT_141	[p5l1101t1808r1142b1844],
33	1	CD	NUMBER	1	nsubj	22	SENT_141	[p5l1101t1808r1142b1844],
34	,	,	O	,	_	0	SENT_141	[p5l1101t1808r1142b1844],
35	21	CD	NUMBER	21	num	36	SENT_141	[p5l1153t1808r1215b1844],
36	)	NN	O	)	appos	33	SENT_141	[p5l1153t1808r1215b1844],
37	.	.	O	.	_	0	SENT_141	[p5l1153t1808r1215b1844],

1	Therefore	RB	O	therefore	advmod	6	SENT_142	[p5l1226t1808r1397b1842],
2	,	,	O	,	_	0	SENT_142	[p5l1226t1808r1397b1842],
3	most	RBS	O	most	advmod	4	SENT_142	[p5l1408t1813r1488b1837],
4	available	JJ	O	available	amod	5	SENT_142	[p5l1498t1808r1645b1837],
5	data	NNS	O	datum	nsubj	6	SENT_142	[p5l1654t1808r1723b1837],
6	regarding	VBG	O	regard	_	0	SENT_142	[p5l1731t1808r1848b1846, p5l550t1858r602b1896],
7	antitumor	NN	O	antitumor	nn	9	SENT_142	[p5l613t1858r773b1887],
8	activity	NN	O	activity	nn	9	SENT_142	[p5l783t1858r905b1896],
9	pertain	NN	O	pertain	dobj	6	SENT_142	[p5l914t1858r1029b1896],
10	to	TO	O	to	_	0	SENT_142	[p5l1038t1863r1069b1887],
11	the	DT	O	the	det	13	SENT_142	[p5l1079t1858r1129b1887],
12	24-h	JJ	O	24-h	amod	13	SENT_142	[p5l1139t1858r1213b1887],
13	schedule	NN	O	schedule	prep_to	9	SENT_142	[p5l1225t1858r1376b1892],
14	,	,	O	,	_	0	SENT_142	[p5l1225t1858r1376b1892],
15	which	WDT	O	which	nsubj	19	SENT_142	[p5l1388t1858r1487b1887],
16	was	VBD	O	be	cop	19	SENT_142	[p5l1497t1867r1559b1887],
17	the	DT	O	the	det	19	SENT_142	[p5l1570t1858r1620b1887],
18	first	JJ	ORDINAL	first	amod	19	SENT_142	[p5l1630t1858r1696b1887],
19	schedule	NN	O	schedule	rcmod	13	SENT_142	[p5l1707t1858r1849b1887],
20	to	TO	O	to	aux	22	SENT_142	[p5l550t1912r581b1937],
21	be	VB	O	be	auxpass	22	SENT_142	[p5l589t1908r628b1937],
22	approved	VBN	O	approve	infmod	19	SENT_142	[p5l637t1908r797b1946],
23	.	.	O	.	_	0	SENT_142	[p5l637t1908r797b1946],

1	However	RB	O	however	advmod	9	SENT_143	[p5l808t1908r968b1942],
2	,	,	O	,	_	0	SENT_143	[p5l808t1908r968b1942],
3	prominent	JJ	O	prominent	amod	5	SENT_143	[p5l977t1908r1147b1946],
4	antitumor	NN	O	antitumor	nn	5	SENT_143	[p5l1156t1908r1316b1937],
5	activity	NN	O	activity	nsubjpass	9	SENT_143	[p5l1325t1908r1447b1946],
6	has	VBZ	O	have	aux	9	SENT_143	[p5l1455t1908r1508b1937],
7	also	RB	O	also	advmod	9	SENT_143	[p5l1519t1908r1583b1937],
8	been	VBN	O	be	auxpass	9	SENT_143	[p5l1591t1908r1669b1937],
9	noted	VBN	O	note	_	0	SENT_143	[p5l1677t1908r1768b1937],
10	with	IN	O	with	prep	9	SENT_143	[p5l1777t1908r1849b1937],

1	199	CD	NUMBER	199	_	0	SENT_144	[p5l310t1969r334b2019],
2	'	''	O	'	_	0	SENT_144	[p5l310t1969r334b2019],
3	7.482353-374	CD	NUMBER	7.482353-374	dep	1	SENT_144	[p5l310t1771r333b1953],
4	.	.	O	.	_	0	SENT_144	[p5l310t1771r333b1953],

1	Downloaded	VBN	O	download	_	0	SENT_145	[p5l310t1590r333b1760],
2	from	IN	O	from	_	0	SENT_145	[p5l310t1517r333b1581],
3	www.annua]reviews.org	NN	O	www.annua]reviews.org	prep_from	1	SENT_145	[p5l310t1184r340b1508],
4	shorter	JJR	O	shorter	amod	5	SENT_145	[p5l552t1974r665b2004],
5	schedules	NNS	O	schedule	dobj	1	SENT_145	[p5l677t1974r844b2009],
6	,	,	O	,	_	0	SENT_145	[p5l677t1974r844b2009],
7	particularly	RB	O	particularly	advmod	5	SENT_145	[p5l857t1974r1047b2012],
8	the	DT	O	the	det	12	SENT_145	[p5l1058t1974r1108b2004],
9	3	CD	NUMBER	3	num	12	SENT_145	[p5l1120t1974r1174b2004],
10	—	NN	O	—	nn	12	SENT_145	[p5l1120t1974r1174b2004],
11	h	NN	O	h	nn	12	SENT_145	[p5l1120t1974r1174b2004],
12	schedule	NN	O	schedule	dep	5	SENT_145	[p5l1186t1974r1337b2004],
13	.	.	O	.	_	0	SENT_145	[p5l1186t1974r1337b2004],

1	Although	IN	O	although	mark	6	SENT_146	[p5l1350t1974r1506b2012],
2	both	DT	O	both	det	3	SENT_146	[p5l1516t1974r1590b2004],
3	schedules	NNS	O	schedule	nsubjpass	6	SENT_146	[p5l1602t1974r1760b2004],
4	have	VBP	O	have	aux	6	SENT_146	[p5l1772t1974r1849b2004],
5	been	VBN	O	be	auxpass	6	SENT_146	[p5l550t2044r627b2073],
6	shown	VBN	O	show	advcl	25	SENT_146	[p5l645t2044r750b2073],
7	to	TO	O	to	aux	9	SENT_146	[p5l767t2048r798b2073],
8	be	VB	O	be	cop	9	SENT_146	[p5l814t2044r852b2073],
9	equivalent	JJ	O	equivalent	xcomp	6	SENT_146	[p5l869t2044r1041b2082],
10	in	IN	O	in	_	0	SENT_146	[p5l1056t2044r1087b2073],
11	the	DT	O	the	det	12	SENT_146	[p5l1104t2044r1153b2073],
12	setting	NN	O	setting	prep_in	9	SENT_146	[p5l1171t2044r1279b2082],
13	of	IN	O	of	_	0	SENT_146	[p5l1296t2044r1332b2073],
14	recurrent	JJ	O	recurrent	amod	16	SENT_146	[p5l1345t2048r1494b2073],
15	ovarian	JJ	O	ovarian	amod	16	SENT_146	[p5l1510t2044r1632b2073],
16	cancer	NN	O	cancer	prep_of	12	SENT_146	[p5l1649t2053r1756b2073],
17	(	CD	NUMBER	(	number	18	SENT_146	[p5l1772t2044r1848b2080],
18	30	CD	NUMBER	30	num	19	SENT_146	[p5l1772t2044r1848b2080],
19	)	NN	O	)	dep	16	SENT_146	[p5l1772t2044r1848b2080],
20	,	,	O	,	_	0	SENT_146	[p5l1772t2044r1848b2080],
21	inferences	NNS	O	inference	nsubjpass	25	SENT_146	[p5l550t2093r718b2122],
22	can	MD	O	can	aux	25	SENT_146	[p5l735t2098r845b2122],
23	not	RB	O	not	neg	25	SENT_146	[p5l735t2098r845b2122],
24	be	VB	O	be	auxpass	25	SENT_146	[p5l860t2093r898b2122],
25	made	VBN	O	make	_	0	SENT_146	[p5l914t2093r1003b2122],
26	about	IN	O	about	_	0	SENT_146	[p5l1019t2093r1110b2122],
27	their	PRP$	O	they	poss	28	SENT_146	[p5l1125t2093r1201b2122],
28	equivalence	JJ	O	equivalence	prep_about	25	SENT_146	[p5l1216t2093r1412b2131],
29	in	IN	O	in	_	0	SENT_146	[p5l1428t2093r1459b2122],
30	other	JJ	O	other	amod	32	SENT_146	[p5l1475t2093r1559b2122],
31	tumor	NN	O	tumor	nn	32	SENT_146	[p5l1574t2098r1673b2122],
32	types	NNS	O	type	prep_in	25	SENT_146	[p5l1688t2098r1773b2131],
33	and	CC	O	and	_	0	SENT_146	[p5l1791t2093r1849b2122],
34	settings	NNS	O	setting	prep_in	25	SENT_146	[p5l552t2143r675b2181],
35	at	IN	O	at	_	0	SENT_146	[p5l684t2148r713b2172],
36	this	DT	O	this	det	37	SENT_146	[p5l719t2143r777b2172],
37	time	NN	O	time	prep_at	32	SENT_146	[p5l786t2143r866b2172],
38	.	.	O	.	_	0	SENT_146	[p5l786t2143r866b2172],

1	Impressive	JJ	O	impressive	amod	2	SENT_147	[p5l876t2143r1056b2181],
2	activity	NN	O	activity	nsubjpass	6	SENT_147	[p5l1064t2143r1186b2181],
3	has	VBZ	O	have	aux	6	SENT_147	[p5l1194t2143r1247b2172],
4	also	RB	O	also	advmod	6	SENT_147	[p5l1256t2143r1321b2172],
5	been	VBN	O	be	auxpass	6	SENT_147	[p5l1328t2143r1406b2172],
6	noted	VBN	O	note	dep	11	SENT_147	[p5l1413t2143r1504b2172],
7	with	IN	O	with	_	0	SENT_147	[p5l1511t2143r1584b2172],
8	more	JJR	O	more	amod	10	SENT_147	[p5l1591t2152r1675b2172],
9	prolonged	JJ	O	prolonged	amod	10	SENT_147	[p5l1682t2143r1849b2181],
10	schedules	NNS	O	schedule	prep_with	6	SENT_147	[p5l552t2193r709b2222],
11	(	VBP	O	(	_	0	SENT_147	[p5l723t2193r783b2229],
12	i.e.	FW	O	i.e.	dobj	11	SENT_147	[p5l723t2193r783b2229],
13	96-h	JJ	O	96-h	amod	14	SENT_147	[p5l797t2193r871b2222],
14	schedule	NN	O	schedule	dep	29	SENT_147	[p5l884t2193r1026b2222],
15	in	IN	O	in	_	0	SENT_147	[p5l1038t2193r1069b2222],
16	advanced	JJ	O	advanced	amod	18	SENT_147	[p5l1081t2193r1236b2222],
17	breast	NN	O	breast	nn	18	SENT_147	[p5l1247t2193r1346b2222],
18	cancer	NN	O	cancer	prep_in	14	SENT_147	[p5l1356t2193r1475b2229],
19	)	CD	NUMBER	)	number	20	SENT_147	[p5l1356t2193r1475b2229],
20	(	CD	NUMBER	(	dep	18	SENT_147	[p5l1489t2193r1564b2229],
21	31	CD	NUMBER	31	num	22	SENT_147	[p5l1489t2193r1564b2229],
22	)	NN	O	)	dep	20	SENT_147	[p5l1489t2193r1564b2229],
23	,	,	O	,	_	0	SENT_147	[p5l1489t2193r1564b2229],
24	and	CC	O	and	_	0	SENT_147	[p5l1578t2193r1636b2222],
25	even	RB	O	even	advmod	26	SENT_147	[p5l1647t2202r1724b2222],
26	shorter	JJR	O	shorter	amod	27	SENT_147	[p5l1737t2193r1850b2222],
27	schedules	NNS	O	schedule	conj_and	18	SENT_147	[p5l552t2243r709b2273],
28	[	CD	NUMBER	[	dep	29	SENT_147	[p5l725t2243r784b2279],
29	i.e.	FW	O	i.e.	dep	11	SENT_147	[p5l725t2243r784b2279],
30	l	NN	O	l	nn	33	SENT_147	[p5l802t2243r852b2272],
31	—	CD	NUMBER	—	num	33	SENT_147	[p5l802t2243r852b2272],
32	h	NN	O	h	nn	33	SENT_147	[p5l802t2243r852b2272],
33	schedule	NN	O	schedule	dep	29	SENT_147	[p5l865t2243r1008b2273],
34	in	IN	O	in	_	0	SENT_147	[p5l1020t2243r1051b2272],
35	advanced	JJ	O	advanced	amod	37	SENT_147	[p5l1064t2243r1219b2273],
36	non	JJ	O	non	amod	37	SENT_147	[p5l1231t2243r1402b2273],
37	—	NN	O	—	prep_in	11	SENT_147	[p5l1231t2243r1402b2273],
38	small	JJ	O	small	amod	41	SENT_147	[p5l1231t2243r1402b2273],
39	cell	NN	O	cell	nn	41	SENT_147	[p5l1415t2243r1473b2273],
40	lung	NN	O	lung	nn	41	SENT_147	[p5l1486t2243r1558b2281],
41	cancer	NN	O	cancer	dep	37	SENT_147	[p5l1571t2252r1678b2273],
42	(	CD	NUMBER	(	num	43	SENT_147	[p5l1690t2243r1848b2279],
43	NSCLC	NN	O	nsclc	nsubj	11	SENT_147	[p5l1690t2243r1848b2279],
44	)	CD	NUMBER	)	number	45	SENT_147	[p5l1690t2243r1848b2279],
45	(	CD	NUMBER	(	dep	43	SENT_147	[p5l551t2294r640b2330],
46	32	CD	NUMBER	32	num	48	SENT_147	[p5l551t2294r640b2330],
47	)	NN	O	)	nn	48	SENT_147	[p5l551t2294r640b2330],
48	]	NN	O	]	dep	45	SENT_147	[p5l551t2294r640b2330],
49	.	.	O	.	_	0	SENT_147	[p5l551t2294r640b2330],

1	Paclitaxel	NN	O	paclitaxel	nsubjpass	4	SENT_148	[p5l600t2345r762b2375],
2	is	VBZ	O	be	auxpass	4	SENT_148	[p5l779t2345r805b2375],
3	generally	RB	O	generally	advmod	4	SENT_148	[p5l824t2345r976b2383],
4	administered	VBN	O	administer	_	0	SENT_148	[p5l994t2345r1206b2375],
5	at	IN	O	at	_	0	SENT_148	[p5l1223t2350r1252b2375],
6	a	DT	O	a	det	7	SENT_148	[p5l1269t2354r1286b2375],
7	dose	NN	O	dose	prep_at	4	SENT_148	[p5l1303t2345r1377b2375],
8	of	IN	O	of	_	0	SENT_148	[p5l1395t2345r1431b2375],
9	175	CD	NUMBER	175	num	10	SENT_148	[p5l1449t2345r1504b2375],
10	mg/m2	NN	O	mg/m2	prep_of	7	SENT_148	[p5l1523t2334r1635b2383],
11	over	IN	O	over	_	0	SENT_148	[p5l1653t2355r1726b2375],
12	3	CD	NUMBER	3	num	13	SENT_148	[p5l1743t2346r1760b2375],
13	h	NN	O	h	prep_over	10	SENT_148	[p5l1779t2345r1799b2374],
14	or	CC	O	or	_	0	SENT_148	[p5l1816t2355r1850b2375],
15	135-175	CD	NUMBER	135-175	num	16	SENT_148	[p5l554t2395r692b2425],
16	mg/m2	NN	O	mg/m2	prep_over	10	SENT_148	[p5l709t2384r821b2433],
17	over	IN	O	over	_	0	SENT_148	[p5l837t2405r909b2425],
18	24	CD	NUMBER	24	num	19	SENT_148	[p5l924t2395r963b2424],
19	h	NN	O	h	prep_over	4	SENT_148	[p5l978t2395r998b2424],
20	every	DT	SET	every	det	22	SENT_148	[p5l1013t2405r1104b2433],
21	three	CD	SET	three	num	22	SENT_148	[p5l1119t2395r1200b2425],
22	weeks	NNS	NUMBER	week	tmod	4	SENT_148	[p5l1215t2395r1316b2425],
23	to	TO	O	to	aux	24	SENT_148	[p5l1332t2400r1363b2425],
24	treat	VB	O	treat	xcomp	4	SENT_148	[p5l1378t2400r1451b2425],
25	patients	NNS	O	patient	dobj	24	SENT_148	[p5l1464t2395r1591b2433],
26	with	IN	O	with	_	0	SENT_148	[p5l1607t2395r1680b2425],
27	advanced	JJ	O	advanced	amod	28	SENT_148	[p5l1695t2395r1849b2425],
28	cancers	NNS	O	cancer	prep_with	24	SENT_148	[p5l550t2454r672b2475],
29	of	IN	O	of	_	0	SENT_148	[p5l690t2445r726b2475],
30	the	DT	O	the	det	31	SENT_148	[p5l741t2445r790b2475],
31	ovary	NN	O	ovary	prep_of	28	SENT_148	[p5l808t2454r900b2483],
32	and	CC	O	and	_	0	SENT_148	[p5l919t2445r977b2475],
33	breast	NN	O	breast	prep_of	28	SENT_148	[p5l994t2445r1100b2475],
34	.	.	O	.	_	0	SENT_148	[p5l994t2445r1100b2475],

1	Most	JJS	O	most	amod	3	SENT_149	[p5l1119t2446r1204b2475],
2	early	JJ	O	early	amod	3	SENT_149	[p5l1221t2445r1302b2483],
3	phase	NN	O	phase	nsubj	6	SENT_149	[p5l1319t2445r1412b2483],
4	II	CD	NUMBER	ii	num	5	SENT_149	[p5l1429t2446r1456b2474],
5	studies	NNS	O	study	dep	3	SENT_149	[p5l1474t2445r1586b2475],
6	utilized	VBD	O	utilize	_	0	SENT_149	[p5l1604t2445r1728b2475],
7	higher	JJR	O	higher	amod	8	SENT_149	[p5l1744t2445r1850b2483],
8	doses	NNS	O	dose	dobj	6	SENT_149	[p5l551t2495r650b2530],
9	,	,	O	,	_	0	SENT_149	[p5l551t2495r650b2530],
10	250	CD	NUMBER	250	num	11	SENT_149	[p5l670t2495r730b2525],
11	mg/m2	NN	O	mg/m2	appos	8	SENT_149	[p5l748t2484r860b2533],
12	over	IN	O	over	_	0	SENT_149	[p5l879t2505r951b2525],
13	24	CD	NUMBER	24	num	14	SENT_149	[p5l969t2495r1008b2524],
14	h	NN	O	h	prep_over	11	SENT_149	[p5l1026t2495r1054b2530],
15	,	,	O	,	_	0	SENT_149	[p5l1026t2495r1054b2530],
16	which	WDT	O	which	nsubj	18	SENT_149	[p5l1074t2495r1174b2525],
17	usually	RB	O	usually	advmod	18	SENT_149	[p5l1191t2495r1310b2533],
18	caused	VBD	O	cause	rcmod	8	SENT_149	[p5l1328t2495r1439b2525],
19	severe	JJ	O	severe	amod	20	SENT_149	[p5l1458t2505r1561b2525],
20	neutropenia	NN	O	neutropenia	dobj	18	SENT_149	[p5l1579t2495r1774b2533],
21	and	CC	O	and	_	0	SENT_149	[p5l1791t2495r1849b2525],
22	often	RB	O	often	advmod	23	SENT_149	[p5l551t2545r634b2575],
23	required	JJ	O	required	conj_and	18	SENT_149	[p5l647t2545r784b2583],
24	hematopoietic	JJ	O	hematopoietic	amod	25	SENT_149	[p5l797t2545r1030b2583],
25	growth	NN	O	growth	dobj	23	SENT_149	[p5l1045t2545r1160b2583],
26	factors	NNS	O	factor	nsubj	27	SENT_149	[p5l1174t2545r1284b2575],
27	(	VBP	O	(	dep	23	SENT_149	[p5l1300t2546r1311b2581],
28	1	CD	NUMBER	1	number	29	SENT_149	[p5l1316t2545r1354b2581],
29	)	CD	NUMBER	)	dobj	27	SENT_149	[p5l1316t2545r1354b2581],
30	.	.	O	.	_	0	SENT_149	[p5l1316t2545r1354b2581],

1	It	PRP	O	it	nsubjpass	4	SENT_150	[p5l1369t2546r1394b2575],
2	should	MD	O	should	aux	4	SENT_150	[p5l1408t2545r1516b2575],
3	be	VB	O	be	auxpass	4	SENT_150	[p5l1529t2545r1568b2575],
4	emphasized	VBN	O	emphasize	_	0	SENT_150	[p5l1581t2545r1776b2583],
5	that	IN	O	that	complm	15	SENT_150	[p5l1788t2545r1850b2575],
6	adequate	JJ	O	adequate	amod	7	SENT_150	[p5l551t2595r696b2633],
7	studies	NNS	O	study	nsubjpass	15	SENT_150	[p5l712t2595r824b2624],
8	of	IN	O	of	_	0	SENT_150	[p5l841t2595r876b2624],
9	dose	NN	O	dose	nn	11	SENT_150	[p5l888t2595r1121b2633],
10	—	NN	O	—	nn	11	SENT_150	[p5l888t2595r1121b2633],
11	response	NN	O	response	prep_of	7	SENT_150	[p5l888t2595r1121b2633],
12	have	VBP	O	have	aux	15	SENT_150	[p5l1136t2595r1213b2624],
13	not	RB	O	not	neg	15	SENT_150	[p5l1228t2599r1281b2624],
14	been	VBN	O	be	auxpass	15	SENT_150	[p5l1294t2595r1372b2624],
15	completed	VBN	O	complete	ccomp	4	SENT_150	[p5l1387t2595r1559b2633],
16	in	IN	O	in	_	0	SENT_150	[p5l1573t2595r1604b2624],
17	many	JJ	O	many	amod	18	SENT_150	[p5l1619t2604r1709b2633],
18	tumors	NNS	O	tumor	prep_in	15	SENT_150	[p5l1725t2600r1847b2624],
19	.	.	O	.	_	0	SENT_150	[p5l1725t2600r1847b2624],

1	The	DT	O	the	det	3	SENT_151	[p5l550t2645r613b2675],
2	following	VBG	O	follow	amod	3	SENT_151	[p5l625t2645r784b2683],
3	doses	NNS	O	dose	nsubjpass	6	SENT_151	[p5l797t2645r886b2675],
4	have	VBP	O	have	aux	6	SENT_151	[p5l899t2645r976b2675],
5	been	VBN	O	be	auxpass	6	SENT_151	[p5l987t2645r1065b2675],
6	recommended	VBN	O	recommend	_	0	SENT_151	[p5l1076t2645r1310b2675],
7	on	IN	O	on	_	0	SENT_151	[p5l1321t2654r1361b2675],
8	less	JJR	O	less	amod	10	SENT_151	[p5l1373t2645r1433b2675],
9	orthodox	JJ	O	orthodox	amod	10	SENT_151	[p5l1446t2645r1593b2675],
10	schedules	NNS	O	schedule	prep_on	6	SENT_151	[p5l1606t2645r1774b2675],
11	:	:	O	:	_	0	SENT_151	[p5l1606t2645r1774b2675],
12	200	CD	NUMBER	200	num	13	SENT_151	[p5l1789t2645r1849b2675],
13	mg/m2	NN	O	mg/m2	nsubj	42	SENT_151	[p5l550t2684r662b2733],
14	over	IN	O	over	_	0	SENT_151	[p5l676t2705r748b2725],
15	1	CD	NUMBER	1	num	16	SENT_151	[p5l765t2696r777b2724],
16	h	NN	O	h	prep_over	13	SENT_151	[p5l793t2695r813b2724],
17	as	IN	O	as	mark	27	SENT_151	[p5l827t2705r859b2725],
18	a	DT	O	a	dep	22	SENT_151	[p5l874t2705r891b2725],
19	either	RB	O	either	advmod	22	SENT_151	[p5l903t2695r997b2725],
20	a	DT	O	a	det	22	SENT_151	[p5l1009t2705r1027b2725],
21	single	JJ	O	single	amod	22	SENT_151	[p5l1040t2695r1136b2733],
22	dose	NN	O	dose	nsubj	27	SENT_151	[p5l1150t2695r1224b2725],
23	or	CC	O	or	_	0	SENT_151	[p5l1238t2705r1271b2725],
24	as	IN	O	as	quantmod	25	SENT_151	[p5l1284t2705r1316b2725],
25	three	CD	NUMBER	three	num	26	SENT_151	[p5l1330t2695r1411b2725],
26	daily	JJ	SET	daily	nsubj	27	SENT_151	[p5l1424t2695r1505b2733],
27	divided	VBN	O	divide	dep	16	SENT_151	[p5l1519t2695r1642b2725],
28	doses	NNS	O	dose	dobj	27	SENT_151	[p5l1655t2695r1744b2725],
29	every	DT	SET	every	quantmod	30	SENT_151	[p5l1759t2705r1849b2733],
30	three	CD	SET	three	num	31	SENT_151	[p5l550t2745r632b2775],
31	weeks	NNS	NUMBER	week	tmod	28	SENT_151	[p5l653t2745r764b2780],
32	,	,	O	,	_	0	SENT_151	[p5l653t2745r764b2780],
33	and	CC	O	and	_	0	SENT_151	[p5l787t2745r845b2775],
34	140	CD	NUMBER	140	num	35	SENT_151	[p5l870t2745r927b2775],
35	mg/m2	NN	O	mg/m2	conj_and	28	SENT_151	[p5l948t2734r1060b2783],
36	over	IN	O	over	_	0	SENT_151	[p5l1082t2754r1155b2775],
37	96	CD	NUMBER	96	num	38	SENT_151	[p5l1176t2745r1215b2775],
38	h	NN	O	h	prep_over	35	SENT_151	[p5l1236t2745r1256b2774],
39	every	DT	SET	every	det	41	SENT_151	[p5l1278t2754r1368b2783],
40	three	CD	SET	three	num	41	SENT_151	[p5l1389t2745r1471b2775],
41	weeks	NNS	NUMBER	week	tmod	27	SENT_151	[p5l1492t2745r1593b2775],
42	(	VBP	O	(	parataxis	6	SENT_151	[p5l1616t2745r1678b2781],
43	31	CD	NUMBER	31	dobj	42	SENT_151	[p5l1616t2745r1678b2781],
44	,	,	O	,	_	0	SENT_151	[p5l1616t2745r1678b2781],
45	32	CD	NUMBER	32	num	46	SENT_151	[p5l1702t2745r1763b2781],
46	)	NN	O	)	appos	43	SENT_151	[p5l1702t2745r1763b2781],
47	.	.	O	.	_	0	SENT_151	[p5l1702t2745r1763b2781],

1	The	DT	O	the	det	3	SENT_152	[p5l1786t2745r1849b2775],
2	following	VBG	O	follow	amod	3	SENT_152	[p5l550t2795r710b2833],
3	premedication	NN	O	premedication	nsubjpass	5	SENT_152	[p5l724t2795r960b2833],
4	is	VBZ	O	be	auxpass	5	SENT_152	[p5l974t2795r999b2825],
5	recommended	VBN	O	recommend	_	0	SENT_152	[p5l1014t2795r1248b2825],
6	to	TO	O	to	aux	7	SENT_152	[p5l1262t2800r1292b2825],
7	prevent	VB	O	prevent	xcomp	5	SENT_152	[p5l1306t2800r1430b2833],
8	major	JJ	O	major	amod	9	SENT_152	[p5l1443t2795r1539b2833],
9	HSR	NN	O	hsr	dobj	7	SENT_152	[p5l1553t2795r1641b2825],
10	:	:	O	:	_	0	SENT_152	[p5l1553t2795r1641b2825],
11	dexametha	NN	O	dexametha	dep	9	SENT_152	[p5l1658t2795r1848b2825],
12	—	CD	NUMBER	—	num	11	SENT_152	[p5l1658t2795r1848b2825],
13	THE	DT	O	the	det	14	SENT_152	[p5l1491t2853r1563b2878],
14	TAXANES	NN	O	taxane	dep	11	SENT_152	[p5l1573t2852r1745b2879],
15	359	CD	NUMBER	359	num	14	SENT_152	[p5l1794t2852r1848b2879],

1	Annu	NNP	PERSON	Annu	_	0	SENT_153	[p5l310t2200r333b2280],
2	.	.	O	.	_	0	SENT_153	[p5l310t2200r333b2280],

1	Rev.	NNP	O	Rev.	nn	2	SENT_154	[p5l310t2129r333b2189],
2	Med	NNP	O	Med	_	0	SENT_154	[p5l310t2052r333b2119],
3	.	.	O	.	_	0	SENT_154	[p5l310t2052r333b2119],

1	by	IN	O	by	_	0	SENT_155	[p5l343t2213r374b2246],
2	University	NNP	ORGANIZATION	University	nn	3	SENT_155	[p5l343t2065r374b2204],
3	o	NN	O	o	prep_by	5	SENT_155	[p5l351t2040r367b2055],
4	f	FW	O	f	dep	3	SENT_155	[p5l343t2007r366b2019],
5	W	NN	O	w	amod	6	SENT_155	[p5l344t1969r367b2000],
6	isconsin	NN	O	isconsin	_	0	SENT_155	[p5l343t1844r367b1952],
7	-	:	O	-	_	0	SENT_155	[p5l357t1825r360b1834],
8	Madison	NNP	O	Madison	dep	6	SENT_155	[p5l343t1699r367b1815],
9	on	IN	O	on	_	0	SENT_155	[p5l351t1657r367b1690],
10	01/05/14	CD	DATE	01/05/14	prep_on	8	SENT_155	[p5l343t1524r367b1648],
11	.	.	O	.	_	0	SENT_155	[p5l343t1524r367b1648],

1	For	IN	O	for	_	0	SENT_156	[p5l344t1466r367b1513],
2	personal	JJ	O	personal	amod	3	SENT_156	[p5l343t1347r374b1459],
3	use	NN	O	use	pobj	1	SENT_156	[p5l351t1294r367b1338],
4	only	RB	O	only	advmod	3	SENT_156	[p5l343t1220r374b1285],
5	.	.	O	.	_	0	SENT_156	[p5l343t1220r374b1285],

1	sone	NN	O	sone	_	0	SENT_157	[p5l551t2946r633b2972],
2	,	,	O	,	_	0	SENT_157	[p5l551t2946r633b2972],
3	20	CD	NUMBER	20	num	4	SENT_157	[p5l647t2937r687b2967],
4	mg	NN	O	mg	appos	1	SENT_157	[p5l699t2946r750b2975],
5	orally	RB	O	orally	advmod	4	SENT_157	[p5l763t2937r858b2975],
6	or	CC	O	or	_	0	SENT_157	[p5l870t2946r904b2967],
7	intravenously	RB	O	intravenously	advmod	9	SENT_157	[p5l915t2937r1139b2975],
8	(	JJ	O	(	amod	9	SENT_157	[p5l1153t2937r1230b2973],
9	i.v.	NN	O	i.v.	conj_or	4	SENT_157	[p5l1153t2937r1230b2973],
10	)	CD	NUMBER	)	number	11	SENT_157	[p5l1153t2937r1230b2973],
11	12	CD	NUMBER	12	num	9	SENT_157	[p5l1247t2937r1283b2966],
12	and	CC	O	and	_	0	SENT_157	[p5l1296t2937r1354b2967],
13	6	CD	NUMBER	6	num	14	SENT_157	[p5l1366t2937r1385b2967],
14	h	NN	O	h	conj_or	4	SENT_157	[p5l1397t2937r1417b2966],
15	before	IN	O	before	_	0	SENT_157	[p5l1428t2937r1533b2967],
16	treatment	NN	O	treatment	prep_before	14	SENT_157	[p5l1545t2942r1710b2972],
17	;	:	O	;	_	0	SENT_157	[p5l1545t2942r1710b2972],
18	diphen	NN	O	diphen	nn	20	SENT_157	[p5l1723t2937r1847b2975],
19	—	NN	O	—	nn	20	SENT_157	[p5l1723t2937r1847b2975],
20	hydramine	NN	O	hydramine	conj_and	14	SENT_157	[p5l549t2987r734b3025],
21	,	,	O	,	_	0	SENT_157	[p5l549t2987r734b3025],
22	50	CD	NUMBER	50	num	24	SENT_157	[p5l750t2987r789b3017],
23	mg	NN	O	mg	nn	24	SENT_157	[p5l804t2996r855b3025],
24	i.v.	NN	O	i.v.	appos	20	SENT_157	[p5l870t2987r920b3017],
25	30	CD	DURATION	30	num	26	SENT_157	[p5l937t2987r976b3017],
26	min	NN	DURATION	min	dep	24	SENT_157	[p5l990t2987r1054b3016],
27	before	IN	O	before	_	0	SENT_157	[p5l1067t2987r1172b3017],
28	treatment	NN	O	treatment	prep_before	26	SENT_157	[p5l1186t2992r1352b3022],
29	;	:	O	;	_	0	SENT_157	[p5l1186t2992r1352b3022],
30	and	CC	O	and	_	0	SENT_157	[p5l1368t2987r1426b3017],
31	an	DT	O	a	det	35	SENT_157	[p5l1440t2996r1478b3017],
32	histamine	NN	O	histamine	nn	35	SENT_157	[p5l1491t2987r1651b3017],
33	H2	NN	O	h2	nn	35	SENT_157	[p5l1665t2988r1848b3028],
34	—	NN	O	—	nn	35	SENT_157	[p5l1665t2988r1848b3028],
35	antago	NN	O	antago	conj_and	14	SENT_157	[p5l1665t2988r1848b3028],
36	—	CD	NUMBER	—	num	37	SENT_157	[p5l1665t2988r1848b3028],
37	nist	NN	O	nist	dep	35	SENT_157	[p5l549t3037r609b3067],
38	such	JJ	O	such	_	0	SENT_157	[p5l624t3037r697b3067],
39	as	IN	O	as	_	0	SENT_157	[p5l712t3046r744b3067],
40	cimetidine	NN	O	cimetidine	nn	41	SENT_157	[p5l759t3037r932b3067],
41	(	NN	O	(	prep_such_as	37	SENT_157	[p5l948t3037r1021b3073],
42	300	CD	NUMBER	300	num	44	SENT_157	[p5l948t3037r1021b3073],
43	mg	NN	O	mg	nn	44	SENT_157	[p5l1036t3038r1110b3075],
44	)	NN	O	)	dep	41	SENT_157	[p5l1036t3038r1110b3075],
45	,	,	O	,	_	0	SENT_157	[p5l1036t3038r1110b3075],
46	famotidine	NN	O	famotidine	appos	1	SENT_157	[p5l1126t3037r1304b3067],
47	(	CD	NUMBER	(	number	48	SENT_157	[p5l1319t3037r1372b3073],
48	20	CD	NUMBER	20	num	50	SENT_157	[p5l1319t3037r1372b3073],
49	mg	NN	O	mg	nn	50	SENT_157	[p5l1386t3038r1460b3075],
50	)	NN	O	)	dep	46	SENT_157	[p5l1386t3038r1460b3075],
51	,	,	O	,	_	0	SENT_157	[p5l1386t3038r1460b3075],
52	or	CC	O	or	_	0	SENT_157	[p5l1476t3046r1510b3067],
53	ranitidine	NN	O	ranitidine	nn	54	SENT_157	[p5l1522t3037r1680b3067],
54	(	NN	O	(	conj_or	46	SENT_157	[p5l1696t3037r1769b3073],
55	150	CD	NUMBER	150	num	56	SENT_157	[p5l1696t3037r1769b3073],
56	mg	NN	O	mg	dep	1	SENT_157	[p5l1783t3037r1847b3075],
57	)	CD	NUMBER	)	num	58	SENT_157	[p5l1783t3037r1847b3075],
58	i.v.	NN	O	i.v.	dep	56	SENT_157	[p5l549t3087r599b3116],
59	30	CD	DURATION	30	num	60	SENT_157	[p5l613t3087r652b3116],
60	min	NN	DURATION	min	dep	1	SENT_157	[p5l664t3087r727b3116],
61	before	IN	O	before	_	0	SENT_157	[p5l738t3087r843b3116],
62	treatment	NN	O	treatment	prep_before	60	SENT_157	[p5l855t3092r1018b3116],
63	.	.	O	.	_	0	SENT_157	[p5l855t3092r1018b3116],

1	The	DT	O	the	det	2	SENT_158	[p5l599t3136r662b3166],
2	importance	NN	O	importance	nsubj	12	SENT_158	[p5l679t3136r864b3174],
3	of	IN	O	of	_	0	SENT_158	[p5l881t3136r917b3166],
4	hepatic	JJ	O	hepatic	amod	5	SENT_158	[p5l930t3136r1048b3174],
5	metabolism	NN	O	metabolism	prep_of	2	SENT_158	[p5l1065t3136r1258b3166],
6	and	CC	O	and	_	0	SENT_158	[p5l1275t3136r1333b3166],
7	biliary	JJ	O	biliary	amod	8	SENT_158	[p5l1349t3136r1456b3174],
8	excretion	NN	O	excretion	prep_of	2	SENT_158	[p5l1473t3136r1626b3166],
9	in	IN	O	in	_	0	SENT_158	[p5l1642t3136r1673b3165],
10	paclitaxel	NN	O	paclitaxel	nn	11	SENT_158	[p5l1689t3136r1849b3174],
11	disposition	NN	O	disposition	prep_in	5	SENT_158	[p5l550t3186r731b3224],
12	suggests	VBZ	O	suggest	_	0	SENT_158	[p5l750t3190r887b3224],
13	that	IN	O	that	complm	17	SENT_158	[p5l906t3186r968b3215],
14	doses	NNS	O	dose	nsubjpass	17	SENT_158	[p5l986t3186r1075b3215],
15	should	MD	O	should	aux	17	SENT_158	[p5l1096t3186r1204b3215],
16	be	VB	O	be	auxpass	17	SENT_158	[p5l1222t3186r1260b3215],
17	modified	VBN	O	modify	ccomp	12	SENT_158	[p5l1279t3186r1427b3215],
18	in	IN	O	in	_	0	SENT_158	[p5l1445t3186r1476b3215],
19	patients	NNS	O	patient	prep_in	17	SENT_158	[p5l1494t3186r1621b3224],
20	with	IN	O	with	_	0	SENT_158	[p5l1640t3186r1713b3215],
21	hepatic	JJ	O	hepatic	amod	22	SENT_158	[p5l1730t3186r1848b3224],
22	dysfunction	NN	O	dysfunction	prep_with	19	SENT_158	[p5l550t3236r752b3274],
23	.	.	O	.	_	0	SENT_158	[p5l550t3236r752b3274],

1	Although	IN	O	although	mark	8	SENT_159	[p5l769t3236r925b3274],
2	official	JJ	O	official	amod	4	SENT_159	[p5l941t3236r1059b3265],
3	dose	NN	O	dose	nn	4	SENT_159	[p5l1075t3236r1149b3265],
4	modifications	NNS	O	modification	nsubjpass	8	SENT_159	[p5l1164t3236r1390b3265],
5	have	VBP	O	have	aux	8	SENT_159	[p5l1406t3236r1483b3265],
6	not	RB	O	not	neg	8	SENT_159	[p5l1499t3241r1551b3265],
7	been	VBN	O	be	auxpass	8	SENT_159	[p5l1565t3236r1643b3265],
8	formulated	VBN	O	formulate	advcl	12	SENT_159	[p5l1658t3236r1847b3271],
9	,	,	O	,	_	0	SENT_159	[p5l1658t3236r1847b3271],
10	preliminary	JJ	O	preliminary	amod	11	SENT_159	[p5l549t3286r741b3324],
11	studies	NNS	O	study	nsubj	12	SENT_159	[p5l757t3286r869b3315],
12	indicate	VBP	O	indicate	_	0	SENT_159	[p5l884t3286r1013b3315],
13	that	IN	O	that	complm	24	SENT_159	[p5l1027t3286r1089b3315],
14	moderate	JJ	O	moderate	amod	15	SENT_159	[p5l1102t3286r1255b3315],
15	elevations	NNS	O	elevation	nsubj	24	SENT_159	[p5l1269t3286r1435b3315],
16	in	IN	O	in	_	0	SENT_159	[p5l1449t3286r1481b3315],
17	serum	NN	O	serum	nn	18	SENT_159	[p5l1496t3295r1595b3315],
18	concentrations	NNS	O	concentration	prep_in	15	SENT_159	[p5l1609t3286r1848b3315],
19	of	IN	O	of	_	0	SENT_159	[p5l550t3336r586b3365],
20	hepatocellular	JJ	O	hepatocellular	amod	21	SENT_159	[p5l595t3336r830b3374],
21	enzymes	NNS	O	enzyme	prep_of	18	SENT_159	[p5l842t3345r984b3374],
22	and/or	JJ	O	and/or	amod	23	SENT_159	[p5l999t3336r1103b3366],
23	bilirubin	NN	O	bilirubin	dep	21	SENT_159	[p5l1115t3336r1257b3365],
24	increase	VB	O	increase	ccomp	12	SENT_159	[p5l1270t3336r1404b3365],
25	the	DT	O	the	det	26	SENT_159	[p5l1417t3336r1466b3365],
26	likelihood	NN	O	likelihood	dobj	24	SENT_159	[p5l1479t3336r1647b3365],
27	of	IN	O	of	_	0	SENT_159	[p5l1659t3336r1695b3365],
28	developAnnu	NNP	O	developAnnu	prep_of	26	SENT_159	[p5l1705t3336r1847b3374, p6l309t1102r332b1182],
29	.	.	O	.	_	0	SENT_159	[p5l1705t3336r1847b3374, p6l309t1102r332b1182],

1	Rev.	NNP	O	Rev.	nn	2	SENT_160	[p6l309t1032r332b1091],
2	Med	NNP	O	Med	_	0	SENT_160	[p6l309t961r332b1021],
3	.	.	O	.	_	0	SENT_160	[p6l328t879r332b883],

1	1997.48:353	CD	NUMBER	1997.48:353	num	2	SENT_161	[p6l309t633r333b865],
2	-374	CD	NUMBER	-374	_	0	SENT_161	[p6l309t633r333b865],
3	.	.	O	.	_	0	SENT_161	[p6l309t633r333b865],

1	Downloaded	VBN	O	download	_	0	SENT_162	[p6l309t452r332b622],
2	from	IN	O	from	_	0	SENT_162	[p6l309t379r332b443],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_162	[p6l309t46r339b370],
4	of	IN	O	of	_	0	SENT_162	[p6l342t853r366b882],
5	Wisconsin	NNP	LOCATION	Wisconsin	prep_of	3	SENT_162	[p6l342t706r366b846],
6	-	:	O	-	_	0	SENT_162	[p6l356t687r359b696],
7	Madison	NNP	O	Madison	dep	3	SENT_162	[p6l342t561r366b677],
8	on	IN	O	on	_	0	SENT_162	[p6l350t519r366b552],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_162	[p6l342t386r366b510],
10	.	.	O	.	_	0	SENT_162	[p6l342t386r366b510],

1	For	IN	O	for	_	0	SENT_163	[p6l343t328r366b375],
2	personal	JJ	O	personal	amod	3	SENT_163	[p6l342t209r373b321],
3	use	NN	O	use	pobj	1	SENT_163	[p6l350t156r366b200],
4	only	RB	O	only	advmod	3	SENT_163	[p6l342t81r373b146],
5	.	.	O	.	_	0	SENT_163	[p6l342t81r373b146],

1	Annu	NNP	PERSON	Annu	_	0	SENT_164	[p6l310t3298r333b3378],
2	.	.	O	.	_	0	SENT_164	[p6l310t3298r333b3378],

1	Rev.	NNP	O	Rev.	nn	2	SENT_165	[p6l310t3227r333b3287],
2	Med	NNP	O	Med	_	0	SENT_165	[p6l310t3150r333b3217],
3	.	.	O	.	_	0	SENT_165	[p6l310t3150r333b3217],

1	1997482353-374	CD	NUMBER	1997482353-374	_	0	SENT_166	[p6l310t2906r334b3137],
2	.	.	O	.	_	0	SENT_166	[p6l310t2906r334b3137],

1	Downloaded	VBN	O	download	_	0	SENT_167	[p6l310t2725r333b2895],
2	from	IN	O	from	_	0	SENT_167	[p6l310t2652r333b2716],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_167	[p6l310t2318r340b2642],
4	by	IN	O	by	_	0	SENT_167	[p6l342t1116r373b1148],
5	University	NNP	ORGANIZATION	University	dep	11	SENT_167	[p6l342t967r373b1106],
6	by	IN	ORGANIZATION	by	_	0	SENT_167	[p6l343t3311r374b3344],
7	University	NNP	ORGANIZATION	University	prep_by	5	SENT_167	[p6l343t3163r374b3302],
8	of	IN	ORGANIZATION	of	_	0	SENT_167	[p6l343t3125r367b3153],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_167	[p6l343t2978r367b3118],
10	-	:	O	-	_	0	SENT_167	[p6l357t2960r360b2968],
11	Madison	NNP	O	Madison	prep_by	1	SENT_167	[p6l343t2834r367b2950],
12	on	IN	O	on	_	0	SENT_167	[p6l351t2792r367b2824],
13	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_167	[p6l343t2658r367b2783],
14	.	.	O	.	_	0	SENT_167	[p6l343t2658r367b2783],

1	For	IN	O	for	_	0	SENT_168	[p6l344t2601r367b2648],
2	personal	JJ	O	personal	amod	3	SENT_168	[p6l343t2481r374b2593],
3	use	NN	O	use	pobj	1	SENT_168	[p6l351t2428r367b2472],
4	only	RB	O	only	advmod	3	SENT_168	[p6l343t2353r374b2418],
5	.	.	O	.	_	0	SENT_168	[p6l343t2353r374b2418],

1	ing	VBG	O	ing	_	0	SENT_169	[p6l549t13r601b51],
2	severe	JJ	O	severe	amod	3	SENT_169	[p6l615t22r718b42],
3	toxicity	NN	O	toxicity	dobj	1	SENT_169	[p6l731t13r865b50],
4	,	,	O	,	_	0	SENT_169	[p6l731t13r865b50],
5	and	CC	O	and	_	0	SENT_169	[p6l880t13r939b42],
6	it	PRP	O	it	nsubj	8	SENT_169	[p6l951t13r974b42],
7	seems	VBZ	O	seem	cop	8	SENT_169	[p6l987t22r1085b42],
8	prudent	JJ	O	prudent	conj_and	1	SENT_169	[p6l1098t13r1225b51],
9	to	TO	O	to	aux	10	SENT_169	[p6l1237t17r1268b42],
10	reduce	VB	O	reduce	xcomp	8	SENT_169	[p6l1281t13r1390b42],
11	paclitaxel	NN	O	paclitaxel	nn	12	SENT_169	[p6l1403t13r1563b51],
12	doses	NNS	O	dose	dobj	10	SENT_169	[p6l1576t13r1665b42],
13	by	IN	O	by	_	0	SENT_169	[p6l1679t13r1719b51],
14	at	IN	O	at	quantmod	16	SENT_169	[p6l1733t17r1762b42],
15	least	JJS	O	least	mwe	14	SENT_169	[p6l1774t13r1849b42],
16	50	CD	PERCENT	50	num	17	SENT_169	[p6l550t62r622b92],
17	%	NN	PERCENT	%	prep_by	10	SENT_169	[p6l550t62r622b92],
18	in	IN	O	in	_	0	SENT_169	[p6l637t62r668b92],
19	patients	NNS	O	patient	prep_in	17	SENT_169	[p6l681t62r808b101],
20	with	IN	O	with	mark	30	SENT_169	[p6l822t63r894b92],
21	moderate	JJ	O	moderate	amod	26	SENT_169	[p6l907t63r1060b92],
22	or	CC	O	or	_	0	SENT_169	[p6l1073t72r1107b92],
23	severe	JJ	O	severe	conj_or	21	SENT_169	[p6l1120t72r1223b92],
24	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	26	SENT_169	[p6l1235t62r1553b101],
25	and/or	NN	O	and/or	nn	26	SENT_169	[p6l1565t63r1670b92],
26	elevations	NNS	O	elevation	nsubj	30	SENT_169	[p6l1682t62r1847b92],
27	in	IN	O	in	_	0	SENT_169	[p6l549t113r580b141],
28	hepatocellular	JJ	O	hepatocellular	amod	29	SENT_169	[p6l596t113r830b150],
29	enzymes	NNS	O	enzyme	prep_in	26	SENT_169	[p6l844t122r987b150],
30	(	VBP	O	(	advcl	10	SENT_169	[p6l1004t113r1079b149],
31	18	CD	NUMBER	18	num	32	SENT_169	[p6l1004t113r1079b149],
32	)	CD	NUMBER	)	dobj	30	SENT_169	[p6l1004t113r1079b149],
33	.	.	O	.	_	0	SENT_169	[p6l1004t113r1079b149],

1	As	IN	O	as	mark	2	SENT_170	[p6l1096t113r1140b142],
2	expected	VBN	O	expect	advcl	19	SENT_170	[p6l1157t113r1303b150],
3	based	VBN	O	base	_	0	SENT_170	[p6l1317t113r1411b142],
4	on	IN	O	on	prepc_based_on	2	SENT_170	[p6l1426t122r1466b142],
5	the	DT	O	the	det	7	SENT_170	[p6l1481t113r1531b142],
6	minimal	JJ	O	minimal	amod	7	SENT_170	[p6l1546t113r1683b142],
7	contribution	NN	O	contribution	pobj	2	SENT_170	[p6l1698t113r1847b142, p6l549t163r613b192],
8	of	IN	O	of	_	0	SENT_170	[p6l627t163r663b192],
9	renal	JJ	O	renal	amod	10	SENT_170	[p6l674t163r756b192],
10	clearance	NN	O	clearance	prep_of	7	SENT_170	[p6l770t163r925b192],
11	to	TO	O	to	_	0	SENT_170	[p6l938t168r969b192],
12	overall	JJ	O	overall	amod	13	SENT_170	[p6l984t163r1097b192],
13	clearance	NN	O	clearance	prep_to	10	SENT_170	[p6l1112t163r1275b198],
14	,	,	O	,	_	0	SENT_170	[p6l1112t163r1275b198],
15	dose	NN	O	dose	nn	16	SENT_170	[p6l1291t163r1365b192],
16	modifications	NNS	O	modification	nsubj	19	SENT_170	[p6l1379t163r1605b192],
17	do	VBP	O	do	aux	19	SENT_170	[p6l1620t163r1659b192],
18	not	RB	O	not	neg	19	SENT_170	[p6l1674t168r1726b192],
19	appear	VB	O	appear	_	0	SENT_170	[p6l1740t172r1850b201],
20	to	TO	O	to	aux	22	SENT_170	[p6l549t217r580b242],
21	be	VB	O	be	auxpass	22	SENT_170	[p6l591t213r630b242],
22	required	VBN	O	require	xcomp	19	SENT_170	[p6l641t213r778b251],
23	in	IN	O	in	_	0	SENT_170	[p6l790t213r821b242],
24	patients	NNS	O	patient	prep_in	22	SENT_170	[p6l831t213r958b251],
25	with	IN	O	with	_	0	SENT_170	[p6l971t213r1043b242],
26	severe	JJ	O	severe	amod	28	SENT_170	[p6l1056t222r1159b242],
27	renal	JJ	O	renal	amod	28	SENT_170	[p6l1170t213r1252b242],
28	insufficiency	NN	O	insufficiency	prep_with	22	SENT_170	[p6l1264t213r1479b251],
29	(	CD	NUMBER	(	number	30	SENT_170	[p6l1491t213r1566b249],
30	18	CD	NUMBER	18	num	31	SENT_170	[p6l1491t213r1566b249],
31	)	NN	O	)	dep	22	SENT_170	[p6l1491t213r1566b249],
32	.	.	O	.	_	0	SENT_170	[p6l1491t213r1566b249],

1	DOCETAXEL	NNP	O	DOCETAXEL	dep	7	SENT_171	[p6l549t349r748b372],
2	Although	IN	O	although	dep	7	SENT_171	[p6l787t343r942b381],
3	several	JJ	O	several	amod	5	SENT_171	[p6l958t343r1073b372],
4	administration	NN	O	administration	nn	5	SENT_171	[p6l1088t343r1326b372],
5	schedules	NNS	O	schedule	nsubjpass	7	SENT_171	[p6l1342t343r1499b372],
6	were	VBD	O	be	auxpass	7	SENT_171	[p6l1515t352r1594b372],
7	studied	VBN	O	study	advcl	17	SENT_171	[p6l1610t343r1727b372],
8	during	IN	O	during	_	0	SENT_171	[p6l1742t343r1848b381],
9	phase	NN	O	phase	prep_during	7	SENT_171	[p6l549t393r642b431],
10	I	PRP	O	I	dep	11	SENT_171	[p6l654t394r667b422],
11	development	NN	O	development	dep	9	SENT_171	[p6l679t393r900b431],
12	,	,	O	,	_	0	SENT_171	[p6l679t393r900b431],
13	docetaxel	NN	O	docetaxel	nsubjpass	17	SENT_171	[p6l914t393r1071b422],
14	has	VBZ	O	have	aux	17	SENT_171	[p6l1082t393r1135b422],
15	been	VBN	O	be	auxpass	17	SENT_171	[p6l1148t393r1226b422],
16	exclusively	RB	O	exclusively	advmod	17	SENT_171	[p6l1237t393r1424b431],
17	evaluted	VBN	O	evalute	dep	32	SENT_171	[p6l1437t393r1576b422],
18	at	IN	O	at	_	0	SENT_171	[p6l1587t398r1616b422],
19	a	DT	O	a	det	20	SENT_171	[p6l1627t402r1645b422],
20	dose	NN	O	dose	prep_at	17	SENT_171	[p6l1656t393r1730b422],
21	of	IN	O	of	_	0	SENT_171	[p6l1743t393r1778b422],
22	100	CD	NUMBER	100	num	23	SENT_171	[p6l1791t393r1848b422],
23	mg/m2	NN	O	mg/m2	prep_of	20	SENT_171	[p6l549t432r661b481],
24	as	IN	O	as	_	0	SENT_171	[p6l676t453r708b473],
25	a	DT	O	a	det	28	SENT_171	[p6l723t453r740b473],
26	1-h	JJ	O	1-h	amod	28	SENT_171	[p6l758t443r808b472],
27	i.v.	NN	O	i.v.	nn	28	SENT_171	[p6l821t443r871b473],
28	infusion	NN	O	infusion	prep_as	23	SENT_171	[p6l887t443r1022b473],
29	every	DT	SET	every	det	31	SENT_171	[p6l1036t453r1126b481],
30	three	CD	SET	three	num	31	SENT_171	[p6l1140t443r1221b473],
31	weeks	NNS	NUMBER	week	tmod	17	SENT_171	[p6l1235t444r1336b473],
32	(	VBP	O	(	_	0	SENT_171	[p6l1352t444r1414b479],
33	27	CD	NUMBER	27	nsubj	32	SENT_171	[p6l1352t444r1414b479],
34	,	,	O	,	_	0	SENT_171	[p6l1352t444r1414b479],
35	33	CD	NUMBER	33	num	36	SENT_171	[p6l1430t444r1491b479],
36	)	NN	O	)	appos	33	SENT_171	[p6l1430t444r1491b479],
37	.	.	O	.	_	0	SENT_171	[p6l1430t444r1491b479],

1	Lower	JJR	O	lower	amod	2	SENT_172	[p6l1507t444r1615b473],
2	doses	NNS	O	dose	tmod	8	SENT_172	[p6l1628t444r1717b473],
3	(	CD	NUMBER	(	dep	2	SENT_172	[p6l1733t443r1846b479],
4	60-75	CD	NUMBER	60-75	num	6	SENT_172	[p6l1733t443r1846b479],
5	mg/m2	NN	O	mg/m2	nn	6	SENT_172	[p6l549t482r674b531],
6	)	NN	O	)	nsubj	8	SENT_172	[p6l549t482r674b531],
7	may	MD	O	may	aux	8	SENT_172	[p6l686t503r756b531],
8	produce	VB	O	produce	_	0	SENT_172	[p6l768t493r900b531],
9	less	JJR	O	less	amod	10	SENT_172	[p6l912t493r972b522],
10	toxicity	NN	O	toxicity	dobj	8	SENT_172	[p6l983t493r1119b531],
11	;	:	O	;	_	0	SENT_172	[p6l983t493r1119b531],
12	however	RB	O	however	advmod	25	SENT_172	[p6l1131t493r1282b528],
13	,	,	O	,	_	0	SENT_172	[p6l1131t493r1282b528],
14	the	DT	O	the	det	17	SENT_172	[p6l1294t493r1343b522],
15	relative	JJ	O	relative	amod	17	SENT_172	[p6l1354t493r1478b522],
16	therapeutic	JJ	O	therapeutic	amod	17	SENT_172	[p6l1489t493r1672b531],
17	advantage	NN	O	advantage	nsubj	25	SENT_172	[p6l1685t493r1850b531],
18	of	IN	O	of	_	0	SENT_172	[p6l550t543r585b573],
19	high	JJ	O	high	prep_of	17	SENT_172	[p6l600t543r674b581],
20	versus	CC	O	versus	prep	19	SENT_172	[p6l692t553r796b573],
21	low	JJ	O	low	amod	22	SENT_172	[p6l815t543r876b573],
22	doses	NNS	O	dose	dep	20	SENT_172	[p6l895t544r985b573],
23	is	VBZ	O	be	cop	25	SENT_172	[p6l1004t543r1030b573],
24	not	RB	O	not	neg	25	SENT_172	[p6l1049t548r1102b573],
25	clear	JJ	O	clear	parataxis	8	SENT_172	[p6l1120t543r1207b573],
26	.	.	O	.	_	0	SENT_172	[p6l1120t543r1207b573],

1	Despite	IN	O	despite	_	0	SENT_173	[p6l1227t543r1352b581],
2	the	DT	O	the	det	3	SENT_173	[p6l1371t544r1420b573],
3	use	NN	O	use	prep_despite	41	SENT_173	[p6l1438t553r1493b573],
4	of	IN	O	of	_	0	SENT_173	[p6l1511t543r1547b573],
5	a	DT	O	a	det	8	SENT_173	[p6l1563t553r1580b573],
6	polysorbate	NN	O	polysorbate	nn	8	SENT_173	[p6l1597t543r1790b581],
7	80	CD	NUMBER	80	num	8	SENT_173	[p6l1810t544r1848b573],
8	formulation	NN	O	formulation	prep_of	3	SENT_173	[p6l549t594r744b623],
9	instead	RB	O	instead	_	0	SENT_173	[p6l761t594r878b623],
10	of	IN	O	of	_	0	SENT_173	[p6l895t594r931b623],
11	Cremophor	NNP	ORGANIZATION	Cremophor	nn	12	SENT_173	[p6l946t594r1134b631],
12	EL	NNP	ORGANIZATION	EL	prep_instead_of	8	SENT_173	[p6l1150t594r1209b628],
13	,	,	O	,	_	0	SENT_173	[p6l1150t594r1209b628],
14	which	WDT	O	which	nsubj	26	SENT_173	[p6l1228t594r1328b623],
15	is	VBZ	O	be	cop	18	SENT_173	[p6l1345t594r1371b623],
16	the	DT	O	the	det	18	SENT_173	[p6l1389t594r1438b623],
17	putative	JJ	O	putative	amod	18	SENT_173	[p6l1455t594r1588b631],
18	constitutent	NN	O	constitutent	dep	41	SENT_173	[p6l1606t594r1798b623],
19	of	IN	O	of	_	0	SENT_173	[p6l1815t594r1851b623],
20	paclitaxel	NN	O	paclitaxel	poss	23	SENT_173	[p6l549t644r738b681],
21	’s	POS	O	’s	_	0	SENT_173	[p6l549t644r738b681],
22	formulation	NN	O	formulation	nn	23	SENT_173	[p6l749t643r943b673],
23	vehicle	NN	O	vehicle	prep_of	18	SENT_173	[p6l953t643r1072b673],
24	and	CC	O	and	_	0	SENT_173	[p6l1082t644r1140b673],
25	is	VBZ	O	be	cop	26	SENT_173	[p6l1150t643r1175b673],
26	responsible	JJ	O	responsible	conj_and	18	SENT_173	[p6l1186t643r1374b681],
27	for	IN	O	for	_	0	SENT_173	[p6l1384t643r1432b673],
28	major	JJ	O	major	amod	29	SENT_173	[p6l1441t643r1537b681],
29	HSR	NN	MISC	hsr	prep_for	26	SENT_173	[p6l1546t644r1634b678],
30	,	,	O	,	_	0	SENT_173	[p6l1546t644r1634b678],
31	high	JJ	O	high	amod	32	SENT_173	[p6l1646t643r1719b681],
32	rates	NNS	O	rate	nsubj	41	SENT_173	[p6l1728t648r1804b673],
33	of	IN	O	of	_	0	SENT_173	[p6l1816t643r1851b673],
34	HSR	NN	O	hsr	nn	37	SENT_173	[p6l549t694r629b723],
35	and	CC	O	and	_	0	SENT_173	[p6l643t694r701b723],
36	ﬂuid	NN	O	ﬂuid	conj_and	34	SENT_173	[p6l713t694r791b723],
37	retention	NN	O	retention	prep_of	32	SENT_173	[p6l803t694r949b723],
38	following	VBG	O	follow	_	0	SENT_173	[p6l962t694r1122b731],
39	docetaxel	NN	O	docetaxel	nn	40	SENT_173	[p6l1135t694r1292b723],
40	infusion	NN	O	infusion	prep_following	37	SENT_173	[p6l1304t694r1440b723],
41	led	VBD	O	lead	_	0	SENT_173	[p6l1452t694r1502b723],
42	to	TO	O	to	_	0	SENT_173	[p6l1514t698r1545b723],
43	the	DT	O	the	det	44	SENT_173	[p6l1558t694r1607b723],
44	use	NN	O	use	prep_to	41	SENT_173	[p6l1620t703r1674b723],
45	of	IN	O	of	_	0	SENT_173	[p6l1687t694r1723b723],
46	several	JJ	O	several	amod	48	SENT_173	[p6l1734t694r1849b723],
47	premedication	NN	O	premedication	nn	48	SENT_173	[p6l549t744r785b782],
48	regimens	NNS	O	regimen	prep_of	44	SENT_173	[p6l800t744r960b782],
49	,	,	O	,	_	0	SENT_173	[p6l800t744r960b782],
50	the	DT	O	the	dep	52	SENT_173	[p6l976t744r1026b773],
51	most	RBS	O	most	advmod	52	SENT_173	[p6l1041t748r1121b773],
52	popular	JJ	O	popular	nsubj	56	SENT_173	[p6l1136t744r1262b782],
53	of	IN	O	of	_	0	SENT_173	[p6l1278t744r1313b773],
54	which	WDT	O	which	prep_of	52	SENT_173	[p6l1326t744r1425b773],
55	is	VBZ	O	be	cop	56	SENT_173	[p6l1441t744r1466b773],
56	dexamethasone	NN	O	dexamethasone	rcmod	48	SENT_173	[p6l1483t744r1746b778],
57	,	,	O	,	_	0	SENT_173	[p6l1483t744r1746b778],
58	8	CD	NUMBER	8	num	59	SENT_173	[p6l1764t744r1780b773],
59	mg	NN	O	mg	appos	56	SENT_173	[p6l1796t753r1848b782],
60	orally	RB	O	orally	advmod	66	SENT_173	[p6l550t794r644b832],
61	twice	RB	O	twice	advmod	62	SENT_173	[p6l653t794r742b823],
62	daily	JJ	SET	daily	advmod	66	SENT_173	[p6l751t794r832b832],
63	for	IN	O	for	_	0	SENT_173	[p6l841t794r889b823],
64	five	CD	DURATION	five	num	65	SENT_173	[p6l897t794r960b823],
65	days	NNS	NUMBER	day	prep_for	62	SENT_173	[p6l970t794r1043b832],
66	starting	VBG	O	start	partmod	59	SENT_173	[p6l1054t794r1176b832],
67	one	CD	DURATION	one	num	68	SENT_173	[p6l1186t803r1244b823],
68	day	NN	NUMBER	day	npadvmod	66	SENT_173	[p6l1253t794r1311b832],
69	before	IN	O	before	_	0	SENT_173	[p6l1320t794r1424b823],
70	docetaxel	NN	O	docetaxel	prep_before	66	SENT_173	[p6l1434t794r1591b823],
71	with	IN	O	with	_	0	SENT_173	[p6l1600t794r1672b823],
72	or	CC	O	or	_	0	SENT_173	[p6l1681t803r1715b823],
73	without	IN	O	without	_	0	SENT_173	[p6l1723t794r1849b823],
74	both	DT	O	both	preconj	76	SENT_173	[p6l549t844r622b873],
75	H1	NN	O	h1	nn	76	SENT_173	[p6l634t845r692b885],
76	—	NN	O	—	prep_without	70	SENT_173	[p6l634t845r692b885],
77	and	CC	O	and	_	0	SENT_173	[p6l706t844r764b873],
78	H2	NN	O	h2	conj_and	76	SENT_173	[p6l775t844r996b885],
79	—	CD	NUMBER	—	num	81	SENT_173	[p6l775t844r996b885],
80	histamine	NN	O	histamine	nn	81	SENT_173	[p6l775t844r996b885],
81	antagonists	NNS	O	antagonist	dobj	66	SENT_173	[p6l1008t844r1192b882],
82	given	VBN	O	give	partmod	81	SENT_173	[p6l1205t844r1296b882],
83	i.v.	NNP	O	i.v.	iobj	82	SENT_173	[p6l1307t844r1357b873],
84	30	CD	DURATION	30	num	85	SENT_173	[p6l1372t844r1411b873],
85	min	NN	DURATION	min	dobj	82	SENT_173	[p6l1423t844r1486b873],
86	before	IN	O	before	_	0	SENT_173	[p6l1498t844r1603b873],
87	docetaxel	NN	O	docetaxel	prep_before	85	SENT_173	[p6l1615t844r1772b873],
88	(	CD	NUMBER	(	number	89	SENT_173	[p6l1785t844r1847b880],
89	27	CD	NUMBER	27	num	87	SENT_173	[p6l1785t844r1847b880],
90	,	,	O	,	_	0	SENT_173	[p6l1785t844r1847b880],

1	33	CD	NUMBER	33	_	0	SENT_174	[p6l550t969r612b1005],
2	)	NN	O	)	dep	1	SENT_174	[p6l550t969r612b1005],
3	.	.	O	.	_	0	SENT_174	[p6l550t969r612b1005],

1	Docetaxel	JJ	O	docetaxel	amod	2	SENT_175	[p6l599t1023r766b1051],
2	clearance	NN	O	clearance	nsubjpass	4	SENT_175	[p6l785t1022r939b1051],
3	was	VBD	O	be	auxpass	4	SENT_175	[p6l957t1032r1020b1051],
4	found	VBN	O	find	_	0	SENT_175	[p6l1039t1022r1135b1051],
5	to	TO	O	to	aux	7	SENT_175	[p6l1154t1027r1184b1051],
6	be	VB	O	be	auxpass	7	SENT_175	[p6l1203t1022r1241b1051],
7	reduced	VBN	O	reduce	xcomp	4	SENT_175	[p6l1259t1022r1390b1051],
8	by	IN	O	by	_	0	SENT_175	[p6l1407t1022r1448b1060],
9	approximately	RB	O	approximately	quantmod	10	SENT_175	[p6l1468t1022r1705b1060],
10	25	CD	PERCENT	25	num	11	SENT_175	[p6l1724t1022r1797b1052],
11	%	NN	PERCENT	%	agent	7	SENT_175	[p6l1724t1022r1797b1052],
12	in	IN	O	in	_	0	SENT_175	[p6l1817t1022r1849b1051],
13	patients	NNS	O	patient	prep_in	11	SENT_175	[p6l549t1072r676b1110],
14	with	IN	O	with	_	0	SENT_175	[p6l696t1072r769b1102],
15	elevations	NNS	O	elevation	prep_with	7	SENT_175	[p6l788t1072r953b1102],
16	in	IN	O	in	_	0	SENT_175	[p6l973t1072r1004b1101],
17	serum	NN	O	serum	nn	18	SENT_175	[p6l1024t1082r1124b1102],
18	concentrations	NNS	O	concentration	prep_in	15	SENT_175	[p6l1143t1072r1382b1102],
19	of	IN	O	of	_	0	SENT_175	[p6l1402t1072r1437b1101],
20	both	DT	O	both	det	22	SENT_175	[p6l1453t1073r1526b1102],
21	hepatocellular	JJ	O	hepatocellular	amod	22	SENT_175	[p6l1545t1072r1779b1110],
22	enzymes	NNS	O	enzyme	nsubj	23	SENT_175	[p6l1797t1082r1847b1101, p6l550t1132r653b1160],
23	(	VBP	O	(	dep	33	SENT_175	[p6l667t1122r847b1158],
24	>	JJR	O	>	amod	26	SENT_175	[p6l667t1122r847b1158],
25	l.5-fold	JJ	O	l.5-fold	amod	26	SENT_175	[p6l667t1122r847b1158],
26	)	NN	O	)	nsubj	31	SENT_175	[p6l667t1122r847b1158],
27	and	CC	O	and	_	0	SENT_175	[p6l861t1123r919b1152],
28	alkaline	NN	O	alkaline	nn	29	SENT_175	[p6l932t1122r1061b1152],
29	phosphatase	NN	O	phosphatase	nsubj	31	SENT_175	[p6l1073t1123r1275b1160],
30	(	CD	NUMBER	(	npadvmod	31	SENT_175	[p6l1289t1122r1478b1158],
31	>	JJR	O	>	xcomp	23	SENT_175	[p6l1289t1122r1478b1158],
32	2.5-fold	JJ	O	2.5-fold	amod	33	SENT_175	[p6l1289t1122r1478b1158],
33	)	NN	O	)	prep_of	18	SENT_175	[p6l1289t1122r1478b1158],
34	,	,	O	,	_	0	SENT_175	[p6l1289t1122r1478b1158],
35	regardless	RB	O	regardless	advmod	36	SENT_175	[p6l1491t1122r1658b1160],
36	of	IN	O	of	advmod	7	SENT_175	[p6l1671t1122r1707b1152],
37	whether	IN	O	whether	complm	43	SENT_175	[p6l1716t1122r1849b1152],
38	or	CC	O	or	_	0	SENT_175	[p6l550t1182r583b1201],
39	not	RB	O	not	ccomp	7	SENT_175	[p6l599t1177r651b1201],
40	the	DT	O	the	det	41	SENT_175	[p6l667t1172r716b1201],
41	elevations	NNS	O	elevation	nsubj	43	SENT_175	[p6l733t1172r898b1201],
42	were	VBD	O	be	cop	43	SENT_175	[p6l915t1182r994b1201],
43	due	JJ	O	due	ccomp	7	SENT_175	[p6l1011t1172r1069b1201],
44	to	TO	O	to	_	0	SENT_175	[p6l1085t1177r1116b1201],
45	hepatic	JJ	O	hepatic	amod	46	SENT_175	[p6l1132t1172r1250b1210],
46	metastases	NNS	O	metastase	prep_to	43	SENT_175	[p6l1267t1177r1452b1207],
47	,	,	O	,	_	0	SENT_175	[p6l1267t1177r1452b1207],
48	and	CC	O	and	_	0	SENT_175	[p6l1470t1172r1528b1201],
49	more	RBR	O	more	advmod	52	SENT_175	[p6l1544t1182r1628b1201],
50	toxicity	NN	O	toxicity	nsubjpass	52	SENT_175	[p6l1644t1172r1769b1210],
51	was	VBD	O	be	auxpass	52	SENT_175	[p6l1785t1182r1847b1201],
52	noted	VBN	O	note	conj_and	4	SENT_175	[p6l549t1222r648b1251],
53	.	.	O	.	_	0	SENT_175	[p6l549t1222r648b1251],

1	Dose	NN	O	dose	nn	2	SENT_176	[p6l667t1223r751b1251],
2	reductions	NNS	O	reduction	nsubjpass	9	SENT_176	[p6l767t1222r938b1251],
3	by	IN	O	by	_	0	SENT_176	[p6l955t1222r996b1260],
4	at	IN	O	at	quantmod	6	SENT_176	[p6l1014t1227r1042b1251],
5	least	JJS	O	least	mwe	4	SENT_176	[p6l1058t1222r1134b1251],
6	25	CD	PERCENT	25	num	7	SENT_176	[p6l1150t1222r1223b1252],
7	%	NN	PERCENT	%	prep_by	2	SENT_176	[p6l1150t1222r1223b1252],
8	are	VBP	O	be	auxpass	9	SENT_176	[p6l1242t1232r1290b1251],
9	recommended	VBN	O	recommend	_	0	SENT_176	[p6l1306t1222r1540b1251],
10	for	IN	O	for	_	0	SENT_176	[p6l1556t1222r1604b1251],
11	such	JJ	O	such	amod	12	SENT_176	[p6l1621t1222r1695b1251],
12	patients	NNS	O	patient	prep_for	9	SENT_176	[p6l1710t1222r1847b1260],
13	,	,	O	,	_	0	SENT_176	[p6l1710t1222r1847b1260],
14	though	RB	O	though	advmod	9	SENT_176	[p6l549t1272r663b1310],
15	more	RBR	O	more	advmod	17	SENT_176	[p6l675t1281r759b1301],
16	substantial	JJ	O	substantial	amod	17	SENT_176	[p6l772t1272r947b1301],
17	reductions	NNS	O	reduction	nsubjpass	20	SENT_176	[p6l958t1272r1129b1301],
18	may	MD	O	may	aux	20	SENT_176	[p6l1142t1281r1212b1310],
19	be	VB	O	be	auxpass	20	SENT_176	[p6l1223t1272r1261b1301],
20	required	VBN	O	require	ccomp	9	SENT_176	[p6l1273t1272r1410b1310],
21	in	IN	O	in	_	0	SENT_176	[p6l1421t1272r1453b1301],
22	the	DT	O	the	det	23	SENT_176	[p6l1464t1272r1514b1301],
23	case	NN	O	case	prep_in	20	SENT_176	[p6l1525t1281r1595b1301],
24	of	IN	O	of	_	0	SENT_176	[p6l1607t1272r1643b1301],
25	hyperbiliru	NN	O	hyperbiliru	nn	27	SENT_176	[p6l1651t1272r1847b1310],
26	—	NN	O	—	nn	27	SENT_176	[p6l1651t1272r1847b1310],
27	binemia	NN	O	binemia	prep_of	23	SENT_176	[p6l549t1322r682b1351],
28	(	CD	NUMBER	(	number	29	SENT_176	[p6l694t1322r756b1358],
29	33	CD	NUMBER	33	dep	27	SENT_176	[p6l694t1322r756b1358],
30	,	,	O	,	_	0	SENT_176	[p6l694t1322r756b1358],
31	34	CD	NUMBER	34	num	32	SENT_176	[p6l770t1322r831b1358],
32	)	NN	O	)	appos	27	SENT_176	[p6l770t1322r831b1358],
33	.	.	O	.	_	0	SENT_176	[p6l770t1322r831b1358],

1	Toxicity	NN	O	toxicity	_	0	SENT_177	[p6l552t1424r709b1467],

1	PACLITAXEL	NN	O	paclitaxel	nn	3	SENT_178	[p6l549t1548r753b1572],
2	Many	JJ	O	many	amod	3	SENT_178	[p6l792t1543r887b1580],
3	obstacles	NNS	O	obstacle	nsubjpass	5	SENT_178	[p6l900t1542r1049b1572],
4	were	VBD	O	be	auxpass	5	SENT_178	[p6l1062t1551r1141b1572],
5	encountered	VBN	O	encounter	_	0	SENT_178	[p6l1153t1542r1354b1572],
6	during	IN	O	during	_	0	SENT_178	[p6l1365t1542r1472b1580],
7	early	JJ	O	early	amod	8	SENT_178	[p6l1484t1542r1565b1580],
8	trials	NNS	O	trial	prep_during	5	SENT_178	[p6l1577t1542r1658b1572],
9	that	WDT	O	that	nsubj	10	SENT_178	[p6l1670t1542r1731b1572],
10	threatened	VBD	O	threaten	rcmod	8	SENT_178	[p6l1742t1542r1847b1572, p6l550t1592r627b1622],
11	the	DT	O	the	det	12	SENT_178	[p6l634t1592r684b1622],
12	prospects	NNS	O	prospects	nsubj	18	SENT_178	[p6l691t1597r846b1630],
13	for	IN	O	for	_	0	SENT_178	[p6l855t1592r903b1622],
14	paclitaxel	NN	O	paclitaxel	nn	15	SENT_178	[p6l910t1592r1080b1630],
15	’	NN	O	’	prep_for	12	SENT_178	[p6l910t1592r1080b1630],
16	s	VBZ	O	s	cop	18	SENT_178	[p6l1086t1601r1099b1622],
17	further	JJ	O	further	amod	18	SENT_178	[p6l1108t1592r1220b1622],
18	development	NN	O	development	ccomp	10	SENT_178	[p6l1228t1592r1449b1630],
19	,	,	O	,	_	0	SENT_178	[p6l1228t1592r1449b1630],
20	particularly	RB	O	particularly	advmod	18	SENT_178	[p6l1457t1592r1648b1630],
21	major	JJ	O	major	amod	22	SENT_178	[p6l1655t1592r1752b1630],
22	HSR	NN	O	hsr	dep	18	SENT_178	[p6l1759t1592r1846b1622],
23	.	.	O	.	_	0	SENT_178	[p6l1759t1592r1846b1622],

1	Neutropenia	NN	O	neutropenia	nsubj	5	SENT_179	[p6l549t1642r754b1680],
2	was	VBD	O	be	cop	5	SENT_179	[p6l766t1651r828b1671],
3	the	DT	O	the	det	5	SENT_179	[p6l842t1642r891b1671],
4	principal	JJ	O	principal	amod	5	SENT_179	[p6l903t1642r1050b1680],
5	toxicity	NN	O	toxicity	_	0	SENT_179	[p6l1063t1642r1197b1680],
6	,	,	O	,	_	0	SENT_179	[p6l1063t1642r1197b1680],
7	but	CC	O	but	_	0	SENT_179	[p6l1211t1642r1264b1671],
8	several	JJ	O	several	amod	10	SENT_179	[p6l1277t1642r1392b1671],
9	other	JJ	O	other	amod	10	SENT_179	[p6l1405t1642r1490b1671],
10	toxicities	NNS	O	toxicity	nsubjpass	16	SENT_179	[p6l1502t1642r1651b1671],
11	and	CC	O	and	_	0	SENT_179	[p6l1666t1642r1724b1671],
12	unique	JJ	O	unique	amod	14	SENT_179	[p6l1736t1642r1848b1680],
13	pharmaceutical	JJ	O	pharmaceutical	amod	14	SENT_179	[p6l549t1692r801b1730],
14	properties	NNS	O	property	conj_and	10	SENT_179	[p6l811t1692r975b1730],
15	were	VBD	O	be	auxpass	16	SENT_179	[p6l988t1701r1067b1722],
16	encountered	VBN	O	encounter	conj_but	5	SENT_179	[p6l1078t1692r1280b1722],
17	(	CD	NUMBER	(	number	18	SENT_179	[p6l1292t1692r1367b1728],
18	35	CD	NUMBER	35	num	19	SENT_179	[p6l1292t1692r1367b1728],
19	)	NN	O	)	dobj	16	SENT_179	[p6l1292t1692r1367b1728],
20	.	.	O	.	_	0	SENT_179	[p6l1292t1692r1367b1728],

1	360	CD	NUMBER	360	num	2	SENT_180	[p6l551t1749r605b1775],
2	ROWINSKY	NN	O	rowinsky	_	0	SENT_180	[p6l644t1749r844b1775],

1	Hypersensitivity	NN	O	hypersensitivity	nn	2	SENT_181	[p6l549t1834r818b1871],
2	reactions	NNS	O	reaction	dep	14	SENT_181	[p6l830t1834r981b1863],
3	A	DT	O	a	det	5	SENT_181	[p6l1021t1833r1050b1862],
4	difficult	JJ	O	difficult	amod	5	SENT_181	[p6l1062t1833r1194b1863],
5	problem	NN	O	problem	dep	2	SENT_181	[p6l1205t1833r1343b1871],
6	encountered	VBN	O	encounter	partmod	5	SENT_181	[p6l1352t1833r1554b1863],
7	during	IN	O	during	_	0	SENT_181	[p6l1564t1833r1670b1871],
8	early	JJ	O	early	amod	10	SENT_181	[p6l1682t1833r1763b1871],
9	drug	NN	O	drug	nn	10	SENT_181	[p6l1775t1833r1849b1871],
10	development	NN	O	development	prep_during	6	SENT_181	[p6l551t1883r764b1921],
11	was	VBD	O	be	cop	14	SENT_181	[p6l772t1892r834b1913],
12	the	DT	O	the	det	14	SENT_181	[p6l844t1883r893b1913],
13	high	JJ	O	high	amod	14	SENT_181	[p6l902t1883r975b1921],
14	incidence	NN	O	incidence	_	0	SENT_181	[p6l984t1883r1141b1913],
15	of	IN	O	of	_	0	SENT_181	[p6l1150t1883r1186b1913],
16	major	JJ	O	major	amod	17	SENT_181	[p6l1192t1883r1288b1921],
17	HSR	NN	O	hsr	prep_of	14	SENT_181	[p6l1296t1883r1384b1918],
18	,	,	O	,	_	0	SENT_181	[p6l1296t1883r1384b1918],
19	manifested	VBN	O	manifest	partmod	17	SENT_181	[p6l1395t1883r1576b1913],
20	by	IN	O	by	_	0	SENT_181	[p6l1583t1883r1624b1921],
21	dyspnea	NN	O	dyspnea	agent	19	SENT_181	[p6l1634t1883r1768b1921],
22	with	IN	O	with	_	0	SENT_181	[p6l1776t1883r1849b1913],
23	bronchospasm	NN	O	bronchospasm	nn	25	SENT_181	[p6l550t1933r797b1971],
24	,	,	O	,	_	0	SENT_181	[p6l550t1933r797b1971],
25	urticaria	NN	O	urticarium	prep_with	19	SENT_181	[p6l809t1933r955b1968],
26	,	,	O	,	_	0	SENT_181	[p6l809t1933r955b1968],
27	and	CC	O	and	_	0	SENT_181	[p6l967t1933r1026b1962],
28	hypotension	NN	O	hypotension	nn	29	SENT_181	[p6l1036t1933r1238b1971],
29	(	NN	O	(	conj_and	25	SENT_181	[p6l1249t1933r1290b1969],
30	1	CD	NUMBER	1	nsubj	14	SENT_181	[p6l1249t1933r1290b1969],
31	,	,	O	,	_	0	SENT_181	[p6l1249t1933r1290b1969],
32	35	CD	NUMBER	35	appos	30	SENT_181	[p6l1303t1933r1351b1968],
33	,	,	O	,	_	0	SENT_181	[p6l1303t1933r1351b1968],
34	36	CD	NUMBER	36	num	35	SENT_181	[p6l1365t1933r1426b1969],
35	)	NN	O	)	appos	32	SENT_181	[p6l1365t1933r1426b1969],
36	.	.	O	.	_	0	SENT_181	[p6l1365t1933r1426b1969],

1	Serious	JJ	O	serious	amod	2	SENT_182	[p6l1440t1933r1561b1963],
2	reactions	NNS	O	reaction	nsubj	4	SENT_182	[p6l1572t1933r1719b1962],
3	usually	RB	O	usually	advmod	4	SENT_182	[p6l1730t1933r1849b1971],
4	occurred	VBD	O	occur	_	0	SENT_182	[p6l551t1983r694b2013],
5	within	IN	O	within	_	0	SENT_182	[p6l703t1983r807b2013],
6	2-3	CD	NUMBER	2-3	num	7	SENT_182	[p6l816t1983r875b2013],
7	min	NN	DURATION	min	prep_within	4	SENT_182	[p6l886t1983r950b2012],
8	after	IN	O	after	_	0	SENT_182	[p6l959t1983r1034b2013],
9	drug	NN	O	drug	nn	10	SENT_182	[p6l1042t1983r1116b2021],
10	administration	NN	O	administration	prep_after	4	SENT_182	[p6l1126t1983r1372b2018],
11	,	,	O	,	_	0	SENT_182	[p6l1126t1983r1372b2018],
12	and	CC	O	and	_	0	SENT_182	[p6l1383t1983r1441b2013],
13	almost	RB	O	almost	advmod	15	SENT_182	[p6l1451t1983r1560b2013],
14	all	DT	O	all	det	15	SENT_182	[p6l1569t1983r1608b2013],
15	HSR	NN	O	hsr	nsubj	16	SENT_182	[p6l1617t1983r1697b2013],
16	occurred	VBD	O	occur	conj_and	4	SENT_182	[p6l1706t1983r1849b2013],
17	within	IN	O	within	_	0	SENT_182	[p6l550t2033r655b2063],
18	the	DT	DURATION	the	det	21	SENT_182	[p6l663t2033r713b2063],
19	first	JJ	DURATION	first	amod	21	SENT_182	[p6l721t2033r787b2063],
20	10	CD	DURATION	10	num	21	SENT_182	[p6l799t2033r835b2063],
21	min	NN	DURATION	min	prep_within	16	SENT_182	[p6l843t2033r906b2062],
22	after	IN	O	after	_	0	SENT_182	[p6l916t2033r990b2063],
23	treatment	NN	O	treatment	prep_after	16	SENT_182	[p6l997t2038r1153b2063],
24	with	IN	O	with	_	0	SENT_182	[p6l1160t2033r1233b2063],
25	the	DT	O	the	det	29	SENT_182	[p6l1241t2033r1290b2063],
26	first	JJ	ORDINAL	first	amod	29	SENT_182	[p6l1299t2033r1365b2063],
27	or	CC	O	or	_	0	SENT_182	[p6l1373t2042r1406b2063],
28	second	JJ	ORDINAL	second	conj_or	26	SENT_182	[p6l1415t2033r1528b2063],
29	dose	NN	O	dose	prep_with	16	SENT_182	[p6l1536t2033r1619b2063],
30	.	.	O	.	_	0	SENT_182	[p6l1536t2033r1619b2063],

1	Most	JJS	O	most	amod	2	SENT_183	[p6l1629t2034r1714b2063],
2	patients	NNS	O	patient	nsubj	3	SENT_183	[p6l1721t2033r1848b2071],
3	recovered	VBD	O	recover	_	0	SENT_183	[p6l550t2083r713b2113],
4	fully	RB	O	fully	advmod	3	SENT_183	[p6l724t2083r801b2121],
5	after	IN	O	after	_	0	SENT_183	[p6l815t2083r890b2112],
6	discontinuation	NN	O	discontinuation	prep_after	3	SENT_183	[p6l902t2083r1156b2112],
7	of	IN	O	of	_	0	SENT_183	[p6l1169t2083r1205b2112],
8	paclitaxel	NN	O	paclitaxel	prep_of	6	SENT_183	[p6l1214t2083r1374b2121],
9	and	CC	O	and	_	0	SENT_183	[p6l1387t2083r1446b2112],
10	occasionally	RB	O	occasionally	advmod	3	SENT_183	[p6l1459t2083r1663b2121],
11	after	IN	O	after	_	0	SENT_183	[p6l1677t2083r1752b2112],
12	treatment	NN	O	treatment	prep_after	3	SENT_183	[p6l1763t2087r1848b2112, p6l550t2138r632b2163],
13	with	IN	O	with	_	0	SENT_183	[p6l645t2133r717b2163],
14	antihistamines	NNS	O	antihistamine	prep_with	3	SENT_183	[p6l730t2133r976b2168],
15	,	,	O	,	_	0	SENT_183	[p6l730t2133r976b2168],
16	ﬂuids	NNS	O	ﬂuids	conj_and	14	SENT_183	[p6l991t2133r1092b2168],
17	,	,	O	,	_	0	SENT_183	[p6l991t2133r1092b2168],
18	and	CC	O	and	_	0	SENT_183	[p6l1108t2133r1166b2163],
19	vasopressors	NNS	O	vasopressor	prep_with	3	SENT_183	[p6l1178t2142r1396b2171],
20	.	.	O	.	_	0	SENT_183	[p6l1178t2142r1396b2171],

1	Although	IN	O	although	mark	9	SENT_184	[p6l1411t2133r1567b2171],
2	as	RB	O	as	quantmod	5	SENT_184	[p6l1580t2142r1612b2163],
3	many	JJ	O	many	quantmod	5	SENT_184	[p6l1625t2142r1715b2171],
4	as	IN	O	as	quantmod	5	SENT_184	[p6l1729t2142r1760b2163],
5	40	CD	PERCENT	40	num	6	SENT_184	[p6l1774t2133r1847b2163],
6	%	NN	PERCENT	%	nsubj	9	SENT_184	[p6l1774t2133r1847b2163],
7	of	IN	O	of	_	0	SENT_184	[p6l551t2183r586b2213],
8	patients	NNS	O	patient	prep_of	6	SENT_184	[p6l603t2183r730b2221],
9	developed	VBD	O	develop	advcl	18	SENT_184	[p6l751t2183r920b2221],
10	ﬂushing	NN	O	ﬂushing	dobj	9	SENT_184	[p6l940t2183r1074b2221],
11	and	CC	O	and	_	0	SENT_184	[p6l1095t2183r1153b2213],
12	rashes	NNS	O	rash	conj_and	10	SENT_184	[p6l1173t2183r1284b2218],
13	,	,	O	,	_	0	SENT_184	[p6l1173t2183r1284b2218],
14	minor	JJ	O	minor	amod	15	SENT_184	[p6l1305t2183r1404b2213],
15	HSR	NN	O	hsr	nsubj	18	SENT_184	[p6l1423t2183r1503b2213],
16	do	VBP	O	do	aux	18	SENT_184	[p6l1523t2183r1562b2213],
17	not	RB	O	not	neg	18	SENT_184	[p6l1583t2188r1635b2213],
18	portend	VB	O	portend	_	0	SENT_184	[p6l1654t2183r1780b2221],
19	the	DT	O	the	det	20	SENT_184	[p6l1800t2183r1849b2213],
20	development	NN	O	development	dobj	18	SENT_184	[p6l551t2233r763b2271],
21	of	IN	O	of	_	0	SENT_184	[p6l775t2233r810b2262],
22	major	JJ	O	major	amod	23	SENT_184	[p6l819t2233r915b2271],
23	reactions	NNS	O	reaction	prep_of	20	SENT_184	[p6l925t2233r1083b2262],
24	.	.	O	.	_	0	SENT_184	[p6l925t2233r1083b2262],

1	HSR	NN	O	hsr	nsubjpass	4	SENT_185	[p6l600t2285r680b2314],
2	were	VBD	O	be	auxpass	4	SENT_185	[p6l693t2294r772b2314],
3	initially	RB	O	initially	advmod	4	SENT_185	[p6l784t2285r912b2323],
4	felt	VBN	O	feel	dep	28	SENT_185	[p6l925t2285r980b2314],
5	to	TO	O	to	aux	7	SENT_185	[p6l992t2289r1022b2314],
6	be	VB	O	be	auxpass	7	SENT_185	[p6l1035t2285r1074b2314],
7	mediated	VBN	O	mediate	xcomp	4	SENT_185	[p6l1087t2285r1238b2314],
8	by	IN	O	by	_	0	SENT_185	[p6l1249t2285r1290b2323],
9	the	DT	O	the	det	11	SENT_185	[p6l1303t2285r1352b2314],
10	direct	JJ	O	direct	amod	11	SENT_185	[p6l1366t2285r1459b2314],
11	release	NN	O	release	agent	7	SENT_185	[p6l1471t2285r1585b2314],
12	of	IN	O	of	_	0	SENT_185	[p6l1598t2285r1633b2314],
13	histamine	NN	O	histamine	prep_of	11	SENT_185	[p6l1643t2285r1803b2314],
14	or	CC	O	or	_	0	SENT_185	[p6l1816t2294r1850b2314],
15	other	JJ	O	other	amod	17	SENT_185	[p6l551t2335r635b2365],
16	vasoactive	JJ	O	vasoactive	amod	17	SENT_185	[p6l653t2335r826b2365],
17	substances	NNS	O	substance	conj_or	11	SENT_185	[p6l846t2335r1030b2370],
18	,	,	O	,	_	0	SENT_185	[p6l846t2335r1030b2370],
19	analogous	JJ	O	analogous	amod	27	SENT_185	[p6l1051t2335r1216b2373],
20	to	TO	O	to	_	0	SENT_185	[p6l1236t2340r1267b2365],
21	the	DT	O	the	det	22	SENT_185	[p6l1286t2335r1335b2365],
22	HSR	NN	O	hsr	prep_to	19	SENT_185	[p6l1354t2335r1434b2365],
23	caused	VBN	O	cause	partmod	22	SENT_185	[p6l1452t2335r1564b2365],
24	by	IN	O	by	_	0	SENT_185	[p6l1582t2335r1622b2373],
25	radiographic	JJ	O	radiographic	amod	26	SENT_185	[p6l1641t2335r1848b2373],
26	contrast	NN	O	contrast	agent	23	SENT_185	[p6l551t2390r681b2415],
27	agents	NNS	O	agent	appos	17	SENT_185	[p6l694t2390r797b2423],
28	(	VBP	O	(	_	0	SENT_185	[p6l812t2386r874b2421],
29	35	CD	NUMBER	35	nsubj	28	SENT_185	[p6l812t2386r874b2421],
30	,	,	O	,	_	0	SENT_185	[p6l812t2386r874b2421],
31	36	CD	NUMBER	36	num	32	SENT_185	[p6l890t2386r951b2421],
32	)	NN	O	)	appos	29	SENT_185	[p6l890t2386r951b2421],
33	.	.	O	.	_	0	SENT_185	[p6l890t2386r951b2421],

1	Although	IN	O	although	mark	6	SENT_186	[p6l966t2386r1122b2423],
2	HSR	NN	O	hsr	nsubjpass	6	SENT_186	[p6l1135t2386r1215b2415],
3	could	MD	O	could	aux	6	SENT_186	[p6l1228t2386r1319b2415],
4	have	VB	O	have	aux	6	SENT_186	[p6l1331t2386r1409b2415],
5	been	VBN	O	be	auxpass	6	SENT_186	[p6l1421t2386r1499b2415],
6	caused	VBN	O	cause	advcl	19	SENT_186	[p6l1512t2386r1624b2415],
7	by	IN	O	by	_	0	SENT_186	[p6l1636t2386r1676b2423],
8	paclitaxel	NN	O	paclitaxel	agent	6	SENT_186	[p6l1689t2386r1849b2423],
9	itself	PRP	O	itself	tmod	6	SENT_186	[p6l550t2436r635b2465],
10	or	CC	O	or	_	0	SENT_186	[p6l644t2445r678b2465],
11	its	PRP$	O	its	poss	14	SENT_186	[p6l689t2436r726b2465],
12	Cremophor	NNP	O	Cremophor	nn	14	SENT_186	[p6l740t2436r928b2474],
13	EL	NNP	O	EL	nn	14	SENT_186	[p6l939t2436r989b2465],
14	vehicle	NN	O	vehicle	conj_or	9	SENT_186	[p6l1001t2436r1128b2470],
15	,	,	O	,	_	0	SENT_186	[p6l1001t2436r1128b2470],
16	the	DT	O	the	det	17	SENT_186	[p6l1141t2436r1191b2465],
17	latter	NN	O	latter	nsubjpass	19	SENT_186	[p6l1203t2436r1287b2465],
18	was	VBD	O	be	auxpass	19	SENT_186	[p6l1298t2445r1360b2465],
19	felt	VBN	O	feel	_	0	SENT_186	[p6l1373t2436r1428b2465],
20	to	TO	O	to	aux	22	SENT_186	[p6l1439t2440r1470b2465],
21	be	VB	O	be	cop	22	SENT_186	[p6l1481t2436r1520b2465],
22	responsible	JJ	O	responsible	xcomp	19	SENT_186	[p6l1531t2436r1719b2474],
23	since	IN	O	since	mark	25	SENT_186	[p6l1733t2436r1815b2465],
24	it	PRP	O	it	nsubj	25	SENT_186	[p6l1827t2436r1850b2465],
25	induces	VBZ	O	induce	advcl	22	SENT_186	[p6l550t2486r675b2515],
26	histamine	NN	O	histamine	nn	27	SENT_186	[p6l687t2486r848b2515],
27	release	NN	O	release	dobj	25	SENT_186	[p6l859t2486r973b2515],
28	and	CC	O	and	_	0	SENT_186	[p6l986t2486r1044b2515],
29	similar	JJ	O	similar	amod	30	SENT_186	[p6l1057t2486r1171b2515],
30	HSR	NN	O	hsr	conj_and	27	SENT_186	[p6l1182t2486r1262b2515],
31	in	IN	O	in	_	0	SENT_186	[p6l1274t2486r1305b2515],
32	dogs	NNS	O	dog	prep_in	27	SENT_186	[p6l1317t2486r1402b2524],
33	.	.	O	.	_	0	SENT_186	[p6l1317t2486r1402b2524],

1	Other	JJ	O	other	amod	2	SENT_187	[p6l1417t2486r1511b2515],
2	drugs	NNS	O	drug	nsubjpass	8	SENT_187	[p6l1522t2486r1612b2524],
3	formulated	VBN	O	formulate	partmod	2	SENT_187	[p6l1625t2486r1806b2515],
4	in	IN	O	in	_	0	SENT_187	[p6l1818t2486r1849b2515],
5	Cremophor	NNP	LOCATION	Cremophor	nn	6	SENT_187	[p6l551t2536r738b2574],
6	EL	NNP	O	EL	prep_in	3	SENT_187	[p6l750t2537r800b2565],
7	are	VBP	O	be	auxpass	8	SENT_187	[p6l812t2545r861b2565],
8	associated	VBN	O	associate	dep	12	SENT_187	[p6l874t2536r1042b2565],
9	with	IN	O	with	_	0	SENT_187	[p6l1053t2536r1126b2565],
10	similar	JJ	O	similar	amod	11	SENT_187	[p6l1139t2536r1253b2565],
11	reactions	NNS	O	reaction	prep_with	8	SENT_187	[p6l1263t2536r1411b2565],
12	(	VBP	O	(	_	0	SENT_187	[p6l1425t2536r1486b2572],
13	35	CD	NUMBER	35	nsubj	12	SENT_187	[p6l1425t2536r1486b2572],
14	,	,	O	,	_	0	SENT_187	[p6l1425t2536r1486b2572],
15	36	CD	NUMBER	36	num	16	SENT_187	[p6l1501t2536r1562b2572],
16	)	NN	O	)	appos	13	SENT_187	[p6l1501t2536r1562b2572],
17	.	.	O	.	_	0	SENT_187	[p6l1501t2536r1562b2572],

1	Early	RB	O	early	advmod	2	SENT_188	[p6l1576t2536r1664b2574],
2	trials	NNS	O	trial	nsubjpass	4	SENT_188	[p6l1676t2536r1757b2565],
3	were	VBD	O	be	auxpass	4	SENT_188	[p6l1770t2545r1849b2565],
4	completed	VBN	O	complete	_	0	SENT_188	[p6l551t2586r722b2624],
5	using	VBG	O	use	xcomp	4	SENT_188	[p6l739t2586r828b2624],
6	24-h	JJ	O	24-h	amod	7	SENT_188	[p6l847t2586r921b2615],
7	infusions	NNS	O	infusion	dobj	5	SENT_188	[p6l939t2586r1089b2615],
8	and	CC	O	and	_	0	SENT_188	[p6l1109t2586r1168b2615],
9	premedication	NN	O	premedication	dobj	5	SENT_188	[p6l1185t2586r1421b2624],
10	with	IN	O	with	_	0	SENT_188	[p6l1439t2586r1511b2615],
11	corticosteroids	NNS	O	corticosteroid	prep_with	5	SENT_188	[p6l1530t2586r1771b2615],
12	and	CC	O	and	_	0	SENT_188	[p6l1791t2586r1849b2615],
13	histamine	NN	O	histamine	nn	15	SENT_188	[p6l550t2636r710b2665],
14	H1	NN	O	h1	nn	15	SENT_188	[p6l725t2637r782b2677],
15	—	NN	O	—	prep_with	5	SENT_188	[p6l725t2637r782b2677],
16	and	CC	O	and	_	0	SENT_188	[p6l799t2636r857b2665],
17	H2-antagonists	NNS	O	h2-antagonist	nsubj	23	SENT_188	[p6l871t2636r1116b2677],
18	since	IN	O	since	_	0	SENT_188	[p6l1133t2636r1215b2665],
19	similar	JJ	O	similar	amod	20	SENT_188	[p6l1231t2636r1345b2665],
20	regimens	NNS	O	regimen	prep_since	17	SENT_188	[p6l1358t2636r1508b2674],
21	have	VBP	O	have	aux	23	SENT_188	[p6l1523t2636r1600b2665],
22	been	VBN	O	be	cop	23	SENT_188	[p6l1614t2636r1692b2665],
23	effective	JJ	O	effective	conj_and	4	SENT_188	[p6l1706t2636r1849b2665],
24	in	IN	O	in	_	0	SENT_188	[p6l550t2686r581b2715],
25	preventing	VBG	O	prevent	prepc_in	23	SENT_188	[p6l592t2686r768b2724],
26	repeated	JJ	O	repeated	amod	27	SENT_188	[p6l779t2686r919b2724],
27	reactions	NNS	O	reaction	dobj	25	SENT_188	[p6l929t2686r1077b2715],
28	to	TO	O	to	_	0	SENT_188	[p6l1089t2691r1120b2715],
29	radiographic	JJ	O	radiographic	amod	31	SENT_188	[p6l1131t2686r1339b2724],
30	contrast	NN	O	contrast	nn	31	SENT_188	[p6l1352t2691r1482b2715],
31	agents	NNS	O	agent	prep_to	25	SENT_188	[p6l1494t2691r1606b2724],
32	.	.	O	.	_	0	SENT_188	[p6l1494t2691r1606b2724],

1	With	IN	O	with	_	0	SENT_189	[p6l1619t2686r1701b2715],
2	standard	JJ	O	standard	amod	3	SENT_189	[p6l1711t2686r1850b2715],
3	premedication	NN	O	premedication	prep_with	11	SENT_189	[p6l550t2736r795b2774],
4	,	,	O	,	_	0	SENT_189	[p6l550t2736r795b2774],
5	the	DT	O	the	det	6	SENT_189	[p6l807t2736r857b2765],
6	incidence	NN	O	incidence	nsubj	11	SENT_189	[p6l869t2736r1026b2765],
7	of	IN	O	of	_	0	SENT_189	[p6l1038t2736r1074b2765],
8	major	JJ	O	major	amod	9	SENT_189	[p6l1083t2736r1179b2774],
9	HSR	NN	O	hsr	prep_of	6	SENT_189	[p6l1190t2736r1270b2765],
10	has	VBZ	O	have	aux	11	SENT_189	[p6l1282t2736r1335b2765],
11	decreased	VBN	O	decrease	_	0	SENT_189	[p6l1348t2736r1510b2765],
12	to	TO	O	to	_	0	SENT_189	[p6l1521t2740r1552b2765],
13	less	JJR	O	less	mwe	14	SENT_189	[p6l1565t2736r1625b2765],
14	than	IN	O	than	quantmod	15	SENT_189	[p6l1637t2736r1707b2765],
15	3	CD	PERCENT	3	num	16	SENT_189	[p6l1720t2736r1771b2765],
16	%	NN	PERCENT	%	prep_to	11	SENT_189	[p6l1720t2736r1771b2765],
17	(	CD	NUMBER	(	number	18	SENT_189	[p6l1786t2736r1848b2772],
18	30	CD	NUMBER	30	num	16	SENT_189	[p6l1786t2736r1848b2772],
19	,	,	O	,	_	0	SENT_189	[p6l1786t2736r1848b2772],
20	35	CD	NUMBER	35	num	21	SENT_189	[p6l551t2786r612b2822],
21	)	NN	O	)	appos	16	SENT_189	[p6l551t2786r612b2822],
22	.	.	O	.	_	0	SENT_189	[p6l551t2786r612b2822],

1	A	DT	O	a	det	2	SENT_190	[p6l625t2786r654b2815],
2	study	NN	O	study	nsubj	14	SENT_190	[p6l666t2786r753b2824],
3	of	IN	O	of	_	0	SENT_190	[p6l765t2786r800b2815],
4	the	DT	O	the	det	6	SENT_190	[p6l808t2786r858b2815],
5	relative	JJ	O	relative	amod	6	SENT_190	[p6l868t2786r991b2815],
6	safety	NN	O	safety	prep_of	2	SENT_190	[p6l1003t2786r1099b2824],
7	and	CC	O	and	_	0	SENT_190	[p6l1110t2786r1169b2815],
8	efficacy	NN	O	efficacy	prep_of	2	SENT_190	[p6l1179t2786r1311b2824],
9	of	IN	O	of	_	0	SENT_190	[p6l1322t2786r1357b2815],
10	two	CD	NUMBER	two	num	13	SENT_190	[p6l1365t2791r1425b2815],
11	different	JJ	O	different	amod	13	SENT_190	[p6l1437t2786r1579b2815],
12	paclitaxel	NN	O	paclitaxel	nn	13	SENT_190	[p6l1588t2786r1748b2824],
13	doses	NNS	O	dose	prep_of	6	SENT_190	[p6l1758t2786r1848b2815],
14	(	VBP	O	(	dep	33	SENT_190	[p6l551t2836r623b2872],
15	135	CD	NUMBER	135	dobj	14	SENT_190	[p6l551t2836r623b2872],
16	vs	CC	O	vs	_	0	SENT_190	[p6l639t2845r674b2865],
17	175	CD	NUMBER	175	num	19	SENT_190	[p6l693t2836r748b2865],
18	mg/m2	NN	O	mg/m2	nn	19	SENT_190	[p6l764t2825r889b2874],
19	)	NN	O	)	nsubj	23	SENT_190	[p6l764t2825r889b2874],
20	and	CC	O	and	_	0	SENT_190	[p6l905t2836r964b2865],
21	two	CD	NUMBER	two	num	22	SENT_190	[p6l977t2841r1038b2865],
22	schedules	NNS	O	schedule	conj_and	19	SENT_190	[p6l1054t2836r1211b2865],
23	(	VBP	O	(	rcmod	15	SENT_190	[p6l1228t2836r1280b2872],
24	24	CD	NUMBER	24	dobj	23	SENT_190	[p6l1228t2836r1280b2872],
25	vs	CC	O	vs	_	0	SENT_190	[p6l1295t2845r1329b2865],
26	3	CD	NUMBER	3	num	28	SENT_190	[p6l1345t2837r1362b2865],
27	h	NN	O	h	nn	28	SENT_190	[p6l1377t2836r1410b2872],
28	)	NN	O	)	conj_vs	24	SENT_190	[p6l1377t2836r1410b2872],
29	with	IN	O	with	_	0	SENT_190	[p6l1425t2836r1498b2865],
30	standard	JJ	O	standard	amod	31	SENT_190	[p6l1513t2836r1651b2865],
31	premedication	NN	O	premedication	prep_with	28	SENT_190	[p6l1664t2836r1848b2874, p6l550t2886r614b2915],
32	has	VBZ	O	have	aux	33	SENT_190	[p6l628t2886r681b2915],
33	shown	VBN	O	show	_	0	SENT_190	[p6l698t2886r804b2915],
34	that	IN	O	that	complm	45	SENT_190	[p6l819t2886r881b2915],
35	the	DT	O	the	det	37	SENT_190	[p6l894t2886r943b2915],
36	overall	JJ	O	overall	amod	37	SENT_190	[p6l958t2886r1072b2915],
37	incidence	NN	O	incidence	nsubj	45	SENT_190	[p6l1086t2886r1243b2915],
38	of	IN	O	of	_	0	SENT_190	[p6l1258t2886r1293b2915],
39	major	JJ	O	major	amod	40	SENT_190	[p6l1305t2886r1401b2924],
40	HSR	NN	O	hsr	prep_of	37	SENT_190	[p6l1415t2886r1494b2915],
41	was	VBD	O	be	cop	45	SENT_190	[p6l1509t2895r1571b2915],
42	low	JJ	O	low	amod	45	SENT_190	[p6l1587t2886r1647b2915],
43	and	CC	O	and	_	0	SENT_190	[p6l1663t2886r1721b2915],
44	similar	JJ	O	similar	amod	45	SENT_190	[p6l1737t2886r1850b2915],
45	(	NN	O	(	ccomp	33	SENT_190	[p6l551t2936r611b2972],
46	2.1	CD	NUMBER	2.1	dep	45	SENT_190	[p6l551t2936r611b2972],
47	vs	CC	O	vs	_	0	SENT_190	[p6l627t2945r662b2965],
48	1.0	CD	PERCENT	1.0	num	49	SENT_190	[p6l679t2936r773b2972],
49	%	NN	PERCENT	%	ccomp	33	SENT_190	[p6l679t2936r773b2972],
50	)	CD	NUMBER	)	dep	49	SENT_190	[p6l679t2936r773b2972],
51	in	IN	O	in	_	0	SENT_190	[p6l786t2936r817b2965],
52	the	DT	O	the	det	53	SENT_190	[p6l830t2936r879b2965],
53	3	CD	NUMBER	3	prep_in	50	SENT_190	[p6l893t2936r924b2965],
54	-	:	O	-	_	0	SENT_190	[p6l893t2936r924b2965],
55	and	CC	O	and	_	0	SENT_190	[p6l938t2936r997b2965],
56	24-h	JJ	O	24-h	amod	57	SENT_190	[p6l1009t2936r1083b2965],
57	groups	NNS	O	group	ccomp	33	SENT_190	[p6l1096t2945r1216b2974],
58	,	,	O	,	_	0	SENT_190	[p6l1096t2945r1216b2974],
59	respectively	RB	O	respectively	advmod	45	SENT_190	[p6l1229t2936r1438b2974],
60	,	,	O	,	_	0	SENT_190	[p6l1229t2936r1438b2974],
61	indicating	VBG	O	indicate	xcomp	33	SENT_190	[p6l1451t2936r1615b2974],
62	that	IN	O	that	complm	69	SENT_190	[p6l1628t2936r1689b2965],
63	premedication	NN	O	premedication	nsubj	69	SENT_190	[p6l1701t2936r1848b2974, p6l550t2986r650b3015],
64	is	VBZ	O	be	cop	69	SENT_190	[p6l661t2986r687b3015],
65	the	DT	O	the	det	69	SENT_190	[p6l699t2986r749b3015],
66	most	RBS	O	most	advmod	67	SENT_190	[p6l760t2991r840b3015],
67	important	JJ	O	important	amod	69	SENT_190	[p6l851t2986r1011b3024],
68	prophylactic	NN	O	prophylactic	nn	69	SENT_190	[p6l1022t2986r1228b3024],
69	measure	NN	O	measure	ccomp	61	SENT_190	[p6l1239t2995r1376b3015],
70	(	CD	NUMBER	(	num	72	SENT_190	[p6l1389t2986r1464b3022],
71	30	CD	NUMBER	30	amod	72	SENT_190	[p6l1389t2986r1464b3022],
72	)	NN	O	)	nsubj	33	SENT_190	[p6l1389t2986r1464b3022],
73	.	.	O	.	_	0	SENT_190	[p6l1389t2986r1464b3022],

1	Hematological	JJ	O	hematological	amod	3	SENT_191	[p6l549t3139r796b3176],
2	toxicity	NN	O	toxicity	nn	3	SENT_191	[p6l808t3140r928b3176],
3	Neutropenia	NNP	O	Neutropenia	nsubj	7	SENT_191	[p6l967t3139r1171b3177],
4	is	VBZ	O	be	cop	7	SENT_191	[p6l1182t3139r1208b3168],
5	the	DT	O	the	det	7	SENT_191	[p6l1221t3139r1270b3168],
6	main	JJ	O	main	amod	7	SENT_191	[p6l1282t3139r1364b3168],
7	toxicity	NN	O	toxicity	_	0	SENT_191	[p6l1376t3139r1501b3177],
8	of	IN	O	of	_	0	SENT_191	[p6l1513t3139r1549b3168],
9	paclitaxel	NN	O	paclitaxel	nn	10	SENT_191	[p6l1557t3139r1718b3177],
10	(	NN	O	(	prep_of	7	SENT_191	[p6l1730t3140r1771b3175],
11	1	CD	NUMBER	1	num	10	SENT_191	[p6l1730t3140r1771b3175],
12	,	,	O	,	_	0	SENT_191	[p6l1730t3140r1771b3175],
13	35	CD	NUMBER	35	num	14	SENT_191	[p6l1786t3139r1847b3175],
14	)	NN	O	)	appos	7	SENT_191	[p6l1786t3139r1847b3175],
15	.	.	O	.	_	0	SENT_191	[p6l1786t3139r1847b3175],

1	The	DT	O	the	det	2	SENT_192	[p6l550t3189r613b3217],
2	onset	NN	O	onset	nsubj	7	SENT_192	[p6l623t3193r710b3217],
3	of	IN	O	of	_	0	SENT_192	[p6l719t3188r755b3217],
4	neutropenia	NN	O	neutropenia	prep_of	2	SENT_192	[p6l762t3188r957b3226],
5	is	VBZ	O	be	cop	7	SENT_192	[p6l966t3188r991b3217],
6	usually	RB	O	usually	advmod	7	SENT_192	[p6l1001t3188r1120b3226],
7	day	NN	DURATION	day	_	0	SENT_192	[p6l1130t3188r1188b3226],
8	8-10	CD	NUMBER	8-10	nsubj	13	SENT_192	[p6l1199t3189r1279b3218],
9	and	CC	O	and	_	0	SENT_192	[p6l1290t3188r1348b3217],
10	recovery	NN	O	recovery	conj_and	8	SENT_192	[p6l1356t3198r1500b3226],
11	is	VBZ	O	be	cop	13	SENT_192	[p6l1509t3188r1535b3217],
12	typically	RB	O	typically	advmod	13	SENT_192	[p6l1546t3188r1689b3226],
13	complete	JJ	O	complete	rcmod	7	SENT_192	[p6l1699t3188r1849b3226],
14	by	IN	O	by	_	0	SENT_192	[p6l550t3238r590b3276],
15	day	NN	DURATION	day	prep_by	13	SENT_192	[p6l605t3239r663b3276],
16	15-21	CD	DATE	15-21	num	15	SENT_192	[p6l681t3238r788b3268],
17	.	.	O	.	_	0	SENT_192	[p6l681t3238r788b3268],

1	Neutropenia	NN	O	neutropenia	nsubj	4	SENT_193	[p6l804t3238r1009b3276],
2	is	VBZ	O	be	cop	4	SENT_193	[p6l1022t3238r1047b3268],
3	not	RB	O	not	neg	4	SENT_193	[p6l1063t3243r1115b3267],
4	cumulative	JJ	O	cumulative	_	0	SENT_193	[p6l1129t3238r1320b3273],
5	,	,	O	,	_	0	SENT_193	[p6l1129t3238r1320b3273],
6	suggesting	VBG	O	suggest	xcomp	4	SENT_193	[p6l1337t3238r1512b3276],
7	that	IN	O	that	complm	12	SENT_193	[p6l1526t3239r1588b3268],
8	paclitaxel	NN	O	paclitaxel	nsubj	12	SENT_193	[p6l1600t3238r1761b3276],
9	does	VBZ	O	do	aux	12	SENT_193	[p6l1775t3239r1848b3268],
10	not	RB	O	not	neg	12	SENT_193	[p6l550t3293r602b3317],
11	irreversibly	RB	O	irreversibly	advmod	12	SENT_193	[p6l622t3288r812b3326],
12	affect	VB	O	affect	ccomp	6	SENT_193	[p6l833t3288r925b3317],
13	immature	JJ	O	immature	amod	15	SENT_193	[p6l945t3288r1102b3317],
14	hematopoietic	JJ	O	hematopoietic	amod	15	SENT_193	[p6l1122t3288r1355b3326],
15	cells	NNS	O	cell	dobj	12	SENT_193	[p6l1376t3288r1458b3317],
16	.	.	O	.	_	0	SENT_193	[p6l1376t3288r1458b3317],

1	At	IN	O	at	_	0	SENT_194	[p6l1480t3289r1521b3317],
2	doses	NNS	O	dose	prep_at	14	SENT_194	[p6l1541t3288r1630b3317],
3	of	IN	O	of	_	0	SENT_194	[p6l1652t3288r1687b3317],
4	200-250	CD	NUMBER	200-250	num	5	SENT_194	[p6l1705t3288r1848b3317],
5	mg/m2	NN	O	mg/m2	prep_of	2	SENT_194	[p6l550t3324r662b3376],
6	given	VBN	O	give	partmod	5	SENT_194	[p6l672t3339r763b3377],
7	over	RP	O	over	prt	6	SENT_194	[p6l773t3348r846b3368],
8	24	CD	NUMBER	24	num	9	SENT_194	[p6l856t3339r895b3368],
9	h	NN	O	h	dobj	6	SENT_194	[p6l905t3339r934b3373],
10	,	,	O	,	_	0	SENT_194	[p6l905t3339r934b3373],
11	neutropenia	NN	O	neutropenia	nsubj	14	SENT_194	[p6l945t3339r1140b3377],
12	is	VBZ	O	be	cop	14	SENT_194	[p6l1149t3339r1175b3368],
13	usually	RB	O	usually	advmod	14	SENT_194	[p6l1185t3339r1303b3377],
14	severe	JJ	O	severe	_	0	SENT_194	[p6l1315t3348r1418b3368],
15	even	RB	O	even	advmod	14	SENT_194	[p6l1428t3348r1505b3368],
16	in	IN	O	in	_	0	SENT_194	[p6l1514t3339r1545b3368],
17	patients	NNS	O	patient	prep_in	14	SENT_194	[p6l1555t3339r1682b3377],
18	who	WP	O	who	nsubj	21	SENT_194	[p6l1692t3339r1762b3368],
19	have	VBP	O	have	aux	21	SENT_194	[p6l1772t3339r1849b3368],
20	not	RB	O	not	neg	21	SENT_194	[p6l550t3393r603b3417],
21	received	VBN	O	receive	rcmod	17	SENT_194	[p6l611t3388r751b3417],
22	prior	RB	O	prior	prep	21	SENT_194	[p6l759t3388r840b3426],
23	myelosuppressive	JJ	O	myelosuppressive	amod	24	SENT_194	[p6l849t3388r1145b3426],
24	therapy	NN	O	therapy	pobj	22	SENT_194	[p6l1154t3388r1286b3426],
25	.	.	O	.	_	0	SENT_194	[p6l1154t3388r1286b3426],

1	However	RB	O	however	advmod	7	SENT_195	[p6l1297t3389r1457b3423],
2	,	,	O	,	_	0	SENT_195	[p6l1297t3389r1457b3423],
3	fever	NN	O	fever	nsubj	7	SENT_195	[p6l1467t3388r1552b3418],
4	and	CC	O	and	_	0	SENT_195	[p6l1561t3388r1619b3417],
5	infections	NNS	O	infection	conj_and	3	SENT_195	[p6l1628t3388r1790b3417],
6	are	VBP	O	be	cop	7	SENT_195	[p6l1801t3397r1849b3417],
7	uncommon	JJ	O	uncommon	_	0	SENT_195	[p6l550t3447r744b3467],
8	.	.	O	.	_	0	SENT_195	[p6l550t3447r744b3467],

1	This	DT	O	this	det	3	SENT_196	[p6l762t3438r834b3467],
2	dose	NN	O	dose	nn	3	SENT_196	[p6l851t3438r925b3467],
3	range	NN	O	range	nsubjpass	6	SENT_196	[p6l941t3447r1032b3476],
4	was	VBD	O	be	auxpass	6	SENT_196	[p6l1049t3447r1111b3467],
5	initially	RB	O	initially	advmod	6	SENT_196	[p6l1128t3438r1255b3476],
6	recommended	VBN	O	recommend	_	0	SENT_196	[p6l1271t3438r1506b3467],
7	for	IN	O	for	_	0	SENT_196	[p6l1521t3438r1569b3467],
8	phase	NN	O	phase	nn	10	SENT_196	[p6l1583t3438r1677b3476],
9	II	CD	NUMBER	ii	num	10	SENT_196	[p6l1693t3439r1719b3467],
10	studies	NNS	O	study	prep_for	6	SENT_196	[p6l1736t3438r1848b3467],
11	because	IN	O	because	_	0	SENT_196	[p6l550t3490r680b3520],
12	the	DT	O	the	det	13	SENT_196	[p6l687t3490r737b3520],
13	duration	NN	O	duration	npadvmod	18	SENT_196	[p6l745t3490r881b3520],
14	of	IN	O	of	_	0	SENT_196	[p6l889t3490r925b3520],
15	severe	JJ	O	severe	amod	17	SENT_196	[p6l931t3499r1034b3520],
16	neutropenia	NN	O	neutropenia	nn	17	SENT_196	[p6l1041t3490r1236b3528],
17	(	NN	O	(	prep_of	13	SENT_196	[p6l1244t3490r1401b3528],
18	<	JJR	O	<	prep_because	6	SENT_196	[p6l1244t3490r1401b3528],
19	500/pl	CD	NUMBER	500/pl	num	20	SENT_196	[p6l1244t3490r1401b3528],
20	)	NN	O	)	nsubj	24	SENT_196	[p6l1244t3490r1401b3528],
21	was	VBD	O	be	cop	24	SENT_196	[p6l1410t3499r1472b3520],
22	usually	RB	O	usually	advmod	24	SENT_196	[p6l1480t3490r1599b3528],
23	short	JJ	O	short	amod	24	SENT_196	[p6l1608t3490r1689b3520],
24	(	NN	O	(	ccomp	18	SENT_196	[p6l1697t3490r1751b3526],
25	<	JJR	O	<	amod	24	SENT_196	[p6l1697t3490r1751b3526],
26	5	CD	DURATION	5	num	27	SENT_196	[p6l1697t3490r1751b3526],
27	days	NNS	NUMBER	day	tmod	25	SENT_196	[p6l1761t3490r1848b3528],
28	)	RB	O	)	advmod	24	SENT_196	[p6l1761t3490r1848b3528],
29	and	CC	O	and	_	0	SENT_196	[p6l551t3540r609b3569],
30	treatment	NN	O	treatment	nn	31	SENT_196	[p6l625t3544r781b3569],
31	delays	NNS	O	delay	nsubj	36	SENT_196	[p6l796t3540r900b3578],
32	for	IN	O	for	_	0	SENT_196	[p6l917t3540r964b3569],
33	unresolved	JJ	O	unresolved	amod	34	SENT_196	[p6l979t3540r1161b3569],
34	toxicity	NN	O	toxicity	prep_for	31	SENT_196	[p6l1177t3540r1302b3578],
35	were	VBD	O	be	cop	36	SENT_196	[p6l1318t3549r1397b3569],
36	rare	JJ	O	rare	conj_and	6	SENT_196	[p6l1413t3549r1485b3569],
37	.	.	O	.	_	0	SENT_196	[p6l1413t3549r1485b3569],

1	Although	IN	O	although	mark	8	SENT_197	[p6l1502t3540r1658b3578],
2	fevers	NNS	O	fever	nsubjpass	8	SENT_197	[p6l1674t3540r1773b3570],
3	and	CC	O	and	_	0	SENT_197	[p6l1791t3540r1849b3569],
4	infectious	JJ	O	infectious	amod	5	SENT_197	[p6l550t3590r711b3620],
5	sequalae	NN	O	sequala	conj_and	2	SENT_197	[p6l722t3590r862b3628],
6	were	VBD	O	be	auxpass	8	SENT_197	[p6l870t3599r949b3620],
7	originally	RB	O	originally	advmod	8	SENT_197	[p6l958t3590r1117b3628],
8	reported	VBN	O	report	advcl	25	SENT_197	[p6l1124t3590r1262b3628],
9	to	TO	O	to	aux	12	SENT_197	[p6l1269t3595r1300b3620],
10	be	VB	O	be	cop	12	SENT_197	[p6l1307t3590r1346b3620],
11	low	JJ	O	low	amod	12	SENT_197	[p6l1354t3590r1414b3620],
12	(	NN	O	(	xcomp	8	SENT_197	[p6l1424t3590r1533b3626],
13	<	JJR	O	<	dep	18	SENT_197	[p6l1424t3590r1533b3626],
14	10	CD	PERCENT	10	num	15	SENT_197	[p6l1424t3590r1533b3626],
15	%	NN	PERCENT	%	nsubj	18	SENT_197	[p6l1424t3590r1533b3626],
16	of	IN	O	of	_	0	SENT_197	[p6l1543t3590r1579b3620],
17	courses	NNS	O	course	prep_of	15	SENT_197	[p6l1584t3590r1720b3626],
18	)	VBP	O	)	dep	12	SENT_197	[p6l1584t3590r1720b3626],
19	at	IN	O	at	_	0	SENT_197	[p6l1729t3595r1758b3620],
20	these	DT	O	these	det	21	SENT_197	[p6l1765t3590r1849b3620],
21	doses	NNS	O	dose	prep_at	18	SENT_197	[p6l551t3640r650b3675],
22	,	,	O	,	_	0	SENT_197	[p6l551t3640r650b3675],
23	these	DT	O	these	det	24	SENT_197	[p6l668t3640r751b3670],
24	complications	NNS	O	complication	nsubj	25	SENT_197	[p6l768t3640r998b3678],
25	occurred	VBD	O	occur	dep	31	SENT_197	[p6l1016t3640r1159b3670],
26	more	RBR	O	more	advmod	27	SENT_197	[p6l1175t3649r1258b3670],
27	frequently	RB	O	frequently	advmod	25	SENT_197	[p6l1275t3640r1443b3678],
28	in	IN	O	in	_	0	SENT_197	[p6l1460t3640r1491b3669],
29	later	JJ	O	later	amod	30	SENT_197	[p6l1507t3640r1580b3670],
30	studies	NNS	O	study	prep_in	25	SENT_197	[p6l1596t3640r1708b3670],
31	(	VBP	O	(	_	0	SENT_197	[p6l1726t3640r1767b3676],
32	1	CD	NUMBER	1	nsubj	31	SENT_197	[p6l1726t3640r1767b3676],
33	,	,	O	,	_	0	SENT_197	[p6l1726t3640r1767b3676],
34	35	CD	NUMBER	35	num	35	SENT_197	[p6l1786t3640r1847b3676],
35	)	NN	O	)	appos	32	SENT_197	[p6l1786t3640r1847b3676],
36	.	.	O	.	_	0	SENT_197	[p6l1786t3640r1847b3676],

1	Therefore	RB	O	therefore	dep	7	SENT_198	[p6l550t3690r721b3724],
2	,	,	O	,	_	0	SENT_198	[p6l550t3690r721b3724],
3	granulocyte	NN	O	granulocyte	nn	7	SENT_198	[p6l741t3690r935b3728],
4	colony	NN	O	colony	nn	7	SENT_198	[p6l954t3690r1265b3728],
5	—	NN	O	—	nn	7	SENT_198	[p6l954t3690r1265b3728],
6	stimulating	NN	O	stimulating	nn	7	SENT_198	[p6l954t3690r1265b3728],
7	factor	NN	O	factor	_	0	SENT_198	[p6l1284t3690r1380b3719],
8	(	CD	NUMBER	(	num	9	SENT_198	[p6l1399t3690r1540b3726],
9	G	NN	O	g	dep	7	SENT_198	[p6l1399t3690r1540b3726],
10	.	.	O	.	_	0	SENT_198	[p6l1399t3690r1540b3726],

1	—	NN	O	—	_	0	SENT_199	[p6l1399t3690r1540b3726],
2	.	.	O	.	_	0	SENT_199	[p6l1399t3690r1540b3726],

1	CSF	NN	O	csf	nn	2	SENT_200	[p6l1399t3690r1540b3726],
2	)	NN	O	)	nsubjpass	5	SENT_200	[p6l1399t3690r1540b3726],
3	is	VBZ	O	be	auxpass	5	SENT_200	[p6l1561t3690r1586b3719],
4	often	RB	O	often	advmod	5	SENT_200	[p6l1606t3690r1690b3719],
5	given	VBN	O	give	_	0	SENT_200	[p6l1709t3690r1799b3728],
6	to	TO	O	to	aux	7	SENT_200	[p6l1818t3694r1848b3719],
7	prevent	VB	O	prevent	xcomp	5	SENT_200	[p6l550t3745r674b3778],
8	complications	NNS	O	complication	dobj	7	SENT_200	[p6l686t3740r916b3778],
9	of	IN	O	of	_	0	SENT_200	[p6l931t3740r967b3770],
10	neutropenia	NN	O	neutropenia	prep_of	8	SENT_200	[p6l977t3740r1172b3778],
11	in	IN	O	in	_	0	SENT_200	[p6l1184t3740r1215b3769],
12	trials	NNS	O	trial	prep_in	7	SENT_200	[p6l1229t3740r1309b3770],
13	of	IN	O	of	_	0	SENT_200	[p6l1324t3740r1359b3770],
14	doses	NNS	O	dose	prep_of	12	SENT_200	[p6l1370t3740r1460b3770],
15	in	IN	O	in	_	0	SENT_200	[p6l1474t3740r1505b3769],
16	the	DT	O	the	det	19	SENT_200	[p6l1518t3740r1567b3770],
17	200-250	CD	NUMBER	200-250	num	19	SENT_200	[p6l1580t3740r1723b3770],
18	mg/m2	NN	O	mg/m2	nn	19	SENT_200	[p6l1737t3726r1849b3778],
19	range	NN	O	range	prep_in	14	SENT_200	[p6l550t3799r649b3828],
20	.	.	O	.	_	0	SENT_200	[p6l550t3799r649b3828],

1	In	IN	O	in	dep	6	SENT_201	[p6l661t3791r694b3819],
2	most	JJS	O	most	amod	3	SENT_201	[p6l703t3795r784b3820],
3	patients	NNS	O	patient	pobj	1	SENT_201	[p6l792t3790r929b3828],
4	,	,	O	,	_	0	SENT_201	[p6l792t3790r929b3828],
5	particularly	RB	O	particularly	advmod	6	SENT_201	[p6l940t3790r1130b3828],
6	those	DT	O	those	_	0	SENT_201	[p6l1139t3790r1225b3820],
7	who	WP	O	who	nsubj	9	SENT_201	[p6l1235t3790r1305b3820],
8	had	VBD	O	have	aux	9	SENT_201	[p6l1315t3790r1374b3820],
9	received	VBN	O	receive	rcmod	6	SENT_201	[p6l1383t3790r1522b3820],
10	large	JJ	O	large	amod	11	SENT_201	[p6l1531t3790r1613b3828],
11	doses	NNS	O	dose	dobj	9	SENT_201	[p6l1622t3790r1712b3820],
12	of	IN	O	of	_	0	SENT_201	[p6l1723t3790r1758b3820],
13	other	JJ	O	other	prep_of	11	SENT_201	[p6l1766t3790r1850b3820],

1	Annu	NNP	PERSON	Annu	_	0	SENT_202	[p7l310t1658r333b1739],
2	.	.	O	.	_	0	SENT_202	[p7l310t1658r333b1739],

1	Rev.	NNP	O	Rev.	nn	2	SENT_203	[p7l310t1587r333b1647],
2	Med	NNP	O	Med	_	0	SENT_203	[p7l310t1510r333b1577],
3	.	.	O	.	_	0	SENT_203	[p7l310t1510r333b1577],

1	1997.48:353	CD	NUMBER	1997.48:353	num	2	SENT_204	[p7l310t1265r334b1497],
2	-374	CD	NUMBER	-374	_	0	SENT_204	[p7l310t1265r334b1497],
3	.	.	O	.	_	0	SENT_204	[p7l310t1265r334b1497],

1	Downloaded	VBN	O	download	_	0	SENT_205	[p7l310t1084r333b1254],
2	from	IN	O	from	_	0	SENT_205	[p7l310t1010r333b1075],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_205	[p7l310t676r340b1001],

1	Med	NNP	O	Med	_	0	SENT_206	[p7l310t3714r333b3782],
2	.	.	O	.	_	0	SENT_206	[p7l310t3714r333b3782],

1	1997.48:353	CD	NUMBER	1997.48:353	num	2	SENT_207	[p7l310t3469r334b3700],
2	-374	CD	NUMBER	-374	_	0	SENT_207	[p7l310t3469r334b3700],
3	.	.	O	.	_	0	SENT_207	[p7l310t3469r334b3700],

1	Downloaded	VBN	O	download	_	0	SENT_208	[p7l310t3288r333b3458],
2	from	IN	O	from	_	0	SENT_208	[p7l310t3215r333b3279],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_208	[p7l310t2880r340b3205],
4	by	IN	O	by	_	0	SENT_208	[p7l343t1671r374b1704],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_208	[p7l343t1523r374b1662],
6	of	IN	ORGANIZATION	of	_	0	SENT_208	[p7l343t1485r367b1513],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_208	[p7l343t1337r367b1478],
8	-	:	O	-	_	0	SENT_208	[p7l357t1319r360b1328],
9	Madison	NNP	O	Madison	prep_by	1	SENT_208	[p7l343t1193r367b1309],
10	on	IN	O	on	_	0	SENT_208	[p7l351t1151r367b1183],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_208	[p7l343t1017r367b1142],
12	.	.	O	.	_	0	SENT_208	[p7l343t1017r367b1142],

1	For	IN	O	for	_	0	SENT_209	[p7l344t960r367b1007],
2	personal	JJ	O	personal	amod	3	SENT_209	[p7l343t840r374b952],
3	use	NN	O	use	pobj	1	SENT_209	[p7l351t787r367b831],
4	only	RB	O	only	advmod	3	SENT_209	[p7l343t712r374b777],
5	.	.	O	.	_	0	SENT_209	[p7l343t712r374b777],

1	rsity	NN	O	rsity	_	0	SENT_210	[p7l343t3727r374b3786],
2	of	IN	O	of	_	0	SENT_210	[p7l343t3688r367b3717],
3	Wisconsin	NNP	LOCATION	Wisconsin	prep_of	1	SENT_210	[p7l343t3542r367b3682],
4	-	:	O	-	_	0	SENT_210	[p7l357t3523r360b3532],
5	Madison	NNP	O	Madison	dep	1	SENT_210	[p7l343t3397r367b3513],
6	on	IN	O	on	_	0	SENT_210	[p7l351t3355r367b3388],
7	01/05/14	CD	DATE	01/05/14	prep_on	5	SENT_210	[p7l343t3221r367b3346],
8	.	.	O	.	_	0	SENT_210	[p7l343t3221r367b3346],

1	For	IN	O	for	_	0	SENT_211	[p7l344t3164r367b3211],
2	personal	JJ	O	personal	amod	3	SENT_211	[p7l343t3044r374b3156],
3	use	NN	O	use	pobj	1	SENT_211	[p7l351t2991r367b3035],
4	only	RB	O	only	advmod	3	SENT_211	[p7l343t2916r374b2981],
5	.	.	O	.	_	0	SENT_211	[p7l343t2916r374b2981],

1	chemotherapy	NN	O	chemotherapy	nn	2	SENT_212	[p7l551t16r783b54],
2	agents	NNS	O	agent	ccomp	7	SENT_212	[p7l797t21r900b54],
3	previously	RB	DATE	previously	advmod	2	SENT_212	[p7l913t16r1096b54],
4	,	,	O	,	_	0	SENT_212	[p7l913t16r1096b54],
5	the	DT	O	the	det	6	SENT_212	[p7l1110t16r1159b45],
6	maximum	NN	O	maximum	nsubj	7	SENT_212	[p7l1172t16r1339b45],
7	tolerated	VBD	O	tolerate	_	0	SENT_212	[p7l1351t16r1495b45],
8	dose	NN	O	dose	nsubj	15	SENT_212	[p7l1508t16r1582b45],
9	without	IN	O	without	_	0	SENT_212	[p7l1595t16r1721b45],
10	G-CSF	NN	O	g-csf	prep_without	8	SENT_212	[p7l1733t16r1849b46],
11	is	VBZ	O	be	cop	15	SENT_212	[p7l550t67r576b96],
12	175	CD	NUMBER	175	number	14	SENT_212	[p7l598t66r653b96],
13	to	TO	O	to	dep	14	SENT_212	[p7l672t71r703b96],
14	200	CD	NUMBER	200	num	15	SENT_212	[p7l721t67r781b96],
15	mg/m2	NN	O	mg/m2	ccomp	7	SENT_212	[p7l799t52r919b104],
16	.	.	O	.	_	0	SENT_212	[p7l799t52r919b104],

1	The	DT	O	the	det	5	SENT_213	[p7l938t67r1001b96],
2	most	RBS	O	most	advmod	3	SENT_213	[p7l1018t71r1098b96],
3	critical	JJ	O	critical	amod	5	SENT_213	[p7l1115t67r1228b96],
4	pharmacological	JJ	O	pharmacological	amod	5	SENT_213	[p7l1244t67r1520b104],
5	determinent	NN	O	determinent	_	0	SENT_213	[p7l1536t67r1733b96],
6	of	IN	O	of	_	0	SENT_213	[p7l1750t67r1785b96],
7	the	DT	O	the	predet	9	SENT_213	[p7l1800t67r1849b96],
8	THE	DT	O	the	det	9	SENT_213	[p7l1492t123r1564b149],
9	TAXANES	NN	O	taxane	prep_of	5	SENT_213	[p7l1573t123r1746b149],
10	361	CD	NUMBER	361	dep	5	SENT_213	[p7l1795t123r1846b149],

1	severity	NN	O	severity	nsubj	6	SENT_214	[p7l552t207r680b245],
2	of	IN	O	of	_	0	SENT_214	[p7l689t207r724b237],
3	neutropenia	NN	O	neutropenia	prep_of	1	SENT_214	[p7l730t207r925b245],
4	is	VBZ	O	be	cop	6	SENT_214	[p7l932t207r957b237],
5	the	DT	O	the	det	6	SENT_214	[p7l967t207r1016b237],
6	duration	NN	O	duration	_	0	SENT_214	[p7l1024t207r1161b237],
7	that	WDT	O	that	dobj	11	SENT_214	[p7l1169t207r1230b237],
8	plasma	NN	O	plasma	nn	9	SENT_214	[p7l1237t207r1354b245],
9	concentrations	NNS	O	concentration	nsubjpass	11	SENT_214	[p7l1362t207r1601b237],
10	are	VBP	O	be	auxpass	11	SENT_214	[p7l1610t216r1659b237],
11	maintained	VBN	O	maintain	rcmod	6	SENT_214	[p7l1666t207r1850b237],
12	above	IN	O	above	_	0	SENT_214	[p7l551t257r648b287],
13	a	DT	O	a	det	16	SENT_214	[p7l663t266r681b287],
14	critical	JJ	O	critical	amod	16	SENT_214	[p7l695t257r808b287],
15	threshold	NN	O	threshold	nn	16	SENT_214	[p7l823t257r976b287],
16	level	NN	O	level	prep_above	11	SENT_214	[p7l991t257r1079b292],
17	,	,	O	,	_	0	SENT_214	[p7l991t257r1079b292],
18	which	WDT	O	which	nsubj	20	SENT_214	[p7l1095t257r1195b287],
19	may	MD	O	may	aux	20	SENT_214	[p7l1210t266r1280b295],
20	explain	VB	O	explain	rcmod	16	SENT_214	[p7l1295t257r1416b295],
21	why	WRB	O	why	advmod	25	SENT_214	[p7l1430t257r1500b295],
22	neutropenia	NN	O	neutropenia	nsubj	25	SENT_214	[p7l1515t257r1710b295],
23	is	VBZ	O	be	cop	25	SENT_214	[p7l1724t257r1749b287],
24	more	RBR	O	more	advmod	25	SENT_214	[p7l1765t266r1849b287],
25	severe	JJ	O	severe	advcl	20	SENT_214	[p7l552t316r655b336],
26	with	IN	O	with	mark	29	SENT_214	[p7l664t307r736b336],
27	longer	JJR	O	longer	amod	28	SENT_214	[p7l746t307r851b345],
28	schedules	NNS	O	schedule	nsubj	29	SENT_214	[p7l861t307r1018b336],
29	(	VBP	O	(	advcl	25	SENT_214	[p7l1029t307r1091b343],
30	37	CD	NUMBER	37	dobj	29	SENT_214	[p7l1029t307r1091b343],
31	,	,	O	,	_	0	SENT_214	[p7l1029t307r1091b343],
32	38	CD	NUMBER	38	num	33	SENT_214	[p7l1103t307r1164b343],
33	)	NN	O	)	appos	30	SENT_214	[p7l1103t307r1164b343],
34	.	.	O	.	_	0	SENT_214	[p7l1103t307r1164b343],

1	This	DT	O	this	nsubj	4	SENT_215	[p7l1175t307r1246b336],
2	does	VBZ	O	do	aux	4	SENT_215	[p7l1257t307r1330b336],
3	not	RB	O	not	neg	4	SENT_215	[p7l1340t312r1392b336],
4	imply	VB	O	imply	_	0	SENT_215	[p7l1401t307r1496b345],
5	that	IN	O	that	complm	11	SENT_215	[p7l1505t307r1567b336],
6	shorter	JJR	O	shorter	amod	7	SENT_215	[p7l1576t307r1690b336],
7	infusions	NNS	O	infusion	nsubjpass	11	SENT_215	[p7l1698t307r1848b336],
8	should	MD	O	should	aux	11	SENT_215	[p7l552t357r660b387],
9	always	RB	O	always	advmod	11	SENT_215	[p7l679t357r791b395],
10	be	VB	O	be	auxpass	11	SENT_215	[p7l810t357r849b387],
11	used	VBN	O	use	ccomp	4	SENT_215	[p7l867t357r942b387],
12	since	IN	O	since	mark	21	SENT_215	[p7l962t357r1044b387],
13	the	DT	O	the	det	15	SENT_215	[p7l1063t357r1112b387],
14	optimal	JJ	O	optimal	amod	15	SENT_215	[p7l1131t357r1256b395],
15	dose	NN	O	dose	nsubjpass	21	SENT_215	[p7l1275t357r1349b387],
16	and	CC	O	and	_	0	SENT_215	[p7l1369t357r1427b387],
17	schedule	NN	O	schedule	nsubjpass	21	SENT_215	[p7l1446t357r1588b387],
18	have	VBP	O	have	aux	21	SENT_215	[p7l1606t357r1683b387],
19	not	RB	O	not	neg	21	SENT_215	[p7l1702t362r1754b387],
20	been	VBN	O	be	auxpass	21	SENT_215	[p7l1772t357r1849b387],
21	determined	VBN	O	determine	advcl	11	SENT_215	[p7l551t407r736b437],
22	for	IN	O	for	_	0	SENT_215	[p7l748t407r796b437],
23	most	JJS	O	most	amod	24	SENT_215	[p7l808t412r888b437],
24	tumors	NNS	O	tumor	prep_for	21	SENT_215	[p7l900t412r1022b437],
25	.	.	O	.	_	0	SENT_215	[p7l900t412r1022b437],

1	Paclitaxel	NN	O	paclitaxel	nsubj	4	SENT_216	[p7l1037t407r1199b437],
2	alone	RB	O	alone	advmod	4	SENT_216	[p7l1212t407r1300b437],
3	rarely	RB	O	rarely	advmod	4	SENT_216	[p7l1312t407r1408b445],
4	causes	VBZ	O	cause	_	0	SENT_216	[p7l1421t416r1526b437],
5	severe	JJ	O	severe	amod	8	SENT_216	[p7l1541t416r1644b437],
6	thrombocy	NN	O	thrombocy	nn	8	SENT_216	[p7l1657t407r1848b445],
7	—	NN	O	—	nn	8	SENT_216	[p7l1657t407r1848b445],
8	topenia	NN	O	topenia	dobj	4	SENT_216	[p7l550t457r672b495],
9	and	CC	O	and	_	0	SENT_216	[p7l683t457r741b486],
10	anemia	NN	O	anemia	dobj	4	SENT_216	[p7l753t457r879b486],
11	.	.	O	.	_	0	SENT_216	[p7l753t457r879b486],

1	Neurotoxicity	NNP	ORGANIZATION	Neurotoxicity	nn	2	SENT_217	[p7l549t571r774b608],
2	Paclitaxel	NN	ORGANIZATION	paclitaxel	nsubj	3	SENT_217	[p7l813t570r976b600],
3	induces	VBZ	O	induce	ccomp	50	SENT_217	[p7l987t570r1112b600],
4	a	DT	O	a	det	6	SENT_217	[p7l1126t579r1143b600],
5	peripheral	JJ	O	peripheral	amod	6	SENT_217	[p7l1153t570r1320b608],
6	neuropathy	NN	O	neuropathy	dobj	3	SENT_217	[p7l1332t570r1517b608],
7	that	WDT	O	that	nsubjpass	9	SENT_217	[p7l1529t570r1590b600],
8	is	VBZ	O	be	auxpass	9	SENT_217	[p7l1602t570r1627b600],
9	typified	VBN	O	typify	rcmod	6	SENT_217	[p7l1640t570r1768b608],
10	by	IN	O	by	_	0	SENT_217	[p7l1779t570r1820b608],
11	a	DT	O	a	det	13	SENT_217	[p7l1833t579r1850b600],
12	glove	NN	O	glove	nn	13	SENT_217	[p7l551t620r868b658],
13	—	NN	O	—	agent	9	SENT_217	[p7l551t620r868b658],
14	and	CC	O	and	_	0	SENT_217	[p7l551t620r868b658],
15	—	NN	O	—	agent	9	SENT_217	[p7l551t620r868b658],
16	stocking	VBG	O	stock	partmod	13	SENT_217	[p7l551t620r868b658],
17	distribution	NN	O	distribution	dobj	16	SENT_217	[p7l885t620r1075b649],
18	of	IN	O	of	_	0	SENT_217	[p7l1092t620r1128b649],
19	sensory	JJ	O	sensory	amod	20	SENT_217	[p7l1143t629r1266b658],
20	symptoms	NNS	O	symptom	prep_of	17	SENT_217	[p7l1285t624r1452b658],
21	such	JJ	O	such	_	0	SENT_217	[p7l1470t620r1544b649],
22	as	IN	O	as	_	0	SENT_217	[p7l1561t629r1592b649],
23	numbness	NN	O	numbness	prep_such_as	20	SENT_217	[p7l1609t620r1773b649],
24	and	CC	O	and	_	0	SENT_217	[p7l1791t620r1849b649],
25	paresthesia	NN	O	paresthesium	prep_such_as	20	SENT_217	[p7l550t670r734b708],
26	and	CC	O	and	_	0	SENT_217	[p7l748t670r806b699],
27	symmetric	JJ	O	symmetric	amod	29	SENT_217	[p7l822t670r993b708],
28	distal	JJ	O	distal	amod	29	SENT_217	[p7l1008t670r1097b699],
29	loss	NN	O	loss	conj_and	20	SENT_217	[p7l1111t670r1173b699],
30	of	IN	O	of	_	0	SENT_217	[p7l1189t670r1224b699],
31	sensation	NN	O	sensation	prep_of	29	SENT_217	[p7l1237t670r1389b699],
32	carried	VBN	O	carry	partmod	31	SENT_217	[p7l1403t670r1517b699],
33	by	IN	O	by	_	0	SENT_217	[p7l1530t670r1570b708],
34	both	DT	O	both	det	37	SENT_217	[p7l1585t670r1658b699],
35	large	JJ	O	large	amod	37	SENT_217	[p7l1672t670r1753b708],
36	(	NN	O	(	nn	37	SENT_217	[p7l1768t671r1848b708, p7l550t721r746b758],
37	proprioception	NN	O	proprioception	agent	32	SENT_217	[p7l1768t671r1848b708, p7l550t721r746b758],
38	,	,	O	,	_	0	SENT_217	[p7l1768t671r1848b708, p7l550t721r746b758],
39	vibration	NN	O	vibration	nn	40	SENT_217	[p7l763t721r924b757],
40	)	NN	O	)	conj_and	37	SENT_217	[p7l763t721r924b757],
41	and	CC	O	and	_	0	SENT_217	[p7l941t721r999b750],
42	small	JJ	O	small	amod	45	SENT_217	[p7l1015t721r1102b750],
43	(	CD	NUMBER	(	tmod	42	SENT_217	[p7l1119t721r1183b758],
44	pin	NN	O	pin	nn	45	SENT_217	[p7l1119t721r1183b758],
45	prick	NN	O	prick	conj_and	37	SENT_217	[p7l1198t721r1291b758],
46	,	,	O	,	_	0	SENT_217	[p7l1198t721r1291b758],
47	temperature	NN	O	temperature	nn	49	SENT_217	[p7l1307t721r1516b758],
48	)	NN	O	)	nn	49	SENT_217	[p7l1307t721r1516b758],
49	fibers	NNS	O	fiber	nsubj	50	SENT_217	[p7l1532t721r1624b750],
50	(	VBP	O	(	_	0	SENT_217	[p7l1641t721r1703b757],
51	35	CD	NUMBER	35	dobj	50	SENT_217	[p7l1641t721r1703b757],
52	,	,	O	,	_	0	SENT_217	[p7l1641t721r1703b757],
53	39	CD	NUMBER	39	appos	51	SENT_217	[p7l1720t721r1768b755],
54	,	,	O	,	_	0	SENT_217	[p7l1720t721r1768b755],
55	40	CD	NUMBER	40	num	56	SENT_217	[p7l1784t721r1847b757],
56	)	NN	O	)	appos	53	SENT_217	[p7l1784t721r1847b757],
57	.	.	O	.	_	0	SENT_217	[p7l1784t721r1847b757],

1	Symptoms	NNS	O	symptom	nsubj	3	SENT_218	[p7l551t771r725b808],
2	may	MD	O	may	aux	3	SENT_218	[p7l734t780r804b808],
3	begin	VB	O	begin	_	0	SENT_218	[p7l811t770r903b808],
4	as	RB	O	as	advmod	5	SENT_218	[p7l911t780r943b800],
5	soon	RB	O	soon	advmod	3	SENT_218	[p7l953t780r1029b800],
6	as	IN	O	as	_	0	SENT_218	[p7l1037t780r1069b800],
7	24-72	CD	NUMBER	24-72	num	8	SENT_218	[p7l1078t771r1180b800],
8	h	NN	O	h	prep_as	3	SENT_218	[p7l1188t770r1208b799],
9	after	IN	O	after	mark	14	SENT_218	[p7l1216t770r1291b800],
10	treatment	NN	O	treatment	nsubj	14	SENT_218	[p7l1297t775r1453b800],
11	with	IN	O	with	_	0	SENT_218	[p7l1460t771r1532b800],
12	higher	JJR	O	higher	amod	13	SENT_218	[p7l1540t770r1645b808],
13	doses	NNS	O	dose	prep_with	10	SENT_218	[p7l1653t771r1742b800],
14	(	VBP	O	(	advcl	3	SENT_218	[p7l1752t771r1849b806],
15	>	JJR	O	>	acomp	14	SENT_218	[p7l1752t771r1849b806],
16	250	CD	NUMBER	250	num	18	SENT_218	[p7l1752t771r1849b806],
17	mg/m2	NN	O	mg/m2	nn	18	SENT_218	[p7l550t806r685b858],
18	)	NN	O	)	dep	14	SENT_218	[p7l550t806r685b858],
19	,	,	O	,	_	0	SENT_218	[p7l550t806r685b858],
20	but	CC	O	but	_	0	SENT_218	[p7l693t821r746b850],
21	they	PRP	O	they	nsubj	23	SENT_218	[p7l753t821r823b858],
22	usually	RB	O	usually	advmod	23	SENT_218	[p7l831t821r949b858],
23	occur	VBP	O	occur	conj_but	3	SENT_218	[p7l957t830r1049b850],
24	only	RB	O	only	advmod	23	SENT_218	[p7l1056t821r1127b858],
25	after	IN	O	after	_	0	SENT_218	[p7l1136t821r1211b850],
26	multiple	JJ	O	multiple	amod	27	SENT_218	[p7l1217t821r1354b859],
27	courses	NNS	O	course	prep_after	23	SENT_218	[p7l1361t830r1483b850],
28	at	IN	O	at	_	0	SENT_218	[p7l1492t825r1521b850],
29	conventional	JJ	O	conventional	amod	30	SENT_218	[p7l1528t821r1740b850],
30	doses	NNS	O	dose	prep_at	27	SENT_218	[p7l1748t821r1847b850],
31	.	.	O	.	_	0	SENT_218	[p7l1748t821r1847b850],

1	Neurotoxicity	NN	O	neurotoxicity	nsubj	5	SENT_219	[p7l550t871r778b909],
2	may	MD	O	may	aux	5	SENT_219	[p7l788t880r858b909],
3	be	VB	O	be	cop	5	SENT_219	[p7l867t871r905b900],
4	more	RBR	O	more	advmod	5	SENT_219	[p7l914t880r998b900],
5	severe	JJ	O	severe	_	0	SENT_219	[p7l1008t880r1111b900],
6	with	IN	O	with	mark	9	SENT_219	[p7l1121t871r1193b900],
7	shorter	JJR	O	shorter	amod	8	SENT_219	[p7l1203t871r1316b900],
8	schedules	NNS	O	schedule	nsubj	9	SENT_219	[p7l1326t871r1483b900],
9	(	VBP	O	(	ccomp	5	SENT_219	[p7l1494t871r1569b907],
10	41	CD	NUMBER	41	num	11	SENT_219	[p7l1494t871r1569b907],
11	)	CD	NUMBER	)	dobj	9	SENT_219	[p7l1494t871r1569b907],
12	.	.	O	.	_	0	SENT_219	[p7l1494t871r1569b907],

1	Although	IN	O	although	mark	4	SENT_220	[p7l1580t871r1735b930],
2	severe	JJ	O	severe	amod	3	SENT_220	[p7l1746t880r1849b900],
3	neurotoxicity	NN	O	neurotoxicity	nsubj	4	SENT_220	[p7l550t921r769b958],
4	precludes	VBZ	O	preclude	advcl	15	SENT_220	[p7l784t921r941b959],
5	increasing	VBG	O	increase	amod	7	SENT_220	[p7l956t921r1125b958],
6	paclitaxel	NN	O	paclitaxel	nn	7	SENT_220	[p7l1139t921r1300b958],
7	doses	NNS	O	dose	dobj	4	SENT_220	[p7l1314t921r1404b950],
8	above	IN	O	above	_	0	SENT_220	[p7l1420t921r1517b950],
9	250	CD	NUMBER	250	num	10	SENT_220	[p7l1532t921r1592b950],
10	mg/m	NNS	O	mg/m	prep_above	7	SENT_220	[p7l1608t921r1704b958],
11	,	,	O	,	_	0	SENT_220	[p7l1722t945r1728b955],
12	severe	JJ	O	severe	amod	13	SENT_220	[p7l1746t930r1849b950],
13	effects	NNS	O	effect	nsubj	15	SENT_220	[p7l551t971r658b1000],
14	are	VBP	O	be	cop	15	SENT_220	[p7l670t980r719b1000],
15	rare	JJ	O	rare	_	0	SENT_220	[p7l729t980r792b1000],
16	at	IN	O	at	_	0	SENT_220	[p7l804t975r832b1000],
17	conventional	JJ	O	conventional	amod	18	SENT_220	[p7l842t971r1054b1000],
18	doses	NNS	O	dose	prep_at	15	SENT_220	[p7l1066t971r1165b1005],
19	,	,	O	,	_	0	SENT_220	[p7l1066t971r1165b1005],
20	even	RB	O	even	advmod	18	SENT_220	[p7l1178t980r1254b1000],
21	in	IN	O	in	_	0	SENT_220	[p7l1265t971r1296b1000],
22	patients	NNS	O	patient	prep_in	20	SENT_220	[p7l1306t971r1433b1009],
23	who	WP	O	who	nsubj	25	SENT_220	[p7l1445t971r1514b1000],
24	previously	RB	DATE	previously	advmod	25	SENT_220	[p7l1526t971r1699b1009],
25	received	VBD	O	receive	rcmod	22	SENT_220	[p7l1710t971r1850b1000],
26	other	JJ	O	other	amod	28	SENT_220	[p7l551t1021r635b1050],
27	neurotoxic	JJ	O	neurotoxic	amod	28	SENT_220	[p7l642t1021r818b1050],
28	agents	NNS	O	agent	dobj	25	SENT_220	[p7l827t1026r930b1059],
29	such	JJ	O	such	_	0	SENT_220	[p7l940t1021r1014b1050],
30	as	IN	O	as	_	0	SENT_220	[p7l1022t1030r1054b1050],
31	cisplatin	NN	O	cisplatin	prep_such_as	28	SENT_220	[p7l1063t1021r1202b1059],
32	(	CD	NUMBER	(	num	31	SENT_220	[p7l1211t1021r1286b1057],
33	42	CD	NUMBER	42	num	34	SENT_220	[p7l1211t1021r1286b1057],
34	)	NN	O	)	dep	18	SENT_220	[p7l1211t1021r1286b1057],
35	.	.	O	.	_	0	SENT_220	[p7l1211t1021r1286b1057],

1	Motor	NNP	O	Motor	nsubj	7	SENT_221	[p7l1296t1022r1399b1050],
2	and	CC	O	and	_	0	SENT_221	[p7l1407t1021r1466b1050],
3	autonomic	JJ	O	autonomic	amod	4	SENT_221	[p7l1474t1021r1646b1050],
4	dysfunction	NN	O	dysfunction	conj_and	1	SENT_221	[p7l1655t1021r1849b1059],
5	may	MD	O	may	aux	7	SENT_221	[p7l550t1080r620b1109],
6	also	RB	O	also	advmod	7	SENT_221	[p7l643t1071r707b1100],
7	occur	VB	O	occur	conj_and	7	SENT_221	[p7l730t1080r829b1105],
8	,	,	O	,	_	0	SENT_221	[p7l730t1080r829b1105],
9	especially	RB	O	especially	advmod	7	SENT_221	[p7l851t1071r1014b1109],
10	at	IN	O	at	_	0	SENT_221	[p7l1038t1075r1066b1100],
11	high	JJ	O	high	amod	12	SENT_221	[p7l1085t1071r1158b1109],
12	doses	NNS	O	dose	prep_at	7	SENT_221	[p7l1180t1071r1269b1100],
13	and	CC	O	and	_	0	SENT_221	[p7l1292t1071r1351b1100],
14	in	IN	O	in	_	0	SENT_221	[p7l1371t1071r1402b1100],
15	patients	NNS	O	patient	prep_in	7	SENT_221	[p7l1423t1071r1550b1109],
16	with	IN	O	with	_	0	SENT_221	[p7l1573t1071r1646b1100],
17	preexisting	VBG	O	preexist	amod	18	SENT_221	[p7l1667t1071r1850b1109],
18	neuropathies	NNS	O	neuropathy	prep_with	15	SENT_221	[p7l550t1121r760b1159],
19	caused	VBN	O	cause	partmod	18	SENT_221	[p7l779t1121r890b1150],
20	by	IN	O	by	_	0	SENT_221	[p7l907t1121r947b1159],
21	diabetes	NN	O	diabetes	nn	22	SENT_221	[p7l966t1121r1100b1150],
22	mellitus	NN	O	mellitus	agent	19	SENT_221	[p7l1118t1121r1249b1150],
23	and	CC	O	and	_	0	SENT_221	[p7l1269t1121r1328b1150],
24	alcoholism	NN	O	alcoholism	agent	19	SENT_221	[p7l1346t1121r1534b1150],
25	.	.	O	.	_	0	SENT_221	[p7l1346t1121r1534b1150],

1	In	IN	O	in	_	0	SENT_222	[p7l1554t1122r1587b1150],
2	addition	NN	O	addition	prep_in	12	SENT_222	[p7l1606t1121r1748b1156],
3	,	,	O	,	_	0	SENT_222	[p7l1606t1121r1748b1156],
4	optic	JJ	O	optic	amod	6	SENT_222	[p7l1768t1121r1848b1159],
5	nerve	NN	O	nerve	nn	6	SENT_222	[p7l550t1181r641b1201],
6	effects	NNS	O	effect	nsubj	12	SENT_222	[p7l650t1171r758b1200],
7	such	JJ	O	such	_	0	SENT_222	[p7l770t1171r843b1200],
8	as	IN	O	as	_	0	SENT_222	[p7l853t1181r885b1200],
9	scintillation	NN	O	scintillation	nn	10	SENT_222	[p7l897t1171r1090b1201],
10	scotomata	NN	O	scotoma	prep_such_as	6	SENT_222	[p7l1101t1176r1267b1201],
11	may	MD	O	may	aux	12	SENT_222	[p7l1275t1181r1345b1209],
12	occur	VB	O	occur	_	0	SENT_222	[p7l1355t1181r1446b1201],
13	(	CD	NUMBER	(	number	14	SENT_222	[p7l1456t1172r1531b1207],
14	43	CD	NUMBER	43	num	15	SENT_222	[p7l1456t1172r1531b1207],
15	)	NN	O	)	dobj	12	SENT_222	[p7l1456t1172r1531b1207],
16	.	.	O	.	_	0	SENT_222	[p7l1456t1172r1531b1207],

1	Transient	JJ	MISC	transient	amod	2	SENT_223	[p7l1542t1171r1698b1201],
2	myalgia	NN	O	myalgium	nsubj	13	SENT_223	[p7l1707t1171r1848b1209],
3	,	,	O	,	_	0	SENT_223	[p7l1707t1171r1848b1209],
4	usually	RB	O	usually	advmod	5	SENT_223	[p7l550t1221r668b1259],
5	noted	VBD	O	note	partmod	2	SENT_223	[p7l677t1221r768b1250],
6	2-5	CD	NUMBER	2-5	num	7	SENT_223	[p7l775t1221r834b1251],
7	days	NNS	NUMBER	day	tmod	5	SENT_223	[p7l844t1221r917b1259],
8	after	IN	O	after	_	0	SENT_223	[p7l927t1221r1002b1250],
9	therapy	NN	O	therapy	prep_after	5	SENT_223	[p7l1008t1221r1140b1259],
10	,	,	O	,	_	0	SENT_223	[p7l1008t1221r1140b1259],
11	is	VBZ	O	be	cop	13	SENT_223	[p7l1149t1221r1175b1250],
12	also	RB	O	also	advmod	13	SENT_223	[p7l1184t1221r1248b1250],
13	common	JJ	O	common	_	0	SENT_223	[p7l1257t1231r1409b1256],
14	,	,	O	,	_	0	SENT_223	[p7l1257t1231r1409b1256],
15	and	CC	O	and	_	0	SENT_223	[p7l1419t1221r1477b1250],
16	a	DT	O	a	det	17	SENT_223	[p7l1485t1231r1502b1250],
17	myopathy	NN	O	myopathy	nsubj	19	SENT_223	[p7l1509t1221r1673b1259],
18	may	MD	O	may	aux	19	SENT_223	[p7l1681t1231r1751b1259],
19	occur	VB	O	occur	conj_and	13	SENT_223	[p7l1759t1231r1850b1250],
20	with	IN	O	with	_	0	SENT_223	[p7l550t1272r623b1301],
21	high	JJ	O	high	amod	22	SENT_223	[p7l634t1272r707b1309],
22	doses	NNS	O	dose	prep_with	19	SENT_223	[p7l719t1272r808b1301],
23	of	IN	O	of	_	0	SENT_223	[p7l821t1272r857b1301],
24	paclitaxel	NN	O	paclitaxel	prep_of	22	SENT_223	[p7l865t1272r1025b1309],
25	combined	VBN	O	combine	prep	19	SENT_223	[p7l1037t1272r1198b1301],
26	with	IN	O	with	pcomp	25	SENT_223	[p7l1210t1272r1282b1301],
27	cisplatin	NN	O	cisplatin	pobj	26	SENT_223	[p7l1294t1272r1433b1309],
28	(	CD	NUMBER	(	number	29	SENT_223	[p7l1445t1272r1507b1307],
29	39	CD	NUMBER	39	dep	27	SENT_223	[p7l1445t1272r1507b1307],
30	,	,	O	,	_	0	SENT_223	[p7l1445t1272r1507b1307],
31	40	CD	NUMBER	40	num	32	SENT_223	[p7l1520t1272r1582b1307],
32	)	NN	O	)	appos	27	SENT_223	[p7l1520t1272r1582b1307],
33	.	.	O	.	_	0	SENT_223	[p7l1520t1272r1582b1307],

1	Cardiac	JJ	O	cardiac	amod	2	SENT_224	[p7l552t1401r685b1431],
2	eﬂects	NNS	O	eﬂects	dep	9	SENT_224	[p7l701t1402r805b1439],
3	Although	IN	O	although	dep	9	SENT_224	[p7l844t1402r1000b1439],
4	cardiac	JJ	O	cardiac	amod	6	SENT_224	[p7l1016t1402r1134b1431],
5	rhythm	NN	O	rhythm	nn	6	SENT_224	[p7l1149t1402r1269b1439],
6	disturbances	NNS	O	disturbance	nsubjpass	9	SENT_224	[p7l1284t1401r1489b1431],
7	have	VBP	O	have	aux	9	SENT_224	[p7l1505t1402r1582b1431],
8	been	VBN	O	be	auxpass	9	SENT_224	[p7l1597t1402r1675b1431],
9	observed	VBN	O	observe	advcl	18	SENT_224	[p7l1691t1401r1848b1436],
10	,	,	O	,	_	0	SENT_224	[p7l1691t1401r1848b1436],
11	the	DT	O	the	det	12	SENT_224	[p7l550t1452r599b1481],
12	importance	NN	O	importance	nsubjpass	18	SENT_224	[p7l614t1452r799b1490],
13	of	IN	O	of	_	0	SENT_224	[p7l813t1452r849b1481],
14	these	DT	O	these	det	15	SENT_224	[p7l860t1452r944b1481],
15	effects	NNS	O	effect	prep_of	12	SENT_224	[p7l959t1452r1066b1481],
16	is	VBZ	O	be	auxpass	18	SENT_224	[p7l1081t1452r1107b1481],
17	not	RB	O	not	neg	18	SENT_224	[p7l1122t1457r1174b1481],
18	known	VBN	O	know	_	0	SENT_224	[p7l1188t1452r1300b1481],
19	(	NN	O	(	dobj	18	SENT_224	[p7l1315t1452r1377b1488],
20	35	CD	NUMBER	35	num	19	SENT_224	[p7l1315t1452r1377b1488],
21	,	,	O	,	_	0	SENT_224	[p7l1315t1452r1377b1488],
22	44	CD	NUMBER	44	appos	19	SENT_224	[p7l1392t1452r1441b1486],
23	,	,	O	,	_	0	SENT_224	[p7l1392t1452r1441b1486],
24	45	CD	NUMBER	45	num	25	SENT_224	[p7l1456t1452r1519b1488],
25	)	NN	O	)	appos	22	SENT_224	[p7l1456t1452r1519b1488],
26	.	.	O	.	_	0	SENT_224	[p7l1456t1452r1519b1488],

1	The	DT	O	the	det	4	SENT_225	[p7l1534t1452r1597b1481],
2	most	RBS	O	most	advmod	3	SENT_225	[p7l1612t1456r1692b1481],
3	common	JJ	O	common	amod	4	SENT_225	[p7l1705t1461r1849b1481],
4	effect	NN	O	effect	nsubj	6	SENT_225	[p7l551t1502r644b1531],
5	is	VBZ	O	be	cop	6	SENT_225	[p7l651t1502r677b1531],
6	bradycardia	NN	O	bradycardium	_	0	SENT_225	[p7l686t1502r889b1539],
7	,	,	O	,	_	0	SENT_225	[p7l686t1502r889b1539],
8	which	WDT	O	which	nsubj	18	SENT_225	[p7l899t1502r999b1531],
9	is	VBZ	O	be	auxpass	11	SENT_225	[p7l1007t1502r1033b1531],
10	rarely	RB	O	rarely	advmod	11	SENT_225	[p7l1042t1502r1137b1539],
11	associated	VBN	O	associate	rcmod	6	SENT_225	[p7l1147t1502r1315b1531],
12	with	IN	O	with	_	0	SENT_225	[p7l1323t1502r1396b1531],
13	hemodynamic	JJ	O	hemodynamic	amod	14	SENT_225	[p7l1404t1502r1637b1539],
14	compromise	NN	O	compromise	prep_with	11	SENT_225	[p7l1646t1502r1849b1539],
15	and	CC	O	and	_	0	SENT_225	[p7l551t1551r609b1580],
16	does	VBZ	O	do	aux	18	SENT_225	[p7l620t1551r693b1580],
17	not	RB	O	not	neg	18	SENT_225	[p7l704t1555r757b1579],
18	appear	VB	O	appear	rcmod	6	SENT_225	[p7l767t1560r877b1588],
19	to	TO	O	to	aux	22	SENT_225	[p7l886t1555r917b1579],
20	be	VB	O	be	cop	22	SENT_225	[p7l927t1550r965b1580],
21	an	DT	O	a	det	22	SENT_225	[p7l976t1560r1014b1579],
22	indication	NN	O	indication	xcomp	18	SENT_225	[p7l1024t1550r1189b1580],
23	for	IN	O	for	_	0	SENT_225	[p7l1199t1550r1247b1579],
24	discontinuing	VBG	O	discontinue	prepc_for	22	SENT_225	[p7l1256t1550r1480b1588],
25	therapy	NN	O	therapy	dobj	24	SENT_225	[p7l1491t1551r1622b1588],
26	.	.	O	.	_	0	SENT_225	[p7l1491t1551r1622b1588],

1	Mobitz	NNP	MISC	Mobitz	nn	2	SENT_226	[p7l1634t1550r1752b1580],
2	types	NNS	O	type	nsubjpass	17	SENT_226	[p7l1762t1555r1848b1588],
3	I	PRP	O	I	nsubj	4	SENT_226	[p7l550t1601r563b1629],
4	(	VBP	O	(	rcmod	2	SENT_226	[p7l577t1601r803b1636],
5	Wenckebach	JJ	O	wenckebach	amod	7	SENT_226	[p7l577t1601r803b1636],
6	syndrome	NN	O	syndrome	nn	7	SENT_226	[p7l817t1601r991b1638],
7	)	NN	O	)	dobj	4	SENT_226	[p7l817t1601r991b1638],
8	and	CC	O	and	_	0	SENT_226	[p7l1007t1601r1065b1630],
9	II	CD	NUMBER	ii	conj_and	7	SENT_226	[p7l1078t1601r1104b1629],
10	and	CC	O	and	_	0	SENT_226	[p7l1118t1601r1176b1630],
11	third-degree	JJ	O	third-degree	amod	13	SENT_226	[p7l1189t1601r1390b1638],
12	heart	NN	O	heart	nn	13	SENT_226	[p7l1404t1601r1486b1630],
13	block	NN	O	block	conj_and	9	SENT_226	[p7l1498t1601r1590b1630],
14	have	VBP	O	have	aux	17	SENT_226	[p7l1602t1601r1680b1630],
15	also	RB	O	also	advmod	17	SENT_226	[p7l1694t1601r1758b1630],
16	been	VBN	O	be	auxpass	17	SENT_226	[p7l1772t1601r1849b1630],
17	noted	VBN	O	note	_	0	SENT_226	[p7l550t1651r650b1685],
18	,	,	O	,	_	0	SENT_226	[p7l550t1651r650b1685],
19	but	CC	O	but	_	0	SENT_226	[p7l661t1651r713b1680],
20	the	DT	O	the	det	21	SENT_226	[p7l722t1651r772b1680],
21	incidence	NN	O	incidence	nsubj	32	SENT_226	[p7l782t1651r939b1680],
22	in	IN	O	in	_	0	SENT_226	[p7l948t1651r979b1680],
23	a	DT	O	a	det	25	SENT_226	[p7l990t1660r1007b1680],
24	large	JJ	O	large	amod	25	SENT_226	[p7l1016t1651r1097b1689],
25	database	NN	O	database	prep_in	21	SENT_226	[p7l1107t1651r1248b1680],
26	was	VBD	O	be	cop	32	SENT_226	[p7l1258t1660r1320b1680],
27	only	RB	O	only	advmod	32	SENT_226	[p7l1331t1651r1403b1689],
28	0.1	CD	PERCENT	0.1	num	29	SENT_226	[p7l1413t1651r1496b1680],
29	%	NN	PERCENT	%	pobj	27	SENT_226	[p7l1413t1651r1496b1680],
30	(	CD	NUMBER	(	number	31	SENT_226	[p7l1509t1651r1583b1687],
31	45	CD	NUMBER	45	num	32	SENT_226	[p7l1509t1651r1583b1687],
32	)	NN	O	)	conj_but	17	SENT_226	[p7l1509t1651r1583b1687],
33	.	.	O	.	_	0	SENT_226	[p7l1509t1651r1583b1687],

1	All	DT	O	all	det	2	SENT_227	[p7l1595t1651r1646b1680],
2	events	NNS	O	event	nsubjpass	9	SENT_227	[p7l1656t1655r1760b1680],
3	were	VBD	O	be	auxpass	6	SENT_227	[p7l1770t1660r1849b1680],
4	asymptomatic	JJ	O	asymptomatic	amod	6	SENT_227	[p7l551t1701r791b1739],
5	,	,	O	,	_	0	SENT_227	[p7l551t1701r791b1739],
6	reversible	JJ	O	reversible	_	0	SENT_227	[p7l805t1701r976b1736],
7	,	,	O	,	_	0	SENT_227	[p7l805t1701r976b1736],
8	and	CC	O	and	_	0	SENT_227	[p7l993t1701r1051b1730],
9	noted	VBD	O	note	conj_and	6	SENT_227	[p7l1065t1701r1156b1730],
10	in	IN	O	in	_	0	SENT_227	[p7l1170t1701r1201b1730],
11	trials	NNS	O	trial	prep_in	9	SENT_227	[p7l1215t1701r1296b1730],
12	that	WDT	O	that	nsubj	13	SENT_227	[p7l1311t1701r1372b1730],
13	required	VBD	O	require	rcmod	11	SENT_227	[p7l1385t1701r1523b1739],
14	continuous	JJ	O	continuous	amod	16	SENT_227	[p7l1537t1701r1716b1730],
15	cardiac	JJ	O	cardiac	amod	16	SENT_227	[p7l1731t1701r1849b1730],
16	monitoring	NN	O	monitoring	dobj	13	SENT_227	[p7l550t1751r742b1789],
17	,	,	O	,	_	0	SENT_227	[p7l550t1751r742b1789],
18	suggesting	VBG	O	suggest	partmod	13	SENT_227	[p7l760t1751r934b1789],
19	that	IN	O	that	complm	23	SENT_227	[p7l949t1751r1011b1781],
20	cardiac	JJ	O	cardiac	amod	21	SENT_227	[p7l1025t1751r1142b1781],
21	effects	NNS	O	effect	nsubjpass	23	SENT_227	[p7l1158t1751r1265b1781],
22	are	VBP	O	be	auxpass	23	SENT_227	[p7l1282t1760r1330b1781],
23	underreported	VBN	O	underreport	ccomp	18	SENT_227	[p7l1344t1751r1584b1789],
24	.	.	O	.	_	0	SENT_227	[p7l1344t1751r1584b1789],

1	It	PRP	O	it	nsubj	3	SENT_228	[p7l1600t1752r1625b1780],
2	is	VBZ	O	be	cop	3	SENT_228	[p7l1639t1751r1665b1781],
3	likely	JJ	O	likely	_	0	SENT_228	[p7l1680t1751r1773b1789],
4	that	IN	O	that	complm	7	SENT_228	[p7l1788t1751r1849b1781],
5	bradyarrhythmias	NNS	O	bradyarrhythmia	nsubjpass	7	SENT_228	[p7l550t1801r840b1839],
6	are	VBP	O	be	auxpass	7	SENT_228	[p7l854t1810r902b1831],
7	caused	VBN	O	cause	ccomp	3	SENT_228	[p7l915t1801r1026b1831],
8	by	IN	O	by	_	0	SENT_228	[p7l1037t1801r1078b1839],
9	paclitaxel	NN	O	paclitaxel	agent	7	SENT_228	[p7l1090t1801r1259b1839],
10	,	,	O	,	_	0	SENT_228	[p7l1090t1801r1259b1839],
11	since	IN	O	since	mark	14	SENT_228	[p7l1273t1801r1356b1831],
12	related	JJ	O	related	amod	13	SENT_228	[p7l1368t1801r1480b1831],
13	taxanes	NNS	O	taxane	nsubj	14	SENT_228	[p7l1491t1806r1613b1831],
14	affect	VBP	O	affect	advcl	7	SENT_228	[p7l1627t1801r1720b1831],
15	cardiac	JJ	O	cardiac	amod	16	SENT_228	[p7l1731t1801r1849b1831],
16	automaticity	NN	O	automaticity	dobj	14	SENT_228	[p7l551t1851r755b1889],
17	and	CC	O	and	_	0	SENT_228	[p7l766t1851r824b1880],
18	conduction	NN	O	conduction	conj_and	16	SENT_228	[p7l833t1851r1025b1886],
19	,	,	O	,	_	0	SENT_228	[p7l833t1851r1025b1886],
20	and	CC	O	and	_	0	SENT_228	[p7l1036t1851r1095b1880],
21	similar	JJ	O	similar	amod	22	SENT_228	[p7l1105t1851r1218b1880],
22	disturbances	NNS	O	disturbance	nsubj	24	SENT_228	[p7l1227t1851r1432b1880],
23	have	VBP	O	have	aux	24	SENT_228	[p7l1442t1851r1519b1880],
24	occurred	VBN	O	occur	conj_and	3	SENT_228	[p7l1529t1851r1673b1880],
25	in	IN	O	in	_	0	SENT_228	[p7l1681t1851r1712b1880],
26	humans	NNS	O	human	prep_in	24	SENT_228	[p7l1721t1851r1848b1880],
27	and	CC	O	and	_	0	SENT_228	[p7l551t1901r609b1931],
28	animals	NNS	O	animal	conj_and	26	SENT_228	[p7l621t1901r747b1931],
29	after	IN	O	after	_	0	SENT_228	[p7l760t1901r835b1931],
30	the	DT	O	the	det	31	SENT_228	[p7l845t1901r894b1931],
31	ingestion	NN	O	ingestion	prep_after	24	SENT_228	[p7l906t1901r1056b1939],
32	of	IN	O	of	_	0	SENT_228	[p7l1068t1901r1104b1931],
33	yew	NN	O	yew	nn	34	SENT_228	[p7l1113t1910r1180b1939],
34	plants	NNS	O	plant	prep_of	31	SENT_228	[p7l1192t1901r1289b1939],
35	(	CD	NUMBER	(	number	36	SENT_228	[p7l1302t1901r1377b1937],
36	45	CD	NUMBER	45	num	37	SENT_228	[p7l1302t1901r1377b1937],
37	)	NN	O	)	dep	34	SENT_228	[p7l1302t1901r1377b1937],
38	.	.	O	.	_	0	SENT_228	[p7l1302t1901r1377b1937],

1	Myocardial	JJ	MISC	myocardial	amod	2	SENT_229	[p7l600t1953r790b1991],
2	ischemia	NN	O	ischemia	nsubjpass	13	SENT_229	[p7l805t1953r960b1988],
3	,	,	O	,	_	0	SENT_229	[p7l805t1953r960b1988],
4	atrial	JJ	O	atrial	amod	5	SENT_229	[p7l978t1953r1061b1983],
5	arrhythmias	NNS	O	arrhythmia	nsubjpass	13	SENT_229	[p7l1078t1953r1282b1991],
6	,	,	O	,	_	0	SENT_229	[p7l1078t1953r1282b1991],
7	and	CC	O	and	_	0	SENT_229	[p7l1300t1953r1358b1983],
8	ventricular	JJ	O	ventricular	amod	9	SENT_229	[p7l1374t1953r1553b1983],
9	tachycardia	NN	O	tachycardia	nsubjpass	13	SENT_229	[p7l1567t1953r1758b1991],
10	have	VBP	O	have	aux	13	SENT_229	[p7l1771t1953r1849b1983],
11	also	RB	O	also	advmod	13	SENT_229	[p7l551t2003r615b2033],
12	been	VBN	O	be	auxpass	13	SENT_229	[p7l634t2003r712b2033],
13	noted	VBN	O	note	_	0	SENT_229	[p7l731t2003r823b2033],
14	(	RB	O	(	advmod	15	SENT_229	[p7l843t2003r904b2039],
15	35	CD	NUMBER	35	dobj	13	SENT_229	[p7l843t2003r904b2039],
16	,	,	O	,	_	0	SENT_229	[p7l843t2003r904b2039],
17	44	CD	NUMBER	44	appos	15	SENT_229	[p7l925t2003r974b2038],
18	,	,	O	,	_	0	SENT_229	[p7l925t2003r974b2038],
19	45	CD	NUMBER	45	num	20	SENT_229	[p7l995t2003r1057b2039],
20	)	NN	O	)	appos	17	SENT_229	[p7l995t2003r1057b2039],
21	.	.	O	.	_	0	SENT_229	[p7l995t2003r1057b2039],

1	Whether	IN	O	whether	complm	3	SENT_230	[p7l1078t2003r1221b2033],
2	there	EX	O	there	expl	3	SENT_230	[p7l1239t2003r1321b2033],
3	is	VBZ	O	be	csubj	13	SENT_230	[p7l1340t2003r1365b2033],
4	a	DT	O	a	det	7	SENT_230	[p7l1386t2012r1403b2033],
5	direct	JJ	O	direct	amod	7	SENT_230	[p7l1422t2003r1515b2033],
6	causal	JJ	O	causal	amod	7	SENT_230	[p7l1534t2003r1635b2033],
7	relationship	NN	O	relationship	nsubj	3	SENT_230	[p7l1654t2003r1848b2041],
8	between	IN	O	between	_	0	SENT_230	[p7l550t2053r687b2083],
9	paclitaxel	NN	O	paclitaxel	prep_between	7	SENT_230	[p7l702t2053r862b2091],
10	and	CC	O	and	_	0	SENT_230	[p7l878t2053r937b2082],
11	these	DT	O	these	det	12	SENT_230	[p7l952t2053r1035b2082],
12	effects	NNS	O	effect	prep_between	7	SENT_230	[p7l1052t2053r1159b2082],
13	is	VBZ	O	be	_	0	SENT_230	[p7l1176t2053r1201b2082],
14	uncertain	JJ	O	uncertain	amod	15	SENT_230	[p7l1218t2053r1371b2082],
15	(	NN	O	(	attr	13	SENT_230	[p7l1387t2053r1462b2089],
16	45	CD	NUMBER	45	num	17	SENT_230	[p7l1387t2053r1462b2089],
17	)	NN	O	)	dep	15	SENT_230	[p7l1387t2053r1462b2089],
18	.	.	O	.	_	0	SENT_230	[p7l1387t2053r1462b2089],

1	There	EX	O	there	expl	2	SENT_231	[p7l1480t2053r1575b2082],
2	is	VBZ	O	be	_	0	SENT_231	[p7l1591t2053r1616b2082],
3	also	RB	O	also	advmod	2	SENT_231	[p7l1634t2053r1698b2082],
4	no	DT	O	no	det	6	SENT_231	[p7l1714t2062r1754b2082],
5	clear	JJ	O	clear	amod	6	SENT_231	[p7l1770t2053r1850b2082],
6	evidence	NN	O	evidence	nsubj	2	SENT_231	[p7l551t2103r696b2133],
7	that	IN	O	that	complm	9	SENT_231	[p7l711t2103r773b2133],
8	paclitaxel	NN	O	paclitaxel	nsubj	9	SENT_231	[p7l787t2103r948b2141],
9	induces	VBZ	O	induce	ccomp	2	SENT_231	[p7l963t2103r1087b2133],
10	cumulative	JJ	O	cumulative	amod	11	SENT_231	[p7l1104t2103r1287b2133],
11	toxicity	NN	O	toxicity	nsubj	12	SENT_231	[p7l1302t2103r1427b2141],
12	nor	CC	O	nor	xcomp	9	SENT_231	[p7l1443t2112r1498b2133],
13	that	IN	O	that	complm	15	SENT_231	[p7l1513t2103r1574b2133],
14	it	PRP	O	it	nsubj	15	SENT_231	[p7l1589t2103r1612b2133],
15	augments	VBZ	O	augment	ccomp	9	SENT_231	[p7l1627t2108r1783b2141],
16	the	DT	O	the	det	18	SENT_231	[p7l1800t2103r1849b2133],
17	cardiac	JJ	O	cardiac	amod	18	SENT_231	[p7l551t2153r668b2183],
18	effects	NNS	O	effect	dobj	15	SENT_231	[p7l680t2153r788b2183],
19	of	IN	O	of	_	0	SENT_231	[p7l801t2153r836b2183],
20	the	DT	O	the	det	21	SENT_231	[p7l845t2153r894b2183],
21	anthracyclines	NNS	O	anthracycline	prep_of	18	SENT_231	[p7l907t2153r1152b2191],
22	.	.	O	.	_	0	SENT_231	[p7l907t2153r1152b2191],

1	Preliminary	JJ	O	preliminary	amod	2	SENT_232	[p7l1165t2153r1360b2191],
2	data	NNS	O	datum	nsubj	4	SENT_232	[p7l1372t2153r1440b2183],
3	also	RB	O	also	advmod	4	SENT_232	[p7l1451t2153r1516b2183],
4	indicate	VBP	O	indicate	_	0	SENT_232	[p7l1527t2153r1657b2183],
5	that	IN	O	that	complm	9	SENT_232	[p7l1669t2153r1730b2183],
6	it	PRP	O	it	nsubj	9	SENT_232	[p7l1741t2153r1763b2183],
7	does	VBZ	O	do	aux	9	SENT_232	[p7l1775t2153r1848b2183],
8	not	RB	O	not	neg	9	SENT_232	[p7l550t2208r603b2232],
9	worsen	VB	O	worsen	ccomp	4	SENT_232	[p7l615t2212r734b2232],
10	myocardial	JJ	O	myocardial	amod	11	SENT_232	[p7l746t2203r931b2241],
11	function	NN	O	function	dobj	9	SENT_232	[p7l944t2203r1081b2232],
12	in	IN	O	in	_	0	SENT_232	[p7l1094t2203r1125b2232],
13	patients	NNS	O	patient	prep_in	11	SENT_232	[p7l1137t2203r1264b2241],
14	with	IN	O	with	_	0	SENT_232	[p7l1278t2203r1351b2233],
15	marginal	JJ	O	marginal	amod	17	SENT_232	[p7l1363t2203r1509b2241],
16	ventricular	JJ	O	ventricular	amod	17	SENT_232	[p7l1522t2203r1701b2233],
17	function	NN	O	function	prep_with	9	SENT_232	[p7l1712t2203r1849b2232],
18	(	CD	NUMBER	(	number	19	SENT_232	[p7l551t2253r626b2289],
19	46	CD	NUMBER	46	num	20	SENT_232	[p7l551t2253r626b2289],
20	)	NN	O	)	dep	9	SENT_232	[p7l551t2253r626b2289],
21	.	.	O	.	_	0	SENT_232	[p7l551t2253r626b2289],

1	However	RB	O	however	advmod	10	SENT_233	[p7l645t2254r804b2288],
2	,	,	O	,	_	0	SENT_233	[p7l645t2254r804b2288],
3	the	DT	O	the	det	4	SENT_233	[p7l823t2253r872b2283],
4	frequency	NN	O	frequency	nsubj	10	SENT_233	[p7l889t2253r1053b2291],
5	of	IN	O	of	_	0	SENT_233	[p7l1070t2253r1106b2283],
6	congestive	JJ	O	congestive	amod	7	SENT_233	[p7l1120t2253r1295b2291],
7	cardiotoxicty	NN	O	cardiotoxicty	prep_of	4	SENT_233	[p7l1312t2253r1529b2291],
8	in	IN	O	in	_	0	SENT_233	[p7l1546t2253r1577b2282],
9	patients	NNS	O	patient	prep_in	7	SENT_233	[p7l1593t2253r1720b2291],
10	treated	VBN	O	treat	_	0	SENT_233	[p7l1738t2253r1850b2283],
11	362	CD	NUMBER	362	num	12	SENT_233	[p7l551t2310r605b2336],
12	ROWINSKY	NN	O	rowinsky	dobj	10	SENT_233	[p7l644t2310r844b2336],

1	with	IN	O	with	_	0	SENT_234	[p7l550t2394r623b2424],
2	paclitaxel	NN	O	paclitaxel	nn	6	SENT_234	[p7l633t2394r793b2432],
3	(	CD	NUMBER	(	num	6	SENT_234	[p7l806t2394r873b2430],
4	3-h	JJ	O	3-h	amod	6	SENT_234	[p7l806t2394r873b2430],
5	schedule	NN	O	schedule	nn	6	SENT_234	[p7l884t2394r1039b2430],
6	)	NN	O	)	prep_with	14	SENT_234	[p7l884t2394r1039b2430],
7	and	CC	O	and	_	0	SENT_234	[p7l1051t2394r1109b2424],
8	doxorubicin	NN	O	doxorubicin	prep_with	14	SENT_234	[p7l1120t2394r1319b2424],
9	may	MD	O	may	aux	14	SENT_234	[p7l1329t2403r1399b2432],
10	be	VB	O	be	aux	14	SENT_234	[p7l1410t2394r1448b2424],
11	be	VB	O	be	auxpass	14	SENT_234	[p7l1458t2394r1497b2424],
12	higher	JJR	O	higher	dep	13	SENT_234	[p7l1507t2394r1613b2432],
13	than	IN	O	than	advmod	14	SENT_234	[p7l1623t2394r1693b2424],
14	expected	VBN	O	expect	_	0	SENT_234	[p7l1704t2394r1850b2432],
15	compared	VBN	O	compare	_	0	SENT_234	[p7l551t2444r713b2482],
16	to	TO	O	to	prepc_compared_to	14	SENT_234	[p7l724t2449r754b2474],
17	the	DT	O	the	det	18	SENT_234	[p7l766t2444r815b2474],
18	anthracyclines	NNS	O	anthracycline	pobj	14	SENT_234	[p7l828t2444r1064b2482],
19	alone	RB	O	alone	advmod	14	SENT_234	[p7l1076t2444r1164b2474],
20	(	RB	O	(	advmod	14	SENT_234	[p7l1177t2444r1251b2480],
21	22	CD	NUMBER	22	num	22	SENT_234	[p7l1177t2444r1251b2480],
22	)	NN	O	)	nsubjpass	14	SENT_234	[p7l1177t2444r1251b2480],
23	.	.	O	.	_	0	SENT_234	[p7l1177t2444r1251b2480],

1	Therefore	RB	O	therefore	advmod	11	SENT_235	[p7l1265t2444r1436b2479],
2	,	,	O	,	_	0	SENT_235	[p7l1265t2444r1436b2479],
3	potential	JJ	O	potential	amod	5	SENT_235	[p7l1447t2444r1591b2482],
4	drug	NN	O	drug	nn	5	SENT_235	[p7l1603t2444r1677b2482],
5	effects	NNS	O	effect	nsubjpass	11	SENT_235	[p7l1689t2444r1797b2474],
6	on	IN	O	on	_	0	SENT_235	[p7l1809t2453r1849b2474],
7	ventricular	JJ	O	ventricular	amod	8	SENT_235	[p7l550t2494r729b2523],
8	function	NN	O	function	prep_on	5	SENT_235	[p7l747t2494r884b2523],
9	should	MD	O	should	aux	11	SENT_235	[p7l905t2494r1013b2523],
10	be	VB	O	be	auxpass	11	SENT_235	[p7l1032t2494r1070b2523],
11	evaluated	VBN	O	evaluate	_	0	SENT_235	[p7l1090t2494r1247b2523],
12	at	IN	O	at	_	0	SENT_235	[p7l1267t2499r1295b2523],
13	lower	JJR	O	lower	amod	16	SENT_235	[p7l1314t2494r1408b2524],
14	cumulative	JJ	O	cumulative	amod	16	SENT_235	[p7l1426t2494r1608b2523],
15	anthracycline	NN	O	anthracycline	nn	16	SENT_235	[p7l1628t2494r1849b2532],
16	doses	NNS	O	dose	prep_at	11	SENT_235	[p7l551t2544r640b2574],
17	than	IN	O	than	mark	21	SENT_235	[p7l662t2544r732b2574],
18	might	MD	O	might	aux	21	SENT_235	[p7l753t2544r850b2582],
19	otherwise	RB	O	otherwise	advmod	21	SENT_235	[p7l870t2544r1029b2574],
20	be	VB	O	be	auxpass	21	SENT_235	[p7l1050t2544r1088b2574],
21	done	VBN	O	do	dep	16	SENT_235	[p7l1110t2544r1188b2574],
22	with	IN	O	with	_	0	SENT_235	[p7l1209t2544r1282b2574],
23	anthracyclines	NNS	O	anthracycline	prep_with	21	SENT_235	[p7l1303t2544r1539b2582],
24	alone	RB	O	alone	advmod	21	SENT_235	[p7l1561t2544r1649b2574],
25	in	IN	O	in	_	0	SENT_235	[p7l1669t2544r1701b2573],
26	patients	NNS	O	patient	prep_in	21	SENT_235	[p7l1721t2544r1848b2582],
27	treated	VBN	O	treat	partmod	26	SENT_235	[p7l550t2594r662b2624],
28	with	IN	O	with	_	0	SENT_235	[p7l674t2594r747b2624],
29	both	DT	O	both	det	30	SENT_235	[p7l758t2594r832b2624],
30	agents	NNS	O	agent	prep_with	27	SENT_235	[p7l845t2599r958b2632],
31	,	,	O	,	_	0	SENT_235	[p7l845t2599r958b2632],
32	and	CC	O	and	_	0	SENT_235	[p7l973t2594r1031b2624],
33	patients	NNS	O	patient	nsubj	49	SENT_235	[p7l1043t2594r1170b2632],
34	treated	VBN	O	treat	partmod	33	SENT_235	[p7l1184t2594r1295b2624],
35	with	IN	O	with	_	0	SENT_235	[p7l1307t2594r1380b2624],
36	the	DT	O	the	det	37	SENT_235	[p7l1392t2594r1442b2624],
37	combination	NN	O	combination	prep_with	34	SENT_235	[p7l1455t2594r1660b2624],
38	of	IN	O	of	_	0	SENT_235	[p7l1673t2594r1709b2624],
39	doxorubicin	NN	O	doxorubicin	prep_of	37	SENT_235	[p7l1719t2594r1848b2624, p7l550t2644r632b2673],
40	and	CC	O	and	_	0	SENT_235	[p7l645t2644r703b2673],
41	paclitaxel	NN	O	paclitaxel	prep_of	37	SENT_235	[p7l715t2644r884b2682],
42	,	,	O	,	_	0	SENT_235	[p7l715t2644r884b2682],
43	particularly	RB	O	particularly	advmod	44	SENT_235	[p7l897t2644r1087b2682],
44	3-h	JJ	O	3-h	amod	45	SENT_235	[p7l1101t2644r1154b2674],
45	schedules	NNS	O	schedule	appos	33	SENT_235	[p7l1168t2644r1335b2679],
46	,	,	O	,	_	0	SENT_235	[p7l1168t2644r1335b2679],
47	should	MD	O	should	aux	49	SENT_235	[p7l1351t2644r1459b2673],
48	not	RB	O	not	neg	49	SENT_235	[p7l1471t2648r1524b2673],
49	receive	VB	O	receive	conj_and	11	SENT_235	[p7l1535t2644r1654b2673],
50	cumulative	JJ	O	cumulative	amod	51	SENT_235	[p7l1667t2644r1849b2673],
51	doses	NNS	O	dose	dobj	49	SENT_235	[p7l551t2695r640b2724],
52	of	IN	O	of	_	0	SENT_235	[p7l661t2695r696b2724],
53	doxorubicin	NN	O	doxorubicin	prep_of	51	SENT_235	[p7l713t2695r912b2724],
54	above	IN	O	above	_	0	SENT_235	[p7l932t2695r1029b2724],
55	360	CD	NUMBER	360	num	56	SENT_235	[p7l1049t2695r1109b2724],
56	mg/m2	NN	O	mg/m2	prep_above	49	SENT_235	[p7l1128t2683r1240b2732],
57	until	IN	O	until	mark	61	SENT_235	[p7l1259t2695r1334b2724],
58	additional	JJ	O	additional	amod	59	SENT_235	[p7l1354t2695r1517b2724],
59	data	NNS	O	datum	nsubj	61	SENT_235	[p7l1537t2695r1605b2724],
60	are	VBP	O	be	cop	61	SENT_235	[p7l1624t2704r1672b2724],
61	available	JJ	O	available	advcl	49	SENT_235	[p7l1691t2695r1847b2724],
62	.	.	O	.	_	0	SENT_235	[p7l1691t2695r1847b2724],

1	Although	IN	O	although	mark	9	SENT_236	[p7l550t2744r706b2782],
2	the	DT	O	the	det	4	SENT_236	[p7l723t2744r772b2774],
3	precise	JJ	O	precise	amod	4	SENT_236	[p7l788t2744r905b2782],
4	risks	NNS	O	risk	nsubjpass	9	SENT_236	[p7l921t2744r998b2774],
5	for	IN	O	for	_	0	SENT_236	[p7l1016t2744r1064b2774],
6	cardiotoxicity	NN	O	cardiotoxicity	prep_for	4	SENT_236	[p7l1080t2744r1309b2782],
7	are	VBP	O	be	auxpass	9	SENT_236	[p7l1326t2753r1375b2774],
8	not	RB	O	not	neg	9	SENT_236	[p7l1391t2749r1444b2774],
9	known	VBN	O	know	advcl	18	SENT_236	[p7l1459t2744r1580b2779],
10	,	,	O	,	_	0	SENT_236	[p7l1459t2744r1580b2779],
11	routine	JJ	O	routine	amod	13	SENT_236	[p7l1598t2744r1714b2774],
12	cardiac	JJ	O	cardiac	amod	13	SENT_236	[p7l1731t2744r1849b2774],
13	monitoring	NN	O	monitoring	nsubj	18	SENT_236	[p7l550t2794r733b2832],
14	during	IN	O	during	_	0	SENT_236	[p7l746t2794r852b2832],
15	treatment	NN	O	treatment	prep_during	13	SENT_236	[p7l865t2798r1021b2823],
16	does	VBZ	O	do	aux	18	SENT_236	[p7l1033t2794r1106b2823],
17	not	RB	O	not	neg	18	SENT_236	[p7l1120t2798r1172b2823],
18	seem	VB	O	seem	_	0	SENT_236	[p7l1185t2803r1268b2823],
19	to	TO	O	to	aux	21	SENT_236	[p7l1280t2798r1311b2823],
20	be	VB	O	be	cop	21	SENT_236	[p7l1323t2794r1362b2823],
21	necessary	JJ	O	necessary	xcomp	18	SENT_236	[p7l1374t2803r1542b2832],
22	,	,	O	,	_	0	SENT_236	[p7l1374t2803r1542b2832],
23	but	CC	O	but	_	0	SENT_236	[p7l1556t2794r1609b2823],
24	it	PRP	O	it	nsubj	26	SENT_236	[p7l1620t2794r1643b2823],
25	is	VBZ	O	be	cop	26	SENT_236	[p7l1655t2794r1680b2823],
26	advisable	JJ	O	advisable	conj_but	18	SENT_236	[p7l1694t2794r1849b2823],
27	for	IN	O	for	_	0	SENT_236	[p7l550t2844r598b2873],
28	patients	NNS	O	patient	prep_for	26	SENT_236	[p7l608t2844r736b2882],
29	who	WP	O	who	nsubj	33	SENT_236	[p7l748t2844r817b2873],
30	may	MD	O	may	aux	33	SENT_236	[p7l830t2853r899b2882],
31	not	RB	O	not	neg	33	SENT_236	[p7l911t2849r964b2873],
32	be	VB	O	be	cop	33	SENT_236	[p7l973t2844r1012b2873],
33	able	JJ	O	able	rcmod	28	SENT_236	[p7l1024t2844r1091b2873],
34	to	TO	O	to	aux	35	SENT_236	[p7l1102t2849r1133b2873],
35	tolerate	VB	O	tolerate	xcomp	33	SENT_236	[p7l1145t2844r1268b2873],
36	bradyarrhythmias	NNS	O	bradyarrhythmia	dobj	35	SENT_236	[p7l1278t2844r1578b2882],
37	.	.	O	.	_	0	SENT_236	[p7l1278t2844r1578b2882],

1	Miscellaneous	JJ	O	miscellaneous	amod	3	SENT_237	[p7l549t2960r788b2989],
2	toxicities	NNS	O	toxicity	nn	3	SENT_237	[p7l799t2961r946b2989],
3	Nausea	NN	MISC	nausea	dep	10	SENT_237	[p7l985t2961r1115b2995],
4	,	,	O	,	_	0	SENT_237	[p7l985t2961r1115b2995],
5	vomiting	VBG	O	vomit	appos	3	SENT_237	[p7l1126t2960r1283b2998],
6	,	,	O	,	_	0	SENT_237	[p7l1126t2960r1283b2998],
7	and	CC	O	and	_	0	SENT_237	[p7l1295t2960r1354b2989],
8	diarrhea	NN	O	diarrhea	conj_and	3	SENT_237	[p7l1364t2960r1499b2989],
9	are	VBP	O	be	cop	10	SENT_237	[p7l1508t2969r1557b2989],
10	infrequent	JJ	O	infrequent	_	0	SENT_237	[p7l1566t2960r1736b2998],
11	(	NN	O	(	nsubj	10	SENT_237	[p7l1746t2961r1787b2996],
12	1	CD	NUMBER	1	num	11	SENT_237	[p7l1746t2961r1787b2996],
13	,	,	O	,	_	0	SENT_237	[p7l1746t2961r1787b2996],
14	21	CD	NUMBER	21	appos	11	SENT_237	[p7l1799t2960r1847b2994],
15	,	,	O	,	_	0	SENT_237	[p7l1799t2960r1847b2994],
16	35	CD	NUMBER	35	num	17	SENT_237	[p7l551t3010r612b3046],
17	)	NN	O	)	appos	14	SENT_237	[p7l551t3010r612b3046],
18	.	.	O	.	_	0	SENT_237	[p7l551t3010r612b3046],

1	Higher	JJR	O	higher	amod	2	SENT_238	[p7l623t3010r737b3048],
2	doses	NNS	O	dose	nsubj	4	SENT_238	[p7l744t3010r834b3039],
3	may	MD	O	may	aux	4	SENT_238	[p7l843t3019r913b3048],
4	cause	VB	O	cause	_	0	SENT_238	[p7l921t3019r1011b3039],
5	mucositis	NN	O	mucositis	dobj	4	SENT_238	[p7l1019t3010r1186b3045],
6	,	,	O	,	_	0	SENT_238	[p7l1019t3010r1186b3045],
7	especially	RB	O	especially	advmod	4	SENT_238	[p7l1195t3010r1359b3048],
8	in	IN	O	in	_	0	SENT_238	[p7l1366t3010r1398b3039],
9	patients	NNS	O	patient	prep_in	4	SENT_238	[p7l1405t3010r1532b3048],
10	with	IN	O	with	_	0	SENT_238	[p7l1541t3010r1613b3039],
11	leukemia	NN	O	leukemia	prep_with	9	SENT_238	[p7l1621t3010r1772b3039],
12	who	WP	O	who	nsubj	16	SENT_238	[p7l1779t3010r1848b3039],
13	may	MD	O	may	aux	16	SENT_238	[p7l550t3069r620b3098],
14	be	VB	O	be	cop	16	SENT_238	[p7l629t3060r668b3089],
15	more	RBR	O	more	advmod	16	SENT_238	[p7l677t3069r761b3089],
16	prone	JJ	O	prone	rcmod	9	SENT_238	[p7l770t3069r864b3098],
17	to	TO	O	to	_	0	SENT_238	[p7l873t3065r904b3089],
18	mucosal	JJ	O	mucosal	amod	20	SENT_238	[p7l914t3060r1050b3089],
19	barrier	NN	O	barrier	nn	20	SENT_238	[p7l1059t3060r1170b3089],
20	disruption	NN	O	disruption	prep_to	16	SENT_238	[p7l1179t3060r1345b3098],
21	and	CC	O	and	_	0	SENT_238	[p7l1355t3060r1414b3089],
22	in	IN	O	in	_	0	SENT_238	[p7l1423t3060r1454b3089],
23	patients	NNS	O	patient	prep_in	31	SENT_238	[p7l1463t3060r1590b3098],
24	with	IN	O	with	_	0	SENT_238	[p7l1600t3060r1673b3089],
25	prolonged	JJ	O	prolonged	amod	26	SENT_238	[p7l1682t3060r1849b3098],
26	(	NN	O	(	prep_with	23	SENT_238	[p7l551t3110r604b3146],
27	96	CD	NUMBER	96	num	30	SENT_238	[p7l551t3110r604b3146],
28	h	NN	O	h	nn	30	SENT_238	[p7l613t3110r645b3146],
29	)	NN	O	)	nn	30	SENT_238	[p7l613t3110r645b3146],
30	infusions	NNS	O	infusion	nsubj	31	SENT_238	[p7l655t3110r805b3139],
31	(	VBP	O	(	conj_and	4	SENT_238	[p7l816t3111r878b3146],
32	31	CD	NUMBER	31	dobj	31	SENT_238	[p7l816t3111r878b3146],
33	,	,	O	,	_	0	SENT_238	[p7l816t3111r878b3146],
34	47	CD	NUMBER	47	num	35	SENT_238	[p7l888t3111r950b3146],
35	)	NN	O	)	appos	32	SENT_238	[p7l888t3111r950b3146],
36	.	.	O	.	_	0	SENT_238	[p7l888t3111r950b3146],

1	Paclitaxel	NN	O	paclitaxel	nsubj	3	SENT_239	[p7l961t3110r1123b3139],
2	also	RB	O	also	advmod	3	SENT_239	[p7l1132t3110r1196b3139],
3	induces	VBZ	O	induce	_	0	SENT_239	[p7l1205t3110r1330b3139],
4	reversible	JJ	O	reversible	amod	5	SENT_239	[p7l1339t3110r1501b3140],
5	alopecia	NN	O	alopecia	dobj	3	SENT_239	[p7l1511t3110r1647b3148],
6	of	IN	O	of	_	0	SENT_239	[p7l1655t3110r1691b3139],
7	the	DT	O	the	det	8	SENT_239	[p7l1697t3110r1746b3139],
8	scalp	NN	O	scalp	prep_of	5	SENT_239	[p7l1756t3110r1848b3148],
9	,	,	O	,	_	0	SENT_239	[p7l1756t3110r1848b3148],
10	and	CC	O	and	_	0	SENT_239	[p7l551t3161r609b3190],
11	loss	NN	O	loss	nsubj	16	SENT_239	[p7l623t3161r685b3190],
12	of	IN	O	of	_	0	SENT_239	[p7l700t3161r735b3190],
13	all	DT	O	all	det	15	SENT_239	[p7l747t3161r786b3190],
14	body	NN	O	body	nn	15	SENT_239	[p7l799t3161r881b3198],
15	hair	NN	O	hair	prep_of	11	SENT_239	[p7l895t3161r959b3190],
16	occurs	VBZ	O	occur	conj_and	3	SENT_239	[p7l972t3170r1077b3190],
17	with	IN	O	with	_	0	SENT_239	[p7l1092t3161r1164b3190],
18	cumulative	JJ	O	cumulative	amod	19	SENT_239	[p7l1178t3160r1360b3190],
19	therapy	NN	O	therapy	prep_with	16	SENT_239	[p7l1373t3161r1505b3198],
20	.	.	O	.	_	0	SENT_239	[p7l1373t3161r1505b3198],

1	Inﬂammation	NN	O	inﬂammation	conj_and	1	SENT_240	[p7l1520t3160r1744b3190],
2	at	IN	O	at	_	0	SENT_240	[p7l1758t3165r1787b3190],
3	the	DT	O	the	det	5	SENT_240	[p7l1799t3161r1849b3190],
4	injection	NN	O	injection	nn	5	SENT_240	[p7l550t3210r694b3248],
5	site	NN	O	site	prep_at	1	SENT_240	[p7l712t3210r767b3239],
6	and	CC	O	and	_	0	SENT_240	[p7l786t3210r844b3239],
7	along	IN	O	along	_	0	SENT_240	[p7l862t3211r951b3248],
8	the	DT	O	the	det	9	SENT_240	[p7l969t3211r1018b3239],
9	course	NN	O	course	prep_along	1	SENT_240	[p7l1036t3220r1142b3239],
10	of	IN	O	of	_	0	SENT_240	[p7l1160t3210r1196b3239],
11	an	DT	O	a	det	13	SENT_240	[p7l1211t3220r1248b3239],
12	injected	VBN	O	inject	amod	13	SENT_240	[p7l1265t3210r1395b3248],
13	vein	NN	O	vein	prep_of	9	SENT_240	[p7l1412t3210r1482b3240],
14	and	CC	O	and	_	0	SENT_240	[p7l1500t3210r1558b3239],
15	in	IN	O	in	_	0	SENT_240	[p7l1575t3210r1606b3239],
16	areas	NNS	O	area	prep_in	23	SENT_240	[p7l1624t3220r1706b3239],
17	of	IN	O	of	_	0	SENT_240	[p7l1724t3210r1760b3239],
18	drug	NN	O	drug	nn	19	SENT_240	[p7l1775t3210r1849b3248],
19	extravasation	NN	O	extravasation	prep_of	16	SENT_240	[p7l551t3261r770b3290],
20	and	CC	O	and	_	0	SENT_240	[p7l782t3261r840b3290],
21	skin	NN	O	skin	nn	22	SENT_240	[p7l852t3261r919b3290],
22	reactions	NNS	O	reaction	conj_and	19	SENT_240	[p7l930t3261r1078b3290],
23	over	IN	O	over	conj_and	13	SENT_240	[p7l1090t3270r1163b3290],
24	previously	RB	DATE	previously	advmod	25	SENT_240	[p7l1173t3261r1347b3298],
25	radiated	VBN	O	radiate	pcomp	23	SENT_240	[p7l1358t3261r1491b3290],
26	sites	NNS	O	site	dobj	25	SENT_240	[p7l1504t3261r1574b3290],
27	occur	VBP	O	occur	_	0	SENT_240	[p7l1587t3270r1678b3290],
28	rarely	RB	O	rarely	advmod	27	SENT_240	[p7l1688t3261r1792b3298],
29	.	.	O	.	_	0	SENT_240	[p7l1688t3261r1792b3298],

1	DOCETAXEL	NNP	MISC	DOCETAXEL	nn	3	SENT_241	[p7l550t3383r748b3406],
2	Myelosuppressian	NNP	MISC	Myelosuppressian	nn	3	SENT_241	[p7l786t3377r1087b3414],
3	A	NNP	O	A	nsubj	11	SENT_241	[p7l1127t3377r1156b3406],
4	reversible	JJ	O	reversible	amod	7	SENT_241	[p7l1170t3377r1341b3411],
5	,	,	O	,	_	0	SENT_241	[p7l1170t3377r1341b3411],
6	noncumulative	JJ	O	noncumulative	amod	7	SENT_241	[p7l1356t3377r1601b3406],
7	neutropenia	NN	O	neutropenia	dep	3	SENT_241	[p7l1614t3377r1810b3415],
8	is	VBZ	O	be	cop	11	SENT_241	[p7l1823t3377r1848b3406],
9	the	DT	O	the	det	11	SENT_241	[p7l550t3427r599b3456],
10	principal	JJ	O	principal	amod	11	SENT_241	[p7l612t3427r758b3465],
11	toxicity	NN	O	toxicity	_	0	SENT_241	[p7l771t3427r896b3465],
12	of	IN	O	of	_	0	SENT_241	[p7l909t3427r945b3456],
13	docetaxel	NN	O	docetaxel	prep_of	11	SENT_241	[p7l955t3427r1121b3456],
14	.	.	O	.	_	0	SENT_241	[p7l955t3427r1121b3456],

1	At	IN	O	at	_	0	SENT_242	[p7l1135t3427r1176b3456],
2	a	DT	O	a	det	3	SENT_242	[p7l1189t3436r1206b3456],
3	dose	NN	O	dose	prep_at	10	SENT_242	[p7l1218t3427r1292b3456],
4	of	IN	O	of	_	0	SENT_242	[p7l1306t3427r1341b3456],
5	100	CD	NUMBER	100	num	6	SENT_242	[p7l1355t3427r1412b3456],
6	mg/m2	NN	O	mg/m2	prep_of	3	SENT_242	[p7l1425t3416r1546b3465],
7	,	,	O	,	_	0	SENT_242	[p7l1425t3416r1546b3465],
8	neutrophil	NN	O	neutrophil	nn	9	SENT_242	[p7l1560t3427r1729b3465],
9	counts	NNS	O	count	nsubj	10	SENT_242	[p7l1742t3432r1848b3456],
10	are	VBP	O	be	_	0	SENT_242	[p7l551t3486r599b3506],
11	usually	RB	O	usually	advmod	10	SENT_242	[p7l615t3477r733b3514],
12	below	IN	O	below	_	0	SENT_242	[p7l749t3477r849b3506],
13	500/ul	NN	O	500/ul	prep_below	10	SENT_242	[p7l867t3477r983b3514],
14	.	.	O	.	_	0	SENT_242	[p7l867t3477r983b3514],

1	The	DT	O	the	det	2	SENT_243	[p7l1001t3477r1064b3506],
2	incidence	NN	O	incidence	nsubj	8	SENT_243	[p7l1080t3477r1237b3506],
3	of	IN	O	of	_	0	SENT_243	[p7l1254t3477r1290b3506],
4	severe	JJ	O	severe	amod	5	SENT_243	[p7l1304t3486r1407b3506],
5	neutropenia	NN	O	neutropenia	prep_of	2	SENT_243	[p7l1423t3477r1619b3515],
6	and	CC	O	and	_	0	SENT_243	[p7l1634t3477r1693b3506],
7	sequalae	NN	O	sequala	prep_of	2	SENT_243	[p7l1709t3477r1849b3515],
8	appear	VBP	O	appear	_	0	SENT_243	[p7l551t3536r660b3565],
9	to	TO	O	to	aux	12	SENT_243	[p7l673t3532r704b3556],
10	be	VB	O	be	cop	12	SENT_243	[p7l719t3527r757b3556],
11	much	RB	O	much	advmod	12	SENT_243	[p7l772t3527r862b3556],
12	less	RBR	O	less	xcomp	8	SENT_243	[p7l877t3527r937b3556],
13	with	IN	O	with	_	0	SENT_243	[p7l953t3527r1025b3556],
14	lower	JJR	O	lower	amod	16	SENT_243	[p7l1040t3527r1133b3556],
15	docetaxel	NN	O	docetaxel	nn	16	SENT_243	[p7l1147t3527r1304b3556],
16	doses	NNS	O	dose	prep_with	12	SENT_243	[p7l1319t3527r1418b3561],
17	,	,	O	,	_	0	SENT_243	[p7l1319t3527r1418b3561],
18	but	CC	O	but	_	0	SENT_243	[p7l1433t3527r1486b3556],
19	only	RB	O	only	advmod	21	SENT_243	[p7l1501t3527r1572b3564],
20	limited	JJ	O	limited	amod	21	SENT_243	[p7l1587t3527r1704b3556],
21	data	NNS	O	datum	nsubj	23	SENT_243	[p7l1718t3527r1786b3556],
22	are	VBP	O	be	cop	23	SENT_243	[p7l1801t3536r1849b3556],
23	available	JJ	O	available	conj_but	8	SENT_243	[p7l551t3577r698b3606],
24	(	NN	O	(	tmod	23	SENT_243	[p7l713t3577r775b3613],
25	27	CD	NUMBER	27	num	24	SENT_243	[p7l713t3577r775b3613],
26	,	,	O	,	_	0	SENT_243	[p7l713t3577r775b3613],
27	33	CD	NUMBER	33	num	28	SENT_243	[p7l791t3577r852b3613],
28	)	NN	O	)	appos	24	SENT_243	[p7l791t3577r852b3613],
29	.	.	O	.	_	0	SENT_243	[p7l791t3577r852b3613],

1	The	DT	O	the	det	2	SENT_244	[p7l868t3577r931b3606],
2	severity	NN	O	severity	nsubj	24	SENT_244	[p7l947t3577r1075b3615],
3	of	IN	O	of	_	0	SENT_244	[p7l1089t3577r1125b3606],
4	neutropenia	NN	O	neutropenia	prep_of	2	SENT_244	[p7l1136t3577r1331b3615],
5	does	VBZ	O	do	aux	7	SENT_244	[p7l1345t3577r1418b3606],
6	not	RB	O	not	neg	7	SENT_244	[p7l1433t3582r1485b3606],
7	seem	VB	O	seem	_	0	SENT_244	[p7l1500t3586r1583b3606],
8	to	TO	O	to	aux	10	SENT_244	[p7l1596t3582r1627b3606],
9	be	VB	O	be	auxpass	10	SENT_244	[p7l1641t3577r1679b3606],
10	related	VBN	O	relate	xcomp	7	SENT_244	[p7l1693t3577r1805b3606],
11	to	TO	O	to	_	0	SENT_244	[p7l1818t3581r1849b3606],
12	schedule	NN	O	schedule	prep_to	10	SENT_244	[p7l551t3627r703b3661],
13	,	,	O	,	_	0	SENT_244	[p7l551t3627r703b3661],
14	but	CC	O	but	_	0	SENT_244	[p7l719t3627r772b3656],
15	there	EX	O	there	expl	24	SENT_244	[p7l786t3627r868b3656],
16	has	VBZ	O	have	aux	24	SENT_244	[p7l883t3627r937b3656],
17	been	VBN	O	be	cop	24	SENT_244	[p7l952t3627r1030b3656],
18	only	RB	O	only	advmod	20	SENT_244	[p7l1046t3627r1117b3664],
19	limited	JJ	O	limited	amod	20	SENT_244	[p7l1133t3627r1250b3656],
20	experience	NN	O	experience	npadvmod	24	SENT_244	[p7l1265t3627r1442b3664],
21	with	IN	O	with	_	0	SENT_244	[p7l1458t3627r1530b3656],
22	infusion	NN	O	infusion	nn	23	SENT_244	[p7l1545t3627r1680b3656],
23	durations	NNS	O	duration	prep_with	20	SENT_244	[p7l1696t3627r1848b3656],
24	greater	JJR	O	greater	conj_but	7	SENT_244	[p7l551t3682r665b3715],
25	than	IN	O	than	mark	35	SENT_244	[p7l672t3677r742b3706],
26	1	CD	NUMBER	1	num	29	SENT_244	[p7l755t3677r767b3706],
27	h.	NN	O	h.	nn	29	SENT_244	[p7l779t3677r807b3706],
28	Significant	JJ	O	significant	amod	29	SENT_244	[p7l819t3677r999b3715],
29	effects	NNS	O	effect	nsubj	35	SENT_244	[p7l1007t3677r1114b3706],
30	on	IN	O	on	_	0	SENT_244	[p7l1124t3686r1164b3706],
31	platelets	NNS	O	platelet	prep_on	29	SENT_244	[p7l1172t3677r1308b3715],
32	and	CC	O	and	_	0	SENT_244	[p7l1318t3677r1376b3706],
33	erythrocytes	NNS	O	erythrocyte	conj_and	31	SENT_244	[p7l1384t3677r1587b3714],
34	are	VBP	O	be	cop	35	SENT_244	[p7l1597t3686r1645b3706],
35	uncommon	JJ	O	uncommon	ccomp	24	SENT_244	[p7l1653t3686r1847b3706],
36	.	.	O	.	_	0	SENT_244	[p7l1653t3686r1847b3706],

1	Annu	NNP	PERSON	Annu	_	0	SENT_245	[p8l310t83r333b164],
2	.	.	O	.	_	0	SENT_245	[p8l310t83r333b164],

1	Rev.	NNP	O	Rev.	_	0	SENT_246	[p8l310t13r333b72],

1	Am	VBP	O	be	cop	2	SENT_247	[p8l310t2353r333b2403],
2	1u	NN	O	1u	_	0	SENT_247	[p8l317t2312r333b2342],
3	.	.	O	.	_	0	SENT_247	[p8l317t2312r333b2342],

1	Rev.	NNP	O	Rev.	nn	2	SENT_248	[p8l310t2227r333b2287],
2	Med	NNP	O	Med	_	0	SENT_248	[p8l310t2149r333b2217],
3	.	.	O	.	_	0	SENT_248	[p8l310t2149r333b2217],

1	l997	NN	O	l997	_	0	SENT_249	[p8l310t1904r334b2135],
2	.48:353	CD	NUMBER	.48:353	number	3	SENT_249	[p8l310t1904r334b2135],
3	-374	CD	NUMBER	-374	num	1	SENT_249	[p8l310t1904r334b2135],
4	.	.	O	.	_	0	SENT_249	[p8l310t1904r334b2135],

1	Downloaded	VBN	O	download	_	0	SENT_250	[p8l310t1724r333b1893],
2	from	IN	O	from	_	0	SENT_250	[p8l310t1650r333b1715],
3	www	NN	O	www	prep_from	1	SENT_250	[p8l310t1422r333b1641],
4	.	.	O	.	_	0	SENT_250	[p8l310t1422r333b1641],

1	annualrevi	NN	O	annualrevus	nn	2	SENT_251	[p8l310t1422r333b1641],
2	ews.org	NN	O	ews.org	_	0	SENT_251	[p8l317t1304r340b1408],
3	ews.org	NN	O	ews.org	dep	2	SENT_251	[p8l316t3545r339b3649],
4	only	RB	O	only	advmod	3	SENT_251	[p8l342t3581r373b3646],
5	.	.	O	.	_	0	SENT_251	[p8l342t3581r373b3646],

1	by	IN	O	by	dep	6	SENT_252	[p8l343t97r374b129],
2	Unive	JJ	PERSON	unive	amod	4	SENT_252	[p8l343t7r367b88],
3	b	NN	O	b	nn	4	SENT_252	[p8l343t2353r367b2369],
4	y	NN	O	y	pobj	1	SENT_252	[p8l351t2325r374b2341],
5	I	PRP	O	I	dep	6	SENT_252	[p8l344t2301r367b2316],
6	lniversity	NN	O	lniversity	_	0	SENT_252	[p8l343t2162r374b2287],
7	of	IN	O	of	_	0	SENT_252	[p8l343t2123r367b2152],
8	Wisconsin	NNP	LOCATION	Wisconsin	prep_of	6	SENT_252	[p8l343t1977r367b2116],
9	-	:	O	-	_	0	SENT_252	[p8l357t1958r360b1967],
10	Madison	NNP	O	Madison	dep	6	SENT_252	[p8l343t1832r367b1948],
11	on	IN	O	on	dep	10	SENT_252	[p8l351t1790r367b1823],
12	01/05/14	CD	DATE	01/05/14	pobj	11	SENT_252	[p8l343t1657r367b1781],
13	.	.	O	.	_	0	SENT_252	[p8l343t1657r367b1781],

1	For	IN	O	for	_	0	SENT_253	[p8l344t1600r367b1647],
2	personal	JJ	O	personal	amod	3	SENT_253	[p8l343t1480r374b1592],
3	use	NN	O	use	pobj	1	SENT_253	[p8l351t1427r367b1471],
4	only	RB	O	only	advmod	3	SENT_253	[p8l343t1340r374b1405],
5	.	.	O	.	_	0	SENT_253	[p8l343t1340r374b1405],

1	Hypersensitivity	NN	O	hypersensitivity	dep	6	SENT_254	[p8l549t14r818b50],
2	Although	IN	O	although	dep	6	SENT_254	[p8l857t13r1013b51],
3	docetaxel	NN	O	docetaxel	nsubjpass	6	SENT_254	[p8l1021t13r1178b42],
4	is	VBZ	O	be	auxpass	6	SENT_254	[p8l1186t13r1211b42],
5	not	RB	O	not	neg	6	SENT_254	[p8l1220t17r1273b42],
6	formulated	VBN	O	formulate	advcl	14	SENT_254	[p8l1280t13r1461b42],
7	in	IN	O	in	_	0	SENT_254	[p8l1468t13r1499b42],
8	Cremophor	NNP	LOCATION	Cremophor	nn	9	SENT_254	[p8l1507t13r1695b51],
9	EL	NNP	LOCATION	EL	prep_in	6	SENT_254	[p8l1702t14r1760b47],
10	,	,	O	,	_	0	SENT_254	[p8l1702t14r1760b47],
11	HSR	NNP	O	HSR	nsubjpass	14	SENT_254	[p8l1769t13r1849b42],
12	have	VBP	O	have	aux	14	SENT_254	[p8l550t63r627b92],
13	been	VBN	O	be	auxpass	14	SENT_254	[p8l639t63r716b92],
14	reported	VBN	O	report	_	0	SENT_254	[p8l728t63r866b101],
15	in	IN	O	in	_	0	SENT_254	[p8l877t63r909b92],
16	as	RB	O	as	quantmod	19	SENT_254	[p8l922t72r953b92],
17	many	JJ	O	many	quantmod	19	SENT_254	[p8l967t72r1057b101],
18	as	IN	O	as	quantmod	19	SENT_254	[p8l1071t72r1102b92],
19	33	CD	PERCENT	33	num	20	SENT_254	[p8l1117t63r1189b92],
20	%	NN	PERCENT	%	prep_in	14	SENT_254	[p8l1117t63r1189b92],
21	of	IN	O	of	_	0	SENT_254	[p8l1203t63r1239b92],
22	patients	NNS	O	patient	prep_of	20	SENT_254	[p8l1248t63r1376b101],
23	receiving	VBG	O	receive	xcomp	14	SENT_254	[p8l1388t63r1542b101],
24	docetaxel	NN	O	docetaxel	dobj	23	SENT_254	[p8l1554t63r1711b92],
25	without	IN	O	without	_	0	SENT_254	[p8l1724t63r1849b92],
26	premedication	NN	O	premedication	prep_without	23	SENT_254	[p8l550t113r786b151],
27	(	CD	NUMBER	(	number	28	SENT_254	[p8l799t113r861b149],
28	27	CD	NUMBER	27	dep	26	SENT_254	[p8l799t113r861b149],
29	,	,	O	,	_	0	SENT_254	[p8l799t113r861b149],
30	33	CD	NUMBER	33	appos	26	SENT_254	[p8l876t113r924b147],
31	,	,	O	,	_	0	SENT_254	[p8l876t113r924b147],
32	48	CD	NUMBER	48	num	33	SENT_254	[p8l937t113r1000b149],
33	)	NN	O	)	appos	30	SENT_254	[p8l937t113r1000b149],
34	.	.	O	.	_	0	SENT_254	[p8l937t113r1000b149],

1	Like	IN	O	like	_	0	SENT_255	[p8l1014t113r1089b142],
2	paclitaxel	NN	O	paclitaxel	prep_like	7	SENT_255	[p8l1101t113r1270b151],
3	,	,	O	,	_	0	SENT_255	[p8l1101t113r1270b151],
4	major	JJ	O	major	amod	5	SENT_255	[p8l1283t113r1380b151],
5	HSR	NN	O	hsr	nsubj	20	SENT_255	[p8l1391t113r1471b142],
6	typically	RB	O	typically	advmod	7	SENT_255	[p8l1483t113r1627b151],
7	occur	VBP	O	occur	conj_and	7	SENT_255	[p8l1640t122r1731b142],
8	during	IN	O	during	_	0	SENT_255	[p8l1742t113r1848b151],
9	the	DT	O	the	det	12	SENT_255	[p8l550t163r599b192],
10	first	JJ	ORDINAL	first	amod	12	SENT_255	[p8l613t163r679b192],
11	two	CD	NUMBER	two	num	12	SENT_255	[p8l692t168r752b192],
12	courses	NNS	O	course	prep_during	7	SENT_255	[p8l767t173r889b192],
13	and	CC	O	and	_	0	SENT_255	[p8l904t163r962b192],
14	within	IN	O	within	_	0	SENT_255	[p8l975t163r1080b192],
15	minutes	NNS	DURATION	minute	prep_within	7	SENT_255	[p8l1093t163r1222b192],
16	after	IN	O	after	_	0	SENT_255	[p8l1237t163r1312b192],
17	treatment	NN	O	treatment	prep_after	15	SENT_255	[p8l1324t168r1480b192],
18	and	CC	O	and	_	0	SENT_255	[p8l1493t163r1551b192],
19	generally	RB	O	generally	advmod	7	SENT_255	[p8l1565t163r1717b201],
20	resolve	VB	O	resolve	conj_and	7	SENT_255	[p8l1730t163r1849b192],
21	within	IN	O	within	_	0	SENT_255	[p8l550t213r655b242],
22	15	CD	DURATION	15	num	23	SENT_255	[p8l670t213r705b243],
23	min	NN	DURATION	min	prep_within	20	SENT_255	[p8l718t213r782b242],
24	after	IN	O	after	_	0	SENT_255	[p8l794t213r868b242],
25	cessation	NN	O	cessation	prep_after	20	SENT_255	[p8l878t213r1028b242],
26	of	IN	O	of	_	0	SENT_255	[p8l1039t213r1075b242],
27	treatment	NN	O	treatment	prep_of	25	SENT_255	[p8l1083t217r1246b242],
28	.	.	O	.	_	0	SENT_255	[p8l1083t217r1246b242],

1	Most	JJS	O	most	amod	2	SENT_256	[p8l1260t214r1345b242],
2	HSR	NN	O	hsr	nsubj	7	SENT_256	[p8l1356t213r1444b248],
3	,	,	O	,	_	0	SENT_256	[p8l1356t213r1444b248],
4	though	RB	O	though	advmod	7	SENT_256	[p8l1455t213r1578b251],
5	,	,	O	,	_	0	SENT_256	[p8l1455t213r1578b251],
6	are	VBP	O	be	cop	7	SENT_256	[p8l1591t222r1639b242],
7	minor	JJ	O	minor	_	0	SENT_256	[p8l1650t213r1756b242],
8	.	.	O	.	_	0	SENT_256	[p8l1650t213r1756b242],

1	Both	CC	O	both	preconj	3	SENT_257	[p8l1770t213r1850b242],
2	the	DT	O	the	det	3	SENT_257	[p8l550t263r599b292],
3	incidence	NN	O	incidence	nsubj	8	SENT_257	[p8l611t263r768b292],
4	and	CC	O	and	_	0	SENT_257	[p8l780t263r838b292],
5	severity	NN	O	severity	conj_and	3	SENT_257	[p8l851t263r979b301],
6	of	IN	O	of	_	0	SENT_257	[p8l991t263r1027b292],
7	HSR	NN	O	hsr	prep_of	3	SENT_257	[p8l1035t263r1115b292],
8	appear	VBP	O	appear	_	0	SENT_257	[p8l1127t272r1236b301],
9	to	TO	O	to	aux	11	SENT_257	[p8l1246t267r1277b292],
10	be	VB	O	be	auxpass	11	SENT_257	[p8l1288t263r1326b292],
11	reduced	VBN	O	reduce	xcomp	8	SENT_257	[p8l1337t263r1468b292],
12	by	IN	O	by	_	0	SENT_257	[p8l1478t263r1518b301],
13	following	VBG	O	follow	amod	14	SENT_257	[p8l1530t263r1689b301],
14	premedication	NN	O	premedication	agent	11	SENT_257	[p8l1700t263r1848b301, p8l550t313r650b342],
15	with	IN	O	with	_	0	SENT_257	[p8l662t313r734b342],
16	corticosteroids	NNS	O	corticosteroid	prep_with	14	SENT_257	[p8l746t313r987b342],
17	and	CC	O	and	_	0	SENT_257	[p8l1000t313r1058b342],
18	H1	NN	O	h1	conj_and	16	SENT_257	[p8l1069t314r1128b346],
19	-	:	O	-	_	0	SENT_257	[p8l1069t314r1128b346],
20	and	CC	O	and	_	0	SENT_257	[p8l1141t313r1199b342],
21	H2	NN	O	h2	agent	11	SENT_257	[p8l1210t313r1430b346],
22	—	CD	NUMBER	—	num	24	SENT_257	[p8l1210t313r1430b346],
23	histamine	NN	O	histamine	nn	24	SENT_257	[p8l1210t313r1430b346],
24	antagonists	NNS	O	antagonist	dep	21	SENT_257	[p8l1442t313r1635b351],
25	.	.	O	.	_	0	SENT_257	[p8l1442t313r1635b351],

1	Fluid	NN	O	fluid	nn	3	SENT_258	[p8l550t426r641b456],
2	retention	NN	O	retention	nn	3	SENT_258	[p8l655t427r802b456],
3	A	NN	O	a	nsubj	27	SENT_258	[p8l841t426r870b455],
4	unique	JJ	O	unique	amod	7	SENT_258	[p8l885t426r997b464],
5	ﬂuid	NN	O	ﬂuid	nn	7	SENT_258	[p8l1013t426r1090b456],
6	retention	NN	O	retention	nn	7	SENT_258	[p8l1104t426r1251b456],
7	syndrome	NN	O	syndrome	nsubj	18	SENT_258	[p8l1267t426r1437b464],
8	,	,	O	,	_	0	SENT_258	[p8l1267t426r1437b464],
9	characterized	VBN	O	characterize	partmod	7	SENT_258	[p8l1454t426r1673b456],
10	by	IN	O	by	_	0	SENT_258	[p8l1687t426r1727b464],
11	edema	NN	O	edema	nn	17	SENT_258	[p8l1743t426r1850b456],
12	and	CC	O	and	_	0	SENT_258	[p8l551t476r609b506],
13	third	JJ	ORDINAL	third	nn	17	SENT_258	[p8l618t476r801b514],
14	—	NN	O	—	nn	17	SENT_258	[p8l618t476r801b514],
15	space	NN	O	space	nn	17	SENT_258	[p8l618t476r801b514],
16	ﬂuid	JJ	O	ﬂuid	amod	17	SENT_258	[p8l809t476r887b506],
17	collections	NNS	O	collection	agent	9	SENT_258	[p8l896t476r1073b506],
18	(	VBP	O	(	rcmod	3	SENT_258	[p8l1084t477r1153b514],
19	e.g.	FW	O	e.g.	nsubj	21	SENT_258	[p8l1084t477r1153b514],
20	pleural	JJ	O	pleural	amod	21	SENT_258	[p8l1163t476r1277b514],
21	effusions	NNS	O	effusion	xcomp	18	SENT_258	[p8l1286t476r1445b511],
22	,	,	O	,	_	0	SENT_258	[p8l1286t476r1445b511],
23	ascites	NNS	O	ascite	nsubj	24	SENT_258	[p8l1457t476r1588b512],
24	)	VBP	O	)	parataxis	18	SENT_258	[p8l1457t476r1588b512],
25	,	,	O	,	_	0	SENT_258	[p8l1457t476r1588b512],
26	may	MD	O	may	aux	27	SENT_258	[p8l1598t485r1668b514],
27	occur	VB	O	occur	_	0	SENT_258	[p8l1678t485r1769b506],
28	with	IN	O	with	_	0	SENT_258	[p8l1777t476r1849b506],
29	docetaxel	NN	O	docetaxel	prep_with	27	SENT_258	[p8l551t526r716b556],
30	.	.	O	.	_	0	SENT_258	[p8l551t526r716b556],

1	It	PRP	O	it	nsubj	4	SENT_259	[p8l729t527r754b556],
2	is	VBZ	O	be	cop	4	SENT_259	[p8l764t526r789b556],
3	most	RBS	O	most	advmod	4	SENT_259	[p8l802t531r882b556],
4	likely	JJ	O	likely	_	0	SENT_259	[p8l892t526r985b564],
5	due	JJ	O	due	_	0	SENT_259	[p8l998t526r1056b556],
6	to	TO	O	to	_	0	SENT_259	[p8l1067t531r1098b556],
7	increased	VBN	O	increase	amod	10	SENT_259	[p8l1108t526r1264b556],
8	capillary	JJ	O	capillary	amod	10	SENT_259	[p8l1275t526r1419b564],
9	permeability	NN	O	permeability	nn	10	SENT_259	[p8l1430t526r1638b564],
10	(	NN	O	(	prep_due_to	4	SENT_259	[p8l1651t526r1713b562],
11	27	CD	NUMBER	27	amod	10	SENT_259	[p8l1651t526r1713b562],
12	,	,	O	,	_	0	SENT_259	[p8l1651t526r1713b562],
13	33	CD	NUMBER	33	appos	10	SENT_259	[p8l1724t526r1772b561],
14	,	,	O	,	_	0	SENT_259	[p8l1724t526r1772b561],
15	48	CD	NUMBER	48	num	16	SENT_259	[p8l1784t526r1847b562],
16	)	NN	O	)	appos	13	SENT_259	[p8l1784t526r1847b562],
17	.	.	O	.	_	0	SENT_259	[p8l1784t526r1847b562],

1	In	IN	O	in	_	0	SENT_260	[p8l550t577r584b605],
2	early	JJ	O	early	amod	3	SENT_260	[p8l596t576r677b614],
3	studies	NNS	O	study	prep_in	21	SENT_260	[p8l689t576r801b605],
4	in	IN	O	in	_	0	SENT_260	[p8l814t576r845b605],
5	which	WDT	O	which	rel	10	SENT_260	[p8l857t576r957b605],
6	prophylactic	NN	O	prophylactic	nn	7	SENT_260	[p8l968t576r1174b614],
7	medication	NN	O	medication	nsubjpass	10	SENT_260	[p8l1185t576r1369b605],
8	was	VBD	O	be	auxpass	10	SENT_260	[p8l1380t585r1442b605],
9	not	RB	O	not	neg	10	SENT_260	[p8l1455t581r1507b605],
10	used	VBN	O	use	rcmod	3	SENT_260	[p8l1518t576r1602b610],
11	,	,	O	,	_	0	SENT_260	[p8l1518t576r1602b610],
12	ﬂuid	JJ	O	ﬂuid	amod	13	SENT_260	[p8l1615t576r1692b605],
13	retention	NN	O	retention	nsubj	21	SENT_260	[p8l1703t576r1849b605],
14	was	VBD	O	be	cop	21	SENT_260	[p8l550t635r612b655],
15	rarely	RB	O	rarely	advmod	16	SENT_260	[p8l633t626r729b664],
16	significant	JJ	O	significant	amod	21	SENT_260	[p8l750t626r923b664],
17	at	IN	O	at	_	0	SENT_260	[p8l943t631r972b655],
18	cumulative	JJ	O	cumulative	amod	20	SENT_260	[p8l991t626r1174b655],
19	docetaxel	NN	O	docetaxel	nn	20	SENT_260	[p8l1194t626r1351b655],
20	doses	NNS	O	dose	prep_at	16	SENT_260	[p8l1371t626r1460b655],
21	<	JJR	O	<	dep	31	SENT_260	[p8l1482t626r1565b655],
22	400	CD	NUMBER	400	num	23	SENT_260	[p8l1482t626r1565b655],
23	mg/m2	NN	O	mg/m2	dep	21	SENT_260	[p8l1585t612r1707b664],
24	,	,	O	,	_	0	SENT_260	[p8l1585t612r1707b664],
25	but	CC	O	but	_	0	SENT_260	[p8l1727t626r1780b655],
26	the	DT	O	the	det	27	SENT_260	[p8l1800t626r1849b655],
27	incidence	NN	O	incidence	dep	31	SENT_260	[p8l550t677r708b706],
28	of	IN	O	of	_	0	SENT_260	[p8l717t677r753b706],
29	severe	JJ	O	severe	amod	30	SENT_260	[p8l761t686r864b706],
30	toxicity	NN	O	toxicity	prep_of	27	SENT_260	[p8l873t677r998b714],
31	increased	VBD	O	increase	_	0	SENT_260	[p8l1008t677r1163b706],
32	sharply	RB	O	sharply	advmod	31	SENT_260	[p8l1173t677r1292b714],
33	at	IN	O	at	_	0	SENT_260	[p8l1303t681r1332b706],
34	cumulative	JJ	O	cumulative	amod	35	SENT_260	[p8l1341t677r1523b706],
35	doses	NNS	O	dose	dep	36	SENT_260	[p8l1533t677r1622b706],
36	>	JJR	O	>	prep_at	31	SENT_260	[p8l1633t677r1717b706],
37	400	CD	NUMBER	400	num	38	SENT_260	[p8l1633t677r1717b706],
38	mg/m2	NN	O	mg/m2	tmod	36	SENT_260	[p8l1726t662r1848b714],
39	,	,	O	,	_	0	SENT_260	[p8l1726t662r1848b714],
40	THE	DT	O	the	det	42	SENT_260	[p8l1492t733r1564b759],
41	TAXAN	NNP	O	TAXAN	nn	42	SENT_260	[p8l1573t733r1704b759],
42	ES	NN	O	e	appos	38	SENT_260	[p8l1705t733r1746b759],
43	363	CD	NUMBER	363	nsubj	31	SENT_260	[p8l1795t733r1847b759],

1	often	RB	O	often	advmod	2	SENT_261	[p8l551t817r634b847],
2	resulting	VBG	O	result	_	0	SENT_261	[p8l646t817r790b855],
3	in	IN	O	in	_	0	SENT_261	[p8l802t817r834b846],
4	treatment	NN	O	treatment	nn	5	SENT_261	[p8l846t822r1002b847],
5	delay	NN	O	delay	prep_in	2	SENT_261	[p8l1014t817r1102b855],
6	or	CC	O	or	_	0	SENT_261	[p8l1115t826r1148b847],
7	termination	NN	O	termination	prep_in	2	SENT_261	[p8l1160t817r1358b847],
8	.	.	O	.	_	0	SENT_261	[p8l1160t817r1358b847],

1	However	RB	O	however	advmod	17	SENT_262	[p8l1372t818r1532b852],
2	,	,	O	,	_	0	SENT_262	[p8l1372t818r1532b852],
3	prophylactic	NN	O	prophylactic	nn	4	SENT_262	[p8l1545t817r1750b855],
4	treatment	NN	O	treatment	nsubj	17	SENT_262	[p8l1763t822r1848b847, p8l550t872r632b897],
5	with	IN	O	with	_	0	SENT_262	[p8l648t867r721b897],
6	corticosteroids	NNS	O	corticosteroid	prep_with	4	SENT_262	[p8l737t867r979b897],
7	with	IN	O	with	_	0	SENT_262	[p8l996t867r1069b897],
8	or	CC	O	or	_	0	SENT_262	[p8l1086t876r1119b897],
9	without	IN	O	without	_	0	SENT_262	[p8l1135t867r1261b897],
10	H1	NN	O	h1	nn	11	SENT_262	[p8l1277t868r1335b900],
11	—	NN	O	—	prep_without	6	SENT_262	[p8l1277t868r1335b900],
12	and	CC	O	and	_	0	SENT_262	[p8l1353t867r1411b897],
13	H2	NN	O	h2	nn	16	SENT_262	[p8l1427t867r1647b900],
14	—	CD	NUMBER	—	num	16	SENT_262	[p8l1427t867r1647b900],
15	histamine	NN	O	histamine	nn	16	SENT_262	[p8l1427t867r1647b900],
16	antagonists	NNS	O	antagonist	prep_with	6	SENT_262	[p8l1664t867r1848b905],
17	appears	VBZ	O	appear	_	0	SENT_262	[p8l551t926r675b955],
18	to	TO	O	to	aux	20	SENT_262	[p8l687t922r718b947],
19	significantly	RB	O	significantly	advmod	20	SENT_262	[p8l732t917r937b955],
20	reduce	VB	O	reduce	xcomp	17	SENT_262	[p8l948t917r1058b947],
21	the	DT	O	the	det	22	SENT_262	[p8l1070t917r1119b947],
22	incidence	NN	O	incidence	dobj	20	SENT_262	[p8l1131t917r1288b947],
23	of	IN	O	of	_	0	SENT_262	[p8l1301t917r1337b947],
24	severe	JJ	O	severe	amod	25	SENT_262	[p8l1347t926r1450b947],
25	effects	NNS	O	effect	prep_of	22	SENT_262	[p8l1463t917r1571b947],
26	and	CC	O	and	_	0	SENT_262	[p8l1584t917r1642b947],
27	increase	VB	O	increase	conj_and	20	SENT_262	[p8l1654t917r1788b947],
28	the	DT	O	the	det	29	SENT_262	[p8l1800t917r1849b947],
29	number	NN	O	number	dobj	27	SENT_262	[p8l550t967r676b997],
30	of	IN	O	of	_	0	SENT_262	[p8l694t967r730b997],
31	courses	NNS	O	course	prep_of	29	SENT_262	[p8l746t976r868b997],
32	before	IN	O	before	mark	39	SENT_262	[p8l886t967r991b997],
33	the	DT	O	the	det	34	SENT_262	[p8l1010t967r1059b997],
34	onset	NN	O	onset	nsubj	39	SENT_262	[p8l1077t972r1164b997],
35	of	IN	O	of	_	0	SENT_262	[p8l1182t967r1218b997],
36	this	DT	O	this	det	38	SENT_262	[p8l1233t967r1291b997],
37	toxicity	NN	O	toxicity	nn	38	SENT_262	[p8l1310t967r1435b1005],
38	(	NN	O	(	prep_of	34	SENT_262	[p8l1455t968r1519b1003],
39	see	VBP	O	see	advcl	27	SENT_262	[p8l1455t968r1519b1003],
40	above	IN	O	above	_	0	SENT_262	[p8l1538t967r1647b1003],
41	)	CD	NUMBER	)	number	42	SENT_262	[p8l1538t967r1647b1003],
42	(	CD	NUMBER	(	prep_above	39	SENT_262	[p8l1668t967r1742b1003],
43	48	CD	NUMBER	48	num	44	SENT_262	[p8l1668t967r1742b1003],
44	)	NN	O	)	dobj	20	SENT_262	[p8l1668t967r1742b1003],
45	.	.	O	.	_	0	SENT_262	[p8l1668t967r1742b1003],

1	Fluid	NN	O	fluid	nn	2	SENT_263	[p8l1762t967r1849b997],
2	retention	NN	O	retention	nsubj	4	SENT_263	[p8l550t1017r696b1047],
3	generally	RB	O	generally	advmod	4	SENT_263	[p8l706t1017r858b1055],
4	resolves	VBZ	O	resolve	_	0	SENT_263	[p8l867t1017r1001b1047],
5	slowly	RB	O	slowly	advmod	4	SENT_263	[p8l1013t1017r1120b1055],
6	after	IN	O	after	mark	9	SENT_263	[p8l1131t1017r1206b1047],
7	docetaxel	NN	O	docetaxel	nsubjpass	9	SENT_263	[p8l1214t1017r1372b1047],
8	is	VBZ	O	be	auxpass	9	SENT_263	[p8l1380t1017r1406b1047],
9	stopped	VBN	O	stop	advcl	4	SENT_263	[p8l1418t1017r1552b1055],
10	.	.	O	.	_	0	SENT_263	[p8l1418t1017r1552b1055],

1	Early	RB	O	early	advmod	2	SENT_264	[p8l1564t1017r1652b1055],
2	recognition	NN	O	recognition	nsubjpass	11	SENT_264	[p8l1661t1017r1849b1055],
3	and	CC	O	and	_	0	SENT_264	[p8l551t1067r609b1096],
4	treatment	NN	O	treatment	nsubjpass	11	SENT_264	[p8l623t1071r779b1096],
5	with	IN	O	with	_	0	SENT_264	[p8l792t1067r865b1096],
6	potent	JJ	O	potent	amod	7	SENT_264	[p8l879t1071r982b1105],
7	diuretics	NNS	O	diuretic	prep_with	2	SENT_264	[p8l996t1067r1136b1096],
8	is	VBZ	O	be	aux	11	SENT_264	[p8l1152t1067r1177b1096],
9	increasingly	RB	O	increasingly	advmod	11	SENT_264	[p8l1193t1067r1394b1105],
10	being	VBG	O	be	auxpass	11	SENT_264	[p8l1408t1067r1499b1105],
11	used	VBN	O	use	_	0	SENT_264	[p8l1513t1067r1589b1096],
12	successfully	RB	O	successfully	advmod	11	SENT_264	[p8l1604t1067r1803b1105],
13	to	TO	O	to	aux	14	SENT_264	[p8l1818t1071r1849b1096],
14	manage	VB	O	manage	xcomp	11	SENT_264	[p8l550t1126r678b1155],
15	ﬂuid	JJ	O	ﬂuid	amod	16	SENT_264	[p8l685t1117r763b1146],
16	retention	NN	O	retention	dobj	14	SENT_264	[p8l770t1117r925b1146],
17	.	.	O	.	_	0	SENT_264	[p8l770t1117r925b1146],

1	The	DT	O	the	det	2	SENT_265	[p8l934t1117r997b1146],
2	incidence	NN	O	incidence	nsubjpass	8	SENT_265	[p8l1006t1117r1163b1146],
3	of	IN	O	of	_	0	SENT_265	[p8l1171t1117r1207b1146],
4	ﬂuid	JJ	O	ﬂuid	amod	5	SENT_265	[p8l1212t1117r1290b1146],
5	retention	NN	O	retention	prep_of	2	SENT_265	[p8l1297t1117r1443b1146],
6	may	MD	O	may	aux	8	SENT_265	[p8l1451t1126r1520b1155],
7	be	VB	O	be	auxpass	8	SENT_265	[p8l1528t1117r1566b1146],
8	reduced	VBN	O	reduce	dep	14	SENT_265	[p8l1574t1117r1705b1146],
9	by	IN	O	by	_	0	SENT_265	[p8l1711t1117r1752b1155],
10	using	VBG	O	use	agent	8	SENT_265	[p8l1760t1117r1848b1155],
11	lower	JJR	O	lower	amod	13	SENT_265	[p8l550t1167r644b1197],
12	single	JJ	O	single	amod	13	SENT_265	[p8l657t1167r754b1205],
13	doses	NNS	O	dose	dobj	10	SENT_265	[p8l767t1167r857b1197],
14	(	VBP	O	(	_	0	SENT_265	[p8l872t1167r985b1203],
15	60-75	CD	NUMBER	60-75	num	17	SENT_265	[p8l872t1167r985b1203],
16	mg/m2	JJ	O	mg/m2	amod	17	SENT_265	[p8l1000t1153r1134b1205],
17	)	NN	O	)	nsubj	14	SENT_265	[p8l1000t1153r1134b1205],
18	.	.	O	.	_	0	SENT_265	[p8l1000t1153r1134b1205],

1	Overall	RB	O	overall	advmod	6	SENT_266	[p8l1149t1167r1280b1202],
2	,	,	O	,	_	0	SENT_266	[p8l1149t1167r1280b1202],
3	these	DT	O	these	det	4	SENT_266	[p8l1294t1167r1378b1197],
4	measures	NNS	O	measure	nsubj	6	SENT_266	[p8l1390t1176r1542b1197],
5	have	VBP	O	have	aux	6	SENT_266	[p8l1556t1167r1633b1197],
6	resulted	VBN	O	result	_	0	SENT_266	[p8l1645t1167r1776b1197],
7	in	IN	O	in	_	0	SENT_266	[p8l1788t1167r1819b1196],
8	a	DT	O	a	det	10	SENT_266	[p8l1833t1177r1850b1197],
9	substantial	JJ	O	substantial	amod	10	SENT_266	[p8l552t1217r726b1247],
10	increase	NN	O	increase	prep_in	6	SENT_266	[p8l738t1217r872b1247],
11	in	IN	O	in	_	0	SENT_266	[p8l884t1217r915b1246],
12	the	DT	O	the	det	13	SENT_266	[p8l926t1217r976b1247],
13	ability	NN	O	ability	prep_in	10	SENT_266	[p8l987t1217r1091b1255],
14	to	TO	O	to	aux	15	SENT_266	[p8l1103t1222r1133b1247],
15	use	VB	O	use	xcomp	6	SENT_266	[p8l1145t1226r1199b1247],
16	docetaxel	NN	O	docetaxel	dobj	15	SENT_266	[p8l1211t1217r1368b1247],
17	as	IN	O	as	_	0	SENT_266	[p8l1380t1226r1412b1247],
18	part	NN	O	part	prep_as	15	SENT_266	[p8l1424t1222r1488b1255],
19	of	IN	O	of	_	0	SENT_266	[p8l1499t1217r1534b1247],
20	general	JJ	O	general	amod	21	SENT_266	[p8l1544t1217r1664b1255],
21	practice	NN	O	practice	prep_of	18	SENT_266	[p8l1675t1217r1813b1255],
22	.	.	O	.	_	0	SENT_266	[p8l1675t1217r1813b1255],

1	Miscellaneous	JJ	O	miscellaneous	amod	3	SENT_267	[p8l549t1310r788b1340],
2	Skin	NN	O	skin	nn	3	SENT_267	[p8l829t1310r903b1340],
3	toxicity	NN	O	toxicity	nsubj	5	SENT_267	[p8l918t1310r1043b1348],
4	may	MD	O	may	aux	5	SENT_267	[p8l1059t1319r1129b1348],
5	occur	VB	O	occur	_	0	SENT_267	[p8l1144t1319r1236b1340],
6	in	IN	O	in	_	0	SENT_267	[p8l1249t1310r1281b1339],
7	50-75	CD	PERCENT	50-75	num	8	SENT_267	[p8l1297t1310r1431b1340],
8	%	NN	PERCENT	%	prep_in	5	SENT_267	[p8l1297t1310r1431b1340],
9	of	IN	O	of	_	0	SENT_267	[p8l1449t1310r1484b1340],
10	patients	NNS	O	patient	prep_of	8	SENT_267	[p8l1496t1310r1623b1348],
11	(	IN	O	(	_	0	SENT_267	[p8l1641t1310r1702b1346],
12	27	CD	NUMBER	27	prep_(	5	SENT_267	[p8l1641t1310r1702b1346],
13	,	,	O	,	_	0	SENT_267	[p8l1641t1310r1702b1346],
14	33	CD	NUMBER	33	appos	12	SENT_267	[p8l1720t1310r1768b1345],
15	,	,	O	,	_	0	SENT_267	[p8l1720t1310r1768b1345],
16	48	CD	NUMBER	48	num	17	SENT_267	[p8l1784t1310r1847b1346],
17	)	NN	O	)	appos	14	SENT_267	[p8l1784t1310r1847b1346],
18	.	.	O	.	_	0	SENT_267	[p8l1784t1310r1847b1346],

1	However	RB	O	however	advmod	5	SENT_268	[p8l550t1361r710b1395],
2	,	,	O	,	_	0	SENT_268	[p8l550t1361r710b1395],
3	premedication	NN	O	premedication	nsubj	5	SENT_268	[p8l729t1361r965b1399],
4	may	MD	O	may	aux	5	SENT_268	[p8l982t1370r1052b1399],
5	reduce	VB	O	reduce	_	0	SENT_268	[p8l1070t1361r1179b1390],
6	the	DT	O	the	det	8	SENT_268	[p8l1197t1361r1246b1390],
7	overall	JJ	O	overall	amod	8	SENT_268	[p8l1265t1361r1378b1390],
8	incidence	NN	O	incidence	dobj	5	SENT_268	[p8l1396t1361r1561b1390],
9	.	.	O	.	_	0	SENT_268	[p8l1396t1361r1561b1390],

1	A	DT	O	a	det	5	SENT_269	[p8l1581t1361r1609b1390],
2	erythematous	JJ	O	erythematous	amod	5	SENT_269	[p8l1627t1361r1848b1399],
3	pruritic	JJ	O	pruritic	amod	5	SENT_269	[p8l550t1424r670b1461],
4	maculopapular	JJ	O	maculopapular	amod	5	SENT_269	[p8l680t1424r926b1461],
5	rash	NN	O	rash	nsubj	13	SENT_269	[p8l934t1424r1003b1453],
6	that	WDT	O	that	nsubj	7	SENT_269	[p8l1012t1424r1074b1453],
7	affects	VBZ	O	affect	rcmod	5	SENT_269	[p8l1084t1424r1191b1453],
8	the	DT	O	the	det	9	SENT_269	[p8l1201t1424r1251b1453],
9	forearms	NNS	O	forearm	dobj	7	SENT_269	[p8l1260t1424r1405b1453],
10	and	CC	O	and	_	0	SENT_269	[p8l1417t1424r1474b1453],
11	hands	NNS	O	hand	dobj	7	SENT_269	[p8l1483t1424r1578b1453],
12	is	VBZ	O	be	cop	13	SENT_269	[p8l1589t1424r1614b1453],
13	typical	JJ	O	typical	_	0	SENT_269	[p8l1625t1424r1745b1461],
14	.	.	O	.	_	0	SENT_269	[p8l1625t1424r1745b1461],

1	Other	JJ	O	other	amod	3	SENT_270	[p8l1757t1424r1850b1453],
2	cutaneous	JJ	O	cutaneous	amod	3	SENT_270	[p8l551t1478r714b1502],
3	effects	NNS	O	effect	nsubj	4	SENT_270	[p8l729t1473r837b1502],
4	include	VBP	O	include	_	0	SENT_270	[p8l852t1473r972b1502],
5	desquarnation	NN	O	desquarnation	dobj	4	SENT_270	[p8l987t1473r1215b1511],
6	of	IN	O	of	_	0	SENT_270	[p8l1230t1473r1266b1502],
7	the	DT	O	the	det	8	SENT_270	[p8l1277t1473r1326b1502],
8	hands	NNS	O	hand	prep_of	5	SENT_270	[p8l1340t1473r1435b1502],
9	and	CC	O	and	_	0	SENT_270	[p8l1450t1473r1509b1502],
10	feet	NNS	O	foot	prep_of	5	SENT_270	[p8l1522t1473r1592b1508],
11	,	,	O	,	_	0	SENT_270	[p8l1522t1473r1592b1508],
12	palmar	JJ	O	palmar	amod	15	SENT_270	[p8l1606t1473r1850b1511],
13	—	CD	NUMBER	—	tmod	12	SENT_270	[p8l1606t1473r1850b1511],
14	plantar	JJ	O	plantar	amod	15	SENT_270	[p8l1606t1473r1850b1511],
15	erythrodysthesia	NN	O	erythrodysthesium	conj_and	5	SENT_270	[p8l551t1523r823b1561],
16	that	WDT	O	that	nsubj	18	SENT_270	[p8l835t1523r897b1552],
17	may	MD	O	may	aux	18	SENT_270	[p8l909t1532r979b1561],
18	respond	VB	O	respond	rcmod	15	SENT_270	[p8l991t1523r1122b1561],
19	to	TO	O	to	_	0	SENT_270	[p8l1134t1528r1165b1552],
20	pyridoxine	NN	O	pyridoxine	prep_to	18	SENT_270	[p8l1178t1523r1356b1561],
21	or	CC	O	or	_	0	SENT_270	[p8l1369t1532r1403b1552],
22	cooling	NN	O	cooling	prep_to	18	SENT_270	[p8l1415t1523r1547b1561],
23	,	,	O	,	_	0	SENT_270	[p8l1415t1523r1547b1561],
24	and	CC	O	and	_	0	SENT_270	[p8l1561t1523r1619b1552],
25	onchodystro	NN	O	onchodystro	nn	27	SENT_270	[p8l1632t1523r1848b1561],
26	—	NN	O	—	nn	27	SENT_270	[p8l1632t1523r1848b1561],
27	phy	NN	O	phy	dobj	4	SENT_270	[p8l550t1573r611b1611],
28	characterized	VBN	O	characterize	partmod	27	SENT_270	[p8l627t1573r847b1602],
29	by	IN	O	by	_	0	SENT_270	[p8l860t1573r901b1611],
30	brown	JJ	O	brown	amod	31	SENT_270	[p8l916t1573r1022b1602],
31	discoloration	NN	O	discoloration	agent	28	SENT_270	[p8l1038t1573r1262b1608],
32	,	,	O	,	_	0	SENT_270	[p8l1038t1573r1262b1608],
33	ridging	NN	O	ridging	appos	31	SENT_270	[p8l1278t1573r1406b1611],
34	,	,	O	,	_	0	SENT_270	[p8l1278t1573r1406b1611],
35	oncholysis	NN	O	oncholysis	appos	31	SENT_270	[p8l1424t1573r1608b1611],
36	,	,	O	,	_	0	SENT_270	[p8l1424t1573r1608b1611],
37	soreness	NN	O	soreness	appos	31	SENT_270	[p8l1627t1582r1773b1608],
38	,	,	O	,	_	0	SENT_270	[p8l1627t1582r1773b1608],
39	and	CC	O	and	_	0	SENT_270	[p8l1791t1573r1849b1602],
40	brittleness	NN	O	brittleness	appos	31	SENT_270	[p8l550t1623r718b1653],
41	of	IN	O	of	_	0	SENT_270	[p8l731t1623r767b1653],
42	the	DT	O	the	det	43	SENT_270	[p8l775t1623r825b1653],
43	fingernails	NNS	O	fingernail	prep_of	33	SENT_270	[p8l837t1623r1021b1661],
44	.	.	O	.	_	0	SENT_270	[p8l837t1623r1021b1661],

1	Alopecia	NNP	PERSON	Alopecia	nsubj	2	SENT_271	[p8l1033t1623r1182b1661],
2	occurs	VBZ	O	occur	_	0	SENT_271	[p8l1194t1633r1299b1653],
3	in	IN	O	in	_	0	SENT_271	[p8l1312t1623r1343b1652],
4	most	JJS	O	most	amod	5	SENT_271	[p8l1354t1628r1434b1653],
5	patients	NNS	O	patient	prep_in	2	SENT_271	[p8l1444t1623r1581b1661],
6	.	.	O	.	_	0	SENT_271	[p8l1444t1623r1581b1661],

1	Docetaxel	NNP	O	Docetaxel	nsubj	2	SENT_272	[p8l600t1674r766b1703],
2	produces	VBZ	O	produce	_	0	SENT_272	[p8l785t1674r932b1712],
3	peripheral	JJ	O	peripheral	amod	4	SENT_272	[p8l952t1674r1119b1712],
4	neurotoxicity	NN	O	neurotoxicity	nsubj	5	SENT_272	[p8l1137t1674r1357b1712],
5	similar	JJ	O	similar	xcomp	2	SENT_272	[p8l1377t1674r1490b1703],
6	to	TO	O	to	_	0	SENT_272	[p8l1508t1678r1538b1703],
7	that	DT	O	that	prep_to	5	SENT_272	[p8l1558t1674r1619b1703],
8	produced	VBN	O	produce	partmod	7	SENT_272	[p8l1637t1674r1790b1712],
9	by	IN	O	by	_	0	SENT_272	[p8l1808t1674r1849b1712],
10	paclitaxel	NN	O	paclitaxel	agent	8	SENT_272	[p8l550t1724r718b1761],
11	.	.	O	.	_	0	SENT_272	[p8l550t1724r718b1761],

1	Although	IN	O	although	mark	7	SENT_273	[p8l741t1724r897b1761],
2	mild	JJ	O	mild	amod	4	SENT_273	[p8l919t1724r994b1753],
3	to	TO	O	to	dep	4	SENT_273	[p8l1016t1728r1046b1753],
4	moderate	JJ	O	moderate	amod	5	SENT_273	[p8l1069t1724r1222b1753],
5	manifestations	NNS	O	manifestation	nsubj	7	SENT_273	[p8l1243t1724r1483b1753],
6	are	VBP	O	be	cop	7	SENT_273	[p8l1506t1733r1555b1753],
7	frequent	JJ	O	frequent	advcl	12	SENT_273	[p8l1577t1724r1722b1761],
8	,	,	O	,	_	0	SENT_273	[p8l1577t1724r1722b1761],
9	severe	JJ	O	severe	amod	10	SENT_273	[p8l1747t1733r1850b1753],
10	toxicity	NN	O	toxicity	nsubj	12	SENT_273	[p8l550t1773r675b1811],
11	is	VBZ	O	be	cop	12	SENT_273	[p8l697t1773r722b1803],
12	uncommon	JJ	O	uncommon	_	0	SENT_273	[p8l745t1783r931b1803],
13	following	VBG	O	follow	xcomp	12	SENT_273	[p8l952t1773r1111b1811],
14	repetitive	JJ	O	repetitive	amod	15	SENT_273	[p8l1132t1773r1288b1811],
15	treatment	NN	O	treatment	dobj	13	SENT_273	[p8l1309t1778r1465b1803],
16	with	IN	O	with	_	0	SENT_273	[p8l1487t1773r1559b1803],
17	docetaxel	NN	O	docetaxel	nn	18	SENT_273	[p8l1581t1773r1738b1803],
18	doses	NNS	O	dose	prep_with	13	SENT_273	[p8l1761t1774r1850b1803],
19	<	JJR	O	<	tmod	13	SENT_273	[p8l551t1824r634b1853],
20	100	CD	NUMBER	100	num	21	SENT_273	[p8l551t1824r634b1853],
21	mg/m2	NN	O	mg/m2	dep	19	SENT_273	[p8l655t1812r776b1861],
22	,	,	O	,	_	0	SENT_273	[p8l655t1812r776b1861],
23	except	IN	O	except	dep	12	SENT_273	[p8l797t1828r904b1861],
24	in	IN	O	in	_	0	SENT_273	[p8l923t1824r955b1852],
25	patients	NNS	O	patient	prep_in	12	SENT_273	[p8l974t1824r1101b1861],
26	with	IN	O	with	_	0	SENT_273	[p8l1122t1824r1195b1853],
27	antecedent	JJ	O	antecedent	amod	28	SENT_273	[p8l1215t1824r1391b1853],
28	disorders	NNS	O	disorder	prep_with	25	SENT_273	[p8l1410t1824r1559b1853],
29	such	JJ	O	such	_	0	SENT_273	[p8l1582t1824r1655b1853],
30	as	IN	O	as	_	0	SENT_273	[p8l1676t1833r1708b1853],
31	alcohol	NN	O	alcohol	nn	32	SENT_273	[p8l1729t1824r1849b1853],
32	abuse	NN	O	abuse	prep_such_as	28	SENT_273	[p8l551t1874r652b1903],
33	.	.	O	.	_	0	SENT_273	[p8l551t1874r652b1903],

1	Myalgias	NNS	O	myalgia	nsubjpass	4	SENT_274	[p8l668t1874r820b1911],
2	are	VBP	O	be	auxpass	4	SENT_274	[p8l837t1883r886b1903],
3	often	RB	O	often	advmod	4	SENT_274	[p8l901t1874r984b1903],
4	noted	VBN	O	note	_	0	SENT_274	[p8l999t1874r1090b1903],
5	in	IN	O	in	_	0	SENT_274	[p8l1105t1874r1136b1902],
6	the	DT	O	the	det	8	SENT_274	[p8l1150t1874r1200b1903],
7	peritreatment	JJ	O	peritreatment	amod	8	SENT_274	[p8l1214t1874r1435b1911],
8	period	NN	O	period	prep_in	4	SENT_274	[p8l1447t1874r1562b1911],
9	,	,	O	,	_	0	SENT_274	[p8l1447t1874r1562b1911],
10	and	CC	O	and	_	0	SENT_274	[p8l1578t1874r1637b1903],
11	malaise	NN	O	malaise	nsubj	15	SENT_274	[p8l1651t1874r1776b1903],
12	is	VBZ	O	be	cop	15	SENT_274	[p8l1791t1874r1816b1903],
13	a	DT	O	a	det	15	SENT_274	[p8l1833t1883r1850b1903],
14	common	JJ	O	common	amod	15	SENT_274	[p8l550t1933r694b1953],
15	complaint	NN	O	complaint	conj_and	4	SENT_274	[p8l711t1923r884b1961],
16	.	.	O	.	_	0	SENT_274	[p8l711t1923r884b1961],

1	There	EX	O	there	expl	2	SENT_275	[p8l903t1923r998b1953],
2	is	VBZ	O	be	_	0	SENT_275	[p8l1015t1923r1041b1953],
3	no	DT	O	no	det	5	SENT_275	[p8l1059t1933r1099b1953],
4	convincing	JJ	O	convincing	amod	5	SENT_275	[p8l1116t1923r1299b1961],
5	evidence	NN	O	evidence	nsubj	2	SENT_275	[p8l1316t1923r1462b1953],
6	that	IN	O	that	complm	9	SENT_275	[p8l1478t1923r1540b1953],
7	directly	RB	O	directly	advmod	9	SENT_275	[p8l1557t1923r1681b1961],
8	links	NNS	O	link	nn	9	SENT_275	[p8l1698t1923r1777b1953],
9	docetaxel	NN	O	docetaxel	dep	5	SENT_275	[p8l1795t1923r1848b1953, p8l550t1974r666b2003],
10	to	TO	O	to	dep	9	SENT_275	[p8l678t1978r709b2003],
11	cardiac	JJ	O	cardiac	amod	12	SENT_275	[p8l721t1974r839b2003],
12	disturbances	NNS	O	disturbance	pobj	10	SENT_275	[p8l851t1974r1066b2008],
13	,	,	O	,	_	0	SENT_275	[p8l851t1974r1066b2008],
14	but	CC	O	but	_	0	SENT_275	[p8l1079t1974r1132b2003],
15	the	DT	O	the	det	16	SENT_275	[p8l1143t1974r1193b2003],
16	potential	NN	O	potential	nsubjpass	24	SENT_275	[p8l1204t1974r1348b2011],
17	for	IN	O	for	_	0	SENT_275	[p8l1360t1974r1408b2003],
18	subclinical	JJ	O	subclinical	amod	20	SENT_275	[p8l1421t1974r1598b2003],
19	cardiac	JJ	O	cardiac	amod	20	SENT_275	[p8l1610t1974r1728b2003],
20	effects	NNS	O	effect	prep_for	16	SENT_275	[p8l1740t1974r1848b2003],
21	has	VBZ	O	have	aux	24	SENT_275	[p8l550t2024r603b2053],
22	not	RB	O	not	neg	24	SENT_275	[p8l624t2028r677b2053],
23	been	VBN	O	be	auxpass	24	SENT_275	[p8l696t2024r773b2053],
24	evaluated	VBN	O	evaluate	conj_but	2	SENT_275	[p8l794t2024r951b2053],
25	as	IN	O	as	prep	24	SENT_275	[p8l971t2033r1003b2053],
26	thoroughly	RB	O	thoroughly	pcomp	25	SENT_275	[p8l1024t2024r1204b2062],
27	as	IN	O	as	prep	24	SENT_275	[p8l1226t2033r1258b2053],
28	with	IN	O	with	pcomp	27	SENT_275	[p8l1279t2024r1351b2053],
29	paclitaxel	NN	O	paclitaxel	pobj	28	SENT_275	[p8l1371t2024r1539b2062],
30	.	.	O	.	_	0	SENT_275	[p8l1371t2024r1539b2062],

1	Stomatitis	NNP	O	Stomatitis	nsubj	8	SENT_276	[p8l1562t2024r1737b2058],
2	,	,	O	,	_	0	SENT_276	[p8l1562t2024r1737b2058],
3	albeit	RB	O	albeit	advmod	4	SENT_276	[p8l1759t2024r1850b2053],
4	uncommon	JJ	O	uncommon	ccomp	8	SENT_276	[p8l550t2082r744b2107],
5	,	,	O	,	_	0	SENT_276	[p8l550t2082r744b2107],
6	is	VBZ	O	be	cop	8	SENT_276	[p8l763t2073r789b2102],
7	more	RBR	O	more	advmod	8	SENT_276	[p8l807t2082r891b2102],
8	frequent	JJ	O	frequent	_	0	SENT_276	[p8l908t2073r1046b2111],
9	with	IN	O	with	_	0	SENT_276	[p8l1063t2073r1135b2102],
10	docetaxel	NN	O	docetaxel	prep_with	8	SENT_276	[p8l1153t2073r1310b2102],
11	than	IN	O	than	prep	8	SENT_276	[p8l1327t2073r1397b2102],
12	with	IN	O	with	pcomp	11	SENT_276	[p8l1415t2073r1487b2102],
13	paclitaxel	NN	O	paclitaxel	pobj	12	SENT_276	[p8l1504t2073r1673b2111],
14	.	.	O	.	_	0	SENT_276	[p8l1504t2073r1673b2111],

1	Vomiting	VBG	O	vomit	nsubjpass	7	SENT_277	[p8l1691t2073r1849b2111],
2	and	CC	O	and	_	0	SENT_277	[p8l551t2123r609b2152],
3	diarrhea	NN	O	diarrhea	conj_and	1	SENT_277	[p8l621t2123r756b2152],
4	may	MD	O	may	aux	7	SENT_277	[p8l766t2132r836b2161],
5	also	RB	O	also	advmod	7	SENT_277	[p8l848t2123r912b2152],
6	be	VB	O	be	auxpass	7	SENT_277	[p8l924t2123r962b2152],
7	observed	VBN	O	observe	_	0	SENT_277	[p8l974t2123r1131b2158],
8	,	,	O	,	_	0	SENT_277	[p8l974t2123r1131b2158],
9	but	CC	O	but	_	0	SENT_277	[p8l1143t2123r1196b2152],
10	severe	JJ	O	severe	amod	11	SENT_277	[p8l1208t2132r1311b2152],
11	toxicity	NN	O	toxicity	nsubj	13	SENT_277	[p8l1323t2123r1448b2161],
12	is	VBZ	O	be	cop	13	SENT_277	[p8l1459t2123r1485b2152],
13	rare	JJ	O	rare	conj_but	7	SENT_277	[p8l1497t2132r1569b2152],
14	.	.	O	.	_	0	SENT_277	[p8l1497t2132r1569b2152],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_278	[p8l547t2212r770b2246],
2	Activity	NN	O	activity	_	0	SENT_278	[p8l778t2212r931b2256],

1	Although	IN	O	although	mark	3	SENT_279	[p8l550t2302r706b2339],
2	paclitaxel	NN	O	paclitaxel	nsubj	3	SENT_279	[p8l717t2302r877b2339],
3	is	VBZ	O	be	advcl	15	SENT_279	[p8l888t2302r914b2331],
4	further	RB	O	further	advmod	3	SENT_279	[p8l926t2302r1039b2331],
5	along	IN	O	along	advmod	3	SENT_279	[p8l1048t2302r1138b2339],
6	in	IN	O	in	_	0	SENT_279	[p8l1150t2302r1181b2330],
7	its	PRP$	O	its	poss	9	SENT_279	[p8l1193t2302r1230b2331],
8	clinical	JJ	O	clinical	amod	9	SENT_279	[p8l1242t2302r1363b2331],
9	development	NN	O	development	prep_in	5	SENT_279	[p8l1375t2302r1596b2339],
10	,	,	O	,	_	0	SENT_279	[p8l1375t2302r1596b2339],
11	both	CC	O	both	preconj	12	SENT_279	[p8l1608t2302r1681b2331],
12	paclitaxel	NN	O	paclitaxel	nsubj	15	SENT_279	[p8l1689t2302r1849b2339],
13	and	CC	O	and	_	0	SENT_279	[p8l551t2363r609b2392],
14	docetaxel	NN	O	docetaxel	conj_and	12	SENT_279	[p8l626t2363r783b2392],
15	seem	VBP	O	seem	_	0	SENT_279	[p8l802t2372r885b2392],
16	to	TO	O	to	aux	17	SENT_279	[p8l902t2367r932b2392],
17	have	VB	O	have	xcomp	15	SENT_279	[p8l950t2363r1027b2392],
18	similar	JJ	O	similar	amod	19	SENT_279	[p8l1046t2363r1160b2392],
19	spectra	NNS	O	spectrum	dobj	17	SENT_279	[p8l1177t2367r1293b2401],
20	of	IN	O	of	_	0	SENT_279	[p8l1310t2363r1345b2392],
21	clinical	JJ	O	clinical	amod	22	SENT_279	[p8l1360t2363r1480b2392],
22	activity	NN	O	activity	prep_of	19	SENT_279	[p8l1498t2363r1629b2401],
23	.	.	O	.	_	0	SENT_279	[p8l1498t2363r1629b2401],

1	Both	DT	O	both	det	2	SENT_280	[p8l1648t2363r1727b2392],
2	agents	NNS	O	agent	nsubj	5	SENT_280	[p8l1745t2367r1848b2401],
3	have	VBP	O	have	aux	5	SENT_280	[p8l550t2412r627b2442],
4	consistently	RB	O	consistently	advmod	5	SENT_280	[p8l640t2412r836b2450],
5	shown	VBN	O	show	_	0	SENT_280	[p8l850t2412r956b2442],
6	impressive	JJ	O	impressive	amod	7	SENT_280	[p8l968t2412r1147b2450],
7	activity	NN	O	activity	dobj	5	SENT_280	[p8l1159t2412r1281b2450],
8	in	IN	O	in	_	0	SENT_280	[p8l1294t2412r1325b2441],
9	advanced	JJ	O	advanced	amod	10	SENT_280	[p8l1338t2412r1492b2442],
10	cancers	NNS	O	cancer	prep_in	5	SENT_280	[p8l1504t2421r1626b2442],
11	of	IN	O	of	_	0	SENT_280	[p8l1639t2412r1675b2442],
12	the	DT	O	the	det	13	SENT_280	[p8l1684t2412r1733b2442],
13	ovary	NN	O	ovary	prep_of	10	SENT_280	[p8l1746t2421r1848b2450],
14	,	,	O	,	_	0	SENT_280	[p8l1746t2421r1848b2450],
15	breast	NN	O	breast	prep_of	10	SENT_280	[p8l550t2462r657b2497],
16	,	,	O	,	_	0	SENT_280	[p8l550t2462r657b2497],
17	lung	NN	O	lung	conj_and	13	SENT_280	[p8l672t2462r753b2500],
18	,	,	O	,	_	0	SENT_280	[p8l672t2462r753b2500],
19	esophagus	NN	O	esophagus	conj_and	13	SENT_280	[p8l770t2462r949b2500],
20	,	,	O	,	_	0	SENT_280	[p8l770t2462r949b2500],
21	bladder	NN	O	bladder	conj_and	13	SENT_280	[p8l965t2462r1097b2497],
22	,	,	O	,	_	0	SENT_280	[p8l965t2462r1097b2497],
23	and	CC	O	and	_	0	SENT_280	[p8l1113t2462r1171b2492],
24	head	NN	O	head	conj_and	13	SENT_280	[p8l1184t2462r1262b2492],
25	and	CC	O	and	_	0	SENT_280	[p8l1276t2462r1334b2492],
26	neck	NN	O	neck	conj_and	13	SENT_280	[p8l1348t2462r1433b2492],
27	.	.	O	.	_	0	SENT_280	[p8l1348t2462r1433b2492],

1	Early	RB	O	early	advmod	2	SENT_281	[p8l1449t2462r1537b2500],
2	reports	NNS	O	report	nsubj	8	SENT_281	[p8l1551t2467r1664b2500],
3	of	IN	O	of	_	0	SENT_281	[p8l1679t2462r1715b2492],
4	activity	NN	O	activity	prep_of	2	SENT_281	[p8l1727t2462r1849b2500],
5	in	IN	O	in	_	0	SENT_281	[p8l550t2512r581b2541],
6	other	JJ	O	other	amod	7	SENT_281	[p8l593t2512r677b2541],
7	cancers	NNS	O	cancer	prep_in	4	SENT_281	[p8l687t2521r809b2541],
8	require	VBP	O	require	_	0	SENT_281	[p8l820t2512r936b2550],
9	confirmation	NN	O	confirmation	dobj	8	SENT_281	[p8l947t2512r1168b2541],
10	.	.	O	.	_	0	SENT_281	[p8l947t2512r1168b2541],

1	The	DT	O	the	det	2	SENT_282	[p8l1181t2512r1244b2541],
2	challenge	NN	O	challenge	nsubj	8	SENT_282	[p8l1255t2512r1412b2550],
3	that	WDT	O	that	nsubj	6	SENT_282	[p8l1423t2512r1484b2541],
4	is	VBZ	O	be	aux	6	SENT_282	[p8l1494t2512r1520b2541],
5	now	RB	DATE	now	advmod	6	SENT_282	[p8l1532t2521r1602b2541],
6	facing	VBG	O	face	rcmod	2	SENT_282	[p8l1613t2512r1715b2550],
7	investigators	NNS	O	investigator	dobj	6	SENT_282	[p8l1726t2512r1848b2541, p8l551t2567r649b2600],
8	is	VBZ	O	be	_	0	SENT_282	[p8l662t2562r688b2592],
9	to	TO	O	to	aux	10	SENT_282	[p8l701t2567r732b2592],
10	develop	VB	O	develop	xcomp	8	SENT_282	[p8l745t2562r874b2600],
11	strategies	NNS	O	strategy	dobj	10	SENT_282	[p8l888t2562r1041b2600],
12	using	VBG	O	use	partmod	11	SENT_282	[p8l1053t2562r1141b2600],
13	the	DT	O	the	det	14	SENT_282	[p8l1154t2562r1203b2592],
14	taxanes	NNS	O	taxane	dobj	12	SENT_282	[p8l1215t2567r1337b2592],
15	as	IN	O	as	_	0	SENT_282	[p8l1351t2571r1382b2592],
16	first	JJ	ORDINAL	first	amod	19	SENT_282	[p8l1395t2562r1536b2592],
17	—	NN	O	—	nn	19	SENT_282	[p8l1395t2562r1536b2592],
18	line	NN	O	line	nn	19	SENT_282	[p8l1395t2562r1536b2592],
19	therapy	NN	O	therapy	prep_as	12	SENT_282	[p8l1549t2562r1671b2600],
20	in	IN	O	in	_	0	SENT_282	[p8l1683t2562r1715b2591],
21	cancers	NNS	O	cancer	prep_in	19	SENT_282	[p8l1727t2571r1849b2592],
22	where	WRB	O	where	advmod	29	SENT_282	[p8l550t2612r650b2642],
23	cure	NN	O	cure	nsubj	29	SENT_282	[p8l662t2621r732b2642],
24	or	CC	O	or	_	0	SENT_282	[p8l743t2621r777b2642],
25	improved	VBN	O	improve	amod	26	SENT_282	[p8l787t2612r945b2650],
26	survival	NN	O	survival	conj_or	23	SENT_282	[p8l958t2612r1088b2642],
27	may	MD	O	may	aux	29	SENT_282	[p8l1100t2621r1170b2650],
28	be	VB	O	be	cop	29	SENT_282	[p8l1181t2612r1220b2642],
29	achievable	JJ	O	achievable	rcmod	21	SENT_282	[p8l1232t2612r1415b2642],
30	.	.	O	.	_	0	SENT_282	[p8l1232t2612r1415b2642],

1	OVARIAN	JJ	O	ovarian	amod	3	SENT_283	[p8l551t2724r703b2748],
2	CANCER	NNP	O	CANCER	nn	3	SENT_283	[p8l714t2724r848b2748],
3	Paclitaxel	NN	O	paclitaxel	nsubjpass	6	SENT_283	[p8l886t2718r1049b2748],
4	was	VBD	O	be	auxpass	6	SENT_283	[p8l1062t2727r1124b2748],
5	initially	RB	O	initially	advmod	6	SENT_283	[p8l1139t2718r1266b2756],
6	approved	VBN	O	approve	_	0	SENT_283	[p8l1281t2718r1433b2756],
7	for	IN	O	for	_	0	SENT_283	[p8l1447t2718r1494b2747],
8	the	DT	O	the	det	9	SENT_283	[p8l1507t2718r1557b2748],
9	treatment	NN	O	treatment	prep_for	6	SENT_283	[p8l1570t2723r1726b2748],
10	of	IN	O	of	_	0	SENT_283	[p8l1739t2718r1775b2748],
11	epithelial	JJ	O	epithelial	amod	13	SENT_283	[p8l1786t2718r1848b2756, p8l550t2768r652b2798],
12	ovarian	JJ	O	ovarian	amod	13	SENT_283	[p8l670t2768r792b2798],
13	cancer	NN	O	cancer	prep_of	9	SENT_283	[p8l810t2777r917b2798],
14	based	VBN	O	base	_	0	SENT_283	[p8l932t2768r1026b2798],
15	on	IN	O	on	prepc_based_on	6	SENT_283	[p8l1044t2777r1084b2798],
16	the	DT	O	the	det	17	SENT_283	[p8l1101t2768r1150b2798],
17	results	NNS	O	result	pobj	6	SENT_283	[p8l1166t2768r1273b2798],
18	of	IN	O	of	_	0	SENT_283	[p8l1291t2768r1327b2798],
19	single	JJ	O	single	amod	22	SENT_283	[p8l1342t2768r1543b2806],
20	—	JJ	O	—	amod	22	SENT_283	[p8l1342t2768r1543b2806],
21	agent	NN	O	agent	nn	22	SENT_283	[p8l1342t2768r1543b2806],
22	trials	NNS	O	trial	prep_of	17	SENT_283	[p8l1559t2768r1640b2798],
23	of	IN	O	of	_	0	SENT_283	[p8l1658t2768r1694b2798],
24	the	DT	O	the	det	26	SENT_283	[p8l1708t2768r1757b2798],
25	24-h	JJ	O	24-h	amod	26	SENT_283	[p8l1775t2768r1849b2797],
26	schedule	NN	O	schedule	prep_of	22	SENT_283	[p8l552t2818r702b2848],
27	.	.	O	.	_	0	SENT_283	[p8l552t2818r702b2848],

1	These	DT	O	these	det	2	SENT_284	[p8l715t2818r813b2848],
2	trials	NNS	O	trial	nsubj	3	SENT_284	[p8l825t2818r905b2848],
3	provided	VBD	O	provide	_	0	SENT_284	[p8l917t2818r1064b2856],
4	the	DT	O	the	det	5	SENT_284	[p8l1075t2818r1124b2848],
5	impetus	NN	O	impetus	dobj	3	SENT_284	[p8l1136t2818r1265b2856],
6	for	IN	O	for	_	0	SENT_284	[p8l1277t2818r1325b2848],
7	studies	NNS	O	study	prep_for	3	SENT_284	[p8l1337t2818r1449b2848],
8	in	IN	O	in	_	0	SENT_284	[p8l1461t2818r1492b2847],
9	other	JJ	O	other	amod	11	SENT_284	[p8l1504t2818r1589b2848],
10	tumor	NN	O	tumor	nn	11	SENT_284	[p8l1599t2823r1698b2848],
11	types	NNS	O	type	prep_in	3	SENT_284	[p8l1709t2823r1803b2856],
12	.	.	O	.	_	0	SENT_284	[p8l1709t2823r1803b2856],

1	In	IN	O	in	_	0	SENT_285	[p8l1816t2819r1850b2847],
2	the	DT	O	the	det	5	SENT_285	[p8l550t2868r600b2897],
3	first	JJ	ORDINAL	first	amod	5	SENT_285	[p8l615t2868r681b2897],
4	five	CD	NUMBER	five	num	5	SENT_285	[p8l696t2868r759b2897],
5	studies	NNS	O	study	prep_in	16	SENT_285	[p8l777t2868r898b2903],
6	,	,	O	,	_	0	SENT_285	[p8l777t2868r898b2903],
7	20-48	CD	PERCENT	20-48	num	8	SENT_285	[p8l916t2868r1050b2898],
8	%	NN	PERCENT	%	nsubj	16	SENT_285	[p8l916t2868r1050b2898],
9	of	IN	O	of	_	0	SENT_285	[p8l1069t2868r1104b2897],
10	women	NNS	O	woman	prep_of	8	SENT_285	[p8l1117t2877r1238b2898],
11	with	IN	O	with	_	0	SENT_285	[p8l1254t2868r1326b2897],
12	refractory	JJ	O	refractory	amod	15	SENT_285	[p8l1341t2868r1503b2906],
13	or	CC	O	or	_	0	SENT_285	[p8l1519t2877r1553b2897],
14	recurrent	JJ	O	recurrent	conj_or	12	SENT_285	[p8l1567t2873r1716b2897],
15	disease	NN	O	disease	prep_with	10	SENT_285	[p8l1731t2868r1849b2897],
16	responded	VBD	O	respond	_	0	SENT_285	[p8l550t2918r720b2956],
17	[	CD	NUMBER	[	dobj	16	SENT_285	[p8l741t2918r875b2954],
18	deﬁned	VBN	O	deﬁned	partmod	17	SENT_285	[p8l741t2918r875b2954],
19	as	IN	O	as	_	0	SENT_285	[p8l895t2927r926b2948],
20	either	CC	O	either	dep	23	SENT_285	[p8l947t2918r1040b2948],
21	a	DT	O	a	det	23	SENT_285	[p8l1059t2927r1077b2948],
22	complete	JJ	O	complete	amod	23	SENT_285	[p8l1095t2918r1245b2956],
23	response	NN	O	response	prep_as	18	SENT_285	[p8l1264t2927r1408b2956],
24	(	CD	NUMBER	(	num	26	SENT_285	[p8l1429t2918r1518b2954],
25	CR	JJ	O	cr	amod	26	SENT_285	[p8l1429t2918r1518b2954],
26	)	NN	O	)	dep	23	SENT_285	[p8l1429t2918r1518b2954],
27	,	,	O	,	_	0	SENT_285	[p8l1429t2918r1518b2954],
28	meaning	VBG	O	mean	partmod	23	SENT_285	[p8l1538t2918r1679b2956],
29	complete	JJ	O	complete	amod	31	SENT_285	[p8l1699t2918r1849b2956],
30	364	CD	NUMBER	364	tmod	29	SENT_285	[p8l550t2975r604b3001],
31	ROWINSKY	NN	O	rowinsky	dobj	28	SENT_285	[p8l643t2975r843b3001],

1	disappearance	NN	O	disappearance	nsubj	16	SENT_286	[p8l550t3059r783b3097],
2	of	IN	O	of	_	0	SENT_286	[p8l796t3059r831b3089],
3	all	DT	O	all	det	4	SENT_286	[p8l842t3059r881b3089],
4	evidence	NN	O	evidence	prep_of	1	SENT_286	[p8l895t3059r1040b3089],
5	of	IN	O	of	_	0	SENT_286	[p8l1053t3059r1089b3089],
6	disease	NN	O	disease	prep_of	4	SENT_286	[p8l1099t3059r1226b3094],
7	,	,	O	,	_	0	SENT_286	[p8l1099t3059r1226b3094],
8	or	CC	O	or	_	0	SENT_286	[p8l1241t3068r1275b3089],
9	a	DT	O	a	det	14	SENT_286	[p8l1288t3068r1305b3089],
10	partial	JJ	O	partial	amod	11	SENT_286	[p8l1316t3059r1421b3097],
11	responses	NNS	O	response	npadvmod	12	SENT_286	[p8l1434t3068r1593b3097],
12	(	JJ	O	(	amod	14	SENT_286	[p8l1608t3060r1693b3095],
13	PR	NN	O	pr	nn	14	SENT_286	[p8l1608t3060r1693b3095],
14	)	NN	O	)	conj_or	1	SENT_286	[p8l1608t3060r1693b3095],
15	,	,	O	,	_	0	SENT_286	[p8l1608t3060r1693b3095],
16	meaning	VBG	O	mean	_	0	SENT_286	[p8l1707t3059r1848b3097],
17	reduction	NN	O	reduction	dobj	16	SENT_286	[p8l549t3109r705b3139],
18	in	IN	O	in	_	0	SENT_286	[p8l718t3109r749b3138],
19	all	DT	O	all	det	20	SENT_286	[p8l762t3109r802b3139],
20	disease	NN	O	disease	prep_in	16	SENT_286	[p8l815t3109r933b3139],
21	by	IN	O	by	_	0	SENT_286	[p8l946t3109r987b3147],
22	at	IN	O	at	quantmod	25	SENT_286	[p8l1001t3114r1029b3139],
23	least	JJS	O	least	mwe	22	SENT_286	[p8l1042t3109r1117b3139],
24	50	CD	PERCENT	50	number	25	SENT_286	[p8l1130t3109r1215b3145],
25	%	NN	PERCENT	%	num	27	SENT_286	[p8l1130t3109r1215b3145],
26	]	CD	NUMBER	]	number	27	SENT_286	[p8l1130t3109r1215b3145],
27	(	CD	NUMBER	(	prep_by	20	SENT_286	[p8l1232t3109r1294b3145],
28	42	CD	NUMBER	42	tmod	16	SENT_286	[p8l1232t3109r1294b3145],
29	,	,	O	,	_	0	SENT_286	[p8l1232t3109r1294b3145],
30	49-52	CD	NUMBER	49-52	num	31	SENT_286	[p8l1308t3109r1432b3145],
31	)	NN	O	)	appos	28	SENT_286	[p8l1308t3109r1432b3145],
32	.	.	O	.	_	0	SENT_286	[p8l1308t3109r1432b3145],

1	Overall	RB	O	overall	advmod	14	SENT_287	[p8l1448t3109r1579b3144],
2	,	,	O	,	_	0	SENT_287	[p8l1448t3109r1579b3144],
3	32	CD	PERCENT	32	num	4	SENT_287	[p8l1595t3109r1667b3139],
4	%	NN	PERCENT	%	nsubj	14	SENT_287	[p8l1595t3109r1667b3139],
5	of	IN	O	of	_	0	SENT_287	[p8l1682t3109r1717b3139],
6	women	NNS	O	woman	prep_of	4	SENT_287	[p8l1728t3118r1848b3139],
7	who	WP	O	who	nsubjpass	9	SENT_287	[p8l550t3159r619b3188],
8	were	VBD	O	be	auxpass	9	SENT_287	[p8l631t3168r710b3188],
9	considered	VBN	O	consider	rcmod	6	SENT_287	[p8l721t3159r900b3188],
10	resistant	JJ	O	resistant	acomp	9	SENT_287	[p8l910t3159r1048b3188],
11	to	TO	O	to	_	0	SENT_287	[p8l1059t3164r1090b3188],
12	platinum	NN	O	platinum	nn	13	SENT_287	[p8l1101t3159r1248b3197],
13	analogs	NNS	O	analog	prep_to	10	SENT_287	[p8l1259t3159r1382b3197],
14	(	VBP	O	(	conj_or	14	SENT_287	[p8l1396t3159r1527b3195],
15	disease	NN	O	disease	nn	16	SENT_287	[p8l1396t3159r1527b3195],
16	progression	NN	O	progression	dobj	14	SENT_287	[p8l1538t3159r1731b3197],
17	during	IN	O	during	_	0	SENT_287	[p8l1742t3159r1849b3197],
18	or	CC	O	or	_	0	SENT_287	[p8l550t3218r584b3239],
19	within	IN	O	within	_	0	SENT_287	[p8l592t3209r697b3239],
20	six	CD	DURATION	six	num	21	SENT_287	[p8l707t3209r752b3239],
21	months	NNS	NUMBER	month	prep_during	14	SENT_287	[p8l761t3209r895b3245],
22	)	RB	O	)	advmod	14	SENT_287	[p8l761t3209r895b3245],
23	and	CC	O	and	_	0	SENT_287	[p8l906t3209r964b3239],
24	38	CD	PERCENT	38	num	25	SENT_287	[p8l973t3209r1045b3239],
25	%	NN	PERCENT	%	advmod	14	SENT_287	[p8l973t3209r1045b3239],
26	of	IN	O	of	_	0	SENT_287	[p8l1056t3209r1092b3239],
27	those	DT	O	those	prep_of	25	SENT_287	[p8l1098t3209r1184b3239],
28	who	WP	O	who	nsubj	29	SENT_287	[p8l1193t3209r1262b3239],
29	relapsed	VBD	O	relapse	rcmod	27	SENT_287	[p8l1271t3209r1409b3247],
30	more	JJR	DURATION	more	mwe	31	SENT_287	[p8l1417t3218r1501b3239],
31	than	IN	DURATION	than	quantmod	32	SENT_287	[p8l1510t3209r1580b3239],
32	six	CD	DURATION	six	num	33	SENT_287	[p8l1590t3209r1635b3239],
33	months	NNS	NUMBER	month	tmod	29	SENT_287	[p8l1644t3209r1764b3239],
34	after	IN	O	after	_	0	SENT_287	[p8l1775t3209r1849b3239],
35	treatment	NN	O	treatment	prep_after	29	SENT_287	[p8l549t3264r705b3289],
36	with	IN	O	with	_	0	SENT_287	[p8l719t3259r792b3289],
37	regimens	NNS	O	regimen	prep_with	29	SENT_287	[p8l806t3259r956b3297],
38	containing	VBG	O	contain	partmod	37	SENT_287	[p8l972t3259r1145b3297],
39	platinum	NN	O	platinum	nn	40	SENT_287	[p8l1159t3259r1306b3297],
40	analogs	NNS	O	analog	dobj	38	SENT_287	[p8l1321t3259r1445b3297],
41	responded	VBD	O	respond	_	0	SENT_287	[p8l1460t3259r1629b3297],
42	to	TO	O	to	_	0	SENT_287	[p8l1643t3264r1674b3289],
43	paclitaxel	NN	O	paclitaxel	prep_to	41	SENT_287	[p8l1688t3259r1849b3297],
44	(	CD	NUMBER	(	num	43	SENT_287	[p8l551t3309r625b3345],
45	21	CD	NUMBER	21	num	46	SENT_287	[p8l551t3309r625b3345],
46	)	NN	O	)	nsubj	41	SENT_287	[p8l551t3309r625b3345],
47	.	.	O	.	_	0	SENT_287	[p8l551t3309r625b3345],

1	These	DT	O	these	det	2	SENT_288	[p8l640t3309r737b3338],
2	results	NNS	O	result	nsubj	14	SENT_288	[p8l750t3309r856b3338],
3	were	VBD	O	be	cop	5	SENT_288	[p8l870t3318r949b3338],
4	much	RB	O	much	advmod	5	SENT_288	[p8l962t3309r1053b3338],
5	better	JJR	O	better	_	0	SENT_288	[p8l1065t3309r1159b3338],
6	than	IN	O	than	_	0	SENT_288	[p8l1171t3309r1241b3338],
7	those	DT	O	those	prep_than	5	SENT_288	[p8l1253t3309r1339b3338],
8	of	IN	O	of	_	0	SENT_288	[p8l1352t3309r1388b3338],
9	other	JJ	O	other	amod	11	SENT_288	[p8l1398t3309r1482b3338],
10	salvage	NN	O	salvage	nn	11	SENT_288	[p8l1495t3309r1617b3347],
11	therapies	NNS	O	therapy	prep_of	7	SENT_288	[p8l1629t3309r1777b3347],
12	and	CC	O	and	_	0	SENT_288	[p8l1791t3309r1849b3338],
13	were	VBD	O	be	cop	14	SENT_288	[p8l549t3368r628b3389],
14	comparable	JJ	O	comparable	conj_and	5	SENT_288	[p8l643t3359r835b3397],
15	to	TO	O	to	_	0	SENT_288	[p8l849t3364r879b3389],
16	the	DT	O	the	det	18	SENT_288	[p8l894t3359r944b3389],
17	early	JJ	O	early	amod	18	SENT_288	[p8l958t3359r1039b3397],
18	results	NNS	O	result	prep_to	14	SENT_288	[p8l1053t3359r1160b3389],
19	of	IN	O	of	_	0	SENT_288	[p8l1176t3359r1212b3389],
20	studies	NNS	O	study	prep_of	18	SENT_288	[p8l1225t3359r1336b3389],
21	with	IN	O	with	_	0	SENT_288	[p8l1352t3359r1424b3389],
22	platinum	NN	O	platinum	nn	23	SENT_288	[p8l1438t3359r1585b3397],
23	analogs	NNS	O	analog	prep_with	14	SENT_288	[p8l1599t3359r1732b3397],
24	,	,	O	,	_	0	SENT_288	[p8l1599t3359r1732b3397],
25	which	WDT	O	which	nsubj	29	SENT_288	[p8l1748t3359r1849b3389],
26	have	VBP	O	have	aux	29	SENT_288	[p8l549t3409r626b3439],
27	been	VBN	O	be	cop	29	SENT_288	[p8l639t3409r716b3439],
28	the	DT	O	the	det	29	SENT_288	[p8l729t3409r779b3439],
29	mainstay	NN	O	mainstay	rcmod	23	SENT_288	[p8l792t3409r940b3447],
30	of	IN	O	of	_	0	SENT_288	[p8l954t3409r989b3439],
31	therapy	NN	O	therapy	prep_of	29	SENT_288	[p8l1000t3409r1131b3447],
32	.	.	O	.	_	0	SENT_288	[p8l1000t3409r1131b3447],

1	The	DT	O	the	det	2	SENT_289	[p8l1146t3409r1209b3439],
2	generalizability	NN	O	generalizability	nsubjpass	17	SENT_289	[p8l1223t3409r1478b3447],
3	of	IN	O	of	_	0	SENT_289	[p8l1492t3409r1528b3439],
4	these	DT	O	these	det	5	SENT_289	[p8l1538t3409r1622b3439],
5	results	NNS	O	result	prep_of	2	SENT_289	[p8l1635t3409r1741b3439],
6	to	TO	O	to	_	0	SENT_289	[p8l1755t3414r1786b3439],
7	the	DT	O	the	det	8	SENT_289	[p8l1799t3409r1849b3439],
8	treatment	NN	O	treatment	prep_to	5	SENT_289	[p8l549t3464r705b3488],
9	of	IN	O	of	_	0	SENT_289	[p8l720t3459r755b3488],
10	this	DT	O	this	det	11	SENT_289	[p8l768t3459r826b3488],
11	disease	NN	O	disease	prep_of	8	SENT_289	[p8l842t3459r960b3488],
12	in	IN	O	in	_	0	SENT_289	[p8l975t3459r1007b3488],
13	general	JJ	O	general	amod	15	SENT_289	[p8l1022t3459r1142b3497],
14	oncology	NN	O	oncology	nn	15	SENT_289	[p8l1158t3459r1310b3497],
15	practice	NN	O	practice	prep_in	11	SENT_289	[p8l1325t3459r1455b3497],
16	was	VBD	O	be	auxpass	17	SENT_289	[p8l1470t3468r1532b3488],
17	demonstrated	VBN	O	demonstrate	_	0	SENT_289	[p8l1549t3459r1771b3488],
18	in	IN	O	in	_	0	SENT_289	[p8l1785t3459r1817b3488],
19	a	DT	O	a	det	23	SENT_289	[p8l1832t3468r1849b3488],
20	National	NNP	ORGANIZATION	National	nn	23	SENT_289	[p8l549t3509r691b3538],
21	Cancer	NNP	ORGANIZATION	Cancer	nn	23	SENT_289	[p8l710t3509r826b3538],
22	Institute	NNP	ORGANIZATION	Institute	nn	23	SENT_289	[p8l844t3509r979b3538],
23	program	NN	O	program	prep_in	17	SENT_289	[p8l997t3518r1137b3547],
24	in	IN	O	in	_	0	SENT_289	[p8l1155t3509r1186b3538],
25	which	WDT	O	which	rel	33	SENT_289	[p8l1205t3509r1305b3538],
26	paclitaxel	NN	O	paclitaxel	nsubjpass	33	SENT_289	[p8l1323t3509r1484b3547],
27	(	CD	NUMBER	(	num	30	SENT_289	[p8l1503t3509r1591b3545],
28	24-h	JJ	O	24-h	amod	30	SENT_289	[p8l1503t3509r1591b3545],
29	schedule	NN	O	schedule	nn	30	SENT_289	[p8l1610t3509r1765b3545],
30	)	NN	O	)	dep	26	SENT_289	[p8l1610t3509r1765b3545],
31	was	VBD	O	be	auxpass	33	SENT_289	[p8l1785t3518r1847b3538],
32	initially	RB	O	initially	advmod	33	SENT_289	[p8l549t3559r677b3597],
33	provided	VBN	O	provide	rcmod	23	SENT_289	[p8l686t3559r833b3597],
34	for	IN	O	for	_	0	SENT_289	[p8l841t3559r889b3588],
35	women	NNS	O	woman	prep_for	33	SENT_289	[p8l898t3569r1019b3589],
36	whose	WP$	O	whose	poss	37	SENT_289	[p8l1028t3559r1132b3589],
37	cancers	NNS	O	cancer	nsubj	39	SENT_289	[p8l1142t3569r1264b3588],
38	had	VBD	O	have	aux	39	SENT_289	[p8l1273t3559r1333b3588],
39	progressed	VBN	O	progress	rcmod	35	SENT_289	[p8l1341t3559r1520b3597],
40	after	IN	O	after	_	0	SENT_289	[p8l1530t3559r1605b3588],
41	treatment	NN	O	treatment	prep_after	39	SENT_289	[p8l1612t3564r1768b3588],
42	with	IN	O	with	_	0	SENT_289	[p8l1776t3559r1849b3589],
43	three	CD	NUMBER	three	num	44	SENT_289	[p8l549t3609r631b3638],
44	regimens	NNS	O	regimen	prep_with	39	SENT_289	[p8l646t3609r805b3647],
45	.	.	O	.	_	0	SENT_289	[p8l646t3609r805b3647],

1	Of	IN	O	of	_	0	SENT_290	[p8l823t3609r868b3639],
2	the	DT	O	the	det	5	SENT_290	[p8l881t3609r930b3638],
3	first	JJ	ORDINAL	first	amod	5	SENT_290	[p8l946t3609r1012b3638],
4	1000	CD	NUMBER	1000	num	5	SENT_290	[p8l1031t3610r1108b3639],
5	patients	NNS	O	patient	prep_of	9	SENT_290	[p8l1123t3609r1261b3647],
6	,	,	O	,	_	0	SENT_290	[p8l1123t3609r1261b3647],
7	22	CD	PERCENT	22	num	8	SENT_290	[p8l1278t3610r1350b3639],
8	%	NN	PERCENT	%	nsubj	9	SENT_290	[p8l1278t3610r1350b3639],
9	responded	VBD	O	respond	_	0	SENT_290	[p8l1367t3609r1537b3647],
10	despite	IN	O	despite	_	0	SENT_290	[p8l1552t3609r1668b3647],
11	their	PRP$	O	they	poss	12	SENT_290	[p8l1684t3609r1759b3638],
12	poor	JJ	O	poor	prep_despite	9	SENT_290	[p8l1773t3619r1849b3647],

1	A	DT	O	a	_	0	SENT_291	[p9l309t1042r332b1063],
2	.	.	O	.	_	0	SENT_291	[p9l316t957r332b1016],

1	nnu	NN	O	nnu	_	0	SENT_292	[p9l316t957r332b1016],
2	.	.	O	.	_	0	SENT_292	[p9l316t957r332b1016],

1	Rev.	NNP	O	Rev.	nn	2	SENT_293	[p9l309t886r332b946],
2	Med	NNP	O	Med	_	0	SENT_293	[p9l309t815r332b876],
3	.	.	O	.	_	0	SENT_293	[p9l328t736r332b740],

1	1997.48:353	CD	NUMBER	1997.48:353	num	2	SENT_294	[p9l309t489r333b722],
2	-374	CD	NUMBER	-374	_	0	SENT_294	[p9l309t489r333b722],
3	.	.	O	.	_	0	SENT_294	[p9l309t489r333b722],

1	Downloaded	VBN	O	download	_	0	SENT_295	[p9l309t309r332b479],
2	from	IN	O	from	_	0	SENT_295	[p9l309t235r332b300],
3	www	NN	O	www	prep_from	1	SENT_295	[p9l309t7r332b226],
4	.	.	O	.	_	0	SENT_295	[p9l309t7r332b226],

1	annualrevi	NN	O	annualrevus	_	0	SENT_296	[p9l309t7r332b226],

1	Annu	NNP	PERSON	Annu	_	0	SENT_297	[p9l309t3175r332b3255],
2	.	.	O	.	_	0	SENT_297	[p9l309t3175r332b3255],

1	Rev.	NNP	O	Rev.	nn	2	SENT_298	[p9l309t3105r332b3164],
2	Med	NNP	O	Med	_	0	SENT_298	[p9l309t3027r332b3094],
3	.	.	O	.	_	0	SENT_298	[p9l309t3027r332b3094],

1	1997.48:353	CD	NUMBER	1997.48:353	num	2	SENT_299	[p9l309t2782r333b3013],
2	-374	CD	NUMBER	-374	_	0	SENT_299	[p9l309t2782r333b3013],
3	.	.	O	.	_	0	SENT_299	[p9l309t2782r333b3013],

1	Downloaded	VBN	O	download	_	0	SENT_300	[p9l309t2601r332b2771],
2	from	IN	O	from	_	0	SENT_300	[p9l309t2527r332b2592],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_300	[p9l309t2194r339b2519],
4	by	IN	O	by	_	0	SENT_300	[p9l342t970r373b1002],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_300	[p9l342t821r373b961],
6	of	IN	ORGANIZATION	of	_	0	SENT_300	[p9l342t710r366b739],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_300	[p9l342t562r366b703],
8	-	:	O	-	_	0	SENT_300	[p9l356t543r359b552],
9	Madison	NNP	O	Madison	prep_by	1	SENT_300	[p9l342t417r366b534],
10	on	IN	O	on	_	0	SENT_300	[p9l350t375r366b408],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_300	[p9l342t242r366b366],
12	.	.	O	.	_	0	SENT_300	[p9l342t242r366b366],

1	For	IN	O	for	dep	13	SENT_301	[p9l343t185r366b231],
2	personal	JJ	O	personal	amod	3	SENT_301	[p9l342t65r373b177],
3	use	NN	O	use	pobj	1	SENT_301	[p9l350t12r366b56],
4	by	IN	O	by	_	0	SENT_301	[p9l342t3189r373b3221],
5	University	NNP	ORGANIZATION	University	prep_by	3	SENT_301	[p9l342t3040r373b3179],
6	of	IN	ORGANIZATION	of	_	0	SENT_301	[p9l342t3001r366b3030],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_301	[p9l342t2854r366b2994],
8	-	:	O	-	_	0	SENT_301	[p9l356t2836r359b2845],
9	Madison	NNP	O	Madison	dep	5	SENT_301	[p9l342t2710r366b2827],
10	on	IN	O	on	_	0	SENT_301	[p9l350t2668r366b2700],
11	01/05	CD	NUMBER	01/05	prep_on	9	SENT_301	[p9l342t2573r366b2659],
12	/	:	O	/	punct	13	SENT_301	[p9l342t2573r366b2659],
13	14	CD	NUMBER	14	_	0	SENT_301	[p9l342t2534r366b2570],
14	.	.	O	.	_	0	SENT_301	[p9l342t2534r366b2570],

1	For	IN	O	for	_	0	SENT_302	[p9l343t2477r366b2524],
2	personal	JJ	O	personal	amod	3	SENT_302	[p9l342t2357r373b2470],
3	use	NN	O	use	pobj	1	SENT_302	[p9l350t2305r366b2348],
4	only	RB	O	only	advmod	3	SENT_302	[p9l342t2230r373b2295],
5	.	.	O	.	_	0	SENT_302	[p9l342t2230r373b2295],

1	prognostic	JJ	O	prognostic	amod	2	SENT_303	[p9l549t16r722b54],
2	characteristics	NNS	O	characteristic	nsubj	3	SENT_303	[p9l735t16r969b45],
3	(	VBP	O	(	_	0	SENT_303	[p9l982t16r1057b52],
4	53	CD	NUMBER	53	num	5	SENT_303	[p9l982t16r1057b52],
5	)	CD	NUMBER	)	dobj	3	SENT_303	[p9l982t16r1057b52],
6	.	.	O	.	_	0	SENT_303	[p9l982t16r1057b52],

1	With	IN	O	with	_	0	SENT_304	[p9l599t68r681b97],
2	the	DT	O	the	det	3	SENT_304	[p9l696t68r746b97],
3	demonstration	NN	O	demonstration	prep_with	29	SENT_304	[p9l762t68r997b97],
4	that	IN	O	that	complm	11	SENT_304	[p9l1013t68r1074b97],
5	paclitaxel	NN	O	paclitaxel	nsubjpass	11	SENT_304	[p9l1088t68r1249b105],
6	and	CC	O	and	_	0	SENT_304	[p9l1265t68r1323b97],
7	cisplatin	NN	O	cisplatin	conj_and	5	SENT_304	[p9l1338t68r1477b105],
8	could	MD	O	could	aux	11	SENT_304	[p9l1492t68r1583b97],
9	be	VB	O	be	auxpass	11	SENT_304	[p9l1598t68r1636b97],
10	safely	RB	O	safely	advmod	11	SENT_304	[p9l1653t68r1749b105],
11	combined	VBN	O	combine	dep	3	SENT_304	[p9l1765t77r1847b97, p9l549t120r641b149],
12	(	NN	O	(	nn	14	SENT_304	[p9l660t120r735b156],
13	19	CD	NUMBER	19	num	14	SENT_304	[p9l660t120r735b156],
14	)	NN	O	)	dobj	11	SENT_304	[p9l660t120r735b156],
15	,	,	O	,	_	0	SENT_304	[p9l660t120r735b156],
16	a	DT	O	a	det	17	SENT_304	[p9l756t129r773b149],
17	regimen	NN	O	regimen	nsubjpass	29	SENT_304	[p9l791t120r926b158],
18	consisting	VBG	O	consist	partmod	17	SENT_304	[p9l944t120r1111b158],
19	of	IN	O	of	_	0	SENT_304	[p9l1131t120r1167b149],
20	paclitaxel	NN	O	paclitaxel	nn	24	SENT_304	[p9l1182t120r1342b158],
21	(	CD	NUMBER	(	num	24	SENT_304	[p9l1361t120r1449b156],
22	24-h	JJ	O	24-h	amod	24	SENT_304	[p9l1361t120r1449b156],
23	schedule	NN	O	schedule	nn	24	SENT_304	[p9l1469t120r1624b156],
24	)	NN	O	)	prep_of	18	SENT_304	[p9l1469t120r1624b156],
25	followed	VBN	O	follow	_	0	SENT_304	[p9l1643t120r1790b149],
26	by	IN	O	by	prepc_followed_by	18	SENT_304	[p9l1808t120r1848b158],
27	cisplatin	NN	O	cisplatin	pobj	18	SENT_304	[p9l550t172r689b210],
28	was	VBD	O	be	auxpass	29	SENT_304	[p9l707t181r769b201],
29	compared	VBN	O	compare	_	0	SENT_304	[p9l790t172r952b210],
30	with	IN	O	with	_	0	SENT_304	[p9l970t172r1043b201],
31	a	DT	O	a	det	33	SENT_304	[p9l1063t181r1080b201],
32	standard	JJ	O	standard	amod	33	SENT_304	[p9l1099t172r1238b201],
33	regimen	NN	O	regimen	prep_with	29	SENT_304	[p9l1256t172r1391b210],
34	of	IN	O	of	_	0	SENT_304	[p9l1410t172r1446b201],
35	cyclophosphamide	NN	O	cyclophosphamide	prep_of	33	SENT_304	[p9l1462t172r1771b210],
36	and	CC	O	and	_	0	SENT_304	[p9l1791t172r1849b201],
37	cisplatin	NN	O	cisplatin	prep_of	33	SENT_304	[p9l550t224r689b262],
38	in	IN	O	in	_	0	SENT_304	[p9l700t224r732b253],
39	untreated	JJ	O	untreated	amod	40	SENT_304	[p9l743t224r897b253],
40	women	NNS	O	woman	prep_in	29	SENT_304	[p9l909t233r1029b253],
41	with	IN	O	with	_	0	SENT_304	[p9l1042t224r1114b253],
42	stage	NN	O	stage	prep_with	40	SENT_304	[p9l1128t229r1210b262],
43	IV	CD	NUMBER	iv	num	42	SENT_304	[p9l1222t225r1265b253],
44	or	CC	O	or	_	0	SENT_304	[p9l1278t233r1311b253],
45	III	CD	NUMBER	iii	num	47	SENT_304	[p9l1322t225r1363b253],
46	ovarian	JJ	O	ovarian	amod	47	SENT_304	[p9l1375t224r1498b253],
47	cancer	NN	O	cancer	prep_in	29	SENT_304	[p9l1510t233r1618b253],
48	(	CD	NUMBER	(	number	49	SENT_304	[p9l1630t224r1704b260],
49	54	CD	NUMBER	54	num	50	SENT_304	[p9l1630t224r1704b260],
50	)	NN	O	)	dep	47	SENT_304	[p9l1630t224r1704b260],
51	.	.	O	.	_	0	SENT_304	[p9l1630t224r1704b260],

1	Clinical	JJ	O	clinical	amod	2	SENT_305	[p9l1719t224r1849b253],
2	responses	NNS	O	response	nsubj	3	SENT_305	[p9l549t286r708b314],
3	occurred	VBD	O	occur	_	0	SENT_305	[p9l727t276r871b305],
4	in	IN	O	in	_	0	SENT_305	[p9l887t276r918b305],
5	60	CD	NUMBER	60	num	8	SENT_305	[p9l936t276r975b306],
6	and	CC	O	and	_	0	SENT_305	[p9l994t276r1052b305],
7	73	CD	PERCENT	73	conj_and	5	SENT_305	[p9l1069t277r1142b306],
8	%	NN	PERCENT	%	prep_in	3	SENT_305	[p9l1069t277r1142b306],
9	of	IN	O	of	_	0	SENT_305	[p9l1161t276r1197b305],
10	women	NNS	O	woman	prep_of	8	SENT_305	[p9l1211t286r1332b305],
11	in	IN	O	in	_	0	SENT_305	[p9l1349t276r1381b305],
12	the	DT	O	the	det	16	SENT_305	[p9l1397t276r1447b305],
13	cyclophosphamide	NN	O	cyclophosphamide	nn	16	SENT_305	[p9l1464t276r1773b314],
14	and	CC	O	and	_	0	SENT_305	[p9l1791t276r1849b305],
15	paclitaxel	NN	O	paclitaxel	nn	16	SENT_305	[p9l549t329r709b366],
16	groups	NNS	O	group	prep_in	10	SENT_305	[p9l721t338r841b366],
17	,	,	O	,	_	0	SENT_305	[p9l721t338r841b366],
18	respectively	RB	O	respectively	advmod	8	SENT_305	[p9l854t329r1053b366],
19	(	CD	NUMBER	(	num	20	SENT_305	[p9l1066t329r1101b364],
20	P	NN	O	p	dep	8	SENT_305	[p9l1066t329r1101b364],
21	=	JJ	O	=	amod	23	SENT_305	[p9l1113t341r1134b352],
22	0.01	CD	NUMBER	0.01	tmod	21	SENT_305	[p9l1146t329r1240b364],
23	)	NN	O	)	dep	20	SENT_305	[p9l1146t329r1240b364],
24	,	,	O	,	_	0	SENT_305	[p9l1146t329r1240b364],
25	and	CC	O	and	_	0	SENT_305	[p9l1253t329r1311b358],
26	paclitaxel	NN	O	paclitaxel	nsubjpass	28	SENT_305	[p9l1322t329r1482b366],
27	was	VBD	O	be	auxpass	28	SENT_305	[p9l1493t338r1555b358],
28	associated	VBN	O	associate	conj_and	3	SENT_305	[p9l1568t329r1737b358],
29	with	IN	O	with	_	0	SENT_305	[p9l1748t329r1821b358],
30	a	DT	O	a	det	32	SENT_305	[p9l1833t338r1850b358],
31	modest	JJ	O	modest	amod	32	SENT_305	[p9l549t381r668b410],
32	improvement	NN	O	improvement	prep_with	28	SENT_305	[p9l686t381r906b419],
33	in	IN	O	in	prep	32	SENT_305	[p9l923t381r954b410],
34	surgically	RB	O	surgically	pcomp	33	SENT_305	[p9l973t381r1133b419],
35	defined	VBN	O	define	partmod	32	SENT_305	[p9l1152t381r1275b410],
36	CR	NN	O	cr	nn	46	SENT_305	[p9l1292t381r1355b415],
37	,	,	O	,	_	0	SENT_305	[p9l1292t381r1355b415],
38	26	CD	NUMBER	26	appos	36	SENT_305	[p9l1375t381r1414b410],
39	vs	CC	O	vs	_	0	SENT_305	[p9l1432t390r1467b410],
40	20	CD	PERCENT	20	num	41	SENT_305	[p9l1486t381r1559b410],
41	%	NN	PERCENT	%	conj_vs	36	SENT_305	[p9l1486t381r1559b410],
42	(	CD	NUMBER	(	num	43	SENT_305	[p9l1579t381r1616b417],
43	P	NN	O	p	dep	41	SENT_305	[p9l1579t381r1616b417],
44	=	JJ	O	=	amod	46	SENT_305	[p9l1633t393r1655b405],
45	0.08	CD	NUMBER	0.08	tmod	44	SENT_305	[p9l1673t381r1766b417],
46	)	NN	O	)	dobj	35	SENT_305	[p9l1673t381r1766b417],
47	.	.	O	.	_	0	SENT_305	[p9l1673t381r1766b417],

1	The	DT	O	the	det	3	SENT_306	[p9l1785t381r1848b410],
2	paclitaxel	NN	O	paclitaxel	nn	3	SENT_306	[p9l549t433r709b471],
3	regimen	NN	O	regimen	nsubj	4	SENT_306	[p9l727t433r862b471],
4	reduced	VBD	O	reduce	_	0	SENT_306	[p9l880t433r1011b462],
5	the	DT	O	the	det	6	SENT_306	[p9l1029t433r1078b462],
6	risk	NN	O	risk	dobj	4	SENT_306	[p9l1096t433r1159b462],
7	of	IN	O	of	_	0	SENT_306	[p9l1177t433r1213b462],
8	recurrence	NN	O	recurrence	prep_of	6	SENT_306	[p9l1228t442r1402b462],
9	by	IN	O	by	_	0	SENT_306	[p9l1419t433r1460b471],
10	32	CD	PERCENT	32	num	11	SENT_306	[p9l1480t433r1563b467],
11	%	NN	PERCENT	%	prep_by	4	SENT_306	[p9l1480t433r1563b467],
12	,	,	O	,	_	0	SENT_306	[p9l1480t433r1563b467],
13	and	CC	O	and	_	0	SENT_306	[p9l1584t433r1642b462],
14	the	DT	O	the	det	16	SENT_306	[p9l1660t433r1709b462],
15	median	JJ	O	median	amod	16	SENT_306	[p9l1728t433r1849b462],
16	duration	NN	O	duration	nsubj	26	SENT_306	[p9l550t485r686b515],
17	of	IN	O	of	_	0	SENT_306	[p9l702t485r737b515],
18	progression	NN	O	progression	npadvmod	20	SENT_306	[p9l749t485r1019b523],
19	—	CD	NUMBER	—	num	18	SENT_306	[p9l749t485r1019b523],
20	free	JJ	O	free	amod	21	SENT_306	[p9l749t485r1019b523],
21	survival	NN	O	survival	prep_of	16	SENT_306	[p9l1036t485r1166b515],
22	was	VBD	O	be	cop	26	SENT_306	[p9l1182t495r1244b515],
23	18	CD	NUMBER	18	nn	26	SENT_306	[p9l1264t486r1299b515],
24	and	CC	O	and	_	0	SENT_306	[p9l1316t485r1374b515],
25	13	CD	DURATION	13	nn	26	SENT_306	[p9l1392t486r1427b515],
26	months	NNS	NUMBER	month	conj_and	4	SENT_306	[p9l1443t486r1563b515],
27	in	IN	O	in	_	0	SENT_306	[p9l1579t485r1610b514],
28	the	DT	O	the	det	32	SENT_306	[p9l1625t486r1674b515],
29	paclitaxel	NN	O	paclitaxel	nn	32	SENT_306	[p9l1688t485r1849b523],
30	and	CC	O	and	_	0	SENT_306	[p9l550t538r608b567],
31	cyclophospharnide	NN	O	cyclophospharnide	nn	32	SENT_306	[p9l625t537r934b575],
32	groups	NNS	O	group	prep_in	26	SENT_306	[p9l950t547r1070b575],
33	,	,	O	,	_	0	SENT_306	[p9l950t547r1070b575],
34	respectively	RB	O	respectively	advmod	26	SENT_306	[p9l1088t537r1295b575],
35	.	.	O	.	_	0	SENT_306	[p9l1088t537r1295b575],

1	More	RBR	O	more	advmod	2	SENT_307	[p9l1313t538r1402b567],
2	importantly	RB	O	importantly	advmod	10	SENT_307	[p9l1418t537r1619b575],
3	,	,	O	,	_	0	SENT_307	[p9l1418t537r1619b575],
4	survival	NN	O	survival	nsubj	10	SENT_307	[p9l1638t537r1769b567],
5	was	VBD	O	be	cop	10	SENT_307	[p9l1785t547r1847b567],
6	significantly	RB	O	significantly	advmod	7	SENT_307	[p9l551t591r755b628],
7	longer	JJR	O	longer	advmod	10	SENT_307	[p9l774t591r880b628],
8	(	CD	NUMBER	(	num	9	SENT_307	[p9l899t591r936b626],
9	P	NN	O	p	npadvmod	10	SENT_307	[p9l899t591r936b626],
10	<	JJR	O	<	_	0	SENT_307	[p9l955t598r976b619],
11	0.001	CD	NUMBER	0.001	num	12	SENT_307	[p9l995t591r1100b626],
12	)	NN	O	)	npadvmod	10	SENT_307	[p9l995t591r1100b626],
13	in	IN	O	in	_	0	SENT_307	[p9l1120t591r1151b619],
14	the	DT	O	the	det	18	SENT_307	[p9l1170t591r1219b620],
15	paclitaxel	NN	O	paclitaxel	nn	18	SENT_307	[p9l1238t591r1398b628],
16	group	NN	O	group	nn	18	SENT_307	[p9l1417t600r1512b628],
17	(	CD	NUMBER	(	num	18	SENT_307	[p9l1532t591r1675b627],
18	median	NN	O	median	prep_in	10	SENT_307	[p9l1532t591r1675b627],
19	,	,	O	,	_	0	SENT_307	[p9l1532t591r1675b627],
20	38	CD	NUMBER	38	appos	18	SENT_307	[p9l1695t591r1733b620],
21	vs	CC	O	vs	_	0	SENT_307	[p9l1754t600r1788b620],
22	24	CD	DURATION	24	num	23	SENT_307	[p9l1809t591r1848b619],
23	months	NNS	NUMBER	month	appos	18	SENT_307	[p9l549t643r693b679],
24	)	RB	O	)	dep	10	SENT_307	[p9l549t643r693b679],
25	,	,	O	,	_	0	SENT_307	[p9l549t643r693b679],
26	suggesting	VBG	O	suggest	xcomp	10	SENT_307	[p9l712t643r887b680],
27	that	IN	O	that	complm	34	SENT_307	[p9l904t643r966b672],
28	it	PRP	O	it	nsubj	34	SENT_307	[p9l982t643r1004b672],
29	should	MD	O	should	aux	34	SENT_307	[p9l1021t643r1130b672],
30	become	VB	O	become	cop	34	SENT_307	[p9l1146t643r1274b672],
31	the	DT	O	the	det	34	SENT_307	[p9l1290t643r1340b672],
32	new	JJ	O	new	amod	34	SENT_307	[p9l1357t652r1424b672],
33	standard	NN	O	standard	nn	34	SENT_307	[p9l1442t643r1580b672],
34	therapy	NN	O	therapy	ccomp	26	SENT_307	[p9l1596t643r1719b681],
35	for	IN	O	for	_	0	SENT_307	[p9l1736t643r1784b672],
36	the	DT	O	the	det	38	SENT_307	[p9l1799t643r1848b672],
37	initial	JJ	O	initial	amod	38	SENT_307	[p9l549t695r645b724],
38	treatment	NN	O	treatment	prep_for	34	SENT_307	[p9l658t699r814b724],
39	of	IN	O	of	_	0	SENT_307	[p9l827t695r863b724],
40	advanced	JJ	O	advanced	amod	42	SENT_307	[p9l874t695r1029b724],
41	ovarian	JJ	O	ovarian	amod	42	SENT_307	[p9l1042t695r1165b724],
42	cancer	NN	O	cancer	prep_of	38	SENT_307	[p9l1179t704r1293b724],
43	.	.	O	.	_	0	SENT_307	[p9l1179t704r1293b724],

1	Current	JJ	DATE	current	amod	2	SENT_308	[p9l1309t695r1434b724],
2	studies	NNS	O	study	nsubj	3	SENT_308	[p9l1448t695r1560b724],
3	address	VBP	O	address	_	0	SENT_308	[p9l1575t695r1697b724],
4	the	DT	O	the	det	5	SENT_308	[p9l1711t695r1760b724],
5	relative	JJ	O	relative	dobj	3	SENT_308	[p9l1773t695r1847b724, p9l549t820r610b849],

1	benefits	NNS	O	benefit	_	0	SENT_309	[p9l627t820r757b849],
2	of	IN	O	of	_	0	SENT_309	[p9l775t820r811b849],
3	carboplatin	NN	O	carboplatin	prep_of	1	SENT_309	[p9l826t820r1011b858],
4	versus	CC	O	versus	prep	3	SENT_309	[p9l1029t829r1132b849],
5	cisplatin	NN	O	cisplatin	dep	4	SENT_309	[p9l1151t820r1289b858],
6	and	CC	O	and	_	0	SENT_309	[p9l1308t820r1366b849],
7	whether	IN	O	whether	dep	18	SENT_309	[p9l1383t820r1516b849],
8	the	DT	O	the	det	9	SENT_309	[p9l1532t820r1582b849],
9	efficacy	NN	O	efficacy	nsubjpass	18	SENT_309	[p9l1600t820r1731b858],
10	of	IN	O	of	_	0	SENT_309	[p9l1749t820r1785b849],
11	the	DT	O	the	det	15	SENT_309	[p9l1799t820r1848b849],
12	paclitaxel	NN	O	paclitaxel	nn	15	SENT_309	[p9l549t872r863b910],
13	—	NN	O	—	nn	15	SENT_309	[p9l549t872r863b910],
14	cisplatin	NN	O	cisplatin	nn	15	SENT_309	[p9l549t872r863b910],
15	regimen	NN	O	regimen	prep_of	9	SENT_309	[p9l875t872r1010b910],
16	could	MD	O	could	aux	18	SENT_309	[p9l1023t872r1114b901],
17	be	VB	O	be	auxpass	18	SENT_309	[p9l1125t872r1164b901],
18	improved	VBN	O	improve	conj_and	1	SENT_309	[p9l1177t872r1335b910],
19	by	IN	O	by	_	0	SENT_309	[p9l1346t872r1387b910],
20	using	VBG	O	use	agent	18	SENT_309	[p9l1399t872r1488b910],
21	shorter	JJR	O	shorter	amod	22	SENT_309	[p9l1502t872r1616b901],
22	(	NN	O	(	dobj	20	SENT_309	[p9l1629t872r1659b908],
23	3	CD	NUMBER	3	num	24	SENT_309	[p9l1629t872r1659b908],
24	h	NN	O	h	dep	31	SENT_309	[p9l1673t872r1705b908],
25	)	CD	NUMBER	)	dep	24	SENT_309	[p9l1673t872r1705b908],
26	or	CC	O	or	_	0	SENT_309	[p9l1719t881r1753b901],
27	more	JJR	O	more	dep	24	SENT_309	[p9l1765t881r1848b901],
28	prolonged	JJ	O	prolonged	amod	29	SENT_309	[p9l549t924r716b962],
29	(	NN	O	(	dep	25	SENT_309	[p9l733t924r785b960],
30	96	CD	NUMBER	96	num	31	SENT_309	[p9l733t924r785b960],
31	h	NN	O	h	dep	20	SENT_309	[p9l801t924r834b960],
32	)	CD	NUMBER	)	num	34	SENT_309	[p9l801t924r834b960],
33	paclitaxel	NN	O	paclitaxel	nn	34	SENT_309	[p9l850t924r1010b962],
34	schedules	NNS	O	schedule	dep	31	SENT_309	[p9l1027t924r1193b953],
35	.	.	O	.	_	0	SENT_309	[p9l1027t924r1193b953],

1	Untreated	JJ	O	untreated	amod	2	SENT_310	[p9l1211t924r1374b953],
2	patients	NNS	O	patient	nsubjpass	6	SENT_310	[p9l1388t924r1515b962],
3	are	VBP	O	be	aux	6	SENT_310	[p9l1532t933r1580b953],
4	also	RB	O	also	advmod	6	SENT_310	[p9l1596t924r1661b953],
5	being	VBG	O	be	auxpass	6	SENT_310	[p9l1676t924r1767b962],
6	randomized	VBN	O	randomize	_	0	SENT_310	[p9l1782t933r1847b953, p9l550t976r691b1005],
7	to	TO	O	to	_	0	SENT_310	[p9l707t981r738b1005],
8	treatment	NN	O	treatment	prep_to	6	SENT_310	[p9l755t981r911b1005],
9	with	IN	O	with	_	0	SENT_310	[p9l928t976r1000b1005],
10	either	CC	O	either	preconj	11	SENT_310	[p9l1017t976r1111b1005],
11	paclitaxel	NN	O	paclitaxel	prep_with	8	SENT_310	[p9l1126t976r1286b1014],
12	and	CC	O	and	_	0	SENT_310	[p9l1304t976r1362b1005],
13	cisplatin	NN	O	cisplatin	conj_and	11	SENT_310	[p9l1378t976r1526b1014],
14	,	,	O	,	_	0	SENT_310	[p9l1378t976r1526b1014],
15	cisplatin	NN	O	cisplatin	prep_to	6	SENT_310	[p9l1544t976r1683b1014],
16	alone	RB	O	alone	advmod	15	SENT_310	[p9l1701t976r1797b1011],
17	,	,	O	,	_	0	SENT_310	[p9l1701t976r1797b1011],
18	or	CC	O	or	_	0	SENT_310	[p9l1815t985r1849b1005],
19	paclitaxel	NN	O	paclitaxel	prep_to	6	SENT_310	[p9l549t1054r709b1092],
20	alone	RB	O	alone	amod	19	SENT_310	[p9l721t1054r809b1083],
21	to	TO	O	to	aux	22	SENT_310	[p9l821t1059r851b1083],
22	determine	VB	O	determine	xcomp	20	SENT_310	[p9l864t1054r1028b1083],
23	whether	IN	O	whether	complm	28	SENT_310	[p9l1039t1054r1172b1083],
24	the	DT	O	the	det	25	SENT_310	[p9l1180t1055r1229b1083],
25	drugs	NNS	O	drug	nsubj	28	SENT_310	[p9l1241t1054r1330b1092],
26	are	VBP	O	be	cop	28	SENT_310	[p9l1343t1064r1392b1083],
27	more	RBR	O	more	advmod	28	SENT_310	[p9l1402t1064r1486b1083],
28	effective	JJ	O	effective	ccomp	22	SENT_310	[p9l1498t1054r1641b1083],
29	in	IN	O	in	_	0	SENT_310	[p9l1651t1054r1682b1083],
30	combination	NN	O	combination	prep_in	28	SENT_310	[p9l1693t1054r1847b1083, p9l549t1106r613b1136],
31	or	CC	O	or	cc	20	SENT_310	[p9l624t1115r658b1136],
32	individually	RB	O	individually	advmod	20	SENT_310	[p9l669t1106r876b1144],
33	.	.	O	.	_	0	SENT_310	[p9l669t1106r876b1144],

1	Two	CD	NUMBER	two	num	3	SENT_311	[p9l599t1159r673b1187],
2	important	JJ	O	important	amod	3	SENT_311	[p9l684t1158r846b1196],
3	issues	NNS	O	issue	nsubj	4	SENT_311	[p9l855t1158r1129b1187],
4	—	VBP	O	—	_	0	SENT_311	[p9l855t1158r1129b1187],
5	whether	IN	O	whether	complm	19	SENT_311	[p9l855t1158r1129b1187],
6	the	DT	O	the	det	7	SENT_311	[p9l1139t1158r1188b1187],
7	schedule	NN	O	schedule	nsubj	19	SENT_311	[p9l1200t1158r1343b1187],
8	of	IN	O	of	_	0	SENT_311	[p9l1353t1158r1389b1187],
9	administration	NN	O	administration	prep_of	7	SENT_311	[p9l1397t1158r1635b1187],
10	of	IN	O	of	_	0	SENT_311	[p9l1645t1158r1681b1187],
11	paclitaxel	NN	O	paclitaxel	prep_of	9	SENT_311	[p9l1688t1158r1849b1196],
12	(	CD	NUMBER	(	num	11	SENT_311	[p9l550t1210r645b1246],
13	short	JJ	O	short	advmod	9	SENT_311	[p9l550t1210r645b1246],
14	versus	CC	O	versus	prep	7	SENT_311	[p9l658t1219r761b1240],
15	long	JJ	O	long	amod	17	SENT_311	[p9l775t1210r848b1248],
16	infusions	NNS	O	infusion	nn	17	SENT_311	[p9l861t1210r1024b1246],
17	)	NN	O	)	dep	14	SENT_311	[p9l861t1210r1024b1246],
18	is	VBZ	O	be	cop	19	SENT_311	[p9l1039t1210r1064b1240],
19	important	JJ	O	important	ccomp	4	SENT_311	[p9l1078t1210r1239b1248],
20	from	IN	O	from	_	0	SENT_311	[p9l1251t1210r1331b1240],
21	either	CC	O	either	preconj	23	SENT_311	[p9l1344t1210r1437b1240],
22	a	DT	O	a	det	23	SENT_311	[p9l1450t1219r1467b1240],
23	toxicologic	JJ	O	toxicologic	prep_from	19	SENT_311	[p9l1479t1210r1664b1248],
24	or	CC	O	or	_	0	SENT_311	[p9l1678t1219r1711b1240],
25	a	DT	O	a	det	27	SENT_311	[p9l1724t1219r1741b1240],
26	therapeutic	JJ	O	therapeutic	amod	27	SENT_311	[p9l1753t1210r1847b1240, p9l549t1262r649b1300],
27	standpoint	NN	O	standpoint	prep_from	19	SENT_311	[p9l663t1262r834b1300],
28	and	CC	O	and	_	0	SENT_311	[p9l848t1262r906b1291],
29	whether	IN	O	whether	complm	35	SENT_311	[p9l919t1262r1052b1291],
30	a	DT	O	a	det	34	SENT_311	[p9l1065t1271r1082b1291],
31	dose	NN	O	dose	nn	34	SENT_311	[p9l1095t1262r1328b1300],
32	—	NN	O	—	nn	34	SENT_311	[p9l1095t1262r1328b1300],
33	response	NN	O	response	nn	34	SENT_311	[p9l1095t1262r1328b1300],
34	relationship	NN	O	relationship	nsubj	35	SENT_311	[p9l1341t1262r1535b1300],
35	exists	VBZ	O	exist	conj_and	19	SENT_311	[p9l1549t1262r1641b1291],
36	in	IN	O	in	mark	45	SENT_311	[p9l1655t1262r1687b1291],
37	the	DT	O	the	det	41	SENT_311	[p9l1699t1262r1749b1291],
38	usual	JJ	O	usual	amod	41	SENT_311	[p9l1762t1262r1848b1291],
39	dosing	NN	O	dosing	nn	41	SENT_311	[p9l550t1314r658b1352],
40	range	NN	O	range	nn	41	SENT_311	[p9l672t1323r856b1352],
41	—	NN	O	—	nsubjpass	45	SENT_311	[p9l672t1323r856b1352],
42	are	VBP	O	be	aux	45	SENT_311	[p9l672t1323r856b1352],
43	also	RB	O	also	advmod	45	SENT_311	[p9l870t1314r935b1344],
44	being	VBG	O	be	auxpass	45	SENT_311	[p9l949t1314r1040b1352],
45	studied	VBN	O	study	advcl	35	SENT_311	[p9l1056t1314r1173b1344],
46	in	IN	O	in	_	0	SENT_311	[p9l1187t1314r1218b1343],
47	refractory	JJ	O	refractory	prep_in	45	SENT_311	[p9l1231t1314r1394b1352],
48	and	CC	O	and	_	0	SENT_311	[p9l1408t1314r1466b1344],
49	recurrent	JJ	O	recurrent	amod	51	SENT_311	[p9l1479t1319r1629b1344],
50	ovarian	JJ	O	ovarian	amod	51	SENT_311	[p9l1642t1314r1765b1344],
51	cancer	NN	O	cancer	prep_in	45	SENT_311	[p9l1779t1323r1847b1344, p9l549t1375r607b1395],
52	.	.	O	.	_	0	SENT_311	[p9l1779t1323r1847b1344, p9l549t1375r607b1395],

1	In	IN	O	in	_	0	SENT_312	[p9l622t1367r655b1395],
2	a	DT	O	a	det	5	SENT_312	[p9l669t1375r687b1395],
3	phase	NN	O	phase	nn	5	SENT_312	[p9l699t1366r792b1404],
4	III	CD	NUMBER	iii	num	5	SENT_312	[p9l806t1367r846b1395],
5	study	NN	O	study	prep_in	22	SENT_312	[p9l861t1366r947b1404],
6	that	WDT	O	that	nsubjpass	9	SENT_312	[p9l961t1366r1023b1395],
7	was	VBD	O	be	auxpass	9	SENT_312	[p9l1036t1375r1098b1395],
8	previously	RB	DATE	previously	advmod	9	SENT_312	[p9l1112t1366r1286b1404],
9	discussed	VBN	O	discuss	rcmod	5	SENT_312	[p9l1300t1366r1458b1395],
10	in	IN	O	in	_	0	SENT_312	[p9l1471t1366r1502b1395],
11	which	WDT	O	which	dobj	14	SENT_312	[p9l1516t1366r1615b1395],
12	patients	NNS	O	patient	nsubjpass	14	SENT_312	[p9l1628t1366r1755b1404],
13	were	VBD	O	be	auxpass	14	SENT_312	[p9l1770t1375r1848b1395],
14	randomized	VBN	O	randomize	prepc_in	9	SENT_312	[p9l549t1417r746b1447],
15	to	TO	O	to	_	0	SENT_312	[p9l767t1422r798b1447],
16	treatment	NN	O	treatment	prep_to	14	SENT_312	[p9l821t1422r978b1447],
17	with	IN	O	with	_	0	SENT_312	[p9l1000t1417r1072b1447],
18	two	CD	NUMBER	two	num	21	SENT_312	[p9l1094t1422r1154b1447],
19	different	JJ	O	different	amod	21	SENT_312	[p9l1177t1417r1319b1447],
20	paclitaxel	NN	O	paclitaxel	nn	21	SENT_312	[p9l1339t1417r1500b1455],
21	doses	NNS	O	dose	prep_with	14	SENT_312	[p9l1521t1417r1610b1447],
22	(	VBP	O	(	_	0	SENT_312	[p9l1634t1417r1706b1453],
23	135	CD	NUMBER	135	dobj	22	SENT_312	[p9l1634t1417r1706b1453],
24	vs	CC	O	vs	_	0	SENT_312	[p9l1730t1426r1765b1447],
25	175	CD	NUMBER	175	num	27	SENT_312	[p9l1791t1417r1846b1447],
26	mg/m2	NN	O	mg/m2	nn	27	SENT_312	[p9l549t1457r674b1506],
27	)	NN	O	)	nsubj	32	SENT_312	[p9l549t1457r674b1506],
28	and	CC	O	and	_	0	SENT_312	[p9l688t1469r746b1498],
29	two	CD	NUMBER	two	num	31	SENT_312	[p9l758t1473r819b1498],
30	different	JJ	O	different	amod	31	SENT_312	[p9l832t1469r974b1498],
31	schedules	NNS	O	schedule	nsubj	32	SENT_312	[p9l986t1469r1144b1498],
32	(	VBP	O	(	rcmod	23	SENT_312	[p9l1158t1469r1210b1504],
33	24	CD	NUMBER	24	dobj	32	SENT_312	[p9l1158t1469r1210b1504],
34	vs	CC	O	vs	_	0	SENT_312	[p9l1223t1478r1258b1498],
35	3	CD	NUMBER	3	num	36	SENT_312	[p9l1272t1469r1289b1498],
36	h	NN	O	h	dobj	32	SENT_312	[p9l1302t1469r1335b1504],
37	)	CD	NUMBER	)	nsubj	22	SENT_312	[p9l1302t1469r1335b1504],
38	given	VBN	O	give	prep	37	SENT_312	[p9l1349t1469r1439b1506],
39	with	IN	O	with	pcomp	38	SENT_312	[p9l1451t1469r1524b1498],
40	premedication	NN	O	premedication	pobj	39	SENT_312	[p9l1535t1469r1772b1506],
41	(	CD	NUMBER	(	num	40	SENT_312	[p9l1784t1469r1848b1504],
42	see	VBP	O	see	rcmod	40	SENT_312	[p9l1784t1469r1848b1504],
43	above	IN	O	above	_	0	SENT_312	[p9l550t1520r670b1556],
44	)	NN	O	)	prep_above	42	SENT_312	[p9l550t1520r670b1556],
45	,	,	O	,	_	0	SENT_312	[p9l550t1520r670b1556],
46	progression	NN	O	progression	appos	44	SENT_312	[p9l690t1520r961b1558],
47	—	CD	NUMBER	—	num	49	SENT_312	[p9l690t1520r961b1558],
48	free	JJ	O	free	amod	49	SENT_312	[p9l690t1520r961b1558],
49	survival	NN	O	survival	nsubj	76	SENT_312	[p9l982t1520r1113b1549],
50	was	VBD	O	be	cop	76	SENT_312	[p9l1133t1529r1196b1549],
51	significantly	RB	O	significantly	advmod	52	SENT_312	[p9l1218t1520r1422b1558],
52	longer	RBR	O	longer	advmod	76	SENT_312	[p9l1442t1520r1547b1558],
53	in	IN	O	in	_	0	SENT_312	[p9l1566t1520r1597b1549],
54	the	DT	O	the	det	58	SENT_312	[p9l1617t1520r1666b1549],
55	high	JJ	O	high	amod	58	SENT_312	[p9l1686t1520r1848b1558],
56	—	NN	O	—	nn	58	SENT_312	[p9l1686t1520r1848b1558],
57	dose	NN	O	dose	nn	58	SENT_312	[p9l1686t1520r1848b1558],
58	group	NN	O	group	prep_in	52	SENT_312	[p9l550t1581r644b1610],
59	than	IN	O	than	_	0	SENT_312	[p9l655t1572r725b1602],
60	in	IN	O	in	_	0	SENT_312	[p9l735t1572r767b1601],
61	the	DT	O	the	det	65	SENT_312	[p9l777t1572r827b1602],
62	low	JJ	O	low	amod	65	SENT_312	[p9l837t1572r988b1602],
63	—	NN	O	—	nn	65	SENT_312	[p9l837t1572r988b1602],
64	dose	NN	O	dose	nn	65	SENT_312	[p9l837t1572r988b1602],
65	group	NN	O	group	prep_in	67	SENT_312	[p9l999t1581r1093b1610],
66	[	CD	NUMBER	[	number	67	SENT_312	[p9l1107t1572r1158b1608],
67	19	CD	NUMBER	19	prep_than	58	SENT_312	[p9l1107t1572r1158b1608],
68	vs	CC	O	vs	_	0	SENT_312	[p9l1169t1581r1204b1602],
69	14	CD	DURATION	14	num	70	SENT_312	[p9l1219t1572r1255b1601],
70	weeks	NNS	NUMBER	week	conj_vs	67	SENT_312	[p9l1266t1572r1367b1602],
71	(	CD	NUMBER	(	num	72	SENT_312	[p9l1380t1573r1417b1608],
72	P	NN	O	p	npadvmod	73	SENT_312	[p9l1380t1573r1417b1608],
73	=	JJ	O	=	amod	67	SENT_312	[p9l1428t1585r1449b1596],
74	0.02	CD	NUMBER	0.02	num	76	SENT_312	[p9l1460t1572r1568b1608],
75	)	CD	NUMBER	)	num	76	SENT_312	[p9l1460t1572r1568b1608],
76	]	NN	O	]	ccomp	42	SENT_312	[p9l1460t1572r1568b1608],
77	,	,	O	,	_	0	SENT_312	[p9l1460t1572r1568b1608],
78	but	CC	O	but	_	0	SENT_312	[p9l1579t1572r1632b1602],
79	survival	NN	O	survival	nsubj	82	SENT_312	[p9l1644t1572r1774b1602],
80	was	VBD	O	be	cop	82	SENT_312	[p9l1785t1581r1847b1602],
81	THE	DT	O	the	det	82	SENT_312	[p9l1491t1629r1563b1655],
82	TAXANES	NN	O	taxane	conj_but	76	SENT_312	[p9l1573t1629r1745b1655],
83	365	CD	NUMBER	365	num	82	SENT_312	[p9l1794t1629r1847b1655],

1	similar	JJ	O	similar	amod	7	SENT_313	[p9l551t1713r664b1743],
2	in	IN	O	in	_	0	SENT_313	[p9l678t1713r709b1742],
3	both	CC	O	both	preconj	4	SENT_313	[p9l723t1713r796b1743],
4	dose	NN	O	dose	prep_in	1	SENT_313	[p9l811t1713r885b1743],
5	and	CC	O	and	_	0	SENT_313	[p9l901t1713r959b1743],
6	schedule	NN	O	schedule	prep_in	1	SENT_313	[p9l975t1713r1117b1743],
7	groups	NNS	O	group	nsubj	8	SENT_313	[p9l1132t1722r1242b1751],
8	(	VBP	O	(	_	0	SENT_313	[p9l1260t1713r1334b1749],
9	30	CD	NUMBER	30	num	10	SENT_313	[p9l1260t1713r1334b1749],
10	)	CD	NUMBER	)	dobj	8	SENT_313	[p9l1260t1713r1334b1749],
11	.	.	O	.	_	0	SENT_313	[p9l1260t1713r1334b1749],

1	Although	IN	O	although	mark	6	SENT_314	[p9l1351t1713r1507b1751],
2	regulatory	JJ	O	regulatory	amod	3	SENT_314	[p9l1521t1713r1690b1751],
3	approval	NN	O	approval	nsubjpass	6	SENT_314	[p9l1706t1713r1849b1751],
4	was	VBD	O	be	auxpass	6	SENT_314	[p9l549t1774r612b1794],
5	originally	RB	O	originally	advmod	6	SENT_314	[p9l627t1765r787b1802],
6	granted	VBN	O	grant	advcl	28	SENT_314	[p9l802t1765r925b1802],
7	for	IN	O	for	_	0	SENT_314	[p9l939t1765r987b1794],
8	paclitaxel	NN	O	paclitaxel	nn	9	SENT_314	[p9l999t1765r1160b1802],
9	doses	NNS	O	dose	prep_for	6	SENT_314	[p9l1174t1765r1264b1794],
10	of	IN	O	of	_	0	SENT_314	[p9l1280t1765r1316b1794],
11	135	CD	NUMBER	135	num	12	SENT_314	[p9l1331t1765r1386b1794],
12	mg/m2	NN	O	mg/m2	prep_of	9	SENT_314	[p9l1403t1753r1515b1802],
13	on	IN	O	on	_	0	SENT_314	[p9l1530t1774r1570b1794],
14	a	DT	O	a	det	16	SENT_314	[p9l1585t1774r1602b1794],
15	24-h	JJ	O	24-h	amod	16	SENT_314	[p9l1616t1765r1691b1793],
16	schedule	NN	O	schedule	prep_on	6	SENT_314	[p9l1706t1765r1849b1794],
17	for	IN	O	for	_	0	SENT_314	[p9l549t1815r597b1844],
18	refractory	JJ	O	refractory	prep_for	16	SENT_314	[p9l609t1815r771b1853],
19	and	CC	O	and	_	0	SENT_314	[p9l786t1815r844b1844],
20	recurrent	JJ	O	recurrent	amod	22	SENT_314	[p9l857t1819r1006b1844],
21	ovarian	JJ	O	ovarian	amod	22	SENT_314	[p9l1019t1815r1141b1844],
22	cancer	NN	O	cancer	prep_for	16	SENT_314	[p9l1155t1824r1270b1849],
23	,	,	O	,	_	0	SENT_314	[p9l1155t1824r1270b1849],
24	these	DT	O	these	det	25	SENT_314	[p9l1285t1815r1369b1844],
25	results	NNS	O	result	nsubj	28	SENT_314	[p9l1382t1815r1488b1844],
26	were	VBD	O	be	cop	28	SENT_314	[p9l1503t1824r1582b1844],
27	the	DT	O	the	det	28	SENT_314	[p9l1595t1815r1644b1844],
28	impetus	NN	O	impetus	_	0	SENT_314	[p9l1658t1815r1787b1853],
29	for	IN	O	for	_	0	SENT_314	[p9l1801t1815r1849b1844],
30	the	DT	O	the	det	32	SENT_314	[p9l549t1866r599b1895],
31	subsequent	JJ	O	subsequent	amod	32	SENT_314	[p9l614t1866r796b1904],
32	approval	NN	O	approval	prep_for	28	SENT_314	[p9l810t1866r953b1904],
33	of	IN	O	of	_	0	SENT_314	[p9l968t1866r1003b1895],
34	paclitaxel	NN	O	paclitaxel	nn	35	SENT_314	[p9l1014t1866r1175b1904],
35	doses	NNS	O	dose	prep_of	32	SENT_314	[p9l1188t1866r1278b1895],
36	of	IN	O	of	_	0	SENT_314	[p9l1293t1866r1329b1895],
37	175	CD	NUMBER	175	num	38	SENT_314	[p9l1344t1866r1399b1895],
38	mg/m2	NN	O	mg/m2	prep_of	35	SENT_314	[p9l1415t1855r1527b1904],
39	on	IN	O	on	_	0	SENT_314	[p9l1542t1875r1582b1895],
40	a	DT	O	a	det	42	SENT_314	[p9l1596t1875r1613b1895],
41	3-h	JJ	O	3-h	amod	42	SENT_314	[p9l1628t1866r1681b1895],
42	schedule	NN	O	schedule	prep_on	38	SENT_314	[p9l1696t1866r1846b1895],
43	.	.	O	.	_	0	SENT_314	[p9l1696t1866r1846b1895],

1	Preliminary	JJ	O	preliminary	amod	2	SENT_315	[p9l549t1917r743b1955],
2	results	NNS	O	result	_	0	SENT_315	[p9l760t1917r867b1946],
3	of	IN	O	of	_	0	SENT_315	[p9l885t1917r921b1946],
4	another	DT	O	another	det	5	SENT_315	[p9l936t1917r1059b1946],
5	trial	NN	O	trial	prep_of	2	SENT_315	[p9l1075t1917r1141b1946],
6	in	IN	O	in	_	0	SENT_315	[p9l1158t1917r1189b1946],
7	which	WDT	O	which	rel	13	SENT_315	[p9l1207t1917r1306b1946],
8	women	NNS	O	woman	nsubjpass	13	SENT_315	[p9l1324t1926r1444b1946],
9	with	IN	O	with	_	0	SENT_315	[p9l1461t1917r1534b1946],
10	platinum-resistant	JJ	O	platinum-resistant	amod	11	SENT_315	[p9l1550t1917r1849b1955],
11	cancer	NN	O	cancer	prep_with	8	SENT_315	[p9l549t1977r657b1997],
12	were	VBD	O	be	auxpass	13	SENT_315	[p9l667t1977r746b1997],
13	randomized	VBN	O	randomize	rcmod	5	SENT_315	[p9l756t1968r951b1997],
14	to	TO	O	to	_	0	SENT_315	[p9l961t1973r992b1997],
15	treatment	NN	O	treatment	prep_to	13	SENT_315	[p9l1003t1972r1159b1997],
16	with	IN	O	with	_	0	SENT_315	[p9l1169t1968r1242b1997],
17	paclitaxel	NN	O	paclitaxel	nn	18	SENT_315	[p9l1251t1968r1412b2006],
18	doses	NNS	O	dose	prep_with	2	SENT_315	[p9l1423t1968r1512b1997],
19	of	IN	O	of	_	0	SENT_315	[p9l1524t1968r1560b1997],
20	either	CC	O	either	preconj	21	SENT_315	[p9l1568t1968r1662b1997],
21	135	CD	NUMBER	135	prep_of	2	SENT_315	[p9l1675t1968r1731b1997],
22	or	CC	O	or	_	0	SENT_315	[p9l1744t1977r1778b1997],
23	250	CD	NUMBER	250	num	25	SENT_315	[p9l1788t1968r1848b1997],
24	mg/m2	NN	O	mg/m2	nn	25	SENT_315	[p9l549t2008r661b2057],
25	(	NN	O	(	conj_or	21	SENT_315	[p9l674t2019r753b2057],
26	plus	CC	O	plus	prep	2	SENT_315	[p9l674t2019r753b2057],
27	G	NN	O	g	dep	26	SENT_315	[p9l766t2019r895b2055],
28	.	.	O	.	_	0	SENT_315	[p9l766t2019r895b2055],

1	—	NN	O	—	_	0	SENT_316	[p9l766t2019r895b2055],
2	.	.	O	.	_	0	SENT_316	[p9l766t2019r895b2055],

1	CSF	NN	O	csf	nn	2	SENT_317	[p9l766t2019r895b2055],
2	)	NN	O	)	nsubj	9	SENT_317	[p9l766t2019r895b2055],
3	over	IN	O	over	_	0	SENT_317	[p9l907t2028r980b2049],
4	24	CD	NUMBER	24	num	5	SENT_317	[p9l991t2019r1031b2048],
5	h	NN	O	h	prep_over	2	SENT_317	[p9l1041t2019r1062b2048],
6	(	CD	NUMBER	(	number	7	SENT_317	[p9l1074t2019r1139b2055],
7	55	CD	NUMBER	55	num	8	SENT_317	[p9l1074t2019r1139b2055],
8	)	NN	O	)	dep	5	SENT_317	[p9l1074t2019r1139b2055],
9	indicated	VBD	O	indicate	ccomp	38	SENT_317	[p9l1151t2019r1303b2049],
10	a	DT	O	a	det	14	SENT_317	[p9l1314t2028r1331b2049],
11	slightly	RB	O	slightly	advmod	12	SENT_317	[p9l1343t2019r1464b2057],
12	higher	JJR	O	higher	amod	14	SENT_317	[p9l1475t2019r1581b2057],
13	response	NN	O	response	nn	14	SENT_317	[p9l1590t2028r1734b2057],
14	rate	NN	O	rate	dobj	9	SENT_317	[p9l1745t2024r1807b2049],
15	in	IN	O	in	_	0	SENT_317	[p9l1817t2019r1849b2048],
16	the	DT	O	the	det	20	SENT_317	[p9l549t2071r599b2100],
17	high	JJ	O	high	amod	20	SENT_317	[p9l610t2071r773b2109],
18	—	NN	O	—	nn	20	SENT_317	[p9l610t2071r773b2109],
19	dose	NN	O	dose	nn	20	SENT_317	[p9l610t2071r773b2109],
20	arm	NN	O	arm	prep_in	14	SENT_317	[p9l786t2080r849b2100],
21	compared	VBN	O	compare	_	0	SENT_317	[p9l861t2071r1023b2109],
22	to	TO	O	to	prepc_compared_to	9	SENT_317	[p9l1035t2076r1065b2100],
23	the	DT	O	the	det	27	SENT_317	[p9l1078t2071r1127b2100],
24	low	JJ	O	low	amod	27	SENT_317	[p9l1139t2071r1290b2100],
25	—	NN	O	—	nn	27	SENT_317	[p9l1139t2071r1290b2100],
26	dose	NN	O	dose	nn	27	SENT_317	[p9l1139t2071r1290b2100],
27	arm	NN	O	arm	pobj	9	SENT_317	[p9l1303t2080r1367b2100],
28	(	CD	NUMBER	(	number	29	SENT_317	[p9l1379t2071r1431b2107],
29	36	CD	NUMBER	36	dep	27	SENT_317	[p9l1379t2071r1431b2107],
30	vs	CC	O	vs	_	0	SENT_317	[p9l1444t2080r1479b2100],
31	28	CD	PERCENT	28	num	32	SENT_317	[p9l1492t2071r1590b2107],
32	%	NN	PERCENT	%	pobj	9	SENT_317	[p9l1492t2071r1590b2107],
33	)	CD	NUMBER	)	dep	32	SENT_317	[p9l1492t2071r1590b2107],
34	;	:	O	;	_	0	SENT_317	[p9l1492t2071r1590b2107],
35	however	RB	O	however	advmod	27	SENT_317	[p9l1603t2071r1754b2106],
36	,	,	O	,	_	0	SENT_317	[p9l1603t2071r1754b2106],
37	there	EX	O	there	expl	38	SENT_317	[p9l1767t2071r1848b2100],
38	was	VBD	O	be	_	0	SENT_317	[p9l549t2131r612b2152],
39	no	DT	O	no	det	41	SENT_317	[p9l631t2131r671b2151],
40	survival	NN	O	survival	nn	41	SENT_317	[p9l692t2122r823b2152],
41	advantage	NN	O	advantage	nsubj	38	SENT_317	[p9l843t2122r1017b2160],
42	.	.	O	.	_	0	SENT_317	[p9l843t2122r1017b2160],

1	A	DT	O	a	det	4	SENT_318	[p9l1037t2122r1067b2151],
2	meta	NN	O	meta	nn	4	SENT_318	[p9l1085t2122r1311b2160],
3	—	NN	O	—	nn	4	SENT_318	[p9l1085t2122r1311b2160],
4	analysis	NN	O	analysis	nsubj	12	SENT_318	[p9l1085t2122r1311b2160],
5	of	IN	O	of	_	0	SENT_318	[p9l1331t2122r1367b2152],
6	phase	NN	O	phase	nn	8	SENT_318	[p9l1382t2122r1475b2160],
7	II	CD	NUMBER	ii	num	8	SENT_318	[p9l1494t2123r1521b2151],
8	trials	NNS	O	trial	prep_of	4	SENT_318	[p9l1539t2122r1620b2152],
9	has	VBZ	O	have	aux	12	SENT_318	[p9l1639t2122r1693b2152],
10	also	RB	O	also	advmod	12	SENT_318	[p9l1713t2122r1778b2152],
11	not	RB	O	not	neg	12	SENT_318	[p9l1796t2127r1849b2152],
12	demonstrated	VBD	O	demonstrate	_	0	SENT_318	[p9l550t2173r772b2202],
13	a	DT	O	a	det	15	SENT_318	[p9l792t2182r810b2202],
14	positive	JJ	O	positive	amod	15	SENT_318	[p9l829t2173r959b2211],
15	relationship	NN	O	relationship	dobj	12	SENT_318	[p9l979t2173r1174b2211],
16	between	IN	O	between	_	0	SENT_318	[p9l1194t2173r1331b2202],
17	paclitaxel	NN	O	paclitaxel	nn	18	SENT_318	[p9l1351t2173r1511b2211],
18	dose	NN	O	dose	prep_between	15	SENT_318	[p9l1531t2173r1606b2202],
19	and	CC	O	and	_	0	SENT_318	[p9l1627t2173r1685b2202],
20	response	NN	O	response	dobj	12	SENT_318	[p9l1704t2182r1848b2211],
21	(	CD	NUMBER	(	number	22	SENT_318	[p9l551t2225r625b2261],
22	56	CD	NUMBER	56	num	23	SENT_318	[p9l551t2225r625b2261],
23	)	NN	O	)	dep	20	SENT_318	[p9l551t2225r625b2261],
24	.	.	O	.	_	0	SENT_318	[p9l551t2225r625b2261],

1	Docetaxel	NNP	O	Docetaxel	nsubjpass	5	SENT_319	[p9l599t2277r766b2305],
2	has	VBZ	O	have	aux	5	SENT_319	[p9l784t2276r837b2305],
3	not	RB	O	not	neg	5	SENT_319	[p9l856t2281r909b2305],
4	been	VBN	O	be	auxpass	5	SENT_319	[p9l926t2276r1003b2305],
5	studied	VBN	O	study	conj_or	5	SENT_319	[p9l1023t2276r1140b2305],
6	as	IN	O	as	prep	5	SENT_319	[p9l1159t2286r1191b2306],
7	extensively	RB	O	extensively	pcomp	6	SENT_319	[p9l1210t2276r1397b2314],
8	as	IN	O	as	_	0	SENT_319	[p9l1416t2286r1448b2306],
9	paclitaxel	NN	O	paclitaxel	prep_as	5	SENT_319	[p9l1466t2276r1626b2314],
10	in	IN	O	in	_	0	SENT_319	[p9l1644t2276r1676b2305],
11	advanced	JJ	O	advanced	amod	13	SENT_319	[p9l1694t2276r1849b2306],
12	ovarian	JJ	O	ovarian	amod	13	SENT_319	[p9l550t2328r672b2358],
13	carcinoma	NN	O	carcinoma	prep_in	9	SENT_319	[p9l689t2329r868b2363],
14	,	,	O	,	_	0	SENT_319	[p9l689t2329r868b2363],
15	particularly	RB	O	particularly	advmod	5	SENT_319	[p9l885t2329r1075b2366],
16	in	IN	O	in	_	0	SENT_319	[p9l1091t2329r1122b2357],
17	combination	NN	O	combination	prep_in	5	SENT_319	[p9l1139t2329r1344b2358],
18	with	IN	O	with	_	0	SENT_319	[p9l1361t2329r1433b2358],
19	other	JJ	O	other	amod	20	SENT_319	[p9l1450t2329r1534b2358],
20	agents	NNS	O	agent	prep_with	17	SENT_319	[p9l1550t2333r1653b2366],
21	or	CC	O	or	_	0	SENT_319	[p9l1671t2338r1704b2358],
22	as	IN	O	as	_	0	SENT_319	[p9l1721t2338r1752b2358],
23	firstline	NN	O	firstline	nn	24	SENT_319	[p9l1769t2329r1847b2358, p9l549t2380r610b2409],
24	therapy	NN	O	therapy	prep_as	5	SENT_319	[p9l623t2380r754b2418],
25	.	.	O	.	_	0	SENT_319	[p9l623t2380r754b2418],

1	However	RB	O	however	advmod	20	SENT_320	[p9l769t2381r928b2414],
2	,	,	O	,	_	0	SENT_320	[p9l769t2381r928b2414],
3	four	CD	NUMBER	four	num	6	SENT_320	[p9l943t2380r1011b2409],
4	phase	NN	O	phase	nn	6	SENT_320	[p9l1023t2380r1117b2418],
5	II	CD	NUMBER	ii	num	6	SENT_320	[p9l1130t2381r1156b2409],
6	studies	NNS	O	study	nsubj	20	SENT_320	[p9l1170t2380r1282b2409],
7	of	IN	O	of	_	0	SENT_320	[p9l1296t2380r1332b2409],
8	docetaxel	NN	O	docetaxel	nn	9	SENT_320	[p9l1343t2380r1500b2409],
9	doses	NNS	O	dose	prep_of	6	SENT_320	[p9l1513t2380r1602b2409],
10	of	IN	O	of	_	0	SENT_320	[p9l1617t2380r1653b2409],
11	100	CD	NUMBER	100	num	12	SENT_320	[p9l1667t2380r1723b2409],
12	mg/m2	NN	O	mg/m2	prep_of	9	SENT_320	[p9l1736t2369r1848b2418],
13	given	VBN	O	give	partmod	12	SENT_320	[p9l550t2432r640b2470],
14	every	DT	SET	every	det	16	SENT_320	[p9l656t2441r747b2470],
15	three	CD	SET	three	num	16	SENT_320	[p9l763t2432r844b2461],
16	weeks	NNS	NUMBER	week	tmod	13	SENT_320	[p9l861t2432r962b2461],
17	involving	VBG	O	involve	xcomp	13	SENT_320	[p9l979t2432r1137b2470],
18	206	CD	NUMBER	206	num	19	SENT_320	[p9l1154t2432r1214b2461],
19	patients	NNS	O	patient	dobj	17	SENT_320	[p9l1230t2432r1357b2470],
20	demonstrated	VBD	O	demonstrate	_	0	SENT_320	[p9l1374t2432r1597b2461],
21	response	NN	O	response	nn	22	SENT_320	[p9l1612t2441r1756b2470],
22	rates	NNS	O	rate	dobj	20	SENT_320	[p9l1771t2436r1848b2461],
23	ranging	VBG	O	range	partmod	22	SENT_320	[p9l549t2483r674b2521],
24	from	IN	O	from	_	0	SENT_320	[p9l689t2483r769b2512],
25	25-41	CD	PERCENT	25-41	num	26	SENT_320	[p9l784t2483r918b2513],
26	%	NN	PERCENT	%	prep_from	23	SENT_320	[p9l784t2483r918b2513],
27	(	CD	NUMBER	(	number	28	SENT_320	[p9l936t2483r998b2519],
28	27	CD	NUMBER	27	num	26	SENT_320	[p9l936t2483r998b2519],
29	,	,	O	,	_	0	SENT_320	[p9l936t2483r998b2519],
30	33	CD	NUMBER	33	appos	26	SENT_320	[p9l1015t2483r1063b2518],
31	,	,	O	,	_	0	SENT_320	[p9l1015t2483r1063b2518],
32	57-60	CD	NUMBER	57-60	num	33	SENT_320	[p9l1080t2483r1203b2519],
33	)	NN	O	)	appos	30	SENT_320	[p9l1080t2483r1203b2519],
34	.	.	O	.	_	0	SENT_320	[p9l1080t2483r1203b2519],

1	Like	IN	O	like	_	0	SENT_321	[p9l1220t2483r1295b2512],
2	paclitaxel	NN	O	paclitaxel	prep_like	6	SENT_321	[p9l1308t2483r1478b2521],
3	,	,	O	,	_	0	SENT_321	[p9l1308t2483r1478b2521],
4	docetaxel	NN	O	docetaxel	nsubj	6	SENT_321	[p9l1494t2483r1651b2512],
5	is	VBZ	O	be	cop	6	SENT_321	[p9l1664t2483r1690b2512],
6	active	JJ	O	active	_	0	SENT_321	[p9l1706t2483r1803b2513],
7	in	IN	O	in	_	0	SENT_321	[p9l1817t2483r1849b2512],
8	disease	NN	O	disease	prep_in	6	SENT_321	[p9l550t2534r668b2564],
9	that	WDT	O	that	nsubj	11	SENT_321	[p9l687t2535r748b2564],
10	is	VBZ	O	be	cop	11	SENT_321	[p9l767t2534r792b2564],
11	refractory	JJ	O	refractory	rcmod	8	SENT_321	[p9l812t2534r974b2572],
12	to	TO	O	to	_	0	SENT_321	[p9l993t2539r1024b2563],
13	platinum	NN	O	platinum	nn	14	SENT_321	[p9l1043t2534r1190b2572],
14	compounds	NNS	O	compound	prep_to	11	SENT_321	[p9l1208t2535r1407b2572],
15	.	.	O	.	_	0	SENT_321	[p9l1208t2535r1407b2572],

1	Among	IN	O	among	_	0	SENT_322	[p9l1427t2535r1550b2572],
2	51	CD	NUMBER	51	num	3	SENT_322	[p9l1570t2535r1606b2564],
3	patients	NNS	O	patient	prep_among	35	SENT_322	[p9l1629t2534r1756b2572],
4	with	IN	O	with	_	0	SENT_322	[p9l1776t2534r1848b2564],
5	platinum	NN	O	platinum	prep_with	3	SENT_322	[p9l549t2586r871b2624],
6	—	CD	NUMBER	—	num	8	SENT_322	[p9l549t2586r871b2624],
7	refractory	JJ	O	refractory	amod	8	SENT_322	[p9l549t2586r871b2624],
8	disease	NN	O	disease	nsubjpass	19	SENT_322	[p9l885t2586r1003b2615],
9	in	IN	O	in	_	0	SENT_322	[p9l1016t2586r1047b2615],
10	one	CD	NUMBER	one	num	11	SENT_322	[p9l1060t2595r1118b2615],
11	study	NN	O	study	prep_in	8	SENT_322	[p9l1133t2586r1229b2624],
12	,	,	O	,	_	0	SENT_322	[p9l1133t2586r1229b2624],
13	a	DT	O	a	det	17	SENT_322	[p9l1244t2595r1262b2615],
14	41	CD	PERCENT	41	num	17	SENT_322	[p9l1273t2586r1346b2616],
15	%	NN	PERCENT	%	nn	17	SENT_322	[p9l1273t2586r1346b2616],
16	response	NN	O	response	nn	17	SENT_322	[p9l1360t2595r1505b2624],
17	rate	NN	O	rate	appos	11	SENT_322	[p9l1517t2591r1578b2615],
18	was	VBD	O	be	auxpass	19	SENT_322	[p9l1591t2595r1653b2615],
19	noted	VBN	O	note	rcmod	5	SENT_322	[p9l1667t2586r1758b2615],
20	(	RB	O	(	amod	22	SENT_322	[p9l1772t2586r1847b2622],
21	57	CD	NUMBER	57	tmod	20	SENT_322	[p9l1772t2586r1847b2622],
22	)	NN	O	)	dobj	19	SENT_322	[p9l1772t2586r1847b2622],
23	,	,	O	,	_	0	SENT_322	[p9l1772t2586r1847b2622],
24	and	CC	O	and	_	0	SENT_322	[p9l550t2638r608b2667],
25	subgroup	NN	O	subgroup	nn	26	SENT_322	[p9l623t2638r774b2676],
26	analysis	NN	O	analysis	dobj	19	SENT_322	[p9l790t2638r921b2676],
27	of	IN	O	of	_	0	SENT_322	[p9l937t2638r972b2667],
28	platinum	NN	O	platinum	prep_of	26	SENT_322	[p9l983t2638r1306b2676],
29	—	CD	NUMBER	—	num	31	SENT_322	[p9l983t2638r1306b2676],
30	refractory	JJ	O	refractory	amod	31	SENT_322	[p9l983t2638r1306b2676],
31	patients	NNS	O	patient	nsubj	35	SENT_322	[p9l1320t2638r1447b2676],
32	in	IN	O	in	_	0	SENT_322	[p9l1462t2638r1493b2667],
33	another	DT	O	another	det	34	SENT_322	[p9l1508t2638r1631b2667],
34	trial	NN	O	trial	prep_in	31	SENT_322	[p9l1644t2638r1709b2667],
35	demonstrated	VBD	O	demonstrate	_	0	SENT_322	[p9l1723t2638r1847b2667, p9l551t2690r659b2719],
36	a	DT	O	a	det	38	SENT_322	[p9l671t2699r688b2719],
37	response	NN	O	response	nn	38	SENT_322	[p9l698t2699r842b2728],
38	rate	NN	O	rate	dobj	35	SENT_322	[p9l853t2695r914b2719],
39	of	IN	O	of	_	0	SENT_322	[p9l926t2690r962b2719],
40	35	CD	PERCENT	35	num	41	SENT_322	[p9l972t2690r1054b2725],
41	%	NN	PERCENT	%	prep_of	38	SENT_322	[p9l972t2690r1054b2725],
42	,	,	O	,	_	0	SENT_322	[p9l972t2690r1054b2725],
43	with	IN	O	with	_	0	SENT_322	[p9l1067t2690r1140b2719],
44	a	DT	O	a	det	46	SENT_322	[p9l1152t2699r1169b2719],
45	median	JJ	O	median	amod	46	SENT_322	[p9l1180t2690r1301b2719],
46	duration	NN	O	duration	prep_with	35	SENT_322	[p9l1312t2690r1448b2719],
47	of	IN	O	of	_	0	SENT_322	[p9l1460t2690r1496b2719],
48	five	CD	DURATION	five	num	49	SENT_322	[p9l1505t2690r1568b2719],
49	months	NNS	NUMBER	month	prep_of	46	SENT_322	[p9l1579t2690r1699b2719],
50	(	RB	O	(	advmod	46	SENT_322	[p9l1713t2690r1788b2726],
51	60	CD	NUMBER	60	num	52	SENT_322	[p9l1713t2690r1788b2726],
52	)	NN	O	)	dep	46	SENT_322	[p9l1713t2690r1788b2726],
53	.	.	O	.	_	0	SENT_322	[p9l1713t2690r1788b2726],

1	BREAST	NN	O	breast	nsubjpass	16	SENT_323	[p9l549t2819r675b2843],
2	CANCER	NNP	O	CANCER	dep	1	SENT_323	[p9l683t2819r816b2843],
3	The	DT	O	the	det	6	SENT_323	[p9l855t2813r918b2842],
4	prominent	JJ	O	prominent	amod	6	SENT_323	[p9l927t2813r1098b2851],
5	antitumor	NN	O	antitumor	nn	6	SENT_323	[p9l1107t2813r1267b2842],
6	activity	NN	O	activity	dep	1	SENT_323	[p9l1276t2813r1398b2851],
7	of	IN	O	of	_	0	SENT_323	[p9l1408t2813r1444b2842],
8	the	DT	O	the	det	9	SENT_323	[p9l1451t2813r1500b2842],
9	taxanes	NNS	O	taxane	prep_of	6	SENT_323	[p9l1509t2818r1631b2842],
10	in	IN	O	in	_	0	SENT_323	[p9l1642t2813r1673b2842],
11	metastatic	JJ	O	metastatic	amod	13	SENT_323	[p9l1682t2813r1848b2842],
12	breast	NN	O	breast	nn	13	SENT_323	[p9l549t2862r648b2892],
13	Cancer	NN	O	cancer	prep_in	9	SENT_323	[p9l657t2872r765b2892],
14	was	VBD	O	be	auxpass	16	SENT_323	[p9l774t2872r836b2892],
15	initially	RB	O	initially	advmod	16	SENT_323	[p9l847t2862r974b2900],
16	demonstrated	VBN	O	demonstrate	_	0	SENT_323	[p9l985t2863r1207b2892],
17	for	IN	O	for	_	0	SENT_323	[p9l1217t2862r1265b2892],
18	paclitaxel	NN	O	paclitaxel	prep_for	16	SENT_323	[p9l1274t2862r1434b2900],
19	(	CD	NUMBER	(	num	21	SENT_323	[p9l1445t2863r1532b2898],
20	24-h	JJ	O	24-h	amod	21	SENT_323	[p9l1445t2863r1532b2898],
21	schedule	NN	O	schedule	dep	18	SENT_323	[p9l1544t2862r1699b2898],
22	)	CD	NUMBER	)	number	23	SENT_323	[p9l1544t2862r1699b2898],
23	(	CD	NUMBER	(	dep	18	SENT_323	[p9l1711t2862r1772b2898],
24	61	CD	NUMBER	61	dep	23	SENT_323	[p9l1711t2862r1772b2898],
25	,	,	O	,	_	0	SENT_323	[p9l1711t2862r1772b2898],
26	62	CD	NUMBER	62	num	27	SENT_323	[p9l1785t2862r1846b2898],
27	)	NN	O	)	appos	18	SENT_323	[p9l1785t2862r1846b2898],
28	.	.	O	.	_	0	SENT_323	[p9l1785t2862r1846b2898],

1	In	IN	O	in	_	0	SENT_324	[p9l549t2913r583b2941],
2	the	DT	O	the	det	4	SENT_324	[p9l599t2912r648b2941],
3	first	JJ	ORDINAL	first	amod	4	SENT_324	[p9l664t2912r730b2941],
4	study	NN	O	study	prep_in	23	SENT_324	[p9l747t2912r843b2950],
5	,	,	O	,	_	0	SENT_324	[p9l747t2912r843b2950],
6	56	CD	PERCENT	56	num	7	SENT_324	[p9l861t2912r933b2941],
7	%	NN	PERCENT	%	nsubj	23	SENT_324	[p9l861t2912r933b2941],
8	of	IN	O	of	_	0	SENT_324	[p9l952t2912r987b2941],
9	women	NNS	O	woman	prep_of	7	SENT_324	[p9l1000t2921r1121b2941],
10	who	WP	O	who	nsubj	12	SENT_324	[p9l1137t2912r1207b2941],
11	had	VBD	O	have	aux	12	SENT_324	[p9l1223t2912r1282b2941],
12	received	VBN	O	receive	rcmod	9	SENT_324	[p9l1297t2912r1438b2941],
13	no	DT	O	no	det	19	SENT_324	[p9l1452t2921r1492b2941],
14	more	JJR	O	more	mwe	15	SENT_324	[p9l1509t2921r1592b2941],
15	than	IN	O	than	quantmod	16	SENT_324	[p9l1609t2912r1679b2941],
16	one	CD	NUMBER	one	num	19	SENT_324	[p9l1695t2921r1753b2941],
17	prior	JJ	O	prior	amod	19	SENT_324	[p9l1768t2912r1849b2950],
18	chemotherapy	NN	O	chemotherapy	nn	19	SENT_324	[p9l550t2962r783b3000],
19	regimen	NN	O	regimen	dobj	12	SENT_324	[p9l795t2962r930b3000],
20	for	IN	O	for	_	0	SENT_324	[p9l943t2962r991b2991],
21	metastatic	JJ	O	metastatic	amod	22	SENT_324	[p9l1003t2962r1169b2991],
22	disease	NN	O	disease	prep_for	19	SENT_324	[p9l1182t2962r1300b2991],
23	responded	VBD	O	respond	_	0	SENT_324	[p9l1313t2962r1483b3000],
24	to	TO	O	to	_	0	SENT_324	[p9l1495t2967r1526b2991],
25	paclitaxel	NN	O	paclitaxel	nn	26	SENT_324	[p9l1539t2962r1699b3000],
26	doses	NNS	O	dose	prep_to	23	SENT_324	[p9l1712t2962r1801b2991],
27	of	IN	O	of	_	0	SENT_324	[p9l1815t2962r1851b2991],
28	200-250	CD	NUMBER	200-250	num	29	SENT_324	[p9l550t3013r693b3042],
29	mg/m2	NN	O	mg/m2	prep_of	26	SENT_324	[p9l701t3001r822b3050],
30	,	,	O	,	_	0	SENT_324	[p9l701t3001r822b3050],
31	and	CC	O	and	_	0	SENT_324	[p9l832t3013r890b3042],
32	the	DT	O	the	det	34	SENT_324	[p9l897t3013r946b3042],
33	median	JJ	O	median	amod	34	SENT_324	[p9l954t3013r1075b3042],
34	progression	NN	O	progression	nsubj	41	SENT_324	[p9l1082t3013r1352b3050],
35	—	CD	NUMBER	—	num	37	SENT_324	[p9l1082t3013r1352b3050],
36	free	JJ	O	free	amod	37	SENT_324	[p9l1082t3013r1352b3050],
37	interval	NN	O	interval	nsubj	40	SENT_324	[p9l1360t3013r1485b3042],
38	was	VBD	O	be	cop	40	SENT_324	[p9l1493t3022r1555b3042],
39	nine	CD	DURATION	nine	num	40	SENT_324	[p9l1564t3013r1634b3042],
40	months	NNS	NUMBER	month	rcmod	34	SENT_324	[p9l1642t3013r1762b3042],
41	(	VBP	O	(	conj_and	23	SENT_324	[p9l1772t3012r1846b3048],
42	61	CD	NUMBER	61	num	43	SENT_324	[p9l1772t3012r1846b3048],
43	)	CD	NUMBER	)	dobj	41	SENT_324	[p9l1772t3012r1846b3048],
44	.	.	O	.	_	0	SENT_324	[p9l1772t3012r1846b3048],

1	A	DT	O	a	det	3	SENT_325	[p9l549t3063r578b3091],
2	response	NN	O	response	nn	3	SENT_325	[p9l588t3072r733b3100],
3	rate	NN	O	rate	nsubjpass	8	SENT_325	[p9l743t3067r805b3091],
4	of	IN	O	of	_	0	SENT_325	[p9l816t3062r851b3091],
5	62	CD	PERCENT	62	num	6	SENT_325	[p9l860t3062r933b3092],
6	%	NN	PERCENT	%	prep_of	3	SENT_325	[p9l860t3062r933b3092],
7	was	VBD	O	be	auxpass	8	SENT_325	[p9l945t3072r1007b3091],
8	noted	VBN	O	note	_	0	SENT_325	[p9l1019t3062r1111b3091],
9	in	IN	O	in	_	0	SENT_325	[p9l1121t3062r1152b3091],
10	a	DT	DURATION	a	det	12	SENT_325	[p9l1163t3072r1180b3091],
11	second	JJ	DURATION	second	amod	12	SENT_325	[p9l1192t3062r1304b3091],
12	trial	NN	O	trial	prep_in	8	SENT_325	[p9l1315t3062r1380b3091],
13	in	IN	O	in	_	0	SENT_325	[p9l1391t3062r1422b3091],
14	which	WDT	O	which	rel	24	SENT_325	[p9l1433t3062r1533b3091],
15	paclitaxel	NN	O	paclitaxel	nn	16	SENT_325	[p9l1543t3062r1703b3100],
16	doses	NNS	O	dose	nsubjpass	24	SENT_325	[p9l1714t3062r1803b3091],
17	of	IN	O	of	_	0	SENT_325	[p9l1816t3062r1851b3091],
18	25	CD	NUMBER	25	num	20	SENT_325	[p9l550t3112r588b3142],
19	o	NN	O	o	nn	20	SENT_325	[p9l591t3113r610b3142],
20	mg/m2	NN	O	mg/m2	prep_of	16	SENT_325	[p9l618t3101r730b3150],
21	and	CC	O	and	_	0	SENT_325	[p9l739t3113r797b3141],
22	G-CSF	NN	O	g-csf	prep_of	16	SENT_325	[p9l805t3113r921b3142],
23	were	VBD	O	be	auxpass	24	SENT_325	[p9l929t3122r1008b3142],
24	given	VBN	O	give	rcmod	12	SENT_325	[p9l1016t3112r1107b3150],
25	to	TO	O	to	_	0	SENT_325	[p9l1115t3117r1145b3142],
26	women	NNS	O	woman	prep_to	24	SENT_325	[p9l1154t3122r1275b3142],
27	who	WP	O	who	nsubj	30	SENT_325	[p9l1283t3113r1352b3142],
28	had	VBD	O	have	aux	30	SENT_325	[p9l1360t3113r1420b3142],
29	previously	RB	DATE	previously	advmod	30	SENT_325	[p9l1427t3112r1601b3150],
30	received	VBN	O	receive	rcmod	26	SENT_325	[p9l1608t3112r1748b3142],
31	either	CC	O	either	prep	30	SENT_325	[p9l1756t3112r1850b3142],
32	adjuvant	JJ	O	adjuvant	amod	33	SENT_325	[p9l550t3162r691b3200],
33	therapy	NN	O	therapy	dep	31	SENT_325	[p9l702t3163r825b3200],
34	only	RB	O	only	advmod	30	SENT_325	[p9l837t3163r909b3200],
35	or	CC	O	or	_	0	SENT_325	[p9l921t3172r954b3191],
36	no	DT	O	no	det	38	SENT_325	[p9l965t3172r1005b3191],
37	prior	JJ	O	prior	amod	38	SENT_325	[p9l1016t3162r1097b3200],
38	therapy	NN	O	therapy	prep_to	24	SENT_325	[p9l1108t3163r1240b3200],
39	,	,	O	,	_	0	SENT_325	[p9l1108t3163r1240b3200],
40	confirming	VBG	O	confirm	partmod	38	SENT_325	[p9l1253t3162r1435b3200],
41	the	DT	O	the	det	43	SENT_325	[p9l1446t3162r1496b3192],
42	high	JJ	O	high	amod	43	SENT_325	[p9l1506t3162r1580b3200],
43	level	NN	O	level	dobj	40	SENT_325	[p9l1591t3162r1670b3192],
44	of	IN	O	of	_	0	SENT_325	[p9l1681t3162r1717b3192],
45	activity	NN	O	activity	prep_of	43	SENT_325	[p9l1727t3162r1849b3200],
46	(	CD	NUMBER	(	num	45	SENT_325	[p9l550t3212r625b3248],
47	62	CD	NUMBER	62	num	48	SENT_325	[p9l550t3212r625b3248],
48	)	NN	O	)	dep	45	SENT_325	[p9l550t3212r625b3248],
49	.	.	O	.	_	0	SENT_325	[p9l550t3212r625b3248],

1	Impressive	JJ	O	impressive	amod	3	SENT_326	[p9l640t3212r820b3250],
2	response	NN	O	response	nn	3	SENT_326	[p9l833t3221r977b3250],
3	rates	NNS	O	rate	nsubjpass	10	SENT_326	[p9l989t3217r1066b3241],
4	of	IN	O	of	_	0	SENT_326	[p9l1079t3212r1115b3241],
5	32-38	CD	PERCENT	32-38	num	6	SENT_326	[p9l1126t3213r1260b3241],
6	%	NN	PERCENT	%	prep_of	3	SENT_326	[p9l1126t3213r1260b3241],
7	have	VBP	O	have	aux	10	SENT_326	[p9l1274t3212r1351b3241],
8	also	RB	O	also	advmod	10	SENT_326	[p9l1364t3212r1429b3241],
9	been	VBN	O	be	auxpass	10	SENT_326	[p9l1441t3212r1519b3241],
10	reported	VBN	O	report	_	0	SENT_326	[p9l1530t3212r1668b3250],
11	with	IN	O	with	_	0	SENT_326	[p9l1680t3212r1752b3241],
12	a	DT	O	a	det	14	SENT_326	[p9l1766t3221r1783b3241],
13	3-h	JJ	O	3-h	amod	14	SENT_326	[p9l1795t3212r1849b3241],
14	schedule	NN	O	schedule	prep_with	10	SENT_326	[p9l551t3262r693b3291],
15	of	IN	O	of	_	0	SENT_326	[p9l701t3262r737b3291],
16	paclitaxel	NN	O	paclitaxel	nn	17	SENT_326	[p9l741t3262r901b3300],
17	(	NN	O	(	prep_of	14	SENT_326	[p9l910t3262r1066b3298],
18	175	CD	NUMBER	175	num	19	SENT_326	[p9l910t3262r1066b3298],
19	—	NN	O	—	dep	17	SENT_326	[p9l910t3262r1066b3298],
20	250	CD	NUMBER	250	num	21	SENT_326	[p9l910t3262r1066b3298],
21	mg/m2	NN	O	mg/m2	dep	17	SENT_326	[p9l1074t3251r1199b3300],
22	)	CD	NUMBER	)	number	23	SENT_326	[p9l1074t3251r1199b3300],
23	(	CD	NUMBER	(	num	24	SENT_326	[p9l1209t3262r1271b3298],
24	63	CD	NUMBER	63	dep	21	SENT_326	[p9l1209t3262r1271b3298],
25	,	,	O	,	_	0	SENT_326	[p9l1209t3262r1271b3298],
26	64	CD	NUMBER	64	num	27	SENT_326	[p9l1281t3262r1343b3298],
27	)	NN	O	)	appos	17	SENT_326	[p9l1281t3262r1343b3298],
28	.	.	O	.	_	0	SENT_326	[p9l1281t3262r1343b3298],

1	In	IN	O	in	_	0	SENT_327	[p9l1352t3263r1386b3291],
2	addition	NN	O	addition	prep_in	12	SENT_327	[p9l1395t3262r1537b3297],
3	,	,	O	,	_	0	SENT_327	[p9l1395t3262r1537b3297],
4	docetaxel	NN	O	docetaxel	nsubj	12	SENT_327	[p9l1547t3263r1704b3292],
5	(	CD	NUMBER	(	number	6	SENT_327	[p9l1712t3263r1848b3298],
6	75	CD	NUMBER	75	dep	4	SENT_327	[p9l1712t3263r1848b3298],
7	—	NN	O	—	nn	10	SENT_327	[p9l1712t3263r1848b3298],
8	100	CD	NUMBER	100	num	10	SENT_327	[p9l1712t3263r1848b3298],
9	mg/m2	NN	O	mg/m2	nn	10	SENT_327	[p9l549t3301r674b3350],
10	)	NN	O	)	dep	4	SENT_327	[p9l549t3301r674b3350],
11	has	VBZ	O	have	aux	12	SENT_327	[p9l684t3313r737b3342],
12	shown	VBN	O	show	_	0	SENT_327	[p9l749t3313r855b3342],
13	significant	JJ	O	significant	amod	14	SENT_327	[p9l865t3313r1038b3350],
14	activity	NN	O	activity	dobj	12	SENT_327	[p9l1048t3313r1170b3350],
15	as	IN	O	as	_	0	SENT_327	[p9l1180t3322r1211b3342],
16	first	JJ	ORDINAL	first	amod	19	SENT_327	[p9l1221t3313r1363b3342],
17	—	NN	O	—	nn	19	SENT_327	[p9l1221t3313r1363b3342],
18	line	NN	O	line	nn	19	SENT_327	[p9l1221t3313r1363b3342],
19	therapy	NN	O	therapy	prep_as	12	SENT_327	[p9l1372t3313r1495b3350],
20	in	IN	O	in	_	0	SENT_327	[p9l1504t3313r1535b3341],
21	metastatic	JJ	O	metastatic	amod	22	SENT_327	[p9l1544t3313r1710b3342],
22	disease	NN	O	disease	prep_in	19	SENT_327	[p9l1720t3313r1847b3347],
23	,	,	O	,	_	0	SENT_327	[p9l1720t3313r1847b3347],
24	with	IN	O	with	_	0	SENT_327	[p9l549t3362r622b3391],
25	response	NN	O	response	nn	26	SENT_327	[p9l635t3371r779b3400],
26	rates	NNS	O	rate	prep_with	12	SENT_327	[p9l791t3366r868b3391],
27	of	IN	O	of	_	0	SENT_327	[p9l882t3362r918b3391],
28	52-68	CD	PERCENT	52-68	num	29	SENT_327	[p9l929t3362r1063b3392],
29	%	NN	PERCENT	%	prep_of	26	SENT_327	[p9l929t3362r1063b3392],
30	(	CD	NUMBER	(	num	32	SENT_327	[p9l1079t3362r1216b3398],
31	65-68	CD	NUMBER	65-68	num	32	SENT_327	[p9l1079t3362r1216b3398],
32	)	NN	O	)	dep	29	SENT_327	[p9l1079t3362r1216b3398],
33	.	.	O	.	_	0	SENT_327	[p9l1079t3362r1216b3398],

1	The	DT	O	the	det	2	SENT_328	[p9l1231t3362r1294b3391],
2	likelihood	NN	O	likelihood	nsubjpass	8	SENT_328	[p9l1307t3362r1474b3391],
3	of	IN	O	of	_	0	SENT_328	[p9l1488t3362r1524b3391],
4	responding	VBG	O	respond	prepc_of	2	SENT_328	[p9l1533t3362r1716b3400],
5	has	VBZ	O	have	aux	8	SENT_328	[p9l1729t3362r1783b3391],
6	not	RB	O	not	neg	8	SENT_328	[p9l1796t3366r1849b3391],
7	been	VBN	O	be	auxpass	8	SENT_328	[p9l549t3412r626b3441],
8	related	VBN	O	relate	_	0	SENT_328	[p9l633t3412r746b3441],
9	to	TO	O	to	_	0	SENT_328	[p9l753t3416r784b3441],
10	hormonal	JJ	O	hormonal	amod	12	SENT_328	[p9l792t3412r950b3441],
11	receptor	NN	O	receptor	nn	12	SENT_328	[p9l957t3417r1093b3450],
12	status	NN	O	status	prep_to	8	SENT_328	[p9l1101t3416r1192b3441],
13	or	CC	O	or	_	0	SENT_328	[p9l1201t3421r1235b3441],
14	to	TO	O	to	_	0	SENT_328	[p9l1242t3416r1273b3441],
15	whether	IN	O	whether	complm	18	SENT_328	[p9l1281t3412r1414b3441],
16	patients	NNS	O	patient	nsubj	18	SENT_328	[p9l1421t3412r1548b3450],
17	had	VBD	O	have	aux	18	SENT_328	[p9l1556t3412r1615b3441],
18	received	VBN	O	receive	prep_to	8	SENT_328	[p9l1622t3412r1762b3441],
19	prior	RB	O	prior	prep	18	SENT_328	[p9l1769t3412r1849b3450],
20	adjuvant	JJ	O	adjuvant	amod	21	SENT_328	[p9l550t3462r691b3500],
21	therapy	NN	O	therapy	pobj	19	SENT_328	[p9l704t3462r835b3500],
22	.	.	O	.	_	0	SENT_328	[p9l704t3462r835b3500],

1	Responses	NNS	O	response	nsubj	13	SENT_329	[p9l850t3463r1023b3500],
2	in	IN	O	in	_	0	SENT_329	[p9l1037t3462r1068b3491],
3	visceral	JJ	O	visceral	amod	5	SENT_329	[p9l1082t3462r1209b3491],
4	metastatic	JJ	O	metastatic	amod	5	SENT_329	[p9l1222t3462r1388b3491],
5	sites	NNS	O	site	prep_in	1	SENT_329	[p9l1402t3462r1482b3497],
6	,	,	O	,	_	0	SENT_329	[p9l1402t3462r1482b3497],
7	especially	RB	O	especially	advmod	8	SENT_329	[p9l1497t3462r1661b3500],
8	liver	NN	O	liver	appos	5	SENT_329	[p9l1674t3462r1757b3497],
9	,	,	O	,	_	0	SENT_329	[p9l1674t3462r1757b3497],
10	have	VBP	O	have	aux	13	SENT_329	[p9l1771t3462r1848b3491],
11	also	RB	O	also	advmod	13	SENT_329	[p9l550t3512r614b3541],
12	been	VBN	O	be	cop	13	SENT_329	[p9l626t3512r704b3541],
13	high	JJ	O	high	_	0	SENT_329	[p9l714t3512r787b3550],
14	with	IN	O	with	prep	13	SENT_329	[p9l799t3512r871b3541],
15	both	CC	O	both	prep	13	SENT_329	[p9l882t3512r955b3541],
16	taxanes	NNS	O	taxane	dep	15	SENT_329	[p9l967t3516r1098b3541],
17	.	.	O	.	_	0	SENT_329	[p9l967t3516r1098b3541],

1	The	DT	O	the	det	3	SENT_330	[p9l599t3563r662b3592],
2	encouraging	JJ	O	encouraging	amod	3	SENT_330	[p9l676t3563r879b3601],
3	results	NNS	O	result	nsubj	8	SENT_330	[p9l893t3563r999b3592],
4	with	IN	O	with	_	0	SENT_330	[p9l1014t3563r1086b3592],
5	the	DT	O	the	det	6	SENT_330	[p9l1100t3563r1149b3592],
6	taxanes	NNS	O	taxane	prep_with	3	SENT_330	[p9l1163t3567r1285b3592],
7	are	VBP	O	be	cop	8	SENT_330	[p9l1301t3572r1349b3592],
8	comparable	JJ	O	comparable	_	0	SENT_330	[p9l1363t3563r1554b3601],
9	to	TO	O	to	_	0	SENT_330	[p9l1567t3568r1598b3592],
10	those	DT	O	those	prep_to	8	SENT_330	[p9l1612t3563r1698b3592],
11	reported	VBN	O	report	partmod	10	SENT_330	[p9l1711t3563r1849b3601],
12	in	IN	O	in	_	0	SENT_330	[p9l549t3614r581b3643],
13	early	JJ	O	early	amod	14	SENT_330	[p9l593t3614r674b3652],
14	studies	NNS	O	study	prep_in	11	SENT_330	[p9l688t3614r800b3643],
15	of	IN	O	of	_	0	SENT_330	[p9l814t3614r850b3643],
16	the	DT	O	the	det	17	SENT_330	[p9l860t3614r909b3643],
17	anthracyclines	NNS	O	anthracycline	prep_of	14	SENT_330	[p9l923t3614r1169b3652],
18	,	,	O	,	_	0	SENT_330	[p9l923t3614r1169b3652],
19	which	WDT	O	which	nsubj	20	SENT_330	[p9l1182t3614r1282b3643],
20	are	VBP	O	be	rcmod	17	SENT_330	[p9l1295t3623r1344b3643],
21	among	IN	O	among	_	0	SENT_330	[p9l1357t3623r1468b3652],
22	the	DT	O	the	det	25	SENT_330	[p9l1480t3614r1530b3643],
23	most	RBS	O	most	advmod	24	SENT_330	[p9l1542t3618r1622b3643],
24	active	JJ	O	active	amod	25	SENT_330	[p9l1635t3614r1732b3643],
25	agents	NNS	O	agent	prep_among	20	SENT_330	[p9l1745t3618r1848b3652],
26	in	IN	O	in	_	0	SENT_330	[p9l549t3666r581b3695],
27	breast	NN	O	breast	nn	28	SENT_330	[p9l592t3666r690b3695],
28	cancer	NN	O	cancer	prep_in	25	SENT_330	[p9l702t3675r817b3695],
29	.	.	O	.	_	0	SENT_330	[p9l702t3675r817b3695],

1	However	RB	O	however	advmod	32	SENT_331	[p9l830t3667r990b3701],
2	,	,	O	,	_	0	SENT_331	[p9l830t3667r990b3701],
3	gauging	VBG	O	gauge	partmod	32	SENT_331	[p9l1003t3666r1135b3704],
4	the	DT	O	the	det	6	SENT_331	[p9l1147t3666r1197b3695],
5	overall	JJ	O	overall	amod	6	SENT_331	[p9l1209t3666r1322b3695],
6	importance	NN	O	importance	dobj	3	SENT_331	[p9l1334t3666r1519b3704],
7	of	IN	O	of	_	0	SENT_331	[p9l1531t3666r1567b3695],
8	these	DT	O	these	det	9	SENT_331	[p9l1575t3666r1659b3695],
9	results	NNS	O	result	prep_of	6	SENT_331	[p9l1671t3666r1777b3695],
10	and	CC	O	and	_	0	SENT_331	[p9l1791t3666r1849b3695],
11	the	DT	O	the	det	13	SENT_331	[p9l549t3717r599b3746],
12	ultimate	JJ	O	ultimate	amod	13	SENT_331	[p9l611t3717r746b3746],
13	role	NN	O	role	dobj	3	SENT_331	[p9l759t3717r822b3746],
14	of	IN	O	of	_	0	SENT_331	[p9l835t3717r871b3746],
15	the	DT	O	the	det	16	SENT_331	[p9l881t3717r931b3746],
16	taxanes	NNS	O	taxane	prep_of	13	SENT_331	[p9l944t3722r1066b3746],
17	in	IN	O	in	_	0	SENT_331	[p9l1079t3717r1111b3746],
18	breast	NN	O	breast	nn	19	SENT_331	[p9l1123t3717r1222b3746],
19	cancer	NN	O	cancer	prep_in	16	SENT_331	[p9l1234t3726r1350b3752],
20	,	,	O	,	_	0	SENT_331	[p9l1234t3726r1350b3752],
21	a	DT	O	a	det	24	SENT_331	[p9l1364t3726r1381b3746],
22	relatively	RB	O	relatively	advmod	23	SENT_331	[p9l1393t3717r1548b3755],
23	responsive	JJ	O	responsive	amod	24	SENT_331	[p9l1561t3717r1737b3755],
24	tumor	NN	O	tumor	nsubjpass	32	SENT_331	[p9l1750t3722r1849b3746],
25	was	VBD	O	be	cop	26	SENT_331	[p9l549t3777r612b3798],
26	difficult	JJ	O	difficult	rcmod	24	SENT_331	[p9l628t3768r760b3798],
27	initially	RB	O	initially	advmod	26	SENT_331	[p9l775t3768r902b3806],
28	since	IN	O	since	_	0	SENT_331	[p9l919t3768r1001b3798],
29	early	JJ	O	early	amod	30	SENT_331	[p9l1017t3768r1098b3806],
30	studies	NNS	O	study	prep_since	26	SENT_331	[p9l1115t3768r1226b3798],
31	were	VBD	O	be	auxpass	32	SENT_331	[p9l1243t3777r1322b3798],
32	performed	VBN	O	perform	_	0	SENT_331	[p9l1336t3768r1508b3806],
33	in	IN	O	in	_	0	SENT_331	[p9l1522t3768r1554b3797],
34	women	NNS	O	woman	prep_in	32	SENT_331	[p9l1569t3777r1689b3798],
35	who	WP	O	who	nsubj	36	SENT_331	[p9l1705t3768r1774b3798],
36	had	VBD	O	have	rcmod	34	SENT_331	[p9l1789t3768r1849b3798],

1	Annu	NNP	PERSON	Annu	_	0	SENT_332	[p10l309t1641r332b1722],
2	.	.	O	.	_	0	SENT_332	[p10l309t1641r332b1722],

1	Rev.	NNP	O	Rev.	nn	2	SENT_333	[p10l309t1571r332b1630],
2	Med	NNP	O	Med	_	0	SENT_333	[p10l309t1492r332b1560],
3	.	.	O	.	_	0	SENT_333	[p10l309t1492r332b1560],

1	l997	NN	O	l997	_	0	SENT_334	[p10l309t1246r333b1478],
2	.48:353	CD	NUMBER	.48:353	number	3	SENT_334	[p10l309t1246r333b1478],
3	-374	CD	NUMBER	-374	num	1	SENT_334	[p10l309t1246r333b1478],
4	.	.	O	.	_	0	SENT_334	[p10l309t1246r333b1478],

1	Downloaded	VBN	O	download	csubj	4	SENT_335	[p10l309t991r332b1161],
2	from	IN	O	from	_	0	SENT_335	[p10l309t917r332b982],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_335	[p10l309t583r339b908],
4	nloaded	VBD	O	nload	_	0	SENT_335	[p10l309t3266r332b3371],
5	from	IN	O	from	_	0	SENT_335	[p10l309t3192r332b3257],
6	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	4	SENT_335	[p10l309t2858r339b3183],
7	on	IN	O	on	_	0	SENT_335	[p10l350t3333r366b3365],
8	01/05/14	CD	DATE	01/05/14	prep_on	4	SENT_335	[p10l342t3198r366b3323],
9	.	.	O	.	_	0	SENT_335	[p10l342t3198r366b3323],

1	For	IN	O	for	_	0	SENT_336	[p10l343t3141r366b3188],
2	personal	JJ	O	personal	amod	3	SENT_336	[p10l342t3021r373b3133],
3	use	NN	O	use	pobj	1	SENT_336	[p10l350t2968r366b3012],
4	only	RB	O	only	advmod	3	SENT_336	[p10l342t2894r373b2959],
5	.	.	O	.	_	0	SENT_336	[p10l342t2894r373b2959],

1	by	IN	O	by	_	0	SENT_337	[p10l342t1655r373b1687],
2	University	NNP	ORGANIZATION	University	prep_by	3	SENT_337	[p10l342t1505r373b1646],
3	of	IN	ORGANIZATION	of	_	0	SENT_337	[p10l342t1466r366b1495],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	pobj	3	SENT_337	[p10l342t1319r366b1460],
5	—	CD	NUMBER	—	num	4	SENT_337	[p10l356t1300r359b1309],
6	Ma	NNP	O	Ma	nn	7	SENT_337	[p10l343t1246r366b1290],
7	dison	NN	O	dison	dep	3	SENT_337	[p10l342t1100r366b1171],
8	on	IN	O	on	_	0	SENT_337	[p10l350t1058r366b1090],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_337	[p10l342t924r366b1049],
10	.	.	O	.	_	0	SENT_337	[p10l342t924r366b1049],

1	For	IN	O	for	_	0	SENT_338	[p10l343t866r366b913],
2	personal	JJ	O	personal	amod	3	SENT_338	[p10l342t746r373b859],
3	use	NN	O	use	pobj	1	SENT_338	[p10l350t694r366b737],
4	only	RB	O	only	advmod	3	SENT_338	[p10l342t619r373b684],
5	.	.	O	.	_	0	SENT_338	[p10l342t619r373b684],

1	366	CD	NUMBER	366	_	0	SENT_339	[p10l550t16r604b42],
2	ROWIN	NNP	O	ROWIN	dep	1	SENT_339	[p10l643t16r769b42],
3	SKY	NNS	O	sky	dep	1	SENT_339	[p10l770t16r843b42],

1	received	VBN	O	receive	_	0	SENT_340	[p10l549t100r689b130],
2	little	JJ	O	little	amod	4	SENT_340	[p10l703t100r777b130],
3	prior	JJ	O	prior	amod	4	SENT_340	[p10l791t100r872b138],
4	therapy	NN	O	therapy	dobj	1	SENT_340	[p10l886t100r1018b138],
5	,	,	O	,	_	0	SENT_340	[p10l886t100r1018b138],
6	unlike	IN	O	unlike	_	0	SENT_340	[p10l1033t100r1136b130],
7	the	DT	O	the	det	8	SENT_340	[p10l1151t100r1200b130],
8	situation	NN	O	situation	prep_unlike	1	SENT_340	[p10l1216t100r1356b130],
9	in	IN	O	in	_	0	SENT_340	[p10l1370t100r1402b129],
10	ovarian	JJ	O	ovarian	amod	11	SENT_340	[p10l1416t100r1539b130],
11	cancer	NN	O	cancer	prep_in	8	SENT_340	[p10l1554t109r1668b130],
12	.	.	O	.	_	0	SENT_340	[p10l1554t109r1668b130],

1	Nevertheless	RB	O	nevertheless	advmod	14	SENT_341	[p10l1684t100r1847b130, p10l549t151r619b186],
2	,	,	O	,	_	0	SENT_341	[p10l1684t100r1847b130, p10l549t151r619b186],
3	the	DT	O	the	det	5	SENT_341	[p10l635t151r684b181],
4	prominent	JJ	O	prominent	amod	5	SENT_341	[p10l699t151r869b189],
5	activity	NN	O	activity	nsubj	14	SENT_341	[p10l884t151r1006b189],
6	of	IN	O	of	_	0	SENT_341	[p10l1021t151r1057b181],
7	both	DT	O	both	det	8	SENT_341	[p10l1068t151r1141b181],
8	taxanes	NNS	O	taxane	prep_of	5	SENT_341	[p10l1156t156r1278b181],
9	in	IN	O	in	_	0	SENT_341	[p10l1293t151r1325b180],
10	heavily	RB	O	heavily	advmod	11	SENT_341	[p10l1338t151r1459b189],
11	pretreated	JJ	O	pretreated	amod	12	SENT_341	[p10l1473t151r1638b189],
12	patients	NNS	O	patient	prep_in	8	SENT_341	[p10l1652t151r1779b189],
13	has	VBZ	O	have	aux	14	SENT_341	[p10l1794t151r1847b181],
14	confirmed	VBN	O	confirm	_	0	SENT_341	[p10l550t202r719b231],
15	the	DT	O	the	det	18	SENT_341	[p10l736t202r785b231],
16	initial	JJ	O	initial	amod	18	SENT_341	[p10l803t202r899b231],
17	high	JJ	O	high	amod	18	SENT_341	[p10l916t202r989b240],
18	level	NN	O	level	dobj	14	SENT_341	[p10l1007t202r1086b231],
19	of	IN	O	of	_	0	SENT_341	[p10l1105t202r1140b231],
20	enthusiasm	NN	O	enthusiasm	prep_of	18	SENT_341	[p10l1156t202r1350b237],
21	,	,	O	,	_	0	SENT_341	[p10l1156t202r1350b237],
22	though	IN	O	though	mark	29	SENT_341	[p10l1369t202r1483b240],
23	the	DT	O	the	det	24	SENT_341	[p10l1501t202r1550b231],
24	likelihood	NN	O	likelihood	nsubj	29	SENT_341	[p10l1568t202r1736b231],
25	of	IN	O	of	_	0	SENT_341	[p10l1753t202r1789b231],
26	responding	VBG	O	respond	prepc_of	24	SENT_341	[p10l1803t211r1847b231, p10l551t253r700b291],
27	is	VBZ	O	be	cop	29	SENT_341	[p10l711t253r737b283],
28	indirectly	RB	O	indirectly	advmod	29	SENT_341	[p10l750t253r907b291],
29	related	JJ	O	related	advcl	14	SENT_341	[p10l918t253r1031b283],
30	to	TO	O	to	_	0	SENT_341	[p10l1042t258r1072b283],
31	the	DT	O	the	det	32	SENT_341	[p10l1084t253r1133b283],
32	extent	NN	O	extent	prep_to	29	SENT_341	[p10l1145t258r1245b283],
33	of	IN	O	of	_	0	SENT_341	[p10l1256t253r1292b283],
34	prior	JJ	O	prior	amod	36	SENT_341	[p10l1300t253r1381b291],
35	therapy	NN	O	therapy	nn	36	SENT_341	[p10l1391t253r1514b291],
36	(	NN	O	(	prep_of	32	SENT_341	[p10l1527t253r1589b289],
37	14	CD	NUMBER	14	dep	36	SENT_341	[p10l1527t253r1589b289],
38	,	,	O	,	_	0	SENT_341	[p10l1527t253r1589b289],
39	69	CD	NUMBER	69	appos	36	SENT_341	[p10l1602t253r1651b288],
40	,	,	O	,	_	0	SENT_341	[p10l1602t253r1651b288],
41	70	CD	NUMBER	70	num	42	SENT_341	[p10l1664t253r1726b289],
42	)	NN	O	)	appos	39	SENT_341	[p10l1664t253r1726b289],
43	.	.	O	.	_	0	SENT_341	[p10l1664t253r1726b289],

1	At	IN	O	at	_	0	SENT_342	[p10l1738t253r1779b282],
2	one	CD	NUMBER	one	num	3	SENT_342	[p10l1791t262r1849b283],
3	center	NN	O	center	prep_at	20	SENT_342	[p10l550t309r658b339],
4	,	,	O	,	_	0	SENT_342	[p10l550t309r658b339],
5	response	NN	O	response	nn	6	SENT_342	[p10l675t313r819b342],
6	rates	NNS	O	rate	nsubj	20	SENT_342	[p10l835t309r911b334],
7	following	VBG	O	follow	_	0	SENT_342	[p10l928t304r1088b342],
8	treatment	NN	O	treatment	prep_following	6	SENT_342	[p10l1105t309r1261b334],
9	with	IN	O	with	_	0	SENT_342	[p10l1276t304r1348b334],
10	moderate	JJ	O	moderate	amod	11	SENT_342	[p10l1364t304r1517b334],
11	doses	NNS	O	dose	prep_with	8	SENT_342	[p10l1533t304r1623b334],
12	of	IN	O	of	_	0	SENT_342	[p10l1640t304r1676b334],
13	paclitaxel	NN	O	paclitaxel	prep_of	11	SENT_342	[p10l1688t304r1849b342],
14	(	CD	NUMBER	(	num	13	SENT_342	[p10l551t355r638b391],
15	24	CD	NUMBER	24	number	16	SENT_342	[p10l551t355r638b391],
16	—	CD	NUMBER	—	num	18	SENT_342	[p10l551t355r638b391],
17	h	NN	O	h	nn	18	SENT_342	[p10l551t355r638b391],
18	schedule	NN	O	schedule	dep	13	SENT_342	[p10l653t355r808b391],
19	)	CD	NUMBER	)	dep	18	SENT_342	[p10l653t355r808b391],
20	ranged	VBD	O	range	_	0	SENT_342	[p10l823t355r935b393],
21	from	IN	O	from	_	0	SENT_342	[p10l949t355r1029b384],
22	38	CD	PERCENT	38	num	23	SENT_342	[p10l1044t355r1116b385],
23	%	NN	PERCENT	%	prep_from	20	SENT_342	[p10l1044t355r1116b385],
24	in	IN	O	in	_	0	SENT_342	[p10l1132t355r1163b384],
25	women	NNS	O	woman	prep_in	20	SENT_342	[p10l1177t364r1298b384],
26	who	WP	O	who	nsubj	27	SENT_342	[p10l1312t355r1381b384],
27	received	VBD	O	receive	rcmod	25	SENT_342	[p10l1395t355r1535b384],
28	one	CD	NUMBER	one	num	30	SENT_342	[p10l1549t364r1607b384],
29	prior	JJ	O	prior	amod	30	SENT_342	[p10l1620t355r1701b393],
30	regimen	NN	O	regimen	dobj	27	SENT_342	[p10l1713t355r1849b393],
31	to	TO	O	to	_	0	SENT_342	[p10l549t411r580b436],
32	17	CD	PERCENT	17	num	33	SENT_342	[p10l598t407r667b437],
33	%	NN	PERCENT	%	prep_to	27	SENT_342	[p10l598t407r667b437],
34	in	IN	O	in	_	0	SENT_342	[p10l683t407r714b436],
35	women	NNS	O	woman	prep_in	27	SENT_342	[p10l728t416r849b436],
36	who	WP	O	who	nsubj	37	SENT_342	[p10l863t407r933b436],
37	received	VBD	O	receive	rcmod	35	SENT_342	[p10l947t407r1087b436],
38	at	IN	O	at	quantmod	40	SENT_342	[p10l1100t411r1129b436],
39	least	JJS	O	least	mwe	38	SENT_342	[p10l1142t407r1218b436],
40	three	CD	NUMBER	three	num	42	SENT_342	[p10l1231t407r1312b436],
41	prior	JJ	O	prior	amod	42	SENT_342	[p10l1325t407r1406b445],
42	regimens	NNS	O	regimen	nsubj	43	SENT_342	[p10l1418t407r1568b445],
43	(	VBP	O	(	ccomp	37	SENT_342	[p10l1584t407r1646b443],
44	14	CD	NUMBER	14	dobj	43	SENT_342	[p10l1584t407r1646b443],
45	,	,	O	,	_	0	SENT_342	[p10l1584t407r1646b443],
46	69	CD	NUMBER	69	appos	44	SENT_342	[p10l1662t407r1710b442],
47	,	,	O	,	_	0	SENT_342	[p10l1662t407r1710b442],
48	70	CD	NUMBER	70	num	49	SENT_342	[p10l1726t407r1788b443],
49	)	NN	O	)	appos	46	SENT_342	[p10l1726t407r1788b443],
50	.	.	O	.	_	0	SENT_342	[p10l1726t407r1788b443],

1	As	IN	O	as	_	0	SENT_343	[p10l1803t407r1847b436],
2	second	JJ	ORDINAL	second	amod	5	SENT_343	[p10l551t458r739b487],
3	—	NN	O	—	nn	5	SENT_343	[p10l551t458r739b487],
4	line	NN	O	line	nn	5	SENT_343	[p10l551t458r739b487],
5	therapy	NN	O	therapy	prep_as	14	SENT_343	[p10l753t458r885b496],
6	,	,	O	,	_	0	SENT_343	[p10l753t458r885b496],
7	docetaxel	NN	O	docetaxel	nn	8	SENT_343	[p10l901t458r1058b487],
8	doses	NNS	O	dose	nsubj	14	SENT_343	[p10l1072t458r1162b487],
9	of	IN	O	of	_	0	SENT_343	[p10l1177t458r1213b487],
10	100	CD	NUMBER	100	num	11	SENT_343	[p10l1228t458r1285b488],
11	mg/m2	NN	O	mg/m2	prep_of	8	SENT_343	[p10l1299t447r1411b496],
12	have	VBP	O	have	aux	14	SENT_343	[p10l1425t458r1502b488],
13	also	RB	O	also	advmod	14	SENT_343	[p10l1517t458r1581b488],
14	produced	VBN	O	produce	_	0	SENT_343	[p10l1595t458r1749b496],
15	striking	JJ	O	striking	amod	16	SENT_343	[p10l1763t458r1847b488, p10l549t509r601b547],
16	activity	NN	O	activity	dobj	14	SENT_343	[p10l618t509r749b547],
17	,	,	O	,	_	0	SENT_343	[p10l618t509r749b547],
18	with	IN	O	with	_	0	SENT_343	[p10l766t509r839b538],
19	response	NN	O	response	nn	20	SENT_343	[p10l854t518r998b547],
20	rates	NNS	O	rate	prep_with	14	SENT_343	[p10l1014t514r1091b538],
21	ranging	VBG	O	range	partmod	20	SENT_343	[p10l1107t509r1232b547],
22	from	IN	O	from	_	0	SENT_343	[p10l1249t509r1329b538],
23	50-58	CD	PERCENT	50-58	num	24	SENT_343	[p10l1344t509r1479b538],
24	%	NN	PERCENT	%	prep_from	21	SENT_343	[p10l1344t509r1479b538],
25	(	CD	NUMBER	(	num	27	SENT_343	[p10l1498t510r1635b545],
26	71-73	CD	NUMBER	71-73	num	27	SENT_343	[p10l1498t510r1635b545],
27	)	NN	O	)	dep	24	SENT_343	[p10l1498t510r1635b545],
28	.	.	O	.	_	0	SENT_343	[p10l1498t510r1635b545],

1	Perhaps	RB	O	perhaps	advmod	10	SENT_344	[p10l1653t509r1782b547],
2	the	DT	O	the	det	5	SENT_344	[p10l1799t509r1848b538],
3	most	RBS	O	most	advmod	4	SENT_344	[p10l549t565r629b590],
4	impressive	JJ	O	impressive	amod	5	SENT_344	[p10l644t561r821b599],
5	results	NNS	O	result	nsubj	10	SENT_344	[p10l836t561r942b590],
6	with	IN	O	with	_	0	SENT_344	[p10l959t561r1031b590],
7	the	DT	O	the	det	8	SENT_344	[p10l1045t561r1095b590],
8	taxanes	NNS	O	taxane	prep_with	5	SENT_344	[p10l1109t566r1232b590],
9	have	VBP	O	have	aux	10	SENT_344	[p10l1247t561r1324b590],
10	been	VBN	O	be	_	0	SENT_344	[p10l1338t561r1416b590],
11	in	IN	O	in	_	0	SENT_344	[p10l1430t561r1461b590],
12	women	NNS	O	woman	prep_in	10	SENT_344	[p10l1476t570r1596b590],
13	whose	WP$	O	whose	poss	14	SENT_344	[p10l1611t561r1715b590],
14	disease	NN	O	disease	nsubj	15	SENT_344	[p10l1730t561r1848b590],
15	progressed	VBN	O	progress	rcmod	12	SENT_344	[p10l549t613r728b650],
16	during	IN	O	during	_	0	SENT_344	[p10l743t612r849b650],
17	prior	JJ	O	prior	amod	18	SENT_344	[p10l864t612r945b650],
18	therapy	NN	O	therapy	prep_during	15	SENT_344	[p10l959t613r1082b650],
19	with	IN	O	with	_	0	SENT_344	[p10l1098t612r1170b642],
20	the	DT	O	the	det	21	SENT_344	[p10l1185t613r1235b642],
21	anthracyclines	NNS	O	anthracycline	prep_with	10	SENT_344	[p10l1251t612r1496b650],
22	.	.	O	.	_	0	SENT_344	[p10l1251t612r1496b650],

1	Among	IN	O	among	_	0	SENT_345	[p10l1513t613r1636b650],
2	68	CD	NUMBER	68	num	4	SENT_345	[p10l1652t612r1690b642],
3	such	JJ	O	such	amod	4	SENT_345	[p10l1708t613r1782b642],
4	patients	NNS	O	patient	prep_among	21	SENT_345	[p10l1796t622r1847b650, p10l549t664r637b693],
5	treated	VBN	O	treat	partmod	4	SENT_345	[p10l652t664r764b693],
6	with	IN	O	with	_	0	SENT_345	[p10l778t664r850b693],
7	docetaxel	NN	O	docetaxel	nn	8	SENT_345	[p10l864t664r1021b693],
8	(	NN	O	(	prep_with	5	SENT_345	[p10l1036t664r1110b700],
9	100	CD	NUMBER	100	num	11	SENT_345	[p10l1036t664r1110b700],
10	mg/m2	NN	O	mg/m2	nn	11	SENT_345	[p10l1124t653r1248b702],
11	)	NN	O	)	dobj	5	SENT_345	[p10l1124t653r1248b702],
12	in	IN	O	in	_	0	SENT_345	[p10l1264t664r1295b693],
13	two	CD	NUMBER	two	num	14	SENT_345	[p10l1309t668r1369b693],
14	trials	NNS	O	trial	prep_in	11	SENT_345	[p10l1384t664r1474b698],
15	,	,	O	,	_	0	SENT_345	[p10l1384t664r1474b698],
16	the	DT	O	the	det	18	SENT_345	[p10l1489t664r1539b693],
17	response	NN	O	response	nn	18	SENT_345	[p10l1552t673r1696b702],
18	rate	NN	O	rate	nsubj	21	SENT_345	[p10l1710t668r1771b693],
19	was	VBD	O	be	cop	21	SENT_345	[p10l1785t673r1847b693],
20	51	CD	PERCENT	51	num	21	SENT_345	[p10l550t716r622b745],
21	%	NN	PERCENT	%	_	0	SENT_345	[p10l550t716r622b745],
22	(	CD	NUMBER	(	number	23	SENT_345	[p10l642t716r703b751],
23	71	CD	NUMBER	71	num	21	SENT_345	[p10l642t716r703b751],
24	,	,	O	,	_	0	SENT_345	[p10l642t716r703b751],
25	72	CD	NUMBER	72	num	26	SENT_345	[p10l721t716r784b751],
26	)	NN	O	)	appos	21	SENT_345	[p10l721t716r784b751],
27	.	.	O	.	_	0	SENT_345	[p10l721t716r784b751],

1	Although	IN	O	although	mark	6	SENT_346	[p10l801t716r958b753],
2	responsiveness	NN	O	responsiveness	nsubj	6	SENT_346	[p10l973t716r1220b753],
3	in	IN	O	in	_	0	SENT_346	[p10l1237t716r1268b744],
4	this	DT	O	this	det	5	SENT_346	[p10l1285t716r1343b745],
5	situation	NN	O	situation	prep_in	2	SENT_346	[p10l1361t716r1501b745],
6	seems	VBZ	O	seem	advcl	26	SENT_346	[p10l1519t725r1617b745],
7	to	TO	O	to	aux	9	SENT_346	[p10l1634t720r1664b745],
8	be	VB	O	be	cop	9	SENT_346	[p10l1681t716r1719b745],
9	greater	JJR	O	greater	xcomp	6	SENT_346	[p10l1735t720r1850b753],
10	with	IN	O	with	_	0	SENT_346	[p10l549t767r622b796],
11	docetaxel	NN	O	docetaxel	prep_with	9	SENT_346	[p10l636t767r802b802],
12	,	,	O	,	_	0	SENT_346	[p10l636t767r802b802],
13	the	DT	O	the	det	14	SENT_346	[p10l817t768r866b796],
14	doses	NNS	O	dose	nsubj	26	SENT_346	[p10l881t767r970b796],
15	of	IN	O	of	_	0	SENT_346	[p10l986t767r1021b796],
16	paclitaxel	NN	O	paclitaxel	prep_of	14	SENT_346	[p10l1032t767r1193b805],
17	and	CC	O	and	_	0	SENT_346	[p10l1207t767r1265b796],
18	docetaxel	NN	O	docetaxel	conj_and	16	SENT_346	[p10l1279t767r1436b796],
19	used	VBN	O	use	partmod	14	SENT_346	[p10l1449t767r1525b796],
20	in	IN	O	in	_	0	SENT_346	[p10l1538t767r1569b796],
21	this	DT	O	this	det	22	SENT_346	[p10l1583t767r1641b796],
22	setting	NN	O	setting	prep_in	19	SENT_346	[p10l1657t767r1764b805],
23	may	MD	O	may	aux	26	SENT_346	[p10l1778t777r1848b805],
24	not	RB	O	not	neg	26	SENT_346	[p10l549t823r602b848],
25	be	VB	O	be	cop	26	SENT_346	[p10l617t819r655b848],
26	comparable	JJ	O	comparable	_	0	SENT_346	[p10l671t819r863b856],
27	since	IN	O	since	mark	31	SENT_346	[p10l879t819r962b848],
28	docetaxel	NN	O	docetaxel	nsubjpass	31	SENT_346	[p10l978t819r1136b848],
29	has	VBZ	O	have	aux	31	SENT_346	[p10l1151t819r1204b848],
30	been	VBN	O	be	auxpass	31	SENT_346	[p10l1221t819r1298b848],
31	evaluted	VBN	O	evalute	advcl	26	SENT_346	[p10l1314t819r1453b848],
32	at	IN	O	at	_	0	SENT_346	[p10l1469t823r1498b848],
33	doses	NNS	O	dose	prep_at	31	SENT_346	[p10l1513t819r1603b848],
34	that	WDT	O	that	nsubj	36	SENT_346	[p10l1619t819r1681b848],
35	generally	RB	O	generally	advmod	36	SENT_346	[p10l1696t819r1848b856],
36	induce	VBP	O	induce	rcmod	33	SENT_346	[p10l549t870r658b899],
37	more	RBR	O	more	advmod	39	SENT_346	[p10l670t879r754b899],
38	profound	JJ	O	profound	amod	39	SENT_346	[p10l765t870r917b908],
39	toxicity	NN	O	toxicity	dobj	36	SENT_346	[p10l928t870r1062b908],
40	.	.	O	.	_	0	SENT_346	[p10l928t870r1062b908],

1	However	RB	O	however	advmod	14	SENT_347	[p10l1075t871r1235b904],
2	,	,	O	,	_	0	SENT_347	[p10l1075t871r1235b904],
3	similar	JJ	O	similar	amod	7	SENT_347	[p10l1249t870r1363b899],
4	activity	NN	O	activity	nn	7	SENT_347	[p10l1374t870r1496b908],
5	(	NN	O	(	nn	7	SENT_347	[p10l1509t870r1666b908],
6	response	NN	O	response	nn	7	SENT_347	[p10l1509t870r1666b908],
7	rate	NN	O	rate	nsubjpass	14	SENT_347	[p10l1677t874r1747b904],
8	,	,	O	,	_	0	SENT_347	[p10l1677t874r1747b904],
9	44	CD	PERCENT	44	number	10	SENT_347	[p10l1760t870r1847b906],
10	%	NN	PERCENT	%	amod	11	SENT_347	[p10l1760t870r1847b906],
11	)	NN	O	)	appos	7	SENT_347	[p10l1760t870r1847b906],
12	has	VBZ	O	have	aux	14	SENT_347	[p10l549t922r602b951],
13	been	VBN	O	be	auxpass	14	SENT_347	[p10l621t922r698b951],
14	observed	VBN	O	observe	_	0	SENT_347	[p10l717t922r866b951],
15	with	IN	O	with	_	0	SENT_347	[p10l884t922r956b951],
16	a	DT	O	a	det	20	SENT_347	[p10l976t931r993b951],
17	lower	JJR	O	lower	amod	20	SENT_347	[p10l1010t922r1104b951],
18	docetaxel	NN	O	docetaxel	nn	20	SENT_347	[p10l1122t922r1279b951],
19	dose	NN	O	dose	nn	20	SENT_347	[p10l1297t922r1372b951],
20	(	NN	O	(	prep_with	14	SENT_347	[p10l1391t922r1444b958],
21	60	CD	NUMBER	60	num	22	SENT_347	[p10l1391t922r1444b958],
22	mg/m2	NN	O	mg/m2	dobj	14	SENT_347	[p10l1462t911r1587b960],
23	)	CD	NUMBER	)	number	24	SENT_347	[p10l1462t911r1587b960],
24	(	CD	NUMBER	(	dep	22	SENT_347	[p10l1608t922r1683b958],
25	74	CD	NUMBER	74	num	26	SENT_347	[p10l1608t922r1683b958],
26	)	NN	O	)	dep	24	SENT_347	[p10l1608t922r1683b958],
27	.	.	O	.	_	0	SENT_347	[p10l1608t922r1683b958],

1	Still	RB	O	still	advmod	13	SENT_348	[p10l1704t922r1780b956],
2	,	,	O	,	_	0	SENT_348	[p10l1704t922r1780b956],
3	the	DT	O	the	det	5	SENT_348	[p10l1799t922r1848b951],
4	impressive	JJ	O	impressive	amod	5	SENT_348	[p10l549t974r727b1012],
5	activity	NN	O	activity	nsubj	13	SENT_348	[p10l739t974r861b1012],
6	with	IN	O	with	prep	5	SENT_348	[p10l872t974r945b1003],
7	both	CC	O	both	dep	6	SENT_348	[p10l954t974r1028b1003],
8	taxanes	NNS	O	taxane	conj	6	SENT_348	[p10l1038t979r1161b1003],
9	in	IN	O	in	_	0	SENT_348	[p10l1172t974r1203b1003],
10	this	DT	O	this	det	12	SENT_348	[p10l1214t974r1271b1003],
11	refractory	JJ	O	refractory	amod	12	SENT_348	[p10l1283t974r1445b1012],
12	setting	NN	O	setting	prep_in	6	SENT_348	[p10l1457t974r1564b1012],
13	implies	VBZ	O	imply	_	0	SENT_348	[p10l1576t974r1695b1012],
14	that	IN	O	that	complm	17	SENT_348	[p10l1707t974r1769b1003],
15	they	PRP	O	they	nsubj	17	SENT_348	[p10l1778t974r1848b1012],
16	may	MD	O	may	aux	17	SENT_348	[p10l549t1035r619b1063],
17	make	VB	O	make	ccomp	13	SENT_348	[p10l631t1026r719b1055],
18	an	DT	O	a	det	21	SENT_348	[p10l731t1035r769b1055],
19	even	RB	O	even	advmod	20	SENT_348	[p10l780t1035r857b1055],
20	greater	JJR	O	greater	amod	21	SENT_348	[p10l869t1030r983b1063],
21	impact	NN	O	impact	dobj	17	SENT_348	[p10l994t1026r1106b1063],
22	in	IN	O	in	_	0	SENT_348	[p10l1116t1026r1147b1054],
23	early	JJ	O	early	amod	25	SENT_348	[p10l1158t1026r1239b1063],
24	disease	NN	O	disease	nn	25	SENT_348	[p10l1252t1026r1369b1055],
25	settings	NNS	O	setting	prep_in	21	SENT_348	[p10l1382t1026r1515b1063],
26	.	.	O	.	_	0	SENT_348	[p10l1382t1026r1515b1063],

1	Further	JJ	O	further	amod	2	SENT_349	[p10l599t1077r721b1106],
2	studies	NNS	O	study	nsubj	10	SENT_349	[p10l735t1077r847b1106],
3	of	IN	O	of	_	0	SENT_349	[p10l863t1077r898b1106],
4	the	DT	O	the	det	5	SENT_349	[p10l910t1077r959b1106],
5	taxanes	NNS	O	taxane	prep_of	2	SENT_349	[p10l973t1082r1095b1106],
6	in	IN	O	in	_	0	SENT_349	[p10l1110t1077r1142b1106],
7	breast	NN	O	breast	nn	8	SENT_349	[p10l1155t1077r1254b1106],
8	cancer	NN	O	cancer	prep_in	5	SENT_349	[p10l1268t1086r1375b1106],
9	will	MD	O	will	aux	10	SENT_349	[p10l1388t1077r1451b1106],
10	focus	VB	O	focus	_	0	SENT_349	[p10l1466t1077r1553b1106],
11	on	IN	O	on	_	0	SENT_349	[p10l1569t1086r1609b1106],
12	defining	VBG	O	define	prepc_on	10	SENT_349	[p10l1623t1077r1759b1115],
13	their	PRP$	O	they	poss	14	SENT_349	[p10l1774t1077r1850b1106],
14	roles	NNS	O	role	dobj	12	SENT_349	[p10l549t1129r628b1158],
15	in	IN	O	in	_	0	SENT_349	[p10l641t1129r672b1158],
16	earlier	JJR	O	earlier	amod	17	SENT_349	[p10l685t1129r790b1158],
17	stages	NNS	O	stage	prep_in	12	SENT_349	[p10l802t1133r900b1167],
18	and	CC	O	and	_	0	SENT_349	[p10l914t1129r981b1163],
19	,	,	O	,	_	0	SENT_349	[p10l914t1129r981b1163],
20	ultimately	RB	O	ultimately	dep	12	SENT_349	[p10l995t1129r1171b1167],
21	,	,	O	,	_	0	SENT_349	[p10l995t1129r1171b1167],
22	in	IN	O	in	_	0	SENT_349	[p10l1184t1129r1215b1158],
23	adjuvant	JJ	O	adjuvant	amod	24	SENT_349	[p10l1228t1129r1369b1167],
24	therapy	NN	O	therapy	prep_in	12	SENT_349	[p10l1381t1129r1503b1167],
25	after	IN	O	after	_	0	SENT_349	[p10l1517t1129r1592b1158],
26	local	JJ	O	local	amod	27	SENT_349	[p10l1602t1129r1681b1158],
27	treatment	NN	O	treatment	prep_after	12	SENT_349	[p10l1694t1133r1849b1158],
28	of	IN	O	of	_	0	SENT_349	[p10l550t1255r585b1284],
29	early	JJ	O	early	amod	31	SENT_349	[p10l598t1255r679b1292],
30	stage	NN	O	stage	nn	31	SENT_349	[p10l695t1259r777b1292],
31	disease	NN	O	disease	prep_of	27	SENT_349	[p10l792t1255r919b1284],
32	.	.	O	.	_	0	SENT_349	[p10l792t1255r919b1284],

1	To	TO	O	to	aux	2	SENT_350	[p10l935t1255r980b1284],
2	accomplish	VB	O	accomplish	purpcl	13	SENT_350	[p10l996t1255r1183b1293],
3	this	DT	O	this	det	4	SENT_350	[p10l1197t1255r1255b1284],
4	objective	NN	O	objective	dobj	2	SENT_350	[p10l1271t1255r1430b1292],
5	,	,	O	,	_	0	SENT_350	[p10l1271t1255r1430b1292],
6	the	DT	O	the	det	10	SENT_350	[p10l1446t1255r1495b1284],
7	Eastern	NNP	ORGANIZATION	Eastern	nn	10	SENT_350	[p10l1510t1255r1633b1284],
8	Cooperative	NNP	ORGANIZATION	Cooperative	nn	10	SENT_350	[p10l1648t1255r1848b1293],
9	Oncology	NNP	ORGANIZATION	Oncology	nn	10	SENT_350	[p10l550t1306r711b1344],
10	Group	NNP	ORGANIZATION	Group	nsubj	13	SENT_350	[p10l728t1306r832b1344],
11	has	VBZ	O	have	aux	13	SENT_350	[p10l848t1306r901b1335],
12	recently	RB	DATE	recently	advmod	13	SENT_350	[p10l918t1306r1050b1344],
13	completed	VBN	O	complete	_	0	SENT_350	[p10l1066t1306r1238b1344],
14	enrollment	NN	O	enrollment	dobj	13	SENT_350	[p10l1254t1306r1432b1335],
15	in	IN	O	in	_	0	SENT_350	[p10l1447t1306r1478b1335],
16	a	DT	O	a	det	17	SENT_350	[p10l1495t1315r1512b1335],
17	study	NN	O	study	prep_in	13	SENT_350	[p10l1529t1306r1616b1344],
18	in	IN	O	in	_	0	SENT_350	[p10l1632t1306r1663b1335],
19	which	WDT	O	which	rel	26	SENT_350	[p10l1679t1306r1779b1335],
20	untreated	JJ	O	untreated	amod	21	SENT_350	[p10l1794t1315r1847b1335, p10l549t1358r661b1387],
21	women	NNS	O	woman	nsubjpass	26	SENT_350	[p10l680t1367r801b1387],
22	with	IN	O	with	_	0	SENT_350	[p10l821t1358r894b1387],
23	metastatic	JJ	O	metastatic	amod	24	SENT_350	[p10l914t1358r1080b1387],
24	disease	NN	O	disease	prep_with	21	SENT_350	[p10l1100t1358r1218b1387],
25	were	VBD	O	be	auxpass	26	SENT_350	[p10l1238t1367r1317b1387],
26	randomized	VBN	O	randomize	rcmod	17	SENT_350	[p10l1336t1358r1532b1387],
27	to	TO	O	to	_	0	SENT_350	[p10l1550t1363r1581b1387],
28	treatment	NN	O	treatment	prep_to	26	SENT_350	[p10l1601t1362r1757b1387],
29	with	IN	O	with	prep	26	SENT_350	[p10l1776t1358r1848b1387],
30	either	CC	O	either	dep	29	SENT_350	[p10l549t1410r643b1439],
31	paclitaxel	NN	O	paclitaxel	conj	29	SENT_350	[p10l656t1410r816b1447],
32	or	CC	O	or	_	0	SENT_350	[p10l830t1419r863b1439],
33	doxorubicin	NN	O	doxorubicin	conj	29	SENT_350	[p10l877t1410r1076b1439],
34	alone	RB	O	alone	advmod	26	SENT_350	[p10l1091t1410r1178b1439],
35	or	CC	O	or	_	0	SENT_350	[p10l1192t1419r1226b1439],
36	both	DT	O	both	det	37	SENT_350	[p10l1238t1410r1311b1439],
37	agents	NNS	O	agent	prep_in	13	SENT_350	[p10l1326t1414r1429b1447],
38	combined	VBN	O	combine	partmod	37	SENT_350	[p10l1444t1410r1614b1439],
39	.	.	O	.	_	0	SENT_350	[p10l1444t1410r1614b1439],

1	If	IN	O	if	mark	5	SENT_351	[p10l1629t1410r1659b1438],
2	the	DT	O	the	det	3	SENT_351	[p10l1669t1410r1719b1439],
3	combination	NN	O	combination	nsubjpass	5	SENT_351	[p10l1733t1410r1847b1439, p10l549t1461r652b1490],
4	is	VBZ	O	be	auxpass	5	SENT_351	[p10l665t1461r691b1490],
5	determined	VBN	O	determine	advcl	13	SENT_351	[p10l706t1461r891b1490],
6	to	TO	O	to	aux	8	SENT_351	[p10l904t1466r935b1490],
7	be	VB	O	be	cop	8	SENT_351	[p10l948t1461r986b1490],
8	superior	JJ	O	superior	xcomp	5	SENT_351	[p10l1002t1461r1144b1499],
9	,	,	O	,	_	0	SENT_351	[p10l1002t1461r1144b1499],
10	it	PRP	O	it	nsubjpass	13	SENT_351	[p10l1159t1461r1181b1490],
11	will	MD	O	will	aux	13	SENT_351	[p10l1195t1461r1258b1490],
12	be	VB	O	be	auxpass	13	SENT_351	[p10l1271t1461r1309b1490],
13	incorporated	VBN	O	incorporate	_	0	SENT_351	[p10l1323t1461r1531b1499],
14	into	IN	O	into	_	0	SENT_351	[p10l1544t1461r1607b1490],
15	trials	NNS	O	trial	prep_into	13	SENT_351	[p10l1622t1461r1702b1490],
16	evaluating	VBG	O	evaluate	partmod	15	SENT_351	[p10l1717t1461r1847b1490, p10l549t1513r601b1551],
17	the	DT	O	the	det	18	SENT_351	[p10l616t1514r665b1543],
18	role	NN	O	role	dobj	16	SENT_351	[p10l680t1513r744b1543],
19	of	IN	O	of	_	0	SENT_351	[p10l759t1513r795b1543],
20	paclitaxel	NN	O	paclitaxel	prep_of	18	SENT_351	[p10l807t1513r967b1551],
21	in	IN	O	in	_	0	SENT_351	[p10l982t1513r1013b1542],
22	adjuvant	JJ	O	adjuvant	amod	23	SENT_351	[p10l1029t1513r1170b1551],
23	therapy	NN	O	therapy	prep_in	20	SENT_351	[p10l1185t1514r1316b1551],
24	.	.	O	.	_	0	SENT_351	[p10l1185t1514r1316b1551],

1	In	IN	O	in	_	0	SENT_352	[p10l1333t1514r1367b1542],
2	another	DT	O	another	det	3	SENT_352	[p10l1383t1513r1506b1543],
3	study	NN	O	study	prep_in	17	SENT_352	[p10l1521t1513r1608b1551],
4	of	IN	O	of	_	0	SENT_352	[p10l1624t1513r1660b1543],
5	the	DT	O	the	det	6	SENT_352	[p10l1672t1513r1722b1543],
6	role	NN	O	role	prep_of	3	SENT_352	[p10l1736t1514r1800b1543],
7	of	IN	O	of	_	0	SENT_352	[p10l1815t1513r1851b1543],
8	paclitaxel	NN	O	paclitaxel	prep_of	6	SENT_352	[p10l549t1565r709b1603],
9	in	IN	O	in	_	0	SENT_352	[p10l723t1565r754b1594],
10	adjuvant	JJ	O	adjuvant	amod	11	SENT_352	[p10l769t1565r910b1603],
11	therapy	NN	O	therapy	prep_in	8	SENT_352	[p10l923t1565r1055b1603],
12	,	,	O	,	_	0	SENT_352	[p10l923t1565r1055b1603],
13	high-risk	JJ	O	high-risk	amod	14	SENT_352	[p10l1070t1565r1220b1603],
14	patients	NNS	O	patient	nsubjpass	17	SENT_352	[p10l1233t1565r1361b1603],
15	are	VBP	O	be	aux	17	SENT_352	[p10l1376t1575r1425b1595],
16	being	VBG	O	be	auxpass	17	SENT_352	[p10l1438t1565r1529b1603],
17	treated	VBN	O	treat	_	0	SENT_352	[p10l1544t1565r1656b1595],
18	with	IN	O	with	_	0	SENT_352	[p10l1669t1565r1742b1595],
19	either	CC	O	either	preconj	26	SENT_352	[p10l1756t1565r1850b1595],
20	high	JJ	O	high	amod	26	SENT_352	[p10l549t1617r631b1655],
21	,	,	O	,	_	0	SENT_352	[p10l549t1617r631b1655],
22	moderate	JJ	O	moderate	amod	26	SENT_352	[p10l646t1617r807b1651],
23	,	,	O	,	_	0	SENT_352	[p10l646t1617r807b1651],
24	or	CC	O	or	_	0	SENT_352	[p10l823t1626r857b1646],
25	low	JJ	O	low	conj_or	22	SENT_352	[p10l869t1617r929b1646],
26	doses	NNS	O	dose	prep_with	17	SENT_352	[p10l944t1617r1034b1646],
27	of	IN	O	of	_	0	SENT_352	[p10l1048t1617r1084b1646],
28	cyclophosphamide	NN	O	cyclophosphamide	prep_of	26	SENT_352	[p10l1095t1617r1404b1655],
29	and	CC	O	and	_	0	SENT_352	[p10l1418t1617r1477b1646],
30	doxorubicin	NN	O	doxorubicin	conj_and	26	SENT_352	[p10l1490t1617r1689b1646],
31	followed	VBN	O	follow	_	0	SENT_352	[p10l1702t1617r1849b1646],
32	by	IN	O	by	prepc_followed_by	17	SENT_352	[p10l549t1669r589b1706],
33	either	CC	O	either	preconj	34	SENT_352	[p10l605t1669r699b1698],
34	paclitaxel	NN	O	paclitaxel	pobj	17	SENT_352	[p10l713t1669r873b1706],
35	or	CC	O	or	_	0	SENT_352	[p10l889t1678r923b1698],
36	no	DT	O	no	det	38	SENT_352	[p10l937t1678r977b1698],
37	further	JJ	O	further	amod	38	SENT_352	[p10l993t1669r1106b1698],
38	treatment	NN	O	treatment	pobj	17	SENT_352	[p10l1120t1673r1283b1698],
39	.	.	O	.	_	0	SENT_352	[p10l1120t1673r1283b1698],

1	The	DT	O	the	det	2	SENT_353	[p10l1300t1669r1364b1698],
2	feasibility	NN	O	feasibility	nsubjpass	28	SENT_353	[p10l1379t1669r1543b1706],
3	of	IN	O	of	_	0	SENT_353	[p10l1559t1669r1595b1698],
4	combining	VBG	O	combine	prepc_of	2	SENT_353	[p10l1608t1669r1783b1706],
5	the	DT	O	the	det	6	SENT_353	[p10l1799t1669r1848b1698],
6	taxanes	NNS	O	taxane	dobj	4	SENT_353	[p10l549t1725r671b1749],
7	with	IN	O	with	_	0	SENT_353	[p10l686t1720r759b1749],
8	other	JJ	O	other	amod	10	SENT_353	[p10l772t1720r857b1749],
9	active	JJ	O	active	amod	10	SENT_353	[p10l870t1720r967b1749],
10	agents	NNS	O	agent	prep_with	4	SENT_353	[p10l981t1725r1084b1758],
11	such	JJ	O	such	_	0	SENT_353	[p10l1100t1720r1174b1749],
12	as	IN	O	as	_	0	SENT_353	[p10l1188t1730r1220b1749],
13	doxorubicin	NN	O	doxorubicin	prep_such_as	10	SENT_353	[p10l1234t1720r1442b1755],
14	,	,	O	,	_	0	SENT_353	[p10l1234t1720r1442b1755],
15	cyclophosphamide	NN	O	cyclophosphamide	prep_such_as	10	SENT_353	[p10l1457t1720r1775b1758],
16	,	,	O	,	_	0	SENT_353	[p10l1457t1720r1775b1758],
17	cisplatin	NN	O	cisplatin	prep_such_as	10	SENT_353	[p10l1790t1720r1847b1749, p10l549t1771r651b1809],
18	,	,	O	,	_	0	SENT_353	[p10l1790t1720r1847b1749, p10l549t1771r651b1809],
19	vinorelbine	NN	O	vinorelbine	prep_such_as	10	SENT_353	[p10l667t1771r863b1806],
20	,	,	O	,	_	0	SENT_353	[p10l667t1771r863b1806],
21	and	CC	O	and	_	0	SENT_353	[p10l880t1771r938b1801],
22	5	CD	NUMBER	5	num	24	SENT_353	[p10l952t1771r1180b1801],
23	—	NN	O	—	nn	24	SENT_353	[p10l952t1771r1180b1801],
24	ﬂuorouracil	NN	O	ﬂuorouracil	prep_such_as	10	SENT_353	[p10l952t1771r1180b1801],
25	is	VBZ	O	be	aux	28	SENT_353	[p10l1195t1771r1220b1801],
26	also	RB	O	also	advmod	28	SENT_353	[p10l1236t1771r1300b1801],
27	being	VBG	O	be	auxpass	28	SENT_353	[p10l1314t1771r1406b1809],
28	evaluated	VBN	O	evaluate	_	0	SENT_353	[p10l1420t1771r1578b1801],
29	(	RB	O	(	advmod	28	SENT_353	[p10l1593t1771r1668b1807],
30	14	CD	NUMBER	14	num	31	SENT_353	[p10l1593t1771r1668b1807],
31	)	NN	O	)	dobj	28	SENT_353	[p10l1593t1771r1668b1807],
32	.	.	O	.	_	0	SENT_353	[p10l1593t1771r1668b1807],

1	Combinations	NNS	O	combination	nsubj	10	SENT_354	[p10l1684t1771r1847b1801, p10l549t1822r628b1851],
2	of	IN	O	of	_	0	SENT_354	[p10l640t1822r676b1851],
3	the	DT	O	the	det	4	SENT_354	[p10l683t1822r733b1851],
4	taxanes	NNS	O	taxane	prep_of	1	SENT_354	[p10l743t1827r866b1851],
5	and	CC	O	and	_	0	SENT_354	[p10l878t1822r936b1851],
6	anthracyclines	NNS	O	anthracycline	prep_of	1	SENT_354	[p10l947t1822r1183b1860],
7	appear	VBP	O	appear	cop	10	SENT_354	[p10l1195t1831r1304b1860],
8	especially	RB	O	especially	advmod	10	SENT_354	[p10l1314t1822r1478b1860],
9	promising	JJ	O	promising	amod	10	SENT_354	[p10l1487t1822r1655b1860],
10	(	NN	O	(	_	0	SENT_354	[p10l1667t1823r1729b1858],
11	22	CD	NUMBER	22	num	10	SENT_354	[p10l1667t1823r1729b1858],
12	,	,	O	,	_	0	SENT_354	[p10l1667t1823r1729b1858],
13	75	CD	NUMBER	75	num	14	SENT_354	[p10l1741t1822r1803b1858],
14	)	NN	O	)	appos	10	SENT_354	[p10l1741t1822r1803b1858],
15	.	.	O	.	_	0	SENT_354	[p10l1741t1822r1803b1858],

1	In	IN	O	in	_	0	SENT_355	[p10l1815t1823r1849b1851],
2	a	DT	O	a	det	3	SENT_355	[p10l550t1882r567b1902],
3	phase	NN	O	phase	prep_in	24	SENT_355	[p10l580t1873r673b1911],
4	I	PRP	O	I	dep	5	SENT_355	[p10l687t1874r700b1902],
5	trial	NN	O	trial	dep	3	SENT_355	[p10l713t1873r779b1902],
6	of	IN	O	of	_	0	SENT_355	[p10l793t1873r829b1902],
7	paclitaxel	NN	O	paclitaxel	nn	11	SENT_355	[p10l839t1873r999b1911],
8	(	CD	NUMBER	(	num	11	SENT_355	[p10l1014t1873r1080b1909],
9	3-h	JJ	O	3-h	amod	11	SENT_355	[p10l1014t1873r1080b1909],
10	schedule	NN	O	schedule	nn	11	SENT_355	[p10l1095t1873r1250b1909],
11	)	NN	O	)	prep_of	5	SENT_355	[p10l1095t1873r1250b1909],
12	and	CC	O	and	_	0	SENT_355	[p10l1266t1873r1324b1902],
13	doxorubicin	NN	O	doxorubicin	prep_of	5	SENT_355	[p10l1338t1873r1545b1908],
14	,	,	O	,	_	0	SENT_355	[p10l1338t1873r1545b1908],
15	94	CD	PERCENT	94	num	16	SENT_355	[p10l1561t1873r1633b1903],
16	%	NN	PERCENT	%	nsubj	24	SENT_355	[p10l1561t1873r1633b1903],
17	of	IN	O	of	_	0	SENT_355	[p10l1649t1873r1685b1902],
18	untreated	JJ	O	untreated	amod	19	SENT_355	[p10l1696t1873r1849b1902],
19	patients	NNS	O	patient	prep_of	16	SENT_355	[p10l549t1924r676b1962],
20	with	IN	O	with	_	0	SENT_355	[p10l692t1924r765b1954],
21	metastatic	JJ	O	metastatic	amod	23	SENT_355	[p10l780t1924r946b1954],
22	breast	NN	O	breast	nn	23	SENT_355	[p10l961t1924r1060b1954],
23	cancer	NN	O	cancer	prep_with	19	SENT_355	[p10l1074t1933r1182b1954],
24	responded	VBD	O	respond	dep	43	SENT_355	[p10l1195t1924r1364b1962],
25	and	CC	O	and	_	0	SENT_355	[p10l1380t1924r1438b1954],
26	41	CD	PERCENT	41	num	27	SENT_355	[p10l1453t1924r1526b1954],
27	%	NN	PERCENT	%	nsubj	28	SENT_355	[p10l1453t1924r1526b1954],
28	had	VBD	O	have	dep	43	SENT_355	[p10l1542t1924r1602b1954],
29	CR	JJ	O	cr	dobj	28	SENT_355	[p10l1617t1924r1680b1959],
30	;	:	O	;	_	0	SENT_355	[p10l1617t1924r1680b1959],
31	however	RB	O	however	advmod	39	SENT_355	[p10l1697t1924r1847b1959],
32	,	,	O	,	_	0	SENT_355	[p10l1697t1924r1847b1959],
33	the	DT	O	the	det	35	SENT_355	[p10l549t1975r599b2005],
34	high	JJ	O	high	amod	35	SENT_355	[p10l610t1975r683b2013],
35	incidence	NN	O	incidence	nsubj	39	SENT_355	[p10l694t1975r851b2005],
36	of	IN	O	of	_	0	SENT_355	[p10l863t1975r899b2005],
37	cardiac	JJ	O	cardiac	amod	38	SENT_355	[p10l908t1975r1025b2005],
38	effects	NNS	O	effect	prep_of	35	SENT_355	[p10l1038t1975r1146b2005],
39	requires	VBZ	O	require	dep	43	SENT_355	[p10l1158t1975r1289b2013],
40	further	JJ	O	further	amod	41	SENT_355	[p10l1302t1975r1414b2005],
41	study	NN	O	study	dobj	39	SENT_355	[p10l1426t1975r1513b2013],
42	(	CD	NUMBER	(	dep	41	SENT_355	[p10l1525t1976r1589b2011],
43	see	VBP	O	see	_	0	SENT_355	[p10l1525t1976r1589b2011],
44	above	IN	O	above	_	0	SENT_355	[p10l1601t1975r1711b2011],
45	)	CD	NUMBER	)	number	46	SENT_355	[p10l1601t1975r1711b2011],
46	(	CD	NUMBER	(	prep_above	43	SENT_355	[p10l1725t1975r1800b2011],
47	22	CD	NUMBER	22	num	48	SENT_355	[p10l1725t1975r1800b2011],
48	)	NN	O	)	nsubj	43	SENT_355	[p10l1725t1975r1800b2011],
49	.	.	O	.	_	0	SENT_355	[p10l1725t1975r1800b2011],

1	Optimal	JJ	O	optimal	amod	2	SENT_356	[p10l600t2027r734b2065],
2	dosing	NN	O	dosing	nsubjpass	6	SENT_356	[p10l748t2027r856b2065],
3	is	VBZ	O	be	aux	6	SENT_356	[p10l870t2027r896b2056],
4	also	RB	O	also	advmod	6	SENT_356	[p10l911t2027r975b2056],
5	being	VBG	O	be	auxpass	6	SENT_356	[p10l989t2027r1080b2065],
6	studied	VBN	O	study	_	0	SENT_356	[p10l1095t2027r1213b2056],
7	in	IN	O	in	_	0	SENT_356	[p10l1226t2027r1257b2056],
8	metastatic	JJ	O	metastatic	amod	10	SENT_356	[p10l1270t2027r1436b2056],
9	breast	NN	O	breast	nn	10	SENT_356	[p10l1449t2027r1548b2056],
10	cancer	NN	O	cancer	prep_in	6	SENT_356	[p10l1561t2036r1676b2056],
11	.	.	O	.	_	0	SENT_356	[p10l1561t2036r1676b2056],

1	The	DT	O	the	det	3	SENT_357	[p10l1691t2027r1754b2056],
2	early	JJ	O	early	amod	3	SENT_357	[p10l1767t2027r1848b2065],
3	results	NNS	O	result	dep	19	SENT_357	[p10l549t2078r655b2107],
4	of	IN	O	of	_	0	SENT_357	[p10l670t2078r706b2107],
5	a	DT	O	a	det	7	SENT_357	[p10l716t2087r734b2107],
6	randomized	JJ	O	randomized	amod	7	SENT_357	[p10l745t2078r940b2107],
7	trial	NN	O	trial	prep_of	3	SENT_357	[p10l953t2078r1018b2107],
8	of	IN	O	of	_	0	SENT_357	[p10l1031t2078r1067b2107],
9	paclitaxel	NN	O	paclitaxel	prep_of	7	SENT_357	[p10l1077t2078r1237b2116],
10	at	IN	O	at	_	0	SENT_357	[p10l1250t2083r1279b2107],
11	135	CD	NUMBER	135	prep_at	9	SENT_357	[p10l1295t2078r1350b2108],
12	or	CC	O	or	_	0	SENT_357	[p10l1365t2087r1399b2107],
13	175	CD	NUMBER	175	conj_or	11	SENT_357	[p10l1415t2078r1470b2108],
14	mg/m2	NN	O	mg/m2	dep	19	SENT_357	[p10l1485t2067r1597b2116],
15	(	CD	NUMBER	(	num	14	SENT_357	[p10l1612t2078r1678b2114],
16	3	CD	NUMBER	3	num	19	SENT_357	[p10l1612t2078r1678b2114],
17	—	NN	O	—	nn	19	SENT_357	[p10l1612t2078r1678b2114],
18	h	NN	O	h	nn	19	SENT_357	[p10l1612t2078r1678b2114],
19	schedule	NN	O	schedule	dep	21	SENT_357	[p10l1692t2078r1848b2114],
20	)	CD	NUMBER	)	dep	19	SENT_357	[p10l1692t2078r1848b2114],
21	indicated	VBD	O	indicate	_	0	SENT_357	[p10l549t2129r700b2159],
22	no	DT	O	no	det	23	SENT_357	[p10l713t2138r753b2159],
23	differences	NNS	O	difference	nsubj	27	SENT_357	[p10l767t2129r948b2159],
24	in	IN	O	in	_	0	SENT_357	[p10l962t2129r993b2158],
25	response	NN	O	response	nn	26	SENT_357	[p10l1006t2138r1150b2167],
26	rates	NNS	O	rate	prep_in	23	SENT_357	[p10l1163t2134r1239b2159],
27	[	VBP	O	[	ccomp	21	SENT_357	[p10l1256t2129r1306b2165],
28	29	CD	NUMBER	29	number	29	SENT_357	[p10l1256t2129r1306b2165],
29	(	CD	NUMBER	(	num	32	SENT_357	[p10l1322t2129r1407b2167],
30	high	JJ	O	high	amod	32	SENT_357	[p10l1322t2129r1407b2167],
31	dose	NN	O	dose	nn	32	SENT_357	[p10l1420t2129r1507b2165],
32	)	NN	O	)	dobj	27	SENT_357	[p10l1420t2129r1507b2165],
33	vs	CC	O	vs	_	0	SENT_357	[p10l1522t2138r1557b2159],
34	22	CD	PERCENT	22	num	35	SENT_357	[p10l1571t2129r1644b2159],
35	%	NN	PERCENT	%	conj_vs	32	SENT_357	[p10l1571t2129r1644b2159],
36	(	CD	NUMBER	(	num	38	SENT_357	[p10l1660t2129r1733b2165],
37	low	JJ	O	low	amod	38	SENT_357	[p10l1660t2129r1733b2165],
38	dose	NN	O	dose	dep	27	SENT_357	[p10l1746t2129r1846b2165],
39	)	NN	O	)	dep	38	SENT_357	[p10l1746t2129r1846b2165],
40	]	CD	NUMBER	]	num	39	SENT_357	[p10l1746t2129r1846b2165],
41	or	CC	O	or	_	0	SENT_357	[p10l550t2189r584b2209],
42	in	IN	O	in	dep	38	SENT_357	[p10l596t2180r627b2209],
43	median	JJ	O	median	amod	45	SENT_357	[p10l641t2180r762b2209],
44	survival	NN	O	survival	nn	45	SENT_357	[p10l777t2180r907b2209],
45	[	NN	O	[	pobj	42	SENT_357	[p10l924t2180r1005b2216],
46	11.7	CD	NUMBER	11.7	number	47	SENT_357	[p10l924t2180r1005b2216],
47	(	CD	NUMBER	(	num	50	SENT_357	[p10l1021t2180r1106b2218],
48	high	JJ	O	high	amod	50	SENT_357	[p10l1021t2180r1106b2218],
49	dose	NN	O	dose	nn	50	SENT_357	[p10l1120t2180r1207b2216],
50	)	NN	O	)	dep	45	SENT_357	[p10l1120t2180r1207b2216],
51	vs	CC	O	vs	_	0	SENT_357	[p10l1222t2189r1257b2209],
52	10.5	CD	DURATION	10.5	num	53	SENT_357	[p10l1275t2180r1341b2210],
53	months	NNS	NUMBER	month	tmod	54	SENT_357	[p10l1355t2180r1476b2209],
54	(	RB	O	(	amod	58	SENT_357	[p10l1492t2180r1565b2216],
55	low	JJ	O	low	amod	58	SENT_357	[p10l1492t2180r1565b2216],
56	dose	NN	O	dose	nn	58	SENT_357	[p10l1579t2180r1690b2216],
57	)	NN	O	)	nn	58	SENT_357	[p10l1579t2180r1690b2216],
58	]	NN	O	]	pobj	42	SENT_357	[p10l1579t2180r1690b2216],
59	,	,	O	,	_	0	SENT_357	[p10l1579t2180r1690b2216],
60	although	IN	O	although	mark	65	SENT_357	[p10l1705t2180r1849b2218],
61	progression	NN	O	progression	nsubj	65	SENT_357	[p10l549t2231r819b2269],
62	—	CD	NUMBER	—	num	64	SENT_357	[p10l549t2231r819b2269],
63	free	JJ	O	free	amod	64	SENT_357	[p10l549t2231r819b2269],
64	survival	NN	O	survival	dep	61	SENT_357	[p10l833t2231r964b2261],
65	was	VBD	O	be	advcl	27	SENT_357	[p10l977t2240r1039b2261],
66	longer	RBR	O	longer	advmod	65	SENT_357	[p10l1052t2231r1158b2269],
67	with	IN	O	with	_	0	SENT_357	[p10l1170t2231r1242b2261],
68	the	DT	O	the	det	71	SENT_357	[p10l1255t2231r1304b2261],
69	higher	JJR	O	higher	amod	71	SENT_357	[p10l1316t2231r1422b2269],
70	dose	NN	O	dose	nn	71	SENT_357	[p10l1434t2231r1508b2261],
71	[	NN	O	[	prep_with	66	SENT_357	[p10l1523t2231r1584b2267],
72	4.2	CD	NUMBER	4.2	dep	79	SENT_357	[p10l1523t2231r1584b2267],
73	vs	CC	O	vs	cc	72	SENT_357	[p10l1597t2240r1632b2261],
74	3	CD	DURATION	3	num	75	SENT_357	[p10l1647t2231r1663b2261],
75	months	NNS	NUMBER	month	dep	72	SENT_357	[p10l1677t2231r1797b2261],
76	(	CD	NUMBER	(	num	77	SENT_357	[p10l1812t2232r1849b2267],
77	P	NN	O	p	dep	79	SENT_357	[p10l1812t2232r1849b2267],
78	THE	DT	O	the	det	79	SENT_357	[p10l1491t2288r1563b2314],
79	TAXANES	NN	O	taxane	dep	65	SENT_357	[p10l1573t2288r1745b2314],
80	367	CD	NUMBER	367	dep	79	SENT_357	[p10l1794t2288r1847b2314],

1	=	JJ	O	=	amod	2	SENT_358	[p10l550t2384r571b2396],
2	0.02	CD	NUMBER	0.02	_	0	SENT_358	[p10l582t2372r678b2408],
3	)	CD	NUMBER	)	num	4	SENT_358	[p10l582t2372r678b2408],
4	]	NN	O	]	dep	2	SENT_358	[p10l582t2372r678b2408],
5	(	CD	NUMBER	(	number	6	SENT_358	[p10l693t2372r768b2408],
6	76	CD	NUMBER	76	num	7	SENT_358	[p10l693t2372r768b2408],
7	)	NN	O	)	dep	4	SENT_358	[p10l693t2372r768b2408],
8	.	.	O	.	_	0	SENT_358	[p10l693t2372r768b2408],

1	These	DT	O	these	det	2	SENT_359	[p10l780t2372r878b2402],
2	results	NNS	O	result	nsubj	3	SENT_359	[p10l888t2372r994b2402],
3	led	VBD	O	lead	_	0	SENT_359	[p10l1006t2372r1056b2402],
4	to	TO	O	to	_	0	SENT_359	[p10l1066t2377r1096b2402],
5	the	DT	O	the	det	7	SENT_359	[p10l1107t2372r1156b2402],
6	regulatory	JJ	O	regulatory	amod	7	SENT_359	[p10l1166t2372r1336b2410],
7	approval	NN	O	approval	prep_to	3	SENT_359	[p10l1347t2372r1490b2410],
8	of	IN	O	of	_	0	SENT_359	[p10l1500t2372r1536b2402],
9	paclitaxel	NN	O	paclitaxel	nn	10	SENT_359	[p10l1543t2372r1704b2410],
10	doses	NNS	O	dose	prep_of	7	SENT_359	[p10l1714t2372r1804b2402],
11	of	IN	O	of	_	0	SENT_359	[p10l1816t2372r1851b2402],
12	175	CD	NUMBER	175	num	13	SENT_359	[p10l553t2423r608b2452],
13	mg/m2	NN	O	mg/m2	prep_of	10	SENT_359	[p10l627t2411r739b2460],
14	(	CD	NUMBER	(	number	15	SENT_359	[p10l757t2423r824b2458],
15	3	CD	NUMBER	3	num	27	SENT_359	[p10l757t2423r824b2458],
16	—	NN	O	—	nn	27	SENT_359	[p10l757t2423r824b2458],
17	h	NN	O	h	nn	27	SENT_359	[p10l757t2423r824b2458],
18	schedule	NN	O	schedule	dep	27	SENT_359	[p10l841t2423r996b2458],
19	)	CD	NUMBER	)	num	18	SENT_359	[p10l841t2423r996b2458],
20	in	IN	O	in	_	0	SENT_359	[p10l1014t2423r1045b2451],
21	metastatic	JJ	O	metastatic	amod	22	SENT_359	[p10l1061t2423r1227b2452],
22	disease	NN	O	disease	prep_in	18	SENT_359	[p10l1245t2423r1363b2452],
23	after	IN	O	after	_	0	SENT_359	[p10l1380t2423r1455b2452],
24	failure	NN	O	failure	prep_after	18	SENT_359	[p10l1470t2423r1576b2452],
25	of	IN	O	of	_	0	SENT_359	[p10l1593t2423r1629b2452],
26	combination	NN	O	combination	prep_of	24	SENT_359	[p10l1643t2423r1849b2452],
27	chemotherapy	NN	O	chemotherapy	dobj	3	SENT_359	[p10l549t2472r782b2510],
28	or	CC	O	or	_	0	SENT_359	[p10l801t2481r835b2502],
29	relapse	NN	O	relapse	conj_or	27	SENT_359	[p10l851t2472r968b2510],
30	within	IN	O	within	_	0	SENT_359	[p10l986t2472r1090b2501],
31	six	CD	DURATION	six	num	32	SENT_359	[p10l1110t2472r1155b2502],
32	months	NNS	NUMBER	month	prep_within	27	SENT_359	[p10l1174t2472r1294b2502],
33	of	IN	O	of	_	0	SENT_359	[p10l1313t2472r1349b2502],
34	adjuvant	JJ	O	adjuvant	amod	35	SENT_359	[p10l1365t2472r1506b2510],
35	therapy	NN	O	therapy	prep_of	32	SENT_359	[p10l1523t2472r1655b2510],
36	.	.	O	.	_	0	SENT_359	[p10l1523t2472r1655b2510],

1	In	IN	O	in	_	0	SENT_360	[p10l1674t2473r1708b2501],
2	another	DT	O	another	det	3	SENT_360	[p10l1726t2472r1850b2502],
3	study	NN	O	study	nsubj	4	SENT_360	[p10l551t2522r638b2560],
4	evaluating	VBG	O	evaluate	prepc_in	19	SENT_360	[p10l655t2522r826b2560],
5	whether	IN	O	whether	complm	8	SENT_360	[p10l842t2522r975b2552],
6	higher	JJR	O	higher	amod	7	SENT_360	[p10l990t2522r1096b2560],
7	doses	NNS	O	dose	nsubj	8	SENT_360	[p10l1111t2522r1201b2552],
8	portend	VBP	O	portend	ccomp	4	SENT_360	[p10l1218t2522r1344b2560],
9	greater	JJR	O	greater	amod	10	SENT_360	[p10l1360t2527r1475b2560],
10	activity	NN	O	activity	dobj	8	SENT_360	[p10l1490t2522r1621b2560],
11	,	,	O	,	_	0	SENT_360	[p10l1490t2522r1621b2560],
12	women	NNS	O	woman	nsubjpass	19	SENT_360	[p10l1639t2531r1760b2552],
13	with	IN	O	with	_	0	SENT_360	[p10l1776t2522r1848b2552],
14	metastatic	JJ	O	metastatic	amod	16	SENT_360	[p10l549t2572r715b2602],
15	breast	NN	O	breast	nn	16	SENT_360	[p10l735t2572r834b2602],
16	cancer	NN	O	cancer	prep_with	12	SENT_360	[p10l853t2581r960b2602],
17	are	VBP	O	be	aux	19	SENT_360	[p10l979t2581r1028b2602],
18	being	VBG	O	be	auxpass	19	SENT_360	[p10l1047t2572r1138b2610],
19	randomized	VBN	O	randomize	_	0	SENT_360	[p10l1157t2572r1352b2602],
20	to	TO	O	to	_	0	SENT_360	[p10l1372t2577r1402b2602],
21	treatment	NN	O	treatment	prep_to	19	SENT_360	[p10l1423t2577r1578b2602],
22	with	IN	O	with	_	0	SENT_360	[p10l1597t2572r1670b2602],
23	paclitaxel	NN	O	paclitaxel	nn	24	SENT_360	[p10l1688t2572r1849b2610],
24	doses	NNS	O	dose	prep_with	19	SENT_360	[p10l550t2622r639b2651],
25	of	IN	O	of	_	0	SENT_360	[p10l658t2622r694b2651],
26	either	CC	O	either	prep	35	SENT_360	[p10l708t2622r802b2651],
27	175	CD	NUMBER	175	dep	26	SENT_360	[p10l822t2622r888b2657],
28	,	,	O	,	_	0	SENT_360	[p10l822t2622r888b2657],
29	210	CD	NUMBER	210	dep	26	SENT_360	[p10l907t2622r976b2657],
30	,	,	O	,	_	0	SENT_360	[p10l907t2622r976b2657],
31	or	CC	O	or	_	0	SENT_360	[p10l996t2631r1029b2651],
32	250	CD	NUMBER	250	num	33	SENT_360	[p10l1046t2622r1106b2652],
33	mg/m2	NN	O	mg/m2	conj_or	27	SENT_360	[p10l1124t2611r1236b2660],
34	(	CD	NUMBER	(	number	35	SENT_360	[p10l1254t2622r1321b2658],
35	3	CD	NUMBER	3	prep_of	24	SENT_360	[p10l1254t2622r1321b2658],
36	—	NN	O	—	nn	38	SENT_360	[p10l1254t2622r1321b2658],
37	h	NN	O	h	nn	38	SENT_360	[p10l1254t2622r1321b2658],
38	schedule	NN	O	schedule	dep	35	SENT_360	[p10l1340t2622r1504b2658],
39	)	CD	NUMBER	)	dep	38	SENT_360	[p10l1340t2622r1504b2658],
40	.	.	O	.	_	0	SENT_360	[p10l1340t2622r1504b2658],

1	Although	IN	O	although	mark	6	SENT_361	[p10l1523t2622r1679b2660],
2	there	EX	O	there	expl	6	SENT_361	[p10l1696t2622r1778b2652],
3	has	VBZ	O	have	aux	6	SENT_361	[p10l1794t2622r1848b2652],
4	been	VBN	O	be	cop	6	SENT_361	[p10l549t2672r626b2702],
5	a	DT	O	a	det	6	SENT_361	[p10l640t2681r658b2702],
6	paucity	NN	O	paucity	advcl	17	SENT_361	[p10l669t2672r790b2710],
7	of	IN	O	of	_	0	SENT_361	[p10l804t2672r840b2702],
8	studies	NNS	O	study	prep_of	6	SENT_361	[p10l852t2672r963b2702],
9	addressing	VBG	O	address	partmod	8	SENT_361	[p10l978t2672r1153b2710],
10	optimal	JJ	O	optimal	amod	11	SENT_361	[p10l1167t2672r1292b2710],
11	dosing	NN	O	dosing	dobj	9	SENT_361	[p10l1306t2672r1414b2710],
12	with	IN	O	with	_	0	SENT_361	[p10l1428t2672r1501b2702],
13	docetaxel	NN	O	docetaxel	prep_with	9	SENT_361	[p10l1514t2672r1680b2707],
14	,	,	O	,	_	0	SENT_361	[p10l1514t2672r1680b2707],
15	this	DT	O	this	det	16	SENT_361	[p10l1694t2672r1752b2702],
16	issue	NN	O	issue	nsubj	17	SENT_361	[p10l1766t2672r1848b2702],
17	is	VBZ	O	be	dep	49	SENT_361	[p10l549t2722r575b2752],
18	important	JJ	O	important	acomp	17	SENT_361	[p10l587t2722r748b2760],
19	because	IN	O	because	mark	25	SENT_361	[p10l757t2722r888b2752],
20	docetaxel	NN	O	docetaxel	nsubjpass	25	SENT_361	[p10l899t2722r1056b2752],
21	has	VBZ	O	have	aux	25	SENT_361	[p10l1066t2722r1120b2752],
22	almost	RB	O	almost	advmod	23	SENT_361	[p10l1133t2722r1242b2752],
23	exclusively	RB	O	exclusively	advmod	25	SENT_361	[p10l1252t2722r1439b2760],
24	been	VBN	O	be	auxpass	25	SENT_361	[p10l1449t2722r1527b2752],
25	evaluated	VBN	O	evaluate	advcl	17	SENT_361	[p10l1538t2722r1696b2752],
26	at	IN	O	at	_	0	SENT_361	[p10l1707t2727r1735b2752],
27	a	DT	O	a	det	28	SENT_361	[p10l1746t2731r1763b2752],
28	dose	NN	O	dose	prep_at	25	SENT_361	[p10l1774t2722r1848b2752],
29	of	IN	O	of	_	0	SENT_361	[p10l550t2772r585b2801],
30	100	CD	NUMBER	100	num	31	SENT_361	[p10l603t2772r660b2802],
31	mg/m2	NN	O	mg/m2	prep_of	28	SENT_361	[p10l677t2761r798b2810],
32	,	,	O	,	_	0	SENT_361	[p10l677t2761r798b2810],
33	which	WDT	O	which	nsubj	34	SENT_361	[p10l816t2772r916b2802],
34	induces	VBZ	O	induce	rcmod	31	SENT_361	[p10l932t2772r1057b2802],
35	severe	JJ	O	severe	amod	36	SENT_361	[p10l1075t2781r1178b2802],
36	neutropenia	NN	O	neutropenia	dobj	34	SENT_361	[p10l1195t2772r1390b2810],
37	in	IN	O	in	_	0	SENT_361	[p10l1405t2772r1436b2801],
38	most	JJS	O	most	amod	39	SENT_361	[p10l1453t2777r1533b2802],
39	patients	NNS	O	patient	prep_in	36	SENT_361	[p10l1548t2772r1685b2810],
40	,	,	O	,	_	0	SENT_361	[p10l1548t2772r1685b2810],
41	and	CC	O	and	_	0	SENT_361	[p10l1704t2772r1762b2802],
42	substantial	JJ	O	substantial	amod	43	SENT_361	[p10l1780t2772r1847b2802, p10l551t2822r669b2851],
43	activity	NN	O	activity	conj_and	36	SENT_361	[p10l692t2822r815b2860],
44	with	IN	O	with	_	0	SENT_361	[p10l838t2822r911b2851],
45	less	JJR	O	less	amod	46	SENT_361	[p10l933t2822r993b2851],
46	toxicity	NN	O	toxicity	prep_with	43	SENT_361	[p10l1017t2822r1143b2860],
47	has	VBZ	O	have	aux	49	SENT_361	[p10l1166t2822r1219b2851],
48	been	VBN	O	be	auxpass	49	SENT_361	[p10l1242t2822r1320b2851],
49	noted	VBN	O	note	_	0	SENT_361	[p10l1342t2822r1433b2851],
50	at	IN	O	at	_	0	SENT_361	[p10l1455t2827r1484b2851],
51	lower	JJR	O	lower	amod	52	SENT_361	[p10l1505t2822r1599b2851],
52	doses	NNS	O	dose	prep_at	49	SENT_361	[p10l1620t2822r1709b2851],
53	(	CD	NUMBER	(	dep	52	SENT_361	[p10l1733t2822r1847b2858],
54	60-75	CD	NUMBER	60-75	num	56	SENT_361	[p10l1733t2822r1847b2858],
55	mg/m2	NN	O	mg/m2	nn	56	SENT_361	[p10l549t2861r683b2910],
56	)	NN	O	)	nsubjpass	49	SENT_361	[p10l549t2861r683b2910],
57	.	.	O	.	_	0	SENT_361	[p10l549t2861r683b2910],

1	Optimal	JJ	O	optimal	amod	2	SENT_362	[p10l600t2924r734b2962],
2	scheduling	NN	O	scheduling	nsubjpass	5	SENT_362	[p10l747t2924r923b2962],
3	has	VBZ	O	have	aux	5	SENT_362	[p10l935t2924r989b2953],
4	been	VBN	O	be	auxpass	5	SENT_362	[p10l1001t2924r1078b2953],
5	studied	VBN	O	study	_	0	SENT_362	[p10l1091t2924r1209b2953],
6	in	IN	O	in	_	0	SENT_362	[p10l1220t2924r1252b2953],
7	a	DT	O	a	det	9	SENT_362	[p10l1264t2933r1281b2953],
8	randomized	JJ	O	randomized	amod	9	SENT_362	[p10l1291t2924r1486b2953],
9	trial	NN	O	trial	prep_in	5	SENT_362	[p10l1497t2924r1562b2953],
10	in	IN	O	in	_	0	SENT_362	[p10l1573t2924r1605b2953],
11	which	WDT	O	which	rel	18	SENT_362	[p10l1616t2924r1717b2953],
12	women	NNS	O	woman	nsubjpass	18	SENT_362	[p10l1728t2933r1849b2953],
13	with	IN	O	with	_	0	SENT_362	[p10l550t2974r622b3003],
14	metastatic	JJ	O	metastatic	amod	16	SENT_362	[p10l637t2974r803b3003],
15	breast	NN	O	breast	nn	16	SENT_362	[p10l817t2974r916b3003],
16	cancer	NN	O	cancer	prep_with	12	SENT_362	[p10l930t2983r1038b3003],
17	were	VBD	O	be	auxpass	18	SENT_362	[p10l1051t2983r1130b3003],
18	treated	VBN	O	treat	rcmod	9	SENT_362	[p10l1145t2974r1257b3003],
19	with	IN	O	with	prep	18	SENT_362	[p10l1271t2974r1343b3003],
20	either	CC	O	either	dep	30	SENT_362	[p10l1358t2974r1451b3003],
21	3	LS	NUMBER	3	amod	25	SENT_362	[p10l1466t2974r1497b3003],
22	-	:	O	-	_	0	SENT_362	[p10l1466t2974r1497b3003],
23	or	CC	O	or	_	0	SENT_362	[p10l1513t2983r1547b3003],
24	24-h	JJ	O	24-h	amod	25	SENT_362	[p10l1561t2974r1635b3003],
25	infusions	NNS	O	infusion	dep	20	SENT_362	[p10l1650t2974r1800b3003],
26	of	IN	O	of	_	0	SENT_362	[p10l1815t2974r1851b3003],
27	paclitaxel	NN	O	paclitaxel	nn	28	SENT_362	[p10l549t3024r709b3062],
28	(	NN	O	(	prep_of	25	SENT_362	[p10l724t3024r796b3060],
29	175	CD	NUMBER	175	num	28	SENT_362	[p10l724t3024r796b3060],
30	mg/m2	NN	O	mg/m2	dep	19	SENT_362	[p10l812t3013r937b3062],
31	)	CD	NUMBER	)	num	30	SENT_362	[p10l812t3013r937b3062],
32	(	CD	NUMBER	(	number	33	SENT_362	[p10l954t3024r1029b3060],
33	41	CD	NUMBER	41	num	34	SENT_362	[p10l954t3024r1029b3060],
34	)	NN	O	)	dep	30	SENT_362	[p10l954t3024r1029b3060],
35	.	.	O	.	_	0	SENT_362	[p10l954t3024r1029b3060],

1	There	EX	O	there	expl	2	SENT_363	[p10l1045t3024r1140b3053],
2	were	VBD	O	be	dep	8	SENT_363	[p10l1155t3033r1234b3053],
3	no	DT	O	no	det	4	SENT_363	[p10l1248t3033r1288b3053],
4	differences	NNS	O	difference	nsubj	2	SENT_363	[p10l1303t3024r1485b3053],
5	in	IN	O	in	_	0	SENT_363	[p10l1500t3024r1531b3053],
6	response	NN	O	response	nn	7	SENT_363	[p10l1545t3033r1689b3062],
7	rates	NNS	O	rate	prep_in	4	SENT_363	[p10l1703t3029r1780b3053],
8	(	VBP	O	(	_	0	SENT_363	[p10l1796t3024r1848b3060],
9	29	CD	NUMBER	29	dobj	8	SENT_363	[p10l1796t3024r1848b3060],
10	vs	CC	O	vs	_	0	SENT_363	[p10l550t3083r584b3103],
11	31	CD	PERCENT	31	num	12	SENT_363	[p10l597t3074r693b3110],
12	%	NN	PERCENT	%	conj_vs	9	SENT_363	[p10l597t3074r693b3110],
13	)	CD	NUMBER	)	nsubj	8	SENT_363	[p10l597t3074r693b3110],
14	,	,	O	,	_	0	SENT_363	[p10l597t3074r693b3110],
15	median	JJ	O	median	amod	16	SENT_363	[p10l705t3074r826b3103],
16	progression	NN	O	progression	appos	13	SENT_363	[p10l836t3074r1106b3112],
17	—	CD	NUMBER	—	num	19	SENT_363	[p10l836t3074r1106b3112],
18	free	JJ	O	free	amod	19	SENT_363	[p10l836t3074r1106b3112],
19	survival	NN	O	survival	dep	16	SENT_363	[p10l1118t3074r1249b3103],
20	(	CD	NUMBER	(	number	21	SENT_363	[p10l1261t3074r1323b3110],
21	3.5	CD	NUMBER	3.5	dep	19	SENT_363	[p10l1261t3074r1323b3110],
22	vs	CC	O	vs	_	0	SENT_363	[p10l1335t3083r1369b3103],
23	4.6	CD	DURATION	4.6	num	24	SENT_363	[p10l1381t3074r1431b3103],
24	months	NNS	NUMBER	month	dep	16	SENT_363	[p10l1442t3074r1585b3110],
25	)	RB	O	)	advmod	24	SENT_363	[p10l1442t3074r1585b3110],
26	,	,	O	,	_	0	SENT_363	[p10l1442t3074r1585b3110],
27	or	CC	O	or	_	0	SENT_363	[p10l1598t3083r1632b3103],
28	survival	NN	O	survival	conj_vs	19	SENT_363	[p10l1643t3074r1773b3103],
29	(	CD	NUMBER	(	number	30	SENT_363	[p10l1785t3074r1847b3110],
30	9.8	CD	NUMBER	9.8	dep	28	SENT_363	[p10l1785t3074r1847b3110],
31	vs	CC	O	vs	_	0	SENT_363	[p10l550t3133r584b3153],
32	13.4	CD	DURATION	13.4	num	33	SENT_363	[p10l604t3124r671b3153],
33	months	NNS	NUMBER	month	conj_vs	28	SENT_363	[p10l686t3124r820b3160],
34	)	RB	O	)	rcmod	33	SENT_363	[p10l686t3124r820b3160],
35	between	IN	O	between	dep	34	SENT_363	[p10l836t3124r973b3153],
36	the	DT	O	the	det	37	SENT_363	[p10l988t3124r1037b3153],
37	3	CD	NUMBER	3	pobj	35	SENT_363	[p10l1053t3124r1084b3153],
38	-	:	O	-	_	0	SENT_363	[p10l1053t3124r1084b3153],
39	and	CC	O	and	_	0	SENT_363	[p10l1101t3124r1159b3153],
40	24-h	JJ	O	24-h	amod	41	SENT_363	[p10l1174t3124r1249b3153],
41	groups	NNS	O	group	conj_and	28	SENT_363	[p10l1264t3133r1384b3162],
42	,	,	O	,	_	0	SENT_363	[p10l1264t3133r1384b3162],
43	respectively	RB	O	respectively	advmod	24	SENT_363	[p10l1400t3124r1607b3162],
44	.	.	O	.	_	0	SENT_363	[p10l1400t3124r1607b3162],

1	However	RB	O	however	advmod	7	SENT_364	[p10l1624t3125r1783b3158],
2	,	,	O	,	_	0	SENT_364	[p10l1624t3125r1783b3158],
3	the	DT	O	the	det	5	SENT_364	[p10l1799t3124r1848b3153],
4	starting	VBG	O	start	amod	5	SENT_364	[p10l551t3174r672b3212],
5	doses	NNS	O	dose	nsubjpass	7	SENT_364	[p10l685t3174r774b3203],
6	were	VBD	O	be	auxpass	7	SENT_364	[p10l788t3183r866b3203],
7	escalated	VBN	O	escalate	_	0	SENT_364	[p10l878t3174r1029b3203],
8	in	IN	O	in	_	0	SENT_364	[p10l1040t3174r1071b3203],
9	more	JJR	O	more	amod	10	SENT_364	[p10l1083t3183r1167b3203],
10	women	NNS	O	woman	prep_in	7	SENT_364	[p10l1179t3183r1300b3203],
11	treated	VBN	O	treat	partmod	10	SENT_364	[p10l1311t3174r1424b3203],
12	with	IN	O	with	_	0	SENT_364	[p10l1435t3174r1507b3203],
13	3-h	JJ	O	3-h	amod	14	SENT_364	[p10l1520t3174r1573b3203],
14	infusions	NNS	O	infusion	prep_with	11	SENT_364	[p10l1584t3174r1734b3203],
15	due	JJ	O	due	_	0	SENT_364	[p10l1747t3174r1805b3203],
16	to	TO	O	to	_	0	SENT_364	[p10l1817t3179r1848b3203],
17	minimal	JJ	O	minimal	amod	18	SENT_364	[p10l549t3224r686b3253],
18	toxicity	NN	O	toxicity	prep_due_to	11	SENT_364	[p10l699t3224r824b3262],
19	at	IN	O	at	_	0	SENT_364	[p10l838t3229r867b3253],
20	the	DT	O	the	det	22	SENT_364	[p10l880t3224r929b3253],
21	starting	VBG	O	start	amod	22	SENT_364	[p10l943t3224r1064b3262],
22	dose	NN	O	dose	prep_at	18	SENT_364	[p10l1078t3224r1161b3253],
23	.	.	O	.	_	0	SENT_364	[p10l1078t3224r1161b3253],

1	It	PRP	O	it	nsubj	4	SENT_365	[p10l1176t3225r1200b3253],
2	is	VBZ	O	be	cop	4	SENT_365	[p10l1213t3224r1238b3253],
3	also	RB	O	also	advmod	4	SENT_365	[p10l1253t3224r1317b3253],
4	important	JJ	O	important	_	0	SENT_365	[p10l1331t3224r1491b3262],
5	to	TO	O	to	aux	6	SENT_365	[p10l1504t3229r1534b3253],
6	note	VB	O	note	xcomp	4	SENT_365	[p10l1548t3229r1618b3253],
7	that	IN	O	that	complm	22	SENT_365	[p10l1631t3224r1692b3253],
8	response	NN	O	response	nn	9	SENT_365	[p10l1704t3233r1848b3262],
9	rates	NNS	O	rate	nsubj	22	SENT_365	[p10l549t3279r625b3304],
10	in	IN	O	in	_	0	SENT_365	[p10l643t3275r675b3303],
11	patients	NNS	O	patient	prep_in	9	SENT_365	[p10l692t3274r819b3312],
12	receiving	VBG	O	receive	partmod	11	SENT_365	[p10l837t3275r990b3312],
13	paclitaxel	NN	O	paclitaxel	dobj	12	SENT_365	[p10l1006t3275r1167b3312],
14	over	IN	O	over	_	0	SENT_365	[p10l1184t3284r1257b3304],
15	3	LS	NUMBER	3	amod	19	SENT_365	[p10l1274t3275r1305b3304],
16	-	:	O	-	_	0	SENT_365	[p10l1274t3275r1305b3304],
17	and	CC	O	and	_	0	SENT_365	[p10l1324t3275r1382b3304],
18	24-h	JJ	O	24-h	conj_and	15	SENT_365	[p10l1400t3275r1474b3303],
19	schedules	NNS	O	schedule	prep_over	13	SENT_365	[p10l1493t3274r1650b3304],
20	were	VBD	O	be	cop	22	SENT_365	[p10l1669t3284r1747b3304],
21	more	RBR	O	more	advmod	22	SENT_365	[p10l1765t3284r1848b3304],
22	disparate	JJ	O	disparate	ccomp	6	SENT_365	[p10l550t3325r697b3363],
23	in	IN	O	in	_	0	SENT_365	[p10l715t3325r746b3354],
24	women	NNS	O	woman	prep_in	22	SENT_365	[p10l765t3334r885b3354],
25	who	WP	O	who	nsubj	26	SENT_365	[p10l903t3325r973b3354],
26	had	VBD	O	have	rcmod	24	SENT_365	[p10l991t3325r1050b3354],
27	no	DT	O	no	det	30	SENT_365	[p10l1068t3334r1108b3354],
28	prior	JJ	O	prior	amod	30	SENT_365	[p10l1126t3325r1206b3363],
29	therapy	NN	O	therapy	nn	30	SENT_365	[p10l1223t3325r1346b3363],
30	(	NN	O	(	dobj	26	SENT_365	[p10l1366t3325r1418b3361],
31	34	CD	NUMBER	34	dep	30	SENT_365	[p10l1366t3325r1418b3361],
32	vs	CC	O	vs	_	0	SENT_365	[p10l1437t3334r1471b3354],
33	57	CD	PERCENT	57	num	34	SENT_365	[p10l1491t3325r1577b3361],
34	%	NN	PERCENT	%	dobj	26	SENT_365	[p10l1491t3325r1577b3361],
35	)	CD	NUMBER	)	dep	34	SENT_365	[p10l1491t3325r1577b3361],
36	compared	VBN	O	compare	_	0	SENT_365	[p10l1597t3325r1759b3363],
37	with	IN	O	with	prepc_compared_with	26	SENT_365	[p10l1776t3325r1848b3354],

1	Annu	NNP	PERSON	Annu	_	0	SENT_366	[p11l309t513r332b594],
2	.	.	O	.	_	0	SENT_366	[p11l309t513r332b594],

1	Rev.	NNP	O	Rev.	nn	2	SENT_367	[p11l309t442r332b502],
2	Med	NNP	O	Med	_	0	SENT_367	[p11l309t364r332b431],
3	.	.	O	.	_	0	SENT_367	[p11l309t364r332b431],

1	1997.48:353	CD	NUMBER	1997.48:353	num	2	SENT_368	[p11l309t119r333b350],
2	-374	CD	NUMBER	-374	_	0	SENT_368	[p11l309t119r333b350],
3	.	.	O	.	_	0	SENT_368	[p11l309t119r333b350],

1	Dow	NNP	MISC	Dow	_	0	SENT_369	[p11l309t44r332b108],
2	by	IN	O	by	_	0	SENT_369	[p11l342t527r373b559],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_369	[p11l343t377r373b517],
4	of	IN	ORGANIZATION	of	_	0	SENT_369	[p11l342t338r366b367],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_369	[p11l342t191r366b332],
6	-	:	O	-	_	0	SENT_369	[p11l356t173r359b182],
7	Madison	NNP	PERSON	Madison	nn	8	SENT_369	[p11l342t47r366b163],
8	Annu	NNP	PERSON	Annu	dep	1	SENT_369	[p11l309t2915r332b2995],
9	.	.	O	.	_	0	SENT_369	[p11l309t2915r332b2995],

1	Rev.	NNP	O	Rev.	nn	2	SENT_370	[p11l309t2844r332b2904],
2	Med	NNP	O	Med	_	0	SENT_370	[p11l309t2766r332b2834],
3	.	.	O	.	_	0	SENT_370	[p11l309t2766r332b2834],

1	1997.48	CD	NUMBER	1997.48	_	0	SENT_371	[p11l309t2590r333b2693],
2	2353-37	CD	NUMBER	2353-37	number	3	SENT_371	[p11l309t2425r332b2525],
3	4	CD	NUMBER	4	num	1	SENT_371	[p11l309t2340r332b2362],
4	.	.	O	.	_	0	SENT_371	[p11l309t2340r332b2362],

1	Downloaded	VBN	O	download	_	0	SENT_372	[p11l309t2159r332b2329],
2	from	IN	O	from	_	0	SENT_372	[p11l309t2085r332b2150],
3	www	NN	O	www	prep_from	1	SENT_372	[p11l309t1856r332b2076],
4	.	.	O	.	_	0	SENT_372	[p11l309t1856r332b2076],

1	annualrevi	NN	O	annualrevus	nn	2	SENT_373	[p11l309t1856r332b2076],
2	ews.org	NN	O	ews.org	_	0	SENT_373	[p11l316t1735r339b1838],
3	by	IN	O	by	_	0	SENT_373	[p11l342t2928r373b2961],
4	University	NNP	ORGANIZATION	University	prep_by	2	SENT_373	[p11l342t2779r373b2919],
5	o	NN	O	o	dep	4	SENT_373	[p11l350t2754r366b2769],
6	f	FW	O	f	nn	5	SENT_373	[p11l342t2681r365b2693],
7	Wisco	FW	PERSON	wisco	nn	5	SENT_373	[p11l342t2590r366b2674],
8	nsin	FW	O	nsin	dep	5	SENT_373	[p11l342t2473r366b2528],
9	l	NN	O	l	dep	5	SENT_373	[p11l343t2425r365b2445],
10	\	CD	NUMBER	\	num	9	SENT_373	[p11l343t2425r365b2445],
11	/	:	O	/	punct	2	SENT_373	[p11l343t2425r365b2445],
12	Iadison	NN	O	iadison	dep	2	SENT_373	[p11l342t2268r366b2364],
13	on	IN	O	on	_	0	SENT_373	[p11l350t2226r366b2258],
14	01/05/14	CD	DATE	01/05/14	prep_on	12	SENT_373	[p11l342t2092r366b2217],
15	.	.	O	.	_	0	SENT_373	[p11l342t2092r366b2217],

1	For	IN	O	for	_	0	SENT_374	[p11l343t2035r366b2082],
2	personal	JJ	O	personal	amod	3	SENT_374	[p11l342t1915r373b2027],
3	use	NN	O	use	pobj	1	SENT_374	[p11l350t1861r366b1905],
4	only	RB	O	only	advmod	3	SENT_374	[p11l342t1770r373b1835],
5	.	.	O	.	_	0	SENT_374	[p11l342t1770r373b1835],

1	those	DT	O	those	nsubj	21	SENT_375	[p11l549t47r635b76],
2	who	WP	O	who	nsubj	3	SENT_375	[p11l649t47r718b76],
3	had	VBD	O	have	rcmod	1	SENT_375	[p11l732t47r791b76],
4	adjuvant	JJ	O	adjuvant	amod	5	SENT_375	[p11l804t47r945b85],
5	therapy	NN	O	therapy	dobj	3	SENT_375	[p11l958t47r1080b85],
6	only	RB	O	only	quantmod	8	SENT_375	[p11l1094t47r1165b85],
7	(	CD	NUMBER	(	number	8	SENT_375	[p11l1180t47r1232b83],
8	36	CD	NUMBER	36	dep	5	SENT_375	[p11l1180t47r1232b83],
9	vs	CC	O	vs	_	0	SENT_375	[p11l1246t56r1281b76],
10	40	CD	PERCENT	40	num	11	SENT_375	[p11l1294t47r1382b83],
11	%	NN	PERCENT	%	dobj	3	SENT_375	[p11l1294t47r1382b83],
12	)	CD	NUMBER	)	dep	11	SENT_375	[p11l1294t47r1382b83],
13	or	CC	O	or	_	0	SENT_375	[p11l1397t56r1430b76],
14	therapy	NN	O	therapy	conj_or	5	SENT_375	[p11l1442t47r1565b85],
15	in	IN	O	in	_	0	SENT_375	[p11l1578t47r1609b76],
16	both	CC	O	both	preconj	17	SENT_375	[p11l1621t47r1694b76],
17	adjuvant	JJ	O	adjuvant	amod	20	SENT_375	[p11l1708t47r1849b85],
18	and	CC	O	and	_	0	SENT_375	[p11l550t97r608b126],
19	metastatic	JJ	O	metastatic	conj_and	17	SENT_375	[p11l621t97r787b126],
20	settings	NNS	O	setting	prep_in	14	SENT_375	[p11l802t97r925b135],
21	(	VBP	O	(	_	0	SENT_375	[p11l941t97r993b133],
22	24	CD	NUMBER	24	dobj	21	SENT_375	[p11l941t97r993b133],
23	vs	CC	O	vs	_	0	SENT_375	[p11l1007t106r1041b126],
24	22	CD	PERCENT	22	num	25	SENT_375	[p11l1056t97r1152b133],
25	%	NN	PERCENT	%	conj_vs	22	SENT_375	[p11l1056t97r1152b133],
26	)	CD	NUMBER	)	dep	25	SENT_375	[p11l1056t97r1152b133],
27	.	.	O	.	_	0	SENT_375	[p11l1056t97r1152b133],

1	In	IN	O	in	_	0	SENT_376	[p11l1168t98r1201b126],
2	another	DT	O	another	det	3	SENT_376	[p11l1215t97r1338b126],
3	study	NN	O	study	prep_in	12	SENT_376	[p11l1352t97r1448b135],
4	,	,	O	,	_	0	SENT_376	[p11l1352t97r1448b135],
5	women	NNS	O	woman	nsubjpass	12	SENT_376	[p11l1463t106r1583b126],
6	with	IN	O	with	_	0	SENT_376	[p11l1597t97r1669b126],
7	metastatic	JJ	O	metastatic	amod	9	SENT_376	[p11l1682t97r1848b126],
8	breast	NN	O	breast	nn	9	SENT_376	[p11l549t147r648b176],
9	cancer	NN	O	cancer	prep_with	5	SENT_376	[p11l662t157r770b176],
10	are	VBP	O	be	aux	12	SENT_376	[p11l785t157r833b176],
11	being	VBG	O	be	auxpass	12	SENT_376	[p11l848t147r939b185],
12	treated	VBN	O	treat	_	0	SENT_376	[p11l955t147r1067b176],
13	with	IN	O	with	prep	12	SENT_376	[p11l1082t147r1154b176],
14	either	CC	O	either	dep	25	SENT_376	[p11l1170t147r1263b176],
15	3	LS	NUMBER	3	amod	19	SENT_376	[p11l1279t148r1310b177],
16	-	:	O	-	_	0	SENT_376	[p11l1279t148r1310b177],
17	or	CC	O	or	_	0	SENT_376	[p11l1327t157r1361b176],
18	24-h	JJ	O	24-h	conj_or	15	SENT_376	[p11l1376t147r1450b176],
19	schedules	NNS	O	schedule	dep	14	SENT_376	[p11l1467t147r1624b177],
20	of	IN	O	of	_	0	SENT_376	[p11l1641t147r1677b176],
21	paclitaxel	NN	O	paclitaxel	nn	22	SENT_376	[p11l1689t147r1849b185],
22	(	NN	O	(	prep_of	19	SENT_376	[p11l550t197r624b233],
23	250	CD	NUMBER	250	num	25	SENT_376	[p11l550t197r624b233],
24	mg/m2	NN	O	mg/m2	nn	25	SENT_376	[p11l635t186r760b235],
25	)	NN	O	)	dep	13	SENT_376	[p11l635t186r760b235],
26	with	IN	O	with	_	0	SENT_376	[p11l772t197r845b226],
27	G	NN	O	g	prep_with	25	SENT_376	[p11l856t197r981b232],
28	.	.	O	.	_	0	SENT_376	[p11l856t197r981b232],

1	—	NN	O	—	_	0	SENT_377	[p11l856t197r981b232],
2	.	.	O	.	_	0	SENT_377	[p11l856t197r981b232],

1	CSF	NN	O	csf	_	0	SENT_378	[p11l856t197r981b232],
2	,	,	O	,	_	0	SENT_378	[p11l856t197r981b232],
3	which	WDT	O	which	nsubj	8	SENT_378	[p11l994t197r1094b226],
4	are	VBP	O	be	cop	8	SENT_378	[p11l1106t206r1154b226],
5	more	RBR	O	more	advmod	6	SENT_378	[p11l1165t206r1249b226],
6	equitoxic	JJ	O	equitoxic	amod	8	SENT_378	[p11l1261t197r1413b235],
7	dose	NN	O	dose	nn	8	SENT_378	[p11l1425t197r1499b226],
8	schedules	NNS	O	schedule	dep	1	SENT_378	[p11l1511t197r1669b226],
9	than	IN	O	than	_	0	SENT_378	[p11l1681t197r1751b226],
10	those	DT	O	those	prep_than	8	SENT_378	[p11l1762t197r1848b226],
11	in	IN	O	in	_	0	SENT_378	[p11l549t247r580b276],
12	the	DT	O	the	det	14	SENT_378	[p11l595t247r644b277],
13	prior	JJ	O	prior	amod	14	SENT_378	[p11l657t247r738b286],
14	study	NN	O	study	prep_in	10	SENT_378	[p11l753t248r848b285],
15	.	.	O	.	_	0	SENT_378	[p11l753t248r848b285],

1	Perhaps	RB	O	perhaps	advmod	11	SENT_379	[p11l864t248r993b286],
2	the	DT	O	the	det	5	SENT_379	[p11l1008t248r1057b277],
3	most	RBS	O	most	advmod	4	SENT_379	[p11l1072t252r1152b277],
4	illustrative	JJ	O	illustrative	amod	5	SENT_379	[p11l1165t247r1341b277],
5	support	NN	O	support	nsubj	11	SENT_379	[p11l1356t252r1479b286],
6	for	IN	O	for	_	0	SENT_379	[p11l1492t247r1540b277],
7	the	DT	O	the	det	8	SENT_379	[p11l1553t248r1602b277],
8	importance	NN	O	importance	prep_for	5	SENT_379	[p11l1617t247r1801b286],
9	of	IN	O	of	_	0	SENT_379	[p11l1816t247r1851b277],
10	schedule	NN	O	schedule	prep_of	8	SENT_379	[p11l551t298r693b327],
11	are	VBP	O	be	_	0	SENT_379	[p11l705t307r754b327],
12	reports	NNS	O	report	dep	23	SENT_379	[p11l765t303r878b336],
13	of	IN	O	of	_	0	SENT_379	[p11l891t298r927b327],
14	responses	NNS	O	response	prep_of	12	SENT_379	[p11l935t307r1095b336],
15	to	TO	O	to	_	0	SENT_379	[p11l1107t303r1138b327],
16	treatment	NN	O	treatment	prep_to	14	SENT_379	[p11l1150t302r1306b327],
17	with	IN	O	with	_	0	SENT_379	[p11l1316t298r1389b327],
18	prolonged	JJ	O	prolonged	amod	19	SENT_379	[p11l1400t298r1567b336],
19	(	NN	O	(	prep_with	16	SENT_379	[p11l1579t298r1632b334],
20	96	CD	NUMBER	96	num	21	SENT_379	[p11l1579t298r1632b334],
21	h	NN	O	h	dep	23	SENT_379	[p11l1644t298r1676b334],
22	)	CD	NUMBER	)	num	23	SENT_379	[p11l1644t298r1676b334],
23	schedules	NNS	O	schedule	dep	11	SENT_379	[p11l1690t298r1848b327],
24	of	IN	O	of	_	0	SENT_379	[p11l550t347r586b376],
25	paclitaxel	NN	O	paclitaxel	prep_of	23	SENT_379	[p11l593t347r753b384],
26	in	IN	O	in	_	0	SENT_379	[p11l765t347r796b375],
27	women	NNS	O	woman	prep_in	11	SENT_379	[p11l808t356r928b376],
28	with	IN	O	with	_	0	SENT_379	[p11l939t347r1011b376],
29	metastatic	JJ	O	metastatic	amod	31	SENT_379	[p11l1022t347r1188b376],
30	breast	NN	O	breast	nn	31	SENT_379	[p11l1200t347r1299b376],
31	cancer	NN	O	cancer	prep_with	11	SENT_379	[p11l1308t356r1415b376],
32	whose	WP$	O	whose	poss	33	SENT_379	[p11l1425t347r1529b376],
33	disease	NN	O	disease	nsubj	34	SENT_379	[p11l1541t347r1659b376],
34	progressed	VBD	O	progress	rcmod	31	SENT_379	[p11l1670t347r1849b384],
35	on	IN	O	on	_	0	SENT_379	[p11l550t406r590b426],
36	shorter	JJR	O	shorter	amod	38	SENT_379	[p11l607t397r720b426],
37	taxane	NN	O	taxane	nn	38	SENT_379	[p11l735t401r842b426],
38	schedules	NNS	O	schedule	prep_on	34	SENT_379	[p11l859t397r1026b426],
39	.	.	O	.	_	0	SENT_379	[p11l859t397r1026b426],

1	Similar	JJ	O	similar	amod	2	SENT_380	[p11l1045t397r1166b426],
2	studies	NNS	O	study	nsubjpass	10	SENT_380	[p11l1182t397r1293b426],
3	of	IN	O	of	_	0	SENT_380	[p11l1311t397r1347b426],
4	alternate	JJ	O	alternate	amod	6	SENT_380	[p11l1360t397r1501b426],
5	docetaxel	NN	O	docetaxel	nn	6	SENT_380	[p11l1516t397r1673b426],
6	schedules	NNS	O	schedule	prep_of	2	SENT_380	[p11l1690t397r1848b426],
7	have	VBP	O	have	aux	10	SENT_380	[p11l549t447r626b476],
8	not	RB	O	not	neg	10	SENT_380	[p11l638t452r690b476],
9	been	VBN	O	be	auxpass	10	SENT_380	[p11l700t447r778b476],
10	performed	VBN	O	perform	_	0	SENT_380	[p11l789t447r969b485],
11	.	.	O	.	_	0	SENT_380	[p11l789t447r969b485],

1	LUNG	NN	O	lung	nn	2	SENT_381	[p11l549t565r641b588],
2	CANCER	NNP	O	CANCER	nsubj	8	SENT_381	[p11l657t565r791b588],
3	Both	CC	O	both	preconj	2	SENT_381	[p11l829t559r909b588],
4	paclitaxel	NN	O	paclitaxel	conj	2	SENT_381	[p11l927t559r1087b597],
5	and	CC	O	and	_	0	SENT_381	[p11l1106t559r1165b588],
6	docetaxel	NN	O	docetaxel	conj_and	4	SENT_381	[p11l1183t559r1340b588],
7	have	VBP	O	have	aux	8	SENT_381	[p11l1358t559r1435b588],
8	demonstrated	VBN	O	demonstrate	_	0	SENT_381	[p11l1454t559r1676b588],
9	favorable	JJ	O	favorable	amod	10	SENT_381	[p11l1694t559r1849b588],
10	results	NNS	O	result	dobj	8	SENT_381	[p11l549t608r655b638],
11	in	IN	O	in	_	0	SENT_381	[p11l664t608r695b637],
12	untreated	JJ	O	untreated	amod	13	SENT_381	[p11l703t608r856b638],
13	patients	NNS	O	patient	prep_in	10	SENT_381	[p11l863t608r990b646],
14	with	IN	O	with	_	0	SENT_381	[p11l1000t608r1072b638],
15	stage	NN	O	stage	nn	16	SENT_381	[p11l1081t613r1164b646],
16	IIIB	NN	O	iiib	prep_with	8	SENT_381	[p11l1172t609r1237b637],
17	and	CC	O	and	_	0	SENT_381	[p11l1248t608r1306b638],
18	IV	CD	NUMBER	iv	num	19	SENT_381	[p11l1314t609r1356b638],
19	NSCLC	NN	O	nsclc	conj_and	16	SENT_381	[p11l1364t608r1505b638],
20	.	.	O	.	_	0	SENT_381	[p11l1364t608r1505b638],

1	In	IN	O	in	_	0	SENT_382	[p11l1515t609r1549b637],
2	one	CD	NUMBER	one	prep_in	29	SENT_382	[p11l1557t617r1615b638],
3	of	IN	O	of	_	0	SENT_382	[p11l1623t608r1659b638],
4	the	DT	O	the	det	6	SENT_382	[p11l1664t608r1713b638],
5	original	JJ	O	original	amod	6	SENT_382	[p11l1721t608r1848b646],
6	studies	NNS	O	study	prep_of	2	SENT_382	[p11l551t658r672b693],
7	,	,	O	,	_	0	SENT_382	[p11l551t658r672b693],
8	a	DT	O	a	det	12	SENT_382	[p11l689t667r706b688],
9	24	CD	PERCENT	24	number	10	SENT_382	[p11l720t658r793b688],
10	%	NN	PERCENT	%	amod	12	SENT_382	[p11l720t658r793b688],
11	response	NN	O	response	nn	12	SENT_382	[p11l809t667r953b696],
12	rate	NN	O	rate	appos	6	SENT_382	[p11l967t663r1037b693],
13	,	,	O	,	_	0	SENT_382	[p11l967t663r1037b693],
14	a	DT	O	a	det	17	SENT_382	[p11l1053t667r1070b688],
15	median	JJ	O	median	amod	17	SENT_382	[p11l1084t658r1205b688],
16	response	NN	O	response	nn	17	SENT_382	[p11l1219t667r1363b696],
17	duration	NN	O	duration	conj_and	2	SENT_382	[p11l1378t658r1515b688],
18	of	IN	O	of	_	0	SENT_382	[p11l1529t658r1565b688],
19	28	CD	DURATION	28	num	20	SENT_382	[p11l1577t658r1615b688],
20	weeks	NNS	NUMBER	week	prep_of	17	SENT_382	[p11l1632t658r1743b693],
21	,	,	O	,	_	0	SENT_382	[p11l1632t658r1743b693],
22	and	CC	O	and	_	0	SENT_382	[p11l1759t658r1817b688],
23	a	DT	O	a	det	25	SENT_382	[p11l1832t667r1849b688],
24	median	JJ	O	median	amod	25	SENT_382	[p11l549t708r670b738],
25	survival	NN	O	survival	conj_and	2	SENT_382	[p11l684t708r815b738],
26	of	IN	O	of	_	0	SENT_382	[p11l829t708r865b738],
27	40	CD	DURATION	40	num	28	SENT_382	[p11l875t708r915b738],
28	weeks	NNS	NUMBER	week	prep_of	25	SENT_382	[p11l929t708r1030b738],
29	(	VBP	O	(	_	0	SENT_382	[p11l1045t708r1098b744],
30	56	CD	DURATION	56	num	31	SENT_382	[p11l1045t708r1098b744],
31	weeks	NNS	NUMBER	week	tmod	29	SENT_382	[p11l1111t708r1213b738],
32	for	IN	O	for	_	0	SENT_382	[p11l1227t708r1275b738],
33	responders	NNS	O	responder	prep_for	29	SENT_382	[p11l1287t708r1478b746],
34	)	CD	NUMBER	)	nsubjpass	36	SENT_382	[p11l1287t708r1478b746],
35	were	VBD	O	be	auxpass	36	SENT_382	[p11l1493t717r1572b738],
36	noted	VBN	O	note	rcmod	33	SENT_382	[p11l1585t708r1676b738],
37	following	VBG	O	follow	_	0	SENT_382	[p11l1689t708r1848b746],
38	treatment	NN	O	treatment	prep_following	36	SENT_382	[p11l549t763r705b787],
39	with	IN	O	with	_	0	SENT_382	[p11l722t758r794b787],
40	high	JJ	O	high	amod	42	SENT_382	[p11l811t758r884b796],
41	paclitaxel	NN	O	paclitaxel	nn	42	SENT_382	[p11l901t758r1061b796],
42	doses	NNS	O	dose	prep_with	38	SENT_382	[p11l1079t758r1168b787],
43	ranging	VBG	O	range	partmod	42	SENT_382	[p11l1186t758r1312b796],
44	from	IN	O	from	_	0	SENT_382	[p11l1329t758r1409b787],
45	200	CD	NUMBER	200	number	47	SENT_382	[p11l1426t758r1487b788],
46	to	TO	NUMBER	to	dep	47	SENT_382	[p11l1504t763r1534b787],
47	250	CD	NUMBER	250	num	48	SENT_382	[p11l1553t758r1613b788],
48	mg/m2	NN	O	mg/m2	prep_from	43	SENT_382	[p11l1630t747r1743b796],
49	(	CD	NUMBER	(	num	51	SENT_382	[p11l1761t758r1849b794],
50	24-h	JJ	O	24-h	amod	51	SENT_382	[p11l1761t758r1849b794],
51	schedule	NN	O	schedule	nsubj	29	SENT_382	[p11l551t808r706b844],
52	)	CD	NUMBER	)	number	53	SENT_382	[p11l551t808r706b844],
53	(	CD	NUMBER	(	dep	51	SENT_382	[p11l720t809r795b844],
54	77	CD	NUMBER	77	num	55	SENT_382	[p11l720t809r795b844],
55	)	NN	O	)	dep	53	SENT_382	[p11l720t809r795b844],
56	.	.	O	.	_	0	SENT_382	[p11l720t809r795b844],

1	In	IN	O	in	_	0	SENT_383	[p11l809t809r843b837],
2	another	DT	O	another	prep_in	9	SENT_383	[p11l855t808r978b838],
3	randomized	VBN	O	randomize	partmod	2	SENT_383	[p11l989t808r1184b838],
4	trial	NN	O	trial	dobj	3	SENT_383	[p11l1196t808r1270b843],
5	,	,	O	,	_	0	SENT_383	[p11l1196t808r1270b843],
6	response	NN	O	response	nn	7	SENT_383	[p11l1283t817r1427b846],
7	rates	NNS	O	rate	nsubj	9	SENT_383	[p11l1439t813r1516b838],
8	were	VBD	O	be	cop	9	SENT_383	[p11l1529t817r1608b838],
9	21	CD	NUMBER	21	_	0	SENT_383	[p11l1620t808r1669b843],
10	,	,	O	,	_	0	SENT_383	[p11l1620t808r1669b843],
11	o	NN	O	o	conj_and	9	SENT_383	[p11l1682t808r1711b843],
12	,	,	O	,	_	0	SENT_383	[p11l1682t808r1711b843],
13	and	CC	O	and	_	0	SENT_383	[p11l1725t808r1783b838],
14	2	CD	PERCENT	2	num	15	SENT_383	[p11l1795t808r1847b838],
15	%	NN	PERCENT	%	conj_and	9	SENT_383	[p11l1795t808r1847b838],
16	for	IN	O	for	_	0	SENT_383	[p11l549t858r597b888],
17	paclitaxel	NN	O	paclitaxel	prep_for	15	SENT_383	[p11l611t858r771b896],
18	and	CC	O	and	_	0	SENT_383	[p11l787t858r846b888],
19	the	DT	O	the	det	22	SENT_383	[p11l861t858r910b888],
20	investigational	JJ	O	investigational	amod	22	SENT_383	[p11l925t858r1168b896],
21	agents	NNS	O	agent	nn	22	SENT_383	[p11l1184t863r1287b896],
22	merbarone	NN	O	merbarone	prep_for	15	SENT_383	[p11l1303t858r1479b888],
23	and	CC	O	and	_	0	SENT_383	[p11l1495t858r1553b888],
24	piroxantrone	NN	O	piroxantrone	conj_and	22	SENT_383	[p11l1568t858r1788b896],
25	,	,	O	,	_	0	SENT_383	[p11l1568t858r1788b896],
26	respectively	RB	O	respectively	advmod	29	SENT_383	[p11l1804t867r1847b888, p11l551t908r716b946],
27	(	CD	NUMBER	(	number	28	SENT_383	[p11l729t908r804b944],
28	78	CD	NUMBER	78	num	29	SENT_383	[p11l729t908r804b944],
29	)	NN	O	)	rcmod	15	SENT_383	[p11l729t908r804b944],
30	.	.	O	.	_	0	SENT_383	[p11l729t908r804b944],

1	The	DT	O	the	det	3	SENT_384	[p11l817t908r880b937],
2	median	JJ	O	median	amod	3	SENT_384	[p11l890t908r1011b937],
3	duration	NN	O	duration	nsubj	10	SENT_384	[p11l1023t908r1160b937],
4	of	IN	O	of	_	0	SENT_384	[p11l1170t908r1206b937],
5	response	NN	O	response	prep_of	3	SENT_384	[p11l1214t917r1358b946],
6	to	TO	O	to	_	0	SENT_384	[p11l1369t913r1399b937],
7	paclitaxel	NN	O	paclitaxel	prep_to	5	SENT_384	[p11l1410t908r1571b946],
8	was	VBD	O	be	cop	10	SENT_384	[p11l1582t917r1645b937],
9	6.5	CD	DURATION	6.5	num	10	SENT_384	[p11l1656t908r1704b938],
10	months	NNS	NUMBER	month	_	0	SENT_384	[p11l1717t908r1847b943],
11	,	,	O	,	_	0	SENT_384	[p11l1717t908r1847b943],
12	the	DT	O	the	det	15	SENT_384	[p11l549t958r599b988],
13	1-year	JJ	DURATION	1-year	amod	15	SENT_384	[p11l616t959r718b996],
14	survival	NN	O	survival	nn	15	SENT_384	[p11l732t958r863b988],
15	rate	NN	O	rate	nsubj	18	SENT_384	[p11l876t963r938b988],
16	was	VBD	O	be	cop	18	SENT_384	[p11l952t967r1014b988],
17	41.7	CD	PERCENT	41.7	num	18	SENT_384	[p11l1028t958r1143b993],
18	%	NN	PERCENT	%	dep	10	SENT_384	[p11l1028t958r1143b993],
19	,	,	O	,	_	0	SENT_384	[p11l1028t958r1143b993],
20	and	CC	O	and	_	0	SENT_384	[p11l1159t958r1217b988],
21	the	DT	O	the	det	23	SENT_384	[p11l1230t958r1280b988],
22	median	JJ	O	median	amod	23	SENT_384	[p11l1293t958r1414b988],
23	survival	NN	O	survival	nsubj	26	SENT_384	[p11l1429t958r1560b988],
24	was	VBD	O	be	cop	26	SENT_384	[p11l1574t967r1636b988],
25	24.1	CD	DURATION	24.1	num	26	SENT_384	[p11l1651t958r1719b988],
26	weeks	NNS	NUMBER	week	conj_and	10	SENT_384	[p11l1736t958r1846b988],
27	.	.	O	.	_	0	SENT_384	[p11l1736t958r1846b988],

1	Activity	NN	O	activity	nsubjpass	5	SENT_385	[p11l549t1008r684b1046],
2	has	VBZ	O	have	aux	5	SENT_385	[p11l694t1008r747b1038],
3	also	RB	O	also	advmod	5	SENT_385	[p11l759t1008r823b1038],
4	been	VBN	O	be	auxpass	5	SENT_385	[p11l833t1008r911b1038],
5	noted	VBN	O	note	_	0	SENT_385	[p11l921t1008r1012b1038],
6	with	IN	O	with	_	0	SENT_385	[p11l1022t1008r1095b1038],
7	shorter	JJR	O	shorter	amod	8	SENT_385	[p11l1106t1008r1219b1038],
8	schedules	NNS	O	schedule	prep_with	5	SENT_385	[p11l1230t1008r1398b1043],
9	,	,	O	,	_	0	SENT_385	[p11l1230t1008r1398b1043],
10	including	VBG	O	include	_	0	SENT_385	[p11l1409t1008r1564b1046],
11	response	NN	O	response	nn	12	SENT_385	[p11l1574t1017r1718b1046],
12	rates	NNS	O	rate	prep_including	8	SENT_385	[p11l1728t1013r1804b1038],
13	of	IN	O	of	_	0	SENT_385	[p11l1816t1008r1851b1038],
14	26	CD	NUMBER	26	prep_of	12	SENT_385	[p11l550t1058r589b1088],
15	and	CC	O	and	_	0	SENT_385	[p11l600t1058r658b1087],
16	23	CD	PERCENT	23	num	17	SENT_385	[p11l667t1058r740b1088],
17	%	NN	PERCENT	%	prep_including	8	SENT_385	[p11l667t1058r740b1088],
18	in	IN	O	in	_	0	SENT_385	[p11l751t1058r782b1087],
19	untreated	JJ	O	untreated	prep_in	17	SENT_385	[p11l791t1058r945b1087],
20	and	CC	O	and	_	0	SENT_385	[p11l954t1058r1012b1087],
21	previously	RB	DATE	previously	advmod	22	SENT_385	[p11l1021t1058r1195b1096],
22	treated	VBN	O	treat	conj_and	5	SENT_385	[p11l1204t1058r1316b1087],
23	patients	NNS	O	patient	dobj	22	SENT_385	[p11l1324t1058r1461b1096],
24	,	,	O	,	_	0	SENT_385	[p11l1324t1058r1461b1096],
25	respectively	RB	O	respectively	advmod	22	SENT_385	[p11l1471t1058r1680b1096],
26	,	,	O	,	_	0	SENT_385	[p11l1471t1058r1680b1096],
27	who	WP	O	who	nsubjpass	29	SENT_385	[p11l1690t1058r1760b1087],
28	were	VBD	O	be	auxpass	29	SENT_385	[p11l1770t1067r1849b1087],
29	treated	VBN	O	treat	dep	22	SENT_385	[p11l549t1108r661b1138],
30	with	IN	O	with	_	0	SENT_385	[p11l672t1108r745b1138],
31	paclitaxel	NN	O	paclitaxel	prep_with	29	SENT_385	[p11l755t1108r916b1146],
32	on	IN	O	on	_	0	SENT_385	[p11l927t1117r967b1138],
33	a	DT	O	a	det	37	SENT_385	[p11l979t1117r996b1138],
34	1	CD	NUMBER	1	number	35	SENT_385	[p11l1011t1108r1062b1137],
35	—	CD	NUMBER	—	num	37	SENT_385	[p11l1011t1108r1062b1137],
36	h	NN	O	h	nn	37	SENT_385	[p11l1011t1108r1062b1137],
37	schedule	NN	O	schedule	prep_on	29	SENT_385	[p11l1074t1108r1216b1138],
38	(	CD	NUMBER	(	number	39	SENT_385	[p11l1229t1108r1304b1144],
39	32	CD	NUMBER	32	num	40	SENT_385	[p11l1229t1108r1304b1144],
40	)	NN	O	)	dep	37	SENT_385	[p11l1229t1108r1304b1144],
41	.	.	O	.	_	0	SENT_385	[p11l1229t1108r1304b1144],

1	368	CD	NUMBER	368	num	2	SENT_386	[p11l550t1165r603b1191],
2	ROWINSKY	NN	O	rowinsky	_	0	SENT_386	[p11l643t1165r843b1191],

1	Docetaxel	NNP	O	Docetaxel	nsubj	4	SENT_387	[p11l599t1249r766b1279],
2	has	VBZ	O	have	aux	4	SENT_387	[p11l782t1249r836b1279],
3	also	RB	O	also	advmod	4	SENT_387	[p11l855t1249r919b1279],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_387	[p11l937t1249r1159b1279],
5	impressive	JJ	O	impressive	amod	6	SENT_387	[p11l1176t1249r1354b1287],
6	activity	NN	O	activity	dobj	4	SENT_387	[p11l1372t1249r1494b1287],
7	in	IN	O	in	_	0	SENT_387	[p11l1511t1249r1543b1278],
8	NSCLC	NNP	O	NSCLC	prep_in	4	SENT_387	[p11l1559t1249r1700b1279],
9	.	.	O	.	_	0	SENT_387	[p11l1559t1249r1700b1279],

1	In	IN	O	in	_	0	SENT_388	[p11l1720t1250r1753b1278],
2	a	DT	O	a	det	3	SENT_388	[p11l1771t1258r1788b1279],
3	review	NN	O	review	prep_in	8	SENT_388	[p11l1804t1258r1847b1279, p11l549t1299r628b1329],
4	of	IN	O	of	_	0	SENT_388	[p11l643t1299r679b1329],
5	phase	NN	O	phase	prep_of	3	SENT_388	[p11l689t1299r783b1337],
6	II	CD	NUMBER	ii	num	7	SENT_388	[p11l797t1300r823b1328],
7	trials	NNS	O	trial	nsubj	8	SENT_388	[p11l837t1299r918b1329],
8	(	VBP	O	(	ccomp	17	SENT_388	[p11l934t1300r1009b1335],
9	33	CD	NUMBER	33	num	10	SENT_388	[p11l934t1300r1009b1335],
10	)	CD	NUMBER	)	dobj	8	SENT_388	[p11l934t1300r1009b1335],
11	,	,	O	,	_	0	SENT_388	[p11l934t1300r1009b1335],
12	docetaxel	NN	O	docetaxel	nn	13	SENT_388	[p11l1025t1299r1182b1329],
13	doses	NNS	O	dose	nsubj	17	SENT_388	[p11l1195t1299r1285b1329],
14	of	IN	O	of	_	0	SENT_388	[p11l1300t1299r1336b1329],
15	100	CD	NUMBER	100	num	16	SENT_388	[p11l1351t1299r1408b1329],
16	mg/m2	NN	O	mg/m2	prep_of	13	SENT_388	[p11l1422t1288r1534b1337],
17	produced	VBD	O	produce	_	0	SENT_388	[p11l1547t1299r1701b1337],
18	cumulative	JJ	O	cumulative	amod	20	SENT_388	[p11l1714t1299r1847b1329, p11l549t1349r610b1379],
19	response	NN	O	response	nn	20	SENT_388	[p11l625t1358r769b1387],
20	rates	NNS	O	rate	dobj	17	SENT_388	[p11l784t1354r860b1379],
21	of	IN	O	of	_	0	SENT_388	[p11l877t1349r913b1378],
22	31	CD	NUMBER	31	prep_of	20	SENT_388	[p11l926t1349r961b1379],
23	and	CC	O	and	_	0	SENT_388	[p11l981t1349r1039b1379],
24	19	CD	PERCENT	19	num	25	SENT_388	[p11l1058t1349r1127b1379],
25	%	NN	PERCENT	%	conj_and	20	SENT_388	[p11l1058t1349r1127b1379],
26	in	IN	O	in	_	0	SENT_388	[p11l1144t1349r1175b1378],
27	patients	NNS	O	patient	prep_in	25	SENT_388	[p11l1190t1349r1317b1387],
28	who	WP	O	who	nsubj	31	SENT_388	[p11l1333t1349r1403b1379],
29	were	VBD	O	be	cop	31	SENT_388	[p11l1418t1358r1497b1379],
30	chemotherapy	NN	O	chemotherapy	nn	31	SENT_388	[p11l1512t1349r1849b1387],
31	—	NN	O	—	rcmod	27	SENT_388	[p11l1512t1349r1849b1387],
32	naive	JJ	O	naive	amod	31	SENT_388	[p11l1512t1349r1849b1387],
33	and	CC	O	and	_	0	SENT_388	[p11l550t1399r608b1429],
34	previously	RB	DATE	previously	advmod	35	SENT_388	[p11l619t1399r793b1437],
35	treated	VBN	O	treat	amod	31	SENT_388	[p11l805t1399r925b1434],
36	,	,	O	,	_	0	SENT_388	[p11l805t1399r925b1434],
37	respectively	RB	O	respectively	advmod	27	SENT_388	[p11l938t1399r1137b1437],
38	(	CD	NUMBER	(	number	39	SENT_388	[p11l1149t1399r1286b1435],
39	79-83	CD	NUMBER	79-83	num	40	SENT_388	[p11l1149t1399r1286b1435],
40	)	NN	O	)	dep	27	SENT_388	[p11l1149t1399r1286b1435],
41	.	.	O	.	_	0	SENT_388	[p11l1149t1399r1286b1435],

1	Lower	JJR	O	lower	amod	2	SENT_389	[p11l1299t1400r1407b1429],
2	doses	NNS	O	dose	nsubj	10	SENT_389	[p11l1417t1399r1507b1429],
3	of	IN	O	of	_	0	SENT_389	[p11l1520t1399r1555b1428],
4	docetaxel	NN	O	docetaxel	prep_of	2	SENT_389	[p11l1564t1399r1722b1429],
5	(	CD	NUMBER	(	num	4	SENT_389	[p11l1733t1399r1846b1435],
6	60-75	CD	NUMBER	60-75	num	7	SENT_389	[p11l1733t1399r1846b1435],
7	mg/m2	NN	O	mg/m2	dep	4	SENT_389	[p11l549t1438r674b1487],
8	)	CD	NUMBER	)	dep	7	SENT_389	[p11l549t1438r674b1487],
9	have	VBP	O	have	aux	10	SENT_389	[p11l686t1449r763b1479],
10	resulted	VBN	O	result	_	0	SENT_389	[p11l775t1449r905b1479],
11	in	IN	O	in	_	0	SENT_389	[p11l916t1449r947b1478],
12	responses	NNS	O	response	prep_in	10	SENT_389	[p11l958t1459r1118b1487],
13	in	IN	O	in	_	0	SENT_389	[p11l1130t1449r1162b1478],
14	19-25	CD	PERCENT	19-25	num	15	SENT_389	[p11l1177t1449r1308b1479],
15	%	NN	PERCENT	%	prep_in	12	SENT_389	[p11l1177t1449r1308b1479],
16	of	IN	O	of	_	0	SENT_389	[p11l1322t1449r1357b1479],
17	untreated	JJ	O	untreated	amod	18	SENT_389	[p11l1366t1449r1519b1479],
18	patients	NNS	O	patient	prep_of	15	SENT_389	[p11l1529t1449r1657b1487],
19	(	IN	O	(	_	0	SENT_389	[p11l1670t1449r1732b1485],
20	84	CD	NUMBER	84	prep_(	10	SENT_389	[p11l1670t1449r1732b1485],
21	,	,	O	,	_	0	SENT_389	[p11l1670t1449r1732b1485],
22	85	CD	NUMBER	85	num	23	SENT_389	[p11l1746t1449r1807b1485],
23	)	NN	O	)	appos	20	SENT_389	[p11l1746t1449r1807b1485],
24	.	.	O	.	_	0	SENT_389	[p11l1746t1449r1807b1485],

1	The	DT	O	the	det	2	SENT_390	[p11l599t1501r662b1530],
2	taxanes	NNS	O	taxane	nsubj	5	SENT_390	[p11l680t1506r803b1530],
3	have	VBP	O	have	aux	5	SENT_390	[p11l821t1501r898b1530],
4	also	RB	O	also	advmod	5	SENT_390	[p11l917t1501r981b1530],
5	shown	VBN	O	show	_	0	SENT_390	[p11l1001t1501r1107b1530],
6	striking	JJ	O	striking	amod	7	SENT_390	[p11l1127t1501r1250b1539],
7	activity	NN	O	activity	dobj	5	SENT_390	[p11l1269t1501r1391b1539],
8	in	IN	O	in	_	0	SENT_390	[p11l1409t1501r1441b1530],
9	small	JJ	O	small	amod	12	SENT_390	[p11l1460t1501r1547b1530],
10	cell	NN	O	cell	nn	12	SENT_390	[p11l1565t1501r1624b1530],
11	lung	NN	O	lung	nn	12	SENT_390	[p11l1641t1501r1713b1539],
12	cancer	NN	O	cancer	prep_in	5	SENT_390	[p11l1732t1510r1847b1530],
13	.	.	O	.	_	0	SENT_390	[p11l1732t1510r1847b1530],

1	Paclitaxel	NN	O	paclitaxel	nn	2	SENT_391	[p11l549t1551r711b1580],
2	doses	NNS	O	dose	_	0	SENT_391	[p11l726t1551r816b1580],
3	of	IN	O	of	_	0	SENT_391	[p11l833t1551r868b1580],
4	250	CD	NUMBER	250	num	5	SENT_391	[p11l881t1551r942b1580],
5	mg/m2	NN	O	mg/m2	prep_of	2	SENT_391	[p11l957t1540r1069b1589],
6	(	CD	NUMBER	(	num	9	SENT_391	[p11l1086t1551r1173b1587],
7	24-h	JJ	O	24-h	amod	9	SENT_391	[p11l1086t1551r1173b1587],
8	schedule	NN	O	schedule	nn	9	SENT_391	[p11l1189t1551r1345b1587],
9	)	NN	O	)	conj_and	9	SENT_391	[p11l1189t1551r1345b1587],
10	without	IN	O	without	_	0	SENT_391	[p11l1361t1551r1487b1580],
11	and	CC	O	and	_	0	SENT_391	[p11l1502t1551r1561b1580],
12	with	IN	O	with	_	0	SENT_391	[p11l1576t1551r1648b1580],
13	G	NN	O	g	prep_without	9	SENT_391	[p11l1664t1551r1780b1581],
14	.	.	O	.	_	0	SENT_391	[p11l1664t1551r1780b1581],

1	—	NN	O	—	_	0	SENT_392	[p11l1664t1551r1780b1581],
2	.	.	O	.	_	0	SENT_392	[p11l1664t1551r1780b1581],

1	CSF	NN	O	csf	nsubj	3	SENT_393	[p11l1664t1551r1780b1581],
2	has	VBZ	O	have	aux	3	SENT_393	[p11l1794t1551r1848b1580],
3	produced	VBN	O	produce	_	0	SENT_393	[p11l549t1601r703b1639],
4	responses	NNS	O	response	dobj	3	SENT_393	[p11l713t1610r872b1639],
5	in	IN	O	in	_	0	SENT_393	[p11l884t1601r915b1630],
6	34	CD	NUMBER	34	prep_in	4	SENT_393	[p11l927t1601r966b1630],
7	and	CC	O	and	_	0	SENT_393	[p11l978t1601r1036b1630],
8	41	CD	PERCENT	41	num	9	SENT_393	[p11l1047t1601r1120b1630],
9	%	NN	PERCENT	%	conj_and	4	SENT_393	[p11l1047t1601r1120b1630],
10	of	IN	O	of	_	0	SENT_393	[p11l1133t1601r1169b1630],
11	chemotherapy	NN	O	chemotherapy	nn	14	SENT_393	[p11l1177t1601r1514b1639],
12	—	NN	O	—	nn	14	SENT_393	[p11l1177t1601r1514b1639],
13	naive	JJ	O	naive	amod	14	SENT_393	[p11l1177t1601r1514b1639],
14	patients	NNS	O	patient	prep_of	9	SENT_393	[p11l1524t1601r1651b1639],
15	with	IN	O	with	_	0	SENT_393	[p11l1664t1601r1736b1630],
16	extensive	JJ	O	extensive	amod	17	SENT_393	[p11l1747t1606r1847b1630, p11l551t1651r615b1680],
17	disease	NN	O	disease	prep_with	3	SENT_393	[p11l631t1651r758b1686],
18	,	,	O	,	_	0	SENT_393	[p11l631t1651r758b1686],
19	respectively	RB	O	respectively	advmod	17	SENT_393	[p11l775t1651r974b1689],
20	(	CD	NUMBER	(	num	21	SENT_393	[p11l991t1651r1053b1687],
21	86	CD	NUMBER	86	dep	17	SENT_393	[p11l991t1651r1053b1687],
22	,	,	O	,	_	0	SENT_393	[p11l991t1651r1053b1687],
23	87	CD	NUMBER	87	num	24	SENT_393	[p11l1072t1651r1133b1687],
24	)	NN	O	)	appos	21	SENT_393	[p11l1072t1651r1133b1687],
25	.	.	O	.	_	0	SENT_393	[p11l1072t1651r1133b1687],

1	Similar	JJ	O	similar	amod	2	SENT_394	[p11l1152t1651r1272b1681],
2	activity	NN	O	activity	nsubjpass	6	SENT_394	[p11l1288t1651r1410b1689],
3	has	VBZ	O	have	aux	6	SENT_394	[p11l1426t1651r1479b1680],
4	also	RB	O	also	advmod	6	SENT_394	[p11l1496t1651r1561b1680],
5	been	VBN	O	be	auxpass	6	SENT_394	[p11l1576t1651r1654b1680],
6	noted	VBN	O	note	_	0	SENT_394	[p11l1669t1651r1761b1680],
7	with	IN	O	with	_	0	SENT_394	[p11l1776t1651r1849b1681],
8	docetaxel	NN	O	docetaxel	prep_with	6	SENT_394	[p11l550t1701r707b1730],
9	in	IN	O	in	_	0	SENT_394	[p11l717t1701r748b1730],
10	small	JJ	O	small	amod	13	SENT_394	[p11l761t1701r848b1730],
11	cell	NN	O	cell	nn	13	SENT_394	[p11l859t1701r917b1730],
12	lung	NN	O	lung	nn	13	SENT_394	[p11l928t1701r1000b1739],
13	cancer	NN	O	cancer	prep_in	8	SENT_394	[p11l1012t1710r1127b1730],
14	.	.	O	.	_	0	SENT_394	[p11l1012t1710r1127b1730],

1	In	IN	O	in	_	0	SENT_395	[p11l1139t1702r1173b1730],
2	one	CD	NUMBER	one	num	3	SENT_395	[p11l1184t1710r1242b1730],
3	study	NN	O	study	prep_in	6	SENT_395	[p11l1254t1701r1350b1739],
4	,	,	O	,	_	0	SENT_395	[p11l1254t1701r1350b1739],
5	responses	NNS	O	response	nsubj	6	SENT_395	[p11l1362t1710r1522b1739],
6	occurred	VBD	O	occur	_	0	SENT_395	[p11l1534t1701r1678b1730],
7	in	IN	O	in	_	0	SENT_395	[p11l1688t1701r1719b1730],
8	25	CD	PERCENT	25	num	9	SENT_395	[p11l1730t1701r1803b1730],
9	%	NN	PERCENT	%	prep_in	6	SENT_395	[p11l1730t1701r1803b1730],
10	of	IN	O	of	_	0	SENT_395	[p11l1816t1701r1851b1730],
11	patients	NNS	O	patient	prep_of	9	SENT_395	[p11l549t1751r686b1789],
12	,	,	O	,	_	0	SENT_395	[p11l549t1751r686b1789],
13	the	DT	O	the	det	14	SENT_395	[p11l704t1751r753b1780],
14	majority	NN	O	majority	appos	11	SENT_395	[p11l771t1751r910b1789],
15	of	IN	O	of	_	0	SENT_395	[p11l928t1751r963b1780],
16	whom	WP	O	whom	nsubj	17	SENT_395	[p11l978t1751r1080b1780],
17	had	VBD	O	have	prepc_of	14	SENT_395	[p11l1097t1751r1156b1780],
18	prior	JJ	O	prior	amod	21	SENT_395	[p11l1172t1751r1253b1789],
19	chemotherapy	NN	O	chemotherapy	nn	21	SENT_395	[p11l1269t1751r1502b1789],
20	and/or	NN	O	and/or	nn	21	SENT_395	[p11l1520t1751r1624b1780],
21	radiotherapy	NN	O	radiotherapy	dobj	17	SENT_395	[p11l1640t1751r1848b1789],
22	(	CD	NUMBER	(	number	23	SENT_395	[p11l551t1802r625b1837],
23	88	CD	NUMBER	88	num	24	SENT_395	[p11l551t1802r625b1837],
24	)	NN	O	)	dobj	6	SENT_395	[p11l551t1802r625b1837],
25	.	.	O	.	_	0	SENT_395	[p11l551t1802r625b1837],

1	Because	IN	O	because	_	0	SENT_396	[p11l599t1872r736b1900],
2	of	IN	O	of	prepc_because_of	25	SENT_396	[p11l754t1871r789b1900],
3	the	DT	O	the	det	5	SENT_396	[p11l803t1871r853b1900],
4	favorable	JJ	O	favorable	amod	5	SENT_396	[p11l870t1871r1025b1900],
5	activity	NN	O	activity	pobj	25	SENT_396	[p11l1043t1871r1165b1909],
6	of	IN	O	of	_	0	SENT_396	[p11l1183t1871r1218b1900],
7	both	DT	O	both	det	8	SENT_396	[p11l1232t1871r1305b1900],
8	taxanes	NNS	O	taxane	prep_of	5	SENT_396	[p11l1322t1876r1444b1900],
9	as	IN	O	as	_	0	SENT_396	[p11l1463t1880r1495b1900],
10	single	JJ	O	single	amod	11	SENT_396	[p11l1514t1871r1610b1909],
11	agents	NNS	O	agent	prep_as	8	SENT_396	[p11l1628t1876r1731b1909],
12	in	IN	O	in	_	0	SENT_396	[p11l1749t1871r1780b1900],
13	advanced	JJ	O	advanced	amod	15	SENT_396	[p11l1798t1871r1847b1900, p11l549t1921r666b1951],
14	lung	NN	O	lung	nn	15	SENT_396	[p11l677t1921r749b1959],
15	cancer	NN	O	cancer	prep_in	11	SENT_396	[p11l761t1931r876b1956],
16	,	,	O	,	_	0	SENT_396	[p11l761t1931r876b1956],
17	the	DT	O	the	det	18	SENT_396	[p11l888t1921r938b1950],
18	development	NN	O	development	nsubj	25	SENT_396	[p11l949t1921r1162b1959],
19	of	IN	O	of	_	0	SENT_396	[p11l1173t1921r1209b1950],
20	taxane-based	JJ	O	taxane-based	amod	22	SENT_396	[p11l1217t1921r1433b1950],
21	combination	NN	O	combination	nn	22	SENT_396	[p11l1443t1921r1649b1950],
22	regimens	NNS	O	regimen	prep_of	18	SENT_396	[p11l1659t1921r1809b1959],
23	is	VBZ	O	be	cop	25	SENT_396	[p11l1822t1921r1847b1950],
24	an	DT	O	a	det	25	SENT_396	[p11l550t1981r587b2001],
25	area	NN	O	area	_	0	SENT_396	[p11l606t1981r674b2001],
26	of	IN	O	of	_	0	SENT_396	[p11l692t1972r727b2001],
27	major	JJ	O	major	amod	28	SENT_396	[p11l743t1972r839b2009],
28	interest	NN	O	interest	prep_of	25	SENT_396	[p11l857t1972r986b2001],
29	.	.	O	.	_	0	SENT_396	[p11l857t1972r986b2001],

1	Perhaps	RB	O	perhaps	advmod	7	SENT_397	[p11l1006t1972r1135b2009],
2	the	DT	O	the	det	5	SENT_397	[p11l1154t1972r1204b2001],
3	most	RBS	O	most	advmod	4	SENT_397	[p11l1222t1976r1302b2001],
4	exciting	JJ	O	exciting	amod	5	SENT_397	[p11l1321t1972r1452b2009],
5	regimen	NN	O	regimen	nsubj	7	SENT_397	[p11l1470t1971r1606b2009],
6	is	VBZ	O	be	cop	7	SENT_397	[p11l1624t1971r1649b2001],
7	that	IN	O	that	_	0	SENT_397	[p11l1669t1972r1730b2001],
8	of	IN	O	of	_	0	SENT_397	[p11l1748t1971r1784b2001],
9	the	DT	O	the	det	10	SENT_397	[p11l1799t1972r1848b2001],
10	combination	NN	O	combination	prep_of	7	SENT_397	[p11l550t2021r755b2051],
11	of	IN	O	of	_	0	SENT_397	[p11l766t2021r802b2050],
12	the	DT	O	the	det	13	SENT_397	[p11l810t2021r860b2050],
13	taxanes	NNS	O	taxane	prep_of	10	SENT_397	[p11l871t2026r993b2050],
14	and	CC	O	and	_	0	SENT_397	[p11l1005t2022r1063b2050],
15	platinum	NN	O	platinum	nn	16	SENT_397	[p11l1073t2021r1221b2059],
16	compounds	NNS	O	compound	prep_of	10	SENT_397	[p11l1232t2021r1430b2059],
17	.	.	O	.	_	0	SENT_397	[p11l1232t2021r1430b2059],

1	In	IN	O	in	_	0	SENT_398	[p11l1443t2022r1476b2050],
2	view	NN	O	view	prep_in	30	SENT_398	[p11l1487t2021r1566b2051],
3	of	IN	O	of	_	0	SENT_398	[p11l1578t2021r1613b2050],
4	the	DT	O	the	det	5	SENT_398	[p11l1621t2021r1670b2051],
5	safety	NN	O	safety	prep_of	2	SENT_398	[p11l1683t2021r1779b2059],
6	and	CC	O	and	_	0	SENT_398	[p11l1791t2021r1849b2051],
7	activity	NN	O	activity	prep_of	2	SENT_398	[p11l550t2072r672b2109],
8	of	IN	O	of	_	0	SENT_398	[p11l692t2072r728b2101],
9	cisplatin	NN	O	cisplatin	prep_of	5	SENT_398	[p11l745t2072r884b2109],
10	combined	VBN	O	combine	prep	9	SENT_398	[p11l904t2072r1066b2101],
11	with	IN	O	with	pcomp	10	SENT_398	[p11l1085t2072r1158b2101],
12	either	CC	O	either	dep	11	SENT_398	[p11l1178t2072r1271b2101],
13	paclitaxel	NN	O	paclitaxel	conj	11	SENT_398	[p11l1289t2072r1449b2109],
14	and	CC	O	and	_	0	SENT_398	[p11l1469t2072r1527b2101],
15	docetaxel	NN	O	docetaxel	conj_and	13	SENT_398	[p11l1547t2072r1704b2101],
16	in	IN	O	in	_	0	SENT_398	[p11l1723t2072r1754b2100],
17	pilot	NN	O	pilot	nn	18	SENT_398	[p11l1773t2072r1849b2109],
18	studies	NNS	O	study	prep_in	13	SENT_398	[p11l551t2122r662b2151],
19	(	VBP	O	(	rcmod	13	SENT_398	[p11l678t2122r815b2158],
20	89-92	CD	NUMBER	89-92	num	21	SENT_398	[p11l678t2122r815b2158],
21	)	CD	NUMBER	)	dobj	19	SENT_398	[p11l678t2122r815b2158],
22	,	,	O	,	_	0	SENT_398	[p11l678t2122r815b2158],
23	the	DT	O	the	det	24	SENT_398	[p11l830t2122r879b2151],
24	efficacy	NN	O	efficacy	nsubjpass	30	SENT_398	[p11l893t2122r1024b2159],
25	of	IN	O	of	_	0	SENT_398	[p11l1038t2122r1073b2151],
26	such	JJ	O	such	amod	27	SENT_398	[p11l1085t2122r1159b2151],
27	regimens	NNS	O	regimen	prep_of	24	SENT_398	[p11l1172t2122r1322b2159],
28	is	VBZ	O	be	aux	30	SENT_398	[p11l1336t2122r1361b2151],
29	being	VBG	O	be	auxpass	30	SENT_398	[p11l1375t2122r1466b2159],
30	evaluated	VBN	O	evaluate	_	0	SENT_398	[p11l1480t2122r1645b2151],
31	.	.	O	.	_	0	SENT_398	[p11l1480t2122r1645b2151],

1	A	DT	O	a	det	4	SENT_399	[p11l1660t2122r1689b2151],
2	phase	NN	O	phase	nn	4	SENT_399	[p11l1701t2122r1795b2160],
3	III	CD	NUMBER	iii	num	4	SENT_399	[p11l1808t2123r1849b2151],
4	trial	NN	O	trial	_	0	SENT_399	[p11l549t2172r615b2201],
5	in	IN	O	in	_	0	SENT_399	[p11l629t2172r660b2200],
6	untreated	JJ	O	untreated	amod	7	SENT_399	[p11l673t2172r827b2201],
7	patients	NNS	O	patient	prep_in	4	SENT_399	[p11l840t2172r967b2209],
8	with	IN	O	with	_	0	SENT_399	[p11l982t2172r1054b2201],
9	stage	NN	O	stage	nn	11	SENT_399	[p11l1069t2176r1152b2209],
10	IV	CD	NUMBER	iv	num	11	SENT_399	[p11l1166t2172r1208b2201],
11	NSCLC	NN	O	nsclc	prep_with	7	SENT_399	[p11l1222t2172r1354b2201],
12	that	IN	O	that	nsubj	13	SENT_399	[p11l1369t2172r1431b2201],
13	compared	VBN	O	compare	rcmod	7	SENT_399	[p11l1444t2172r1606b2209],
14	standard	NN	O	standard	nn	15	SENT_399	[p11l1620t2172r1758b2201],
15	therapy	NN	O	therapy	dobj	13	SENT_399	[p11l1771t2172r1847b2201, p11l550t2231r607b2260],
16	consisting	VBG	O	consist	partmod	15	SENT_399	[p11l620t2222r787b2260],
17	of	IN	O	of	_	0	SENT_399	[p11l800t2222r836b2251],
18	etoposide	NN	O	etoposide	prep_of	4	SENT_399	[p11l846t2222r1003b2260],
19	plus	CC	O	plus	prep	4	SENT_399	[p11l1015t2222r1083b2260],
20	cisplatin	NN	O	cisplatin	dep	19	SENT_399	[p11l1096t2222r1235b2260],
21	with	IN	O	with	_	0	SENT_399	[p11l1248t2222r1320b2251],
22	cisplatin	NN	O	cisplatin	prep_with	4	SENT_399	[p11l1333t2222r1472b2260],
23	plus	CC	O	plus	prep	4	SENT_399	[p11l1484t2222r1551b2260],
24	24-h	JJ	O	24-h	amod	25	SENT_399	[p11l1565t2222r1639b2251],
25	infusions	NNS	O	infusion	dep	23	SENT_399	[p11l1652t2222r1801b2251],
26	of	IN	O	of	_	0	SENT_399	[p11l1815t2222r1851b2251],
27	paclitaxel	NN	O	paclitaxel	prep_of	4	SENT_399	[p11l549t2272r709b2310],
28	given	VBN	O	give	prep	4	SENT_399	[p11l729t2272r819b2310],
29	at	IN	O	at	pcomp	28	SENT_399	[p11l840t2277r868b2301],
30	either	CC	O	either	preconj	33	SENT_399	[p11l888t2272r981b2301],
31	a	DT	O	a	det	33	SENT_399	[p11l1001t2281r1018b2301],
32	low	JJ	O	low	amod	33	SENT_399	[p11l1036t2272r1097b2301],
33	dose	NN	O	dose	pobj	29	SENT_399	[p11l1117t2272r1191b2301],
34	or	CC	O	or	_	0	SENT_399	[p11l1212t2281r1245b2301],
35	a	DT	O	a	det	37	SENT_399	[p11l1265t2281r1282b2301],
36	high	JJ	O	high	amod	37	SENT_399	[p11l1300t2272r1373b2310],
37	dose	NN	O	dose	conj_or	33	SENT_399	[p11l1393t2272r1467b2301],
38	plus	CC	O	plus	prep	4	SENT_399	[p11l1486t2272r1554b2310],
39	G	NN	O	g	dep	38	SENT_399	[p11l1575t2272r1691b2301],
40	.	.	O	.	_	0	SENT_399	[p11l1575t2272r1691b2301],

1	—	NN	O	—	_	0	SENT_400	[p11l1575t2272r1691b2301],
2	.	.	O	.	_	0	SENT_400	[p11l1575t2272r1691b2301],

1	CSF	NN	O	csf	nsubj	2	SENT_401	[p11l1575t2272r1691b2301],
2	revealed	VBD	O	reveal	_	0	SENT_401	[p11l1709t2272r1849b2301],
3	significantly	RB	O	significantly	advmod	6	SENT_401	[p11l551t2322r755b2359],
4	(	CD	NUMBER	(	num	5	SENT_401	[p11l771t2322r808b2358],
5	P	NN	O	p	npadvmod	6	SENT_401	[p11l771t2322r808b2358],
6	<	JJR	O	<	amod	11	SENT_401	[p11l823t2329r844b2351],
7	0.001	CD	NUMBER	0.001	number	8	SENT_401	[p11l859t2322r964b2357],
8	)	CD	NUMBER	)	npadvmod	9	SENT_401	[p11l859t2322r964b2357],
9	higher	JJR	O	higher	dep	6	SENT_401	[p11l979t2322r1085b2359],
10	response	NN	O	response	nn	11	SENT_401	[p11l1098t2331r1242b2359],
11	rates	NNS	O	rate	dobj	2	SENT_401	[p11l1257t2326r1333b2351],
12	for	IN	O	for	_	0	SENT_401	[p11l1349t2322r1396b2351],
13	both	DT	O	both	det	15	SENT_401	[p11l1410t2322r1483b2351],
14	paclitaxel	NN	O	paclitaxel	nn	15	SENT_401	[p11l1497t2322r1657b2359],
15	arms	NNS	O	arm	prep_for	2	SENT_401	[p11l1672t2331r1749b2351],
16	compared	VBN	O	compare	partmod	15	SENT_401	[p11l1765t2331r1848b2351, p11l549t2433r641b2471],

1	with	IN	O	with	_	0	SENT_402	[p11l652t2433r724b2462],
2	standard	JJ	O	standard	amod	4	SENT_402	[p11l737t2433r875b2462],
3	therapy	NN	O	therapy	nn	4	SENT_402	[p11l886t2433r1009b2471],
4	(	NN	O	(	prep_with	20	SENT_402	[p11l1022t2433r1075b2469],
5	32	CD	NUMBER	32	nsubj	20	SENT_402	[p11l1022t2433r1075b2469],
6	vs	CC	O	vs	_	0	SENT_402	[p11l1087t2442r1122b2462],
7	27	CD	NUMBER	27	nsubj	20	SENT_402	[p11l1135t2433r1173b2462],
8	vs	CC	O	vs	_	0	SENT_402	[p11l1186t2442r1220b2462],
9	12	CD	PERCENT	12	num	10	SENT_402	[p11l1237t2433r1320b2469],
10	%	NN	PERCENT	%	nsubj	20	SENT_402	[p11l1237t2433r1320b2469],
11	)	CD	NUMBER	)	dep	10	SENT_402	[p11l1237t2433r1320b2469],
12	and	CC	O	and	_	0	SENT_402	[p11l1334t2433r1392b2462],
13	no	DT	O	no	det	15	SENT_402	[p11l1403t2442r1443b2462],
14	significant	JJ	O	significant	amod	15	SENT_402	[p11l1456t2433r1629b2471],
15	difference	NN	O	difference	nsubj	20	SENT_402	[p11l1641t2433r1807b2462],
16	in	IN	O	in	_	0	SENT_402	[p11l1818t2433r1849b2462],
17	median	JJ	O	median	amod	19	SENT_402	[p11l549t2483r670b2512],
18	survival	NN	O	survival	nn	19	SENT_402	[p11l687t2483r817b2512],
19	times	NNS	O	time	prep_in	15	SENT_402	[p11l833t2483r921b2512],
20	(	VBP	O	(	_	0	SENT_402	[p11l938t2483r1001b2519],
21	9.6	CD	NUMBER	9.6	dobj	20	SENT_402	[p11l938t2483r1001b2519],
22	vs	CC	O	vs	_	0	SENT_402	[p11l1016t2493r1051b2512],
23	10	CD	DURATION	10	num	24	SENT_402	[p11l1071t2484r1107b2513],
24	months	NNS	NUMBER	month	conj_vs	21	SENT_402	[p11l1123t2483r1256b2519],
25	)	RB	O	)	advmod	20	SENT_402	[p11l1123t2483r1256b2519],
26	between	IN	O	between	_	0	SENT_402	[p11l1272t2483r1410b2512],
27	the	DT	O	the	det	29	SENT_402	[p11l1424t2483r1474b2512],
28	paclitaxel	NN	O	paclitaxel	nn	29	SENT_402	[p11l1488t2483r1757b2521],
29	—	NN	O	—	prep_between	20	SENT_402	[p11l1488t2483r1757b2521],
30	based	VBN	O	base	partmod	29	SENT_402	[p11l1488t2483r1757b2521],
31	regimens	NNS	O	regimen	dobj	30	SENT_402	[p11l1771t2483r1847b2521, p11l549t2603r644b2628],
32	,	,	O	,	_	0	SENT_402	[p11l1771t2483r1847b2521, p11l549t2603r644b2628],

1	though	IN	O	though	mark	5	SENT_403	[p11l657t2594r772b2631],
2	median	JJ	O	median	amod	3	SENT_403	[p11l784t2594r904b2623],
3	survival	NN	O	survival	nsubj	5	SENT_403	[p11l918t2594r1048b2623],
4	was	VBD	O	be	cop	5	SENT_403	[p11l1061t2603r1123b2623],
5	longer	JJR	O	longer	advcl	16	SENT_403	[p11l1136t2594r1242b2631],
6	than	IN	O	than	_	0	SENT_403	[p11l1252t2594r1322b2623],
7	these	DT	O	these	prep_than	5	SENT_403	[p11l1334t2594r1418b2623],
8	compared	VBN	O	compare	_	0	SENT_403	[p11l1430t2594r1592b2631],
9	with	IN	O	with	prepc_compared_with	7	SENT_403	[p11l1603t2594r1675b2623],
10	the	DT	O	the	det	12	SENT_403	[p11l1687t2594r1736b2623],
11	standard	JJ	O	standard	amod	12	SENT_403	[p11l1750t2594r1847b2623, p11l550t2644r601b2673],
12	arm	NN	O	arm	pobj	7	SENT_403	[p11l615t2653r678b2673],
13	(	CD	NUMBER	(	number	14	SENT_403	[p11l693t2644r755b2680],
14	7.7	CD	DURATION	7.7	num	15	SENT_403	[p11l693t2644r755b2680],
15	months	NNS	NUMBER	month	nsubj	16	SENT_403	[p11l770t2644r904b2680],
16	)	VBP	O	)	_	0	SENT_403	[p11l770t2644r904b2680],
17	(	CD	NUMBER	(	number	18	SENT_403	[p11l920t2644r995b2680],
18	93	CD	NUMBER	93	num	19	SENT_403	[p11l920t2644r995b2680],
19	)	NN	O	)	dobj	16	SENT_403	[p11l920t2644r995b2680],
20	.	.	O	.	_	0	SENT_403	[p11l920t2644r995b2680],

1	The	DT	O	the	det	2	SENT_404	[p11l1011t2644r1074b2673],
2	study	NN	O	study	nsubj	4	SENT_404	[p11l1089t2644r1176b2681],
3	also	RB	O	also	advmod	4	SENT_404	[p11l1191t2644r1256b2673],
4	incorporated	VBN	O	incorporate	_	0	SENT_404	[p11l1270t2644r1479b2682],
5	quality	NN	O	quality	dobj	4	SENT_404	[p11l1492t2644r1605b2682],
6	of	IN	O	of	_	0	SENT_404	[p11l1620t2644r1656b2673],
7	life	NN	O	life	nn	8	SENT_404	[p11l1667t2644r1720b2673],
8	assessments	NNS	O	assessment	prep_of	5	SENT_404	[p11l1735t2653r1847b2673, p11l549t2758r646b2782],

1	to	TO	O	to	aux	2	SENT_405	[p11l666t2758r697b2782],
2	determine	VB	O	determine	_	0	SENT_405	[p11l717t2753r881b2782],
3	whether	IN	O	whether	complm	9	SENT_405	[p11l901t2753r1034b2782],
4	the	DT	O	the	det	6	SENT_405	[p11l1052t2753r1101b2782],
5	increased	VBN	O	increase	amod	6	SENT_405	[p11l1120t2753r1276b2782],
6	toxicity	NN	O	toxicity	nsubj	9	SENT_405	[p11l1294t2753r1419b2791],
7	and	CC	O	and	_	0	SENT_405	[p11l1440t2753r1498b2782],
8	resources	NNS	O	resource	nsubj	9	SENT_405	[p11l1516t2762r1671b2782],
9	expended	VBN	O	expend	ccomp	2	SENT_405	[p11l1691t2753r1849b2791],
10	with	IN	O	with	_	0	SENT_405	[p11l550t2803r622b2832],
11	higher	JJR	O	higher	amod	13	SENT_405	[p11l634t2803r739b2841],
12	drug	NN	O	drug	nn	13	SENT_405	[p11l751t2803r825b2841],
13	doses	NNS	O	dose	prep_with	9	SENT_405	[p11l838t2803r928b2832],
14	and	CC	O	and	_	0	SENT_405	[p11l942t2803r1000b2832],
15	G	NN	O	g	conj_and	13	SENT_405	[p11l1012t2803r1128b2832],
16	.	.	O	.	_	0	SENT_405	[p11l1012t2803r1128b2832],

1	—	NN	O	—	_	0	SENT_406	[p11l1012t2803r1128b2832],
2	.	.	O	.	_	0	SENT_406	[p11l1012t2803r1128b2832],

1	CSF	NN	O	csf	nsubjpass	3	SENT_407	[p11l1012t2803r1128b2832],
2	are	VBP	O	be	auxpass	3	SENT_407	[p11l1141t2812r1190b2832],
3	warranted	VBN	O	warrant	_	0	SENT_407	[p11l1202t2803r1374b2832],
4	.	.	O	.	_	0	SENT_407	[p11l1202t2803r1374b2832],

1	Another	DT	O	another	det	3	SENT_408	[p11l1388t2803r1524b2832],
2	promising	JJ	O	promising	amod	3	SENT_408	[p11l1535t2803r1702b2841],
3	regimen	NN	O	regimen	nsubj	6	SENT_408	[p11l1713t2803r1849b2841],
4	is	VBZ	O	be	cop	6	SENT_408	[p11l549t2853r575b2883],
5	the	DT	O	the	det	6	SENT_408	[p11l588t2853r637b2883],
6	combination	NN	O	combination	_	0	SENT_408	[p11l649t2853r855b2883],
7	of	IN	O	of	_	0	SENT_408	[p11l867t2853r902b2882],
8	paclitaxel	NN	O	paclitaxel	prep_of	6	SENT_408	[p11l911t2853r1071b2891],
9	and	CC	O	and	_	0	SENT_408	[p11l1083t2853r1141b2883],
10	carboplatin	NN	O	carboplatin	conj_and	8	SENT_408	[p11l1153t2853r1346b2891],
11	.	.	O	.	_	0	SENT_408	[p11l1153t2853r1346b2891],

1	In	IN	O	in	_	0	SENT_409	[p11l1360t2854r1393b2882],
2	a	DT	O	a	det	5	SENT_409	[p11l1405t2863r1423b2882],
3	phase	NN	O	phase	nn	5	SENT_409	[p11l1433t2853r1526b2891],
4	II	CD	NUMBER	ii	num	5	SENT_409	[p11l1538t2854r1565b2882],
5	trial	NN	O	trial	prep_in	18	SENT_409	[p11l1576t2853r1642b2882],
6	in	IN	O	in	_	0	SENT_409	[p11l1653t2853r1684b2882],
7	untreated	JJ	O	untreated	amod	8	SENT_409	[p11l1696t2853r1849b2883],
8	advanced	JJ	O	advanced	amod	9	SENT_409	[p11l550t2904r705b2933],
9	NSCLC	NNP	LOCATION	NSCLC	prep_in	5	SENT_409	[p11l722t2904r864b2938],
10	,	,	O	,	_	0	SENT_409	[p11l722t2904r864b2938],
11	paclitaxel	NN	O	paclitaxel	npadvmod	13	SENT_409	[p11l883t2904r1044b2941],
12	(	CD	NUMBER	(	num	11	SENT_409	[p11l1063t2904r1150b2939],
13	24-h	JJ	O	24-h	amod	15	SENT_409	[p11l1063t2904r1150b2939],
14	schedule	NN	O	schedule	nn	15	SENT_409	[p11l1170t2904r1325b2940],
15	)	NN	O	)	nsubj	18	SENT_409	[p11l1170t2904r1325b2940],
16	plus	CC	O	plus	prep	15	SENT_409	[p11l1344t2904r1412b2941],
17	carboplatin	NN	O	carboplatin	dep	16	SENT_409	[p11l1431t2904r1616b2941],
18	resulted	VBD	O	result	_	0	SENT_409	[p11l1634t2904r1764b2933],
19	in	IN	O	in	_	0	SENT_409	[p11l1782t2904r1813b2933],
20	a	DT	O	a	det	22	SENT_409	[p11l1832t2913r1849b2933],
21	response	NN	O	response	nn	22	SENT_409	[p11l549t2963r693b2991],
22	rate	NN	O	rate	prep_in	18	SENT_409	[p11l705t2958r767b2983],
23	of	IN	O	of	_	0	SENT_409	[p11l780t2954r816b2983],
24	62	CD	PERCENT	62	num	25	SENT_409	[p11l826t2954r909b2988],
25	%	NN	PERCENT	%	prep_of	22	SENT_409	[p11l826t2954r909b2988],
26	,	,	O	,	_	0	SENT_409	[p11l826t2954r909b2988],
27	a	DT	O	a	det	29	SENT_409	[p11l925t2963r942b2983],
28	CR	JJ	O	cr	amod	29	SENT_409	[p11l954t2954r1008b2983],
29	rate	NN	O	rate	appos	25	SENT_409	[p11l1020t2958r1082b2983],
30	of	IN	O	of	_	0	SENT_409	[p11l1095t2954r1130b2983],
31	9	CD	PERCENT	9	num	32	SENT_409	[p11l1141t2954r1203b2988],
32	%	NN	PERCENT	%	prep_of	29	SENT_409	[p11l1141t2954r1203b2988],
33	,	,	O	,	_	0	SENT_409	[p11l1141t2954r1203b2988],
34	and	CC	O	and	_	0	SENT_409	[p11l1218t2954r1276b2983],
35	impressive	JJ	O	impressive	amod	37	SENT_409	[p11l1288t2954r1467b2991],
36	survival	NN	O	survival	nn	37	SENT_409	[p11l1481t2954r1612b2983],
37	rates	NNS	O	rate	nsubj	38	SENT_409	[p11l1624t2958r1701b2983],
38	(	VBP	O	(	conj_and	18	SENT_409	[p11l1715t2954r1849b2990],
39	median	JJ	O	median	amod	40	SENT_409	[p11l1715t2954r1849b2990],
40	progression	NN	O	progression	dobj	38	SENT_409	[p11l549t3004r819b3042],
41	—	CD	NUMBER	—	num	44	SENT_409	[p11l549t3004r819b3042],
42	free	JJ	O	free	amod	44	SENT_409	[p11l549t3004r819b3042],
43	survival	NN	O	survival	nn	44	SENT_409	[p11l836t3004r967b3033],
44	time	NN	O	time	dep	40	SENT_409	[p11l982t3004r1064b3039],
45	,	,	O	,	_	0	SENT_409	[p11l982t3004r1064b3039],
46	28	CD	DURATION	28	num	47	SENT_409	[p11l1081t3004r1119b3033],
47	weeks	NNS	NUMBER	week	appos	44	SENT_409	[p11l1137t3004r1248b3039],
48	;	:	O	;	_	0	SENT_409	[p11l1137t3004r1248b3039],
49	median	JJ	O	median	amod	50	SENT_409	[p11l1266t3004r1386b3033],
50	survival	NN	O	survival	dep	44	SENT_409	[p11l1403t3004r1543b3039],
51	,	,	O	,	_	0	SENT_409	[p11l1403t3004r1543b3039],
52	53	CD	DURATION	53	num	53	SENT_409	[p11l1560t3004r1598b3033],
53	weeks	NNS	NUMBER	week	appos	50	SENT_409	[p11l1615t3004r1727b3039],
54	;	:	O	;	_	0	SENT_409	[p11l1615t3004r1727b3039],
55	1-year	JJ	DURATION	1-year	amod	57	SENT_409	[p11l1748t3004r1849b3042],
56	survival	NN	O	survival	nn	57	SENT_409	[p11l551t3054r681b3083],
57	rate	NN	O	rate	dep	44	SENT_409	[p11l700t3059r770b3089],
58	,	,	O	,	_	0	SENT_409	[p11l700t3059r770b3089],
59	54	CD	PERCENT	54	num	60	SENT_409	[p11l790t3054r877b3090],
60	%	NN	PERCENT	%	appos	57	SENT_409	[p11l790t3054r877b3090],
61	)	CD	NUMBER	)	number	62	SENT_409	[p11l790t3054r877b3090],
62	(	CD	NUMBER	(	num	60	SENT_409	[p11l898t3054r973b3090],
63	94	CD	NUMBER	94	num	64	SENT_409	[p11l898t3054r973b3090],
64	)	NN	O	)	dep	60	SENT_409	[p11l898t3054r973b3090],
65	.	.	O	.	_	0	SENT_409	[p11l898t3054r973b3090],

1	Although	IN	O	although	mark	10	SENT_410	[p11l993t3054r1150b3092],
2	the	DT	O	the	det	3	SENT_410	[p11l1168t3054r1217b3083],
3	feasibility	NN	O	feasibility	nsubj	10	SENT_410	[p11l1236t3054r1400b3092],
4	and	CC	O	and	_	0	SENT_410	[p11l1419t3054r1478b3083],
5	activity	NN	O	activity	nsubj	10	SENT_410	[p11l1497t3054r1618b3092],
6	with	IN	O	with	_	0	SENT_410	[p11l1637t3054r1710b3083],
7	taxanebased	JJ	O	taxanebased	amod	8	SENT_410	[p11l1728t3058r1848b3083, p11l549t3104r643b3133],
8	regimens	NNS	O	regimen	prep_with	3	SENT_410	[p11l657t3104r807b3142],
9	may	MD	O	may	aux	10	SENT_410	[p11l823t3113r892b3142],
10	portend	VB	O	portend	advcl	29	SENT_410	[p11l907t3104r1034b3142],
11	improved	JJ	O	improved	amod	12	SENT_410	[p11l1048t3104r1206b3142],
12	palliation	NN	O	palliation	dobj	10	SENT_410	[p11l1220t3104r1376b3142],
13	of	IN	O	of	_	0	SENT_410	[p11l1390t3104r1426b3133],
14	advanced	JJ	O	advanced	amod	15	SENT_410	[p11l1439t3104r1594b3133],
15	disease	NN	O	disease	prep_of	12	SENT_410	[p11l1608t3104r1735b3138],
16	,	,	O	,	_	0	SENT_410	[p11l1608t3104r1735b3138],
17	incorporation	NN	O	incorporation	nsubj	29	SENT_410	[p11l1751t3104r1848b3133, p11l549t3154r686b3192],
18	of	IN	O	of	_	0	SENT_410	[p11l697t3154r733b3183],
19	novel	JJ	O	novel	amod	20	SENT_410	[p11l741t3154r831b3183],
20	regimens	NNS	O	regimen	prep_of	17	SENT_410	[p11l842t3154r992b3192],
21	into	IN	O	into	_	0	SENT_410	[p11l1003t3154r1066b3183],
22	the	DT	O	the	det	24	SENT_410	[p11l1077t3154r1126b3183],
23	multimodality	NN	O	multimodality	nn	24	SENT_410	[p11l1137t3154r1370b3192],
24	therapy	NN	O	therapy	prep_into	20	SENT_410	[p11l1381t3154r1504b3192],
25	of	IN	O	of	_	0	SENT_410	[p11l1515t3154r1550b3183],
26	early	JJ	O	early	amod	27	SENT_410	[p11l1558t3154r1639b3192],
27	disease	NN	O	disease	prep_of	24	SENT_410	[p11l1650t3154r1768b3183],
28	may	MD	O	may	aux	29	SENT_410	[p11l1778t3163r1848b3192],
29	lead	VB	O	lead	_	0	SENT_410	[p11l549t3204r618b3233],
30	to	TO	O	to	_	0	SENT_410	[p11l634t3208r664b3233],
31	even	RB	O	even	advmod	32	SENT_410	[p11l682t3213r758b3233],
32	greater	JJR	O	greater	amod	33	SENT_410	[p11l775t3208r889b3242],
33	effects	NNS	O	effect	prep_to	29	SENT_410	[p11l905t3204r1013b3233],
34	on	IN	O	on	_	0	SENT_410	[p11l1031t3213r1071b3233],
35	survival	NN	O	survival	prep_on	29	SENT_410	[p11l1089t3204r1228b3233],
36	.	.	O	.	_	0	SENT_410	[p11l1089t3204r1228b3233],

1	Since	IN	O	since	mark	5	SENT_411	[p11l1248t3204r1337b3233],
2	paclitaxel	NN	O	paclitaxel	nsubjpass	5	SENT_411	[p11l1353t3204r1514b3242],
3	has	VBZ	O	have	aux	5	SENT_411	[p11l1529t3204r1583b3233],
4	been	VBN	O	be	auxpass	5	SENT_411	[p11l1600t3204r1677b3233],
5	shown	VBN	O	show	advcl	17	SENT_411	[p11l1695t3204r1801b3233],
6	to	TO	O	to	aux	7	SENT_411	[p11l1817t3209r1848b3233],
7	enhance	VB	O	enhance	xcomp	5	SENT_411	[p11l550t3254r684b3283],
8	the	DT	O	the	det	9	SENT_411	[p11l695t3254r744b3283],
9	effects	NNS	O	effect	dobj	7	SENT_411	[p11l757t3254r865b3283],
10	of	IN	O	of	_	0	SENT_411	[p11l878t3254r914b3283],
11	ionizing	VBG	O	ionize	prepc_of	9	SENT_411	[p11l923t3254r1057b3292],
12	radiation	NN	O	radiation	dobj	11	SENT_411	[p11l1068t3254r1215b3283],
13	in	FW	O	in	nn	14	SENT_411	[p11l1226t3254r1258b3283],
14	vitro	FW	O	vitro	advmod	11	SENT_411	[p11l1270t3254r1355b3289],
15	,	,	O	,	_	0	SENT_411	[p11l1270t3254r1355b3289],
16	locally	RB	O	locally	advmod	17	SENT_411	[p11l1368t3254r1479b3292],
17	advanced	VBD	O	advance	_	0	SENT_411	[p11l1492t3254r1647b3283],
18	lung	NN	O	lung	nn	19	SENT_411	[p11l1658t3254r1730b3292],
19	cancer	NN	O	cancer	nsubj	25	SENT_411	[p11l1742t3263r1850b3283],
20	may	MD	O	may	aux	25	SENT_411	[p11l549t3313r619b3342],
21	also	RB	O	also	advmod	25	SENT_411	[p11l632t3304r696b3333],
22	be	VB	O	be	cop	25	SENT_411	[p11l707t3304r745b3333],
23	an	DT	O	a	det	25	SENT_411	[p11l757t3313r795b3333],
24	ideal	JJ	O	ideal	amod	25	SENT_411	[p11l805t3304r885b3333],
25	setting	NN	O	setting	ccomp	17	SENT_411	[p11l897t3304r1005b3342],
26	to	TO	O	to	aux	27	SENT_411	[p11l1016t3308r1047b3333],
27	evaluate	VB	O	evaluate	infmod	25	SENT_411	[p11l1059t3304r1195b3333],
28	the	DT	O	the	det	29	SENT_411	[p11l1206t3304r1255b3333],
29	feasibility	NN	O	feasibility	dobj	27	SENT_411	[p11l1266t3304r1430b3342],
30	and	CC	O	and	_	0	SENT_411	[p11l1442t3304r1500b3333],
31	benefits	NNS	O	benefit	dobj	27	SENT_411	[p11l1510t3304r1640b3333],
32	achieved	VBN	O	achieve	partmod	29	SENT_411	[p11l1652t3304r1798b3333],
33	by	IN	O	by	_	0	SENT_411	[p11l1808t3304r1848b3342],
34	combining	VBG	O	combine	agent	32	SENT_411	[p11l550t3354r725b3392],
35	these	DT	O	these	det	36	SENT_411	[p11l737t3354r821b3383],
36	modalities	NNS	O	modality	nsubj	37	SENT_411	[p11l832t3354r1003b3383],
37	(	VBP	O	(	ccomp	34	SENT_411	[p11l1017t3354r1091b3390],
38	95	CD	NUMBER	95	number	39	SENT_411	[p11l1017t3354r1091b3390],
39	)	CD	NUMBER	)	dobj	37	SENT_411	[p11l1017t3354r1091b3390],
40	.	.	O	.	_	0	SENT_411	[p11l1017t3354r1091b3390],

1	HEAD	NN	O	head	_	0	SENT_412	[p11l549t3467r640b3490],
2	AND	CC	O	and	_	0	SENT_412	[p11l654t3467r725b3490],
3	NECK	NN	O	neck	nn	4	SENT_412	[p11l739t3467r830b3491],
4	CANCER	NNP	O	CANCER	nsubj	10	SENT_412	[p11l843t3467r977b3491],
5	Both	CC	O	both	preconj	4	SENT_412	[p11l1015t3461r1095b3491],
6	paclitaxel	NN	O	paclitaxel	nsubj	10	SENT_412	[p11l1110t3461r1271b3499],
7	and	CC	O	and	_	0	SENT_412	[p11l1287t3461r1345b3491],
8	docetaxel	NN	O	docetaxel	conj_and	4	SENT_412	[p11l1361t3461r1518b3491],
9	have	VBP	O	have	aux	10	SENT_412	[p11l1533t3461r1611b3491],
10	demonstrated	VBN	O	demonstrate	rcmod	1	SENT_412	[p11l1627t3461r1849b3491],
11	impressive	JJ	O	impressive	amod	12	SENT_412	[p11l549t3511r727b3549],
12	activity	NN	O	activity	dobj	10	SENT_412	[p11l737t3511r859b3549],
13	in	IN	O	in	_	0	SENT_412	[p11l868t3511r899b3540],
14	patients	NNS	O	patient	prep_in	12	SENT_412	[p11l906t3511r1034b3549],
15	with	IN	O	with	_	0	SENT_412	[p11l1043t3511r1116b3541],
16	locally	RB	O	locally	advmod	17	SENT_412	[p11l1124t3511r1236b3549],
17	recurrent	JJ	O	recurrent	amod	21	SENT_412	[p11l1243t3516r1393b3541],
18	or	CC	O	or	_	0	SENT_412	[p11l1401t3520r1435b3541],
19	metastatic	JJ	O	metastatic	conj_or	17	SENT_412	[p11l1442t3511r1608b3541],
20	squamous	JJ	O	squamous	amod	21	SENT_412	[p11l1618t3520r1780b3549],
21	cell	NN	O	cell	prep_with	10	SENT_412	[p11l1790t3511r1849b3541],
22	THE	DT	O	the	det	23	SENT_412	[p11l1491t3569r1563b3595],
23	TAXANES	NN	O	taxane	dep	21	SENT_412	[p11l1573t3569r1745b3596],
24	369	CD	NUMBER	369	dep	23	SENT_412	[p11l1794t3569r1848b3596],

1	from	IN	O	from	_	0	SENT_413	[p12l7t3234r64b3394],
2	ww	NN	O	ww	pobj	1	SENT_413	[p12l26t3096r65b3212],
3	5/14	CD	NUMBER	5/14	num	2	SENT_413	[p12l89t3251r147b3411],
4	.	.	O	.	_	0	SENT_413	[p12l89t3251r147b3411],

1	For	IN	O	for	_	0	SENT_414	[p12l91t3110r147b3224],

1	Annu	NNP	PERSON	Annu	_	0	SENT_415	[p12l309t1593r332b1673],
2	.	.	O	.	_	0	SENT_415	[p12l309t1593r332b1673],

1	Rev.	NNP	O	Rev.	nn	2	SENT_416	[p12l309t1508r332b1568],
2	Med	NNP	O	Med	_	0	SENT_416	[p12l309t1431r332b1498],
3	.	.	O	.	_	0	SENT_416	[p12l309t1431r332b1498],

1	199	CD	NUMBER	199	_	0	SENT_417	[p12l309t1368r333b1418],
2	‘	CD	NUMBER	‘	num	3	SENT_417	[p12l309t1368r333b1418],
3	7.482353-37	CD	NUMBER	7.482353-37	dep	1	SENT_417	[p12l309t1198r332b1352],
4	'	''	O	'	_	0	SENT_417	[p12l309t1111r332b1138],
5	4	LS	NUMBER	4	dep	3	SENT_417	[p12l309t1111r332b1138],
6	.	.	O	.	_	0	SENT_417	[p12l309t1111r332b1138],

1	Downloaded	VBN	O	download	_	0	SENT_418	[p12l309t930r332b1100],
2	from	IN	O	from	_	0	SENT_418	[p12l309t856r332b921],
3	www.annualreviews.org	NN	O	www.annualreviews.org	nn	4	SENT_418	[p12l309t522r339b847],
4	Iadison	NN	O	iadison	prep_from	1	SENT_418	[p12l342t1039r366b1138],
5	on	IN	O	on	_	0	SENT_418	[p12l350t997r366b1029],
6	01/05/14	CD	DATE	01/05/14	prep_on	4	SENT_418	[p12l342t863r366b988],
7	.	.	O	.	_	0	SENT_418	[p12l342t863r366b988],

1	For	IN	O	for	_	0	SENT_419	[p12l343t806r366b853],
2	personal	JJ	O	personal	amod	3	SENT_419	[p12l342t686r373b798],
3	use	NN	O	use	pobj	1	SENT_419	[p12l350t633r366b677],
4	only	RB	O	only	advmod	3	SENT_419	[p12l342t558r373b623],
5	.	.	O	.	_	0	SENT_419	[p12l342t558r373b623],

1	w.annualreviews.org	NN	O	w.annualreviews.org	nn	3	SENT_420	[p12l309t2816r339b3093],
2	personal	JJ	O	personal	amod	3	SENT_420	[p12l342t2979r373b3092],
3	use	NN	O	use	nsubj	4	SENT_420	[p12l350t2926r366b2970],
4	only	RB	O	only	_	0	SENT_420	[p12l342t2851r373b2917],
5	.	.	O	.	_	0	SENT_420	[p12l342t2851r373b2917],

1	by	IN	O	by	dep	6	SENT_421	[p12l342t1606r373b1639],
2	I	PRP	O	I	dep	3	SENT_421	[p12l343t1583r366b1597],
3	Jniversity	NN	O	jniversity	pobj	1	SENT_421	[p12l342t1444r373b1569],
4	of	IN	O	of	_	0	SENT_421	[p12l342t1406r366b1434],
5	W	NNP	O	W	prep_of	3	SENT_421	[p12l343t1368r366b1399],
6	isconsin	NN	O	isconsin	_	0	SENT_421	[p12l342t1243r366b1351],
7	-	:	O	-	_	0	SENT_421	[p12l356t1225r359b1233],
8	IV	CD	NUMBER	iv	dep	6	SENT_421	[p12l343t1198r365b1215],

1	carcinoma	NN	O	carcinoma	_	0	SENT_422	[p12l550t36r727b66],
2	of	IN	O	of	_	0	SENT_422	[p12l738t36r774b66],
3	the	DT	O	the	det	4	SENT_422	[p12l782t36r833b66],
4	head	NN	O	head	prep_of	1	SENT_422	[p12l844t36r924b66],
5	and	CC	O	and	_	0	SENT_422	[p12l936t36r995b66],
6	neck	NN	O	neck	prep_of	1	SENT_422	[p12l1006t36r1094b66],
7	.	.	O	.	_	0	SENT_422	[p12l1006t36r1094b66],

1	In	IN	O	in	_	0	SENT_423	[p12l1108t37r1142b65],
2	one	CD	NUMBER	one	num	3	SENT_423	[p12l1154t45r1213b66],
3	phase	NN	O	phase	prep_in	12	SENT_423	[p12l1223t36r1320b74],
4	II	CD	NUMBER	ii	num	5	SENT_423	[p12l1332t37r1359b65],
5	trial	NN	O	trial	dep	3	SENT_423	[p12l1370t36r1448b71],
6	,	,	O	,	_	0	SENT_423	[p12l1370t36r1448b71],
7	43	CD	PERCENT	43	num	8	SENT_423	[p12l1460t36r1535b66],
8	%	NN	PERCENT	%	nsubj	12	SENT_423	[p12l1460t36r1535b66],
9	of	IN	O	of	_	0	SENT_423	[p12l1548t36r1585b66],
10	chemotherapynaive	JJ	O	chemotherapynaive	amod	11	SENT_423	[p12l1593t36r1847b74, p12l549t86r639b116],
11	patients	NNS	O	patient	prep_of	8	SENT_423	[p12l652t86r780b124],
12	responded	VBD	O	respond	_	0	SENT_423	[p12l794t86r964b124],
13	to	TO	O	to	_	0	SENT_423	[p12l977t91r1008b116],
14	paclitaxel	NN	O	paclitaxel	nn	15	SENT_423	[p12l1022t86r1182b124],
15	(	NN	O	(	prep_to	12	SENT_423	[p12l1197t86r1271b122],
16	250	CD	NUMBER	250	num	18	SENT_423	[p12l1197t86r1271b122],
17	mg/m2	NN	O	mg/m2	nn	18	SENT_423	[p12l1285t75r1409b124],
18	)	NN	O	)	dobj	12	SENT_423	[p12l1285t75r1409b124],
19	with	IN	O	with	_	0	SENT_423	[p12l1425t86r1497b116],
20	G	NN	O	g	prep_with	18	SENT_423	[p12l1511t86r1636b121],
21	.	.	O	.	_	0	SENT_423	[p12l1511t86r1636b121],

1	—	NN	O	—	_	0	SENT_424	[p12l1511t86r1636b121],
2	.	.	O	.	_	0	SENT_424	[p12l1511t86r1636b121],

1	CSF	NN	O	csf	nsubj	13	SENT_425	[p12l1511t86r1636b121],
2	,	,	O	,	_	0	SENT_425	[p12l1511t86r1636b121],
3	which	WDT	O	which	nsubj	4	SENT_425	[p12l1651t86r1751b116],
4	compares	VBZ	O	compare	rcmod	1	SENT_425	[p12l1765t96r1847b116, p12l549t145r635b174],
5	favorably	RB	O	favorably	advmod	4	SENT_425	[p12l655t136r812b174],
6	with	IN	O	with	_	0	SENT_425	[p12l832t136r904b166],
7	response	NN	O	response	nn	8	SENT_425	[p12l923t145r1067b174],
8	rates	NNS	O	rate	prep_with	4	SENT_425	[p12l1086t141r1163b166],
9	achieved	VBN	O	achieve	partmod	8	SENT_425	[p12l1184t136r1329b166],
10	with	IN	O	with	_	0	SENT_425	[p12l1348t136r1421b166],
11	standard	JJ	O	standard	amod	12	SENT_425	[p12l1442t136r1580b166],
12	agents	NNS	O	agent	prep_with	9	SENT_425	[p12l1599t141r1702b174],
13	(	VBP	O	(	_	0	SENT_425	[p12l1724t136r1798b172],
14	96	CD	NUMBER	96	number	15	SENT_425	[p12l1724t136r1798b172],
15	)	CD	NUMBER	)	dobj	13	SENT_425	[p12l1724t136r1798b172],
16	.	.	O	.	_	0	SENT_425	[p12l1724t136r1798b172],

1	A	DT	O	a	det	3	SENT_426	[p12l1819t136r1848b165],
2	response	NN	O	response	nn	3	SENT_426	[p12l549t195r693b224],
3	rate	NN	O	rate	nsubjpass	10	SENT_426	[p12l707t191r769b216],
4	of	IN	O	of	_	0	SENT_426	[p12l784t186r820b216],
5	26	CD	PERCENT	26	num	6	SENT_426	[p12l832t186r905b216],
6	%	NN	PERCENT	%	prep_of	3	SENT_426	[p12l832t186r905b216],
7	has	VBZ	O	have	aux	10	SENT_426	[p12l921t186r975b216],
8	also	RB	O	also	advmod	10	SENT_426	[p12l991t186r1056b216],
9	been	VBN	O	be	auxpass	10	SENT_426	[p12l1070t186r1148b216],
10	reported	VBN	O	report	_	0	SENT_426	[p12l1162t186r1300b224],
11	in	IN	O	in	_	0	SENT_426	[p12l1314t186r1346b215],
12	patients	NNS	O	patient	prep_in	10	SENT_426	[p12l1359t186r1487b224],
13	with	IN	O	with	_	0	SENT_426	[p12l1503t186r1575b216],
14	nasopharyngeal	JJ	O	nasopharyngeal	amod	18	SENT_426	[p12l1590t186r1848b224],
15	carcinoma	NN	O	carcinoma	nn	18	SENT_426	[p12l549t236r721b266],
16	(	NN	O	(	nn	18	SENT_426	[p12l731t236r806b272],
17	97	CD	NUMBER	97	num	18	SENT_426	[p12l731t236r806b272],
18	)	NN	O	)	prep_with	12	SENT_426	[p12l731t236r806b272],
19	.	.	O	.	_	0	SENT_426	[p12l731t236r806b272],

1	Additionally	RB	O	additionally	advmod	17	SENT_427	[p12l817t236r1034b274],
2	,	,	O	,	_	0	SENT_427	[p12l817t236r1034b274],
3	response	NN	O	response	nn	4	SENT_427	[p12l1044t245r1188b274],
4	rates	NNS	O	rate	nsubjpass	17	SENT_427	[p12l1197t241r1274b266],
5	ranging	VBG	O	range	partmod	4	SENT_427	[p12l1283t236r1409b274],
6	from	IN	O	from	_	0	SENT_427	[p12l1418t236r1498b266],
7	32-42	CD	PERCENT	32-42	num	8	SENT_427	[p12l1508t236r1642b266],
8	%	NN	PERCENT	%	prep_from	5	SENT_427	[p12l1508t236r1642b266],
9	in	IN	O	in	_	0	SENT_427	[p12l1653t236r1685b265],
10	advanced	JJ	O	advanced	amod	11	SENT_427	[p12l1694t236r1849b266],
11	head	NN	O	head	prep_in	8	SENT_427	[p12l549t286r627b315],
12	and	CC	O	and	_	0	SENT_427	[p12l638t286r696b315],
13	neck	NN	O	neck	nn	14	SENT_427	[p12l706t286r785b315],
14	cancer	NN	O	cancer	conj_and	11	SENT_427	[p12l794t295r902b315],
15	have	VBP	O	have	aux	17	SENT_427	[p12l911t286r988b315],
16	been	VBN	O	be	auxpass	17	SENT_427	[p12l999t286r1077b315],
17	reported	VBN	O	report	_	0	SENT_427	[p12l1086t286r1224b324],
18	with	IN	O	with	_	0	SENT_427	[p12l1235t286r1307b315],
19	docetaxel	NN	O	docetaxel	nn	20	SENT_427	[p12l1318t286r1476b315],
20	(	NN	O	(	prep_with	17	SENT_427	[p12l1487t286r1561b322],
21	100	CD	NUMBER	100	num	22	SENT_427	[p12l1487t286r1561b322],
22	mg/m2	NN	O	mg/m2	dep	20	SENT_427	[p12l1572t275r1697b324],
23	)	CD	NUMBER	)	number	24	SENT_427	[p12l1572t275r1697b324],
24	(	CD	NUMBER	(	dep	20	SENT_427	[p12l1710t286r1772b322],
25	98	CD	NUMBER	98	dep	24	SENT_427	[p12l1710t286r1772b322],
26	,	,	O	,	_	0	SENT_427	[p12l1710t286r1772b322],
27	99	CD	NUMBER	99	num	28	SENT_427	[p12l1785t286r1846b322],
28	)	NN	O	)	appos	20	SENT_427	[p12l1785t286r1846b322],
29	.	.	O	.	_	0	SENT_427	[p12l1785t286r1846b322],

1	Further	JJ	O	further	amod	2	SENT_428	[p12l549t336r671b366],
2	development	NN	O	development	nsubj	12	SENT_428	[p12l691t336r904b374],
3	of	IN	O	of	_	0	SENT_428	[p12l924t336r960b366],
4	the	DT	O	the	det	5	SENT_428	[p12l978t336r1027b366],
5	taxanes	NNS	O	taxane	prep_of	2	SENT_428	[p12l1048t341r1170b366],
6	in	IN	O	in	_	0	SENT_428	[p12l1191t336r1223b365],
7	head	NN	O	head	nn	10	SENT_428	[p12l1243t336r1320b366],
8	and	CC	O	and	_	0	SENT_428	[p12l1341t336r1400b366],
9	neck	NN	O	neck	nn	10	SENT_428	[p12l1420t336r1498b366],
10	cancer	NN	O	cancer	prep_in	5	SENT_428	[p12l1518t345r1625b366],
11	will	MD	O	will	aux	12	SENT_428	[p12l1644t336r1707b366],
12	include	VB	O	include	_	0	SENT_428	[p12l1728t336r1848b366],
13	assessments	NNS	O	assessment	dobj	12	SENT_428	[p12l550t391r747b416],
14	of	IN	O	of	_	0	SENT_428	[p12l762t386r797b416],
15	high	JJ	O	high	prep_of	13	SENT_428	[p12l806t386r879b424],
16	versus	CC	O	versus	prep	15	SENT_428	[p12l892t395r995b416],
17	low	JJ	O	low	amod	18	SENT_428	[p12l1009t386r1070b416],
18	doses	NNS	O	dose	dep	16	SENT_428	[p12l1083t386r1172b416],
19	of	IN	O	of	_	0	SENT_428	[p12l1186t386r1222b416],
20	the	DT	O	the	det	21	SENT_428	[p12l1231t386r1281b416],
21	taxanes	NNS	O	taxane	prep_of	15	SENT_428	[p12l1293t391r1415b416],
22	alone	RB	O	alone	dep	15	SENT_428	[p12l1429t386r1516b416],
23	and	CC	O	and	_	0	SENT_428	[p12l1529t386r1587b416],
24	in	IN	O	in	dep	15	SENT_428	[p12l1599t386r1630b415],
25	combination	NN	O	combination	nn	26	SENT_428	[p12l1643t386r1849b416],
26	regimens	NNS	O	regimen	pobj	24	SENT_428	[p12l549t436r699b474],
27	and	CC	O	and	_	0	SENT_428	[p12l715t436r774b465],
28	evaluations	NNS	O	evaluation	pobj	24	SENT_428	[p12l788t436r974b465],
29	of	IN	O	of	_	0	SENT_428	[p12l990t436r1026b465],
30	various	JJ	O	various	amod	31	SENT_428	[p12l1038t436r1158b465],
31	schedules	NNS	O	schedule	prep_of	13	SENT_428	[p12l1175t436r1332b465],
32	of	IN	O	of	_	0	SENT_428	[p12l1348t436r1384b465],
33	the	DT	O	the	det	34	SENT_428	[p12l1396t436r1445b465],
34	taxanes	NNS	O	taxane	prep_of	31	SENT_428	[p12l1460t441r1582b465],
35	in	IN	O	in	_	0	SENT_428	[p12l1597t436r1628b465],
36	combination	NN	O	combination	prep_in	34	SENT_428	[p12l1643t436r1849b465],
37	with	IN	O	with	_	0	SENT_428	[p12l549t486r622b515],
38	other	JJ	O	other	amod	40	SENT_428	[p12l634t486r718b515],
39	active	JJ	O	active	amod	40	SENT_428	[p12l730t486r826b515],
40	drugs	NNS	O	drug	prep_with	12	SENT_428	[p12l838t486r927b524],
41	such	JJ	O	such	_	0	SENT_428	[p12l941t486r1015b515],
42	as	IN	O	as	_	0	SENT_428	[p12l1027t495r1059b515],
43	the	DT	O	the	det	45	SENT_428	[p12l1071t486r1120b515],
44	platinum	NN	O	platinum	nn	45	SENT_428	[p12l1131t486r1279b524],
45	compounds	NNS	O	compound	prep_such_as	40	SENT_428	[p12l1290t486r1478b524],
46	and	CC	O	and	_	0	SENT_428	[p12l1491t486r1550b515],
47	5	CD	NUMBER	5	num	49	SENT_428	[p12l1562t486r1798b515],
48	—	NN	O	—	nn	49	SENT_428	[p12l1562t486r1798b515],
49	ﬂuorouracil	NN	O	ﬂuorouracil	prep_such_as	40	SENT_428	[p12l1562t486r1798b515],
50	.	.	O	.	_	0	SENT_428	[p12l1562t486r1798b515],

1	OTHER	JJ	O	other	amod	3	SENT_429	[p12l550t603r660b627],
2	CAN	NN	O	can	nn	3	SENT_429	[p12l667t603r736b627],
3	CERS	NN	O	cer	nsubj	44	SENT_429	[p12l737t603r817b627],
4	Although	IN	O	although	mark	8	SENT_429	[p12l857t597r1014b635],
5	the	DT	O	the	det	6	SENT_429	[p12l1023t597r1073b626],
6	taxanes	NNS	O	taxane	nsubj	8	SENT_429	[p12l1083t602r1205b626],
7	were	VBD	O	be	cop	8	SENT_429	[p12l1216t607r1295b627],
8	active	JJ	O	active	advcl	32	SENT_429	[p12l1306t597r1403b626],
9	in	IN	O	in	_	0	SENT_429	[p12l1412t597r1444b626],
10	melanoma	NN	O	melanoma	prep_in	8	SENT_429	[p12l1453t597r1625b626],
11	in	IN	O	in	_	0	SENT_429	[p12l1634t597r1666b626],
12	preclinical	JJ	O	preclinical	amod	13	SENT_429	[p12l1675t597r1849b635],
13	studies	NNS	O	study	prep_in	8	SENT_429	[p12l551t647r662b677],
14	and	CC	O	and	_	0	SENT_429	[p12l682t648r741b677],
15	activity	NN	O	activity	nsubjpass	17	SENT_429	[p12l760t647r882b685],
16	was	VBD	O	be	auxpass	17	SENT_429	[p12l900t657r962b677],
17	noted	VBN	O	note	advcl	32	SENT_429	[p12l982t647r1073b677],
18	in	IN	O	in	_	0	SENT_429	[p12l1091t647r1123b676],
19	phase	NN	O	phase	prep_in	17	SENT_429	[p12l1140t648r1234b685],
20	I	PRP	O	I	dep	21	SENT_429	[p12l1252t648r1265b676],
21	trials	NNS	O	trial	dep	19	SENT_429	[p12l1283t647r1374b682],
22	,	,	O	,	_	0	SENT_429	[p12l1283t647r1374b682],
23	marginal	JJ	O	marginal	amod	25	SENT_429	[p12l1393t647r1539b685],
24	response	NN	O	response	nn	25	SENT_429	[p12l1557t657r1701b685],
25	rates	NNS	O	rate	nsubj	32	SENT_429	[p12l1719t652r1796b677],
26	of	IN	O	of	_	0	SENT_429	[p12l1815t647r1851b676],
27	12-18	CD	PERCENT	12-18	num	28	SENT_429	[p12l553t698r684b727],
28	%	NN	PERCENT	%	prep_of	25	SENT_429	[p12l553t698r684b727],
29	and	CC	O	and	_	0	SENT_429	[p12l701t698r759b727],
30	13-17	CD	PERCENT	13-17	num	31	SENT_429	[p12l777t698r908b727],
31	%	NN	PERCENT	%	prep_of	25	SENT_429	[p12l777t698r908b727],
32	occurred	VBD	O	occur	rcmod	3	SENT_429	[p12l924t698r1068b727],
33	with	IN	O	with	_	0	SENT_429	[p12l1081t698r1154b727],
34	paclitaxel	NN	O	paclitaxel	prep_with	32	SENT_429	[p12l1167t698r1327b735],
35	and	CC	O	and	_	0	SENT_429	[p12l1342t698r1400b727],
36	docetaxel	NN	O	docetaxel	conj_and	34	SENT_429	[p12l1414t698r1580b732],
37	,	,	O	,	_	0	SENT_429	[p12l1414t698r1580b732],
38	respectively	RB	O	respectively	advmod	32	SENT_429	[p12l1594t698r1803b735],
39	,	,	O	,	_	0	SENT_429	[p12l1594t698r1803b735],
40	in	IN	O	in	_	0	SENT_429	[p12l1818t698r1849b726],
41	phase	NN	O	phase	nn	43	SENT_429	[p12l549t747r642b785],
42	II	CD	NUMBER	ii	num	43	SENT_429	[p12l656t748r683b776],
43	studies	NNS	O	study	prep_in	32	SENT_429	[p12l698t747r810b777],
44	(	VBP	O	(	_	0	SENT_429	[p12l826t748r867b783],
45	1	CD	NUMBER	1	dobj	44	SENT_429	[p12l826t748r867b783],
46	,	,	O	,	_	0	SENT_429	[p12l826t748r867b783],
47	21	CD	NUMBER	21	appos	45	SENT_429	[p12l883t748r931b782],
48	,	,	O	,	_	0	SENT_429	[p12l883t748r931b782],
49	100	CD	NUMBER	100	appos	45	SENT_429	[p12l951t748r1016b782],
50	,	,	O	,	_	0	SENT_429	[p12l951t748r1016b782],
51	101	CD	NUMBER	101	num	52	SENT_429	[p12l1036t748r1115b783],
52	)	NN	O	)	appos	45	SENT_429	[p12l1036t748r1115b783],
53	.	.	O	.	_	0	SENT_429	[p12l1036t748r1115b783],

1	Paclitaxel	NN	O	paclitaxel	nsubj	13	SENT_430	[p12l1131t747r1293b777],
2	was	VBD	O	be	cop	3	SENT_430	[p12l1306t757r1368b777],
3	inactive	JJ	O	inactive	dep	18	SENT_430	[p12l1383t747r1513b777],
4	in	IN	O	in	_	0	SENT_430	[p12l1526t747r1558b776],
5	colorectal	JJ	O	colorectal	prep_in	3	SENT_430	[p12l1572t747r1742b782],
6	,	,	O	,	_	0	SENT_430	[p12l1572t747r1742b782],
7	renal	JJ	O	renal	conj_and	3	SENT_430	[p12l1756t747r1847b782],
8	,	,	O	,	_	0	SENT_430	[p12l1756t747r1847b782],
9	prostate	NN	O	prostate	conj_and	3	SENT_430	[p12l549t802r688b835],
10	,	,	O	,	_	0	SENT_430	[p12l549t802r688b835],
11	pancreatic	JJ	O	pancreatic	conj_and	3	SENT_430	[p12l699t798r877b835],
12	,	,	O	,	_	0	SENT_430	[p12l699t798r877b835],
13	gastric	JJ	O	gastric	conj_and	3	SENT_430	[p12l889t798r1007b835],
14	,	,	O	,	_	0	SENT_430	[p12l889t798r1007b835],
15	and	CC	O	and	_	0	SENT_430	[p12l1019t798r1078b827],
16	brain	NN	O	brain	nn	17	SENT_430	[p12l1087t798r1172b827],
17	cancers	NNS	O	cancer	conj_and	3	SENT_430	[p12l1182t807r1304b827],
18	(	VBP	O	(	_	0	SENT_430	[p12l1316t798r1357b833],
19	1	CD	NUMBER	1	nsubj	18	SENT_430	[p12l1316t798r1357b833],
20	,	,	O	,	_	0	SENT_430	[p12l1316t798r1357b833],
21	21	CD	NUMBER	21	appos	19	SENT_430	[p12l1369t798r1418b832],
22	,	,	O	,	_	0	SENT_430	[p12l1369t798r1418b832],
23	102	CD	NUMBER	102	number	24	SENT_430	[p12l1434t798r1513b833],
24	)	CD	NUMBER	)	appos	21	SENT_430	[p12l1434t798r1513b833],
25	.	.	O	.	_	0	SENT_430	[p12l1434t798r1513b833],

1	Although	IN	O	although	mark	3	SENT_431	[p12l1525t798r1681b835],
2	docetaxel	NN	O	docetaxel	nsubj	3	SENT_431	[p12l1692t798r1849b827],
3	showed	VBD	O	show	advcl	23	SENT_431	[p12l551t848r675b877],
4	no	DT	O	no	det	5	SENT_431	[p12l686t857r726b877],
5	activity	NN	O	activity	dobj	3	SENT_431	[p12l738t848r860b885],
6	in	IN	O	in	_	0	SENT_431	[p12l871t848r902b877],
7	colorectal	JJ	O	colorectal	amod	10	SENT_431	[p12l913t848r1075b877],
8	and	CC	O	and	_	0	SENT_431	[p12l1086t848r1144b877],
9	renal	JJ	O	renal	conj_and	7	SENT_431	[p12l1154t848r1236b877],
10	cancers	NNS	O	cancer	prep_in	3	SENT_431	[p12l1248t857r1379b882],
11	,	,	O	,	_	0	SENT_431	[p12l1248t857r1379b882],
12	response	NN	O	response	nn	13	SENT_431	[p12l1391t857r1534b886],
13	rates	NNS	O	rate	nsubjpass	23	SENT_431	[p12l1545t852r1622b877],
14	ranging	VBG	O	range	partmod	13	SENT_431	[p12l1633t848r1758b885],
15	from	IN	O	from	_	0	SENT_431	[p12l1769t848r1849b877],
16	20-29	CD	PERCENT	20-29	num	17	SENT_431	[p12l550t898r684b927],
17	%	NN	PERCENT	%	prep_from	14	SENT_431	[p12l550t898r684b927],
18	and	CC	O	and	_	0	SENT_431	[p12l696t898r755b927],
19	14-24	CD	PERCENT	14-24	num	20	SENT_431	[p12l768t898r899b927],
20	%	NN	PERCENT	%	conj_and	17	SENT_431	[p12l768t898r899b927],
21	have	VBP	O	have	aux	23	SENT_431	[p12l910t898r987b927],
22	been	VBN	O	be	auxpass	23	SENT_431	[p12l996t898r1074b927],
23	noted	VBN	O	note	_	0	SENT_431	[p12l1083t898r1174b927],
24	in	IN	O	in	_	0	SENT_431	[p12l1183t898r1214b926],
25	pancreatic	JJ	O	pancreatic	amod	28	SENT_431	[p12l1223t898r1392b935],
26	and	CC	O	and	_	0	SENT_431	[p12l1402t898r1460b927],
27	gastric	JJ	O	gastric	conj_and	25	SENT_431	[p12l1470t898r1578b935],
28	cancers	NNS	O	cancer	prep_in	23	SENT_431	[p12l1588t907r1720b932],
29	,	,	O	,	_	0	SENT_431	[p12l1588t907r1720b932],
30	respectively	RB	O	respectively	dep	32	SENT_431	[p12l1730t907r1847b935, p12l549t948r642b985],
31	(	CD	NUMBER	(	num	32	SENT_431	[p12l653t948r715b984],
32	27	CD	NUMBER	27	dep	28	SENT_431	[p12l653t948r715b984],
33	,	,	O	,	_	0	SENT_431	[p12l653t948r715b984],
34	33	CD	NUMBER	33	appos	32	SENT_431	[p12l728t948r776b982],
35	,	,	O	,	_	0	SENT_431	[p12l728t948r776b982],
36	103-106	CD	NUMBER	103-106	num	37	SENT_431	[p12l791t948r953b983],
37	)	NN	O	)	appos	32	SENT_431	[p12l791t948r953b983],
38	.	.	O	.	_	0	SENT_431	[p12l791t948r953b983],

1	Interesting	JJ	O	interesting	ccomp	8	SENT_432	[p12l965t948r1150b985],
2	,	,	O	,	_	0	SENT_432	[p12l965t948r1150b985],
3	some	DT	O	some	det	6	SENT_432	[p12l1163t957r1247b977],
4	taxane-based	JJ	O	taxane-based	amod	6	SENT_432	[p12l1257t948r1473b977],
5	combination	NN	O	combination	nn	6	SENT_432	[p12l1482t948r1688b977],
6	regimens	NNS	O	regimen	nsubj	8	SENT_432	[p12l1697t948r1847b985],
7	have	VBP	O	have	aux	8	SENT_432	[p12l549t998r626b1027],
8	resulted	VBN	O	result	_	0	SENT_432	[p12l637t998r768b1027],
9	in	IN	O	in	_	0	SENT_432	[p12l779t998r810b1027],
10	impressive	JJ	O	impressive	amod	11	SENT_432	[p12l821t998r999b1036],
11	activity	NN	O	activity	prep_in	8	SENT_432	[p12l1011t998r1133b1036],
12	in	IN	O	in	_	0	SENT_432	[p12l1145t998r1176b1027],
13	cancers	NNS	O	cancer	prep_in	8	SENT_432	[p12l1188t1007r1310b1027],
14	that	WDT	O	that	nsubj	18	SENT_432	[p12l1320t998r1382b1027],
15	have	VBP	O	have	aux	18	SENT_432	[p12l1392t998r1469b1027],
16	not	RB	O	not	neg	18	SENT_432	[p12l1480t1003r1532b1027],
17	been	VBN	O	be	cop	18	SENT_432	[p12l1542t998r1620b1027],
18	responsive	JJ	O	responsive	rcmod	13	SENT_432	[p12l1630t998r1806b1036],
19	to	TO	O	to	_	0	SENT_432	[p12l1818t1002r1848b1027],
20	the	DT	O	the	det	21	SENT_432	[p12l549t1048r599b1077],
21	taxanes	NNS	O	taxane	prep_to	18	SENT_432	[p12l616t1052r739b1077],
22	alone	RB	O	alone	advmod	18	SENT_432	[p12l758t1048r855b1082],
23	,	,	O	,	_	0	SENT_432	[p12l758t1048r855b1082],
24	such	JJ	O	such	_	0	SENT_432	[p12l875t1048r949b1077],
25	as	IN	O	as	_	0	SENT_432	[p12l968t1057r999b1077],
26	paclitaxel	NN	O	paclitaxel	prep_such_as	13	SENT_432	[p12l1017t1048r1177b1085],
27	and	CC	O	and	_	0	SENT_432	[p12l1196t1048r1254b1077],
28	estramustine	NN	O	estramustine	prep_such_as	13	SENT_432	[p12l1272t1048r1480b1077],
29	in	IN	O	in	_	0	SENT_432	[p12l1497t1048r1528b1076],
30	advanced	JJ	O	advanced	amod	35	SENT_432	[p12l1547t1048r1702b1077],
31	prostate	NN	O	prostate	nn	35	SENT_432	[p12l1718t1052r1848b1085],
32	cancer	NN	O	cancer	nn	35	SENT_432	[p12l550t1107r657b1127],
33	(	NN	O	(	nn	35	SENT_432	[p12l674t1098r769b1134],
34	107	CD	NUMBER	107	num	35	SENT_432	[p12l674t1098r769b1134],
35	)	NN	O	)	prep_in	26	SENT_432	[p12l674t1098r769b1134],
36	.	.	O	.	_	0	SENT_432	[p12l674t1098r769b1134],

1	Both	DT	O	both	preconj	2	SENT_433	[p12l788t1098r867b1127],
2	paclitaxel	NN	O	paclitaxel	nsubj	5	SENT_433	[p12l884t1098r1044b1136],
3	and	CC	O	and	_	0	SENT_433	[p12l1061t1098r1119b1127],
4	docetaxel	NN	O	docetaxel	conj_and	2	SENT_433	[p12l1136t1098r1293b1127],
5	appear	VBP	O	appear	_	0	SENT_433	[p12l1310t1107r1419b1136],
6	to	TO	O	to	aux	9	SENT_433	[p12l1434t1102r1465b1127],
7	be	VB	O	be	cop	9	SENT_433	[p12l1481t1098r1520b1127],
8	modestly	RB	O	modestly	advmod	9	SENT_433	[p12l1536t1098r1686b1136],
9	active	JJ	O	active	xcomp	5	SENT_433	[p12l1704t1098r1801b1127],
10	in	IN	O	in	_	0	SENT_433	[p12l1818t1098r1849b1127],
11	locally	RB	O	locally	advmod	12	SENT_433	[p12l549t1208r660b1246],
12	recurrent	JJ	O	recurrent	amod	17	SENT_433	[p12l678t1213r827b1237],
13	or	CC	O	or	_	0	SENT_433	[p12l845t1217r878b1237],
14	metastatic	JJ	O	metastatic	amod	15	SENT_433	[p12l896t1208r1062b1237],
15	squamous	JJ	O	squamous	conj_or	12	SENT_433	[p12l1081t1217r1243b1246],
16	cell	NN	O	cell	nn	17	SENT_433	[p12l1263t1208r1321b1237],
17	carcinoma	NN	O	carcinoma	prep_in	9	SENT_433	[p12l1339t1208r1511b1237],
18	of	IN	O	of	_	0	SENT_433	[p12l1528t1208r1564b1237],
19	the	DT	O	the	det	20	SENT_433	[p12l1579t1208r1628b1237],
20	cervix	NN	O	cervix	prep_of	17	SENT_433	[p12l1646t1208r1757b1243],
21	,	,	O	,	_	0	SENT_433	[p12l1646t1208r1757b1243],
22	with	IN	O	with	_	0	SENT_433	[p12l1776t1208r1848b1237],
23	response	NN	O	response	nn	24	SENT_433	[p12l549t1267r693b1296],
24	rates	NNS	O	rate	prep_with	9	SENT_433	[p12l705t1263r781b1287],
25	of	IN	O	of	_	0	SENT_433	[p12l794t1258r830b1287],
26	17	CD	NUMBER	17	prep_of	24	SENT_433	[p12l843t1259r878b1287],
27	and	CC	O	and	_	0	SENT_433	[p12l891t1258r950b1287],
28	14	CD	PERCENT	14	num	29	SENT_433	[p12l965t1258r1044b1293],
29	%	NN	PERCENT	%	conj_and	26	SENT_433	[p12l965t1258r1044b1293],
30	,	,	O	,	_	0	SENT_433	[p12l965t1258r1044b1293],
31	respectively	RB	O	respectively	dep	33	SENT_433	[p12l1057t1258r1256b1296],
32	(	CD	NUMBER	(	num	33	SENT_433	[p12l1269t1258r1352b1294],
33	108	CD	NUMBER	108	dep	9	SENT_433	[p12l1269t1258r1352b1294],
34	,	,	O	,	_	0	SENT_433	[p12l1269t1258r1352b1294],
35	109	CD	NUMBER	109	num	36	SENT_433	[p12l1369t1258r1448b1294],
36	)	NN	O	)	appos	33	SENT_433	[p12l1369t1258r1448b1294],
37	.	.	O	.	_	0	SENT_433	[p12l1369t1258r1448b1294],

1	A	DT	O	a	det	4	SENT_434	[p12l1461t1258r1490b1287],
2	modest	JJ	O	modest	amod	4	SENT_434	[p12l1502t1258r1621b1287],
3	response	NN	O	response	nn	4	SENT_434	[p12l1632t1267r1776b1296],
4	rate	NN	O	rate	nsubjpass	10	SENT_434	[p12l1787t1262r1849b1287],
5	of	IN	O	of	_	0	SENT_434	[p12l550t1308r586b1337],
6	17	CD	PERCENT	17	num	7	SENT_434	[p12l600t1308r669b1337],
7	%	NN	PERCENT	%	prep_of	4	SENT_434	[p12l600t1308r669b1337],
8	has	VBZ	O	have	aux	10	SENT_434	[p12l683t1308r737b1337],
9	been	VBN	O	be	auxpass	10	SENT_434	[p12l750t1308r828b1337],
10	reported	VBN	O	report	_	0	SENT_434	[p12l840t1308r978b1346],
11	with	IN	O	with	_	0	SENT_434	[p12l991t1308r1063b1337],
12	paclitaxel	NN	O	paclitaxel	prep_with	10	SENT_434	[p12l1076t1308r1236b1346],
13	in	IN	O	in	_	0	SENT_434	[p12l1249t1308r1280b1337],
14	non	JJ	O	non	prep_in	10	SENT_434	[p12l1293t1308r1543b1346],
15	.	.	O	.	_	0	SENT_434	[p12l1293t1308r1543b1346],

1	—	NN	O	—	_	0	SENT_435	[p12l1293t1308r1543b1346],
2	.	.	O	.	_	0	SENT_435	[p12l1293t1308r1543b1346],

1	Hodgkin	NN	PERSON	hodgkin	poss	3	SENT_436	[p12l1293t1308r1543b1346],
2	’s	POS	O	’s	_	0	SENT_436	[p12l1293t1308r1543b1346],
3	lymphoma	NN	O	lymphoma	nsubj	15	SENT_436	[p12l1557t1308r1734b1346],
4	in	IN	O	in	_	0	SENT_436	[p12l1746t1308r1777b1337],
5	one	CD	NUMBER	one	num	6	SENT_436	[p12l1790t1317r1848b1337],
6	study	NN	O	study	prep_in	3	SENT_436	[p12l551t1374r647b1412],
7	,	,	O	,	_	0	SENT_436	[p12l551t1374r647b1412],
8	whereas	IN	O	whereas	mark	9	SENT_436	[p12l661t1374r794b1403],
9	14	CD	NUMBER	14	dep	6	SENT_436	[p12l811t1374r847b1403],
10	and	CC	O	and	_	0	SENT_436	[p12l860t1374r919b1403],
11	29	CD	PERCENT	29	num	12	SENT_436	[p12l931t1374r1003b1403],
12	%	NN	PERCENT	%	nsubj	15	SENT_436	[p12l931t1374r1003b1403],
13	of	IN	O	of	_	0	SENT_436	[p12l1018t1374r1054b1403],
14	primary	JJ	O	primary	prep_of	12	SENT_436	[p12l1062t1374r1192b1412],
15	refractory	JJ	O	refractory	_	0	SENT_436	[p12l1205t1374r1367b1412],
16	and	CC	O	and	_	0	SENT_436	[p12l1379t1374r1438b1403],
17	relapsed	VBD	O	relapse	conj_and	15	SENT_436	[p12l1449t1374r1587b1412],
18	non	JJ	O	non	acomp	17	SENT_436	[p12l1598t1374r1847b1412],
19	.	.	O	.	_	0	SENT_436	[p12l1598t1374r1847b1412],

1	—	NN	O	—	_	0	SENT_437	[p12l1598t1374r1847b1412],
2	.	.	O	.	_	0	SENT_437	[p12l1598t1374r1847b1412],

1	Hodgkin	NN	PERSON	hodgkin	poss	3	SENT_438	[p12l1598t1374r1847b1412],
2	’s	POS	O	’s	_	0	SENT_438	[p12l1598t1374r1847b1412],
3	lymphomas	NNS	O	lymphoma	nsubj	7	SENT_438	[p12l549t1423r751b1461],
4	,	,	O	,	_	0	SENT_438	[p12l549t1423r751b1461],
5	respectively	RB	O	respectively	advmod	7	SENT_438	[p12l763t1423r971b1461],
6	,	,	O	,	_	0	SENT_438	[p12l763t1423r971b1461],
7	responded	VBD	O	respond	_	0	SENT_438	[p12l983t1423r1153b1461],
8	in	IN	O	in	_	0	SENT_438	[p12l1164t1423r1195b1452],
9	another	DT	O	another	det	11	SENT_438	[p12l1208t1423r1331b1452],
10	trial	NN	O	trial	nn	11	SENT_438	[p12l1341t1423r1407b1452],
11	(	NN	O	(	prep_in	7	SENT_438	[p12l1419t1424r1501b1459],
12	110	CD	NUMBER	110	tmod	7	SENT_438	[p12l1419t1424r1501b1459],
13	,	,	O	,	_	0	SENT_438	[p12l1419t1424r1501b1459],
14	111	CD	NUMBER	111	num	15	SENT_438	[p12l1518t1424r1597b1459],
15	)	NN	O	)	appos	12	SENT_438	[p12l1518t1424r1597b1459],
16	.	.	O	.	_	0	SENT_438	[p12l1518t1424r1597b1459],

1	Beneficial	NNP	O	Beneficial	nn	2	SENT_439	[p12l599t1474r768b1503],
2	effects	NNS	O	effect	nsubjpass	6	SENT_439	[p12l781t1474r889b1503],
3	have	VBP	O	have	aux	6	SENT_439	[p12l902t1474r979b1503],
4	also	RB	O	also	advmod	6	SENT_439	[p12l992t1474r1057b1503],
5	been	VBN	O	be	auxpass	6	SENT_439	[p12l1069t1474r1147b1503],
6	noted	VBN	O	note	_	0	SENT_439	[p12l1159t1474r1250b1503],
7	with	IN	O	with	_	0	SENT_439	[p12l1262t1474r1335b1503],
8	paclitaxel	NN	O	paclitaxel	nn	12	SENT_439	[p12l1347t1474r1507b1512],
9	(	CD	NUMBER	(	num	12	SENT_439	[p12l1520t1474r1608b1510],
10	24-h	JJ	O	24-h	amod	12	SENT_439	[p12l1520t1474r1608b1510],
11	schedule	NN	O	schedule	nn	12	SENT_439	[p12l1621t1474r1776b1510],
12	)	NN	O	)	prep_with	6	SENT_439	[p12l1621t1474r1776b1510],
13	and	CC	O	and	_	0	SENT_439	[p12l1791t1474r1849b1503],
14	G	NN	O	g	conj_and	12	SENT_439	[p12l550t1524r666b1553],
15	.	.	O	.	_	0	SENT_439	[p12l550t1524r666b1553],

1	—	NN	O	—	_	0	SENT_440	[p12l550t1524r666b1553],
2	.	.	O	.	_	0	SENT_440	[p12l550t1524r666b1553],

1	CSF	NN	O	csf	_	0	SENT_441	[p12l550t1524r666b1553],
2	in	IN	O	in	_	0	SENT_441	[p12l684t1524r715b1553],
3	patients	NNS	O	patient	prep_in	1	SENT_441	[p12l732t1524r860b1562],
4	with	IN	O	with	_	0	SENT_441	[p12l879t1524r951b1553],
5	germ	NN	O	germ	nn	6	SENT_441	[p12l970t1533r1054b1562],
6	cell	NN	O	cell	prep_with	1	SENT_441	[p12l1072t1524r1139b1558],
7	,	,	O	,	_	0	SENT_441	[p12l1072t1524r1139b1558],
8	bladder	NN	O	bladder	prep_with	1	SENT_441	[p12l1158t1524r1290b1558],
9	,	,	O	,	_	0	SENT_441	[p12l1158t1524r1290b1558],
10	and	CC	O	and	_	0	SENT_441	[p12l1310t1524r1369b1553],
11	esophageal	NN	O	esophageal	nn	12	SENT_441	[p12l1387t1524r1569b1562],
12	cancers	NNS	O	cancer	conj_and	6	SENT_441	[p12l1588t1533r1719b1553],
13	.	.	O	.	_	0	SENT_441	[p12l1588t1533r1719b1553],

1	In	IN	O	in	_	0	SENT_442	[p12l1738t1525r1772b1553],
2	one	CD	NUMBER	one	num	3	SENT_442	[p12l1790t1533r1848b1553],
3	study	NN	O	study	prep_in	17	SENT_442	[p12l551t1588r647b1626],
4	,	,	O	,	_	0	SENT_442	[p12l551t1588r647b1626],
5	42	CD	PERCENT	42	num	6	SENT_442	[p12l659t1588r732b1618],
6	%	NN	PERCENT	%	nsubj	17	SENT_442	[p12l659t1588r732b1618],
7	of	IN	O	of	_	0	SENT_442	[p12l745t1588r781b1617],
8	patients	NNS	O	patient	prep_of	6	SENT_442	[p12l788t1588r915b1626],
9	with	IN	O	with	_	0	SENT_442	[p12l927t1588r1000b1618],
10	advanced	JJ	O	advanced	amod	13	SENT_442	[p12l1011t1588r1166b1617],
11	transitional	JJ	O	transitional	amod	13	SENT_442	[p12l1176t1588r1361b1617],
12	cell	NN	O	cell	nn	13	SENT_442	[p12l1372t1588r1430b1617],
13	carcinoma	NN	O	carcinoma	prep_with	8	SENT_442	[p12l1441t1588r1612b1617],
14	of	IN	O	of	_	0	SENT_442	[p12l1622t1588r1658b1617],
15	the	DT	O	the	det	16	SENT_442	[p12l1666t1588r1715b1617],
16	bladder	NN	O	bladder	prep_of	13	SENT_442	[p12l1725t1588r1849b1617],
17	responded	VBD	O	respond	_	0	SENT_442	[p12l549t1639r719b1676],
18	(	CD	NUMBER	(	number	19	SENT_442	[p12l738t1639r834b1674],
19	112	CD	NUMBER	112	num	20	SENT_442	[p12l738t1639r834b1674],
20	)	NN	O	)	dobj	17	SENT_442	[p12l738t1639r834b1674],
21	.	.	O	.	_	0	SENT_442	[p12l738t1639r834b1674],

1	A	DT	O	a	det	5	SENT_443	[p12l854t1639r883b1667],
2	32	CD	PERCENT	32	number	3	SENT_443	[p12l902t1639r974b1668],
3	%	NN	PERCENT	%	amod	5	SENT_443	[p12l902t1639r974b1668],
4	response	NN	O	response	nn	5	SENT_443	[p12l994t1648r1138b1676],
5	rate	NN	O	rate	nsubjpass	8	SENT_443	[p12l1157t1643r1218b1668],
6	was	VBD	O	be	auxpass	8	SENT_443	[p12l1236t1648r1298b1668],
7	also	RB	O	also	advmod	8	SENT_443	[p12l1319t1639r1383b1668],
8	noted	VBN	O	note	_	0	SENT_443	[p12l1402t1639r1493b1668],
9	in	IN	O	in	_	0	SENT_443	[p12l1511t1639r1542b1667],
10	patients	NNS	O	patient	prep_in	8	SENT_443	[p12l1560t1639r1687b1676],
11	with	IN	O	with	_	0	SENT_443	[p12l1706t1639r1779b1668],
12	advanced	JJ	O	advanced	amod	14	SENT_443	[p12l1798t1639r1847b1668, p12l549t1688r666b1717],
13	esophageal	JJ	O	esophageal	amod	14	SENT_443	[p12l677t1688r860b1726],
14	carcinoma	NN	O	carcinoma	prep_with	8	SENT_443	[p12l871t1688r1051b1723],
15	,	,	O	,	_	0	SENT_443	[p12l871t1688r1051b1723],
16	despite	IN	O	despite	_	0	SENT_443	[p12l1064t1688r1180b1726],
17	a	DT	O	a	det	19	SENT_443	[p12l1193t1697r1210b1717],
18	low	JJ	O	low	amod	19	SENT_443	[p12l1221t1688r1281b1717],
19	level	NN	O	level	prep_despite	8	SENT_443	[p12l1293t1688r1372b1717],
20	of	IN	O	of	_	0	SENT_443	[p12l1384t1688r1420b1717],
21	activity	NN	O	activity	prep_of	19	SENT_443	[p12l1429t1688r1551b1726],
22	with	IN	O	with	_	0	SENT_443	[p12l1563t1688r1635b1717],
23	paclitaxel	NN	O	paclitaxel	prep_with	21	SENT_443	[p12l1646t1688r1806b1726],
24	in	IN	O	in	_	0	SENT_443	[p12l1817t1688r1849b1717],
25	other	JJ	O	other	amod	27	SENT_443	[p12l550t1738r634b1768],
26	gastrointestinal	JJ	O	gastrointestinal	amod	27	SENT_443	[p12l646t1738r897b1776],
27	cancers	NNS	O	cancer	prep_in	23	SENT_443	[p12l910t1747r1032b1768],
28	(	VBP	O	(	rcmod	27	SENT_443	[p12l1046t1738r1141b1774],
29	113	CD	NUMBER	113	number	30	SENT_443	[p12l1046t1738r1141b1774],
30	)	CD	NUMBER	)	dobj	28	SENT_443	[p12l1046t1738r1141b1774],
31	.	.	O	.	_	0	SENT_443	[p12l1046t1738r1141b1774],

1	In	IN	O	in	_	0	SENT_444	[p12l1156t1739r1189b1767],
2	addition	NN	O	addition	prep_in	11	SENT_444	[p12l1203t1738r1345b1773],
3	,	,	O	,	_	0	SENT_444	[p12l1203t1738r1345b1773],
4	a	DT	O	a	det	8	SENT_444	[p12l1360t1747r1377b1768],
5	24	CD	PERCENT	24	number	6	SENT_444	[p12l1389t1738r1462b1768],
6	%	NN	PERCENT	%	amod	8	SENT_444	[p12l1389t1738r1462b1768],
7	response	NN	O	response	nn	8	SENT_444	[p12l1475t1747r1620b1776],
8	rate	NN	O	rate	nsubjpass	11	SENT_444	[p12l1632t1743r1693b1768],
9	has	VBZ	O	have	aux	11	SENT_444	[p12l1705t1738r1758b1768],
10	been	VBN	O	be	auxpass	11	SENT_444	[p12l1771t1738r1849b1768],
11	observed	VBN	O	observe	_	0	SENT_444	[p12l550t1788r698b1818],
12	in	IN	O	in	_	0	SENT_444	[p12l719t1788r751b1817],
13	patients	NNS	O	patient	prep_in	11	SENT_444	[p12l772t1788r899b1826],
14	with	IN	O	with	_	0	SENT_444	[p12l922t1788r995b1818],
15	cisp1atin	NN	O	cisp1atin	npadvmod	17	SENT_444	[p12l1015t1788r1306b1826],
16	—	CD	NUMBER	—	num	15	SENT_444	[p12l1015t1788r1306b1826],
17	resistant	JJ	O	resistant	amod	18	SENT_444	[p12l1015t1788r1306b1826],
18	germ	NN	O	germ	prep_with	11	SENT_444	[p12l1327t1797r1411b1826],
19	cell	NN	O	cell	nn	20	SENT_444	[p12l1432t1788r1490b1818],
20	malignancies	NNS	O	malignancy	nsubj	21	SENT_444	[p12l1511t1788r1728b1826],
21	(	VBP	O	(	rcmod	18	SENT_444	[p12l1752t1788r1847b1824],
22	114	CD	NUMBER	114	number	23	SENT_444	[p12l1752t1788r1847b1824],
23	)	CD	NUMBER	)	dobj	21	SENT_444	[p12l1752t1788r1847b1824],
24	.	.	O	.	_	0	SENT_444	[p12l1752t1788r1847b1824],

1	Although	IN	O	although	mark	4	SENT_445	[p12l549t1838r705b1876],
2	phase	NN	O	phase	nsubj	4	SENT_445	[p12l717t1838r811b1876],
3	II	CD	NUMBER	ii	num	2	SENT_445	[p12l824t1839r850b1867],
4	results	VBZ	O	result	advcl	21	SENT_445	[p12l863t1838r969b1867],
5	with	IN	O	with	mark	13	SENT_445	[p12l983t1838r1056b1867],
6	docetaxel	NN	O	docetaxel	nsubj	13	SENT_445	[p12l1069t1838r1226b1867],
7	in	IN	O	in	_	0	SENT_445	[p12l1238t1838r1270b1867],
8	these	DT	O	these	det	10	SENT_445	[p12l1283t1838r1366b1867],
9	tumor	NN	O	tumor	nn	10	SENT_445	[p12l1379t1843r1478b1867],
10	types	NNS	O	type	prep_in	6	SENT_445	[p12l1490t1842r1575b1876],
11	are	VBP	O	be	cop	13	SENT_445	[p12l1590t1847r1638b1867],
12	less	RBR	O	less	advmod	13	SENT_445	[p12l1651t1838r1711b1867],
13	mature	JJ	O	mature	advcl	4	SENT_445	[p12l1724t1842r1847b1873],
14	,	,	O	,	_	0	SENT_445	[p12l1724t1842r1847b1873],
15	docetaxel	JJ	O	docetaxel	amod	16	SENT_445	[p12l550t1888r707b1918],
16	doses	NNS	O	dose	nsubj	21	SENT_445	[p12l719t1888r809b1918],
17	of	IN	O	of	_	0	SENT_445	[p12l823t1888r859b1918],
18	100	CD	NUMBER	100	num	19	SENT_445	[p12l873t1888r930b1918],
19	mg/m2	NN	O	mg/m2	prep_of	16	SENT_445	[p12l942t1877r1054b1926],
20	have	VBP	O	have	aux	21	SENT_445	[p12l1067t1888r1144b1918],
21	demonstrated	VBN	O	demonstrate	_	0	SENT_445	[p12l1156t1888r1379b1918],
22	an	DT	O	a	det	25	SENT_445	[p12l1391t1898r1429b1918],
23	impressive	JJ	O	impressive	amod	25	SENT_445	[p12l1441t1888r1619b1926],
24	response	NN	O	response	nn	25	SENT_445	[p12l1631t1898r1775b1926],
25	rate	NN	O	rate	dobj	21	SENT_445	[p12l1787t1893r1848b1918],
26	of	IN	O	of	_	0	SENT_445	[p12l550t1938r585b1968],
27	50	CD	PERCENT	50	num	28	SENT_445	[p12l598t1938r670b1968],
28	%	NN	PERCENT	%	prep_of	25	SENT_445	[p12l598t1938r670b1968],
29	in	IN	O	in	_	0	SENT_445	[p12l686t1938r717b1967],
30	previously	RB	DATE	previously	advmod	31	SENT_445	[p12l731t1938r905b1976],
31	untreated	JJ	O	untreated	amod	32	SENT_445	[p12l919t1938r1073b1968],
32	patients	NNS	O	patient	prep_in	28	SENT_445	[p12l1086t1938r1213b1976],
33	with	IN	O	with	_	0	SENT_445	[p12l1228t1938r1301b1968],
34	advanced	JJ	O	advanced	amod	37	SENT_445	[p12l1316t1938r1470b1968],
35	transitional	JJ	O	transitional	amod	37	SENT_445	[p12l1484t1938r1669b1968],
36	cell	NN	O	cell	nn	37	SENT_445	[p12l1684t1938r1742b1968],
37	carcinoma	NN	O	carcinoma	prep_with	21	SENT_445	[p12l1756t1938r1847b1968, p12l549t1997r641b2017],
38	of	IN	O	of	_	0	SENT_445	[p12l656t1988r692b2017],
39	the	DT	O	the	det	43	SENT_445	[p12l704t1988r753b2017],
40	bladder	NN	O	bladder	nn	43	SENT_445	[p12l768t1988r893b2017],
41	(	NN	O	(	nn	43	SENT_445	[p12l909t1988r1004b2024],
42	115	CD	NUMBER	115	num	43	SENT_445	[p12l909t1988r1004b2024],
43	)	NN	O	)	prep_of	37	SENT_445	[p12l909t1988r1004b2024],
44	.	.	O	.	_	0	SENT_445	[p12l909t1988r1004b2024],

1	The	DT	O	the	det	2	SENT_446	[p12l1022t1988r1085b2017],
2	agent	NN	O	agent	nsubj	5	SENT_446	[p12l1101t1993r1189b2026],
3	has	VBZ	O	have	aux	5	SENT_446	[p12l1203t1988r1257b2017],
4	also	RB	O	also	advmod	5	SENT_446	[p12l1274t1988r1339b2017],
5	demonstrated	VBN	O	demonstrate	_	0	SENT_446	[p12l1355t1988r1577b2017],
6	modest	JJ	O	modest	amod	10	SENT_446	[p12l1592t1988r1711b2017],
7	activity	NN	O	activity	nn	10	SENT_446	[p12l1727t1988r1848b2026],
8	(	NN	O	(	nn	10	SENT_446	[p12l550t2039r707b2076],
9	response	NN	O	response	nn	10	SENT_446	[p12l550t2039r707b2076],
10	rate	NN	O	rate	dobj	5	SENT_446	[p12l725t2043r796b2073],
11	,	,	O	,	_	0	SENT_446	[p12l725t2043r796b2073],
12	18	CD	PERCENT	18	num	13	SENT_446	[p12l819t2038r903b2074],
13	%	NN	PERCENT	%	appos	10	SENT_446	[p12l819t2038r903b2074],
14	)	CD	NUMBER	)	dep	13	SENT_446	[p12l819t2038r903b2074],
15	as	IN	O	as	mark	44	SENT_446	[p12l924t2047r956b2068],
16	second	JJ	ORDINAL	second	amod	19	SENT_446	[p12l977t2038r1165b2068],
17	—	NN	O	—	nn	19	SENT_446	[p12l977t2038r1165b2068],
18	line	NN	O	line	nn	19	SENT_446	[p12l977t2038r1165b2068],
19	therapy	NN	O	therapy	nsubjpass	44	SENT_446	[p12l1184t2038r1307b2076],
20	in	IN	O	in	_	0	SENT_446	[p12l1325t2038r1357b2067],
21	patients	NNS	O	patient	prep_in	19	SENT_446	[p12l1375t2038r1502b2076],
22	with	IN	O	with	_	0	SENT_446	[p12l1522t2038r1595b2068],
23	advanced	JJ	O	advanced	amod	26	SENT_446	[p12l1614t2038r1769b2068],
24	soft	JJ	O	soft	amod	26	SENT_446	[p12l1789t2038r1849b2068],
25	tissue	NN	O	tissue	nn	26	SENT_446	[p12l549t2088r642b2118],
26	sarcoma	NN	O	sarcoma	prep_with	21	SENT_446	[p12l657t2097r794b2118],
27	(	CD	NUMBER	(	number	28	SENT_446	[p12l808t2088r904b2124],
28	116	CD	NUMBER	116	num	29	SENT_446	[p12l808t2088r904b2124],
29	)	NN	O	)	dep	26	SENT_446	[p12l808t2088r904b2124],
30	,	,	O	,	_	0	SENT_446	[p12l808t2088r904b2124],
31	whereas	IN	O	whereas	mark	38	SENT_446	[p12l919t2088r1052b2118],
32	impressive	JJ	O	impressive	amod	33	SENT_446	[p12l1067t2088r1245b2126],
33	activity	NN	O	activity	dep	38	SENT_446	[p12l1260t2088r1382b2126],
34	with	IN	O	with	_	0	SENT_446	[p12l1396t2088r1468b2118],
35	response	NN	O	response	nn	36	SENT_446	[p12l1481t2097r1625b2126],
36	rates	NNS	O	rate	prep_with	33	SENT_446	[p12l1638t2093r1715b2118],
37	as	RB	O	as	advmod	38	SENT_446	[p12l1730t2097r1761b2118],
38	high	JJ	O	high	dep	26	SENT_446	[p12l1775t2088r1848b2126],
39	as	IN	O	as	_	0	SENT_446	[p12l550t2147r582b2167],
40	53	CD	PERCENT	53	num	41	SENT_446	[p12l598t2138r670b2168],
41	%	NN	PERCENT	%	prep_as	38	SENT_446	[p12l598t2138r670b2168],
42	has	VBZ	O	have	aux	44	SENT_446	[p12l686t2138r740b2167],
43	been	VBN	O	be	auxpass	44	SENT_446	[p12l755t2138r832b2167],
44	reported	VBN	O	report	advcl	5	SENT_446	[p12l846t2138r984b2176],
45	with	IN	O	with	_	0	SENT_446	[p12l997t2138r1070b2167],
46	paclitaxel	NN	O	paclitaxel	prep_with	44	SENT_446	[p12l1084t2138r1244b2176],
47	in	IN	O	in	_	0	SENT_446	[p12l1258t2138r1289b2167],
48	patients	NNS	O	patient	prep_in	44	SENT_446	[p12l1303t2138r1430b2176],
49	with	IN	O	with	_	0	SENT_446	[p12l1446t2138r1518b2167],
50	advanced	JJ	O	advanced	amod	51	SENT_446	[p12l1533t2138r1688b2167],
51	Kaposi	NN	PERSON	kaposus	poss	56	SENT_446	[p12l1702t2138r1847b2176],
52	’s	POS	O	’s	_	0	SENT_446	[p12l1702t2138r1847b2176],
53	sarcoma	NN	O	sarcoma	nn	56	SENT_446	[p12l551t2197r687b2217],
54	(	NN	O	(	nn	56	SENT_446	[p12l699t2188r794b2224],
55	117	CD	NUMBER	117	num	56	SENT_446	[p12l699t2188r794b2224],
56	)	NN	O	)	prep_with	48	SENT_446	[p12l699t2188r794b2224],
57	.	.	O	.	_	0	SENT_446	[p12l699t2188r794b2224],

1	370	CD	NUMBER	370	_	0	SENT_447	[p12l550t2245r604b2271],
2	ROWIN	NNP	O	ROWIN	dep	1	SENT_447	[p12l643t2245r769b2271],
3	SKY	NNS	O	sky	dep	1	SENT_447	[p12l770t2245r843b2271],

1	FUTURE	JJ	DATE	future	amod	2	SENT_448	[p12l549t2332r742b2367],
2	DIRECTIONS	NNS	O	direction	_	0	SENT_448	[p12l756t2332r1048b2367],

1	The	DT	O	the	det	3	SENT_449	[p12l549t2417r612b2447],
2	antitumor	NN	O	antitumor	nn	3	SENT_449	[p12l626t2417r786b2447],
3	spectrum	NN	O	spectrum	nsubj	7	SENT_449	[p12l799t2422r949b2455],
4	of	IN	O	of	_	0	SENT_449	[p12l962t2417r998b2447],
5	the	DT	O	the	det	6	SENT_449	[p12l1008t2417r1057b2447],
6	taxanes	NNS	O	taxane	prep_of	3	SENT_449	[p12l1070t2422r1192b2447],
7	appears	VBZ	O	appear	_	0	SENT_449	[p12l1207t2426r1330b2455],
8	to	TO	O	to	aux	11	SENT_449	[p12l1344t2422r1374b2447],
9	be	VB	O	be	cop	11	SENT_449	[p12l1387t2417r1425b2447],
10	the	DT	O	the	det	11	SENT_449	[p12l1438t2417r1487b2447],
11	broadest	JJS	O	broadest	xcomp	7	SENT_449	[p12l1499t2417r1640b2447],
12	of	IN	O	of	_	0	SENT_449	[p12l1652t2417r1688b2447],
13	any	DT	O	any	det	14	SENT_449	[p12l1698t2426r1756b2455],
14	class	NN	O	class	prep_of	11	SENT_449	[p12l1769t2417r1847b2447],
15	of	IN	O	of	_	0	SENT_449	[p12l550t2467r585b2497],
16	anticancer	JJ	O	anticancer	amod	17	SENT_449	[p12l596t2467r765b2497],
17	agents	NNS	O	agent	prep_of	14	SENT_449	[p12l777t2472r889b2505],
18	.	.	O	.	_	0	SENT_449	[p12l777t2472r889b2505],

1	The	DT	O	the	det	2	SENT_450	[p12l904t2467r967b2497],
2	demonstration	NN	O	demonstration	nsubj	15	SENT_450	[p12l980t2467r1216b2497],
3	of	IN	O	of	_	0	SENT_450	[p12l1229t2467r1264b2497],
4	prominent	JJ	O	prominent	amod	5	SENT_450	[p12l1274t2467r1444b2505],
5	activity	NN	O	activity	prep_of	2	SENT_450	[p12l1457t2467r1579b2505],
6	in	IN	O	in	_	0	SENT_450	[p12l1592t2467r1623b2496],
7	patients	NNS	O	patient	prep_in	5	SENT_450	[p12l1635t2467r1762b2505],
8	with	IN	O	with	_	0	SENT_450	[p12l1776t2467r1848b2497],
9	advanced	JJ	O	advanced	amod	10	SENT_450	[p12l550t2517r705b2547],
10	stages	NNS	O	stage	prep_with	7	SENT_450	[p12l718t2522r816b2555],
11	of	IN	O	of	_	0	SENT_450	[p12l831t2517r866b2547],
12	many	JJ	O	many	amod	14	SENT_450	[p12l876t2526r967b2555],
13	refractory	JJ	O	refractory	amod	14	SENT_450	[p12l980t2517r1142b2555],
14	cancers	NNS	O	cancer	prep_of	10	SENT_450	[p12l1155t2526r1277b2547],
15	implies	VBZ	O	imply	_	0	SENT_450	[p12l1290t2517r1410b2555],
16	that	IN	O	that	complm	20	SENT_450	[p12l1424t2517r1486b2547],
17	the	DT	O	the	det	18	SENT_450	[p12l1498t2517r1547b2547],
18	taxanes	NNS	O	taxane	nsubj	20	SENT_450	[p12l1560t2522r1682b2547],
19	may	MD	O	may	aux	20	SENT_450	[p12l1695t2526r1765b2555],
20	play	VB	O	play	ccomp	15	SENT_450	[p12l1778t2517r1848b2555],
21	an	DT	O	a	det	24	SENT_450	[p12l550t2576r587b2597],
22	even	RB	O	even	advmod	23	SENT_450	[p12l602t2576r679b2597],
23	greater	JJR	O	greater	amod	24	SENT_450	[p12l694t2572r808b2605],
24	role	NN	O	role	dobj	20	SENT_450	[p12l821t2567r885b2597],
25	in	IN	O	in	_	0	SENT_450	[p12l900t2567r931b2596],
26	early	JJ	O	early	amod	28	SENT_450	[p12l946t2567r1027b2605],
27	stage	NN	O	stage	nn	28	SENT_450	[p12l1044t2572r1126b2605],
28	disease	NN	O	disease	prep_in	20	SENT_450	[p12l1141t2567r1268b2602],
29	,	,	O	,	_	0	SENT_450	[p12l1141t2567r1268b2602],
30	which	WDT	O	which	nsubj	33	SENT_450	[p12l1285t2567r1385b2597],
31	is	VBZ	O	be	cop	33	SENT_450	[p12l1400t2567r1425b2597],
32	the	DT	O	the	det	33	SENT_450	[p12l1441t2567r1490b2597],
33	setting	NN	O	setting	rcmod	28	SENT_450	[p12l1507t2567r1614b2605],
34	in	IN	O	in	_	0	SENT_450	[p12l1629t2567r1661b2596],
35	which	WDT	O	which	rel	39	SENT_450	[p12l1675t2567r1775b2597],
36	any	DT	O	any	det	38	SENT_450	[p12l1791t2576r1848b2605],
37	novel	JJ	O	novel	amod	38	SENT_450	[p12l549t2617r640b2646],
38	agent	NN	O	agent	nsubj	39	SENT_450	[p12l658t2622r747b2655],
39	has	VBZ	O	have	rcmod	33	SENT_450	[p12l763t2617r816b2646],
40	the	DT	O	the	det	41	SENT_450	[p12l835t2617r884b2646],
41	potential	NN	O	potential	dobj	39	SENT_450	[p12l901t2617r1045b2655],
42	of	IN	O	of	_	0	SENT_450	[p12l1063t2617r1099b2646],
43	making	VBG	O	make	prepc_of	41	SENT_450	[p12l1113t2617r1236b2655],
44	its	PRP$	O	its	poss	46	SENT_450	[p12l1254t2617r1291b2646],
45	greatest	JJS	O	greatest	amod	46	SENT_450	[p12l1310t2622r1438b2655],
46	impact	NN	O	impact	dobj	43	SENT_450	[p12l1454t2617r1567b2655],
47	on	IN	O	on	_	0	SENT_450	[p12l1583t2626r1623b2646],
48	survival	NN	O	survival	prep_on	46	SENT_450	[p12l1642t2617r1773b2646],
49	and	CC	O	and	_	0	SENT_450	[p12l1791t2617r1849b2646],
50	cure	NN	O	cure	prep_on	46	SENT_450	[p12l550t2676r628b2697],
51	.	.	O	.	_	0	SENT_450	[p12l550t2676r628b2697],

1	The	DT	O	the	det	3	SENT_451	[p12l644t2667r707b2697],
2	significant	JJ	O	significant	amod	3	SENT_451	[p12l723t2667r897b2705],
3	prolongation	NN	O	prolongation	nsubj	23	SENT_451	[p12l910t2667r1122b2705],
4	in	IN	O	in	_	0	SENT_451	[p12l1136t2667r1168b2696],
5	survival	NN	O	survival	prep_in	3	SENT_451	[p12l1183t2667r1314b2697],
6	that	WDT	O	that	nsubjpass	9	SENT_451	[p12l1329t2667r1391b2697],
7	has	VBZ	O	have	aux	9	SENT_451	[p12l1404t2667r1458b2697],
8	been	VBN	O	be	auxpass	9	SENT_451	[p12l1473t2667r1551b2697],
9	demonstrated	VBN	O	demonstrate	rcmod	5	SENT_451	[p12l1565t2667r1787b2697],
10	for	IN	O	for	_	0	SENT_451	[p12l1801t2667r1849b2697],
11	paclitaxel	NN	O	paclitaxel	prep_for	9	SENT_451	[p12l549t2717r709b2755],
12	as	IN	O	as	_	0	SENT_451	[p12l730t2726r762b2747],
13	part	NN	O	part	prep_as	9	SENT_451	[p12l783t2722r847b2755],
14	of	IN	O	of	_	0	SENT_451	[p12l867t2717r903b2747],
15	first-line	JJ	O	first-line	amod	16	SENT_451	[p12l920t2717r1062b2747],
16	treatment	NN	O	treatment	prep_of	13	SENT_451	[p12l1082t2722r1238b2747],
17	in	IN	O	in	_	0	SENT_451	[p12l1258t2717r1289b2746],
18	patients	NNS	O	patient	prep_in	9	SENT_451	[p12l1309t2717r1436b2755],
19	with	IN	O	with	_	0	SENT_451	[p12l1457t2717r1530b2747],
20	advanced	JJ	O	advanced	amod	22	SENT_451	[p12l1551t2717r1706b2747],
21	ovarian	JJ	O	ovarian	amod	22	SENT_451	[p12l1726t2717r1849b2747],
22	cancer	NN	O	cancer	prep_with	18	SENT_451	[p12l550t2776r657b2796],
23	is	VBZ	O	be	_	0	SENT_451	[p12l674t2767r699b2796],
24	such	JJ	O	such	prep	23	SENT_451	[p12l720t2767r794b2796],
25	an	DT	O	a	det	26	SENT_451	[p12l812t2776r850b2796],
26	example	NN	O	example	dep	24	SENT_451	[p12l868t2767r1015b2805],
27	.	.	O	.	_	0	SENT_451	[p12l868t2767r1015b2805],

1	Similar	JJ	O	similar	amod	2	SENT_452	[p12l1036t2767r1156b2797],
2	impacts	NNS	O	impact	nsubj	13	SENT_452	[p12l1173t2767r1300b2805],
3	in	IN	O	in	_	0	SENT_452	[p12l1319t2767r1350b2796],
4	more	JJR	O	more	amod	6	SENT_452	[p12l1368t2776r1451b2796],
5	common	JJ	O	common	amod	6	SENT_452	[p12l1470t2776r1614b2796],
6	malignancies	NNS	O	malignancy	prep_in	2	SENT_452	[p12l1631t2767r1848b2805],
7	such	JJ	O	such	_	0	SENT_452	[p12l551t2817r624b2846],
8	as	IN	O	as	_	0	SENT_452	[p12l641t2826r672b2846],
9	breast	NN	O	breast	prep_such_as	6	SENT_452	[p12l688t2817r787b2846],
10	and	CC	O	and	_	0	SENT_452	[p12l804t2817r862b2846],
11	ovary	NN	O	ovary	prep_such_as	6	SENT_452	[p12l877t2826r970b2855],
12	may	MD	O	may	aux	13	SENT_452	[p12l986t2826r1056b2855],
13	translate	VB	O	translate	_	0	SENT_452	[p12l1072t2817r1211b2846],
14	into	IN	O	into	_	0	SENT_452	[p12l1226t2817r1289b2846],
15	substantial	JJ	O	substantial	amod	16	SENT_452	[p12l1307t2817r1481b2846],
16	advantages	NNS	O	advantage	prep_into	13	SENT_452	[p12l1498t2817r1679b2855],
17	in	IN	O	in	_	0	SENT_452	[p12l1695t2817r1726b2846],
18	cancer	NN	O	cancer	nn	19	SENT_452	[p12l1742t2826r1850b2846],
19	therapy	NN	O	therapy	prep_in	16	SENT_452	[p12l549t2867r681b2905],
20	.	.	O	.	_	0	SENT_452	[p12l549t2867r681b2905],

1	In	IN	O	in	_	0	SENT_453	[p12l695t2868r728b2896],
2	addition	NN	O	addition	prep_in	19	SENT_453	[p12l741t2867r884b2902],
3	,	,	O	,	_	0	SENT_453	[p12l741t2867r884b2902],
4	the	DT	O	the	det	5	SENT_453	[p12l897t2867r947b2897],
5	recognition	NN	O	recognition	nsubj	19	SENT_453	[p12l959t2867r1147b2905],
6	of	IN	O	of	_	0	SENT_453	[p12l1160t2867r1195b2897],
7	the	DT	O	the	det	9	SENT_453	[p12l1205t2867r1254b2897],
8	novel	JJ	O	novel	amod	9	SENT_453	[p12l1267t2867r1357b2897],
9	mechanism	NN	O	mechanism	prep_of	5	SENT_453	[p12l1370t2867r1558b2897],
10	of	IN	O	of	_	0	SENT_453	[p12l1570t2867r1606b2897],
11	action	NN	O	action	prep_of	9	SENT_453	[p12l1616t2867r1716b2897],
12	and	CC	O	and	_	0	SENT_453	[p12l1729t2867r1787b2897],
13	the	DT	O	the	det	14	SENT_453	[p12l1799t2867r1848b2897],
14	utility	NN	O	utility	prep_of	5	SENT_453	[p12l549t2917r647b2955],
15	of	IN	O	of	_	0	SENT_453	[p12l660t2917r696b2947],
16	the	DT	O	the	det	17	SENT_453	[p12l705t2918r755b2947],
17	taxanes	NNS	O	taxane	prep_of	14	SENT_453	[p12l768t2922r890b2947],
18	has	VBZ	O	have	aux	19	SENT_453	[p12l903t2918r956b2947],
19	increased	VBN	O	increase	_	0	SENT_453	[p12l970t2917r1125b2947],
20	our	PRP$	O	we	poss	21	SENT_453	[p12l1138t2927r1193b2947],
21	appreciation	NN	O	appreciation	dobj	19	SENT_453	[p12l1205t2917r1408b2955],
22	of	IN	O	of	_	0	SENT_453	[p12l1421t2917r1456b2947],
23	the	DT	O	the	det	24	SENT_453	[p12l1466t2918r1516b2947],
24	potential	NN	O	potential	prep_of	21	SENT_453	[p12l1528t2917r1672b2955],
25	of	IN	O	of	_	0	SENT_453	[p12l1685t2917r1720b2947],
26	antimicrotubule	JJ	O	antimicrotubule	amod	27	SENT_453	[p12l1731t2917r1847b2947, p12l550t2968r704b2997],
27	agents	NNS	O	agent	prep_of	24	SENT_453	[p12l717t2972r820b3006],
28	in	IN	O	in	_	0	SENT_453	[p12l832t2968r863b2997],
29	the	DT	O	the	det	30	SENT_453	[p12l874t2968r924b2997],
30	treatment	NN	O	treatment	prep_in	19	SENT_453	[p12l935t2972r1091b2997],
31	of	IN	O	of	_	0	SENT_453	[p12l1102t2968r1138b2997],
32	cancer	NN	O	cancer	prep_of	30	SENT_453	[p12l1147t2977r1262b2997],
33	.	.	O	.	_	0	SENT_453	[p12l1147t2977r1262b2997],

1	Literature	NNP	O	Literature	nsubj	2	SENT_454	[p12l599t3191r1055b3267],
2	Cited	VBD	O	cite	_	0	SENT_454	[p12l1079t3188r1320b3267],

1	Annu	NNP	PERSON	Annu	_	0	SENT_455	[p13l8t1432r64b1630],
2	.	.	O	.	_	0	SENT_455	[p13l8t1432r64b1630],

1	Rev.	NNP	O	Rev.	nn	2	SENT_456	[p13l8t1258r65b1404],
2	Med	NNP	O	Med	_	0	SENT_456	[p13l7t1065r64b1231],
3	.	.	O	.	_	0	SENT_456	[p13l7t1065r64b1231],

1	1997.48:353	CD	NUMBER	1997.48:353	num	2	SENT_457	[p13l7t457r65b1030],
2	-374	CD	NUMBER	-374	_	0	SENT_457	[p13l7t457r65b1030],
3	.	.	O	.	_	0	SENT_457	[p13l7t457r65b1030],

1	Downloaded	VBN	O	download	_	0	SENT_458	[p13l7t10r65b430],
2	by	IN	O	by	_	0	SENT_458	[p13l90t1465r164b1546],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_458	[p13l89t1096r164b1442],
4	of	IN	ORGANIZATION	of	_	0	SENT_458	[p13l89t1000r147b1071],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	7	SENT_458	[p13l90t637r147b984],
6	—	NNP	O	—	nn	7	SENT_458	[p13l124t591r130b612],
7	Madison	NNP	O	Madison	prep_of	3	SENT_458	[p13l90t279r147b566],
8	on	IN	O	on	_	0	SENT_458	[p13l107t176r147b255],
9	01/0	CD	NUMBER	01/0	prep_on	7	SENT_458	[p13l90t9r147b153],

1	.	.	O	.	_	0	SENT_459	[p13l709t71r719b81],

1	Rowinsky	NNP	PERSON	Rowinsky	nn	2	SENT_460	[p13l756t23r1086b98],
2	EK	NNP	PERSON	EK	_	0	SENT_460	[p13l1107t25r1233b92],
3	,	,	O	,	_	0	SENT_460	[p13l1107t25r1233b92],
4	Onetto	NNP	PERSON	Onetto	nn	5	SENT_460	[p13l1259t24r1478b81],
5	N	NNP	PERSON	N	appos	2	SENT_460	[p13l1499t25r1574b91],
6	,	,	O	,	_	0	SENT_460	[p13l1499t25r1574b91],
7	Canetta	NNP	O	Canetta	nn	8	SENT_460	[p13l1599t24r1848b81],
8	RM	NN	O	rm	appos	2	SENT_460	[p13l1867t25r2011b92],
9	,	,	O	,	_	0	SENT_460	[p13l1867t25r2011b92],
10	Arbuck	NNP	O	Arbuck	nn	11	SENT_460	[p13l2034t24r2144b80, p13l755t105r916b164],
11	SG	NNP	O	SG	appos	2	SENT_460	[p13l943t106r1061b164],
12	.	.	O	.	_	0	SENT_460	[p13l943t106r1061b164],

1	1992	CD	DATE	1992	_	0	SENT_461	[p13l1101t106r1270b164],
2	.	.	O	.	_	0	SENT_461	[p13l1101t106r1270b164],

1	Taxol	NNP	O	Taxol	_	0	SENT_462	[p13l1303t105r1503b164],
2	:	:	O	:	_	0	SENT_462	[p13l1303t105r1503b164],
3	the	DT	O	the	det	5	SENT_462	[p13l1536t105r1633b164],
4	prototypic	JJ	O	prototypic	amod	5	SENT_462	[p13l1661t106r1994b180],
5	taxane	NN	O	taxane	dep	1	SENT_462	[p13l2022t114r2145b164, p13l757t207r886b256],
6	,	,	O	,	_	0	SENT_462	[p13l2022t114r2145b164, p13l757t207r886b256],
7	an	DT	O	a	det	10	SENT_462	[p13l923t207r997b246],
8	important	JJ	O	important	amod	10	SENT_462	[p13l1029t188r1345b263],
9	new	JJ	O	new	amod	10	SENT_462	[p13l1376t207r1510b246],
10	class	NN	O	class	appos	5	SENT_462	[p13l1544t188r1699b246],
11	of	IN	O	of	_	0	SENT_462	[p13l1734t188r1805b246],
12	antitumor	JJ	O	antitumor	amod	13	SENT_462	[p13l1833t188r2148b246],
13	agents	NNS	O	agent	prep_of	10	SENT_462	[p13l757t280r980b346],
14	.	.	O	.	_	0	SENT_462	[p13l757t280r980b346],

1	Sem	NNP	O	Sem	_	0	SENT_463	[p13l1006t271r1154b329],
2	.	.	O	.	_	0	SENT_463	[p13l1006t271r1154b329],

1	Oncol	NN	O	oncol	_	0	SENT_464	[p13l1187t270r1395b329],
2	.	.	O	.	_	0	SENT_464	[p13l1187t270r1395b329],

1	192646-62	CD	NUMBER	192646-62	_	0	SENT_465	[p13l1432t270r1772b329],
2	.	.	O	.	_	0	SENT_465	[p13l709t401r719b411],

1	Bissery	NNP	O	Bissery	nn	2	SENT_466	[p13l756t353r999b428],
2	M-C	NNP	O	M-C	_	0	SENT_466	[p13l1022t353r1192b421],
3	,	,	O	,	_	0	SENT_466	[p13l1022t353r1192b421],
4	Nohynek	NNP	O	Nohynek	nn	5	SENT_466	[p13l1217t353r1518b428],
5	G	NNP	O	G	appos	2	SENT_466	[p13l1538t353r1612b421],
6	,	,	O	,	_	0	SENT_466	[p13l1538t353r1612b421],
7	Sanderlink	NNP	O	Sanderlink	nn	8	SENT_466	[p13l1638t353r1990b411],
8	G-J	NNP	O	G-J	appos	2	SENT_466	[p13l2010t353r2143b421],
9	,	,	O	,	_	0	SENT_466	[p13l2010t353r2143b421],
10	Lavelle	NNP	PERSON	Lavelle	nn	11	SENT_466	[p13l756t436r999b493],
11	F.	NNP	O	F.	appos	2	SENT_466	[p13l1023t437r1077b493],
12	1995	CD	DATE	1995	dep	11	SENT_466	[p13l1111t436r1282b494],
13	.	.	O	.	_	0	SENT_466	[p13l1111t436r1282b494],

1	Docetaxel	NNP	O	Docetaxel	nn	3	SENT_467	[p13l1310t436r1641b493],
2	(	NNP	O	(	nn	3	SENT_467	[p13l1666t436r2083b507],
3	Taxotere	NNP	O	Taxotere	nsubj	4	SENT_467	[p13l1666t436r2083b507],
4	®	VBD	O	®	_	0	SENT_467	[p13l1666t436r2083b507],
5	)	CD	NUMBER	)	dobj	4	SENT_467	[p13l1666t436r2083b507],
6	:	:	O	:	_	0	SENT_467	[p13l1666t436r2083b507],
7	a	DT	O	a	det	8	SENT_467	[p13l2113t454r2147b493],
8	review	NN	O	review	dep	5	SENT_467	[p13l755t519r977b576],
9	of	IN	O	of	_	0	SENT_467	[p13l1014t519r1085b576],
10	preclinical	JJ	O	preclinical	amod	13	SENT_467	[p13l1114t519r1457b593],
11	and	CC	O	and	_	0	SENT_467	[p13l1494t519r1610b576],
12	clinical	JJ	O	clinical	amod	13	SENT_467	[p13l1644t519r1882b576],
13	experience	NN	O	experience	prep_of	8	SENT_467	[p13l1918t519r2144b593, p13l757t619r921b659],
14	.	.	O	.	_	0	SENT_467	[p13l1918t519r2144b593, p13l757t619r921b659],

1	Part	NN	O	part	nn	2	SENT_468	[p13l958t602r1090b659],
2	I	NN	O	i	_	0	SENT_468	[p13l1120t602r1163b659],
3	:	:	O	:	_	0	SENT_468	[p13l1120t602r1163b659],
4	Preclinical	JJ	O	preclinical	amod	5	SENT_468	[p13l1200t601r1548b659],
5	experience	NN	O	experience	dep	2	SENT_468	[p13l1580t601r1950b675],
6	.	.	O	.	_	0	SENT_468	[p13l1580t601r1950b675],

1	AntiCancer	JJ	O	anticancer	amod	2	SENT_469	[p13l1980t602r2144b659, p13l760t685r999b742],
2	Drugs	NNS	O	drug	_	0	SENT_469	[p13l1016t686r1221b757],
3	6:339	CD	NUMBER	6:339	num	4	SENT_469	[p13l1245t683r1548b742],
4	-55	CD	NUMBER	-55	dep	2	SENT_469	[p13l1245t683r1548b742],

1	.	.	O	.	_	0	SENT_470	[p13l709t814r719b824],

1	Rao	NNP	PERSON	Rao	nn	2	SENT_471	[p13l756t768r885b824],
2	S	NNP	O	S	_	0	SENT_471	[p13l928t766r988b834],
3	,	,	O	,	_	0	SENT_471	[p13l928t766r988b834],
4	Krauss	NNP	ORGANIZATION	Krauss	nn	5	SENT_471	[p13l1032t768r1256b824],
5	NE	NNS	ORGANIZATION	ne	appos	2	SENT_471	[p13l1297t768r1423b834],
6	,	,	O	,	_	0	SENT_471	[p13l1297t768r1423b834],
7	Heerding	VBG	O	heerd	partmod	2	SENT_471	[p13l1467t765r1769b841],
8	JM	NN	O	jm	dobj	7	SENT_471	[p13l1809t768r1930b834],
9	,	,	O	,	_	0	SENT_471	[p13l1809t768r1930b834],
10	et	FW	O	et	nn	11	SENT_471	[p13l1973t774r2031b824],
11	al.	FW	O	al.	appos	8	SENT_471	[p13l2070t766r2143b824],
12	1994	CD	DATE	1994	dep	11	SENT_471	[p13l764t848r934b907],
13	.	.	O	.	_	0	SENT_471	[p13l764t848r934b907],

1	3	CD	NUMBER	3	_	0	SENT_472	[p13l974t844r1903b923],
2	’	NN	O	’	dep	1	SENT_472	[p13l974t844r1903b923],
3	.	.	O	.	_	0	SENT_472	[p13l974t844r1903b923],

1	—	NN	O	—	_	0	SENT_473	[p13l974t844r1903b923],
2	.	.	O	.	_	0	SENT_473	[p13l974t844r1903b923],

1	(	NN	O	(	nn	2	SENT_474	[p13l974t844r1903b923],
2	p-Azidobenzamido	NN	O	p-azidobenzamido	_	0	SENT_474	[p13l974t844r1903b923],
3	)	CD	NUMBER	)	num	5	SENT_474	[p13l974t844r1903b923],
4	taxol	NN	O	taxol	nn	5	SENT_474	[p13l974t844r1903b923],
5	photolabels	NNS	O	photolabel	dep	2	SENT_474	[p13l1935t848r2145b923, p13l756t931r943b989],
6	the	DT	O	the	det	10	SENT_474	[p13l984t931r1082b989],
7	N-terminal	JJ	O	n-terminal	amod	10	SENT_474	[p13l1120t931r1478b989],
8	31	CD	NUMBER	31	num	10	SENT_474	[p13l1519t932r1590b990],
9	amino	NN	O	amino	nn	10	SENT_474	[p13l1636t931r1836b989],
10	acids	NNS	O	acid	dep	2	SENT_474	[p13l1877t931r2039b989],
11	of	IN	O	of	prep	10	SENT_474	[p13l2082t931r2153b989],

1	B	NN	O	b	_	0	SENT_475	[p13l760t1009r1074b1089],
2	—	CD	NUMBER	—	num	3	SENT_475	[p13l760t1009r1074b1089],
3	tubulin	NN	O	tubulin	dep	1	SENT_475	[p13l760t1009r1074b1089],
4	.	.	O	.	_	0	SENT_475	[p13l760t1009r1074b1089],

1	J.	NNP	O	J.	nn	2	SENT_476	[p13l1098t1015r1148b1071],
2	Biol	NNP	O	Biol	_	0	SENT_476	[p13l1176t1013r1324b1071],
3	.	.	O	.	_	0	SENT_476	[p13l1176t1013r1324b1071],

1	Chem	NNP	O	Chem	_	0	SENT_477	[p13l1358t1013r1556b1071],
2	.	.	O	.	_	0	SENT_477	[p13l1358t1013r1556b1071],

1	269:3132	CD	NUMBER	269:3132	num	2	SENT_478	[p13l1587t1013r2015b1072],
2	-34	CD	NUMBER	-34	_	0	SENT_478	[p13l1587t1013r2015b1072],

1	.	.	O	.	_	0	SENT_479	[p13l709t1144r719b1153],

1	Manfredi	NNP	PERSON	Manfredi	nn	2	SENT_480	[p13l756t1096r1059b1153],
2	JJ	NN	PERSON	jj	_	0	SENT_480	[p13l1085t1097r1165b1164],
3	,	,	O	,	_	0	SENT_480	[p13l1085t1097r1165b1164],
4	Horwitz	NNP	ORGANIZATION	Horwitz	nn	5	SENT_480	[p13l1195t1096r1461b1154],
5	SB	NN	ORGANIZATION	sb	appos	2	SENT_480	[p13l1489t1096r1602b1154],
6	.	.	O	.	_	0	SENT_480	[p13l1489t1096r1602b1154],

1	1984	CD	DATE	1984	_	0	SENT_481	[p13l1640t1096r1809b1154],
2	.	.	O	.	_	0	SENT_481	[p13l1640t1096r1809b1154],

1	Taxol	NNP	O	Taxol	_	0	SENT_482	[p13l1840t1096r2041b1153],
2	:	:	O	:	_	0	SENT_482	[p13l1840t1096r2041b1153],
3	an	DT	O	a	det	5	SENT_482	[p13l2073t1114r2147b1153],
4	antimitotic	JJ	O	antimitotic	amod	5	SENT_482	[p13l758t1179r1105b1236],
5	agent	NN	O	agent	dep	1	SENT_482	[p13l1128t1188r1304b1253],
6	with	IN	O	with	_	0	SENT_482	[p13l1321t1179r1464b1237],
7	a	DT	O	a	det	9	SENT_482	[p13l1485t1197r1519b1236],
8	new	JJ	O	new	amod	9	SENT_482	[p13l1537t1197r1671b1237],
9	mechanism	NN	O	mechanism	prep_with	5	SENT_482	[p13l1691t1179r2064b1236],
10	of	IN	O	of	_	0	SENT_482	[p13l2082t1179r2153b1236],
11	action	NN	O	action	prep_of	9	SENT_482	[p13l758t1261r969b1319],
12	.	.	O	.	_	0	SENT_482	[p13l758t1261r969b1319],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_483	[p13l995t1262r1372b1319],
2	.	.	O	.	_	0	SENT_483	[p13l995t1262r1372b1319],

1	Ther	NNP	O	Ther	_	0	SENT_484	[p13l1405t1261r1558b1319],
2	25:83	CD	NUMBER	25:83	num	3	SENT_484	[p13l1588t1261r1930b1319],
3	-125	CD	NUMBER	-125	dep	1	SENT_484	[p13l1588t1261r1930b1319],

1	.	.	O	.	_	0	SENT_485	[p13l709t1392r719b1402],

1	Diaz	NNP	PERSON	Diaz	nn	2	SENT_486	[p13l756t1344r909b1402],
2	JF	NNP	O	JF	_	0	SENT_486	[p13l944t1345r1030b1412],
3	,	,	O	,	_	0	SENT_486	[p13l944t1345r1030b1412],
4	Andreu	NNP	PERSON	Andreu	nn	5	SENT_486	[p13l1067t1344r1311b1402],
5	JM	NN	O	jm	appos	2	SENT_486	[p13l1345t1345r1465b1402],
6	.	.	O	.	_	0	SENT_486	[p13l1345t1345r1465b1402],

1	1993	CD	DATE	1993	_	0	SENT_487	[p13l1512t1344r1681b1402],
2	.	.	O	.	_	0	SENT_487	[p13l1512t1344r1681b1402],

1	Assembly	NN	O	assembly	_	0	SENT_488	[p13l1721t1344r2045b1418],
2	of	IN	O	of	_	0	SENT_488	[p13l2082t1344r2153b1402],
3	puriﬁed	JJ	O	puriﬁed	amod	4	SENT_488	[p13l755t1426r1014b1501],
4	GDP-tubulin	NN	O	gdp-tubulin	prep_of	1	SENT_488	[p13l1033t1426r1453b1484],
5	into	IN	O	into	_	0	SENT_488	[p13l1472t1426r1596b1484],
6	microtubules	NNS	O	microtubule	prep_into	4	SENT_488	[p13l1615t1426r2038b1484],
7	induced	VBN	O	induce	partmod	6	SENT_488	[p13l2059t1426r2145b1484, p13l757t1509r951b1567],
8	by	IN	O	by	_	0	SENT_488	[p13l979t1509r1060b1584],
9	taxol	NN	O	taxol	agent	7	SENT_488	[p13l1089t1509r1251b1567],
10	and	CC	O	and	_	0	SENT_488	[p13l1282t1509r1398b1567],
11	taxotere	NN	O	taxotere	conj_and	9	SENT_488	[p13l1426t1518r1705b1567],
12	:	:	O	:	_	0	SENT_488	[p13l1426t1518r1705b1567],
13	reversibility	NN	O	reversibility	dep	1	SENT_488	[p13l1738t1509r2144b1584],
14	,	,	O	,	_	0	SENT_488	[p13l1738t1509r2144b1584],
15	ligand	NN	O	ligand	nn	16	SENT_488	[p13l756t1592r958b1667],
16	stoichiometry	NN	O	stoichiometry	conj_and	13	SENT_488	[p13l981t1592r1425b1667],
17	and	CC	O	and	_	0	SENT_488	[p13l1447t1592r1563b1650],
18	competition	NN	O	competition	dep	1	SENT_488	[p13l1581t1592r1985b1667],
19	.	.	O	.	_	0	SENT_488	[p13l1581t1592r1985b1667],

1	Biochemistry	NNP	O	Biochemistry	_	0	SENT_489	[p13l2005t1594r2143b1650, p13l757t1674r1073b1748],
2	3222747-55	CD	NUMBER	3222747-55	dep	1	SENT_489	[p13l1098t1674r1481b1732],
3	.	.	O	.	_	0	SENT_489	[p13l709t1804r719b1815],

1	Ringel	NNP	PERSON	Ringel	nn	2	SENT_490	[p13l756t1756r972b1832],
2	I	NNP	PERSON	I	_	0	SENT_490	[p13l1002t1758r1045b1825],
3	,	,	O	,	_	0	SENT_490	[p13l1002t1758r1045b1825],
4	Horwitz	NNP	O	Horwitz	nn	5	SENT_490	[p13l1078t1756r1345b1814],
5	SB	NN	O	sb	appos	2	SENT_490	[p13l1377t1757r1489b1815],
6	.	.	O	.	_	0	SENT_490	[p13l1377t1757r1489b1815],

1	1991	CD	DATE	1991	_	0	SENT_491	[p13l1531t1757r1701b1815],
2	.	.	O	.	_	0	SENT_491	[p13l1531t1757r1701b1815],

1	Studies	NNS	O	study	_	0	SENT_492	[p13l1738t1756r1972b1815],
2	with	IN	O	with	_	0	SENT_492	[p13l2004t1756r2147b1814],
3	RP56976	NN	O	rp56976	prep_with	1	SENT_492	[p13l756t1838r1058b1897],
4	(	CD	NUMBER	(	num	3	SENT_492	[p13l1088t1839r1441b1910],
5	Taxotere	NNP	O	Taxotere	dep	1	SENT_492	[p13l1088t1839r1441b1910],
6	)	CD	NUMBER	)	num	5	SENT_492	[p13l1088t1839r1441b1910],
7	:	:	O	:	_	0	SENT_492	[p13l1088t1839r1441b1910],
8	a	DT	O	a	det	10	SENT_492	[p13l1474t1857r1508b1897],
9	semisynthetic	JJ	O	semisynthetic	amod	10	SENT_492	[p13l1536t1838r1980b1914],
10	analogue	NN	O	analogue	dep	1	SENT_492	[p13l2009t1857r2145b1897, p13l756t1920r936b1994],
11	of	IN	O	of	_	0	SENT_492	[p13l952t1920r1023b1977],
12	taxol	NN	O	taxol	prep_of	10	SENT_492	[p13l1032t1920r1209b1977],
13	.	.	O	.	_	0	SENT_492	[p13l1032t1920r1209b1977],

1	J.	NNP	MISC	J.	nn	2	SENT_493	[p13l1226t1922r1275b1978],
2	Natl.	NNP	MISC	Natl.	nsubj	3	SENT_493	[p13l1296t1920r1449b1978],
3	Can	MD	MISC	can	_	0	SENT_493	[p13l1477t1921r1620b1978],
4	.	.	O	.	_	0	SENT_493	[p13l1477t1921r1620b1978],

1	Inst	NNP	O	Inst	_	0	SENT_494	[p13l1641t1922r1776b1978],
2	.	.	O	.	_	0	SENT_494	[p13l1641t1922r1776b1978],

1	83:28	CD	NUMBER	83:28	num	2	SENT_495	[p13l1802t1920r1980b1978],
2	8-91	CD	NUMBER	8-91	_	0	SENT_495	[p13l1988t1920r2139b1978],
3	.	.	O	.	_	0	SENT_495	[p13l709t2050r719b2060],

1	Jordon	NNP	PERSON	Jordon	nn	2	SENT_496	[p13l756t2002r978b2060],
2	MA	NNP	PERSON	MA	_	0	SENT_496	[p13l1003t2003r1152b2070],
3	,	,	O	,	_	0	SENT_496	[p13l1003t2003r1152b2070],
4	Wendell	NNP	PERSON	Wendell	nn	5	SENT_496	[p13l1181t2002r1450b2060],
5	K	NNP	PERSON	K	appos	2	SENT_496	[p13l1477t2004r1550b2070],
6	,	,	O	,	_	0	SENT_496	[p13l1477t2004r1550b2070],
7	Gardiner	NNP	PERSON	Gardiner	nn	8	SENT_496	[p13l1582t2002r1872b2060],
8	S	NNP	O	S	appos	2	SENT_496	[p13l1898t2003r1956b2070],
9	,	,	O	,	_	0	SENT_496	[p13l1898t2003r1956b2070],
10	et	FW	O	et	nn	11	SENT_496	[p13l1987t2011r2045b2060],
11	al.	FW	O	al.	appos	2	SENT_496	[p13l2071t2002r2143b2060],
12	1996	CD	DATE	1996	dep	11	SENT_496	[p13l764t2084r934b2142],
13	.	.	O	.	_	0	SENT_496	[p13l764t2084r934b2142],

1	Mitotic	JJ	O	mitotic	amod	2	SENT_497	[p13l963t2084r1199b2142],
2	block	NN	O	block	nsubj	15	SENT_497	[p13l1224t2084r1407b2142],
3	induced	VBN	O	induce	partmod	2	SENT_497	[p13l1427t2084r1687b2142],
4	in	IN	O	in	_	0	SENT_497	[p13l1711t2084r1773b2141],
5	HeLa	NN	O	helum	nn	6	SENT_497	[p13l1795t2086r1977b2142],
6	cells	NNS	O	cell	prep_in	3	SENT_497	[p13l2000t2084r2145b2142],
7	by	IN	O	by	_	0	SENT_497	[p13l755t2166r836b2240],
8	low	JJ	O	low	amod	9	SENT_497	[p13l855t2166r974b2223],
9	concentrations	NNS	O	concentration	agent	3	SENT_497	[p13l996t2166r1468b2223],
10	of	IN	O	of	_	0	SENT_497	[p13l1491t2166r1562b2223],
11	paclitaxel	NN	O	paclitaxel	nn	14	SENT_497	[p13l1574t2166r1891b2240],
12	(	CD	NUMBER	(	num	14	SENT_497	[p13l1913t2166r2146b2236],
13	Taxol	NN	O	taxol	nn	14	SENT_497	[p13l1913t2166r2146b2236],
14	)	NN	O	)	prep_of	9	SENT_497	[p13l1913t2166r2146b2236],
15	results	VBZ	O	result	_	0	SENT_497	[p13l755t2248r966b2305],
16	in	IN	O	in	_	0	SENT_497	[p13l996t2248r1057b2305],
17	abnormal	JJ	O	abnormal	amod	19	SENT_497	[p13l1085t2248r1391b2305],
18	mitotic	JJ	O	mitotic	amod	19	SENT_497	[p13l1417t2248r1644b2305],
19	exit	NN	O	exit	prep_in	15	SENT_497	[p13l1673t2248r1794b2305],
20	and	CC	O	and	_	0	SENT_497	[p13l1821t2248r1937b2305],
21	apoptotic	JJ	O	apoptotic	amod	23	SENT_497	[p13l1965t2266r2145b2322, p13l756t2331r897b2388],
22	cell	NN	O	cell	nn	23	SENT_497	[p13l922t2331r1038b2388],
23	death	NN	O	death	conj_and	19	SENT_497	[p13l1061t2331r1251b2388],
24	.	.	O	.	_	0	SENT_497	[p13l1061t2331r1251b2388],

1	Cancer	NN	O	cancer	_	0	SENT_498	[p13l1281t2332r1520b2389],
2	Res	NNP	O	Res	dep	1	SENT_498	[p13l1536t2333r1669b2388],
3	.	.	O	.	_	0	SENT_498	[p13l1536t2333r1669b2388],

1	562816-25	CD	NUMBER	562816-25	_	0	SENT_499	[p13l1700t2330r2042b2388],

1	.	.	O	.	_	0	SENT_500	[p13l709t2459r719b2469],

1	Haldar	NNP	PERSON	Haldar	nn	2	SENT_501	[p13l756t2411r979b2469],
2	S	NNP	O	S	_	0	SENT_501	[p13l1009t2412r1068b2480],
3	,	,	O	,	_	0	SENT_501	[p13l1009t2412r1068b2480],
4	Chintapalli	NNP	PERSON	Chintapalli	nn	5	SENT_501	[p13l1101t2411r1460b2486],
5	J	NNP	PERSON	J	appos	2	SENT_501	[p13l1488t2413r1518b2470],
6	,	,	O	,	_	0	SENT_501	[p13l1524t2459r1536b2480],
7	Croce	NNP	PERSON	Croce	nn	8	SENT_501	[p13l1569t2412r1761b2470],
8	CM	NN	O	cm	appos	5	SENT_501	[p13l1791t2412r1933b2470],
9	.	.	O	.	_	0	SENT_501	[p13l1791t2412r1933b2470],

1	1996	CD	DATE	1996	_	0	SENT_502	[p13l1972t2411r2142b2470],
2	.	.	O	.	_	0	SENT_502	[p13l1972t2411r2142b2470],

1	Taxol	NN	O	taxol	nsubj	2	SENT_503	[p13l756t2493r938b2550],
2	induces	VBZ	O	induce	_	0	SENT_503	[p13l976t2493r1223b2550],
3	bcl	NN	O	bcl	nn	4	SENT_503	[p13l1261t2493r1425b2550],
4	—	NN	O	—	dobj	2	SENT_503	[p13l1261t2493r1425b2550],
5	2	CD	NUMBER	2	num	6	SENT_503	[p13l1261t2493r1425b2550],
6	phosphorylation	NN	O	phosphorylation	dep	4	SENT_503	[p13l1463t2493r1995b2567],
7	and	CC	O	and	_	0	SENT_503	[p13l2032t2493r2148b2550],
8	death	NN	O	death	dobj	2	SENT_503	[p13l757t2575r932b2634],
9	of	IN	O	of	_	0	SENT_503	[p13l955t2575r1026b2634],
10	prostate	NN	O	prostate	nn	12	SENT_503	[p13l1041t2584r1299b2651],
11	cancer	NN	O	cancer	nn	12	SENT_503	[p13l1322t2594r1536b2634],
12	cells	NNS	O	cell	prep_of	8	SENT_503	[p13l1557t2575r1720b2634],
13	.	.	O	.	_	0	SENT_503	[p13l1557t2575r1720b2634],

1	Cancer	NN	O	cancer	_	0	SENT_504	[p13l1750t2577r1990b2634],
2	Res	NNP	O	Res	dep	1	SENT_504	[p13l2007t2578r2139b2634],
3	.	.	O	.	_	0	SENT_504	[p13l2007t2578r2139b2634],

1	56	CD	NUMBER	56	_	0	SENT_505	[p13l757t2657r853b2715],
2	:	:	O	:	_	0	SENT_505	[p13l757t2657r853b2715],
3	1253-55	CD	NUMBER	1253-55	dep	1	SENT_505	[p13l869t2657r1141b2715],

1	.	.	O	.	_	0	SENT_506	[p13l709t2787r719b2797],

1	Schiff	NNP	PERSON	Schiff	nn	2	SENT_507	[p13l758t2739r958b2797],
2	PB	NN	O	pb	_	0	SENT_507	[p13l975t2741r1092b2807],
3	,	,	O	,	_	0	SENT_507	[p13l975t2741r1092b2807],
4	Gubits	JJ	O	gubits	amod	5	SENT_507	[p13l1118t2739r1331b2797],
5	R	NN	O	r	appos	2	SENT_507	[p13l1355t2741r1426b2807],
6	,	,	O	,	_	0	SENT_507	[p13l1355t2741r1426b2807],
7	Kashimawo	NNP	LOCATION	Kashimawo	nn	8	SENT_507	[p13l1451t2739r1840b2797],
8	S	NNP	LOCATION	S	appos	2	SENT_507	[p13l1864t2740r1923b2807],
9	,	,	O	,	_	0	SENT_507	[p13l1864t2740r1923b2807],
10	Geard	NNP	PERSON	Geard	nn	11	SENT_507	[p13l1949t2739r2148b2797],
11	CR	NN	PERSON	cr	appos	2	SENT_507	[p13l757t2822r880b2880],
12	.	.	O	.	_	0	SENT_507	[p13l757t2822r880b2880],

1	1995	CD	DATE	1995	_	0	SENT_508	[p13l924t2821r1094b2880],
2	.	.	O	.	_	0	SENT_508	[p13l924t2821r1094b2880],

1	Paclitaxel	NN	O	paclitaxel	_	0	SENT_509	[p13l1131t2821r1451b2879],
2	with	IN	O	with	_	0	SENT_509	[p13l1485t2821r1628b2880],
3	ionizing	VBG	O	ionize	amod	4	SENT_509	[p13l1660t2821r1925b2896],
4	radiation	NN	O	radiation	prep_with	1	SENT_509	[p13l1957t2821r2145b2879, p13l756t2903r896b2961],
5	.	.	O	.	_	0	SENT_509	[p13l1957t2821r2145b2879, p13l756t2903r896b2961],

1	In	IN	O	in	_	0	SENT_510	[p13l918t2905r985b2960],
2	Paclitaxel	NN	O	paclitaxel	prep_in	7	SENT_510	[p13l1000t2903r1333b2961],
3	in	IN	O	in	_	0	SENT_510	[p13l1352t2906r1410b2961],
4	Cancer	NNP	O	Cancer	nn	5	SENT_510	[p13l1432t2905r1671b2962],
5	Treatment	NN	O	treatment	prep_in	2	SENT_510	[p13l1688t2906r2029b2970],
6	,	,	O	,	_	0	SENT_510	[p13l1688t2906r2029b2970],
7	ed	VBN	O	ed	_	0	SENT_510	[p13l2051t2903r2142b2961],
8	.	.	O	.	_	0	SENT_510	[p13l2051t2903r2142b2961],

1	WG	NNP	PERSON	WG	nn	2	SENT_511	[p13l183t3231r375b3312],
2	McGuire	NNP	PERSON	McGuire	_	0	SENT_511	[p13l422t3231r862b3327],
3	,	,	O	,	_	0	SENT_511	[p13l422t3231r862b3327],
4	EK	NNP	PERSON	EK	nn	5	SENT_511	[p13l911t3233r1066b3310],
5	Rowinsky	NNP	PERSON	Rowinsky	appos	2	SENT_511	[p13l1109t3231r1591b3336],
6	,	,	O	,	_	0	SENT_511	[p13l1109t3231r1591b3336],
7	pp	NN	O	pp	appos	5	SENT_511	[p13l1640t3256r1778b3336],
8	.	.	O	.	_	0	SENT_511	[p13l1640t3256r1778b3336],

1	81-90	CD	NUMBER	81-90	_	0	SENT_512	[p13l1834t3231r2138b3313],
2	.	.	O	.	_	0	SENT_512	[p13l1834t3231r2138b3313],

1	New	NNP	LOCATION	New	nn	2	SENT_513	[p13l183t3348r400b3428],
2	York	NNP	LOCATION	York	_	0	SENT_513	[p13l431t3346r677b3428],
3	:	:	O	:	_	0	SENT_513	[p13l431t3346r677b3428],
4	Dekker	NNP	PERSON	Dekker	dep	2	SENT_513	[p13l713t3346r1052b3428],

1	10	CD	NUMBER	10	_	0	SENT_514	[p13l7t3463r131b3545],
2	.	.	O	.	_	0	SENT_514	[p13l7t3463r131b3545],

1	Cabral	NNP	PERSON	Cabral	nn	2	SENT_515	[p13l185t3463r490b3545],
2	F	NN	O	f	_	0	SENT_515	[p13l528t3465r604b3559],
3	,	,	O	,	_	0	SENT_515	[p13l528t3465r604b3559],
4	Barlow	NNP	PERSON	Barlow	nn	5	SENT_515	[p13l649t3463r984b3544],
5	SB	NN	O	sb	appos	2	SENT_515	[p13l1027t3463r1187b3545],
6	.	.	O	.	_	0	SENT_515	[p13l1027t3463r1187b3545],

1	1991	CD	DATE	1991	_	0	SENT_516	[p13l1242t3463r1482b3545],
2	.	.	O	.	_	0	SENT_516	[p13l1242t3463r1482b3545],

1	Resistance	NN	O	resistance	_	0	SENT_517	[p13l1527t3463r2019b3544],
2	to	TO	O	to	_	0	SENT_517	[p13l2057t3475r2144b3544],
3	antimitotic	JJ	O	antimitotic	amod	4	SENT_517	[p13l187t3580r677b3662],
4	agents	NNS	O	agent	prep_to	1	SENT_517	[p13l714t3592r1000b3686],
5	as	IN	O	as	_	0	SENT_517	[p13l1038t3606r1127b3662],
6	genetic	JJ	O	genetic	amod	7	SENT_517	[p13l1164t3580r1490b3686],
7	probes	NNS	O	probe	prep_as	1	SENT_517	[p13l1525t3580r1827b3686],
8	of	IN	O	of	_	0	SENT_517	[p13l1863t3580r1965b3662],
9	microtubule	NN	O	microtubule	nn	10	SENT_517	[p13l1987t3580r2141b3660, p13l185t3696r616b3777],
10	structure	NN	O	structure	prep_of	1	SENT_517	[p13l675t3708r1070b3777],
11	and	CC	O	and	_	0	SENT_517	[p13l1127t3696r1290b3777],
12	function	NN	O	function	prep_of	1	SENT_517	[p13l1342t3696r1745b3778],
13	.	.	O	.	_	0	SENT_517	[p13l1342t3696r1745b3778],

1	Pharm	NNP	O	Pharm	_	0	SENT_518	[p13l1800t3696r2132b3778],
2	.	.	O	.	_	0	SENT_518	[p13l1800t3696r2132b3778],

1	Then	RB	O	then	dep	2	SENT_519	[p14l190t25r405b106],
2	52:159	CD	NUMBER	52:159	dep	4	SENT_519	[p14l448t24r925b108],
3	—	CD	NUMBER	—	num	4	SENT_519	[p14l448t24r925b108],
4	71	CD	NUMBER	71	_	0	SENT_519	[p14l448t24r925b108],

1	Horwitz	NNP	O	Horwitz	nn	2	SENT_520	[p14l185t141r560b222],
2	SB	NN	O	sb	_	0	SENT_520	[p14l600t141r761b237],
3	,	,	O	,	_	0	SENT_520	[p14l600t141r761b237],
4	Cohen	NNP	PERSON	Cohen	nn	5	SENT_520	[p14l802t141r1101b223],
5	D	NNP	O	D	appos	2	SENT_520	[p14l1135t143r1241b237],
6	,	,	O	,	_	0	SENT_520	[p14l1135t143r1241b237],
7	Rao	NNP	PERSON	Rao	nn	8	SENT_520	[p14l1281t143r1464b222],
8	S	NNP	O	S	appos	2	SENT_520	[p14l1502t141r1586b237],
9	,	,	O	,	_	0	SENT_520	[p14l1502t141r1586b237],
10	et	FW	O	et	nn	11	SENT_520	[p14l1628t153r1708b222],
11	al.	FW	O	al.	appos	2	SENT_520	[p14l1745t141r1846b222],
12	1993	CD	DATE	1993	dep	11	SENT_520	[p14l1898t141r2137b223],
13	.	.	O	.	_	0	SENT_520	[p14l1898t141r2137b223],

1	Taxolz	NN	MISC	taxolz	nn	2	SENT_521	[p14l185t258r468b340],
2	mechanisms	NNS	O	mechanism	_	0	SENT_521	[p14l536t258r1104b340],
3	of	IN	O	of	_	0	SENT_521	[p14l1171t258r1272b340],
4	action	NN	O	action	prep_of	2	SENT_521	[p14l1329t258r1607b340],
5	and	CC	O	and	_	0	SENT_521	[p14l1671t258r1834b340],
6	resistance	NN	O	resistance	conj_and	4	SENT_521	[p14l1893t258r2141b340, p14l185t378r851b480],
7	.	.	O	.	_	0	SENT_521	[p14l1893t258r2141b340, p14l185t378r851b480],

1	Monogr	NNP	O	Monogr	_	0	SENT_522	[p14l1893t258r2141b340, p14l185t378r851b480],
2	:	:	O	:	_	0	SENT_522	[p14l1893t258r2141b340, p14l185t378r851b480],

1	Natl.	NNP	O	Natl.	nn	2	SENT_523	[p14l880t375r1096b457],
2	Cancerlnst	NNP	O	Cancerlnst	_	0	SENT_523	[p14l1136t377r1678b457],
3	.	.	O	.	_	0	SENT_523	[p14l1136t377r1678b457],

1	15	CD	NUMBER	15	number	2	SENT_524	[p14l1723t375r1820b457],
2	:63	CD	NUMBER	:63	num	3	SENT_524	[p14l1835t375r2141b457],
3	—	NN	O	—	_	0	SENT_524	[p14l1835t375r2141b457],
4	67	CD	NUMBER	67	num	6	SENT_524	[p14l1835t375r2141b457],
5	Webster	NNP	ORGANIZATION	Webster	nn	6	SENT_524	[p14l183t494r559b575],
6	L	NNP	ORGANIZATION	L	dep	3	SENT_524	[p14l593t496r687b589],
7	,	,	O	,	_	0	SENT_524	[p14l593t496r687b589],
8	Linenmyer	NNP	O	Linenmyer	nn	9	SENT_524	[p14l729t494r1235b599],
9	M	NNP	O	M	appos	6	SENT_524	[p14l1268t496r1394b590],
10	,	,	O	,	_	0	SENT_524	[p14l1268t496r1394b590],
11	Millward	NNP	PERSON	Millward	nn	12	SENT_524	[p14l1436t494r1863b575],
12	M	NNP	PERSON	M	appos	6	SENT_524	[p14l1897t496r2022b590],
13	,	,	O	,	_	0	SENT_524	[p14l1897t496r2022b590],
14	et	FW	O	et	nn	15	SENT_524	[p14l2065t506r2146b575],
15	al.	FW	O	al.	appos	6	SENT_524	[p14l187t609r288b691],
16	1993	CD	DATE	1993	dep	15	SENT_524	[p14l352t610r592b691],
17	.	.	O	.	_	0	SENT_524	[p14l352t610r592b691],

1	Measurement	NN	O	measurement	nsubj	14	SENT_525	[p14l646t611r1276b691],
2	of	IN	O	of	_	0	SENT_525	[p14l1322t609r1422b691],
3	cremophor	NN	O	cremophor	nn	4	SENT_525	[p14l1462t609r1961b715],
4	EL	NN	O	el	prep_of	1	SENT_525	[p14l2005t611r2145b689],
5	following	VBG	O	follow	_	0	SENT_525	[p14l185t725r628b831],
6	taxolz	NN	O	taxolz	nn	8	SENT_525	[p14l659t725r911b807],
7	plasma	NN	O	plasma	nn	8	SENT_525	[p14l947t725r1275b831],
8	levels	NNS	O	level	prep_following	4	SENT_525	[p14l1303t725r1565b807],
9	sufficient	JJ	O	sufficient	amod	8	SENT_525	[p14l1603t725r2031b807],
10	to	TO	O	to	aux	11	SENT_525	[p14l2058t737r2144b807],
11	reverse	VB	O	reverse	xcomp	9	SENT_525	[p14l183t867r516b923],
12	drug	NN	O	drug	nn	13	SENT_525	[p14l579t841r785b947],
13	exclusion	NN	O	exclusion	dobj	11	SENT_525	[p14l850t841r1289b923],
14	mediated	VBN	O	mediate	_	0	SENT_525	[p14l1350t841r1772b923],
15	by	IN	O	by	_	0	SENT_525	[p14l1830t841r1944b947],
16	the	DT	O	the	det	18	SENT_525	[p14l2006t841r2144b923],
17	multidrug-resistant	JJ	O	multidrug-resistant	amod	18	SENT_525	[p14l185t957r1059b1062],
18	phenotype	NN	O	phenotype	prep_by	14	SENT_525	[p14l1150t957r1652b1062],
19	.	.	O	.	_	0	SENT_525	[p14l1150t957r1652b1062],

1	J.	NNP	MISC	J.	nn	2	SENT_526	[p14l1746t960r1816b1039],
2	Natl.	NNP	MISC	Natl.	nsubj	3	SENT_526	[p14l1916t957r2132b1039],
3	Can	MD	MISC	can	_	0	SENT_526	[p14l190t1076r393b1156],
4	.	.	O	.	_	0	SENT_526	[p14l190t1076r393b1156],

1	Inst	NNP	O	Inst	_	0	SENT_527	[p14l432t1077r623b1156],
2	.	.	O	.	_	0	SENT_527	[p14l432t1077r623b1156],

1	85:1685	CD	NUMBER	85:1685	_	0	SENT_528	[p14l670t1074r1213b1156],
2	—	CD	NUMBER	—	num	3	SENT_528	[p14l670t1074r1213b1156],
3	90	CD	NUMBER	90	dep	1	SENT_528	[p14l670t1074r1213b1156],

1	Millward	NNP	PERSON	Millward	nn	2	SENT_529	[p14l185t1191r614b1272],
2	MJ	NNP	PERSON	MJ	_	0	SENT_529	[p14l644t1193r815b1287],
3	,	,	O	,	_	0	SENT_529	[p14l644t1193r815b1287],
4	Webster	NNP	PERSON	Webster	nn	5	SENT_529	[p14l850t1191r1227b1272],
5	D	NNP	O	D	appos	2	SENT_529	[p14l1256t1193r1362b1287],
6	,	,	O	,	_	0	SENT_529	[p14l1256t1193r1362b1287],
7	Rischin	NNP	PERSON	Rischin	nn	8	SENT_529	[p14l1399t1191r1748b1272],
8	D	NNP	PERSON	D	appos	2	SENT_529	[p14l1779t1193r1886b1287],
9	,	,	O	,	_	0	SENT_529	[p14l1779t1193r1886b1287],
10	et	FW	O	et	nn	11	SENT_529	[p14l1923t1203r2005b1272],
11	al.	FW	O	al.	appos	2	SENT_529	[p14l2038t1191r2139b1272],
12	1996	CD	DATE	1996	dep	11	SENT_529	[p14l195t1308r435b1391],
13	.	.	O	.	_	0	SENT_529	[p14l195t1308r435b1391],

1	Plasma	NN	O	plasma	nn	2	SENT_530	[p14l499t1308r832b1390],
2	concentrations	NNS	O	concentration	dep	9	SENT_530	[p14l888t1308r1553b1390],
3	of	IN	O	of	_	0	SENT_530	[p14l1615t1308r1715b1390],
4	polysor	NN	O	polysor	nn	7	SENT_530	[p14l1762t1308r2141b1414],
5	—	CD	NUMBER	—	num	7	SENT_530	[p14l1762t1308r2141b1414],
6	bate	NN	O	bate	nn	7	SENT_530	[p14l183t1424r374b1505],
7	8O	NN	O	8o	prep_of	2	SENT_530	[p14l426t1424r534b1506],
8	(	CD	NUMBER	(	dep	9	SENT_530	[p14l584t1425r923b1524],
9	Tween	NNP	O	Tween	dep	12	SENT_530	[p14l584t1425r923b1524],
10	80	CD	NUMBER	80	num	9	SENT_530	[p14l973t1424r1116b1524],
11	)	CD	NUMBER	)	dep	9	SENT_530	[p14l973t1424r1116b1524],
12	in	IN	O	in	_	0	SENT_530	[p14l1166t1424r1253b1505],
13	patients	NNS	O	patient	pobj	12	SENT_530	[p14l1297t1424r1651b1529],
14	following	VBG	O	follow	_	0	SENT_530	[p14l1699t1424r2143b1529],
15	docetaxel	NN	O	docetaxel	prep_following	13	SENT_530	[p14l185t1543r625b1624],
16	(	CD	NUMBER	(	num	15	SENT_530	[p14l687t1543r1157b1643],
17	Taxotere	NNP	O	Taxotere	dep	15	SENT_530	[p14l687t1543r1157b1643],
18	)	CD	NUMBER	)	num	17	SENT_530	[p14l687t1543r1157b1643],
19	or	CC	O	or	_	0	SENT_530	[p14l1219t1568r1314b1624],
20	etoposide	NN	O	etoposide	prep_following	13	SENT_530	[p14l1371t1543r1832b1648],
21	.	.	O	.	_	0	SENT_530	[p14l1371t1543r1832b1648],

1	Proc	NNP	O	Proc	_	0	SENT_531	[p14l1894t1545r2132b1624],
2	.	.	O	.	_	0	SENT_531	[p14l1894t1545r2132b1624],

1	9th	JJ	ORDINAL	9th	amod	2	SENT_532	[p14l185t1658r328b1740],
2	N	NN	O	n	_	0	SENT_532	[p14l349t1661r436b1740],
3	CI-EORTC	NN	MISC	ci-eortc	nn	4	SENT_532	[p14l436t1660r952b1740],
4	Symp	NN	MISC	symp	dep	2	SENT_532	[p14l970t1660r1237b1761],
5	.	.	O	.	_	0	SENT_532	[p14l970t1660r1237b1761],

1	New	NNP	O	New	_	0	SENT_533	[p14l1266t1661r1474b1740],
2	Drugs	NNPS	O	Drugs	dep	1	SENT_533	[p14l1493t1661r1782b1761],
3	Cancer	NNP	O	Cancer	rcmod	2	SENT_533	[p14l1813t1660r2148b1740],
4	Ther.	NNP	O	Ther.	rcmod	3	SENT_533	[p14l190t1775r455b1871],
5	,	,	O	,	_	0	SENT_533	[p14l190t1775r455b1871],
6	p.	NN	O	p.	dep	8	SENT_533	[p14l489t1801r569b1881],
7	95	CD	NUMBER	95	dep	6	SENT_533	[p14l607t1775r713b1858],
8	(	NN	O	(	dep	4	SENT_533	[p14l754t1775r1099b1876],
9	Abstr	NN	O	abstr	dep	8	SENT_533	[p14l754t1775r1099b1876],
10	.	.	O	.	_	0	SENT_533	[p14l754t1775r1099b1876],
11	)	SYM	O	)	dep	3	SENT_533	[p14l754t1775r1099b1876],

1	Seidman	NN	PERSON	seidman	_	0	SENT_534	[p14l188t1891r588b1973],
2	AD	NN	O	ad	dep	1	SENT_534	[p14l624t1892r812b1973],
3	.	.	O	.	_	0	SENT_534	[p14l624t1892r812b1973],

1	1995	CD	DATE	1995	_	0	SENT_535	[p14l867t1891r1108b1974],
2	.	.	O	.	_	0	SENT_535	[p14l867t1891r1108b1974],

1	The	DT	O	the	det	3	SENT_536	[p14l1153t1891r1328b1973],
2	emerging	VBG	O	emerge	amod	3	SENT_536	[p14l1369t1891r1799b1997],
3	role	NN	O	role	_	0	SENT_536	[p14l1835t1891r2013b1973],
4	of	IN	O	of	_	0	SENT_536	[p14l2052t1891r2153b1973],
5	paclitaxel	NN	O	paclitaxel	prep_of	3	SENT_536	[p14l183t2009r630b2114],
6	in	IN	O	in	_	0	SENT_536	[p14l682t2009r771b2088],
7	breast	NN	O	breast	nn	9	SENT_536	[p14l822t2009r1099b2090],
8	cancer	NN	O	cancer	nn	9	SENT_536	[p14l1152t2034r1453b2090],
9	therapy	NN	O	therapy	prep_in	5	SENT_536	[p14l1504t2009r1862b2114],
10	.	.	O	.	_	0	SENT_536	[p14l1504t2009r1862b2114],

1	Clin	NNP	O	Clin	_	0	SENT_537	[p14l1926t2009r2132b2091],
2	.	.	O	.	_	0	SENT_537	[p14l1926t2009r2132b2091],

1	Canceic	JJ	O	canceic	_	0	SENT_538	[p14l190t2126r527b2206],
2	Res	NNP	O	Res	dep	1	SENT_538	[p14l565t2127r750b2206],
3	.	.	O	.	_	0	SENT_538	[p14l565t2127r750b2206],

1	13247-50	CD	NUMBER	13247-50	_	0	SENT_539	[p14l804t2124r1225b2206],

1	Colarusso	NNP	PERSON	Colarusso	nn	2	SENT_540	[p14l186t2241r644b2323],
2	PJ	NNP	PERSON	PJ	_	0	SENT_540	[p14l699t2244r831b2337],
3	,	,	O	,	_	0	SENT_540	[p14l699t2244r831b2337],
4	Ranganathan	NNP	PERSON	Ranganathan	nn	5	SENT_540	[p14l891t2241r1492b2347],
5	S	NNP	O	S	appos	2	SENT_540	[p14l1549t2242r1632b2337],
6	,	,	O	,	_	0	SENT_540	[p14l1549t2242r1632b2337],
7	Benetatos	NNP	PERSON	Benetatos	nn	8	SENT_540	[p14l1692t2244r2141b2323],
8	CA	NNP	O	CA	appos	2	SENT_540	[p14l185t2359r368b2453],
9	,	,	O	,	_	0	SENT_540	[p14l185t2359r368b2453],
10	et	FW	O	et	nn	11	SENT_540	[p14l429t2369r510b2439],
11	al.	FW	O	al.	appos	2	SENT_540	[p14l565t2357r667b2439],
12	1996	CD	DATE	1996	dep	11	SENT_540	[p14l738t2357r979b2440],
13	.	.	O	.	_	0	SENT_540	[p14l738t2357r979b2440],

1	Altered	JJ	O	altered	amod	4	SENT_541	[p14l1038t2357r1384b2439],
2	tubulin	NN	O	tubulin	nn	4	SENT_541	[p14l1436t2357r1759b2439],
3	isotype	NN	O	isotype	nn	4	SENT_541	[p14l1814t2357r2144b2463],
4	expression	NN	O	expression	_	0	SENT_541	[p14l185t2473r677b2578],
5	in	IN	O	in	_	0	SENT_541	[p14l702t2473r789b2554],
6	a	DT	O	a	det	7	SENT_541	[p14l815t2499r864b2554],
7	non	JJ	O	non	prep_in	4	SENT_541	[p14l886t2474r1406b2554],
8	.	.	O	.	_	0	SENT_541	[p14l886t2474r1406b2554],

1	—	NN	O	—	_	0	SENT_542	[p14l886t2474r1406b2554],
2	.	.	O	.	_	0	SENT_542	[p14l886t2474r1406b2554],

1	MDR1	NN	O	mdr1	nsubj	2	SENT_543	[p14l886t2474r1406b2554],
2	mediated	VBD	O	mediate	_	0	SENT_543	[p14l1441t2473r1863b2554],
3	paclitaxel	NN	O	paclitaxel	npadvmod	5	SENT_543	[p14l1884t2473r2141b2578, p14l185t2590r831b2672],
4	—	CD	NUMBER	—	num	3	SENT_543	[p14l1884t2473r2141b2578, p14l185t2590r831b2672],
5	resistant	JJ	O	resistant	amod	10	SENT_543	[p14l1884t2473r2141b2578, p14l185t2590r831b2672],
6	human	JJ	O	human	amod	10	SENT_543	[p14l882t2590r1195b2672],
7	prostate	NN	O	prostate	nn	10	SENT_543	[p14l1247t2602r1611b2696],
8	carcinoma	NN	O	carcinoma	nn	10	SENT_543	[p14l1668t2590r2146b2672],
9	cell	NN	O	cell	nn	10	SENT_543	[p14l185t2706r349b2786],
10	line	NN	O	line	dep	2	SENT_543	[p14l370t2706r562b2787],
11	.	.	O	.	_	0	SENT_543	[p14l370t2706r562b2787],

1	Proc	NNP	O	Proc	_	0	SENT_544	[p14l586t2709r824b2787],
2	.	.	O	.	_	0	SENT_544	[p14l586t2709r824b2787],

1	Am	NNP	O	Am	_	0	SENT_545	[p14l848t2707r1026b2787],
2	.	.	O	.	_	0	SENT_545	[p14l848t2707r1026b2787],

1	Assoc	NNP	O	Assoc	_	0	SENT_546	[p14l1049t2707r1342b2787],
2	.	.	O	.	_	0	SENT_546	[p14l1049t2707r1342b2787],

1	Can	MD	O	can	_	0	SENT_547	[p14l1378t2708r1581b2788],
2	.	.	O	.	_	0	SENT_547	[p14l1378t2708r1581b2788],

1	Res	NNP	O	Res	_	0	SENT_548	[p14l1608t2709r1794b2788],
2	.	.	O	.	_	0	SENT_548	[p14l1608t2709r1794b2788],

1	372439	CD	NUMBER	372439	_	0	SENT_549	[p14l1830t2706r2142b2788],

1	(	NN	O	(	nn	2	SENT_550	[p14l188t2824r534b2925],
2	Abstr	NN	O	abstr	_	0	SENT_550	[p14l188t2824r534b2925],
3	.	.	O	.	_	0	SENT_550	[p14l188t2824r534b2925],
4	)	SYM	O	)	dep	2	SENT_550	[p14l188t2824r534b2925],

1	Rowinsky	NNP	PERSON	Rowinsky	nn	2	SENT_551	[p14l185t2940r649b3045],
2	EK	NNP	PERSON	EK	_	0	SENT_551	[p14l689t2942r866b3036],
3	,	,	O	,	_	0	SENT_551	[p14l689t2942r866b3036],
4	Donehower	NNP	PERSON	Donehower	nn	5	SENT_551	[p14l909t2940r1448b3022],
5	RC	NNP	O	RC	appos	2	SENT_551	[p14l1485t2940r1661b3036],
6	,	,	O	,	_	0	SENT_551	[p14l1485t2940r1661b3036],
7	Jones	NNP	PERSON	Jones	nn	8	SENT_551	[p14l1703t2942r1954b3022],
8	RJ	NN	PERSON	rj	appos	2	SENT_551	[p14l1996t2942r2141b3036],
9	,	,	O	,	_	0	SENT_551	[p14l1996t2942r2141b3036],
10	Tucker	NNP	PERSON	Tucker	nn	11	SENT_551	[p14l185t3059r508b3140],
11	RW	NNP	O	RW	appos	2	SENT_551	[p14l569t3061r757b3140],
12	.	.	O	.	_	0	SENT_551	[p14l569t3061r757b3140],

1	1988	CD	DATE	1988	_	0	SENT_552	[p14l837t3059r1077b3141],
2	.	.	O	.	_	0	SENT_552	[p14l837t3059r1077b3141],

1	Microtubule	JJ	O	microtubule	amod	2	SENT_553	[p14l1144t3059r1710b3140],
2	changes	NNS	O	change	nsubj	9	SENT_553	[p14l1776t3059r2142b3164],
3	and	CC	O	and	_	0	SENT_553	[p14l187t3176r351b3257],
4	cytotoxicity	NN	O	cytotoxicity	nsubj	9	SENT_553	[p14l424t3176r967b3281],
5	in	IN	O	in	_	0	SENT_553	[p14l1041t3176r1129b3255],
6	leukemic	JJ	O	leukemic	amod	8	SENT_553	[p14l1200t3176r1620b3257],
7	cell	NN	O	cell	nn	8	SENT_553	[p14l1694t3176r1858b3257],
8	lines	NNS	O	line	prep_in	4	SENT_553	[p14l1929t3176r2141b3257],
9	treated	VBN	O	treat	_	0	SENT_553	[p14l185t3291r497b3373],
10	with	IN	O	with	_	0	SENT_553	[p14l542t3291r744b3373],
11	taxol	NN	O	taxol	prep_with	9	SENT_553	[p14l788t3291r1038b3373],
12	.	.	O	.	_	0	SENT_553	[p14l788t3291r1038b3373],

1	Cancer	NN	O	cancer	_	0	SENT_554	[p14l1096t3293r1432b3374],
2	Res	NNP	O	Res	dep	1	SENT_554	[p14l1469t3294r1654b3373],
3	.	.	O	.	_	0	SENT_554	[p14l1469t3294r1654b3373],

1	4824093Dumontet	NN	O	4824093dumontet	_	0	SENT_555	[p14l1711t3292r2146b3375, p14l185t3529r646b3608],

1	C	NN	O	c	_	0	SENT_556	[p14l681t3527r778b3622],
2	,	,	O	,	_	0	SENT_556	[p14l681t3527r778b3622],
3	Duran	NNP	ORGANIZATION	Duran	nn	4	SENT_556	[p14l818t3529r1106b3608],
4	GE	NNP	ORGANIZATION	GE	appos	1	SENT_556	[p14l1144t3527r1319b3623],
5	,	,	O	,	_	0	SENT_556	[p14l1144t3527r1319b3623],
6	Steger	NNP	PERSON	Steger	nn	7	SENT_556	[p14l1362t3527r1654b3632],
7	KA	NN	O	ka	appos	1	SENT_556	[p14l1690t3527r1878b3623],
8	,	,	O	,	_	0	SENT_556	[p14l1690t3527r1878b3623],
9	et	FW	O	et	nn	10	SENT_556	[p14l1919t3539r2001b3608],
10	al.	FW	O	al.	appos	1	SENT_556	[p14l2038t3527r2139b3608],
11	.	.	O	.	_	0	SENT_556	[p14l2038t3527r2139b3608],

1	from	IN	O	from	_	0	SENT_557	[p15l7t2118r64b2278],
2	www.annualreViews.org	NN	O	www.annualreviews.org	pobj	1	SENT_557	[p15l7t1293r82b2096],
3	5/14	CD	NUMBER	5/14	num	2	SENT_557	[p15l89t2135r147b2295],
4	.	.	O	.	_	0	SENT_557	[p15l89t2135r147b2295],

1	For	IN	O	for	_	0	SENT_558	[p15l91t1994r147b2108],
2	personal	JJ	O	personal	amod	3	SENT_558	[p15l90t1695r164b1973],
3	use	NN	O	use	pobj	1	SENT_558	[p15l107t1565r147b1673],
4	only	RB	O	only	advmod	3	SENT_558	[p15l90t1381r164b1541],
5	.	.	O	.	_	0	SENT_558	[p15l90t1381r164b1541],

1	Med	NNP	O	Med	_	0	SENT_559	[p15l7t3498r64b3664],
2	.	.	O	.	_	0	SENT_559	[p15l7t3498r64b3664],

1	1997.48:353	CD	NUMBER	1997.48:353	num	2	SENT_560	[p15l7t2889r65b3463],
2	-374	CD	NUMBER	-374	_	0	SENT_560	[p15l7t2889r65b3463],
3	.	.	O	.	_	0	SENT_560	[p15l7t2889r65b3463],

1	Downloaded	VBN	O	download	_	0	SENT_561	[p15l7t2442r65b2862],
2	rsity	NN	O	rsity	dobj	1	SENT_561	[p15l90t3529r164b3674],
3	of	IN	O	of	_	0	SENT_561	[p15l89t3434r147b3505],
4	Wisconsin	NNP	LOCATION	Wisconsin	nn	6	SENT_561	[p15l90t3068r147b3418],
5	—	NNP	O	—	nn	6	SENT_561	[p15l124t3023r130b3044],
6	Madison	NNP	O	Madison	prep_of	2	SENT_561	[p15l90t2711r147b2998],
7	on	IN	O	on	_	0	SENT_561	[p15l107t2608r147b2687],
8	01/0	CD	NUMBER	01/0	prep_on	6	SENT_561	[p15l90t2441r147b2585],

1	1996	CD	DATE	1996	_	0	SENT_562	[p15l764t100r934b158],
2	.	.	O	.	_	0	SENT_562	[p15l764t100r934b158],

1	Resistance	NN	O	resistance	nn	2	SENT_563	[p15l981t100r1330b157],
2	mechanisms	NNS	O	mechanism	_	0	SENT_563	[p15l1374t100r1776b157],
3	in	IN	O	in	_	0	SENT_563	[p15l1821t100r1883b156],
4	human	JJ	O	human	amod	6	SENT_563	[p15l1925t100r2147b157],
5	sarcoma	NN	O	sarcoma	nn	6	SENT_563	[p15l759t199r1030b238],
6	mutants	NNS	O	mutant	prep_in	2	SENT_563	[p15l1044t189r1299b238],
7	derived	VBN	O	derive	partmod	6	SENT_563	[p15l1319t180r1564b239],
8	by	IN	O	by	_	0	SENT_563	[p15l1578t180r1659b255],
9	single	JJ	O	single	agent	7	SENT_563	[p15l1679t180r1893b255],
10	-	:	O	-	_	0	SENT_563	[p15l1679t180r1893b255],
11	step	NN	O	step	nn	12	SENT_563	[p15l1901t189r2028b255],
12	exposure	NN	O	exposure	dep	2	SENT_563	[p15l2045t199r2144b238, p15l755t280r973b336],
13	to	TO	O	to	_	0	SENT_563	[p15l1006t270r1067b319],
14	paclitaxel	NN	O	paclitaxel	nn	17	SENT_563	[p15l1099t262r1416b336],
15	(	CD	NUMBER	(	num	17	SENT_563	[p15l1450t262r1701b332],
16	Taxol	NN	O	taxol	nn	17	SENT_563	[p15l1450t262r1701b332],
17	)	NN	O	)	prep_to	12	SENT_563	[p15l1450t262r1701b332],
18	.	.	O	.	_	0	SENT_563	[p15l1450t262r1701b332],

1	Cancer	NN	O	cancer	_	0	SENT_564	[p15l1741t263r1980b320],
2	Res	NNP	O	Res	dep	1	SENT_564	[p15l2007t264r2138b320],
3	.	.	O	.	_	0	SENT_564	[p15l2007t264r2138b320],

1	56	CD	NUMBER	56	_	0	SENT_565	[p15l757t343r853b401],
2	:	:	O	:	_	0	SENT_565	[p15l757t343r853b401],
3	1091-97	CD	NUMBER	1091-97	num	5	SENT_565	[p15l869t344r1142b402],
4	Rowinsky	NNP	O	Rowinsky	nn	5	SENT_565	[p15l756t424r1086b498],
5	EK	NNP	O	EK	dep	1	SENT_565	[p15l1127t425r1251b481],
6	.	.	O	.	_	0	SENT_565	[p15l1127t425r1251b481],

1	1995	CD	DATE	1995	_	0	SENT_566	[p15l1305t424r1474b482],
2	.	.	O	.	_	0	SENT_566	[p15l1305t424r1474b482],

1	Pharmacology	NN	O	pharmacology	_	0	SENT_567	[p15l1519t424r1990b498],
2	and	CC	O	and	_	0	SENT_567	[p15l2032t424r2148b481],
3	metabolism	NN	O	metabolism	conj_and	1	SENT_567	[p15l756t506r1153b563],
4	.	.	O	.	_	0	SENT_567	[p15l756t506r1153b563],

1	In	IN	O	in	_	0	SENT_568	[p15l1176t507r1243b562],
2	Paclitaxel	NN	O	paclitaxel	prep_in	7	SENT_568	[p15l1261t506r1594b563],
3	in	IN	O	in	_	0	SENT_568	[p15l1613t508r1672b563],
4	Cancer	NNP	O	Cancer	nn	5	SENT_568	[p15l1696t507r1935b564],
5	Treatment	NN	O	treatment	prep_in	2	SENT_568	[p15l1955t508r2143b563, p15l756t599r931b656],
6	,	,	O	,	_	0	SENT_568	[p15l1955t508r2143b563, p15l756t599r931b656],
7	ed	VBN	O	ed	_	0	SENT_568	[p15l954t588r1045b645],
8	.	.	O	.	_	0	SENT_568	[p15l954t588r1045b645],

1	WG	NNP	PERSON	WG	nn	2	SENT_569	[p15l1067t588r1204b645],
2	McGuire	NNP	PERSON	McGuire	_	0	SENT_569	[p15l1222t588r1535b655],
3	,	,	O	,	_	0	SENT_569	[p15l1222t588r1535b655],
4	EK	NNP	PERSON	EK	nn	5	SENT_569	[p15l1556t589r1665b644],
5	Rowinsky	NNP	PERSON	Rowinsky	appos	2	SENT_569	[p15l1683t588r2024b662],
6	,	,	O	,	_	0	SENT_569	[p15l1683t588r2024b662],
7	pp	NN	O	pp	appos	5	SENT_569	[p15l2045t605r2142b662],
8	.	.	O	.	_	0	SENT_569	[p15l2045t605r2142b662],

1	91-120	CD	NUMBER	91-120	_	0	SENT_570	[p15l757t669r1016b726],
2	.	.	O	.	_	0	SENT_570	[p15l757t669r1016b726],

1	New	NNP	LOCATION	New	nn	2	SENT_571	[p15l1041t670r1195b726],
2	York	NNP	LOCATION	York	_	0	SENT_571	[p15l1217t668r1391b726],
3	:	:	O	:	_	0	SENT_571	[p15l1217t668r1391b726],
4	Dekker	NNP	PERSON	Dekker	nn	6	SENT_571	[p15l1417t668r1658b726],
5	Rowinsky	NNP	PERSON	Rowinsky	nn	6	SENT_571	[p15l756t750r1086b824],
6	EK	NNP	O	EK	dep	2	SENT_571	[p15l1108t751r1233b818],
7	,	,	O	,	_	0	SENT_571	[p15l1108t751r1233b818],
8	Gilbert	NNP	PERSON	Gilbert	nn	9	SENT_571	[p15l1259t750r1489b808],
9	M	NNP	PERSON	M	appos	6	SENT_571	[p15l1509t751r1598b818],
10	,	,	O	,	_	0	SENT_571	[p15l1509t751r1598b818],
11	McGuire	NNP	PERSON	McGuire	nn	12	SENT_571	[p15l1621t750r1915b808],
12	WP	NNP	O	WP	appos	6	SENT_571	[p15l1935t751r2065b818],
13	,	,	O	,	_	0	SENT_571	[p15l1935t751r2065b818],
14	et	FW	O	et	nn	15	SENT_571	[p15l2090t758r2148b807],
15	al.	FW	O	al.	appos	6	SENT_571	[p15l758t831r830b890],
16	1991	CD	DATE	1991	dep	15	SENT_571	[p15l866t832r1036b891],
17	.	.	O	.	_	0	SENT_571	[p15l866t832r1036b891],

1	Sequences	NNS	O	sequence	_	0	SENT_572	[p15l1067t832r1408b907],
2	of	IN	O	of	_	0	SENT_572	[p15l1435t831r1506b890],
3	taxol	NN	O	taxol	prep_of	1	SENT_572	[p15l1523t831r1686b890],
4	and	CC	O	and	_	0	SENT_572	[p15l1712t831r1827b890],
5	cisplatin	NN	O	cisplatin	prep_of	1	SENT_572	[p15l1851t831r2141b907],
6	:	:	O	:	_	0	SENT_572	[p15l1851t831r2141b907],
7	a	DT	O	a	det	9	SENT_572	[p15l758t931r792b970],
8	phase	NN	O	phase	nn	9	SENT_572	[p15l810t913r995b987],
9	I	NN	O	i	dep	1	SENT_572	[p15l1017t914r1042b970],
10	and	CC	O	and	_	0	SENT_572	[p15l1064t913r1180b970],
11	pharmacologic	JJ	O	pharmacologic	amod	12	SENT_572	[p15l1197t913r1681b987],
12	study	NN	O	study	conj_and	9	SENT_572	[p15l1705t913r1888b987],
13	.	.	O	.	_	0	SENT_572	[p15l1705t913r1888b987],

1	J.	NNP	PERSON	J.	nn	2	SENT_573	[p15l1910t915r1959b971],
2	Clin	NNP	PERSON	Clin	_	0	SENT_573	[p15l1992t913r2138b971],
3	.	.	O	.	_	0	SENT_573	[p15l1992t913r2138b971],

1	Oncol	NN	O	oncol	_	0	SENT_574	[p15l760t995r967b1053],
2	.	.	O	.	_	0	SENT_574	[p15l760t995r967b1053],

1	9:1692	CD	NUMBER	9:1692	num	4	SENT_575	[p15l998t995r1382b1053],
2	-703	CD	NUMBER	-703	num	4	SENT_575	[p15l998t995r1382b1053],
3	Rowinsky	NNP	PERSON	Rowinsky	nn	4	SENT_575	[p15l756t1076r1086b1151],
4	EK	NNP	O	EK	_	0	SENT_575	[p15l1109t1078r1234b1145],
5	,	,	O	,	_	0	SENT_575	[p15l1109t1078r1234b1145],
6	Citardi	NNP	O	Citardi	nn	7	SENT_575	[p15l1261t1076r1486b1135],
7	M	NNP	O	M	appos	4	SENT_575	[p15l1509t1078r1597b1145],
8	,	,	O	,	_	0	SENT_575	[p15l1509t1078r1597b1145],
9	Noe	NNP	ORGANIZATION	Noe	nn	10	SENT_575	[p15l1623t1078r1758b1134],
10	DA	NNP	ORGANIZATION	DA	appos	4	SENT_575	[p15l1784t1077r1918b1145],
11	,	,	O	,	_	0	SENT_575	[p15l1784t1077r1918b1145],
12	Donehower	NNP	PERSON	Donehower	nn	13	SENT_575	[p15l1944t1078r2145b1134, p15l756t1158r961b1215],
13	RC	NNP	O	RC	appos	4	SENT_575	[p15l984t1158r1107b1216],
14	.	.	O	.	_	0	SENT_575	[p15l984t1158r1107b1216],

1	1993	CD	DATE	1993	_	0	SENT_576	[p15l1145t1158r1315b1216],
2	.	.	O	.	_	0	SENT_576	[p15l1145t1158r1315b1216],

1	Sequence-dependent	JJ	O	sequence-dependent	amod	2	SENT_577	[p15l1345t1158r2022b1232],
2	cytotoxicity	NN	O	cytotoxicity	_	0	SENT_577	[p15l2044t1176r2144b1232, p15l756t1240r1066b1315],
3	between	IN	O	between	_	0	SENT_577	[p15l1083t1240r1356b1298],
4	cisplatin	NN	O	cisplatin	prep_between	2	SENT_577	[p15l1373t1240r1648b1315],
5	and	CC	O	and	_	0	SENT_577	[p15l1666t1240r1783b1297],
6	the	DT	O	the	det	9	SENT_577	[p15l1798t1240r1896b1297],
7	antimicrotubule	JJ	O	antimicrotubule	amod	9	SENT_577	[p15l1915t1240r2145b1297, p15l757t1323r1062b1380],
8	agents	NNS	O	agent	nn	9	SENT_577	[p15l1101t1331r1305b1397],
9	taxol	NN	O	taxol	prep_between	2	SENT_577	[p15l1343t1323r1505b1380],
10	and	CC	O	and	_	0	SENT_577	[p15l1542t1323r1658b1380],
11	Vincristine	NN	O	vincristine	conj_and	9	SENT_577	[p15l1693t1323r2052b1380],
12	.	.	O	.	_	0	SENT_577	[p15l1693t1323r2052b1380],

1	J.	NNP	O	J.	nn	3	SENT_578	[p15l2090t1325r2138b1381],
2	Cancer	NNP	O	Cancer	nn	3	SENT_578	[p15l760t1406r999b1463],
3	Res	NNP	O	Res	_	0	SENT_578	[p15l1016t1407r1148b1463],
4	.	.	O	.	_	0	SENT_578	[p15l1016t1407r1148b1463],

1	Clin	NNP	O	Clin	_	0	SENT_579	[p15l1182t1405r1329b1463],
2	.	.	O	.	_	0	SENT_579	[p15l1182t1405r1329b1463],

1	Oncol	NN	O	oncol	_	0	SENT_580	[p15l1363t1405r1570b1463],
2	.	.	O	.	_	0	SENT_580	[p15l1363t1405r1570b1463],

1	1191737-43	CD	NUMBER	1191737-43	num	3	SENT_581	[p15l1607t1405r1981b1463],
2	Rowinsky	NNP	PERSON	Rowinsky	nn	3	SENT_581	[p15l756t1487r1086b1562],
3	EK	NNP	O	EK	_	0	SENT_581	[p15l1101t1489r1227b1556],
4	,	,	O	,	_	0	SENT_581	[p15l1101t1489r1227b1556],
5	Donehower	NNP	PERSON	Donehower	nn	6	SENT_581	[p15l1245t1487r1628b1545],
6	RC	NNP	O	RC	appos	3	SENT_581	[p15l1640t1488r1764b1545],
7	.	.	O	.	_	0	SENT_581	[p15l1640t1488r1764b1545],

1	1995	CD	DATE	1995	_	0	SENT_582	[p15l1791t1487r1961b1546],
2	.	.	O	.	_	0	SENT_582	[p15l1791t1487r1961b1546],

1	Drug	NN	O	drug	nn	2	SENT_583	[p15l1981t1489r2146b1562],
2	therapy	NN	O	therapy	_	0	SENT_583	[p15l756t1569r1016b1645],
3	:	:	O	:	_	0	SENT_583	[p15l756t1569r1016b1645],
4	paclitaxel	NN	O	paclitaxel	nn	7	SENT_583	[p15l1036t1569r1352b1645],
5	(	CD	NUMBER	(	num	7	SENT_583	[p15l1368t1570r1441b1641],
6	T	NN	O	t	nn	7	SENT_583	[p15l1368t1570r1441b1641],
7	axol	NN	O	axol	dep	2	SENT_583	[p15l1439t1570r1620b1641],
8	)	NN	O	)	dep	7	SENT_583	[p15l1439t1570r1620b1641],
9	.	.	O	.	_	0	SENT_583	[p15l1439t1570r1620b1641],

1	N.	NNP	O	N.	nn	2	SENT_584	[p15l1634t1572r1703b1628],
2	Engl	NNP	O	Engl	_	0	SENT_584	[p15l1723t1569r1891b1644],
3	.	.	O	.	_	0	SENT_584	[p15l1723t1569r1891b1644],

1	J.	NNP	O	J.	nn	2	SENT_585	[p15l1910t1572r1960b1628],
2	Med	NNP	O	Med	_	0	SENT_585	[p15l1978t1570r2138b1628],
3	.	.	O	.	_	0	SENT_585	[p15l1978t1570r2138b1628],

1	332	CD	NUMBER	332	_	0	SENT_586	[p15l758t1653r894b1711],
2	:	:	O	:	_	0	SENT_586	[p15l758t1653r894b1711],
3	1004-14	CD	NUMBER	1004-14	dep	1	SENT_586	[p15l909t1653r1185b1711],
4	Gianni	NNP	PERSON	Gianni	nn	5	SENT_586	[p15l757t1735r977b1793],
5	L	NNP	PERSON	L	dep	1	SENT_586	[p15l996t1737r1062b1803],
6	,	,	O	,	_	0	SENT_586	[p15l996t1737r1062b1803],
7	Munzone	NNP	O	Munzone	nn	8	SENT_586	[p15l1083t1737r1391b1793],
8	E	NNP	O	E	appos	1	SENT_586	[p15l1411t1737r1477b1803],
9	,	,	O	,	_	0	SENT_586	[p15l1411t1737r1477b1803],
10	Capri	NNP	O	Capri	nn	11	SENT_586	[p15l1499t1735r1679b1810],
11	G	NNP	O	G	appos	1	SENT_586	[p15l1697t1736r1771b1803],
12	,	,	O	,	_	0	SENT_586	[p15l1697t1736r1771b1803],
13	et	FW	O	et	nn	14	SENT_586	[p15l1794t1744r1851b1793],
14	al.	FW	O	al.	appos	1	SENT_586	[p15l1870t1735r1942b1793],
15	1995	CD	DATE	1995	dep	14	SENT_586	[p15l1972t1735r2142b1794],
16	.	.	O	.	_	0	SENT_586	[p15l1972t1735r2142b1794],

1	Paclitaxel	NN	O	paclitaxel	_	0	SENT_587	[p15l756t1817r1076b1875],
2	by	IN	O	by	_	0	SENT_587	[p15l1104t1817r1185b1891],
3	3-hour	JJ	DURATION	3-hour	amod	4	SENT_587	[p15l1214t1817r1430b1875],
4	infusion	NN	O	infusion	prep_by	1	SENT_587	[p15l1457t1817r1723b1875],
5	in	IN	O	in	_	0	SENT_587	[p15l1751t1817r1813b1874],
6	combination	NN	O	combination	prep_in	4	SENT_587	[p15l1841t1817r2145b1875, p15l756t1900r881b1958],
7	with	IN	O	with	_	0	SENT_587	[p15l900t1900r1044b1958],
8	bolus	NN	O	bolus	nn	9	SENT_587	[p15l1060t1900r1234b1958],
9	doxorubicin	NN	O	doxorubicin	prep_with	6	SENT_587	[p15l1256t1900r1648b1958],
10	in	IN	O	in	_	0	SENT_587	[p15l1666t1900r1729b1957],
11	women	NNS	O	woman	prep_in	9	SENT_587	[p15l1747t1918r1987b1958],
12	with	IN	O	with	_	0	SENT_587	[p15l2004t1900r2147b1958],
13	untreated	JJ	O	untreated	amod	14	SENT_587	[p15l756t1982r1059b2040],
14	metastatic	JJ	O	metastatic	amod	16	SENT_587	[p15l1076t1982r1404b2040],
15	breast	NN	O	breast	nn	16	SENT_587	[p15l1421t1982r1618b2040],
16	cancer	NN	O	cancer	prep_with	11	SENT_587	[p15l1633t2001r1862b2040],
17	:	:	O	:	_	0	SENT_587	[p15l1633t2001r1862b2040],
18	high	JJ	O	high	amod	20	SENT_587	[p15l1884t1982r2028b2057],
19	antitumor	NN	O	antitumor	nn	20	SENT_587	[p15l2046t2001r2144b2040, p15l756t2066r996b2124],
20	efficacy	NN	O	efficacy	dep	1	SENT_587	[p15l1033t2066r1294b2140],
21	and	CC	O	and	_	0	SENT_587	[p15l1333t2066r1449b2124],
22	cardiac	JJ	O	cardiac	amod	23	SENT_587	[p15l1488t2065r1720b2124],
23	effects	NNS	O	effect	conj_and	20	SENT_587	[p15l1760t2065r1974b2124],
24	in	IN	O	in	_	0	SENT_587	[p15l2013t2065r2075b2123],
25	a	DT	O	a	det	28	SENT_587	[p15l2113t2084r2147b2124],
26	dose	NN	O	dose	nn	28	SENT_587	[p15l757t2147r1167b2222],
27	—	NN	O	—	nn	28	SENT_587	[p15l757t2147r1167b2222],
28	finding	NN	O	finding	prep_in	20	SENT_587	[p15l757t2147r1167b2222],
29	and	CC	O	and	_	0	SENT_587	[p15l1206t2147r1322b2206],
30	sequence-finding	NN	O	sequence-finding	nn	31	SENT_587	[p15l1361t2147r1919b2222],
31	study	NN	O	study	prep_in	20	SENT_587	[p15l1960t2147r2143b2222],
32	.	.	O	.	_	0	SENT_587	[p15l1960t2147r2143b2222],

1	J.	NNP	PERSON	J.	nn	2	SENT_588	[p15l755t2233r803b2289],
2	Clin	NNP	PERSON	Clin	_	0	SENT_588	[p15l838t2230r985b2289],
3	.	.	O	.	_	0	SENT_588	[p15l838t2230r985b2289],

1	Oncol	NN	O	oncol	_	0	SENT_589	[p15l1019t2230r1226b2289],
2	.	.	O	.	_	0	SENT_589	[p15l1019t2230r1226b2289],

1	13:2688	CD	NUMBER	13:2688	_	0	SENT_590	[p15l1263t2230r1642b2289],
2	—	CD	NUMBER	—	num	3	SENT_590	[p15l1263t2230r1642b2289],
3	99	CD	NUMBER	99	dep	1	SENT_590	[p15l1263t2230r1642b2289],

1	Kennedy	NNP	PERSON	Kennedy	nn	2	SENT_591	[p15l757t2456r1050b2530],
2	MJ	NNP	PERSON	MJ	_	0	SENT_591	[p15l1094t2457r1215b2524],
3	,	,	O	,	_	0	SENT_591	[p15l1094t2457r1215b2524],
4	Zahurak	NNP	O	Zahurak	nn	5	SENT_591	[p15l1263t2456r1537b2513],
5	ML	NNP	O	ML	appos	2	SENT_591	[p15l1578t2457r1717b2524],
6	,	,	O	,	_	0	SENT_591	[p15l1578t2457r1717b2524],
7	Donehower	NNP	PERSON	Donehower	nn	8	SENT_591	[p15l1765t2456r2149b2513],
8	RC	NNP	O	RC	appos	2	SENT_591	[p15l756t2538r881b2606],
9	,	,	O	,	_	0	SENT_591	[p15l756t2538r881b2606],
10	et	FW	O	et	nn	11	SENT_591	[p15l903t2547r961b2596],
11	al.	FW	O	al.	appos	2	SENT_591	[p15l979t2538r1051b2596],
12	1995	CD	DATE	1995	dep	11	SENT_591	[p15l1082t2538r1252b2597],
13	.	.	O	.	_	0	SENT_591	[p15l1082t2538r1252b2597],

1	Phase	NN	O	phase	nn	2	SENT_592	[p15l1275t2538r1464b2596],
2	I	NN	O	i	nsubj	12	SENT_592	[p15l1483t2540r1508b2595],
3	and	CC	O	and	_	0	SENT_592	[p15l1529t2538r1645b2596],
4	pharmacologic	JJ	O	pharmacologic	amod	5	SENT_592	[p15l1661t2538r2146b2613],
5	study	NN	O	study	conj_and	2	SENT_592	[p15l759t2620r931b2695],
6	of	IN	O	of	_	0	SENT_592	[p15l953t2620r1024b2678],
7	sequences	NNS	O	sequence	prep_of	2	SENT_592	[p15l1040t2639r1367b2695],
8	of	IN	O	of	_	0	SENT_592	[p15l1390t2620r1461b2678],
9	paclitaxel	NN	O	paclitaxel	prep_of	7	SENT_592	[p15l1473t2620r1790b2695],
10	and	CC	O	and	_	0	SENT_592	[p15l1810t2620r1926b2678],
11	cyclophosphamide	NN	O	cyclophosphamide	prep_of	7	SENT_592	[p15l1945t2620r2144b2695, p15l755t2703r1190b2778],
12	supported	VBN	O	support	_	0	SENT_592	[p15l1251t2703r1570b2778],
13	by	IN	O	by	_	0	SENT_592	[p15l1624t2703r1705b2778],
14	granulocyte	NN	O	granulocyte	nn	16	SENT_592	[p15l1763t2703r2147b2778],
15	colony-stimulating	JJ	O	colony-stimulating	amod	16	SENT_592	[p15l757t2785r1370b2860],
16	factor	NN	O	factor	prep_by	12	SENT_592	[p15l1407t2785r1597b2843],
17	in	IN	O	in	_	0	SENT_592	[p15l1632t2785r1694b2842],
18	women	NNS	O	woman	prep_in	16	SENT_592	[p15l1729t2803r1970b2843],
19	with	IN	O	with	_	0	SENT_592	[p15l2004t2785r2147b2843],
20	previous1y	JJ	O	previous1y	amod	21	SENT_592	[p15l755t2869r1351b2943],
21	—	NN	O	—	prep_with	12	SENT_592	[p15l755t2869r1351b2943],
22	treated	VBN	O	treat	partmod	21	SENT_592	[p15l755t2869r1351b2943],
23	metastatic	JJ	O	metastatic	amod	25	SENT_592	[p15l1364t2869r1693b2926],
24	breast	NN	O	breast	nn	25	SENT_592	[p15l1708t2869r1905b2926],
25	cancer	NN	O	cancer	dobj	22	SENT_592	[p15l1920t2887r2142b2926],
26	.	.	O	.	_	0	SENT_592	[p15l1920t2887r2142b2926],

1	J.	NNP	PERSON	J.	nn	2	SENT_593	[p15l755t2953r803b3009],
2	Clin	NNP	PERSON	Clin	_	0	SENT_593	[p15l838t2951r985b3009],
3	.	.	O	.	_	0	SENT_593	[p15l838t2951r985b3009],

1	Oncol	NN	O	oncol	_	0	SENT_594	[p15l1018t2951r1226b3009],
2	.	.	O	.	_	0	SENT_594	[p15l1018t2951r1226b3009],

1	14:783	CD	NUMBER	14:783	_	0	SENT_595	[p15l1263t2952r1596b3009],
2	-91	CD	NUMBER	-91	num	4	SENT_595	[p15l1263t2952r1596b3009],
3	Keams	NNP	O	Keams	nn	4	SENT_595	[p15l757t3035r985b3091],
4	CM	NN	O	cm	dep	1	SENT_595	[p15l1022t3033r1164b3101],
5	,	,	O	,	_	0	SENT_595	[p15l1022t3033r1164b3101],
6	Gianni	NNP	PERSON	Gianni	nn	7	SENT_595	[p15l1201t3032r1420b3091],
7	L	NNP	PERSON	L	appos	4	SENT_595	[p15l1453t3035r1519b3101],
8	,	,	O	,	_	0	SENT_595	[p15l1453t3035r1519b3101],
9	Egorin	NNP	O	Egorin	nn	10	SENT_595	[p15l1554t3032r1775b3107],
10	MJ	NNP	O	MJ	appos	4	SENT_595	[p15l1807t3034r1927b3091],
11	.	.	O	.	_	0	SENT_595	[p15l1807t3034r1927b3091],

1	1995	CD	DATE	1995	_	0	SENT_596	[p15l1972t3032r2142b3091],
2	.	.	O	.	_	0	SENT_596	[p15l1972t3032r2142b3091],

1	Paclitaxel	NN	O	paclitaxel	_	0	SENT_597	[p15l756t3116r1076b3174],
2	pharmacokinetics	NNS	O	pharmacokinetic	dep	1	SENT_597	[p15l1111t3116r1685b3191],
3	and	CC	O	and	_	0	SENT_597	[p15l1726t3116r1841b3174],
4	pharmacodynamics	NNS	O	pharmacodynamic	dep	1	SENT_597	[p15l1874t3116r2145b3191, p15l757t3198r1163b3273],
5	.	.	O	.	_	0	SENT_597	[p15l1874t3116r2145b3191, p15l757t3198r1163b3273],

1	Sem	NNP	O	Sem	_	0	SENT_598	[p15l1186t3200r1333b3257],
2	.	.	O	.	_	0	SENT_598	[p15l1186t3200r1333b3257],

1	Oncol	NN	O	oncol	_	0	SENT_599	[p15l1364t3198r1571b3257],
2	.	.	O	.	_	0	SENT_599	[p15l1364t3198r1571b3257],

1	22	CD	NUMBER	22	num	2	SENT_600	[p15l1599t3198r1913b3273],
2	(	CD	NUMBER	(	_	0	SENT_600	[p15l1599t3198r1913b3273],
3	Suppl	NNP	O	Suppl	dep	2	SENT_600	[p15l1599t3198r1913b3273],
4	.	.	O	.	_	0	SENT_600	[p15l1599t3198r1913b3273],

1	6	CD	NUMBER	6	num	2	SENT_601	[p15l1937t3198r2018b3269],
2	)	NN	O	)	_	0	SENT_601	[p15l1937t3198r2018b3269],
3	:	:	O	:	_	0	SENT_601	[p15l1937t3198r2018b3269],
4	1623	CD	DATE	1623	dep	2	SENT_601	[p15l2034t3198r2148b3257, p15l757t3281r832b3339],
5	Knick	NNP	O	Knick	nn	6	SENT_601	[p15l757t3364r956b3423],
6	VC	NNP	O	VC	dep	2	SENT_601	[p15l974t3365r1104b3433],
7	,	,	O	,	_	0	SENT_601	[p15l974t3365r1104b3433],
8	Eberwein	NNP	PERSON	Eberwein	nn	9	SENT_601	[p15l1127t3365r1441b3423],
9	DJ	NNP	O	DJ	appos	2	SENT_601	[p15l1461t3366r1567b3433],
10	,	,	O	,	_	0	SENT_601	[p15l1461t3366r1567b3433],
11	Miller	NNP	PERSON	Miller	nn	12	SENT_601	[p15l1590t3364r1794b3423],
12	CG	NNP	O	CG	appos	2	SENT_601	[p15l1813t3365r1941b3423],
13	.	.	O	.	_	0	SENT_601	[p15l1813t3365r1941b3423],

1	1995	CD	DATE	1995	_	0	SENT_602	[p15l1972t3364r2142b3423],
2	.	.	O	.	_	0	SENT_602	[p15l1972t3364r2142b3423],

1	Vinorelbine	NNP	O	Vinorelbine	_	0	SENT_603	[p15l756t3447r1139b3505],
2	tartrate	JJ	O	tartrate	amod	5	SENT_603	[p15l1169t3456r1399b3505],
3	and	CC	O	and	_	0	SENT_603	[p15l1429t3447r1545b3505],
4	paclitaxel	NN	O	paclitaxel	conj_and	2	SENT_603	[p15l1572t3447r1888b3522],
5	combinations	NNS	O	combination	dep	1	SENT_603	[p15l1918t3447r2145b3505, p15l756t3530r1008b3588],
6	:	:	O	:	_	0	SENT_603	[p15l1918t3447r2145b3505, p15l756t3530r1008b3588],
7	enhanced	VBN	O	enhance	amod	8	SENT_603	[p15l1043t3530r1352b3588],
8	activity	NN	O	activity	dep	1	SENT_603	[p15l1383t3530r1623b3605],
9	against	IN	O	against	prep	8	SENT_603	[p15l1655t3530r1885b3605],
10	in	FW	O	in	nn	11	SENT_603	[p15l1913t3530r1975b3587],
11	vivo	FW	O	vivo	dep	12	SENT_603	[p15l2003t3530r2146b3588],
12	P388	NN	O	p388	dep	15	SENT_603	[p15l756t3613r921b3671],
13	murine	JJ	O	murine	amod	15	SENT_603	[p15l950t3613r1180b3670],
14	leukemia	NN	O	leukemia	nn	15	SENT_603	[p15l1207t3613r1505b3670],
15	cells	NNS	O	cell	dep	9	SENT_603	[p15l1532t3613r1695b3670],
16	.	.	O	.	_	0	SENT_603	[p15l1532t3613r1695b3670],

1	J.	NNP	MISC	J.	nn	2	SENT_604	[p15l1723t3615r1772b3671],
2	Natl.	NNP	MISC	Natl.	nsubj	3	SENT_604	[p15l1804t3613r1959b3671],
3	Can	MD	MISC	can	_	0	SENT_604	[p15l1996t3614r2139b3671],
4	.	.	O	.	_	0	SENT_604	[p15l1996t3614r2139b3671],

1	Annu	NNP	PERSON	Annu	_	0	SENT_605	[p16l7t301r64b499],
2	.	.	O	.	_	0	SENT_605	[p16l7t301r64b499],

1	Rev.	NNP	O	Rev.	_	0	SENT_606	[p16l8t127r64b274],

1	by	IN	O	by	_	0	SENT_607	[p16l90t335r164b415],
2	Unive	NNP	PERSON	Unive	pobj	1	SENT_607	[p16l90t113r147b311],

1	Inst	NNP	O	Inst	_	0	SENT_608	[p16l755t134r889b190],
2	.	.	O	.	_	0	SENT_608	[p16l755t134r889b190],

1	87	CD	NUMBER	87	_	0	SENT_609	[p16l923t132r1306b190],
2	:	:	O	:	_	0	SENT_609	[p16l923t132r1306b190],
3	l072	CD	NUMBER	l072	dep	1	SENT_609	[p16l923t132r1306b190],
4	—	CD	NUMBER	—	number	5	SENT_609	[p16l923t132r1306b190],
5	77	CD	NUMBER	77	dep	3	SENT_609	[p16l923t132r1306b190],

1	26	CD	NUMBER	26	_	0	SENT_610	[p16l622t214r718b272],
2	.	.	O	.	_	0	SENT_610	[p16l622t214r718b272],

1	Bissery	NNP	O	Bissery	nn	2	SENT_611	[p16l756t214r999b289],
2	MC	NNP	O	MC	_	0	SENT_611	[p16l1022t214r1166b282],
3	,	,	O	,	_	0	SENT_611	[p16l1022t214r1166b282],
4	Vrignaud	NNP	PERSON	Vrignaud	nn	5	SENT_611	[p16l1192t214r1495b289],
5	P	NN	PERSON	p	appos	2	SENT_611	[p16l1517t216r1569b282],
6	,	,	O	,	_	0	SENT_611	[p16l1517t216r1569b282],
7	Bayssas	NNP	O	Bayssas	nn	8	SENT_611	[p16l1594t216r1855b289],
8	M	NNP	O	M	appos	2	SENT_611	[p16l1879t216r1969b283],
9	,	,	O	,	_	0	SENT_611	[p16l1879t216r1969b283],
10	Lavelle	NNP	PERSON	Lavelle	nn	11	SENT_611	[p16l1993t216r2145b272, p16l757t297r871b355],
11	F.	NNP	O	F.	appos	2	SENT_611	[p16l897t298r950b355],
12	1995	CD	DATE	1995	dep	11	SENT_611	[p16l988t296r1158b356],
13	.	.	O	.	_	0	SENT_611	[p16l988t296r1158b356],

1	Preclinical	JJ	O	preclinical	_	0	SENT_612	[p16l1187t296r1535b355],
2	in	FW	O	in	nn	3	SENT_612	[p16l1560t296r1622b353],
3	vivo	FW	O	vivo	advmod	4	SENT_612	[p16l1646t296r1788b355],
4	activity	NN	O	activity	rcmod	1	SENT_612	[p16l1816t296r2056b372],
5	of	IN	O	of	_	0	SENT_612	[p16l2082t296r2153b355],
6	docetaXel	NN	O	docetaxel	nn	7	SENT_612	[p16l757t379r1439b454],
7	—	NN	O	—	prep_of	4	SENT_612	[p16l757t379r1439b454],
8	containing	VBG	O	contain	partmod	1	SENT_612	[p16l757t379r1439b454],
9	combinations	NNS	O	combination	dobj	8	SENT_612	[p16l1477t379r1931b437],
10	.	.	O	.	_	0	SENT_612	[p16l1477t379r1931b437],

1	Proc	NNP	O	Proc	_	0	SENT_613	[p16l1970t381r2139b437],
2	.	.	O	.	_	0	SENT_613	[p16l1970t381r2139b437],

1	Am	NNP	O	Am	_	0	SENT_614	[p16l751t463r876b520],
2	.	.	O	.	_	0	SENT_614	[p16l751t463r876b520],

1	Soc	NN	O	soc	_	0	SENT_615	[p16l907t463r1036b521],
2	.	.	O	.	_	0	SENT_615	[p16l907t463r1036b521],

1	Clin	NNP	O	Clin	_	0	SENT_616	[p16l1070t462r1217b521],
2	.	.	O	.	_	0	SENT_616	[p16l1070t462r1217b521],

1	Oncol	NN	O	oncol	_	0	SENT_617	[p16l1250t462r1458b521],
2	.	.	O	.	_	0	SENT_617	[p16l1250t462r1458b521],

1	14:489	CD	NUMBER	14:489	number	2	SENT_618	[p16l1495t463r1711b521],
2	(	CD	NUMBER	(	_	0	SENT_618	[p16l1737t462r1982b534],
3	Abstr	NNP	O	Abstr	dep	2	SENT_618	[p16l1737t462r1982b534],
4	.	.	O	.	_	0	SENT_618	[p16l1737t462r1982b534],
5	)	NN	O	)	dep	2	SENT_618	[p16l1737t462r1982b534],

1	van	NN	PERSON	van	nn	3	SENT_619	[p16l756t563r874b603],
2	Oosterom	NNP	PERSON	Oosterom	nn	3	SENT_619	[p16l895t545r1217b603],
3	AT	NNP	O	AT	_	0	SENT_619	[p16l1236t545r1345b613],
4	,	,	O	,	_	0	SENT_619	[p16l1236t545r1345b613],
5	Schrijvers	NNP	O	Schrijvers	nn	6	SENT_619	[p16l1371t544r1697b619],
6	D.	NNP	O	D.	appos	3	SENT_619	[p16l1721t546r1794b602],
7	1995	CD	DATE	1995	dep	6	SENT_619	[p16l1826t544r1996b603],
8	.	.	O	.	_	0	SENT_619	[p16l1826t544r1996b603],

1	Docetaxel	NNP	O	Docetaxel	nn	3	SENT_620	[p16l2021t546r2145b602, p16l757t626r988b685],
2	(	CD	NUMBER	(	num	3	SENT_620	[p16l1002t627r1420b698],
3	TaXotere	NNP	O	TaXotere	nsubj	5	SENT_620	[p16l1002t627r1420b698],
4	®	CD	NUMBER	®	number	5	SENT_620	[p16l1002t627r1420b698],
5	)	CD	NUMBER	)	_	0	SENT_620	[p16l1002t627r1420b698],
6	,	,	O	,	_	0	SENT_620	[p16l1002t627r1420b698],
7	a	DT	O	a	det	8	SENT_620	[p16l1440t645r1474b685],
8	review	NN	O	review	appos	5	SENT_620	[p16l1486t626r1708b685],
9	of	IN	O	of	_	0	SENT_620	[p16l1725t626r1796b685],
10	preclinical	JJ	O	preclinical	amod	13	SENT_620	[p16l1803t626r2148b702],
11	and	CC	O	and	_	0	SENT_620	[p16l758t708r874b765],
12	clinical	JJ	O	clinical	amod	13	SENT_620	[p16l915t708r1151b765],
13	experience	NN	O	experience	prep_of	8	SENT_620	[p16l1193t708r1561b782],
14	.	.	O	.	_	0	SENT_620	[p16l1193t708r1561b782],

1	Part	NNP	O	Part	nn	2	SENT_621	[p16l1606t709r1737b765],
2	II	NNP	O	II	_	0	SENT_621	[p16l1776t709r1846b765],
3	:	:	O	:	_	0	SENT_621	[p16l1776t709r1846b765],
4	Clinical	JJ	O	clinical	amod	5	SENT_621	[p16l1892t708r2147b766],
5	experience	NN	O	experience	dep	2	SENT_621	[p16l757t790r1156b865],
6	.	.	O	.	_	0	SENT_621	[p16l757t790r1156b865],

1	Anti-Cancer	JJ	MISC	anti-cancer	amod	2	SENT_622	[p16l1186t791r1628b849],
2	Drugs	NNS	MISC	drug	_	0	SENT_622	[p16l1654t792r1871b864],
3	6:35658	CD	NUMBER	6:35658	num	5	SENT_622	[p16l1904t789r2145b848, p16l757t871r836b929],
4	Bruno	NNP	PERSON	Bruno	nn	5	SENT_622	[p16l756t953r958b1009],
5	R	NN	PERSON	r	dep	2	SENT_622	[p16l980t953r1050b1020],
6	,	,	O	,	_	0	SENT_622	[p16l980t953r1050b1020],
7	Dorr	NNP	PERSON	Dorr	nn	8	SENT_622	[p16l1074t953r1228b1009],
8	MB	NNP	O	MB	appos	5	SENT_622	[p16l1248t953r1390b1020],
9	,	,	O	,	_	0	SENT_622	[p16l1248t953r1390b1020],
10	Montay	NNP	O	Montay	nn	11	SENT_622	[p16l1415t953r1668b1026],
11	G	NNP	O	G	appos	5	SENT_622	[p16l1691t952r1764b1020],
12	,	,	O	,	_	0	SENT_622	[p16l1691t952r1764b1020],
13	et	FW	O	et	nn	14	SENT_622	[p16l1789t960r1846b1009],
14	al.	FW	O	al.	appos	5	SENT_622	[p16l1868t952r1940b1009],
15	1994	CD	DATE	1994	dep	14	SENT_622	[p16l1973t952r2142b1010],
16	.	.	O	.	_	0	SENT_622	[p16l1973t952r2142b1010],

1	Design	NN	O	design	_	0	SENT_623	[p16l756t1033r988b1109],
2	and	CC	O	and	_	0	SENT_623	[p16l1019t1033r1134b1092],
3	implementation	NN	O	implementation	conj_and	1	SENT_623	[p16l1163t1033r1675b1109],
4	of	IN	O	of	_	0	SENT_623	[p16l1705t1033r1776b1092],
5	population	NN	O	population	nn	7	SENT_623	[p16l1799t1033r2147b1109],
6	pharmacokinetic	JJ	O	pharmacokinetic	amod	7	SENT_623	[p16l755t1117r1298b1191],
7	studies	NNS	O	study	prep_of	1	SENT_623	[p16l1330t1117r1551b1174],
8	during	IN	O	during	_	0	SENT_623	[p16l1582t1117r1791b1191],
9	the	DT	O	the	det	10	SENT_623	[p16l1819t1117r1917b1174],
10	development	NN	O	development	prep_during	1	SENT_623	[p16l1945t1117r2145b1174, p16l757t1206r1002b1273],
11	of	IN	O	of	_	0	SENT_623	[p16l1020t1197r1092b1255],
12	docetaxel	NN	O	docetaxel	nn	15	SENT_623	[p16l1106t1197r1419b1255],
13	(	CD	NUMBER	(	num	15	SENT_623	[p16l1440t1197r1812b1268],
14	RP56976	NN	O	rp56976	nn	15	SENT_623	[p16l1440t1197r1812b1268],
15	)	NN	O	)	prep_of	10	SENT_623	[p16l1440t1197r1812b1268],
16	,	,	O	,	_	0	SENT_623	[p16l1440t1197r1812b1268],
17	a	DT	O	a	det	20	SENT_623	[p16l1836t1216r1871b1255],
18	new	JJ	O	new	amod	20	SENT_623	[p16l1889t1216r2023b1256],
19	anticancer	JJ	O	anticancer	amod	20	SENT_623	[p16l2046t1216r2144b1255, p16l756t1279r1015b1336],
20	drug	NN	O	drug	appos	15	SENT_623	[p16l1046t1279r1209b1353],
21	.	.	O	.	_	0	SENT_623	[p16l1046t1279r1209b1353],

1	Clin	NNP	O	Clin	_	0	SENT_624	[p16l1249t1279r1395b1337],
2	.	.	O	.	_	0	SENT_624	[p16l1249t1279r1395b1337],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_625	[p16l1434t1279r1810b1336],
2	.	.	O	.	_	0	SENT_625	[p16l1434t1279r1810b1336],

1	Then	RB	O	then	advmod	2	SENT_626	[p16l1853t1279r2007b1336],
2	55	CD	NUMBER	55	_	0	SENT_626	[p16l2045t1279r2141b1337],
3	:	:	O	:	_	0	SENT_626	[p16l2045t1279r2141b1337],
4	161	CD	NUMBER	161	number	5	SENT_626	[p16l764t1360r870b1419],
5	(	CD	NUMBER	(	dep	2	SENT_626	[p16l902t1361r1148b1432],
6	Abstr	NNP	O	Abstr	nn	8	SENT_626	[p16l902t1361r1148b1432],
7	.	.	O	.	_	0	SENT_626	[p16l902t1361r1148b1432],
8	)	NN	O	)	dep	2	SENT_626	[p16l902t1361r1148b1432],

1	Marre	NNP	PERSON	Marre	nn	2	SENT_627	[p16l756t1443r955b1499],
2	F	NN	O	f	_	0	SENT_627	[p16l978t1443r1032b1510],
3	,	,	O	,	_	0	SENT_627	[p16l978t1443r1032b1510],
4	Sanderink	NNP	ORGANIZATION	Sanderink	nn	5	SENT_627	[p16l1062t1442r1391b1500],
5	G-J	NNP	O	G-J	appos	2	SENT_627	[p16l1414t1442r1547b1510],
6	,	,	O	,	_	0	SENT_627	[p16l1414t1442r1547b1510],
7	de	FW	PERSON	de	nn	9	SENT_627	[p16l1573t1442r1648b1499],
8	Sousa	FW	PERSON	sousa	nn	9	SENT_627	[p16l1673t1442r1867b1500],
9	G	NN	PERSON	g	appos	2	SENT_627	[p16l1890t1442r1964b1510],
10	,	,	O	,	_	0	SENT_627	[p16l1890t1442r1964b1510],
11	et	FW	O	et	nn	12	SENT_627	[p16l1990t1451r2048b1499],
12	al.	FW	O	al.	appos	2	SENT_627	[p16l2071t1442r2143b1499],
13	1996	CD	DATE	1996	dep	12	SENT_627	[p16l764t1524r934b1583],
14	.	.	O	.	_	0	SENT_627	[p16l764t1524r934b1583],

1	Hepatic	JJ	O	hepatic	amod	2	SENT_628	[p16l989t1524r1240b1599],
2	biotransformation	NN	O	biotransformation	_	0	SENT_628	[p16l1290t1524r1875b1582],
3	of	IN	O	of	_	0	SENT_628	[p16l1925t1524r1996b1582],
4	docetaxel	NN	O	docetaxel	nn	6	SENT_628	[p16l2041t1524r2144b1582, p16l757t1605r987b1663],
5	(	CD	NUMBER	(	num	6	SENT_628	[p16l1012t1606r1346b1677],
6	Taxotere	NNP	O	Taxotere	prep_of	2	SENT_628	[p16l1012t1606r1346b1677],
7	)	CD	NUMBER	)	dep	6	SENT_628	[p16l1012t1606r1346b1677],
8	in	FW	O	in	nn	9	SENT_628	[p16l1370t1605r1432b1662],
9	vitro	FW	O	vitro	advmod	7	SENT_628	[p16l1454t1605r1623b1663],
10	:	:	O	:	_	0	SENT_628	[p16l1454t1605r1623b1663],
11	involvement	NN	O	involvement	dep	2	SENT_628	[p16l1651t1605r2060b1663],
12	of	IN	O	of	_	0	SENT_628	[p16l2082t1605r2153b1663],
13	the	DT	O	the	det	15	SENT_628	[p16l756t1687r853b1744],
14	CYP3A	NN	O	cyp3a	nn	15	SENT_628	[p16l883t1687r1140b1745],
15	subfamily	NN	O	subfamily	prep_of	11	SENT_628	[p16l1166t1687r1488b1761],
16	in	IN	O	in	_	0	SENT_628	[p16l1517t1687r1579b1744],
17	humans	NNS	O	human	prep_in	15	SENT_628	[p16l1605t1687r1876b1744],
18	.	.	O	.	_	0	SENT_628	[p16l1605t1687r1876b1744],

1	Cancer	NN	O	cancer	_	0	SENT_629	[p16l1910t1688r2149b1745],
2	Res	NNP	O	Res	dep	1	SENT_629	[p16l754t1771r886b1827],
3	.	.	O	.	_	0	SENT_629	[p16l754t1771r886b1827],

1	56:1296	CD	NUMBER	56:1296	num	2	SENT_630	[p16l917t1769r1345b1827],
2	—	NN	O	—	_	0	SENT_630	[p16l917t1769r1345b1827],
3	302	CD	NUMBER	302	dep	2	SENT_630	[p16l917t1769r1345b1827],

1	THE	DT	O	the	det	2	SENT_631	[p16l905t2089r1155b2176],
2	TAXANES	NN	O	taxane	_	0	SENT_631	[p16l1189t2087r1787b2177],
3	371	CD	NUMBER	371	dep	2	SENT_631	[p16l1958t2087r2136b2177],

1	Eisenhauer	NNP	PERSON	Eisenhauer	nn	2	SENT_632	[p16l193t2374r705b2454],
2	E	NNP	O	E	_	0	SENT_632	[p16l779t2376r871b2470],
3	,	,	O	,	_	0	SENT_632	[p16l779t2376r871b2470],
4	ten	CD	NUMBER	ten	num	7	SENT_632	[p16l953t2386r1092b2454],
5	Bokkel	NNP	PERSON	Bokkel	nn	7	SENT_632	[p16l1167t2374r1495b2454],
6	Huinink	NNP	PERSON	Huinink	nn	7	SENT_632	[p16l1571t2374r1948b2454],
7	W	NNP	PERSON	W	appos	2	SENT_632	[p16l2019t2376r2139b2469],
8	,	,	O	,	_	0	SENT_632	[p16l2019t2376r2139b2469],
9	Swenerton	NNP	O	Swenerton	nn	10	SENT_632	[p16l197t2490r684b2571],
10	KD	NN	O	kd	appos	2	SENT_632	[p16l721t2491r908b2585],
11	,	,	O	,	_	0	SENT_632	[p16l721t2491r908b2585],
12	et	FW	O	et	nn	13	SENT_632	[p16l951t2501r1031b2571],
13	al.	FW	O	al.	appos	2	SENT_632	[p16l1067t2489r1168b2571],
14	1994	CD	DATE	1994	dep	13	SENT_632	[p16l1220t2490r1458b2571],
15	.	.	O	.	_	0	SENT_632	[p16l1220t2490r1458b2571],

1	European	JJ	MISC	european	_	0	SENT_633	[p16l1501t2490r2141b2595],
2	.	.	O	.	_	0	SENT_633	[p16l1501t2490r2141b2595],

1	—	NN	O	—	_	0	SENT_634	[p16l1501t2490r2141b2595],
2	.	.	O	.	_	0	SENT_634	[p16l1501t2490r2141b2595],

1	Ca	NN	O	ca	nn	4	SENT_635	[p16l1501t2490r2141b2595],
2	nadian	JJ	O	nadian	amod	4	SENT_635	[p16l193t2605r498b2685],
3	randomized	JJ	O	randomized	amod	4	SENT_635	[p16l520t2605r1062b2685],
4	trial	NN	O	trial	_	0	SENT_635	[p16l1085t2605r1266b2685],
5	of	IN	O	of	_	0	SENT_635	[p16l1290t2605r1389b2685],
6	taxol	NN	O	taxol	prep_of	4	SENT_635	[p16l1406t2605r1630b2685],
7	in	IN	O	in	_	0	SENT_635	[p16l1654t2605r1741b2685],
8	relapsed	VBN	O	relapse	prepc_in	6	SENT_635	[p16l1762t2605r2145b2709],
9	ovarian	JJ	O	ovarian	amod	10	SENT_635	[p16l195t2721r537b2803],
10	cancer	NN	O	cancer	dobj	8	SENT_635	[p16l569t2747r892b2803],
11	:	:	O	:	_	0	SENT_635	[p16l569t2747r892b2803],
12	high	JJ	O	high	dep	4	SENT_635	[p16l932t2721r1135b2827],
13	vs	CC	O	vs	_	0	SENT_635	[p16l1166t2747r1262b2803],
14	low	JJ	O	low	amod	15	SENT_635	[p16l1301t2721r1469b2803],
15	dose	NN	O	dose	dep	4	SENT_635	[p16l1505t2721r1712b2803],
16	and	CC	O	and	_	0	SENT_635	[p16l1750t2721r1912b2803],
17	long	JJ	O	long	dep	4	SENT_635	[p16l1943t2721r2144b2827],
18	vs	CC	O	vs	_	0	SENT_635	[p16l194t2863r291b2918],
19	short	JJ	O	short	amod	20	SENT_635	[p16l329t2837r553b2919],
20	infusion	NN	O	infusion	conj_vs	17	SENT_635	[p16l583t2837r977b2919],
21	.	.	O	.	_	0	SENT_635	[p16l583t2837r977b2919],

1	J.	NNP	PERSON	J.	nn	2	SENT_636	[p16l1011t2840r1080b2919],
2	Clin	NNP	PERSON	Clin	_	0	SENT_636	[p16l1128t2837r1335b2919],
3	.	.	O	.	_	0	SENT_636	[p16l1128t2837r1335b2919],

1	Oncol	NN	O	oncol	_	0	SENT_637	[p16l1382t2837r1672b2919],
2	.	.	O	.	_	0	SENT_637	[p16l1382t2837r1672b2919],

1	1222654Wilson	NN	O	1222654wilson	_	0	SENT_638	[p16l1725t2837r2148b2919, p16l192t3071r518b3151],

1	WH	NN	PERSON	wh	_	0	SENT_639	[p16l546t3073r762b3166],
2	,	,	O	,	_	0	SENT_639	[p16l546t3073r762b3166],
3	Berg	NNP	PERSON	Berg	nn	4	SENT_639	[p16l795t3073r1014b3175],
4	S	NNP	O	S	appos	1	SENT_639	[p16l1046t3071r1130b3166],
5	,	,	O	,	_	0	SENT_639	[p16l1046t3071r1130b3166],
6	Bryant	NNP	PERSON	Bryant	nn	7	SENT_639	[p16l1163t3073r1475b3175],
7	G	NNP	PERSON	G	appos	1	SENT_639	[p16l1503t3071r1607b3166],
8	,	,	O	,	_	0	SENT_639	[p16l1503t3071r1607b3166],
9	et	FW	O	et	nn	10	SENT_639	[p16l1642t3083r1724b3151],
10	al.	FW	O	al.	appos	1	SENT_639	[p16l1753t3071r1854b3151],
11	1994	CD	DATE	1994	dep	10	SENT_639	[p16l1899t3071r2138b3153],
12	.	.	O	.	_	0	SENT_639	[p16l1899t3071r2138b3153],

1	Paclitaxel	NN	O	paclitaxel	_	0	SENT_640	[p16l193t3187r644b3269],
2	in	IN	O	in	_	0	SENT_640	[p16l673t3187r762b3267],
3	doXorubicin	NN	O	doxorubicin	prep_in	1	SENT_640	[p16l793t3187r1834b3293],
4	—	CD	NUMBER	—	number	5	SENT_640	[p16l793t3187r1834b3293],
5	refractory	JJ	O	refractory	dep	1	SENT_640	[p16l793t3187r1834b3293],
6	or	CC	O	or	_	0	SENT_640	[p16l1866t3213r1960b3269],
7	mitoXantrone	JJ	O	mitoxantrone	amod	8	SENT_640	[p16l1988t3187r2141b3267, p16l193t3303r1172b3407],
8	—	NN	O	—	dep	1	SENT_640	[p16l1988t3187r2141b3267, p16l193t3303r1172b3407],
9	refractory	JJ	O	refractory	amod	11	SENT_640	[p16l1988t3187r2141b3267, p16l193t3303r1172b3407],
10	breast	NN	O	breast	nn	11	SENT_640	[p16l1279t3303r1556b3383],
11	cancer	NN	O	cancer	dep	5	SENT_640	[p16l1660t3329r1983b3383],
12	:	:	O	:	_	0	SENT_640	[p16l1660t3329r1983b3383],
13	a	DT	O	a	det	16	SENT_640	[p16l2099t3329r2146b3383],
14	phase	NN	O	phase	nn	16	SENT_640	[p16l192t3420r452b3525],
15	I/II	NN	O	i/ii	nn	16	SENT_640	[p16l485t3421r630b3501],
16	trial	NN	O	trial	dep	1	SENT_640	[p16l661t3420r843b3501],
17	of	IN	O	of	_	0	SENT_640	[p16l876t3420r975b3501],
18	96	CD	DURATION	96	num	20	SENT_640	[p16l1000t3419r1109b3502],
19	hour	NN	NUMBER	hour	nn	20	SENT_640	[p16l1142t3421r1352b3501],
20	infusion	NN	O	infusion	prep_of	16	SENT_640	[p16l1380t3419r1776b3501],
21	.	.	O	.	_	0	SENT_640	[p16l1380t3419r1776b3501],

1	J.	NNP	PERSON	J.	nn	2	SENT_641	[p16l1811t3423r1879b3502],
2	Clin	NNP	PERSON	Clin	_	0	SENT_641	[p16l1927t3420r2132b3502],
3	.	.	O	.	_	0	SENT_641	[p16l1927t3420r2132b3502],

1	Oncol	NN	O	oncol	_	0	SENT_642	[p16l199t3535r489b3617],
2	.	.	O	.	_	0	SENT_642	[p16l199t3535r489b3617],

1	12:1621	CD	NUMBER	12:1621	_	0	SENT_643	[p16l543t3535r1075b3617],
2	—	CD	NUMBER	—	num	3	SENT_643	[p16l543t3535r1075b3617],
3	29	CD	NUMBER	29	dep	1	SENT_643	[p16l543t3535r1075b3617],

1	Hainsworth	NNP	PERSON	Hainsworth	nn	2	SENT_644	[p17l193t24r729b106],
2	JD	NNP	O	JD	_	0	SENT_644	[p17l758t27r909b120],
3	,	,	O	,	_	0	SENT_644	[p17l758t27r909b120],
4	Thompson	NNP	PERSON	Thompson	nn	5	SENT_644	[p17l944t24r1434b130],
5	DS	NN	O	d	appos	2	SENT_644	[p17l1465t26r1635b120],
6	,	,	O	,	_	0	SENT_644	[p17l1465t26r1635b120],
7	Greco	NNP	PERSON	Greco	nn	8	SENT_644	[p17l1672t25r1948b106],
8	FA	NNP	O	FA	appos	5	SENT_644	[p17l1979t26r2138b106],
9	.	.	O	.	_	0	SENT_644	[p17l1979t26r2138b106],

1	1995	CD	DATE	1995	_	0	SENT_645	[p17l204t140r442b223],
2	.	.	O	.	_	0	SENT_645	[p17l204t140r442b223],

1	Paclitaxel	NN	O	paclitaxel	_	0	SENT_646	[p17l480t140r930b222],
2	by	IN	O	by	_	0	SENT_646	[p17l958t140r1071b246],
3	1-hour	JJ	DURATION	1-hour	amod	4	SENT_646	[p17l1112t140r1408b222],
4	infusion	NN	O	infusion	prep_by	1	SENT_646	[p17l1435t140r1832b222],
5	:	:	O	:	_	0	SENT_646	[p17l1435t140r1832b222],
6	an	DT	O	a	det	8	SENT_646	[p17l1873t166r1977b222],
7	active	JJ	O	active	amod	8	SENT_646	[p17l2009t166r2141b222, p17l193t256r362b336],
8	drug	NN	O	drug	dep	1	SENT_646	[p17l398t256r604b360],
9	in	IN	O	in	_	0	SENT_646	[p17l640t256r727b336],
10	metastatic	JJ	O	metastatic	amod	12	SENT_646	[p17l761t256r1220b336],
11	non	JJ	O	non	amod	12	SENT_646	[p17l1257t256r1713b336],
12	—	NN	O	—	prep_in	8	SENT_646	[p17l1257t256r1713b336],
13	small	JJ	O	small	amod	16	SENT_646	[p17l1257t256r1713b336],
14	cell	NN	O	cell	nn	16	SENT_646	[p17l1748t256r1910b336],
15	lung	NN	O	lung	nn	16	SENT_646	[p17l1944t256r2144b360],
16	cancer	NN	O	cancer	dep	8	SENT_646	[p17l195t398r508b454],
17	.	.	O	.	_	0	SENT_646	[p17l195t398r508b454],

1	J.	NNP	PERSON	J.	nn	2	SENT_647	[p17l542t375r611b454],
2	Clin	NNP	PERSON	Clin	_	0	SENT_647	[p17l659t372r866b454],
3	.	.	O	.	_	0	SENT_647	[p17l659t372r866b454],

1	Oncol	NN	O	oncol	_	0	SENT_648	[p17l913t372r1203b454],
2	.	.	O	.	_	0	SENT_648	[p17l913t372r1203b454],

1	13:1609	CD	NUMBER	13:1609	_	0	SENT_649	[p17l1256t372r1790b454],
2	—	CD	NUMBER	—	num	3	SENT_649	[p17l1256t372r1790b454],
3	14	CD	NUMBER	14	dep	1	SENT_649	[p17l1256t372r1790b454],

1	Cortex	NN	O	cortex	nn	2	SENT_650	[p17l195t491r503b571],
2	JE	NN	O	je	_	0	SENT_650	[p17l546t492r683b586],
3	,	,	O	,	_	0	SENT_650	[p17l546t492r683b586],
4	Pazdur	NNP	PERSON	Pazdur	nn	5	SENT_650	[p17l730t490r1050b571],
5	R.	NNP	O	R.	appos	2	SENT_650	[p17l1090t492r1187b571],
6	1995	CD	DATE	1995	dep	5	SENT_650	[p17l1246t489r1484b572],
7	.	.	O	.	_	0	SENT_650	[p17l1246t489r1484b572],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_651	[p17l1533t490r2018b571],
2	.	.	O	.	_	0	SENT_651	[p17l1533t490r2018b571],

1	J.	NNP	PERSON	J.	nn	2	SENT_652	[p17l2064t494r2132b572],
2	Clin	NNP	PERSON	Clin	_	0	SENT_652	[p17l199t605r406b687],
3	.	.	O	.	_	0	SENT_652	[p17l199t605r406b687],

1	Oncol	NN	O	oncol	_	0	SENT_653	[p17l452t605r744b687],
2	.	.	O	.	_	0	SENT_653	[p17l452t605r744b687],

1	13:2643	CD	NUMBER	13:2643	_	0	SENT_654	[p17l796t605r1326b687],
2	—	CD	NUMBER	—	num	3	SENT_654	[p17l796t605r1326b687],
3	55	CD	NUMBER	55	dep	1	SENT_654	[p17l796t605r1326b687],

1	Oulid-Aissa	NN	O	oulid-aissa	nn	2	SENT_655	[p17l195t722r748b802],
2	D	NN	O	d	_	0	SENT_655	[p17l784t724r890b817],
3	,	,	O	,	_	0	SENT_655	[p17l784t724r890b817],
4	Bruno	NNP	PERSON	Bruno	nn	5	SENT_655	[p17l932t724r1215b802],
5	R	NNP	PERSON	R	appos	2	SENT_655	[p17l1255t724r1354b817],
6	,	,	O	,	_	0	SENT_655	[p17l1255t724r1354b817],
7	Lebecq	NNP	O	Lebecq	nn	8	SENT_655	[p17l1395t722r1733b826],
8	A	NNP	O	A	appos	2	SENT_655	[p17l1769t722r1875b817],
9	,	,	O	,	_	0	SENT_655	[p17l1769t722r1875b817],
10	et	FW	O	et	nn	11	SENT_655	[p17l1918t734r2000b802],
11	al.	FW	O	al.	appos	2	SENT_655	[p17l2038t722r2139b802],
12	1996	CD	DATE	1996	dep	11	SENT_655	[p17l204t838r442b921],
13	.	.	O	.	_	0	SENT_655	[p17l204t838r442b921],

1	Taxotere	NNP	O	Taxotere	nn	2	SENT_656	[p17l487t841r885b920],
2	safety	NN	O	safety	_	0	SENT_656	[p17l928t838r1196b944],
3	in	IN	O	in	_	0	SENT_656	[p17l1232t838r1321b918],
4	patients	NNS	O	patient	prep_in	2	SENT_656	[p17l1356t838r1708b944],
5	with	IN	O	with	_	0	SENT_656	[p17l1750t838r1950b920],
6	impaired	JJ	O	impaired	amod	8	SENT_656	[p17l1988t838r2141b918, p17l192t955r479b1060],
7	liver	NN	O	liver	nn	8	SENT_656	[p17l513t954r723b1036],
8	function	NN	O	function	prep_with	2	SENT_656	[p17l756t954r1158b1036],
9	.	.	O	.	_	0	SENT_656	[p17l756t954r1158b1036],

1	Proc	NNP	O	Proc	_	0	SENT_657	[p17l1197t958r1434b1036],
2	.	.	O	.	_	0	SENT_657	[p17l1197t958r1434b1036],

1	Am	NNP	O	Am	_	0	SENT_658	[p17l1472t956r1649b1036],
2	.	.	O	.	_	0	SENT_658	[p17l1472t956r1649b1036],

1	Soc	NN	O	soc	_	0	SENT_659	[p17l1694t957r1875b1037],
2	.	.	O	.	_	0	SENT_659	[p17l1694t957r1875b1037],

1	Clin	NNP	O	Clin	_	0	SENT_660	[p17l1927t955r2132b1037],
2	.	.	O	.	_	0	SENT_660	[p17l1927t955r2132b1037],

1	Oncol	NN	O	oncol	_	0	SENT_661	[p17l199t1071r489b1153],
2	.	.	O	.	_	0	SENT_661	[p17l199t1071r489b1153],

1	15:476	CD	NUMBER	15:476	number	2	SENT_662	[p17l543t1071r847b1153],
2	(	CD	NUMBER	(	_	0	SENT_662	[p17l882t1071r1226b1172],
3	Abstr	NNP	O	Abstr	dep	2	SENT_662	[p17l882t1071r1226b1172],
4	.	.	O	.	_	0	SENT_662	[p17l882t1071r1226b1172],
5	)	NN	O	)	dep	2	SENT_662	[p17l882t1071r1226b1172],

1	Rowinsky	NNP	PERSON	Rowinsky	nn	2	SENT_663	[p17l193t1187r656b1293],
2	EK	NNP	O	EK	_	0	SENT_663	[p17l699t1189r875b1283],
3	,	,	O	,	_	0	SENT_663	[p17l699t1189r875b1283],
4	Eisenhauer	NNP	PERSON	Eisenhauer	nn	5	SENT_663	[p17l921t1187r1432b1269],
5	EA	NN	PERSON	ea	appos	2	SENT_663	[p17l1472t1188r1649b1283],
6	,	,	O	,	_	0	SENT_663	[p17l1472t1188r1649b1283],
7	Chaudhry	NNP	PERSON	Chaudhry	nn	8	SENT_663	[p17l1696t1187r2145b1293],
8	V	NNP	PERSON	V	appos	2	SENT_663	[p17l193t1306r282b1399],
9	,	,	O	,	_	0	SENT_663	[p17l193t1306r282b1399],
10	et	FW	O	et	nn	11	SENT_663	[p17l334t1315r414b1385],
11	al.	FW	O	al.	appos	2	SENT_663	[p17l459t1303r560b1385],
12	1993	CD	DATE	1993	dep	11	SENT_663	[p17l621t1305r859b1387],
13	.	.	O	.	_	0	SENT_663	[p17l621t1305r859b1387],

1	Clinical	JJ	O	clinical	amod	2	SENT_664	[p17l913t1303r1272b1385],
2	toxicities	NNS	O	toxicity	nsubj	3	SENT_664	[p17l1315t1303r1729b1385],
3	encountered	VBD	O	encounter	_	0	SENT_664	[p17l1778t1329r2141b1385, p17l193t1420r423b1500],
4	With	IN	O	with	_	0	SENT_664	[p17l480t1420r680b1501],
5	taxol	NN	O	taxol	prep_with	3	SENT_664	[p17l741t1420r991b1500],
6	.	.	O	.	_	0	SENT_664	[p17l741t1420r991b1500],

1	Sem	NNP	O	Sem	_	0	SENT_665	[p17l1055t1422r1262b1502],
2	.	.	O	.	_	0	SENT_665	[p17l1055t1422r1262b1502],

1	Oncol	NN	O	oncol	_	0	SENT_666	[p17l1336t1420r1628b1502],
2	.	.	O	.	_	0	SENT_666	[p17l1336t1420r1628b1502],

1	20	CD	NUMBER	20	num	2	SENT_667	[p17l1699t1420r2139b1524],
2	(	CD	NUMBER	(	_	0	SENT_667	[p17l1699t1420r2139b1524],
3	Suppl	NNP	O	Suppl	dep	2	SENT_667	[p17l1699t1420r2139b1524],
4	.	.	O	.	_	0	SENT_667	[p17l1699t1420r2139b1524],

1	3	CD	NUMBER	3	num	2	SENT_668	[p17l197t1536r543b1635],
2	)	NN	O	)	_	0	SENT_668	[p17l197t1536r543b1635],
3	:1	CD	NUMBER	:1	number	4	SENT_668	[p17l197t1536r543b1635],
4	—	CD	NUMBER	—	dep	2	SENT_668	[p17l197t1536r543b1635],
5	15	CD	NUMBER	15	dep	4	SENT_668	[p17l197t1536r543b1635],
6	Weiss	NNP	ORGANIZATION	Weiss	nn	7	SENT_668	[p17l192t1652r461b1734],
7	R	NN	ORGANIZATION	r	dep	2	SENT_668	[p17l503t1654r602b1748],
8	,	,	O	,	_	0	SENT_668	[p17l503t1654r602b1748],
9	Donehower	NNP	PERSON	Donehower	nn	10	SENT_668	[p17l647t1652r1184b1734],
10	RC	NNP	O	RC	appos	7	SENT_668	[p17l1222t1653r1398b1748],
11	,	,	O	,	_	0	SENT_668	[p17l1222t1653r1398b1748],
12	Wiernik	NNP	O	Wiernik	nn	13	SENT_668	[p17l1439t1652r1814b1734],
13	PH	NNP	O	PH	appos	2	SENT_668	[p17l1851t1654r2021b1748],
14	,	,	O	,	_	0	SENT_668	[p17l1851t1654r2021b1748],
15	et	FW	O	et	nn	16	SENT_668	[p17l2066t1664r2148b1734],
16	al.	FW	O	al.	appos	2	SENT_668	[p17l195t1769r296b1849],
17	1990	CD	DATE	1990	dep	16	SENT_668	[p17l371t1769r609b1851],
18	.	.	O	.	_	0	SENT_668	[p17l371t1769r609b1851],

1	Hypersenstivity	NN	O	hypersenstivity	nn	2	SENT_669	[p17l673t1769r1397b1873],
2	reactions	NNS	O	reaction	_	0	SENT_669	[p17l1454t1769r1863b1849],
3	from	IN	O	from	_	0	SENT_669	[p17l1925t1769r2146b1849],
4	taxol	NN	O	taxol	prep_from	2	SENT_669	[p17l193t1885r444b1967],
5	.	.	O	.	_	0	SENT_669	[p17l193t1885r444b1967],

1	J.	NNP	PERSON	J.	nn	2	SENT_670	[p17l477t1888r546b1967],
2	Clin	NNP	PERSON	Clin	_	0	SENT_670	[p17l595t1885r800b1967],
3	.	.	O	.	_	0	SENT_670	[p17l595t1885r800b1967],

1	Oncol	NN	O	oncol	_	0	SENT_671	[p17l847t1885r1137b1967],
2	.	.	O	.	_	0	SENT_671	[p17l847t1885r1137b1967],

1	8:1263	CD	NUMBER	8:1263	_	0	SENT_672	[p17l1184t1885r1663b1967],
2	—	CD	NUMBER	—	num	3	SENT_672	[p17l1184t1885r1663b1967],
3	68	CD	NUMBER	68	dep	1	SENT_672	[p17l1184t1885r1663b1967],

1	Huizing	VBG	O	huize	_	0	SENT_673	[p17l193t2004r560b2108],
2	MT	NN	O	mt	dobj	1	SENT_673	[p17l593t2006r778b2098],
3	,	,	O	,	_	0	SENT_673	[p17l593t2006r778b2098],
4	Keung	NNP	ORGANIZATION	Keung	nn	5	SENT_673	[p17l817t2006r1118b2108],
5	ACF	NNP	ORGANIZATION	ACF	appos	2	SENT_673	[p17l1152t2004r1389b2098],
6	,	,	O	,	_	0	SENT_673	[p17l1152t2004r1389b2098],
7	Rosing	NNP	PERSON	Rosing	nn	8	SENT_673	[p17l1425t2004r1748b2108],
8	H	NNP	PERSON	H	appos	2	SENT_673	[p17l1781t2006r1887b2098],
9	,	,	O	,	_	0	SENT_673	[p17l1781t2006r1887b2098],
10	et	FW	O	et	nn	11	SENT_673	[p17l1925t2016r2007b2084],
11	al.	FW	O	al.	appos	2	SENT_673	[p17l2038t2004r2139b2084],
12	1993	CD	DATE	1993	dep	11	SENT_673	[p17l204t2119r442b2200],
13	.	.	O	.	_	0	SENT_673	[p17l204t2119r442b2200],

1	Pharmacokinetics	NNS	O	pharmacokinetic	nsubj	8	SENT_674	[p17l496t2118r1306b2200],
2	of	IN	O	of	_	0	SENT_674	[p17l1357t2118r1457b2200],
3	paclitaxel	NN	O	paclitaxel	prep_of	1	SENT_674	[p17l1493t2118r1936b2224],
4	and	CC	O	and	_	0	SENT_674	[p17l1984t2118r2146b2200],
5	metabolites	NNS	O	metabolite	prep_of	1	SENT_674	[p17l193t2234r718b2314],
6	in	IN	O	in	_	0	SENT_674	[p17l767t2234r854b2314],
7	a	DT	O	a	prep_in	1	SENT_674	[p17l902t2260r949b2314],
8	randomized	VBN	O	randomize	_	0	SENT_674	[p17l993t2234r1535b2314],
9	comparative	JJ	O	comparative	amod	10	SENT_674	[p17l1581t2234r2144b2338],
10	study	NN	O	study	nsubj	17	SENT_674	[p17l197t2348r439b2454],
11	in	IN	O	in	_	0	SENT_674	[p17l485t2348r573b2428],
12	platinum	NN	O	platinum	nn	13	SENT_674	[p17l614t2348r1520b2454],
13	—	NN	O	—	prep_in	10	SENT_674	[p17l614t2348r1520b2454],
14	pretreated	JJ	O	pretreated	amod	17	SENT_674	[p17l614t2348r1520b2454],
15	ovarian	JJ	O	ovarian	amod	17	SENT_674	[p17l1564t2348r1906b2430],
16	cancer	NN	O	cancer	nn	17	SENT_674	[p17l1950t2374r2141b2430, p17l195t2490r334b2546],
17	patients	NNS	O	patient	xcomp	8	SENT_674	[p17l362t2465r739b2570],
18	.	.	O	.	_	0	SENT_674	[p17l362t2465r739b2570],

1	J.	NNP	PERSON	J.	nn	2	SENT_675	[p17l774t2469r843b2547],
2	Clin	NNP	PERSON	Clin	_	0	SENT_675	[p17l892t2465r1097b2547],
3	.	.	O	.	_	0	SENT_675	[p17l892t2465r1097b2547],

1	Oncol	NN	O	oncol	_	0	SENT_676	[p17l1144t2465r1436b2547],
2	.	.	O	.	_	0	SENT_676	[p17l1144t2465r1436b2547],

1	11:2127	CD	NUMBER	11:2127	num	5	SENT_677	[p17l1487t2464r2012b2546],
2	—	CD	NUMBER	—	num	5	SENT_677	[p17l1487t2464r2012b2546],
3	35	CD	NUMBER	35	num	5	SENT_677	[p17l1487t2464r2012b2546],
4	Gianni	NNP	ORGANIZATION	Gianni	nn	5	SENT_677	[p17l195t2580r503b2662],
5	L	NNP	ORGANIZATION	L	_	0	SENT_677	[p17l535t2582r628b2676],
6	,	,	O	,	_	0	SENT_677	[p17l535t2582r628b2676],
7	Kearns	NNP	PERSON	Kearns	nn	8	SENT_677	[p17l666t2582r986b2662],
8	C	NNP	O	C	appos	5	SENT_677	[p17l1022t2581r1119b2676],
9	,	,	O	,	_	0	SENT_677	[p17l1022t2581r1119b2676],
10	Gianni	NNP	PERSON	Gianni	nn	11	SENT_677	[p17l1156t2580r1464b2662],
11	A	NNP	O	A	appos	5	SENT_677	[p17l1496t2581r1601b2676],
12	,	,	O	,	_	0	SENT_677	[p17l1496t2581r1601b2676],
13	et	FW	O	et	nn	14	SENT_677	[p17l1639t2592r1719b2662],
14	al.	FW	O	al.	appos	5	SENT_677	[p17l1751t2580r1852b2662],
15	1995	CD	DATE	1995	dep	14	SENT_677	[p17l1899t2580r2138b2662],
16	.	.	O	.	_	0	SENT_677	[p17l1899t2580r2138b2662],

1	Nonlinear	JJ	O	nonlinear	amod	2	SENT_678	[p17l193t2697r652b2779],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_678	[p17l699t2697r1504b2803],
3	and	CC	O	and	_	0	SENT_678	[p17l1561t2697r1724b2779],
4	metabolism	NN	O	metabolism	conj_and	2	SENT_678	[p17l1771t2697r2141b2779, p17l193t2813r390b2895],
5	of	IN	O	of	_	0	SENT_678	[p17l423t2813r522b2895],
6	paclitaxel	NN	O	paclitaxel	prep_of	4	SENT_678	[p17l544t2813r989b2919],
7	and	CC	O	and	_	0	SENT_678	[p17l1022t2813r1186b2895],
8	its	PRP$	O	its	poss	9	SENT_678	[p17l1215t2813r1317b2895],
9	pharmacokineticl	NN	O	pharmacokineticl	conj_and	2	SENT_678	[p17l1350t2813r2150b2919],
10	pharmacodynamic	JJ	O	pharmacodynamic	amod	11	SENT_678	[p17l192t2929r1038b3033],
11	relationships	NNS	O	relationship	dep	2	SENT_678	[p17l1135t2929r1715b3033],
12	in	IN	O	in	_	0	SENT_678	[p17l1814t2929r1901b3009],
13	humans	NNS	O	human	prep_in	11	SENT_678	[p17l1993t2929r2141b3009, p17l193t3071r458b3127],
14	.	.	O	.	_	0	SENT_678	[p17l1993t2929r2141b3009, p17l193t3071r458b3127],

1	J.	NNP	PERSON	J.	nn	2	SENT_679	[p17l492t3049r560b3129],
2	Clin	NNP	PERSON	Clin	_	0	SENT_679	[p17l609t3047r814b3129],
3	.	.	O	.	_	0	SENT_679	[p17l609t3047r814b3129],

1	Oncol	NN	O	oncol	_	0	SENT_680	[p17l862t3047r1153b3129],
2	.	.	O	.	_	0	SENT_680	[p17l862t3047r1153b3129],

1	13:180	CD	NUMBER	13:180	number	2	SENT_681	[p17l1204t3047r1681b3129],
2	—	CD	NUMBER	—	num	3	SENT_681	[p17l1204t3047r1681b3129],
3	9O	NN	O	9o	_	0	SENT_681	[p17l1204t3047r1681b3129],

1	Rowinsky	NNP	PERSON	Rowinsky	nn	2	SENT_682	[p17l193t3162r656b3268],
2	EK	NNP	O	EK	_	0	SENT_682	[p17l682t3164r859b3258],
3	,	,	O	,	_	0	SENT_682	[p17l682t3164r859b3258],
4	Chaudhry	NNP	PERSON	Chaudhry	nn	5	SENT_682	[p17l888t3162r1337b3268],
5	V	NNP	PERSON	V	appos	2	SENT_682	[p17l1361t3164r1451b3258],
6	,	,	O	,	_	0	SENT_682	[p17l1361t3164r1451b3258],
7	Cornblath	NNP	O	Cornblath	nn	8	SENT_682	[p17l1481t3162r1935b3244],
8	DR	NN	O	dr	appos	2	SENT_682	[p17l1958t3164r2141b3258],
9	,	,	O	,	_	0	SENT_682	[p17l1958t3164r2141b3258],
10	Donehower	NNP	PERSON	Donehower	nn	11	SENT_682	[p17l193t3278r732b3358],
11	RC	NNP	O	RC	appos	2	SENT_682	[p17l756t3278r929b3359],
12	.	.	O	.	_	0	SENT_682	[p17l756t3278r929b3359],

1	1993	CD	DATE	1993	_	0	SENT_683	[p17l974t3278r1212b3360],
2	.	.	O	.	_	0	SENT_683	[p17l974t3278r1212b3360],

1	The	DT	O	the	det	2	SENT_684	[p17l1246t3278r1420b3358],
2	neurotoxicty	NN	O	neurotoxicty	_	0	SENT_684	[p17l1449t3278r2024b3382],
3	of	IN	O	of	_	0	SENT_684	[p17l2054t3278r2153b3358],
4	taxol	NN	O	taxol	prep_of	2	SENT_684	[p17l193t3394r444b3474],
5	.	.	O	.	_	0	SENT_684	[p17l193t3394r444b3474],

1	Monogit	NNP	O	Monogit	nn	4	SENT_685	[p17l482t3397r859b3498],
2	Natl.	NNP	O	Natl.	nn	4	SENT_685	[p17l902t3394r1116b3476],
3	Cancer	NNP	O	Cancer	nn	4	SENT_685	[p17l1170t3396r1505b3476],
4	Inst	NNP	O	Inst	_	0	SENT_685	[p17l1535t3397r1724b3475],
5	.	.	O	.	_	0	SENT_685	[p17l1535t3397r1724b3475],

1	15:10715	CD	NUMBER	15:10715	_	0	SENT_686	[p17l1783t3394r2146b3475, p17l204t3512r301b3592],

1	Chaudhry	NNP	O	Chaudhry	nn	2	SENT_687	[p18l195t24r644b130],
2	V	NNP	O	V	_	0	SENT_687	[p18l683t26r772b120],
3	,	,	O	,	_	0	SENT_687	[p18l683t26r772b120],
4	Rowinsky	NNP	PERSON	Rowinsky	nn	5	SENT_687	[p18l814t24r1276b130],
5	EK	NNP	O	EK	appos	2	SENT_687	[p18l1315t26r1491b120],
6	,	,	O	,	_	0	SENT_687	[p18l1315t26r1491b120],
7	Sartorius	NNP	PERSON	Sartorius	nn	8	SENT_687	[p18l1536t24r1943b106],
8	SE	NN	O	se	appos	2	SENT_687	[p18l1988t25r2141b120],
9	,	,	O	,	_	0	SENT_687	[p18l1988t25r2141b120],
10	et	FW	O	et	nn	11	SENT_687	[p18l195t152r275b220],
11	al.	FW	O	al.	appos	2	SENT_687	[p18l336t140r437b220],
12	1994	CD	DATE	1994	dep	11	SENT_687	[p18l515t140r753b222],
13	.	.	O	.	_	0	SENT_687	[p18l515t140r753b222],

1	Peripheral	JJ	O	peripheral	amod	2	SENT_688	[p18l820t140r1290b244],
2	neuropathy	NN	O	neuropathy	_	0	SENT_688	[p18l1350t140r1863b244],
3	from	IN	O	from	_	0	SENT_688	[p18l1925t140r2146b220],
4	taxol	NN	O	taxol	nn	8	SENT_688	[p18l193t256r421b338],
5	and	CC	O	and	_	0	SENT_688	[p18l487t256r651b338],
6	cisplatin	NN	O	cisplatin	nn	8	SENT_688	[p18l716t256r1101b362],
7	combination	NN	O	combination	nn	8	SENT_688	[p18l1168t256r1738b338],
8	chemotherapy	NN	O	chemotherapy	prep_from	2	SENT_688	[p18l1804t256r2141b338, p18l193t372r559b476],
9	:	:	O	:	_	0	SENT_688	[p18l1804t256r2141b338, p18l193t372r559b476],
10	clinical	JJ	O	clinical	dep	2	SENT_688	[p18l619t372r953b452],
11	and	CC	O	and	_	0	SENT_688	[p18l1006t372r1168b452],
12	electrophysiological	JJ	O	electrophysiological	amod	13	SENT_688	[p18l1220t372r2144b476],
13	studies	NNS	O	study	dep	2	SENT_688	[p18l197t488r534b570],
14	.	.	O	.	_	0	SENT_688	[p18l197t488r534b570],

1	Ann	NNP	PERSON	Ann	_	0	SENT_689	[p18l562t490r770b570],
2	.	.	O	.	_	0	SENT_689	[p18l562t490r770b570],

1	Neurol	NNP	O	Neurol	_	0	SENT_690	[p18l808t488r1142b570],
2	.	.	O	.	_	0	SENT_690	[p18l808t488r1142b570],

1	352490-97	CD	NUMBER	352490-97	num	3	SENT_691	[p18l1187t488r1668b570],
2	Peretz	NNP	ORGANIZATION	Peretz	nn	3	SENT_691	[p18l193t608r479b687],
3	T	NN	ORGANIZATION	t	_	0	SENT_691	[p18l506t608r588b701],
4	,	,	O	,	_	0	SENT_691	[p18l506t608r588b701],
5	Sulkes	NNP	PERSON	Sulkes	nn	6	SENT_691	[p18l621t605r920b687],
6	A	NNP	O	A	appos	3	SENT_691	[p18l949t606r1054b701],
7	,	,	O	,	_	0	SENT_691	[p18l949t606r1054b701],
8	Chollet	NNP	PERSON	Chollet	nn	9	SENT_691	[p18l1085t605r1420b687],
9	P	NN	PERSON	p	appos	3	SENT_691	[p18l1442t608r1514b701],
10	,	,	O	,	_	0	SENT_691	[p18l1442t608r1514b701],
11	et	FW	O	et	nn	12	SENT_691	[p18l1545t617r1627b687],
12	al.	FW	O	al.	appos	3	SENT_691	[p18l1651t605r1752b687],
13	1995	CD	DATE	1995	dep	12	SENT_691	[p18l1795t605r2033b687],
14	.	.	O	.	_	0	SENT_691	[p18l1795t605r2033b687],

1	A	DT	O	a	det	2	SENT_692	[p18l2064t606r2145b685],
2	multicenter	JJ	O	multicenter	nsubj	3	SENT_692	[p18l193t722r717b804],
3	randomized	VBN	O	randomize	_	0	SENT_692	[p18l807t722r1351b804],
4	study	NN	O	study	dobj	3	SENT_692	[p18l1449t722r1691b828],
5	of	IN	O	of	_	0	SENT_692	[p18l1788t722r1887b804],
6	two	CD	NUMBER	two	num	7	SENT_692	[p18l1976t735r2144b804],
7	schedules	NNS	O	schedule	prep_of	4	SENT_692	[p18l197t838r637b918],
8	of	IN	O	of	_	0	SENT_692	[p18l671t838r771b918],
9	paclitaxel	NN	O	paclitaxel	prep_of	7	SENT_692	[p18l793t838r1236b942],
10	in	IN	O	in	_	0	SENT_692	[p18l1267t838r1354b918],
11	patients	NNS	O	patient	prep_in	3	SENT_692	[p18l1383t838r1736b942],
12	with	IN	O	with	_	0	SENT_692	[p18l1769t838r1969b919],
13	advanced	JJ	O	advanced	amod	15	SENT_692	[p18l2002t838r2141b918, p18l194t956r519b1036],
14	breast	NN	O	breast	nn	15	SENT_692	[p18l604t956r878b1036],
15	cancer	NN	O	cancer	prep_with	11	SENT_692	[p18l966t980r1278b1036],
16	.	.	O	.	_	0	SENT_692	[p18l966t980r1278b1036],

1	Eur	NNP	O	Eur	_	0	SENT_693	[p18l1369t958r1547b1036],
2	.	.	O	.	_	0	SENT_693	[p18l1369t958r1547b1036],

1	J.	NNP	O	J.	nn	2	SENT_694	[p18l1641t958r1710b1038],
2	Cancer	NNP	O	Cancer	_	0	SENT_694	[p18l1814t957r2148b1038],
3	31A	NN	O	31a	nn	5	SENT_694	[p18l197t1071r718b1177],
4	(	CD	NUMBER	(	num	5	SENT_694	[p18l197t1071r718b1177],
5	Suppl	NNP	O	Suppl	dep	2	SENT_694	[p18l197t1071r718b1177],
6	.	.	O	.	_	0	SENT_694	[p18l197t1071r718b1177],

1	5	CD	NUMBER	5	num	2	SENT_695	[p18l758t1071r1054b1172],
2	)	CD	NUMBER	)	_	0	SENT_695	[p18l758t1071r1054b1172],
3	:	:	O	:	_	0	SENT_695	[p18l758t1071r1054b1172],
4	S75	CD	NUMBER	s75	number	5	SENT_695	[p18l758t1071r1054b1172],
5	(	CD	NUMBER	(	dep	2	SENT_695	[p18l1093t1071r1438b1172],
6	Abstr	NNP	O	Abstr	nn	8	SENT_695	[p18l1093t1071r1438b1172],
7	.	.	O	.	_	0	SENT_695	[p18l1093t1071r1438b1172],
8	)	NN	O	)	dep	5	SENT_695	[p18l1093t1071r1438b1172],

1	McGuire	NNP	PERSON	McGuire	nn	2	SENT_696	[p18l193t1187r606b1267],
2	WP	NNP	O	WP	_	0	SENT_696	[p18l651t1189r833b1282],
3	,	,	O	,	_	0	SENT_696	[p18l651t1189r833b1282],
4	Rowinsky	NNP	PERSON	Rowinsky	nn	5	SENT_696	[p18l883t1187r1346b1291],
5	EK	NNP	O	EK	appos	2	SENT_696	[p18l1392t1189r1568b1282],
6	,	,	O	,	_	0	SENT_696	[p18l1392t1189r1568b1282],
7	Rosenshein	NNP	PERSON	Rosenshein	nn	8	SENT_696	[p18l1616t1187r2146b1267],
8	NB	NN	O	nb	appos	2	SENT_696	[p18l193t1306r376b1399],
9	,	,	O	,	_	0	SENT_696	[p18l193t1306r376b1399],
10	et	FW	O	et	nn	11	SENT_696	[p18l423t1315r505b1385],
11	al.	FW	O	al.	appos	2	SENT_696	[p18l549t1303r650b1385],
12	1989	CD	DATE	1989	dep	11	SENT_696	[p18l709t1305r948b1386],
13	.	.	O	.	_	0	SENT_696	[p18l709t1305r948b1386],

1	Taxolz	NNP	O	Taxolz	_	0	SENT_697	[p18l998t1303r1278b1385],
2	a	DT	O	a	det	7	SENT_697	[p18l1331t1329r1380b1385],
3	unique	JJ	O	unique	amod	7	SENT_697	[p18l1418t1303r1729b1409],
4	antineo	JJ	O	antineo	amod	7	SENT_697	[p18l1774t1303r2141b1385],
5	—	NN	O	—	nn	7	SENT_697	[p18l1774t1303r2141b1385],
6	plastic	NN	O	plastic	nn	7	SENT_697	[p18l192t1421r489b1525],
7	agent	NN	O	agent	dep	1	SENT_697	[p18l553t1433r798b1525],
8	with	IN	O	with	_	0	SENT_697	[p18l859t1421r1059b1501],
9	significant	JJ	O	significant	amod	10	SENT_697	[p18l1123t1421r1601b1525],
10	activity	NN	O	activity	prep_with	7	SENT_697	[p18l1661t1421r1998b1525],
11	in	IN	O	in	_	0	SENT_697	[p18l2059t1421r2146b1499],
12	advanced	JJ	O	advanced	amod	15	SENT_697	[p18l195t1535r628b1617],
13	ovarian	JJ	O	ovarian	amod	15	SENT_697	[p18l709t1535r1050b1617],
14	epithelial	JJ	O	epithelial	amod	15	SENT_697	[p18l1130t1535r1552b1641],
15	neoplasms	NNS	O	neoplasm	prep_in	10	SENT_697	[p18l1632t1535r2139b1641],
16	.	.	O	.	_	0	SENT_697	[p18l1632t1535r2139b1641],

1	Ann	NNP	PERSON	Ann	_	0	SENT_698	[p18l185t1652r394b1732],
2	.	.	O	.	_	0	SENT_698	[p18l185t1652r394b1732],

1	Intern	NNP	O	Intern	_	0	SENT_699	[p18l433t1654r732b1732],
2	.	.	O	.	_	0	SENT_699	[p18l433t1654r732b1732],

1	Med	NNP	O	Med	_	0	SENT_700	[p18l770t1651r995b1732],
2	.	.	O	.	_	0	SENT_700	[p18l770t1651r995b1732],

1	111:273	CD	NUMBER	111:273	num	5	SENT_701	[p18l1048t1651r1570b1733],
2	—	CD	NUMBER	—	num	5	SENT_701	[p18l1048t1651r1570b1733],
3	79	CD	NUMBER	79	num	5	SENT_701	[p18l1048t1651r1570b1733],
4	Capri	NNP	O	Capri	nn	5	SENT_701	[p18l195t1768r447b1874],
5	G	NNP	O	G	_	0	SENT_701	[p18l471t1769r574b1864],
6	,	,	O	,	_	0	SENT_701	[p18l471t1769r574b1864],
7	Munzone	NNP	O	Munzone	nn	8	SENT_701	[p18l600t1771r1032b1850],
8	E	NNP	O	E	appos	5	SENT_701	[p18l1055t1771r1147b1864],
9	,	,	O	,	_	0	SENT_701	[p18l1055t1771r1147b1864],
10	Tarenzi	NNP	O	Tarenzi	nn	11	SENT_701	[p18l1175t1768r1516b1850],
11	E	NNP	O	E	appos	5	SENT_701	[p18l1536t1771r1629b1864],
12	,	,	O	,	_	0	SENT_701	[p18l1536t1771r1629b1864],
13	et	FW	O	et	nn	14	SENT_701	[p18l1656t1780r1738b1850],
14	al.	FW	O	al.	appos	5	SENT_701	[p18l1760t1768r1861b1850],
15	1994	CD	DATE	1994	dep	14	SENT_701	[p18l1901t1770r2139b1851],
16	.	.	O	.	_	0	SENT_701	[p18l1901t1770r2139b1851],

1	Optic	JJ	O	optic	amod	3	SENT_702	[p18l195t1884r444b1988],
2	nerve	NN	O	nerve	nn	3	SENT_702	[p18l494t1910r746b1965],
3	disturbances	NNS	O	disturbance	_	0	SENT_702	[p18l798t1884r1392b1964],
4	:	:	O	:	_	0	SENT_702	[p18l798t1884r1392b1964],
5	a	DT	O	a	det	7	SENT_702	[p18l1451t1910r1498b1964],
6	new	JJ	O	new	amod	7	SENT_702	[p18l1545t1910r1733b1965],
7	form	NN	O	form	dep	3	SENT_702	[p18l1783t1884r2005b1964],
8	of	IN	O	of	_	0	SENT_702	[p18l2052t1884r2153b1964],
9	paclitaxel	NN	O	paclitaxel	nn	10	SENT_702	[p18l192t2000r637b2106],
10	neurotoxicity	NN	O	neurotoxicity	prep_of	7	SENT_702	[p18l669t2000r1292b2106],
11	.	.	O	.	_	0	SENT_702	[p18l669t2000r1292b2106],

1	J.	NNP	MISC	J.	nn	2	SENT_703	[p18l1326t2003r1396b2082],
2	Natl.	NNP	MISC	Natl.	nsubj	3	SENT_703	[p18l1435t2000r1653b2082],
3	Can	MD	MISC	can	_	0	SENT_703	[p18l1701t2002r1903b2082],
4	.	.	O	.	_	0	SENT_703	[p18l1701t2002r1903b2082],

1	Inst	NNP	O	Inst	_	0	SENT_704	[p18l1943t2003r2132b2082],
2	.	.	O	.	_	0	SENT_704	[p18l1943t2003r2132b2082],

1	86	CD	NUMBER	86	_	0	SENT_705	[p18l198t2116r329b2198],
2	:	:	O	:	_	0	SENT_705	[p18l198t2116r329b2198],
3	1	CD	NUMBER	1	number	4	SENT_705	[p18l352t2118r385b2196],
4	101	CD	NUMBER	101	dep	1	SENT_705	[p18l404t2117r552b2198],

1	44	CD	NUMBER	44	_	0	SENT_706	[p18l6t2233r140b2313],
2	.	.	O	.	_	0	SENT_706	[p18l6t2233r140b2313],

1	Rowinsky	NNP	PERSON	Rowinsky	nn	2	SENT_707	[p18l193t2233r656b2337],
2	EK	NNP	O	EK	_	0	SENT_707	[p18l694t2235r870b2328],
3	,	,	O	,	_	0	SENT_707	[p18l694t2235r870b2328],
4	McGuire	NNP	PERSON	McGuire	nn	5	SENT_707	[p18l911t2233r1325b2313],
5	WP	NNP	O	WP	appos	2	SENT_707	[p18l1361t2235r1542b2328],
6	,	,	O	,	_	0	SENT_707	[p18l1361t2235r1542b2328],
7	Guarnieri	NNP	PERSON	Guarnieri	nn	8	SENT_707	[p18l1586t2233r2021b2313],
8	T	NN	O	t	appos	2	SENT_707	[p18l2058t2235r2139b2328],
9	,	,	O	,	_	0	SENT_707	[p18l2058t2235r2139b2328],
10	et	FW	O	et	nn	11	SENT_707	[p18l194t2361r275b2429],
11	al.	FW	O	al.	appos	2	SENT_707	[p18l305t2349r406b2429],
12	1991	CD	DATE	1991	dep	11	SENT_707	[p18l452t2349r1052b2431],
13	.	.	O	.	_	0	SENT_707	[p18l452t2349r1052b2431],

1	Cardiac	JJ	O	cardiac	amod	2	SENT_708	[p18l452t2349r1052b2431],
2	disturbances	NNS	O	disturbance	_	0	SENT_708	[p18l1083t2349r1651b2429],
3	during	IN	O	during	_	0	SENT_708	[p18l1684t2349r1978b2453],
4	the	DT	O	the	prep_during	2	SENT_708	[p18l2007t2349r2145b2429],

1	372	CD	NUMBER	372	num	2	SENT_709	[p18l604t2639r738b2703],
2	ROWINSKY	NN	O	rowinsky	_	0	SENT_709	[p18l833t2639r1329b2703],

1	administration	NN	O	administration	_	0	SENT_710	[p18l757t2843r1226b2900],
2	of	IN	O	of	_	0	SENT_710	[p18l1258t2843r1329b2900],
3	taxol	NN	O	taxol	prep_of	1	SENT_710	[p18l1353t2843r1530b2900],
4	.	.	O	.	_	0	SENT_710	[p18l1353t2843r1530b2900],

1	J.	NNP	PERSON	J.	nn	2	SENT_711	[p18l1562t2845r1611b2901],
2	Clin	NNP	PERSON	Clin	_	0	SENT_711	[p18l1653t2843r1799b2901],
3	.	.	O	.	_	0	SENT_711	[p18l1653t2843r1799b2901],

1	Oncol	NN	O	oncol	_	0	SENT_712	[p18l1840t2843r2048b2901],
2	.	.	O	.	_	0	SENT_712	[p18l1840t2843r2048b2901],

1	9	CD	NUMBER	9	_	0	SENT_713	[p18l2086t2843r2141b2901],
2	:	:	O	:	_	0	SENT_713	[p18l2086t2843r2141b2901],
3	1704-12	CD	DATE	1704-12	dep	1	SENT_713	[p18l764t2924r1040b2981],

1	45	CD	NUMBER	45	_	0	SENT_714	[p18l621t3005r718b3062],
2	.	.	O	.	_	0	SENT_714	[p18l621t3005r718b3062],

1	Arbuck	NNP	O	Arbuck	nn	2	SENT_715	[p18l756t3005r1002b3062],
2	SG	NNP	O	SG	_	0	SENT_715	[p18l1019t3005r1138b3073],
3	,	,	O	,	_	0	SENT_715	[p18l1019t3005r1138b3073],
4	Strauss	NNP	PERSON	Strauss	nn	5	SENT_715	[p18l1160t3005r1390b3062],
5	H	NNP	O	H	appos	2	SENT_715	[p18l1410t3006r1484b3073],
6	,	,	O	,	_	0	SENT_715	[p18l1410t3006r1484b3073],
7	Rowinsky	NNP	PERSON	Rowinsky	nn	8	SENT_715	[p18l1504t3005r1834b3079],
8	EK	NNP	O	EK	appos	2	SENT_715	[p18l1851t3006r1976b3073],
9	,	,	O	,	_	0	SENT_715	[p18l1851t3006r1976b3073],
10	et	FW	O	et	nn	11	SENT_715	[p18l1997t3013r2054b3062],
11	a1	FW	O	a1	appos	2	SENT_715	[p18l2071t3005r2143b3062],
12	.	.	O	.	_	0	SENT_715	[p18l2071t3005r2143b3062],

1	1993	CD	DATE	1993	_	0	SENT_716	[p18l764t3087r934b3146],
2	.	.	O	.	_	0	SENT_716	[p18l764t3087r934b3146],

1	Areas	NNS	O	area	nn	2	SENT_717	[p18l952t3087r1148b3145],
2	sessment	NN	O	sessment	nsubj	7	SENT_717	[p18l1155t3096r1449b3145],
3	of	IN	O	of	_	0	SENT_717	[p18l1462t3086r1533b3145],
4	the	DT	O	the	det	6	SENT_717	[p18l1540t3086r1637b3145],
5	cardiac	JJ	O	cardiac	amod	6	SENT_717	[p18l1652t3086r1885b3145],
6	toxicity	NN	O	toxicity	prep_of	2	SENT_717	[p18l1899t3086r2146b3162],
7	associated	VBN	O	associate	_	0	SENT_717	[p18l758t3168r1092b3225],
8	with	IN	O	with	_	0	SENT_717	[p18l1119t3168r1262b3226],
9	taxol	NN	O	taxol	prep_with	7	SENT_717	[p18l1290t3168r1468b3225],
10	.	.	O	.	_	0	SENT_717	[p18l1290t3168r1468b3225],

1	Monogr	NNP	O	Monogr	nn	4	SENT_718	[p18l1496t3170r1765b3242],
2	Natl.	NNP	O	Natl.	nn	4	SENT_718	[p18l1796t3168r1950b3226],
3	Cancer	NNP	O	Cancer	nn	4	SENT_718	[p18l1989t3169r2143b3226, p18l757t3269r863b3306],
4	Inst	NNP	O	Inst	_	0	SENT_718	[p18l880t3251r1015b3306],
5	.	.	O	.	_	0	SENT_718	[p18l880t3251r1015b3306],

1	15	CD	NUMBER	15	_	0	SENT_719	[p18l1053t3248r1142b3306],
2	:	:	O	:	_	0	SENT_719	[p18l1053t3248r1142b3306],
3	117-32	CD	NUMBER	117-32	dep	1	SENT_719	[p18l1158t3249r1389b3306],

1	53-374	NN	O	53-374	_	0	SENT_720	[p19l7t2179r65b2403],
2	.	.	O	.	_	0	SENT_720	[p19l7t2179r65b2403],

1	Downloaded	VBN	O	download	_	0	SENT_721	[p19l7t1732r65b2152],
2	from	IN	O	from	_	0	SENT_721	[p19l7t1550r64b1710],
3	www.annualreviews.org	NN	O	www.annualreviews.org	nn	4	SENT_721	[p19l7t725r82b1528],
4	n	NN	O	n	prep_from	1	SENT_721	[p19l107t2358r146b2403],
5	-	:	O	-	_	0	SENT_721	[p19l124t2313r130b2334],
6	Madison	NNP	O	Madison	dep	4	SENT_721	[p19l90t2001r147b2288],
7	on	IN	O	on	_	0	SENT_721	[p19l107t1898r147b1977],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_721	[p19l89t1567r147b1874],
9	.	.	O	.	_	0	SENT_721	[p19l89t1567r147b1874],

1	For	IN	O	for	_	0	SENT_722	[p19l91t1426r147b1540],
2	personal	JJ	O	personal	amod	3	SENT_722	[p19l90t1127r164b1405],
3	use	NN	O	use	pobj	1	SENT_722	[p19l107t997r147b1105],
4	only	RB	O	only	advmod	3	SENT_722	[p19l90t813r164b973],
5	.	.	O	.	_	0	SENT_722	[p19l90t813r164b973],

1	by	IN	O	by	_	0	SENT_723	[p19l89t3372r164b3453],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_723	[p19l89t3003r164b3349],
3	of	IN	ORGANIZATION	of	_	0	SENT_723	[p19l89t2908r147b2979],
4	Wisconsi	NNP	ORGANIZATION	Wisconsi	prep_of	2	SENT_723	[p19l89t2589r147b2892],

1	Annu	NNP	PERSON	Annu	_	0	SENT_724	[p19l8t3339r64b3537],
2	.	.	O	.	_	0	SENT_724	[p19l8t3339r64b3537],

1	Rev.	NNP	O	Rev.	nn	2	SENT_725	[p19l8t3165r64b3311],
2	Med	NNP	O	Med	_	0	SENT_725	[p19l7t2972r64b3138],
3	.	.	O	.	_	0	SENT_725	[p19l7t2972r64b3138],

1	l997	NN	O	l997	_	0	SENT_726	[p19l7t2620r65b2938],
2	.48:3	CD	NUMBER	.48:3	num	1	SENT_726	[p19l7t2620r65b2938],

1	Burtness	NN	O	burtness	nn	2	SENT_727	[p19l756t21r1039b77],
2	B	NN	O	b	_	0	SENT_727	[p19l1072t21r1142b87],
3	,	,	O	,	_	0	SENT_727	[p19l1072t21r1142b87],
4	Harrold	NNP	ORGANIZATION	Harrold	nn	5	SENT_727	[p19l1175t20r1429b77],
5	L	NNP	ORGANIZATION	L	appos	2	SENT_727	[p19l1457t21r1524b88],
6	,	,	O	,	_	0	SENT_727	[p19l1457t21r1524b88],
7	Beaulieu	NNP	ORGANIZATION	Beaulieu	nn	8	SENT_727	[p19l1557t20r1845b77],
8	N	NNP	ORGANIZATION	N	appos	2	SENT_727	[p19l1874t21r1950b88],
9	,	,	O	,	_	0	SENT_727	[p19l1874t21r1950b88],
10	et	FW	O	et	nn	11	SENT_727	[p19l1983t29r2041b77],
11	al.	FW	O	al.	appos	2	SENT_727	[p19l2071t20r2143b77],
12	1996	CD	DATE	1996	dep	11	SENT_727	[p19l764t100r934b159],
13	.	.	O	.	_	0	SENT_727	[p19l764t100r934b159],

1	Use	NN	O	use	nsubj	9	SENT_728	[p19l979t102r1105b159],
2	of	IN	O	of	_	0	SENT_728	[p19l1147t100r1218b158],
3	paclitaxel	NN	O	paclitaxel	prep_of	1	SENT_728	[p19l1253t100r1569b175],
4	in	IN	O	in	_	0	SENT_728	[p19l1609t100r1672b158],
5	patients	NNS	O	patient	prep_in	3	SENT_728	[p19l1710t100r1961b175],
6	with	IN	O	with	_	0	SENT_728	[p19l2003t100r2147b159],
7	cardiomyopathy	NN	O	cardiomyopathy	prep_with	5	SENT_728	[p19l757t182r1285b256],
8	is	VBZ	O	be	cop	9	SENT_728	[p19l1329t182r1380b239],
9	safe	JJ	O	safe	_	0	SENT_728	[p19l1428t182r1572b239],
10	.	.	O	.	_	0	SENT_728	[p19l1428t182r1572b239],

1	Proc	NNP	O	Proc	_	0	SENT_729	[p19l1619t184r1788b239],
2	.	.	O	.	_	0	SENT_729	[p19l1619t184r1788b239],

1	Am	NNP	O	Am	_	0	SENT_730	[p19l1833t183r1960b239],
2	.	.	O	.	_	0	SENT_730	[p19l1833t183r1960b239],

1	Soc	NN	O	soc	_	0	SENT_731	[p19l2010t183r2138b240],
2	.	.	O	.	_	0	SENT_731	[p19l2010t183r2138b240],

1	Clin	NNP	O	Clin	_	0	SENT_732	[p19l760t263r906b322],
2	.	.	O	.	_	0	SENT_732	[p19l760t263r906b322],

1	Oncol	NN	O	oncol	_	0	SENT_733	[p19l940t263r1148b322],
2	.	.	O	.	_	0	SENT_733	[p19l940t263r1148b322],

1	152147	CD	NUMBER	152147	number	2	SENT_734	[p19l1186t263r1401b322],
2	(	CD	NUMBER	(	_	0	SENT_734	[p19l1427t263r1673b335],
3	Abstr	NNP	O	Abstr	dep	2	SENT_734	[p19l1427t263r1673b335],
4	.	.	O	.	_	0	SENT_734	[p19l1427t263r1673b335],
5	)	NN	O	)	dep	2	SENT_734	[p19l1427t263r1673b335],

1	Rowinsky	NNP	PERSON	Rowinsky	nn	2	SENT_735	[p19l756t345r1086b419],
2	EK	NNP	O	EK	_	0	SENT_735	[p19l1121t346r1247b413],
3	,	,	O	,	_	0	SENT_735	[p19l1121t346r1247b413],
4	Burke	NNP	PERSON	Burke	nn	5	SENT_735	[p19l1284t345r1482b402],
5	PJ	NNP	PERSON	PJ	appos	2	SENT_735	[p19l1516t346r1610b413],
6	,	,	O	,	_	0	SENT_735	[p19l1516t346r1610b413],
7	Karp	NNP	PERSON	Karp	nn	8	SENT_735	[p19l1648t346r1808b419],
8	JE	NNP	O	JE	appos	2	SENT_735	[p19l1843t346r1941b413],
9	,	,	O	,	_	0	SENT_735	[p19l1843t346r1941b413],
10	et	FW	O	et	nn	11	SENT_735	[p19l1978t354r2037b402],
11	al.	FW	O	al.	appos	2	SENT_735	[p19l2071t345r2143b402],
12	1989	CD	DATE	1989	dep	11	SENT_735	[p19l764t428r934b486],
13	.	.	O	.	_	0	SENT_735	[p19l764t428r934b486],

1	Phase	NN	O	phase	nn	2	SENT_736	[p19l958t427r1148b485],
2	I	NN	O	i	_	0	SENT_736	[p19l1168t429r1193b484],
3	and	CC	O	and	_	0	SENT_736	[p19l1215t427r1331b485],
4	pharmacodynamic	JJ	O	pharmacodynamic	amod	5	SENT_736	[p19l1348t427r1952b503],
5	study	NN	O	study	conj_and	2	SENT_736	[p19l1974t427r2146b502],
6	of	IN	O	of	_	0	SENT_736	[p19l757t508r828b566],
7	taxol	NN	O	taxol	prep_of	2	SENT_736	[p19l844t508r1006b566],
8	in	IN	O	in	_	0	SENT_736	[p19l1027t508r1090b566],
9	refractory	JJ	O	refractory	amod	12	SENT_736	[p19l1110t508r1431b583],
10	adult	JJ	O	adult	amod	12	SENT_736	[p19l1455t508r1617b566],
11	acute	JJ	O	acute	amod	12	SENT_736	[p19l1637t517r1807b566],
12	leukemia	NN	O	leukemia	prep_in	2	SENT_736	[p19l1829t508r2142b567],
13	.	.	O	.	_	0	SENT_736	[p19l1829t508r2142b567],

1	Cancer	NN	O	cancer	_	0	SENT_737	[p19l760t591r999b648],
2	Res	NNP	O	Res	dep	1	SENT_737	[p19l1016t592r1148b647],
3	.	.	O	.	_	0	SENT_737	[p19l1016t592r1148b647],

1	49:4640	CD	NUMBER	49:4640	_	0	SENT_738	[p19l1178t590r1565b648],
2	—	CD	NUMBER	—	num	3	SENT_738	[p19l1178t590r1565b648],
3	47	CD	NUMBER	47	dep	1	SENT_738	[p19l1178t590r1565b648],

1	Rowinsky	NNP	PERSON	Rowinsky	nn	2	SENT_739	[p19l756t672r1086b747],
2	EK	NNP	O	EK	_	0	SENT_739	[p19l1109t673r1234b740],
3	,	,	O	,	_	0	SENT_739	[p19l1109t673r1234b740],
4	Donehower	NNP	PERSON	Donehower	nn	5	SENT_739	[p19l1260t672r1644b730],
5	RC	NNP	O	RC	appos	2	SENT_739	[p19l1665t672r1789b730],
6	.	.	O	.	_	0	SENT_739	[p19l1665t672r1789b730],

1	1996	CD	DATE	1996	_	0	SENT_740	[p19l1824t672r1993b731],
2	.	.	O	.	_	0	SENT_740	[p19l1824t672r1993b731],

1	Antimicrotubule	JJ	O	antimicrotubule	amod	2	SENT_741	[p19l2020t673r2144b729, p19l756t755r1194b812],
2	agents	NNS	O	agent	_	0	SENT_741	[p19l1236t764r1458b829],
3	.	.	O	.	_	0	SENT_741	[p19l1236t764r1458b829],

1	In	IN	O	in	_	0	SENT_742	[p19l1503t756r1569b811],
2	Cancer	NN	O	cancer	nn	3	SENT_742	[p19l1613t756r1852b813],
3	Chemotherapy	NN	O	chemotherapy	prep_in	5	SENT_742	[p19l1893t755r2143b813, p19l758t837r1022b911],
4	,	,	O	,	_	0	SENT_742	[p19l1893t755r2143b813, p19l758t837r1022b911],
5	ed	VBN	O	ed	_	0	SENT_742	[p19l1075t837r1166b895],
6	.	.	O	.	_	0	SENT_742	[p19l1075t837r1166b895],

1	B	NN	O	b	nn	2	SENT_743	[p19l1220t838r1268b894],
2	Chabner	NNP	PERSON	Chabner	_	0	SENT_743	[p19l1323t837r1612b905],
3	,	,	O	,	_	0	SENT_743	[p19l1323t837r1612b905],
4	J	NNP	PERSON	J	nn	5	SENT_743	[p19l1664t838r1694b895],
5	Collins	NNP	PERSON	Collins	appos	2	SENT_743	[p19l1744t837r1995b905],
6	,	,	O	,	_	0	SENT_743	[p19l1744t837r1995b905],
7	pp	NN	O	pp	appos	5	SENT_743	[p19l2045t855r2142b911],
8	.	.	O	.	_	0	SENT_743	[p19l2045t855r2142b911],

1	263-96	CD	NUMBER	263-96	_	0	SENT_744	[p19l757t919r1016b978],
2	.	.	O	.	_	0	SENT_744	[p19l757t919r1016b978],

1	Philadelphia	NNP	LOCATION	Philadelphia	_	0	SENT_745	[p19l1042t919r1466b994],
2	:	:	O	:	_	0	SENT_745	[p19l1042t919r1466b994],
3	Lippincott-Raven	NNP	PERSON	Lippincott-Raven	nn	5	SENT_745	[p19l1493t919r2069b994],
4	Einzig	NNP	PERSON	Einzig	nn	5	SENT_745	[p19l756t1001r968b1077],
5	AI	NNP	O	AI	dep	1	SENT_745	[p19l988t1002r1091b1070],
6	,	,	O	,	_	0	SENT_745	[p19l988t1002r1091b1070],
7	Wiernik	NNP	ORGANIZATION	Wiernik	nn	8	SENT_745	[p19l1113t1001r1379b1060],
8	P	NN	ORGANIZATION	p	appos	5	SENT_745	[p19l1396t1003r1448b1070],
9	,	,	O	,	_	0	SENT_745	[p19l1396t1003r1448b1070],
10	Sasloff	FW	PERSON	sasloff	dep	5	SENT_745	[p19l1473t1001r1706b1060],
11	J	NN	PERSON	j	dep	5	SENT_745	[p19l1720t1003r1751b1060],
12	,	,	O	,	_	0	SENT_745	[p19l1755t1049r1768b1070],
13	et	FW	O	et	nn	14	SENT_745	[p19l1791t1011r1850b1060],
14	al.	FW	O	al.	appos	11	SENT_745	[p19l1869t1002r1941b1060],
15	1992	CD	DATE	1992	dep	14	SENT_745	[p19l1972t1002r2143b1060],
16	.	.	O	.	_	0	SENT_745	[p19l1972t1002r2143b1060],

1	Phase	NN	O	phase	nn	3	SENT_746	[p19l756t1085r946b1143],
2	II	CD	NUMBER	ii	num	3	SENT_746	[p19l973t1086r1025b1142],
3	study	NN	O	study	nsubj	8	SENT_746	[p19l1053t1085r1226b1160],
4	and	CC	O	and	_	0	SENT_746	[p19l1253t1085r1369b1143],
5	long	JJ	O	long	amod	7	SENT_746	[p19l1393t1085r1715b1160],
6	—	JJ	O	—	amod	7	SENT_746	[p19l1393t1085r1715b1160],
7	term	NN	O	term	nsubj	8	SENT_746	[p19l1393t1085r1715b1160],
8	follow	VB	O	follow	_	0	SENT_746	[p19l1739t1085r1949b1143],
9	up	IN	O	up	advmod	8	SENT_746	[p19l1975t1103r2054b1160],
10	of	IN	O	of	_	0	SENT_746	[p19l2082t1085r2153b1143],
11	patients	NNS	O	patient	prep_of	8	SENT_746	[p19l755t1167r1006b1242],
12	treated	VBN	O	treat	partmod	11	SENT_746	[p19l1051t1167r1273b1225],
13	with	IN	O	with	_	0	SENT_746	[p19l1315t1167r1458b1225],
14	taxol	NN	O	taxol	prep_with	12	SENT_746	[p19l1500t1167r1662b1225],
15	for	IN	O	for	_	0	SENT_746	[p19l1703t1167r1799b1225],
16	advanced	JJ	O	advanced	amod	18	SENT_746	[p19l1841t1167r2148b1225],
17	ovarian	JJ	O	ovarian	amod	18	SENT_746	[p19l757t1249r1000b1307],
18	adenocarcinoma	NN	O	adenocarcinoma	prep_for	14	SENT_746	[p19l1042t1249r1591b1307],
19	.	.	O	.	_	0	SENT_746	[p19l1042t1249r1591b1307],

1	J.	NNP	PERSON	J.	nn	2	SENT_747	[p19l1633t1251r1683b1307],
2	Clin	NNP	PERSON	Clin	_	0	SENT_747	[p19l1733t1249r1880b1307],
3	.	.	O	.	_	0	SENT_747	[p19l1733t1249r1880b1307],

1	Oncol	NN	O	oncol	_	0	SENT_748	[p19l1932t1249r2139b1307],
2	.	.	O	.	_	0	SENT_748	[p19l1932t1249r2139b1307],

1	Thigpen	NNP	PERSON	Thigpen	nn	2	SENT_749	[p19l756t1414r1028b1489],
2	T	NN	O	t	_	0	SENT_749	[p19l1052t1416r1112b1483],
3	,	,	O	,	_	0	SENT_749	[p19l1052t1416r1112b1483],
4	Blessing	NN	O	blessing	nn	5	SENT_749	[p19l1139t1414r1419b1489],
5	J	NN	O	j	appos	2	SENT_749	[p19l1443t1416r1474b1473],
6	,	,	O	,	_	0	SENT_749	[p19l1479t1463r1491b1483],
7	Ball	NNP	O	Ball	nn	8	SENT_749	[p19l1520t1414r1653b1472],
8	H	NNP	O	H	appos	2	SENT_749	[p19l1678t1416r1753b1483],
9	,	,	O	,	_	0	SENT_749	[p19l1678t1416r1753b1483],
10	et	FW	O	et	nn	11	SENT_749	[p19l1781t1423r1839b1472],
11	al.	FW	O	al.	appos	2	SENT_749	[p19l1864t1414r1936b1472],
12	1994	CD	DATE	1994	dep	11	SENT_749	[p19l1973t1415r2143b1473],
13	.	.	O	.	_	0	SENT_749	[p19l1973t1415r2143b1473],

1	Phase	NN	O	phase	nn	3	SENT_750	[p19l756t1498r946b1556],
2	II	CD	NUMBER	ii	num	3	SENT_750	[p19l973t1499r1025b1555],
3	trial	NN	O	trial	_	0	SENT_750	[p19l1051t1497r1180b1556],
4	of	IN	O	of	_	0	SENT_750	[p19l1207t1497r1278b1556],
5	paclitaxel	NN	O	paclitaxel	prep_of	3	SENT_750	[p19l1297t1497r1613b1572],
6	in	IN	O	in	_	0	SENT_750	[p19l1639t1497r1701b1555],
7	patients	NNS	O	patient	prep_in	3	SENT_750	[p19l1725t1497r1976b1572],
8	with	IN	O	with	_	0	SENT_750	[p19l2004t1497r2147b1556],
9	progressive	JJ	O	progressive	amod	11	SENT_750	[p19l755t1579r1132b1654],
10	ovarian	JJ	O	ovarian	amod	11	SENT_750	[p19l1162t1579r1405b1637],
11	carcinoma	NN	O	carcinoma	prep_with	3	SENT_750	[p19l1433t1579r1774b1637],
12	after	IN	O	after	_	0	SENT_750	[p19l1802t1579r1951b1637],
13	platinum	NN	O	platinum	nn	14	SENT_750	[p19l1976t1579r2144b1654, p19l756t1662r1116b1720],
14	—	NN	O	—	prep_after	3	SENT_750	[p19l1976t1579r2144b1654, p19l756t1662r1116b1720],
15	based	VBN	O	base	partmod	3	SENT_750	[p19l1976t1579r2144b1654, p19l756t1662r1116b1720],
16	chemotherapy	NN	O	chemotherapy	dobj	15	SENT_750	[p19l1151t1662r1629b1737],
17	:	:	O	:	_	0	SENT_750	[p19l1151t1662r1629b1737],
18	a	DT	O	a	det	22	SENT_750	[p19l1671t1681r1705b1720],
19	Gynecological	JJ	ORGANIZATION	gynecological	amod	22	SENT_750	[p19l1741t1662r2145b1737, p19l757t1745r850b1803],
20	Oncology	NNP	ORGANIZATION	Oncology	nn	22	SENT_750	[p19l876t1745r1195b1820],
21	Group	NNP	ORGANIZATION	Group	nn	22	SENT_750	[p19l1221t1745r1427b1820],
22	study	NN	O	study	dep	16	SENT_750	[p19l1455t1745r1638b1820],
23	.	.	O	.	_	0	SENT_750	[p19l1455t1745r1638b1820],

1	J.	NNP	PERSON	J.	nn	2	SENT_751	[p19l1664t1748r1713b1804],
2	Clin	NNP	PERSON	Clin	_	0	SENT_751	[p19l1749t1745r1896b1804],
3	.	.	O	.	_	0	SENT_751	[p19l1749t1745r1896b1804],

1	Oncol	NN	O	oncol	_	0	SENT_752	[p19l1932t1745r2139b1804],
2	.	.	O	.	_	0	SENT_752	[p19l1932t1745r2139b1804],

1	12	CD	NUMBER	12	_	0	SENT_753	[p19l764t1828r853b1886],
2	:	:	O	:	_	0	SENT_753	[p19l764t1828r853b1886],
3	1748-5	CD	NUMBER	1748-5	number	4	SENT_753	[p19l869t1828r1100b1886],
4	3	CD	NUMBER	3	dep	1	SENT_753	[p19l1109t1828r1141b1886],

1	Kohn	NNP	ORGANIZATION	Kohn	nn	2	SENT_754	[p19l757t1910r937b1968],
2	EC	NNP	ORGANIZATION	EC	_	0	SENT_754	[p19l959t1911r1078b1979],
3	,	,	O	,	_	0	SENT_754	[p19l959t1911r1078b1979],
4	Sarosy	NNP	PERSON	Sarosy	nn	5	SENT_754	[p19l1106t1911r1326b1985],
5	G	NNP	PERSON	G	appos	2	SENT_754	[p19l1350t1911r1424b1979],
6	,	,	O	,	_	0	SENT_754	[p19l1350t1911r1424b1979],
7	Bicher	NNP	PERSON	Bicher	nn	8	SENT_754	[p19l1449t1910r1667b1968],
8	A	NNP	O	A	appos	2	SENT_754	[p19l1687t1911r1762b1979],
9	,	,	O	,	_	0	SENT_754	[p19l1687t1911r1762b1979],
10	et	FW	O	et	nn	11	SENT_754	[p19l1788t1919r1846b1968],
11	al.	FW	O	al.	appos	2	SENT_754	[p19l1867t1910r1939b1968],
12	1994	CD	DATE	1994	dep	11	SENT_754	[p19l1972t1911r2142b1969],
13	.	.	O	.	_	0	SENT_754	[p19l1972t1911r2142b1969],

1	Dose	NN	O	dose	nn	2	SENT_755	[p19l756t1993r1182b2050],
2	—	NN	O	—	nsubj	4	SENT_755	[p19l756t1993r1182b2050],
3	intense	JJ	O	intense	amod	4	SENT_755	[p19l756t1993r1182b2050],
4	taxolz	NN	O	taxolz	_	0	SENT_755	[p19l1217t1993r1394b2050],
5	high	JJ	O	high	amod	7	SENT_755	[p19l1433t1993r1578b2067],
6	response	NN	O	response	nn	7	SENT_755	[p19l1610t2011r1896b2067],
7	rate	NN	O	rate	dobj	4	SENT_755	[p19l1930t2002r2052b2050],
8	in	IN	O	in	_	0	SENT_755	[p19l2085t1993r2147b2050],
9	patients	NNS	O	patient	prep_in	7	SENT_755	[p19l755t2075r1006b2150],
10	with	IN	O	with	_	0	SENT_755	[p19l1047t2075r1191b2133],
11	platinum	NN	O	platinum	npadvmod	13	SENT_755	[p19l1227t2075r1817b2150],
12	—	CD	NUMBER	—	num	11	SENT_755	[p19l1227t2075r1817b2150],
13	resistant	JJ	O	resistant	amod	16	SENT_755	[p19l1227t2075r1817b2150],
14	recurrent	JJ	O	recurrent	amod	16	SENT_755	[p19l1852t2084r2149b2133],
15	ovarian	JJ	O	ovarian	amod	16	SENT_755	[p19l757t2159r1001b2216],
16	cancer	NN	O	cancer	prep_with	4	SENT_755	[p19l1038t2176r1260b2216],
17	.	.	O	.	_	0	SENT_755	[p19l1038t2176r1260b2216],

1	J.	NNP	O	J.	nn	4	SENT_756	[p19l1300t2161r1349b2217],
2	Natl.	NNP	O	Natl.	nn	4	SENT_756	[p19l1391t2159r1545b2216],
3	Cancer	NNP	O	Cancer	nn	4	SENT_756	[p19l1594t2160r1833b2217],
4	Inst	NNP	O	Inst	_	0	SENT_756	[p19l1864t2161r2000b2216],
5	.	.	O	.	_	0	SENT_756	[p19l1864t2161r2000b2216],

1	86	CD	NUMBER	86	_	0	SENT_757	[p19l2047t2159r2141b2216],
2	:	:	O	:	_	0	SENT_757	[p19l2047t2159r2141b2216],

1	18-24	CD	NUMBER	18-24	num	3	SENT_758	[p19l764t2242r958b2299],
2	Sarosy	NNP	O	Sarosy	nn	3	SENT_758	[p19l759t2323r978b2397],
3	G	NNP	O	G	_	0	SENT_758	[p19l1005t2323r1078b2391],
4	,	,	O	,	_	0	SENT_758	[p19l1005t2323r1078b2391],
5	Kohn	NNP	PERSON	Kohn	nn	6	SENT_758	[p19l1108t2322r1288b2381],
6	E	NNP	O	E	appos	3	SENT_758	[p19l1312t2324r1378b2391],
7	,	,	O	,	_	0	SENT_758	[p19l1312t2324r1378b2391],
8	Stone	NNP	O	Stone	nn	9	SENT_758	[p19l1409t2323r1591b2381],
9	DA	NNP	O	DA	appos	3	SENT_758	[p19l1617t2323r1751b2391],
10	,	,	O	,	_	0	SENT_758	[p19l1617t2323r1751b2391],
11	et	FW	O	et	nn	12	SENT_758	[p19l1780t2332r1838b2381],
12	al.	FW	O	al.	appos	3	SENT_758	[p19l1864t2323r1935b2381],
13	1992	CD	DATE	1992	dep	12	SENT_758	[p19l1972t2323r2142b2381],
14	.	.	O	.	_	0	SENT_758	[p19l1972t2323r2142b2381],

1	Phase	NN	O	phase	_	0	SENT_759	[p19l756t2592r946b2650],
2	I	CD	NUMBER	i	num	3	SENT_759	[p19l967t2594r993b2649],
3	study	NN	O	study	dep	1	SENT_759	[p19l1017t2592r1189b2667],
4	of	IN	O	of	_	0	SENT_759	[p19l1211t2592r1283b2650],
5	taxol	NN	O	taxol	prep_of	3	SENT_759	[p19l1297t2592r1459b2650],
6	and	CC	O	and	_	0	SENT_759	[p19l1481t2592r1597b2650],
7	granulocyte	NN	O	granulocyte	prep_of	3	SENT_759	[p19l1618t2592r2001b2667],
8	colony-stimulating	JJ	O	colony-stimulating	amod	9	SENT_759	[p19l2023t2592r2145b2650, p19l757t2674r1270b2749],
9	factor	NN	O	factor	dep	1	SENT_759	[p19l1300t2674r1490b2732],
10	in	IN	O	in	_	0	SENT_759	[p19l1517t2674r1579b2731],
11	patients	NNS	O	patient	prep_in	9	SENT_759	[p19l1606t2674r1857b2749],
12	with	IN	O	with	_	0	SENT_759	[p19l1888t2674r2030b2732],
13	refractory	JJ	O	refractory	amod	15	SENT_759	[p19l2057t2693r2145b2732, p19l756t2757r1013b2832],
14	ovarian	JJ	O	ovarian	amod	15	SENT_759	[p19l1035t2757r1279b2814],
15	cancer	NN	O	cancer	prep_with	11	SENT_759	[p19l1300t2775r1523b2814],
16	.	.	O	.	_	0	SENT_759	[p19l1300t2775r1523b2814],

1	J.	NNP	PERSON	J.	nn	2	SENT_760	[p19l1546t2759r1595b2815],
2	Clin	NNP	PERSON	Clin	_	0	SENT_760	[p19l1628t2757r1776b2815],
3	.	.	O	.	_	0	SENT_760	[p19l1628t2757r1776b2815],

1	Oncol	NN	O	oncol	_	0	SENT_761	[p19l1807t2757r2015b2815],
2	.	.	O	.	_	0	SENT_761	[p19l1807t2757r2015b2815],

1	10	CD	NUMBER	10	_	0	SENT_762	[p19l2051t2757r2141b2814],
2	:	:	O	:	_	0	SENT_762	[p19l2051t2757r2141b2814],
3	1	CD	NUMBER	1	number	4	SENT_762	[p19l765t2840r788b2896],
4	165-70	CD	NUMBER	165-70	dep	1	SENT_762	[p19l802t2839r1038b2897],

1	Trimble	NNP	O	Trimble	nn	2	SENT_763	[p19l756t2922r1015b2979],
2	EL	NNP	O	EL	_	0	SENT_763	[p19l1030t2923r1146b2990],
3	,	,	O	,	_	0	SENT_763	[p19l1030t2923r1146b2990],
4	Adams	NNP	PERSON	Adams	nn	5	SENT_763	[p19l1163t2922r1393b2979],
5	JD	NNP	O	JD	appos	2	SENT_763	[p19l1409t2923r1516b2989],
6	,	,	O	,	_	0	SENT_763	[p19l1409t2923r1516b2989],
7	Vena	NNP	PERSON	Vena	nn	8	SENT_763	[p19l1534t2923r1697b2979],
8	D	NNP	PERSON	D	appos	2	SENT_763	[p19l1710t2923r1785b2990],
9	,	,	O	,	_	0	SENT_763	[p19l1710t2923r1785b2990],
10	et	FW	O	et	nn	11	SENT_763	[p19l1803t2930r1861b2979],
11	a1	FW	O	a1	appos	2	SENT_763	[p19l1875t2921r1947b2979],
12	.	.	O	.	_	0	SENT_763	[p19l1875t2921r1947b2979],

1	1993	CD	DATE	1993	_	0	SENT_764	[p19l1973t2922r2143b2980],
2	.	.	O	.	_	0	SENT_764	[p19l1973t2922r2143b2980],

1	Paclitaxel	NN	O	paclitaxel	_	0	SENT_765	[p19l756t3004r1076b3062],
2	for	IN	O	for	_	0	SENT_765	[p19l1109t3004r1204b3062],
3	platinum	NN	O	platinum	prep_for	1	SENT_765	[p19l1233t3004r1871b3079],
4	—	CD	NUMBER	—	num	7	SENT_765	[p19l1233t3004r1871b3079],
5	refractory	JJ	O	refractory	amod	7	SENT_765	[p19l1233t3004r1871b3079],
6	ovarian	JJ	O	ovarian	amod	7	SENT_765	[p19l1904t3004r2148b3062],
7	cancer	NN	O	cancer	dep	1	SENT_765	[p19l757t3105r987b3145],
8	:	:	O	:	_	0	SENT_765	[p19l757t3105r987b3145],
9	results	NNS	O	result	dep	1	SENT_765	[p19l1011t3087r1222b3145],
10	from	IN	O	from	_	0	SENT_765	[p19l1245t3087r1404b3145],
11	the	DT	O	the	det	14	SENT_765	[p19l1423t3087r1521b3145],
12	first	JJ	ORDINAL	first	amod	14	SENT_765	[p19l1543t3087r1673b3145],
13	1,000	CD	NUMBER	1,000	num	14	SENT_765	[p19l1700t3087r1874b3155],
14	patients	NNS	O	patient	prep_from	9	SENT_765	[p19l1894t3087r2145b3162],
15	registered	VBN	O	register	partmod	9	SENT_765	[p19l755t3169r1079b3244],
16	to	TO	O	to	_	0	SENT_765	[p19l1119t3178r1180b3227],
17	National	NNP	O	National	nn	21	SENT_765	[p19l1223t3169r1503b3227],
18	Cancer	NNP	O	Cancer	nn	21	SENT_765	[p19l1544t3170r1776b3227],
19	Treatment	NN	O	treatment	nn	21	SENT_765	[p19l1815t3171r2148b3227],
20	Referral	NNP	O	Referral	nn	21	SENT_765	[p19l756t3252r1024b3309],
21	Center	NNP	O	Center	prep_to	15	SENT_765	[p19l1057t3252r1274b3310],
22	9103	CD	NUMBER	9103	num	21	SENT_765	[p19l1306t3252r1482b3310],
23	.	.	O	.	_	0	SENT_765	[p19l1306t3252r1482b3310],

1	J.	NNP	PERSON	J.	nn	2	SENT_766	[p19l1517t3254r1566b3310],
2	Clin	NNP	PERSON	Clin	_	0	SENT_766	[p19l1609t3252r1757b3310],
3	.	.	O	.	_	0	SENT_766	[p19l1609t3252r1757b3310],

1	Oncol	NN	O	oncol	_	0	SENT_767	[p19l1800t3252r2008b3310],
2	.	.	O	.	_	0	SENT_767	[p19l1800t3252r2008b3310],

1	11	CD	NUMBER	11	_	0	SENT_768	[p19l2055t3252r2141b3309],
2	:	:	O	:	_	0	SENT_768	[p19l2055t3252r2141b3309],

1	McGuire	NNP	PERSON	McGuire	nn	2	SENT_769	[p19l756t3416r1050b3475],
2	WP	NNP	O	WP	_	0	SENT_769	[p19l1065t3418r1195b3485],
3	,	,	O	,	_	0	SENT_769	[p19l1065t3418r1195b3485],
4	Hoskins	NNP	PERSON	Hoskins	nn	5	SENT_769	[p19l1213t3416r1478b3474],
5	WJ	NNP	O	WJ	appos	2	SENT_769	[p19l1495t3418r1621b3485],
6	,	,	O	,	_	0	SENT_769	[p19l1495t3418r1621b3485],
7	Brady	NNP	PERSON	Brady	nn	8	SENT_769	[p19l1639t3416r1838b3491],
8	MF	NN	O	mf	appos	2	SENT_769	[p19l1852t3418r1980b3485],
9	,	,	O	,	_	0	SENT_769	[p19l1852t3418r1980b3485],
10	et	FW	O	et	nn	11	SENT_769	[p19l1998t3425r2056b3474],
11	al.	FW	O	al.	appos	2	SENT_769	[p19l2071t3416r2143b3474],
12	1996	CD	DATE	1996	dep	11	SENT_769	[p19l764t3499r934b3558],
13	.	.	O	.	_	0	SENT_769	[p19l764t3499r934b3558],

1	Cyclophosphamide	NNP	O	Cyclophosphamide	nsubj	4	SENT_770	[p19l1001t3499r1631b3575],
2	and	CC	O	and	_	0	SENT_770	[p19l1695t3499r1811b3558],
3	cisplatin	NN	O	cisplatin	conj_and	1	SENT_770	[p19l1873t3499r2147b3574],
4	compared	VBN	O	compare	_	0	SENT_770	[p19l757t3581r1078b3656],
5	with	IN	O	with	_	0	SENT_770	[p19l1110t3581r1253b3640],
6	paclitaxel	NN	O	paclitaxel	prep_with	4	SENT_770	[p19l1284t3581r1600b3656],
7	and	CC	O	and	_	0	SENT_770	[p19l1633t3581r1749b3639],
8	cisplatin	NN	O	cisplatin	prep_with	4	SENT_770	[p19l1780t3581r2054b3657],
9	in	IN	O	in	_	0	SENT_770	[p19l2085t3581r2147b3638],
10	patients	NNS	O	patient	prep_in	4	SENT_770	[p19l755t3663r1006b3739],
11	with	IN	O	with	_	0	SENT_770	[p19l1028t3663r1172b3722],
12	stage	NN	O	stage	prep_with	10	SENT_770	[p19l1193t3673r1358b3739],
13	III	CD	NUMBER	iii	num	12	SENT_770	[p19l1378t3665r1457b3721],
14	and	CC	O	and	_	0	SENT_770	[p19l1479t3663r1595b3722],
15	stage	NN	O	stage	conj_and	4	SENT_770	[p19l1615t3673r1780b3739],
16	IV	CD	NUMBER	iv	num	18	SENT_770	[p19l1800t3665r1883b3722],
17	ovarian	JJ	O	ovarian	amod	18	SENT_770	[p19l1904t3663r2148b3722],
18	cancer	NN	O	cancer	dobj	15	SENT_770	[p19l757t3763r980b3802],
19	.	.	O	.	_	0	SENT_770	[p19l757t3763r980b3802],

1	N.	NNP	O	N.	nn	2	SENT_771	[p19l1004t3747r1072b3803],
2	Engl	NNP	O	Engl	_	0	SENT_771	[p19l1100t3745r1268b3818],
3	.	.	O	.	_	0	SENT_771	[p19l1100t3745r1268b3818],

1	J.	NNP	O	J.	nn	2	SENT_772	[p19l1295t3747r1345b3803],
2	Med	NNP	O	Med	_	0	SENT_772	[p19l1372t3745r1532b3803],
3	.	.	O	.	_	0	SENT_772	[p19l1372t3745r1532b3803],

1	334:1	CD	NUMBER	334:1	num	2	SENT_773	[p19l1563t3745r1826b3803],
2	-6	CD	NUMBER	-6	_	0	SENT_773	[p19l1563t3745r1826b3803],

1	55	CD	NUMBER	55	_	0	SENT_774	[p20l623t10r718b69],
2	.	.	O	.	_	0	SENT_774	[p20l623t10r718b69],

1	Omura	NNP	PERSON	Omura	nn	2	SENT_775	[p20l757t11r984b69],
2	GA	NNP	O	GA	_	0	SENT_775	[p20l1010t11r1143b79],
3	,	,	O	,	_	0	SENT_775	[p20l1010t11r1143b79],
4	Brady	NNP	PERSON	Brady	nn	5	SENT_775	[p20l1171t11r1370b86],
5	MF	NN	O	mf	appos	2	SENT_775	[p20l1394t12r1521b79],
6	,	,	O	,	_	0	SENT_775	[p20l1394t12r1521b79],
7	Delmore	NNP	PERSON	Delmore	nn	8	SENT_775	[p20l1550t11r1834b69],
8	JE	NNP	PERSON	JE	appos	2	SENT_775	[p20l1860t12r1959b79],
9	,	,	O	,	_	0	SENT_775	[p20l1860t12r1959b79],
10	et	FW	O	et	nn	11	SENT_775	[p20l1988t20r2045b69],
11	al.	FW	O	al.	appos	2	SENT_775	[p20l2071t11r2143b69],
12	1995	CD	DATE	1995	dep	11	SENT_775	[p20l764t92r934b151],
13	.	.	O	.	_	0	SENT_775	[p20l764t92r934b151],

1	A	DT	O	a	det	3	SENT_776	[p20l962t93r1020b149],
2	randomized	JJ	O	randomized	amod	3	SENT_776	[p20l1037t92r1424b150],
3	trial	NN	O	trial	_	0	SENT_776	[p20l1446t92r1576b150],
4	of	IN	O	of	_	0	SENT_776	[p20l1599t92r1670b150],
5	paclitaxel	NN	O	paclitaxel	prep_of	3	SENT_776	[p20l1687t92r2004b167],
6	at	IN	O	at	_	0	SENT_776	[p20l2029t101r2086b150],
7	2	CD	NUMBER	2	num	9	SENT_776	[p20l2108t93r2146b149],
8	dose	NN	O	dose	nn	9	SENT_776	[p20l757t174r904b231],
9	levels	NNS	O	level	prep_at	5	SENT_776	[p20l923t174r1110b231],
10	and	CC	O	and	_	0	SENT_776	[p20l1131t174r1247b231],
11	filgastrim	NN	O	filgastrim	nn	14	SENT_776	[p20l1263t174r1581b248],
12	(	CD	NUMBER	(	num	14	SENT_776	[p20l1598t174r1878b245],
13	G-CSF	NN	O	g-csf	nn	14	SENT_776	[p20l1598t174r1878b245],
14	)	NN	O	)	conj_and	5	SENT_776	[p20l1598t174r1878b245],
15	in	IN	O	in	_	0	SENT_776	[p20l1899t174r1961b231],
16	platinum	NN	O	platinum	nn	20	SENT_776	[p20l1976t174r2145b248, p20l756t274r901b314],
17	pretreated	JJ	O	pretreated	amod	20	SENT_776	[p20l921t255r1248b331],
18	epithelial	JJ	O	epithelial	amod	20	SENT_776	[p20l1269t255r1571b331],
19	ovarian	JJ	O	ovarian	amod	20	SENT_776	[p20l1592t255r1836b314],
20	cancer	NN	O	cancer	prep_in	14	SENT_776	[p20l1857t274r2086b314],
21	:	:	O	:	_	0	SENT_776	[p20l1857t274r2086b314],
22	a	DT	O	a	det	25	SENT_776	[p20l2113t274r2148b314],
23	Gynecologic	JJ	ORGANIZATION	gynecologic	amod	25	SENT_776	[p20l757t338r1171b412],
24	Oncology	NNP	ORGANIZATION	Oncology	nn	25	SENT_776	[p20l1229t338r1548b412],
25	Group	NNP	ORGANIZATION	Group	dep	3	SENT_776	[p20l1605t338r1829b412],
26	,	,	O	,	_	0	SENT_776	[p20l1605t338r1829b412],
27	SWOG	NNP	O	SWOG	conj_and	25	SENT_776	[p20l1888t338r2144b405],
28	,	,	O	,	_	0	SENT_776	[p20l1888t338r2144b405],
29	NCCTG	NNP	LOCATION	NCCTG	conj_and	25	SENT_776	[p20l756t420r1050b488],
30	,	,	O	,	_	0	SENT_776	[p20l756t420r1050b488],
31	and	CC	O	and	_	0	SENT_776	[p20l1076t419r1192b477],
32	ECOG	NN	ORGANIZATION	ecog	nn	33	SENT_776	[p20l1212t420r1433b478],
33	study	NN	O	study	dep	3	SENT_776	[p20l1457t419r1640b494],
34	.	.	O	.	_	0	SENT_776	[p20l1457t419r1640b494],

1	Proc	NNP	O	Proc	_	0	SENT_777	[p20l1664t421r1833b478],
2	.	.	O	.	_	0	SENT_777	[p20l1664t421r1833b478],

1	Am	NNP	O	Am	_	0	SENT_778	[p20l1856t420r1981b478],
2	.	.	O	.	_	0	SENT_778	[p20l1856t420r1981b478],

1	Soc	NN	O	soc	_	0	SENT_779	[p20l2010t420r2138b478],
2	.	.	O	.	_	0	SENT_779	[p20l2010t420r2138b478],

1	Clin	NNP	O	Clin	_	0	SENT_780	[p20l760t501r906b560],
2	.	.	O	.	_	0	SENT_780	[p20l760t501r906b560],

1	Oncol	NN	O	oncol	_	0	SENT_781	[p20l940t501r1148b560],
2	.	.	O	.	_	0	SENT_781	[p20l940t501r1148b560],

1	15:280	CD	NUMBER	15:280	number	2	SENT_782	[p20l1186t501r1403b559],
2	(	CD	NUMBER	(	_	0	SENT_782	[p20l1427t501r1673b572],
3	Abstr	NNP	O	Abstr	dep	2	SENT_782	[p20l1427t501r1673b572],
4	.	.	O	.	_	0	SENT_782	[p20l1427t501r1673b572],
5	)	NN	O	)	dep	2	SENT_782	[p20l1427t501r1673b572],

1	56	CD	NUMBER	56	_	0	SENT_783	[p20l623t582r718b641],
2	.	.	O	.	_	0	SENT_783	[p20l623t582r718b641],

1	Rowinsky	NNP	PERSON	Rowinsky	nn	2	SENT_784	[p20l756t582r1086b658],
2	EK	NNP	O	EK	_	0	SENT_784	[p20l1100t584r1227b651],
3	,	,	O	,	_	0	SENT_784	[p20l1100t584r1227b651],
4	Mackey	NNP	PERSON	Mackey	nn	5	SENT_784	[p20l1244t582r1507b658],
5	MK	NNP	O	MK	appos	2	SENT_784	[p20l1521t584r1670b651],
6	,	,	O	,	_	0	SENT_784	[p20l1521t584r1670b651],
7	Goodman	NNP	PERSON	Goodman	nn	8	SENT_784	[p20l1689t582r2009b641],
8	SN	NNP	O	SN	appos	5	SENT_784	[p20l2025t583r2142b641],
9	.	.	O	.	_	0	SENT_784	[p20l2025t583r2142b641],

1	1995	CD	DATE	1995	_	0	SENT_785	[p20l765t664r934b722],
2	.	.	O	.	_	0	SENT_785	[p20l765t664r934b722],

1	Meta	NN	O	meta	nn	2	SENT_786	[p20l965t665r1133b721],
2	analysis	NN	O	analysis	_	0	SENT_786	[p20l1160t664r1419b738],
3	of	IN	O	of	_	0	SENT_786	[p20l1447t664r1518b721],
4	paclitaxel	NN	O	paclitaxel	nn	5	SENT_786	[p20l1538t664r1855b738],
5	doseresponse	NN	O	doseresponse	prep_of	2	SENT_786	[p20l1881t664r2145b721, p20l759t765r977b821],
6	and	CC	O	and	_	0	SENT_786	[p20l1015t746r1131b804],
7	dose-intensity	NN	O	dose-intensity	conj_and	5	SENT_786	[p20l1166t746r1622b821],
8	in	IN	O	in	_	0	SENT_786	[p20l1656t746r1719b804],
9	recurrent	JJ	O	recurrent	prep_in	2	SENT_786	[p20l1751t756r2048b804],
10	or	CC	O	or	_	0	SENT_786	[p20l2081t765r2148b804],
11	refractory	JJ	O	refractory	amod	13	SENT_786	[p20l755t827r1077b902],
12	ovarian	JJ	O	ovarian	amod	13	SENT_786	[p20l1110t827r1354b886],
13	cancer	NN	O	cancer	prep_in	2	SENT_786	[p20l1385t846r1608b885],
14	.	.	O	.	_	0	SENT_786	[p20l1385t846r1608b885],

1	Proc	NNP	O	Proc	_	0	SENT_787	[p20l1643t829r1812b886],
2	.	.	O	.	_	0	SENT_787	[p20l1643t829r1812b886],

1	Am	NNP	O	Am	_	0	SENT_788	[p20l1845t828r1971b885],
2	.	.	O	.	_	0	SENT_788	[p20l1845t828r1971b885],

1	Soc	NN	O	soc	_	0	SENT_789	[p20l2010t828r2139b886],
2	.	.	O	.	_	0	SENT_789	[p20l2010t828r2139b886],

1	Clin	NNP	O	Clin	_	0	SENT_790	[p20l760t909r906b968],
2	.	.	O	.	_	0	SENT_790	[p20l760t909r906b968],

1	Oncol	NN	O	oncol	_	0	SENT_791	[p20l940t909r1148b968],
2	.	.	O	.	_	0	SENT_791	[p20l940t909r1148b968],

1	151284	CD	NUMBER	151284	number	2	SENT_792	[p20l1186t909r1403b967],
2	(	CD	NUMBER	(	_	0	SENT_792	[p20l1427t909r1673b980],
3	Abstr	NNP	O	Abstr	dep	2	SENT_792	[p20l1427t909r1673b980],
4	.	.	O	.	_	0	SENT_792	[p20l1427t909r1673b980],
5	)	NN	O	)	dep	2	SENT_792	[p20l1427t909r1673b980],

1	57	CD	NUMBER	57	_	0	SENT_793	[p20l623t991r718b1049],
2	.	.	O	.	_	0	SENT_793	[p20l623t991r718b1049],

1	Kavanagh	NNP	PERSON	Kavanagh	nn	2	SENT_794	[p20l758t991r1087b1065],
2	J	NNP	PERSON	J	_	0	SENT_794	[p20l1105t992r1135b1049],
3	,	,	O	,	_	0	SENT_794	[p20l1141t1039r1153b1059],
4	Kudelka	NNP	PERSON	Kudelka	nn	9	SENT_794	[p20l1176t991r1452b1048],
5	A	NNP	O	A	nn	9	SENT_794	[p20l1469t991r1544b1059],
6	,	,	O	,	_	0	SENT_794	[p20l1469t991r1544b1059],
7	Gonzales	NNP	PERSON	Gonzales	appos	9	SENT_794	[p20l1566t991r1867b1049],
8	de	IN	PERSON	de	amod	9	SENT_794	[p20l1888t991r1962b1048],
9	Leon	NNP	PERSON	Leon	appos	2	SENT_794	[p20l1980t992r2147b1048],

1	C	NN	O	c	_	0	SENT_795	[p20l193t1327r291b1421],
2	,	,	O	,	_	0	SENT_795	[p20l193t1327r291b1421],
3	et	FW	O	et	nn	4	SENT_795	[p20l333t1339r413b1407],
4	al.	FW	O	al.	appos	1	SENT_795	[p20l449t1326r550b1407],
5	1994	CD	DATE	1994	dep	4	SENT_795	[p20l604t1327r842b1408],
6	.	.	O	.	_	0	SENT_795	[p20l604t1327r842b1408],

1	Phase	NN	O	phase	_	0	SENT_796	[p20l884t1326r1150b1407],
2	II	CD	NUMBER	ii	num	3	SENT_796	[p20l1188t1328r1261b1405],
3	study	NN	O	study	dep	1	SENT_796	[p20l1301t1326r1543b1431],
4	of	IN	O	of	_	0	SENT_796	[p20l1579t1325r1680b1407],
5	docetaxel	NN	O	docetaxel	prep_of	3	SENT_796	[p20l1708t1326r2146b1407],
6	in	IN	O	in	_	0	SENT_796	[p20l192t1441r279b1521],
7	patients	NNS	O	patient	prep_in	5	SENT_796	[p20l335t1441r688b1547],
8	with	IN	O	with	_	0	SENT_796	[p20l748t1441r949b1523],
9	epithelial	JJ	O	epithelial	amod	11	SENT_796	[p20l1006t1441r1430b1547],
10	ovarian	JJ	O	ovarian	amod	11	SENT_796	[p20l1487t1441r1828b1523],
11	carcinoma	NN	O	carcinoma	prep_with	7	SENT_796	[p20l1887t1441r2141b1523, p20l192t1583r446b1637],
12	refractory	JJ	O	refractory	dep	1	SENT_796	[p20l465t1557r915b1661],
13	to	TO	O	to	_	0	SENT_796	[p20l936t1569r1023b1637],
14	platinum	NN	O	platinum	prep_to	12	SENT_796	[p20l1040t1557r1468b1661],
15	.	.	O	.	_	0	SENT_796	[p20l1040t1557r1468b1661],

1	J	NN	O	j	_	0	SENT_797	[p20l1493t1560r1552b1639],
2	.	.	O	.	_	0	SENT_797	[p20l1548t1624r1562b1637],

1	C	NN	O	c	_	0	SENT_798	[p20l1600t1559r1672b1638],
2	lin	NN	O	lin	dep	1	SENT_798	[p20l1673t1557r1805b1637],
3	.	.	O	.	_	0	SENT_798	[p20l1673t1557r1805b1637],

1	Oncol	NN	O	oncol	_	0	SENT_799	[p20l1842t1557r2134b1639],
2	.	.	O	.	_	0	SENT_799	[p20l1842t1557r2134b1639],

1	2:837	CD	NUMBER	2:837	_	0	SENT_800	[p20l193t1675r622b1755],
2	—	CD	NUMBER	—	num	3	SENT_800	[p20l193t1675r622b1755],
3	42	CD	NUMBER	42	dep	1	SENT_800	[p20l193t1675r622b1755],

1	Piccart	NNP	PERSON	Piccart	nn	3	SENT_801	[p20l192t1790r512b1871],
2	J	NNP	PERSON	J	nn	3	SENT_801	[p20l531t1792r573b1872],
3	H	NNP	PERSON	H	_	0	SENT_801	[p20l578t1792r682b1886],
4	,	,	O	,	_	0	SENT_801	[p20l578t1792r682b1886],
5	Gore	NNP	PERSON	Gore	nn	6	SENT_801	[p20l712t1790r938b1872],
6	M	NNP	O	M	appos	3	SENT_801	[p20l961t1792r1086b1886],
7	,	,	O	,	_	0	SENT_801	[p20l961t1792r1086b1886],
8	ten	CD	NUMBER	ten	num	11	SENT_801	[p20l1113t1802r1253b1871],
9	Bokkel	NNP	PERSON	Bokkel	nn	11	SENT_801	[p20l1273t1790r1602b1871],
10	Huinink	NNP	PERSON	Huinink	nn	11	SENT_801	[p20l1626t1790r2002b1871],
11	W	NNP	PERSON	W	appos	3	SENT_801	[p20l2019t1792r2139b1886],
12	,	,	O	,	_	0	SENT_801	[p20l2019t1792r2139b1886],
13	et	FW	O	et	nn	14	SENT_801	[p20l192t1921r274b1989],
14	al.	FW	O	al.	appos	3	SENT_801	[p20l308t1908r410b1989],
15	1995	CD	DATE	1995	dep	14	SENT_801	[p20l460t1907r672b1990],
16	.	.	O	.	_	0	SENT_801	[p20l685t1975r698b1989],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_802	[p20l739t1908r1226b1989],
2	:	:	O	:	_	0	SENT_802	[p20l739t1908r1226b1989],
3	an	DT	O	a	det	6	SENT_802	[p20l1270t1933r1374b1989],
4	active	JJ	O	active	amod	6	SENT_802	[p20l1409t1907r1679b1989],
5	new	JJ	O	new	amod	6	SENT_802	[p20l1713t1933r1901b1989],
6	drug	NN	O	drug	dep	1	SENT_802	[p20l1937t1908r2143b2013],
7	for	IN	O	for	_	0	SENT_802	[p20l192t2024r326b2104],
8	the	DT	O	the	det	9	SENT_802	[p20l355t2024r491b2104],
9	treatment	NN	O	treatment	prep_for	6	SENT_802	[p20l526t2036r959b2104],
10	of	IN	O	of	prep	9	SENT_802	[p20l990t2024r1089b2104],
11	advanced	JJ	O	advanced	amod	13	SENT_802	[p20l1115t2024r1546b2104],
12	ovarian	JJ	O	ovarian	amod	13	SENT_802	[p20l1577t2024r1918b2104],
13	cancer	NN	O	cancer	dep	10	SENT_802	[p20l1949t2050r2141b2104, p20l192t2166r347b2222],
14	.	.	O	.	_	0	SENT_802	[p20l1949t2050r2141b2104, p20l192t2166r347b2222],
15	]	SYM	O	]	dep	1	SENT_802	[p20l381t2143r450b2222],

1	.	.	O	.	_	0	SENT_803	[p20l381t2143r450b2222],

1	Natl.	NNP	O	Natl.	nn	3	SENT_804	[p20l487t2140r703b2222],
2	Cancer	NNP	O	Cancer	nn	3	SENT_804	[p20l752t2142r1087b2222],
3	Inst	NNP	O	Inst	_	0	SENT_804	[p20l1111t2143r1301b2222],
4	.	.	O	.	_	0	SENT_804	[p20l1111t2143r1301b2222],

1	872686-81	CD	NUMBER	872686-81	_	0	SENT_805	[p20l1348t2140r1821b2222],

1	Aapro	NNP	O	Aapro	nn	2	SENT_806	[p20l192t2257r477b2361],
2	M	NNP	O	M	_	0	SENT_806	[p20l510t2259r635b2352],
3	,	,	O	,	_	0	SENT_806	[p20l510t2259r635b2352],
4	Pujade	NNP	PERSON	Pujade	appos	2	SENT_806	[p20l673t2257r1430b2361],
5	.	.	O	.	_	0	SENT_806	[p20l673t2257r1430b2361],

1	—	NN	O	—	_	0	SENT_807	[p20l673t2257r1430b2361],
2	.	.	O	.	_	0	SENT_807	[p20l673t2257r1430b2361],

1	Lauraine	NNP	O	Lauraine	nn	2	SENT_808	[p20l673t2257r1430b2361],
2	E	NNP	O	E	_	0	SENT_808	[p20l1464t2259r1557b2353],
3	,	,	O	,	_	0	SENT_808	[p20l1464t2259r1557b2353],
4	Lhomme	NNP	PERSON	Lhomme	nn	5	SENT_808	[p20l1595t2257r2009b2337],
5	C	NNP	O	C	appos	2	SENT_808	[p20l2043t2257r2141b2352],
6	,	,	O	,	_	0	SENT_808	[p20l2043t2257r2141b2352],
7	et	FW	O	et	nn	8	SENT_808	[p20l192t2387r274b2455],
8	al.	FW	O	al.	appos	2	SENT_808	[p20l340t2375r441b2455],
9	1994	CD	DATE	1994	dep	8	SENT_808	[p20l522t2375r761b2457],
10	.	.	O	.	_	0	SENT_808	[p20l522t2375r761b2457],

1	EORTC	NNP	O	EORTC	_	0	SENT_809	[p20l830t2375r1197b2455],
2	Clinical	JJ	O	clinical	amod	4	SENT_809	[p20l1265t2375r1623b2455],
3	Screening	NNP	O	Screening	nn	4	SENT_809	[p20l1690t2375r2144b2479],
4	Group	NNP	O	Group	dep	1	SENT_809	[p20l194t2489r508b2595],
5	:	:	O	:	_	0	SENT_809	[p20l194t2489r508b2595],
6	phase	NN	O	phase	nn	8	SENT_809	[p20l546t2489r808b2595],
7	II	CD	NUMBER	ii	num	8	SENT_809	[p20l844t2491r917b2569],
8	study	NN	O	study	dep	1	SENT_809	[p20l953t2489r1196b2595],
9	of	IN	O	of	_	0	SENT_809	[p20l1230t2489r1329b2571],
10	Taxotere	NNP	O	Taxotere	prep_of	8	SENT_809	[p20l1355t2491r1753b2571],
11	in	IN	O	in	_	0	SENT_809	[p20l1786t2489r1873b2569],
12	ovarian	JJ	O	ovarian	amod	13	SENT_809	[p20l1906t2515r2141b2571, p20l192t2605r331b2687],
13	cancer	NN	O	cancer	prep_in	10	SENT_809	[p20l388t2631r702b2687],
14	.	.	O	.	_	0	SENT_809	[p20l388t2631r702b2687],

1	Ann	NNP	PERSON	Ann	_	0	SENT_810	[p20l757t2607r966b2687],
2	.	.	O	.	_	0	SENT_810	[p20l757t2607r966b2687],

1	Oncol	NN	O	oncol	_	0	SENT_811	[p20l1040t2605r1332b2687],
2	.	.	O	.	_	0	SENT_811	[p20l1040t2605r1332b2687],

1	5	CD	NUMBER	5	num	2	SENT_812	[p20l1402t2605r1451b2687],
2	(	CD	NUMBER	(	_	0	SENT_812	[p20l1463t2605r1785b2711],
3	Suppl	NNP	O	Suppl	dep	2	SENT_812	[p20l1463t2605r1785b2711],
4	.	.	O	.	_	0	SENT_812	[p20l1463t2605r1785b2711],

1	5	CD	NUMBER	5	_	0	SENT_813	[p20l1850t2605r2144b2706],
2	)	CD	NUMBER	)	number	3	SENT_813	[p20l1850t2605r2144b2706],
3	:202	CD	NUMBER	:202	num	5	SENT_813	[p20l1850t2605r2144b2706],
4	(	NN	O	(	nn	5	SENT_813	[p20l195t2722r540b2823],
5	Abstr	NN	PERSON	abstr	dep	1	SENT_813	[p20l195t2722r540b2823],
6	.	.	O	.	_	0	SENT_813	[p20l195t2722r540b2823],
7	)	SYM	O	)	dep	1	SENT_813	[p20l195t2722r540b2823],

1	Francis	NNP	PERSON	Francis	nn	2	SENT_814	[p20l192t2838r526b2919],
2	P	NN	PERSON	p	_	0	SENT_814	[p20l557t2840r629b2934],
3	,	,	O	,	_	0	SENT_814	[p20l557t2840r629b2934],
4	Schneider	NNP	PERSON	Schneider	nn	5	SENT_814	[p20l665t2838r1121b2920],
5	J	NNP	PERSON	J	appos	2	SENT_814	[p20l1146t2840r1188b2920],
6	,	,	O	,	_	0	SENT_814	[p20l1197t2906r1213b2934],
7	Hann	NNP	PERSON	Hann	nn	8	SENT_814	[p20l1245t2840r1494b2919],
8	L	NNP	O	L	appos	2	SENT_814	[p20l1520t2840r1612b2934],
9	,	,	O	,	_	0	SENT_814	[p20l1520t2840r1612b2934],
10	et	FW	O	et	nn	11	SENT_814	[p20l1645t2850r1727b2919],
11	al.	FW	O	al.	appos	2	SENT_814	[p20l1753t2838r1856b2920],
12	1994	CD	DATE	1994	dep	11	SENT_814	[p20l1899t2838r2138b2920],
13	.	.	O	.	_	0	SENT_814	[p20l1899t2838r2138b2920],

1	Phase	NN	O	phase	nn	3	SENT_815	[p20l192t2955r458b3035],
2	II	CD	NUMBER	ii	num	3	SENT_815	[p20l496t2957r571b3035],
3	trial	NN	O	trial	_	0	SENT_815	[p20l607t2955r789b3035],
4	of	IN	O	of	_	0	SENT_815	[p20l828t2955r927b3035],
5	docetaxel	NN	O	docetaxel	prep_of	3	SENT_815	[p20l957t2955r1393b3035],
6	in	IN	O	in	_	0	SENT_815	[p20l1430t2955r1517b3035],
7	patients	NNS	O	patient	prep_in	3	SENT_815	[p20l1551t2955r1905b3059],
8	with	IN	O	with	_	0	SENT_815	[p20l1944t2955r2144b3035],
9	platinum	NN	O	platinum	nn	12	SENT_815	[p20l190t3072r599b3177],
10	refractory	JJ	O	refractory	amod	12	SENT_815	[p20l623t3071r1074b3177],
11	ovarian	JJ	O	ovarian	amod	12	SENT_815	[p20l1103t3072r1444b3153],
12	cancer	NN	O	cancer	prep_with	7	SENT_815	[p20l1471t3097r1783b3153],
13	.	.	O	.	_	0	SENT_815	[p20l1471t3097r1783b3153],

1	J.	NNP	O	J.	nn	2	SENT_816	[p20l1814t3075r1882b3154],
2	C	NNP	O	C	_	0	SENT_816	[p20l1927t3074r2000b3154],
3	lin	NN	O	lin	dep	2	SENT_816	[p20l2001t3072r2132b3153],
4	.	.	O	.	_	0	SENT_816	[p20l2001t3072r2132b3153],

1	Oncol	NN	O	oncol	_	0	SENT_817	[p20l197t3187r488b3269],
2	.	.	O	.	_	0	SENT_817	[p20l197t3187r488b3269],

1	12:2301	CD	NUMBER	12:2301	_	0	SENT_818	[p20l541t3188r1014b3269],
2	—	CD	NUMBER	—	num	3	SENT_818	[p20l541t3188r1014b3269],
3	8	CD	NUMBER	8	dep	1	SENT_818	[p20l541t3188r1014b3269],

1	Holmes	NNP	ORGANIZATION	Holmes	nn	2	SENT_819	[p20l192t3304r545b3385],
2	FA	NNP	ORGANIZATION	FA	_	0	SENT_819	[p20l588t3304r750b3400],
3	,	,	O	,	_	0	SENT_819	[p20l588t3304r750b3400],
4	Walters	NNP	ORGANIZATION	Walters	nn	5	SENT_819	[p20l795t3304r1136b3385],
5	RS	NN	ORGANIZATION	r	appos	2	SENT_819	[p20l1181t3304r1345b3400],
6	,	,	O	,	_	0	SENT_819	[p20l1181t3304r1345b3400],
7	Theriault	NNP	O	Theriault	nn	8	SENT_819	[p20l1391t3304r1811b3385],
8	RL	NNP	O	RL	appos	2	SENT_819	[p20l1850t3306r2019b3400],
9	,	,	O	,	_	0	SENT_819	[p20l1850t3306r2019b3400],
10	et	FW	O	et	nn	11	SENT_819	[p20l2066t3316r2146b3385],
11	al.	FW	O	al.	appos	2	SENT_819	[p20l194t3421r295b3503],
12	1991	CD	DATE	1991	dep	11	SENT_819	[p20l354t3423r592b3505],
13	.	.	O	.	_	0	SENT_819	[p20l354t3423r592b3505],

1	Phase	NN	O	phase	nn	3	SENT_820	[p20l641t3421r908b3503],
2	II	CD	NUMBER	ii	num	3	SENT_820	[p20l952t3424r1025b3502],
3	trial	NN	O	trial	_	0	SENT_820	[p20l1068t3421r1249b3503],
4	of	IN	O	of	_	0	SENT_820	[p20l1293t3421r1392b3503],
5	taxol	NN	O	taxol	prep_of	3	SENT_820	[p20l1426t3421r1677b3517],
6	,	,	O	,	_	0	SENT_820	[p20l1426t3421r1677b3517],
7	an	DT	O	a	det	9	SENT_820	[p20l1727t3447r1832b3503],
8	active	JJ	O	active	amod	9	SENT_820	[p20l1875t3421r2144b3503],
9	drug	NN	O	drug	appos	3	SENT_820	[p20l193t3540r399b3644],
10	in	IN	O	in	_	0	SENT_820	[p20l451t3540r538b3618],
11	metastatic	JJ	O	metastatic	amod	13	SENT_820	[p20l588t3540r1048b3620],
12	breast	NN	O	breast	nn	13	SENT_820	[p20l1099t3540r1376b3620],
13	cancer	NN	O	cancer	prep_in	9	SENT_820	[p20l1424t3564r1737b3620],
14	.	.	O	.	_	0	SENT_820	[p20l1424t3564r1737b3620],

1	J.	NNP	O	J.	nn	4	SENT_821	[p20l1790t3542r1859b3621],
2	Natl.	NNP	O	Natl.	nn	4	SENT_821	[p20l1916t3540r2132b3620],
3	Cancer	NNP	O	Cancer	nn	4	SENT_821	[p20l197t3656r533b3736],
4	Inst	NNP	O	Inst	_	0	SENT_821	[p20l557t3657r747b3736],
5	.	.	O	.	_	0	SENT_821	[p20l557t3657r747b3736],

1	83	CD	NUMBER	83	_	0	SENT_822	[p20l794t3655r926b3736],
2	:	:	O	:	_	0	SENT_822	[p20l794t3655r926b3736],
3	1797-805	CD	NUMBER	1797-805	dep	1	SENT_822	[p20l948t3654r1387b3736],

1	62	CD	NUMBER	62	_	0	SENT_823	[p21l6t24r138b106],
2	.	.	O	.	_	0	SENT_823	[p21l6t24r138b106],

1	Reichman	NNP	PERSON	Reichman	nn	2	SENT_824	[p21l192t24r656b106],
2	B	NNP	PERSON	B	_	0	SENT_824	[p21l699t26r799b120],
3	,	,	O	,	_	0	SENT_824	[p21l699t26r799b120],
4	Seidman	NNP	PERSON	Seidman	nn	5	SENT_824	[p21l849t24r1249b106],
5	A	NNP	O	A	appos	2	SENT_824	[p21l1291t25r1395b120],
6	,	,	O	,	_	0	SENT_824	[p21l1291t25r1395b120],
7	Crown	NNP	O	Crown	nn	8	SENT_824	[p21l1445t25r1755b106],
8	J	NNP	O	J	appos	2	SENT_824	[p21l1797t26r1864b120],
9	,	,	O	,	_	0	SENT_824	[p21l1797t26r1864b120],
10	et	FW	O	et	nn	11	SENT_824	[p21l1913t38r1995b106],
11	al.	FW	O	al.	appos	2	SENT_824	[p21l2038t24r2139b106],
12	.	.	O	.	_	0	SENT_824	[p21l2038t24r2139b106],

1	1993	CD	DATE	1993	_	0	SENT_825	[p21l202t143r441b224],
2	.	.	O	.	_	0	SENT_825	[p21l202t143r441b224],

1	Paclitaxel	NN	O	paclitaxel	nn	5	SENT_826	[p21l498t141r948b222],
2	and	CC	O	and	_	0	SENT_826	[p21l1000t141r1164b222],
3	recombinant	JJ	O	recombinant	conj_and	1	SENT_826	[p21l1211t141r1786b222],
4	human	JJ	O	human	amod	5	SENT_826	[p21l1833t141r2146b222],
5	granulocyte	NN	O	granulocyte	_	0	SENT_826	[p21l193t257r731b361],
6	colony-stimulating	JJ	O	colony-stimulating	amod	7	SENT_826	[p21l797t257r1658b361],
7	factor	NN	O	factor	dep	5	SENT_826	[p21l1722t257r1990b337],
8	as	IN	O	as	_	0	SENT_826	[p21l2052t283r2141b337],
9	initial	JJ	O	initial	amod	10	SENT_826	[p21l192t373r456b455],
10	chemotherapy	NN	O	chemotherapy	prep_as	7	SENT_826	[p21l501t373r1148b479],
11	for	IN	O	for	_	0	SENT_826	[p21l1192t373r1326b455],
12	metastatic	JJ	O	metastatic	amod	14	SENT_826	[p21l1365t373r1828b455],
13	breast	NN	O	breast	nn	14	SENT_826	[p21l1870t373r2148b455],
14	cancer	NN	O	cancer	prep_for	10	SENT_826	[p21l192t515r505b571],
15	.	.	O	.	_	0	SENT_826	[p21l192t515r505b571],

1	J.	NNP	PERSON	J.	nn	2	SENT_827	[p21l541t492r609b571],
2	Clin	NNP	PERSON	Clin	_	0	SENT_827	[p21l658t489r865b571],
3	.	.	O	.	_	0	SENT_827	[p21l658t489r865b571],

1	Oncol	NN	O	oncol	_	0	SENT_828	[p21l912t489r1202b571],
2	.	.	O	.	_	0	SENT_828	[p21l912t489r1202b571],

1	11:1943	CD	NUMBER	11:1943	_	0	SENT_829	[p21l1256t489r1776b571],
2	—	CD	NUMBER	—	num	3	SENT_829	[p21l1256t489r1776b571],
3	51	CD	NUMBER	51	dep	1	SENT_829	[p21l1256t489r1776b571],

1	Gianni	NNP	PERSON	Gianni	nn	2	SENT_830	[p21l194t606r502b686],
2	L	NNP	PERSON	L	_	0	SENT_830	[p21l528t608r621b701],
3	,	,	O	,	_	0	SENT_830	[p21l528t608r621b701],
4	Munzone	NNP	O	Munzone	nn	5	SENT_830	[p21l651t608r1084b686],
5	E	NNP	O	E	appos	2	SENT_830	[p21l1111t608r1204b701],
6	,	,	O	,	_	0	SENT_830	[p21l1111t608r1204b701],
7	Capri	NNP	O	Capri	nn	8	SENT_830	[p21l1235t606r1486b710],
8	G	NNP	O	G	appos	2	SENT_830	[p21l1515t606r1618b701],
9	,	,	O	,	_	0	SENT_830	[p21l1515t606r1618b701],
10	et	FW	O	et	nn	11	SENT_830	[p21l1649t618r1730b686],
11	al.	FW	O	al.	appos	2	SENT_830	[p21l1757t606r1858b686],
12	1995	CD	DATE	1995	dep	11	SENT_830	[p21l1899t606r2139b688],
13	.	.	O	.	_	0	SENT_830	[p21l1899t606r2139b688],

1	Paclitaxel	NN	O	paclitaxel	_	0	SENT_831	[p21l192t722r642b803],
2	in	IN	O	in	_	0	SENT_831	[p21l663t722r750b802],
3	metastatic	JJ	O	metastatic	amod	5	SENT_831	[p21l769t722r1230b803],
4	breast	NN	O	breast	nn	5	SENT_831	[p21l1251t722r1529b803],
5	cancer	NN	O	cancer	prep_in	1	SENT_831	[p21l1546t748r1868b804],
6	:	:	O	:	_	0	SENT_831	[p21l1546t748r1868b804],
7	a	DT	O	a	det	8	SENT_831	[p21l1897t748r1945b803],
8	trial	NN	O	trial	dep	1	SENT_831	[p21l1963t722r2144b803],
9	of	IN	O	of	_	0	SENT_831	[p21l194t839r293b921],
10	two	CD	NUMBER	two	num	11	SENT_831	[p21l331t853r500b921],
11	doses	NNS	O	dose	prep_of	8	SENT_831	[p21l548t840r797b921],
12	by	IN	O	by	_	0	SENT_831	[p21l846t839r959b945],
13	a	DT	O	a	det	15	SENT_831	[p21l1007t865r1056b921],
14	3-hour	JJ	DURATION	3-hour	amod	15	SENT_831	[p21l1103t840r1406b921],
15	infusion	NN	O	infusion	prep_by	11	SENT_831	[p21l1449t839r1823b921],
16	in	IN	O	in	_	0	SENT_831	[p21l1868t840r1955b919],
17	patients	NNS	O	patient	prep_in	15	SENT_831	[p21l1998t865r2141b945, p21l192t955r435b1037],
18	with	IN	O	with	_	0	SENT_831	[p21l458t955r660b1037],
19	disease	NN	O	disease	prep_with	17	SENT_831	[p21l682t955r1009b1037],
20	recurrent	JJ	O	recurrent	amod	19	SENT_831	[p21l1030t967r1446b1037],
21	after	IN	O	after	_	0	SENT_831	[p21l1465t955r1675b1037],
22	prior	JJ	O	prior	amod	23	SENT_831	[p21l1689t955r1913b1061],
23	therapy	NN	O	therapy	prep_after	20	SENT_831	[p21l1930t955r2141b1037, p21l194t1097r355b1175],
24	with	IN	O	with	_	0	SENT_831	[p21l409t1071r610b1151],
25	anthracyclines	NNS	O	anthracycline	prep_with	23	SENT_831	[p21l663t1071r1345b1175],
26	.	.	O	.	_	0	SENT_831	[p21l663t1071r1345b1175],

1	J.	NNP	O	J.	nn	4	SENT_832	[p21l1400t1074r1468b1153],
2	Natl.	NNP	O	Natl.	nn	4	SENT_832	[p21l1529t1071r1745b1152],
3	Cancer	NNP	O	Cancer	nn	4	SENT_832	[p21l1814t1073r2148b1153],
4	Inst	NNP	O	Inst	_	0	SENT_832	[p21l188t1190r378b1268],
5	.	.	O	.	_	0	SENT_832	[p21l188t1190r378b1268],

1	87	CD	NUMBER	87	_	0	SENT_833	[p21l426t1189r557b1268],
2	:	:	O	:	_	0	SENT_833	[p21l426t1189r557b1268],
3	1169-75	CD	NUMBER	1169-75	dep	1	SENT_833	[p21l580t1187r957b1270],

1	64	CD	NUMBER	64	_	0	SENT_834	[p21l6t1304r138b1385],
2	.	.	O	.	_	0	SENT_834	[p21l6t1304r138b1385],

1	Seidman	NN	PERSON	seidman	nn	2	SENT_835	[p21l195t1304r593b1385],
2	AD	NN	O	ad	_	0	SENT_835	[p21l633t1305r823b1400],
3	,	,	O	,	_	0	SENT_835	[p21l633t1305r823b1400],
4	Tiersten	NNP	O	Tiersten	nn	8	SENT_835	[p21l868t1304r1239b1385],
5	A	NNP	O	A	nn	8	SENT_835	[p21l1280t1305r1385b1400],
6	,	,	O	,	_	0	SENT_835	[p21l1280t1305r1385b1400],
7	Hudis	NNP	PERSON	Hudis	appos	8	SENT_835	[p21l1431t1303r1701b1385],
8	C.	NNP	O	C.	appos	2	SENT_835	[p21l1746t1305r1842b1385],
9	1995	CD	DATE	1995	num	8	SENT_835	[p21l1899t1303r2138b1386],
10	.	.	O	.	_	0	SENT_835	[p21l1899t1303r2138b1386],

1	Phase	NN	O	phase	nn	3	SENT_836	[p21l192t1419r458b1501],
2	II	CD	NUMBER	ii	num	3	SENT_836	[p21l496t1421r571b1499],
3	trial	NN	O	trial	_	0	SENT_836	[p21l607t1419r790b1501],
4	of	IN	O	of	_	0	SENT_836	[p21l828t1419r927b1501],
5	paclitaxel	NN	O	paclitaxel	prep_of	3	SENT_836	[p21l955t1419r1400b1525],
6	by	IN	O	by	_	0	SENT_836	[p21l1433t1419r1548b1525],
7	3-hour	JJ	DURATION	3-hour	amod	8	SENT_836	[p21l1588t1419r1890b1501],
8	infusion	NN	O	infusion	prep_by	3	SENT_836	[p21l1924t1419r2141b1501, p21l195t1535r382b1617],
9	as	IN	O	as	_	0	SENT_836	[p21l404t1561r491b1617],
10	initial	JJ	O	initial	amod	13	SENT_836	[p21l515t1535r778b1617],
11	and	CC	O	and	_	0	SENT_836	[p21l800t1535r964b1617],
12	salvage	NN	O	salvage	amod	13	SENT_836	[p21l986t1535r1324b1641],
13	chemotherapy	NN	O	chemotherapy	prep_as	3	SENT_836	[p21l1346t1535r1993b1641],
14	for	IN	O	for	_	0	SENT_836	[p21l2013t1535r2146b1617],
15	metastatic	JJ	O	metastatic	amod	17	SENT_836	[p21l192t1651r653b1733],
16	breast	NN	O	breast	nn	17	SENT_836	[p21l712t1651r987b1733],
17	cancer	NN	O	cancer	prep_for	13	SENT_836	[p21l1044t1677r1357b1733],
18	.	.	O	.	_	0	SENT_836	[p21l1044t1677r1357b1733],

1	J.	NNP	PERSON	J.	nn	2	SENT_837	[p21l1419t1654r1487b1733],
2	Clin	NNP	PERSON	Clin	_	0	SENT_837	[p21l1563t1651r1769b1733],
3	.	.	O	.	_	0	SENT_837	[p21l1563t1651r1769b1733],

1	Oncol	NN	O	oncol	_	0	SENT_838	[p21l1842t1651r2134b1733],
2	.	.	O	.	_	0	SENT_838	[p21l1842t1651r2134b1733],

1	Trudeau	NNP	O	Trudeau	nn	2	SENT_839	[p21l192t1886r569b1967],
2	ME	NNP	O	ME	_	0	SENT_839	[p21l604t1888r797b1981],
3	,	,	O	,	_	0	SENT_839	[p21l604t1888r797b1981],
4	Eisenhauer	NNP	PERSON	Eisenhauer	nn	5	SENT_839	[p21l837t1886r1348b1967],
5	EA	NN	PERSON	ea	appos	2	SENT_839	[p21l1381t1887r1557b1981],
6	,	,	O	,	_	0	SENT_839	[p21l1381t1887r1557b1981],
7	Higgins	NNP	PERSON	Higgins	nn	8	SENT_839	[p21l1595t1885r1953b1991],
8	BP	NNP	O	BP	appos	2	SENT_839	[p21l1993t1888r2139b1981],
9	,	,	O	,	_	0	SENT_839	[p21l1993t1888r2139b1981],
10	et	FW	O	et	nn	11	SENT_839	[p21l192t2013r274b2083],
11	al.	FW	O	al.	appos	2	SENT_839	[p21l308t2001r409b2083],
12	1996	CD	DATE	1996	dep	11	SENT_839	[p21l458t2001r698b2083],
13	.	.	O	.	_	0	SENT_839	[p21l458t2001r698b2083],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_840	[p21l734t2001r1199b2083],
2	in	IN	O	in	_	0	SENT_840	[p21l1230t2001r1317b2081],
3	patients	NNS	O	patient	prep_in	1	SENT_840	[p21l1348t2001r1701b2107],
4	with	IN	O	with	_	0	SENT_840	[p21l1736t2001r1937b2083],
5	metastatic	JJ	O	metastatic	amod	7	SENT_840	[p21l1968t2027r2141b2083, p21l192t2117r512b2197],
6	breast	NN	O	breast	nn	7	SENT_840	[p21l534t2117r809b2197],
7	cancer	NN	O	cancer	prep_with	3	SENT_840	[p21l830t2143r1152b2197],
8	:	:	O	:	_	0	SENT_840	[p21l830t2143r1152b2197],
9	a	DT	O	a	det	12	SENT_840	[p21l1183t2143r1232b2197],
10	phase	NN	O	phase	nn	12	SENT_840	[p21l1249t2117r1510b2221],
11	II	CD	NUMBER	ii	num	12	SENT_840	[p21l1532t2119r1606b2197],
12	study	NN	O	study	dep	1	SENT_840	[p21l1630t2117r1871b2221],
13	of	IN	O	of	_	0	SENT_840	[p21l1894t2117r1993b2197],
14	the	DT	O	the	det	17	SENT_840	[p21l2007t2117r2144b2197],
15	National	NNP	ORGANIZATION	National	nn	17	SENT_840	[p21l192t2233r585b2315],
16	Cancer	NNP	ORGANIZATION	Cancer	nn	17	SENT_840	[p21l724t2233r1048b2315],
17	Institute	NNP	ORGANIZATION	Institute	prep_of	12	SENT_840	[p21l1183t2233r1554b2315],
18	of	IN	ORGANIZATION	of	_	0	SENT_840	[p21l1694t2233r1795b2314],
19	Canada	NNP	ORGANIZATION	Canada	prep_of	17	SENT_840	[p21l1925t2233r2141b2315, p21l194t2352r828b2432],
20	.	.	O	.	_	0	SENT_840	[p21l1925t2233r2141b2315, p21l194t2352r828b2432],

1	—	NN	O	—	_	0	SENT_841	[p21l1925t2233r2141b2315, p21l194t2352r828b2432],
2	.	.	O	.	_	0	SENT_841	[p21l1925t2233r2141b2315, p21l194t2352r828b2432],

1	C1inica1	NN	O	c1inica1	_	0	SENT_842	[p21l1925t2233r2141b2315, p21l194t2352r828b2432],

1	Trials	NNP	O	Trials	nn	2	SENT_843	[p21l854t2352r1110b2432],
2	Group	NNP	O	Group	_	0	SENT_843	[p21l1141t2352r1454b2456],
3	.	.	O	.	_	0	SENT_843	[p21l1141t2352r1454b2456],

1	J.	NNP	PERSON	J.	nn	2	SENT_844	[p21l1482t2354r1550b2433],
2	Clin	NNP	PERSON	Clin	_	0	SENT_844	[p21l1595t2352r1800b2433],
3	.	.	O	.	_	0	SENT_844	[p21l1595t2352r1800b2433],

1	Oncol	NN	O	oncol	_	0	SENT_845	[p21l1842t2352r2134b2433],
2	.	.	O	.	_	0	SENT_845	[p21l1842t2352r2134b2433],

1	14:422	CD	NUMBER	14:422	_	0	SENT_846	[p21l202t2468r675b2548],
2	—	CD	NUMBER	—	num	3	SENT_846	[p21l202t2468r675b2548],
3	28	CD	NUMBER	28	dep	1	SENT_846	[p21l202t2468r675b2548],

1	Hudis	NNP	PERSON	Hudis	nn	2	SENT_847	[p21l192t2583r462b2664],
2	CA	NNP	O	CA	_	0	SENT_847	[p21l494t2583r675b2679],
3	,	,	O	,	_	0	SENT_847	[p21l494t2583r675b2679],
4	Seidman	NNP	PERSON	Seidman	nn	5	SENT_847	[p21l710t2583r1107b2665],
5	AD	NN	O	ad	appos	2	SENT_847	[p21l1134t2583r1322b2679],
6	,	,	O	,	_	0	SENT_847	[p21l1134t2583r1322b2679],
7	Crown	NNP	O	Crown	nn	9	SENT_847	[p21l1357t2583r1666b2665],
8	J	NNP	O	J	nn	9	SENT_847	[p21l1692t2585r1734b2665],
9	PA	NN	O	pa	appos	2	SENT_847	[p21l1738t2583r1896b2679],
10	,	,	O	,	_	0	SENT_847	[p21l1738t2583r1896b2679],
11	et	FW	O	et	nn	12	SENT_847	[p21l1930t2595r2011b2664],
12	al.	FW	O	al.	appos	2	SENT_847	[p21l2038t2583r2139b2664],
13	1996	CD	DATE	1996	dep	12	SENT_847	[p21l202t2700r441b2783],
14	.	.	O	.	_	0	SENT_847	[p21l202t2700r441b2783],

1	Phase	NN	O	phase	_	0	SENT_848	[p21l477t2700r743b2782],
2	II	CD	NUMBER	ii	dep	1	SENT_848	[p21l773t2703r848b2780],
3	and	CC	O	and	_	0	SENT_848	[p21l877t2700r1041b2782],
4	pharmacologic	JJ	O	pharmacologic	amod	5	SENT_848	[p21l1067t2700r1746b2806],
5	study	NN	O	study	dep	1	SENT_848	[p21l1781t2700r2023b2806],
6	of	IN	O	of	_	0	SENT_848	[p21l2052t2700r2153b2782],
7	docetaxel	NN	O	docetaxel	prep_of	1	SENT_848	[p21l193t2816r630b2896],
8	as	IN	O	as	_	0	SENT_848	[p21l673t2842r761b2896],
9	initial	JJ	O	initial	amod	10	SENT_848	[p21l806t2816r1068b2896],
10	chemotherapy	NN	O	chemotherapy	prep_as	7	SENT_848	[p21l1108t2816r1757b2920],
11	for	IN	O	for	_	0	SENT_848	[p21l1797t2816r1931b2896],
12	metastatic	JJ	O	metastatic	amod	14	SENT_848	[p21l1968t2842r2141b2896, p21l192t2932r512b3014],
13	breast	NN	O	breast	nn	14	SENT_848	[p21l560t2932r837b3014],
14	cancer	NN	O	cancer	prep_for	10	SENT_848	[p21l884t2958r1197b3014],
15	.	.	O	.	_	0	SENT_848	[p21l884t2958r1197b3014],

1	J.	NNP	PERSON	J.	nn	2	SENT_849	[p21l1247t2935r1317b3014],
2	Clin	NNP	PERSON	Clin	_	0	SENT_849	[p21l1381t2932r1586b3014],
3	.	.	O	.	_	0	SENT_849	[p21l1381t2932r1586b3014],

1	Oncol	NN	O	oncol	_	0	SENT_850	[p21l1651t2932r1943b3014],
2	.	.	O	.	_	0	SENT_850	[p21l1651t2932r1943b3014],

1	14	CD	NUMBER	14	_	0	SENT_851	[p21l2012t2933r2136b3014],
2	:	:	O	:	_	0	SENT_851	[p21l2012t2933r2136b3014],

1	Chevallier	NNP	PERSON	Chevallier	nn	2	SENT_852	[p21l193t3166r670b3248],
2	B	NNP	O	B	_	0	SENT_852	[p21l699t3169r799b3262],
3	,	,	O	,	_	0	SENT_852	[p21l699t3169r799b3262],
4	Fumoleau	NNP	PERSON	Fumoleau	nn	5	SENT_852	[p21l835t3166r1294b3248],
5	P	NN	PERSON	p	appos	2	SENT_852	[p21l1325t3169r1398b3262],
6	,	,	O	,	_	0	SENT_852	[p21l1325t3169r1398b3262],
7	Kerbrat	NN	PERSON	kerbrat	nn	8	SENT_852	[p21l1435t3166r1786b3248],
8	P	NN	PERSON	p	appos	2	SENT_852	[p21l1814t3169r1887b3262],
9	,	,	O	,	_	0	SENT_852	[p21l1814t3169r1887b3262],
10	et	FW	O	et	nn	11	SENT_852	[p21l1925t3178r2005b3248],
11	al.	FW	O	al.	appos	2	SENT_852	[p21l2038t3166r2139b3248],
12	1995	CD	DATE	1995	dep	11	SENT_852	[p21l202t3283r441b3365],
13	.	.	O	.	_	0	SENT_852	[p21l202t3283r441b3365],

1	Docetaxel	NNP	O	Docetaxel	nsubj	6	SENT_853	[p21l484t3283r948b3363],
2	is	VBZ	O	be	cop	6	SENT_853	[p21l983t3283r1054b3363],
3	a	DT	O	a	det	6	SENT_853	[p21l1094t3309r1142b3363],
4	major	JJ	O	major	amod	6	SENT_853	[p21l1177t3283r1444b3387],
5	cytotoxic	JJ	O	cytotoxic	amod	6	SENT_853	[p21l1478t3283r1899b3387],
6	drug	NN	O	drug	_	0	SENT_853	[p21l1937t3283r2143b3387],
7	for	IN	O	for	_	0	SENT_853	[p21l192t3399r326b3481],
8	the	DT	O	the	det	9	SENT_853	[p21l345t3400r481b3481],
9	treatment	NN	O	treatment	prep_for	6	SENT_853	[p21l503t3413r938b3481],
10	of	IN	O	of	_	0	SENT_853	[p21l955t3399r1056b3481],
11	advanced	JJ	O	advanced	amod	13	SENT_853	[p21l1070t3400r1501b3481],
12	breast	NN	O	breast	nn	13	SENT_853	[p21l1520t3400r1795b3481],
13	cancer	NN	O	cancer	prep_of	9	SENT_853	[p21l1815t3425r2137b3481],
14	:	:	O	:	_	0	SENT_853	[p21l1815t3425r2137b3481],

1	a	DT	O	a	det	2	SENT_854	[p22l194t50r241b106],
2	phase	NN	O	phase	_	0	SENT_854	[p22l289t24r550b130],
3	II	CD	NUMBER	ii	num	4	SENT_854	[p22l599t26r672b104],
4	trial	NN	O	trial	dep	2	SENT_854	[p22l722t24r903b106],
5	of	IN	O	of	_	0	SENT_854	[p22l953t24r1053b106],
6	the	DT	O	the	det	8	SENT_854	[p22l1092t24r1230b106],
7	Clinical	JJ	O	clinical	amod	8	SENT_854	[p22l1280t24r1639b106],
8	Screening	NN	O	screening	prep_of	4	SENT_854	[p22l1690t24r2144b130],
9	Cooperative	NNP	O	Cooperative	nn	10	SENT_854	[p22l192t140r750b244],
10	Group	NNP	O	Group	dep	2	SENT_854	[p22l809t140r1096b244],
11	of	IN	O	of	_	0	SENT_854	[p22l1155t140r1254b220],
12	the	DT	O	the	det	14	SENT_854	[p22l1303t140r1439b220],
13	European	NNP	ORGANIZATION	European	nn	14	SENT_854	[p22l1494t142r1932b244],
14	Organization	NNP	ORGANIZATION	Organization	prep_of	10	SENT_854	[p22l1988t140r2141b220, p22l192t256r668b362],
15	for	IN	ORGANIZATION	for	_	0	SENT_854	[p22l708t256r841b338],
16	Research	NNP	ORGANIZATION	Research	prep_for	14	SENT_854	[p22l880t256r1303b338],
17	and	CC	O	and	_	0	SENT_854	[p22l1343t256r1506b338],
18	Treatment	NN	O	treatment	prep_of	10	SENT_854	[p22l1545t259r2012b338],
19	of	IN	O	of	_	0	SENT_854	[p22l2052t256r2153b338],
20	Cancer	NN	O	cancer	prep_of	18	SENT_854	[p22l192t374r531b455],
21	.	.	O	.	_	0	SENT_854	[p22l192t374r531b455],

1	J.	NNP	PERSON	J.	nn	2	SENT_855	[p22l566t376r634b456],
2	Clin	NNP	PERSON	Clin	_	0	SENT_855	[p22l682t374r889b456],
3	.	.	O	.	_	0	SENT_855	[p22l682t374r889b456],

1	Oncol	NN	O	oncol	_	0	SENT_856	[p22l936t374r1228b456],
2	.	.	O	.	_	0	SENT_856	[p22l936t374r1228b456],

1	l3	NN	O	l3	_	0	SENT_857	[p22l1280t374r1757b455],
2	:3	CD	NUMBER	:3	num	3	SENT_857	[p22l1280t374r1757b455],
3	l4	NN	O	l4	dep	1	SENT_857	[p22l1280t374r1757b455],
4	—	CD	NUMBER	—	number	5	SENT_857	[p22l1280t374r1757b455],
5	22	CD	NUMBER	22	dep	3	SENT_857	[p22l1280t374r1757b455],

1	Fumoleau	NNP	PERSON	Fumoleau	nn	2	SENT_858	[p22l192t489r649b571],
2	P	NN	PERSON	p	_	0	SENT_858	[p22l687t492r759b585],
3	,	,	O	,	_	0	SENT_858	[p22l687t492r759b585],
4	Chevallier	NNP	PERSON	Chevallier	nn	5	SENT_858	[p22l802t489r1277b571],
5	B	NNP	O	B	appos	2	SENT_858	[p22l1313t491r1413b585],
6	,	,	O	,	_	0	SENT_858	[p22l1313t491r1413b585],
7	Dieras	NNP	O	Dieras	nn	8	SENT_858	[p22l1452t489r1750b571],
8	V	NNP	O	V	appos	2	SENT_858	[p22l1788t491r1878b585],
9	,	,	O	,	_	0	SENT_858	[p22l1788t491r1878b585],
10	et	FW	O	et	nn	11	SENT_858	[p22l1920t501r2002b571],
11	al.	FW	O	al.	appos	2	SENT_858	[p22l2038t489r2139b571],
12	1994	CD	DATE	1994	dep	11	SENT_858	[p22l202t606r441b688],
13	.	.	O	.	_	0	SENT_858	[p22l202t606r441b688],

1	Evaluation	NN	O	evaluation	_	0	SENT_859	[p22l473t606r968b687],
2	of	IN	O	of	_	0	SENT_859	[p22l995t606r1096b686],
3	two	CD	NUMBER	two	num	4	SENT_859	[p22l1113t618r1282b687],
4	doses	NNS	O	dose	prep_of	1	SENT_859	[p22l1310t606r1559b686],
5	of	IN	O	of	_	0	SENT_859	[p22l1590t606r1690b686],
6	docetaxel	NN	O	docetaxel	prep_of	1	SENT_859	[p22l1708t606r2146b686],

1	(	NNP	O	(	nn	2	SENT_860	[p22l195t725r663b824],
2	Taxotere	NNP	O	Taxotere	_	0	SENT_860	[p22l195t725r663b824],
3	)	RB	O	)	advmod	2	SENT_860	[p22l195t725r663b824],
4	as	IN	O	as	_	0	SENT_860	[p22l694t749r783b805],
5	first-line	JJ	O	first-line	amod	6	SENT_860	[p22l814t723r1205b805],
6	therapy	NN	O	therapy	prep_as	2	SENT_860	[p22l1231t723r1574b829],
7	in	IN	O	in	_	0	SENT_860	[p22l1600t723r1687b803],
8	advanced	JJ	O	advanced	amod	10	SENT_860	[p22l1715t723r2146b805],
9	breast	NN	O	breast	nn	10	SENT_860	[p22l190t839r467b919],
10	cancer	NN	O	cancer	prep_in	2	SENT_860	[p22l498t865r811b919],
11	.	.	O	.	_	0	SENT_860	[p22l498t865r811b919],

1	Report	NNP	O	Report	_	0	SENT_861	[p22l847t841r1160b943],
2	of	IN	O	of	_	0	SENT_861	[p22l1190t839r1289b919],
3	the	DT	O	the	det	7	SENT_861	[p22l1313t839r1449b919],
4	EORTC	NNP	O	EORTC	nn	7	SENT_861	[p22l1480t839r1847b920],
5	Clinical	JJ	O	clinical	amod	7	SENT_861	[p22l1882t839r2141b920, p22l192t955r323b1037],
6	Screening	NNP	O	Screening	nn	7	SENT_861	[p22l348t955r802b1061],
7	Group	NNP	O	Group	prep_of	1	SENT_861	[p22l828t955r1116b1061],
8	(	CD	NUMBER	(	num	9	SENT_861	[p22l1143t955r1870b1056],
9	EORTC-CSG	NN	O	eortc-csg	dep	1	SENT_861	[p22l1143t955r1870b1056],
10	)	NN	O	)	dep	9	SENT_861	[p22l1143t955r1870b1056],
11	.	.	O	.	_	0	SENT_861	[p22l1143t955r1870b1056],

1	Proc	NNP	O	Proc	_	0	SENT_862	[p22l1895t958r2132b1037],
2	.	.	O	.	_	0	SENT_862	[p22l1895t958r2132b1037],

1	2nd	JJ	ORDINAL	2nd	amod	2	SENT_863	[p22l190t1071r366b1153],
2	Em	NN	O	em	_	0	SENT_863	[p22l395t1074r573b1152],
3	:	:	O	:	_	0	SENT_863	[p22l395t1074r573b1152],
4	Congr	NNP	O	Congr	dep	2	SENT_863	[p22l623t1073r912b1175],
5	.	.	O	.	_	0	SENT_863	[p22l623t1073r912b1175],

1	Senology	NNP	O	Senology	nn	5	SENT_864	[p22l958t1071r1386b1175],
2	,	,	O	,	_	0	SENT_864	[p22l958t1071r1386b1175],
3	Vienna	NNP	LOCATION	Vienna	appos	5	SENT_864	[p22l1440t1074r1762b1165],
4	,	,	O	,	_	0	SENT_864	[p22l1440t1074r1762b1165],
5	Austria	NNP	LOCATION	Austria	_	0	SENT_864	[p22l1802t1073r2145b1153],
6	(	CD	NUMBER	(	num	5	SENT_864	[p22l195t1187r540b1286],
7	Abstr	NNP	O	Abstr	dep	5	SENT_864	[p22l195t1187r540b1286],
8	.	.	O	.	_	0	SENT_864	[p22l195t1187r540b1286],
9	)	NN	O	)	dep	5	SENT_864	[p22l195t1187r540b1286],

1	69	CD	NUMBER	69	_	0	SENT_865	[p22l6t1303r138b1385],
2	.	.	O	.	_	0	SENT_865	[p22l6t1303r138b1385],

1	Seidman	NN	PERSON	seidman	nn	2	SENT_866	[p22l195t1303r592b1385],
2	AD	NN	O	ad	_	0	SENT_866	[p22l614t1303r802b1399],
3	,	,	O	,	_	0	SENT_866	[p22l614t1303r802b1399],
4	Reichman	NNP	PERSON	Reichman	nn	5	SENT_866	[p22l828t1303r1293b1384],
5	BS	NNP	O	BS	appos	2	SENT_866	[p22l1313t1303r1477b1399],
6	,	,	O	,	_	0	SENT_866	[p22l1313t1303r1477b1399],
7	Crown	NNP	O	Crown	nn	8	SENT_866	[p22l1503t1303r1812b1385],
8	J	NNP	O	J	appos	2	SENT_866	[p22l1835t1305r1877b1385],
9	PA	NN	O	pa	dep	8	SENT_866	[p22l1880t1303r2038b1399],
10	,	,	O	,	_	0	SENT_866	[p22l1880t1303r2038b1399],
11	et	FW	O	et	nn	14	SENT_866	[p22l2066t1315r2146b1385],
12	w.annualreviews.org	FW	O	w.annualreviews.org	nn	14	SENT_866	[p22l7t2785r82b3469],
13	personal	JJ	O	personal	amod	14	SENT_866	[p22l90t3188r164b3466],
14	use	NN	O	use	appos	2	SENT_866	[p22l107t3058r147b3166],
15	only	RB	O	only	advmod	14	SENT_866	[p22l89t2873r164b3033],
16	.	.	O	.	_	0	SENT_866	[p22l89t2873r164b3033],

1	al.	FW	O	al.	_	0	SENT_867	[p22l757t1586r830b1643],
2	1995	CD	DATE	1995	dep	1	SENT_867	[p22l885t1585r1055b1644],
3	.	.	O	.	_	0	SENT_867	[p22l885t1585r1055b1644],

1	Paclitaxel	NN	O	paclitaxel	_	0	SENT_868	[p22l1104t1586r1424b1643],
2	as	IN	O	as	_	0	SENT_868	[p22l1469t1604r1533b1643],
3	second	JJ	ORDINAL	second	amod	6	SENT_868	[p22l1581t1586r1805b1643],
4	and	CC	O	and	_	0	SENT_868	[p22l1849t1586r1965b1643],
5	subsequent	JJ	O	subsequent	amod	6	SENT_868	[p22l2010t1586r2144b1643, p22l759t1675r1007b1741],
6	therapy	NN	O	therapy	prep_as	1	SENT_868	[p22l1033t1666r1278b1741],
7	for	IN	O	for	_	0	SENT_868	[p22l1305t1666r1400b1724],
8	metastatic	JJ	O	metastatic	amod	10	SENT_868	[p22l1427t1666r1755b1724],
9	breast	NN	O	breast	nn	10	SENT_868	[p22l1784t1666r1981b1724],
10	cancer	NN	O	cancer	prep_for	1	SENT_868	[p22l2008t1685r2144b1724, p22l757t1766r872b1805],
11	:	:	O	:	_	0	SENT_868	[p22l2008t1685r2144b1724, p22l757t1766r872b1805],
12	activity	NN	O	activity	dep	1	SENT_868	[p22l899t1748r1139b1822],
13	independent	JJ	O	independent	amod	12	SENT_868	[p22l1160t1748r1559b1822],
14	of	IN	O	of	_	0	SENT_868	[p22l1578t1748r1649b1805],
15	prior	JJ	O	prior	amod	17	SENT_868	[p22l1662t1748r1822b1822],
16	anthracycline	NN	O	anthracycline	nn	17	SENT_868	[p22l1841t1748r2144b1822, p22l757t1830r912b1889],
17	response	NN	O	response	prep_of	12	SENT_868	[p22l933t1849r1236b1906],
18	.	.	O	.	_	0	SENT_868	[p22l933t1849r1236b1906],

1	J.	NNP	PERSON	J.	nn	2	SENT_869	[p22l1260t1833r1309b1889],
2	Clin	NNP	PERSON	Clin	_	0	SENT_869	[p22l1343t1830r1490b1889],
3	.	.	O	.	_	0	SENT_869	[p22l1343t1830r1490b1889],

1	Oncol	NN	O	oncol	_	0	SENT_870	[p22l1524t1830r1731b1889],
2	.	.	O	.	_	0	SENT_870	[p22l1524t1830r1731b1889],

1	l3	NN	O	l3	_	0	SENT_871	[p22l1769t1830r2145b1890],
2	:1152	CD	NUMBER	:1152	number	3	SENT_871	[p22l1769t1830r2145b1890],
3	—	CD	NUMBER	—	dep	1	SENT_871	[p22l1769t1830r2145b1890],
4	59	CD	NUMBER	59	num	5	SENT_871	[p22l1769t1830r2145b1890],
5	Seidman	NN	O	seidman	dep	3	SENT_871	[p22l758t1912r1042b1970],
6	A	NN	O	a	dep	1	SENT_871	[p22l1073t1913r1148b1980],
7	,	,	O	,	_	0	SENT_871	[p22l1073t1913r1148b1980],
8	Crown	NNP	O	Crown	nn	9	SENT_871	[p22l1183t1912r1404b1970],
9	J	NNP	O	J	appos	6	SENT_871	[p22l1434t1913r1464b1970],
10	,	,	O	,	_	0	SENT_871	[p22l1470t1960r1482b1980],
11	Reichman	NNP	PERSON	Reichman	nn	12	SENT_871	[p22l1516t1912r1847b1969],
12	B	NNP	O	B	appos	1	SENT_871	[p22l1877t1913r1947b1980],
13	,	,	O	,	_	0	SENT_871	[p22l1877t1913r1947b1980],
14	et	FW	O	et	nn	15	SENT_871	[p22l1982t1920r2039b1969],
15	al.	FW	O	al.	appos	1	SENT_871	[p22l2071t1912r2143b1969],
16	1993	CD	DATE	1993	dep	15	SENT_871	[p22l764t1996r934b2054],
17	.	.	O	.	_	0	SENT_871	[p22l764t1996r934b2054],

1	Lack	NN	O	lack	_	0	SENT_872	[p22l953t1996r1118b2053],
2	of	IN	O	of	_	0	SENT_872	[p22l1132t1996r1203b2053],
3	cross-resistance	NN	O	cross-resistance	prep_of	1	SENT_872	[p22l1214t1996r1731b2053],
4	of	IN	O	of	_	0	SENT_872	[p22l1748t1996r1819b2053],
5	taxol	NN	O	taxol	prep_of	1	SENT_872	[p22l1827t1996r1989b2053],
6	with	IN	O	with	_	0	SENT_872	[p22l2004t1996r2147b2053],
7	anthracycline	NN	O	anthracycline	prep_with	1	SENT_872	[p22l758t2077r1194b2152],
8	in	IN	O	in	_	0	SENT_872	[p22l1213t2077r1275b2134],
9	the	DT	O	the	det	10	SENT_872	[p22l1292t2077r1390b2135],
10	treatment	NN	O	treatment	prep_in	7	SENT_872	[p22l1409t2086r1718b2135],
11	of	IN	O	of	_	0	SENT_872	[p22l1734t2077r1805b2135],
12	metastatic	JJ	O	metastatic	amod	14	SENT_872	[p22l1817t2077r2145b2135],
13	breast	NN	O	breast	nn	14	SENT_872	[p22l755t2158r952b2216],
14	cancer	NN	O	cancer	prep_of	10	SENT_872	[p22l973t2176r1186b2216],
15	(	CD	NUMBER	(	num	17	SENT_872	[p22l1208t2159r1457b2230],
16	MBC	NN	O	mbc	nn	17	SENT_872	[p22l1208t2159r1457b2230],
17	)	NN	O	)	dep	14	SENT_872	[p22l1208t2159r1457b2230],
18	.	.	O	.	_	0	SENT_872	[p22l1208t2159r1457b2230],

1	Proc	NNP	O	Proc	_	0	SENT_873	[p22l1482t2160r1650b2216],
2	.	.	O	.	_	0	SENT_873	[p22l1482t2160r1650b2216],

1	Am	NNP	O	Am	_	0	SENT_874	[p22l1674t2159r1800b2216],
2	.	.	O	.	_	0	SENT_874	[p22l1674t2159r1800b2216],

1	Soc	NN	O	soc	_	0	SENT_875	[p22l1829t2159r1958b2217],
2	.	.	O	.	_	0	SENT_875	[p22l1829t2159r1958b2217],

1	Clin	NNP	O	Clin	_	0	SENT_876	[p22l1992t2158r2138b2217],
2	.	.	O	.	_	0	SENT_876	[p22l1992t2158r2138b2217],

1	Oncol	NN	O	oncol	_	0	SENT_877	[p22l760t2240r967b2299],
2	.	.	O	.	_	0	SENT_877	[p22l760t2240r967b2299],

1	12:63	CD	NUMBER	12:63	number	2	SENT_878	[p22l1005t2240r1176b2298],
2	(	CD	NUMBER	(	_	0	SENT_878	[p22l1206t2240r1451b2311],
3	Abstr	NNP	O	Abstr	dep	2	SENT_878	[p22l1206t2240r1451b2311],
4	.	.	O	.	_	0	SENT_878	[p22l1206t2240r1451b2311],
5	)	NN	O	)	dep	2	SENT_878	[p22l1206t2240r1451b2311],

1	Ravdin	NN	PERSON	ravdin	nn	2	SENT_879	[p22l756t2322r992b2380],
2	P	NN	PERSON	p	_	0	SENT_879	[p22l1014t2324r1066b2390],
3	,	,	O	,	_	0	SENT_879	[p22l1014t2324r1066b2390],
4	Burris	NNP	ORGANIZATION	Burris	nn	5	SENT_879	[p22l1093t2322r1294b2380],
5	HA	NNP	ORGANIZATION	HA	appos	2	SENT_879	[p22l1320t2323r1454b2390],
6	,	,	O	,	_	0	SENT_879	[p22l1320t2323r1454b2390],
7	Cook	NNP	ORGANIZATION	Cook	nn	8	SENT_879	[p22l1483t2322r1659b2380],
8	G	NNP	ORGANIZATION	G	appos	2	SENT_879	[p22l1681t2323r1755b2390],
9	,	,	O	,	_	0	SENT_879	[p22l1681t2323r1755b2390],
10	et	FW	O	et	nn	11	SENT_879	[p22l1784t2332r1842b2380],
11	al.	FW	O	al.	appos	2	SENT_879	[p22l1865t2322r1937b2380],
12	1995	CD	DATE	1995	dep	11	SENT_879	[p22l1972t2322r2143b2381],
13	.	.	O	.	_	0	SENT_879	[p22l1972t2322r2143b2381],

1	Phase	NN	O	phase	_	0	SENT_880	[p22l756t2404r946b2461],
2	II	CD	NUMBER	ii	num	3	SENT_880	[p22l970t2405r1023b2461],
3	trial	NN	O	trial	dep	1	SENT_880	[p22l1047t2404r1176b2461],
4	of	IN	O	of	_	0	SENT_880	[p22l1202t2404r1273b2461],
5	docetaxel	NN	O	docetaxel	prep_of	3	SENT_880	[p22l1291t2404r1603b2461],
6	in	IN	O	in	_	0	SENT_880	[p22l1627t2404r1689b2461],
7	advanced	JJ	O	advanced	amod	8	SENT_880	[p22l1713t2404r2021b2462],
8	anthracycline-resistant	JJ	O	anthracycline-resistant	prep_in	5	SENT_880	[p22l2046t2422r2145b2461, p22l756t2486r1419b2561],

1	or	CC	O	or	_	0	SENT_881	[p22l1469t2505r1536b2544],
2	anthracenedioneresistant	JJ	O	anthracenedioneresistant	amod	4	SENT_881	[p22l1587t2486r2145b2544, p22l755t2568r1029b2626],
3	breast	NN	O	breast	nn	4	SENT_881	[p22l1053t2568r1250b2626],
4	cancer	NN	O	cancer	dep	1	SENT_881	[p22l1275t2586r1499b2626],
5	.	.	O	.	_	0	SENT_881	[p22l1275t2586r1499b2626],

1	J.	NNP	PERSON	J.	nn	2	SENT_882	[p22l1529t2570r1577b2626],
2	Clin	NNP	PERSON	Clin	_	0	SENT_882	[p22l1617t2568r1763b2626],
3	.	.	O	.	_	0	SENT_882	[p22l1617t2568r1763b2626],

1	Oncol	NN	O	oncol	_	0	SENT_883	[p22l1802t2568r2010b2626],
2	.	.	O	.	_	0	SENT_883	[p22l1802t2568r2010b2626],

1	13	CD	NUMBER	13	_	0	SENT_884	[p22l2051t2569r2141b2626],
2	:	:	O	:	_	0	SENT_884	[p22l2051t2569r2141b2626],

1	Valero	NNP	ORGANIZATION	Valero	nn	2	SENT_885	[p22l756t2732r968b2790],
2	V	NNP	O	V	_	0	SENT_885	[p22l1003t2733r1066b2800],
3	,	,	O	,	_	0	SENT_885	[p22l1003t2733r1066b2800],
4	Holmes	NNP	ORGANIZATION	Holmes	nn	5	SENT_885	[p22l1104t2732r1356b2789],
5	FA	NNP	ORGANIZATION	FA	appos	2	SENT_885	[p22l1392t2733r1506b2800],
6	,	,	O	,	_	0	SENT_885	[p22l1392t2733r1506b2800],
7	Walters	NNP	ORGANIZATION	Walters	nn	8	SENT_885	[p22l1543t2732r1787b2789],
8	RS	NN	ORGANIZATION	r	appos	2	SENT_885	[p22l1825t2732r1940b2800],
9	,	,	O	,	_	0	SENT_885	[p22l1825t2732r1940b2800],
10	et	FW	O	et	nn	11	SENT_885	[p22l1978t2741r2036b2789],
11	al.	FW	O	al.	appos	2	SENT_885	[p22l2071t2732r2143b2789],
12	1995	CD	DATE	1995	dep	11	SENT_885	[p22l763t2815r934b2874],
13	.	.	O	.	_	0	SENT_885	[p22l763t2815r934b2874],

1	Phase	NN	O	phase	_	0	SENT_886	[p22l974t2815r1164b2872],
2	II	CD	NUMBER	ii	num	3	SENT_886	[p22l1201t2817r1253b2871],
3	trial	NN	O	trial	dep	1	SENT_886	[p22l1290t2815r1419b2872],
4	of	IN	O	of	_	0	SENT_886	[p22l1455t2815r1526b2872],
5	docetaxelz	NN	O	docetaxelz	prep_of	3	SENT_886	[p22l1557t2815r1886b2872],
6	a	DT	O	a	det	12	SENT_886	[p22l1928t2833r1962b2872],
7	new	JJ	O	new	amod	12	SENT_886	[p22l1997t2833r2143b2883],
8	,	,	O	,	_	0	SENT_886	[p22l1997t2833r2143b2883],
9	highly	RB	O	highly	advmod	10	SENT_886	[p22l755t2897r962b2972],
10	effective	JJ	O	effective	amod	12	SENT_886	[p22l986t2897r1268b2955],
11	antineoplastic	JJ	O	antineoplastic	amod	12	SENT_886	[p22l1293t2897r1742b2972],
12	agent	NN	O	agent	dep	1	SENT_886	[p22l1768t2906r1944b2972],
13	in	IN	O	in	_	0	SENT_886	[p22l1965t2897r2027b2954],
14	the	DT	O	the	det	15	SENT_886	[p22l2049t2897r2146b2955],
15	management	NN	O	management	prep_in	12	SENT_886	[p22l756t2988r1175b3055],
16	of	IN	O	of	_	0	SENT_886	[p22l1225t2980r1296b3037],
17	patients	NNS	O	patient	prep_of	15	SENT_886	[p22l1340t2980r1592b3055],
18	with	IN	O	with	_	0	SENT_886	[p22l1646t2980r1789b3037],
19	anthracycline	NN	O	anthracycline	npadvmod	21	SENT_886	[p22l1841t2980r2144b3055, p22l757t3062r1215b3120],
20	—	CD	NUMBER	—	num	19	SENT_886	[p22l1841t2980r2144b3055, p22l757t3062r1215b3120],
21	resistant	JJ	O	resistant	amod	24	SENT_886	[p22l1841t2980r2144b3055, p22l757t3062r1215b3120],
22	metastatic	JJ	O	metastatic	amod	24	SENT_886	[p22l1245t3062r1572b3120],
23	breast	NN	O	breast	nn	24	SENT_886	[p22l1606t3062r1803b3120],
24	cancer	NN	O	cancer	prep_with	17	SENT_886	[p22l1833t3080r2055b3120],
25	.	.	O	.	_	0	SENT_886	[p22l1833t3080r2055b3120],

1	J.	NNP	O	J.	_	0	SENT_887	[p22l2090t3064r2138b3120],

1	Clin	NNP	O	Clin	_	0	SENT_888	[p22l760t3146r906b3204],
2	.	.	O	.	_	0	SENT_888	[p22l760t3146r906b3204],

1	Oncol	NN	O	oncol	_	0	SENT_889	[p22l940t3146r1148b3204],
2	.	.	O	.	_	0	SENT_889	[p22l940t3146r1148b3204],

1	13:2886	CD	NUMBER	13:2886	_	0	SENT_890	[p22l1186t3146r1566b3204],
2	—	CD	NUMBER	—	num	3	SENT_890	[p22l1186t3146r1566b3204],
3	94	CD	NUMBER	94	dep	1	SENT_890	[p22l1186t3146r1566b3204],

1	ten	CD	NUMBER	ten	num	4	SENT_891	[p22l756t3237r855b3286],
2	Bokkel	NNP	PERSON	Bokkel	nn	4	SENT_891	[p22l881t3228r1115b3286],
3	Huinink	NNP	PERSON	Huinink	nn	4	SENT_891	[p22l1141t3228r1409b3286],
4	WW	NNP	O	WW	_	0	SENT_891	[p22l1432t3229r1595b3296],
5	,	,	O	,	_	0	SENT_891	[p22l1432t3229r1595b3296],
6	Prove	NNP	O	Prove	nn	7	SENT_891	[p22l1624t3230r1813b3286],
7	AM	NNP	O	AM	appos	4	SENT_891	[p22l1840t3229r1988b3296],
8	,	,	O	,	_	0	SENT_891	[p22l1840t3229r1988b3296],
9	Piccart	NNP	PERSON	Piccart	nn	10	SENT_891	[p22l2017t3228r2144b3286, p22l757t3318r879b3368],
10	M	NNP	O	M	appos	4	SENT_891	[p22l910t3311r999b3378],
11	,	,	O	,	_	0	SENT_891	[p22l910t3311r999b3378],
12	et	FW	O	et	nn	13	SENT_891	[p22l1036t3319r1094b3368],
13	al.	FW	O	al.	appos	4	SENT_891	[p22l1128t3310r1200b3368],
14	1994	CD	DATE	1994	dep	13	SENT_891	[p22l1245t3310r1415b3368],
15	.	.	O	.	_	0	SENT_891	[p22l1245t3310r1415b3368],

1	A	DT	O	a	det	2	SENT_892	[p22l1452t3311r1510b3367],
2	phase	NN	O	phase	_	0	SENT_892	[p22l1537t3310r1723b3384],
3	II	CD	NUMBER	ii	num	4	SENT_892	[p22l1757t3311r1809b3367],
4	trial	NN	O	trial	dep	2	SENT_892	[p22l1842t3310r1971b3368],
5	with	IN	O	with	_	0	SENT_892	[p22l2003t3310r2147b3368],
6	docetaxel	NN	O	docetaxel	prep_with	4	SENT_892	[p22l757t3393r1069b3451],
7	(	CD	NUMBER	(	num	6	SENT_892	[p22l1104t3393r1437b3464],
8	Taxotere	NNP	O	Taxotere	dep	2	SENT_892	[p22l1104t3393r1437b3464],
9	)	CD	NUMBER	)	num	8	SENT_892	[p22l1104t3393r1437b3464],
10	in	IN	O	in	_	0	SENT_892	[p22l1472t3393r1535b3449],
11	second	JJ	ORDINAL	second	amod	14	SENT_892	[p22l1571t3393r1942b3451],
12	—	NN	O	—	nn	14	SENT_892	[p22l1571t3393r1942b3451],
13	line	NN	O	line	nn	14	SENT_892	[p22l1571t3393r1942b3451],
14	treat70	NN	O	treat70	prep_in	8	SENT_892	[p22l1976t3401r2145b3451, p22l622t1912r718b1970],
15	.	.	O	.	_	0	SENT_892	[p22l1976t3401r2145b3451, p22l622t1912r718b1970],

1	Annu	NNP	PERSON	Annu	_	0	SENT_893	[p23l8t1751r64b1949],
2	.	.	O	.	_	0	SENT_893	[p23l8t1751r64b1949],

1	Rev.	NNP	O	Rev.	nn	2	SENT_894	[p23l8t1577r65b1723],
2	Med	NNP	O	Med	_	0	SENT_894	[p23l7t1384r64b1550],
3	.	.	O	.	_	0	SENT_894	[p23l7t1384r64b1550],

1	1997.48:353	CD	NUMBER	1997.48:353	num	2	SENT_895	[p23l7t776r65b1349],
2	—	NN	O	—	_	0	SENT_895	[p23l7t776r65b1349],
3	374	CD	NUMBER	374	num	2	SENT_895	[p23l7t776r65b1349],
4	.	.	O	.	_	0	SENT_895	[p23l7t776r65b1349],

1	Downloaded	VBN	O	download	_	0	SENT_896	[p23l7t329r65b749],
2	from	IN	O	from	_	0	SENT_896	[p23l7t147r64b307],
3	ww	NN	O	ww	prep_from	1	SENT_896	[p23l26t9r65b125],
4	by	IN	O	by	_	0	SENT_896	[p23l89t1784r164b1865],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_896	[p23l90t1415r164b1761],
6	of	IN	ORGANIZATION	of	_	0	SENT_896	[p23l89t1319r147b1390],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	9	SENT_896	[p23l89t955r147b1303],
8	—	NNP	O	—	nn	9	SENT_896	[p23l124t910r130b931],
9	Madison	NNP	O	Madison	prep_of	5	SENT_896	[p23l90t598r147b885],
10	on	IN	O	on	_	0	SENT_896	[p23l107t495r147b574],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_896	[p23l89t164r147b471],
12	.	.	O	.	_	0	SENT_896	[p23l89t164r147b471],

1	For	IN	O	for	_	0	SENT_897	[p23l91t23r147b137],
2	ment	NN	O	ment	pobj	1	SENT_897	[p23l756t20r920b69],
3	with	IN	O	with	_	0	SENT_897	[p23l974t11r1117b69],
4	chemotherapy	NN	O	chemotherapy	prep_with	2	SENT_897	[p23l1173t11r1634b86],
5	for	IN	O	for	_	0	SENT_897	[p23l1691t11r1785b69],
6	advanced	JJ	O	advanced	amod	8	SENT_897	[p23l1841t11r2148b69],
7	breast	NN	O	breast	nn	8	SENT_897	[p23l755t94r952b153],
8	cancer	NN	O	cancer	prep_for	4	SENT_897	[p23l973t113r1196b153],
9	.	.	O	.	_	0	SENT_897	[p23l973t113r1196b153],

1	Ann	NNP	PERSON	Ann	_	0	SENT_898	[p23l1217t96r1365b153],
2	.	.	O	.	_	0	SENT_898	[p23l1217t96r1365b153],

1	Oncol	NN	O	oncol	_	0	SENT_899	[p23l1399t94r1606b153],
2	.	.	O	.	_	0	SENT_899	[p23l1399t94r1606b153],

1	5	CD	NUMBER	5	_	0	SENT_900	[p23l1637t94r1671b153],
2	:527	CD	NUMBER	:527	num	3	SENT_900	[p23l1682t94r1942b153],
3	—	NN	O	—	dep	1	SENT_900	[p23l1682t94r1942b153],
4	32	CD	NUMBER	32	dep	1	SENT_900	[p23l1682t94r1942b153],

1	Taguchi	NNP	PERSON	Taguchi	nn	2	SENT_901	[p23l756t176r1016b251],
2	T	NN	O	t	_	0	SENT_901	[p23l1056t178r1115b245],
3	,	,	O	,	_	0	SENT_901	[p23l1056t178r1115b245],
4	Adachi	NNP	PERSON	Adachi	nn	5	SENT_901	[p23l1157t176r1392b234],
5	I	NNP	O	I	appos	2	SENT_901	[p23l1432t178r1475b245],
6	,	,	O	,	_	0	SENT_901	[p23l1432t178r1475b245],
7	Enomoto	NNP	PERSON	Enomoto	nn	8	SENT_901	[p23l1517t178r1815b234],
8	K	NNP	PERSON	K	appos	2	SENT_901	[p23l1857t178r1930b245],
9	,	,	O	,	_	0	SENT_901	[p23l1857t178r1930b245],
10	et	FW	O	et	nn	11	SENT_901	[p23l1974t185r2032b234],
11	al.	FW	O	al.	appos	2	SENT_901	[p23l2071t176r2143b234],
12	1994	CD	DATE	1994	dep	11	SENT_901	[p23l764t259r934b318],
13	.	.	O	.	_	0	SENT_901	[p23l764t259r934b318],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_902	[p23l955t259r1286b317],
2	(	CD	NUMBER	(	num	4	SENT_902	[p23l1306t259r1658b330],
3	RP56976	NN	O	rp56976	nn	4	SENT_902	[p23l1306t259r1658b330],
4	)	NN	O	)	dep	1	SENT_902	[p23l1306t259r1658b330],
5	in	IN	O	in	_	0	SENT_902	[p23l1678t259r1740b316],
6	advanced	JJ	O	advanced	amod	10	SENT_902	[p23l1758t259r2065b317],
7	or	CC	O	or	_	0	SENT_902	[p23l2082t278r2148b317],
8	recurrent	JJ	O	recurrent	amod	10	SENT_902	[p23l755t351r1051b400],
9	breast	NN	O	breast	nn	10	SENT_902	[p23l1063t342r1260b400],
10	cancer	NN	O	cancer	prep_in	4	SENT_902	[p23l1274t361r1504b400],
11	:	:	O	:	_	0	SENT_902	[p23l1274t361r1504b400],
12	early	JJ	O	early	amod	15	SENT_902	[p23l1524t342r1685b417],
13	and	CC	O	and	_	0	SENT_902	[p23l1701t342r1816b400],
14	late	JJ	O	late	conj_and	12	SENT_902	[p23l1831t342r1945b400],
15	phase	NN	O	phase	dep	1	SENT_902	[p23l1961t342r2146b417],
16	II	CD	NUMBER	ii	num	18	SENT_902	[p23l756t426r809b482],
17	clinical	JJ	O	clinical	amod	18	SENT_902	[p23l833t425r1072b483],
18	studies	NNS	O	study	dep	15	SENT_902	[p23l1098t425r1318b483],
19	in	IN	O	in	_	0	SENT_902	[p23l1344t425r1407b482],
20	Japan	NNP	LOCATION	Japan	prep_in	18	SENT_902	[p23l1429t426r1631b500],
21	.	.	O	.	_	0	SENT_902	[p23l1429t426r1631b500],

1	Proc	NNP	O	Proc	_	0	SENT_903	[p23l1658t427r1828b483],
2	.	.	O	.	_	0	SENT_903	[p23l1658t427r1828b483],

1	Am	NNP	O	Am	_	0	SENT_904	[p23l1852t426r1979b483],
2	.	.	O	.	_	0	SENT_904	[p23l1852t426r1979b483],

1	Soc	NN	O	soc	_	0	SENT_905	[p23l2009t426r2139b483],
2	.	.	O	.	_	0	SENT_905	[p23l2009t426r2139b483],

1	Clin	NNP	O	Clin	_	0	SENT_906	[p23l760t507r906b566],
2	.	.	O	.	_	0	SENT_906	[p23l760t507r906b566],

1	Oncol	NN	O	oncol	_	0	SENT_907	[p23l940t507r1148b566],
2	.	.	O	.	_	0	SENT_907	[p23l940t507r1148b566],

1	13:331	CD	NUMBER	13:331	number	2	SENT_908	[p23l1186t508r1396b566],
2	(	CD	NUMBER	(	_	0	SENT_908	[p23l1427t507r1673b579],
3	Abstr	NNP	O	Abstr	dep	2	SENT_908	[p23l1427t507r1673b579],
4	.	.	O	.	_	0	SENT_908	[p23l1427t507r1673b579],
5	)	NN	O	)	dep	2	SENT_908	[p23l1427t507r1673b579],

1	Bourgeois	JJ	MISC	bourgeois	amod	2	SENT_909	[p23l756t590r1088b665],
2	H	NN	O	h	_	0	SENT_909	[p23l1105t591r1180b658],
3	,	,	O	,	_	0	SENT_909	[p23l1105t591r1180b658],
4	Gruia	NNP	O	Gruia	nn	5	SENT_909	[p23l1200t590r1384b647],
5	G	NNP	O	G	appos	2	SENT_909	[p23l1400t590r1473b658],
6	,	,	O	,	_	0	SENT_909	[p23l1400t590r1473b658],
7	Dieras	NNP	O	Dieras	nn	8	SENT_909	[p23l1492t590r1704b647],
8	V	NNP	O	V	appos	2	SENT_909	[p23l1720t591r1783b658],
9	,	,	O	,	_	0	SENT_909	[p23l1720t591r1783b658],
10	et	FW	O	et	nn	11	SENT_909	[p23l1801t599r1859b647],
11	al.	FW	O	al.	appos	2	SENT_909	[p23l1874t590r1946b647],
12	1996	CD	DATE	1996	dep	11	SENT_909	[p23l1973t590r2143b648],
13	.	.	O	.	_	0	SENT_909	[p23l1973t590r2143b648],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_910	[p23l756t673r1087b730],
2	in	IN	O	in	_	0	SENT_910	[p23l1134t672r1197b729],
3	combination	NN	O	combination	prep_in	1	SENT_910	[p23l1245t672r1651b730],
4	with	IN	O	with	_	0	SENT_910	[p23l1699t672r1842b730],
5	doXorubicin	NN	O	doxorubicin	prep_with	1	SENT_910	[p23l1890t672r2145b730, p23l755t756r918b813],

1	as	IN	O	as	_	0	SENT_911	[p23l957t774r1019b813],
2	1st	CD	ORDINAL	1st	num	4	SENT_911	[p23l1067t756r1154b813],
3	line	NN	O	line	nn	4	SENT_911	[p23l1189t756r1309b813],
4	CT	NN	O	ct	prep_as	5	SENT_911	[p23l1347t756r1449b813],
5	of	IN	O	of	_	0	SENT_911	[p23l1485t756r1556b813],
6	metastatic	JJ	O	metastatic	amod	8	SENT_911	[p23l1587t756r1914b813],
7	breast	NN	O	breast	nn	8	SENT_911	[p23l1951t756r2148b813],
8	cancer	NN	O	cancer	pobj	5	SENT_911	[p23l757t856r986b896],
9	:	:	O	:	_	0	SENT_911	[p23l757t856r986b896],
10	a	DT	O	a	det	11	SENT_911	[p23l1016t856r1051b896],
11	phase	NN	O	phase	dep	5	SENT_911	[p23l1072t838r1257b913],
12	I	PRP	O	I	dep	11	SENT_911	[p23l1281t839r1307b895],
13	dose	NN	O	dose	nn	15	SENT_911	[p23l1332t838r1478b896],
14	finding	NN	O	finding	nn	15	SENT_911	[p23l1502t838r1735b913],
15	study	NN	O	study	dep	11	SENT_911	[p23l1761t838r1944b913],
16	.	.	O	.	_	0	SENT_911	[p23l1761t838r1944b913],

1	Proc	NNP	O	Proc	_	0	SENT_912	[p23l1970t840r2139b896],
2	.	.	O	.	_	0	SENT_912	[p23l1970t840r2139b896],

1	Am	NNP	O	Am	_	0	SENT_913	[p23l751t921r876b978],
2	.	.	O	.	_	0	SENT_913	[p23l751t921r876b978],

1	Soc	NN	O	soc	_	0	SENT_914	[p23l907t921r1036b978],
2	.	.	O	.	_	0	SENT_914	[p23l907t921r1036b978],

1	Clin	NNP	O	Clin	_	0	SENT_915	[p23l1070t920r1217b978],
2	.	.	O	.	_	0	SENT_915	[p23l1070t920r1217b978],

1	Oncol	NN	O	oncol	_	0	SENT_916	[p23l1250t920r1458b978],
2	.	.	O	.	_	0	SENT_916	[p23l1250t920r1458b978],

1	15:148	CD	NUMBER	15:148	number	2	SENT_917	[p23l1495t920r1710b978],
2	(	CD	NUMBER	(	_	0	SENT_917	[p23l1737t920r1982b991],
3	Abstr	NNP	O	Abstr	dep	2	SENT_917	[p23l1737t920r1982b991],
4	.	.	O	.	_	0	SENT_917	[p23l1737t920r1982b991],
5	)	NN	O	)	dep	2	SENT_917	[p23l1737t920r1982b991],

1	Gelmon	JJ	PERSON	gelmon	amod	2	SENT_918	[p23l757t1003r1019b1061],
2	K	NN	PERSON	k	_	0	SENT_918	[p23l1045t1005r1118b1071],
3	,	,	O	,	_	0	SENT_918	[p23l1045t1005r1118b1071],
4	Nabholtz	NNP	ORGANIZATION	Nabholtz	nn	5	SENT_918	[p23l1145t1003r1443b1061],
5	JM	NN	ORGANIZATION	jm	appos	2	SENT_918	[p23l1468t1005r1589b1071],
6	,	,	O	,	_	0	SENT_918	[p23l1468t1005r1589b1071],
7	Bontenbal	NNP	O	Bontenbal	nn	8	SENT_918	[p23l1616t1003r1950b1061],
8	M	NNP	O	M	appos	2	SENT_918	[p23l1973t1005r2063b1071],
9	,	,	O	,	_	0	SENT_918	[p23l1973t1005r2063b1071],
10	et	FW	O	et	nn	11	SENT_918	[p23l2090t1011r2148b1061],
11	al.	FW	O	al.	appos	2	SENT_918	[p23l758t1085r830b1143],
12	1994	CD	DATE	1994	dep	11	SENT_918	[p23l864t1086r1034b1144],
13	.	.	O	.	_	0	SENT_918	[p23l864t1086r1034b1144],

1	Randomized	VBN	O	randomize	_	0	SENT_919	[p23l1060t1085r1473b1143],
2	trial	NN	O	trial	dobj	1	SENT_919	[p23l1494t1085r1623b1143],
3	of	IN	O	of	_	0	SENT_919	[p23l1647t1085r1718b1143],
4	two	CD	NUMBER	two	num	5	SENT_919	[p23l1734t1094r1855b1143],
5	doses	NNS	O	dose	prep_of	2	SENT_919	[p23l1878t1086r2055b1143],
6	of	IN	O	of	_	0	SENT_919	[p23l2082t1085r2153b1143],
7	paclitaxel	NN	O	paclitaxel	prep_of	5	SENT_919	[p23l755t1168r1072b1243],
8	in	IN	O	in	_	0	SENT_919	[p23l1098t1168r1160b1225],
9	metastatic	JJ	O	metastatic	amod	11	SENT_919	[p23l1185t1168r1513b1226],
10	breast	NN	O	breast	nn	11	SENT_919	[p23l1540t1168r1736b1226],
11	cancer	NN	O	cancer	prep_in	1	SENT_919	[p23l1761t1186r1975b1226],
12	after	IN	O	after	_	0	SENT_919	[p23l2001t1168r2149b1226],
13	failure	NN	O	failure	prep_after	1	SENT_919	[p23l756t1250r967b1308],
14	of	IN	O	of	_	0	SENT_919	[p23l1011t1250r1082b1308],
15	standard	JJ	O	standard	amod	16	SENT_919	[p23l1121t1250r1395b1308],
16	therapy	NN	O	therapy	prep_of	13	SENT_919	[p23l1435t1250r1690b1325],
17	.	.	O	.	_	0	SENT_919	[p23l1435t1250r1690b1325],

1	Ann	NNP	PERSON	Ann	_	0	SENT_920	[p23l1730t1251r1878b1308],
2	.	.	O	.	_	0	SENT_920	[p23l1730t1251r1878b1308],

1	Oncol	NN	O	oncol	_	0	SENT_921	[p23l1931t1250r2139b1309],
2	.	.	O	.	_	0	SENT_921	[p23l1931t1250r2139b1309],

1	5	CD	NUMBER	5	num	2	SENT_922	[p23l757t1333r1029b1408],
2	(	CD	NUMBER	(	_	0	SENT_922	[p23l757t1333r1029b1408],
3	Suppl	NNP	O	Suppl	dep	2	SENT_922	[p23l757t1333r1029b1408],
4	.	.	O	.	_	0	SENT_922	[p23l757t1333r1029b1408],

1	5	CD	NUMBER	5	num	5	SENT_923	[p23l1057t1333r1264b1404],
2	)	CD	NUMBER	)	num	5	SENT_923	[p23l1057t1333r1264b1404],
3	:198	CD	NUMBER	:198	num	5	SENT_923	[p23l1057t1333r1264b1404],
4	Murphy	NNP	ORGANIZATION	Murphy	nn	5	SENT_923	[p23l756t1416r1018b1491],
5	WK	NNP	ORGANIZATION	WK	_	0	SENT_923	[p23l1043t1417r1197b1484],
6	,	,	O	,	_	0	SENT_923	[p23l1043t1417r1197b1484],
7	Fossella	NNP	PERSON	Fossella	nn	8	SENT_923	[p23l1224t1416r1493b1474],
8	FV	NNP	O	FV	appos	5	SENT_923	[p23l1516t1417r1626b1484],
9	,	,	O	,	_	0	SENT_923	[p23l1516t1417r1626b1484],
10	Winn	NNP	PERSON	Winn	nn	11	SENT_923	[p23l1653t1416r1831b1474],
11	RJ	NN	PERSON	rj	appos	5	SENT_923	[p23l1857t1417r1959b1484],
12	,	,	O	,	_	0	SENT_923	[p23l1857t1417r1959b1484],
13	et	FW	O	et	nn	14	SENT_923	[p23l1988t1425r2046b1474],
14	al.	FW	O	al.	appos	5	SENT_923	[p23l2071t1416r2143b1474],
15	1993	CD	DATE	1993	dep	14	SENT_923	[p23l764t1499r934b1557],
16	.	.	O	.	_	0	SENT_923	[p23l764t1499r934b1557],

1	Phase	NN	O	phase	_	0	SENT_924	[p23l974t1499r1164b1556],
2	II	CD	NUMBER	ii	num	3	SENT_924	[p23l1201t1500r1254b1555],
3	study	NN	O	study	dep	1	SENT_924	[p23l1292t1499r1464b1574],
4	of	IN	O	of	_	0	SENT_924	[p23l1501t1499r1572b1556],
5	taxol	NN	O	taxol	prep_of	3	SENT_924	[p23l1602t1499r1763b1556],
6	in	IN	O	in	_	0	SENT_924	[p23l1798t1499r1861b1555],
7	patients	NNS	O	patient	prep_in	5	SENT_924	[p23l1894t1499r2145b1574],
8	with	IN	O	with	_	0	SENT_924	[p23l756t1581r900b1639],
9	untreated	JJ	O	untreated	amod	10	SENT_924	[p23l925t1581r1229b1639],
10	non	JJ	O	non	amod	11	SENT_924	[p23l1255t1581r1580b1639],
11	—	NN	O	—	prep_with	7	SENT_924	[p23l1255t1581r1580b1639],
12	small	JJ	O	small	amod	15	SENT_924	[p23l1255t1581r1580b1639],
13	cell	NN	O	cell	nn	15	SENT_924	[p23l1607t1581r1723b1639],
14	lung	NN	O	lung	nn	15	SENT_924	[p23l1749t1581r1892b1656],
15	cancer	NN	O	cancer	dep	3	SENT_924	[p23l1919t1599r2143b1639],
16	.	.	O	.	_	0	SENT_924	[p23l1919t1599r2143b1639],

1	J.	NNP	O	J.	nn	4	SENT_925	[p23l755t1666r803b1722],
2	Natl.	NNP	O	Natl.	nn	4	SENT_925	[p23l831t1664r985b1722],
3	Cancer	NNP	O	Cancer	nn	4	SENT_925	[p23l1019t1665r1258b1722],
4	Inst	NNP	O	Inst	_	0	SENT_925	[p23l1275t1666r1410b1721],
5	.	.	O	.	_	0	SENT_925	[p23l1275t1666r1410b1721],

1	852384-88	CD	NUMBER	852384-88	_	0	SENT_926	[p23l1443t1664r1784b1722],

1	Chang	NNP	PERSON	Chang	nn	2	SENT_927	[p23l757t1746r968b1821],
2	A	NNP	O	A	_	0	SENT_927	[p23l984t1747r1060b1814],
3	,	,	O	,	_	0	SENT_927	[p23l984t1747r1060b1814],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_927	[p23l1079t1746r1224b1803],
5	K	NNP	PERSON	K	appos	2	SENT_927	[p23l1239t1748r1312b1814],
6	,	,	O	,	_	0	SENT_927	[p23l1239t1748r1312b1814],
7	Glick	NNP	PERSON	Glick	nn	8	SENT_927	[p23l1333t1746r1514b1804],
8	J	NNP	PERSON	J	appos	2	SENT_927	[p23l1527t1748r1575b1814],
9	,	,	O	,	_	0	SENT_927	[p23l1527t1748r1575b1814],
10	et	FW	O	et	nn	11	SENT_927	[p23l1594t1755r1653b1804],
11	al.	FW	O	al.	appos	2	SENT_927	[p23l1667t1746r1740b1804],
12	1993	CD	DATE	1993	dep	11	SENT_927	[p23l1767t1747r1936b1805],
13	.	.	O	.	_	0	SENT_927	[p23l1767t1747r1936b1805],

1	Phase	NN	O	phase	nn	3	SENT_928	[p23l1956t1746r2146b1804],
2	II	CD	NUMBER	ii	num	3	SENT_928	[p23l756t1830r809b1886],
3	study	NN	O	study	_	0	SENT_928	[p23l838t1828r1010b1903],
4	of	IN	O	of	_	0	SENT_928	[p23l1037t1828r1108b1886],
5	taxol	NN	O	taxol	prep_of	3	SENT_928	[p23l1129t1828r1307b1897],
6	,	,	O	,	_	0	SENT_928	[p23l1129t1828r1307b1897],
7	merbarone	NN	O	merbarone	prep_of	3	SENT_928	[p23l1335t1828r1702b1897],
8	,	,	O	,	_	0	SENT_928	[p23l1335t1828r1702b1897],
9	and	CC	O	and	_	0	SENT_928	[p23l1732t1828r1847b1886],
10	piroXantrone	NN	O	piroxantrone	prep_of	3	SENT_928	[p23l1871t1828r2144b1903, p23l756t1921r922b1970],
11	in	IN	O	in	_	0	SENT_928	[p23l949t1911r1011b1969],
12	stage	NN	O	stage	prep_in	5	SENT_928	[p23l1041t1920r1205b1986],
13	IV	CD	NUMBER	iv	num	19	SENT_928	[p23l1232t1913r1316b1970],
14	non	JJ	O	non	amod	19	SENT_928	[p23l1342t1911r1668b1970],
15	—	JJ	O	—	amod	19	SENT_928	[p23l1342t1911r1668b1970],
16	small	JJ	O	small	amod	19	SENT_928	[p23l1342t1911r1668b1970],
17	cell	NN	O	cell	nn	19	SENT_928	[p23l1696t1911r1811b1970],
18	lung	NN	O	lung	nn	19	SENT_928	[p23l1838t1912r1980b1987],
19	cancer	NN	O	cancer	dep	3	SENT_928	[p23l2008t1930r2144b1970, p23l757t2012r874b2062],
20	;	:	O	;	_	0	SENT_928	[p23l2008t1930r2144b1970, p23l757t2012r874b2062],
21	the	DT	O	the	det	25	SENT_928	[p23l929t1993r1026b2051],
22	Eastern	NNP	ORGANIZATION	Eastern	nn	25	SENT_928	[p23l1080t1995r1326b2051],
23	Cooperative	NNP	ORGANIZATION	Cooperative	nn	25	SENT_928	[p23l1377t1993r1773b2068],
24	Oncology	NNP	ORGANIZATION	Oncology	nn	25	SENT_928	[p23l1827t1993r2146b2069],
25	Group	NNP	ORGANIZATION	Group	dep	3	SENT_928	[p23l757t2076r963b2151],
26	(	CD	NUMBER	(	num	29	SENT_928	[p23l1010t2076r1282b2147],
27	ECOG	NNP	O	ECOG	nn	29	SENT_928	[p23l1010t2076r1282b2147],
28	)	CD	NUMBER	)	num	29	SENT_928	[p23l1010t2076r1282b2147],
29	results	NNS	O	result	dep	25	SENT_928	[p23l1327t2075r1558b2134],
30	.	.	O	.	_	0	SENT_928	[p23l1327t2075r1558b2134],

1	J.	NNP	O	J.	nn	4	SENT_929	[p23l1603t2078r1653b2134],
2	Natl.	NNP	O	Natl.	nn	4	SENT_929	[p23l1701t2075r1855b2134],
3	Cancer	NNP	O	Cancer	nn	4	SENT_929	[p23l1910t2077r2150b2134],
4	Inst	NNP	O	Inst	_	0	SENT_929	[p23l755t2159r890b2215],
5	.	.	O	.	_	0	SENT_929	[p23l755t2159r890b2215],

1	852388-94	CD	NUMBER	852388-94	_	0	SENT_930	[p23l923t2157r1267b2215],

1	Ceny	JJ	ORGANIZATION	ceny	amod	2	SENT_931	[p23l757t2241r927b2315],
2	T	NN	ORGANIZATION	t	_	0	SENT_931	[p23l953t2242r1012b2308],
3	,	,	O	,	_	0	SENT_931	[p23l953t2242r1012b2308],
4	Kaplan	NNP	PERSON	Kaplan	nn	5	SENT_931	[p23l1042t2241r1275b2315],
5	S	NNP	O	S	appos	2	SENT_931	[p23l1302t2241r1362b2309],
6	,	,	O	,	_	0	SENT_931	[p23l1302t2241r1362b2309],
7	Pavlidis	NNP	PERSON	Pavlidis	nn	8	SENT_931	[p23l1390t2241r1649b2298],
8	N	NNP	PERSON	N	appos	2	SENT_931	[p23l1676t2242r1752b2309],
9	,	,	O	,	_	0	SENT_931	[p23l1676t2242r1752b2309],
10	et	FW	O	et	nn	11	SENT_931	[p23l1781t2249r1839b2298],
11	al.	FW	O	al.	appos	2	SENT_931	[p23l1864t2241r1936b2298],
12	1994	CD	DATE	1994	dep	11	SENT_931	[p23l1973t2241r2143b2299],
13	.	.	O	.	_	0	SENT_931	[p23l1973t2241r2143b2299],

1	Docetaxel	NNP	O	Docetaxel	nn	4	SENT_932	[p23l756t2321r1087b2379],
2	(	NNP	O	(	nn	4	SENT_932	[p23l1108t2322r1441b2393],
3	Taxotere	NNP	O	Taxotere	nn	4	SENT_932	[p23l1108t2322r1441b2393],
4	)	NN	O	)	nsubj	6	SENT_932	[p23l1108t2322r1441b2393],
5	is	VBZ	O	be	cop	6	SENT_932	[p23l1461t2321r1512b2379],
6	active	JJ	O	active	_	0	SENT_932	[p23l1533t2321r1724b2379],
7	in	IN	O	in	_	0	SENT_932	[p23l1742t2321r1805b2378],
8	non	JJ	O	non	amod	13	SENT_932	[p23l1821t2321r2147b2379],
9	—	JJ	O	—	amod	10	SENT_932	[p23l1821t2321r2147b2379],
10	small	JJ	O	small	amod	13	SENT_932	[p23l1821t2321r2147b2379],
11	cell	NN	O	cell	nn	13	SENT_932	[p23l757t2403r873b2460],
12	lung	NN	O	lung	nn	13	SENT_932	[p23l914t2403r1056b2477],
13	cancer	NN	O	cancer	prep_in	6	SENT_932	[p23l1099t2421r1328b2460],
14	:	:	O	:	_	0	SENT_932	[p23l1099t2421r1328b2460],
15	a	DT	O	a	det	18	SENT_932	[p23l1376t2421r1410b2460],
16	phase	NN	O	phase	nn	18	SENT_932	[p23l1449t2403r1634b2477],
17	II	CD	NUMBER	ii	num	18	SENT_932	[p23l1677t2404r1730b2460],
18	trial	NN	O	trial	dep	13	SENT_932	[p23l1771t2403r1900b2460],
19	of	IN	O	of	_	0	SENT_932	[p23l1942t2403r2013b2460],
20	the	DT	O	the	det	21	SENT_932	[p23l2049t2403r2146b2460],
21	EORTC	NN	O	eortc	prep_of	18	SENT_932	[p23l756t2486r1017b2544],
22	early	JJ	O	early	amod	24	SENT_932	[p23l1038t2485r1200b2561],
23	clinical	JJ	O	clinical	amod	24	SENT_932	[p23l1218t2485r1455b2544],
24	trials	NNS	O	trial	tmod	6	SENT_932	[p23l1473t2485r1633b2544],
25	group	NN	O	group	nn	28	SENT_932	[p23l1654t2504r1841b2561],
26	(	CD	NUMBER	(	num	28	SENT_932	[p23l1862t2486r2142b2557],
27	ECTG	NN	O	ectg	nn	28	SENT_932	[p23l1862t2486r2142b2557],
28	)	NN	O	)	dep	24	SENT_932	[p23l1862t2486r2142b2557],
29	.	.	O	.	_	0	SENT_932	[p23l1862t2486r2142b2557],

1	Br	NN	O	br	_	0	SENT_933	[p23l754t2569r839b2624],
2	.	.	O	.	_	0	SENT_933	[p23l754t2569r839b2624],

1	J.	NNP	O	J.	nn	2	SENT_934	[p23l867t2569r916b2625],
2	Cancer	NNP	O	Cancer	_	0	SENT_934	[p23l950t2568r1190b2625],
3	70:384	CD	NUMBER	70:384	number	4	SENT_934	[p23l1208t2567r1553b2624],
4	—	CD	NUMBER	—	dep	2	SENT_934	[p23l1208t2567r1553b2624],
5	87	CD	NUMBER	87	dep	4	SENT_934	[p23l1208t2567r1553b2624],

1	Francis	NNP	PERSON	Francis	nn	2	SENT_935	[p23l756t2649r994b2707],
2	PA	NN	PERSON	pa	_	0	SENT_935	[p23l1014t2650r1126b2718],
3	,	,	O	,	_	0	SENT_935	[p23l1014t2650r1126b2718],
4	Rigas	NNP	ORGANIZATION	Rigas	nn	5	SENT_935	[p23l1146t2649r1329b2725],
5	JR	NNP	ORGANIZATION	JR	appos	2	SENT_935	[p23l1348t2651r1451b2718],
6	,	,	O	,	_	0	SENT_935	[p23l1348t2651r1451b2718],
7	Kris	NNP	PERSON	Kris	nn	8	SENT_935	[p23l1473t2649r1608b2707],
8	MG	NN	PERSON	mg	appos	2	SENT_935	[p23l1628t2650r1777b2718],
9	,	,	O	,	_	0	SENT_935	[p23l1628t2650r1777b2718],
10	et	FW	O	et	nn	11	SENT_935	[p23l1797t2658r1855b2707],
11	al.	FW	O	al.	appos	2	SENT_935	[p23l1872t2649r1944b2707],
12	1994	CD	DATE	1994	dep	11	SENT_935	[p23l1972t2650r2142b2708],
13	.	.	O	.	_	0	SENT_935	[p23l1972t2650r2142b2708],

1	Phase	NN	O	phase	_	0	SENT_936	[p23l756t2731r946b2788],
2	II	CD	NUMBER	ii	num	3	SENT_936	[p23l966t2732r1019b2788],
3	docetaxel	NN	O	docetaxel	dep	1	SENT_936	[p23l1038t2731r1350b2788],
4	in	IN	O	in	_	0	SENT_936	[p23l1368t2731r1430b2788],
5	patients	NNS	O	patient	prep_in	3	SENT_936	[p23l1447t2731r1699b2805],
6	with	IN	O	with	_	0	SENT_936	[p23l1721t2731r1863b2788],
7	stage	NN	O	stage	prep_with	5	SENT_936	[p23l1884t2739r2048b2805],
8	III	CD	NUMBER	iii	num	7	SENT_936	[p23l2066t2732r2147b2788],
9	and	CC	O	and	_	0	SENT_936	[p23l758t2813r874b2872],
10	IV	CD	NUMBER	iv	num	16	SENT_936	[p23l896t2815r980b2872],
11	non	JJ	O	non	amod	16	SENT_936	[p23l1004t2813r1330b2872],
12	—	JJ	O	—	amod	16	SENT_936	[p23l1004t2813r1330b2872],
13	small	JJ	O	small	amod	16	SENT_936	[p23l1004t2813r1330b2872],
14	cell	NN	O	cell	nn	16	SENT_936	[p23l1353t2813r1470b2872],
15	lung	NN	O	lung	nn	16	SENT_936	[p23l1492t2813r1634b2889],
16	cancer	NN	O	cancer	prep_with	5	SENT_936	[p23l1659t2832r1881b2872],
17	.	.	O	.	_	0	SENT_936	[p23l1659t2832r1881b2872],

1	J.	NNP	PERSON	J.	nn	2	SENT_937	[p23l1908t2816r1956b2872],
2	Clin	NNP	PERSON	Clin	_	0	SENT_937	[p23l1992t2813r2138b2872],
3	.	.	O	.	_	0	SENT_937	[p23l1992t2813r2138b2872],

1	Oncol	NN	O	oncol	_	0	SENT_938	[p23l760t2895r968b2953],
2	.	.	O	.	_	0	SENT_938	[p23l760t2895r968b2953],

1	12:1232	CD	NUMBER	12:1232	_	0	SENT_939	[p23l1005t2895r1383b2953],
2	—	CD	NUMBER	—	num	3	SENT_939	[p23l1005t2895r1383b2953],
3	37	CD	NUMBER	37	dep	1	SENT_939	[p23l1005t2895r1383b2953],

1	Fossella	NNP	PERSON	Fossella	nn	2	SENT_940	[p23l756t2977r1025b3035],
2	FV	NNP	O	FV	_	0	SENT_940	[p23l1058t2979r1167b3046],
3	,	,	O	,	_	0	SENT_940	[p23l1058t2979r1167b3046],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_940	[p23l1204t2979r1326b3035],
5	JS	NNP	O	JS	appos	2	SENT_940	[p23l1360t2978r1454b3046],
6	,	,	O	,	_	0	SENT_940	[p23l1360t2978r1454b3046],
7	Murphy	NNP	PERSON	Murphy	nn	8	SENT_940	[p23l1492t2977r1753b3053],
8	WK	NNP	DURATION	WK	appos	2	SENT_940	[p23l1788t2979r1941b3046],
9	,	,	O	,	_	0	SENT_940	[p23l1788t2979r1941b3046],
10	et	FW	O	et	nn	11	SENT_940	[p23l1979t2986r2037b3035],
11	al.	FW	O	al.	appos	2	SENT_940	[p23l2071t2977r2143b3035],
12	1994	CD	DATE	1994	dep	11	SENT_940	[p23l764t3060r934b3118],
13	.	.	O	.	_	0	SENT_940	[p23l764t3060r934b3118],

1	Phase	NN	O	phase	nn	3	SENT_941	[p23l956t3059r1146b3117],
2	II	CD	NUMBER	ii	num	3	SENT_941	[p23l1165t3061r1217b3117],
3	study	NN	O	study	_	0	SENT_941	[p23l1238t3059r1410b3134],
4	of	IN	O	of	_	0	SENT_941	[p23l1429t3059r1500b3117],
5	docetaxel	NN	O	docetaxel	prep_of	3	SENT_941	[p23l1514t3059r1824b3117],
6	for	IN	O	for	_	0	SENT_941	[p23l1842t3059r1938b3117],
7	recurrent	JJ	O	recurrent	amod	11	SENT_941	[p23l1952t3078r2144b3117, p23l755t3150r883b3198],
8	or	CC	O	or	_	0	SENT_941	[p23l907t3159r974b3198],
9	metastatic	JJ	O	metastatic	amod	11	SENT_941	[p23l997t3141r1326b3198],
10	non	JJ	O	non	amod	11	SENT_941	[p23l1350t3141r1676b3198],
11	—	NN	O	—	prep_for	3	SENT_941	[p23l1350t3141r1676b3198],
12	small	JJ	O	small	amod	15	SENT_941	[p23l1350t3141r1676b3198],
13	cell	NN	O	cell	nn	15	SENT_941	[p23l1701t3141r1816b3198],
14	lung	NN	O	lung	nn	15	SENT_941	[p23l1840t3141r1982b3215],
15	cancer	NN	O	cancer	dep	11	SENT_941	[p23l2007t3159r2144b3198, p23l757t3241r865b3280],
16	.	.	O	.	_	0	SENT_941	[p23l2007t3159r2144b3198, p23l757t3241r865b3280],

1	J.	NNP	PERSON	J.	nn	2	SENT_942	[p23l890t3225r940b3281],
2	Clin	NNP	PERSON	Clin	_	0	SENT_942	[p23l974t3223r1121b3281],
3	.	.	O	.	_	0	SENT_942	[p23l974t3223r1121b3281],

1	Oncol	NN	O	oncol	_	0	SENT_943	[p23l1155t3223r1362b3281],
2	.	.	O	.	_	0	SENT_943	[p23l1155t3223r1362b3281],

1	l2	NN	O	l2	_	0	SENT_944	[p23l1400t3223r1779b3281],
2	:	:	O	:	_	0	SENT_944	[p23l1400t3223r1779b3281],
3	l238	CD	NUMBER	l238	dep	1	SENT_944	[p23l1400t3223r1779b3281],
4	—	CD	NUMBER	—	number	5	SENT_944	[p23l1400t3223r1779b3281],
5	44	CD	NUMBER	44	dep	3	SENT_944	[p23l1400t3223r1779b3281],

1	THE	DT	O	the	det	2	SENT_945	[p23l908t3544r1158b3631],
2	TAXANES	NN	O	taxane	_	0	SENT_945	[p23l1192t3542r1792b3633],
3	373	CD	NUMBER	373	dep	2	SENT_945	[p23l1965t3542r2146b3633],

1	Burris	NNP	PERSON	Burris	nn	2	SENT_946	[p24l193t106r476b186],
2	H	NNP	O	H	_	0	SENT_946	[p24l519t108r624b202],
3	,	,	O	,	_	0	SENT_946	[p24l519t108r624b202],
4	Eckardt	NNP	PERSON	Eckardt	nn	5	SENT_946	[p24l669t106r1027b186],
5	J	NNP	PERSON	J	appos	2	SENT_946	[p24l1065t108r1132b202],
6	,	,	O	,	_	0	SENT_946	[p24l1065t108r1132b202],
7	Fields	NNP	O	Fields	nn	8	SENT_946	[p24l1176t106r1452b186],
8	S	NNP	O	S	appos	2	SENT_946	[p24l1499t106r1583b201],
9	,	,	O	,	_	0	SENT_946	[p24l1499t106r1583b201],
10	et	FW	O	et	nn	11	SENT_946	[p24l1628t118r1709b186],
11	al.	FW	O	al.	appos	2	SENT_946	[p24l1750t106r1851b186],
12	1993	CD	DATE	1993	dep	11	SENT_946	[p24l1905t106r2144b188],
13	.	.	O	.	_	0	SENT_946	[p24l1905t106r2144b188],

1	Phase	NN	O	phase	_	0	SENT_947	[p24l193t221r460b303],
2	II	CD	NUMBER	ii	num	3	SENT_947	[p24l498t223r572b301],
3	trials	NNS	O	trial	dep	1	SENT_947	[p24l608t221r833b303],
4	of	IN	O	of	_	0	SENT_947	[p24l873t221r973b303],
5	Taxotere	NNP	O	Taxotere	prep_of	3	SENT_947	[p24l1002t224r1400b303],
6	in	IN	O	in	_	0	SENT_947	[p24l1437t221r1525b301],
7	patients	NNS	O	patient	prep_in	5	SENT_947	[p24l1557t221r1911b327],
8	with	IN	O	with	_	0	SENT_947	[p24l1951t221r2152b303],
9	non-small	JJ	O	non-small	amod	12	SENT_947	[p24l193t337r651b418],
10	cell	NN	O	cell	nn	12	SENT_947	[p24l687t337r849b418],
11	lung	NN	O	lung	nn	12	SENT_947	[p24l880t337r1081b442],
12	cancer	NN	O	cancer	prep_with	7	SENT_947	[p24l1116t363r1430b418],
13	.	.	O	.	_	0	SENT_947	[p24l1116t363r1430b418],

1	Proc	NNP	O	Proc	_	0	SENT_948	[p24l1466t340r1704b418],
2	.	.	O	.	_	0	SENT_948	[p24l1466t340r1704b418],

1	Am	NNP	O	Am	_	0	SENT_949	[p24l1738t338r1916b418],
2	.	.	O	.	_	0	SENT_949	[p24l1738t338r1916b418],

1	Soc	NN	O	soc	_	0	SENT_950	[p24l1958t339r2139b419],
2	.	.	O	.	_	0	SENT_950	[p24l1958t339r2139b419],

1	Clin	NNP	O	Clin	_	0	SENT_951	[p24l199t455r406b537],
2	.	.	O	.	_	0	SENT_951	[p24l199t455r406b537],

1	Oncol	NN	O	oncol	_	0	SENT_952	[p24l453t455r746b537],
2	.	.	O	.	_	0	SENT_952	[p24l453t455r746b537],

1	12:335	CD	NUMBER	12:335	number	2	SENT_953	[p24l798t455r1099b537],
2	(	CD	NUMBER	(	_	0	SENT_953	[p24l1138t455r1484b556],
3	Abstr	NNP	O	Abstr	dep	2	SENT_953	[p24l1138t455r1484b556],
4	.	.	O	.	_	0	SENT_953	[p24l1138t455r1484b556],
5	)	NN	O	)	dep	2	SENT_953	[p24l1138t455r1484b556],

1	Fossella	NNP	PERSON	Fossella	nn	2	SENT_954	[p24l193t571r572b652],
2	FV	NNP	O	FV	_	0	SENT_954	[p24l596t573r750b667],
3	,	,	O	,	_	0	SENT_954	[p24l596t573r750b667],
4	Less	RBR	O	less	advmod	5	SENT_954	[p24l781t573r989b652],
5	J	NN	O	j	amod	6	SENT_954	[p24l1018t573r1060b653],
6	S	NN	O	s	appos	2	SENT_954	[p24l1067t571r1149b667],
7	,	,	O	,	_	0	SENT_954	[p24l1067t571r1149b667],
8	Shin	NNP	PERSON	Shin	nn	9	SENT_954	[p24l1183t571r1389b653],
9	DM	NN	PERSON	dm	appos	6	SENT_954	[p24l1414t573r1623b667],
10	,	,	O	,	_	0	SENT_954	[p24l1414t573r1623b667],
11	et	FW	O	et	nn	12	SENT_954	[p24l1654t583r1735b652],
12	al.	FW	O	al.	appos	2	SENT_954	[p24l1762t571r1864b653],
13	1995	CD	DATE	1995	dep	12	SENT_954	[p24l1905t571r2144b653],
14	.	.	O	.	_	0	SENT_954	[p24l1905t571r2144b653],

1	Phase	NN	O	phase	_	0	SENT_955	[p24l193t689r460b770],
2	II	CD	NUMBER	ii	num	3	SENT_955	[p24l488t691r562b768],
3	study	NN	O	study	dep	1	SENT_955	[p24l591t689r834b794],
4	of	IN	O	of	_	0	SENT_955	[p24l861t688r961b770],
5	docetaxel	NN	O	docetaxel	prep_of	3	SENT_955	[p24l979t689r1419b770],
6	for	IN	O	for	_	0	SENT_955	[p24l1443t688r1576b770],
7	advanced	JJ	O	advanced	amod	12	SENT_955	[p24l1602t689r2035b770],
8	or	CC	O	or	_	0	SENT_955	[p24l2059t714r2153b770],
9	metastatic	JJ	O	metastatic	conj_or	7	SENT_955	[p24l193t804r656b885],
10	platinum-refractory	JJ	O	platinum-refractory	amod	12	SENT_955	[p24l725t804r1623b909],
11	non-small	JJ	O	non-small	amod	12	SENT_955	[p24l1694t804r2153b885],
12	cell	NN	O	cell	prep_for	5	SENT_955	[p24l195t921r358b1003],
13	lung	NN	O	lung	nn	14	SENT_955	[p24l387t921r586b1027],
14	cancer	NN	O	cancer	dep	3	SENT_955	[p24l617t947r930b1003],
15	.	.	O	.	_	0	SENT_955	[p24l617t947r930b1003],

1	J.	NNP	PERSON	J.	nn	2	SENT_956	[p24l962t924r1032b1003],
2	Clin	NNP	PERSON	Clin	_	0	SENT_956	[p24l1077t921r1285b1003],
3	.	.	O	.	_	0	SENT_956	[p24l1077t921r1285b1003],

1	Oncol	NN	O	oncol	_	0	SENT_957	[p24l1330t921r1621b1003],
2	.	.	O	.	_	0	SENT_957	[p24l1330t921r1621b1003],

1	13:645	CD	NUMBER	13:645	num	5	SENT_958	[p24l1673t921r2141b1003],
2	—	CD	NUMBER	—	num	5	SENT_958	[p24l1673t921r2141b1003],
3	51	CD	NUMBER	51	num	5	SENT_958	[p24l1673t921r2141b1003],
4	Miller	NNP	ORGANIZATION	Miller	nn	5	SENT_958	[p24l193t1037r481b1118],
5	VA	NNP	ORGANIZATION	VA	_	0	SENT_958	[p24l507t1037r680b1133],
6	,	,	O	,	_	0	SENT_958	[p24l507t1037r680b1133],
7	Rigas	NNP	ORGANIZATION	Rigas	nn	8	SENT_958	[p24l715t1037r971b1142],
8	JR	NNP	ORGANIZATION	JR	appos	5	SENT_958	[p24l1004t1039r1149b1133],
9	,	,	O	,	_	0	SENT_958	[p24l1004t1039r1149b1133],
10	Kris	NNP	PERSON	Kris	nn	11	SENT_958	[p24l1184t1037r1374b1118],
11	MG	NN	PERSON	mg	appos	5	SENT_958	[p24l1407t1037r1616b1133],
12	,	,	O	,	_	0	SENT_958	[p24l1407t1037r1616b1133],
13	et	FW	O	et	nn	14	SENT_958	[p24l1649t1049r1731b1118],
14	al.	FW	O	al.	appos	5	SENT_958	[p24l1760t1037r1862b1118],
15	1994	CD	DATE	1994	dep	14	SENT_958	[p24l1906t1037r2145b1119],
16	.	.	O	.	_	0	SENT_958	[p24l1906t1037r2145b1119],

1	Phase	NN	O	phase	nn	3	SENT_959	[p24l193t1157r460b1237],
2	II	CD	NUMBER	ii	num	3	SENT_959	[p24l502t1158r575b1236],
3	trial	NN	O	trial	nsubj	6	SENT_959	[p24l614t1155r795b1237],
4	of	IN	O	of	_	0	SENT_959	[p24l837t1155r936b1237],
5	docetaxel	NN	O	docetaxel	prep_of	3	SENT_959	[p24l969t1156r1405b1237],
6	given	VBN	O	give	_	0	SENT_959	[p24l1447t1155r1698b1261],
7	at	IN	O	at	_	0	SENT_959	[p24l1740t1169r1820b1237],
8	a	DT	O	a	det	9	SENT_959	[p24l1857t1181r1906b1237],
9	dose	NN	O	dose	prep_at	6	SENT_959	[p24l1943t1156r2150b1237],
10	of	IN	O	of	_	0	SENT_959	[p24l195t1272r295b1354],
11	75	CD	NUMBER	75	num	12	SENT_959	[p24l333t1272r439b1354],
12	mg/m2	NN	O	mg/m2	prep_of	9	SENT_959	[p24l488t1244r797b1378],
13	with	IN	O	with	_	0	SENT_959	[p24l842t1272r1044b1354],
14	prednisone	NN	O	prednisone	nn	15	SENT_959	[p24l1086t1272r1590b1378],
15	premedica	NN	O	premedica	prep_with	12	SENT_959	[p24l1633t1272r2148b1378],
16	—	CD	NUMBER	—	num	17	SENT_959	[p24l1633t1272r2148b1378],
17	tion	NN	O	tion	dobj	6	SENT_959	[p24l193t1388r370b1470],
18	in	IN	O	in	_	0	SENT_959	[p24l420t1388r507b1468],
19	non-small	JJ	O	non-small	amod	22	SENT_959	[p24l558t1388r1017b1470],
20	cell	NN	O	cell	nn	22	SENT_959	[p24l1068t1388r1231b1470],
21	lung	NN	O	lung	nn	22	SENT_959	[p24l1281t1388r1482b1494],
22	cancer	NN	O	cancer	prep_in	17	SENT_959	[p24l1534t1414r1848b1470],
23	.	.	O	.	_	0	SENT_959	[p24l1534t1414r1848b1470],

1	Proc	NNP	O	Proc	_	0	SENT_960	[p24l1902t1391r2139b1470],
2	.	.	O	.	_	0	SENT_960	[p24l1902t1391r2139b1470],

1	Am	NNP	O	Am	_	0	SENT_961	[p24l185t1507r363b1587],
2	.	.	O	.	_	0	SENT_961	[p24l185t1507r363b1587],

1	Soc	NN	O	soc	_	0	SENT_962	[p24l406t1507r588b1587],
2	.	.	O	.	_	0	SENT_962	[p24l406t1507r588b1587],

1	Clin	NNP	O	Clin	_	0	SENT_963	[p24l635t1505r842b1587],
2	.	.	O	.	_	0	SENT_963	[p24l635t1505r842b1587],

1	Oncol	NN	O	oncol	_	0	SENT_964	[p24l889t1505r1182b1587],
2	.	.	O	.	_	0	SENT_964	[p24l889t1505r1182b1587],

1	132364	CD	NUMBER	132364	number	2	SENT_965	[p24l1234t1505r1540b1587],
2	(	CD	NUMBER	(	_	0	SENT_965	[p24l1574t1505r1920b1606],
3	Abstr	NNP	O	Abstr	dep	2	SENT_965	[p24l1574t1505r1920b1606],
4	.	.	O	.	_	0	SENT_965	[p24l1574t1505r1920b1606],
5	)	NN	O	)	dep	2	SENT_965	[p24l1574t1505r1920b1606],

1	Kunitoh	NN	MISC	kunitoh	nn	2	SENT_966	[p24l195t1621r568b1702],
2	H	NN	O	h	_	0	SENT_966	[p24l612t1623r717b1717],
3	,	,	O	,	_	0	SENT_966	[p24l612t1623r717b1717],
4	Watanabe	NNP	PERSON	Watanabe	nn	5	SENT_966	[p24l765t1621r1214b1702],
5	K	NNP	PERSON	K	appos	2	SENT_966	[p24l1262t1623r1365b1717],
6	,	,	O	,	_	0	SENT_966	[p24l1262t1623r1365b1717],
7	Onoshi	NNP	ORGANIZATION	Onoshi	nn	8	SENT_966	[p24l1415t1621r1744b1703],
8	T	NN	ORGANIZATION	t	appos	2	SENT_966	[p24l1788t1623r1871b1717],
9	,	,	O	,	_	0	SENT_966	[p24l1788t1623r1871b1717],
10	et	FW	O	et	nn	11	SENT_966	[p24l1921t1633r2002b1702],
11	al.	FW	O	al.	appos	2	SENT_966	[p24l2045t1621r2146b1702],
12	.	.	O	.	_	0	SENT_966	[p24l2045t1621r2146b1702],

1	1996	CD	DATE	1996	_	0	SENT_967	[p24l204t1738r443b1820],
2	.	.	O	.	_	0	SENT_967	[p24l204t1738r443b1820],

1	Phase	NN	O	phase	_	0	SENT_968	[p24l504t1738r771b1819],
2	II	CD	NUMBER	ii	num	3	SENT_968	[p24l826t1740r900b1819],
3	trial	NN	O	trial	dep	1	SENT_968	[p24l954t1738r1135b1819],
4	of	IN	O	of	_	0	SENT_968	[p24l1191t1738r1290b1819],
5	docetaxel	NN	O	docetaxel	prep_of	3	SENT_968	[p24l1339t1738r1775b1819],
6	in	IN	O	in	_	0	SENT_968	[p24l1829t1738r1916b1819],
7	previously	RB	DATE	previously	advmod	8	SENT_968	[p24l1966t1764r2148b1843, p24l193t1857r529b1962],
8	untreated	JJ	O	untreated	amod	11	SENT_968	[p24l563t1857r992b1938],
9	advanced	JJ	O	advanced	amod	11	SENT_968	[p24l1028t1857r1461b1938],
10	non	JJ	O	non	amod	11	SENT_968	[p24l1496t1857r1954b1938],
11	—	NN	O	—	prep_in	5	SENT_968	[p24l1496t1857r1954b1938],
12	small	JJ	O	small	amod	15	SENT_968	[p24l1496t1857r1954b1938],
13	cell	NN	O	cell	nn	15	SENT_968	[p24l1989t1857r2152b1938],
14	lung	NN	O	lung	nn	15	SENT_968	[p24l193t1972r394b2078],
15	cancer	NN	O	cancer	dep	3	SENT_968	[p24l427t1998r741b2054],
16	.	.	O	.	_	0	SENT_968	[p24l427t1998r741b2054],

1	J.	NNP	PERSON	J.	nn	2	SENT_969	[p24l776t1975r846b2054],
2	Clin	NNP	PERSON	Clin	_	0	SENT_969	[p24l894t1972r1100b2054],
3	.	.	O	.	_	0	SENT_969	[p24l894t1972r1100b2054],

1	Oncol	NN	O	oncol	_	0	SENT_970	[p24l1147t1972r1440b2054],
2	.	.	O	.	_	0	SENT_970	[p24l1147t1972r1440b2054],

1	14:1649	CD	NUMBER	14:1649	num	2	SENT_971	[p24l1492t1972r2023b2054],
2	—	CD	NUMBER	—	_	0	SENT_971	[p24l1492t1972r2023b2054],
3	55	CD	NUMBER	55	num	5	SENT_971	[p24l1492t1972r2023b2054],
4	Ettinger	NN	O	ettinger	nn	5	SENT_971	[p24l193t2088r563b2193],
5	DS	NN	O	d	nn	2	SENT_971	[p24l621t2088r792b2184],
6	,	,	O	,	_	0	SENT_971	[p24l621t2088r792b2184],
7	Finkelstein	NNP	PERSON	Finkelstein	nn	8	SENT_971	[p24l856t2088r1364b2169],
8	DM	NN	O	dm	appos	2	SENT_971	[p24l1424t2090r1632b2184],
9	,	,	O	,	_	0	SENT_971	[p24l1424t2090r1632b2184],
10	Sarma	FW	PERSON	sarma	dep	2	SENT_971	[p24l1698t2088r1991b2170],
11	R	NN	PERSON	r	dep	2	SENT_971	[p24l2048t2090r2148b2184],
12	,	,	O	,	_	0	SENT_971	[p24l2048t2090r2148b2184],
13	Johnson	NNP	PERSON	Johnson	nn	14	SENT_971	[p24l193t2205r572b2287],
14	DH	NNP	O	DH	appos	11	SENT_971	[p24l601t2208r790b2287],
15	.	.	O	.	_	0	SENT_971	[p24l601t2208r790b2287],

1	1993	CD	DATE	1993	_	0	SENT_972	[p24l838t2207r1078b2288],
2	.	.	O	.	_	0	SENT_972	[p24l838t2207r1078b2288],

1	Phase	NN	O	phase	_	0	SENT_973	[p24l1116t2205r1383b2287],
2	II	CD	NUMBER	ii	num	3	SENT_973	[p24l1416t2208r1491b2285],
3	study	NN	O	study	dep	1	SENT_973	[p24l1527t2205r1768b2311],
4	of	IN	O	of	_	0	SENT_973	[p24l1801t2205r1902b2287],
5	taxol	NN	O	taxol	prep_of	3	SENT_973	[p24l1925t2205r2153b2287],
6	in	IN	O	in	_	0	SENT_973	[p24l193t2323r281b2402],
7	patients	NNS	O	patient	prep_in	5	SENT_973	[p24l319t2323r672b2428],
8	with	IN	O	with	_	0	SENT_973	[p24l715t2323r916b2404],
9	extensive	JJ	O	extensive	amod	11	SENT_973	[p24l957t2323r1662b2428],
10	—	JJ	O	—	amod	11	SENT_973	[p24l957t2323r1662b2428],
11	stage	NN	O	stage	prep_with	7	SENT_973	[p24l957t2323r1662b2428],
12	small	JJ	O	small	amod	15	SENT_973	[p24l1706t2323r1950b2404],
13	cell	NN	O	cell	nn	15	SENT_973	[p24l1989t2323r2151b2404],
14	lung	NN	O	lung	nn	15	SENT_973	[p24l193t2438r394b2544],
15	cancer	NN	O	cancer	dep	3	SENT_973	[p24l444t2464r757b2520],
16	.	.	O	.	_	0	SENT_973	[p24l444t2464r757b2520],

1	Proc	NNP	O	Proc	_	0	SENT_974	[p24l809t2441r1048b2520],
2	.	.	O	.	_	0	SENT_974	[p24l809t2441r1048b2520],

1	Am	NNP	O	Am	_	0	SENT_975	[p24l1098t2440r1275b2520],
2	.	.	O	.	_	0	SENT_975	[p24l1098t2440r1275b2520],

1	Soc	NN	O	soc	_	0	SENT_976	[p24l1334t2440r1515b2520],
2	.	.	O	.	_	0	SENT_976	[p24l1334t2440r1515b2520],

1	Clin	NNP	O	Clin	_	0	SENT_977	[p24l1579t2438r1785b2520],
2	.	.	O	.	_	0	SENT_977	[p24l1579t2438r1785b2520],

1	Oncol	NN	O	oncol	_	0	SENT_978	[p24l1848t2438r2141b2520],
2	.	.	O	.	_	0	SENT_978	[p24l1848t2438r2141b2520],

1	12:329	CD	NUMBER	12:329	number	2	SENT_979	[p24l204t2556r508b2637],
2	(	CD	NUMBER	(	_	0	SENT_979	[p24l545t2555r891b2656],
3	Abstr	NNP	O	Abstr	dep	2	SENT_979	[p24l545t2555r891b2656],
4	.	.	O	.	_	0	SENT_979	[p24l545t2555r891b2656],
5	)	NN	O	)	dep	2	SENT_979	[p24l545t2555r891b2656],

1	Kirschling	VBG	O	kirschle	amod	2	SENT_980	[p24l195t2671r676b2777],
2	RJ	NN	O	rj	nsubj	8	SENT_980	[p24l720t2674r863b2767],
3	,	,	O	,	_	0	SENT_980	[p24l720t2674r863b2767],
4	Jung	NNP	PERSON	Jung	nn	5	SENT_980	[p24l910t2674r1124b2777],
5	SH	NNP	O	SH	appos	2	SENT_980	[p24l1170t2673r1337b2767],
6	,	,	O	,	_	0	SENT_980	[p24l1170t2673r1337b2767],
7	Jett	NNP	PERSON	Jett	dep	8	SENT_980	[p24l1382t2674r1543b2753],
8	JR.	NNP	O	JR.	_	0	SENT_980	[p24l1581t2674r1724b2753],
9	1994	CD	DATE	1994	num	8	SENT_980	[p24l1783t2673r2022b2754],
10	.	.	O	.	_	0	SENT_980	[p24l1783t2673r2022b2754],

1	A	DT	O	a	det	4	SENT_981	[p24l2071t2673r2151b2751],
2	phase	NN	O	phase	nn	4	SENT_981	[p24l192t2787r453b2892],
3	II	CD	NUMBER	ii	num	4	SENT_981	[p24l505t2789r579b2868],
4	trial	NN	O	trial	_	0	SENT_981	[p24l629t2787r811b2868],
5	of	IN	O	of	_	0	SENT_981	[p24l863t2787r963b2868],
6	taxol	NN	O	taxol	prep_of	4	SENT_981	[p24l1004t2787r1232b2868],
7	and	CC	O	and	_	0	SENT_981	[p24l1283t2787r1447b2868],
8	GCSF	NN	ORGANIZATION	gcsf	prep_of	4	SENT_981	[p24l1497t2787r1784b2869],
9	in	IN	O	in	_	0	SENT_981	[p24l1832t2787r1919b2868],
10	previously	RB	DATE	previously	advmod	11	SENT_981	[p24l1966t2813r2148b2892, p24l193t2904r529b3010],
11	untreated	JJ	O	untreated	amod	12	SENT_981	[p24l581t2904r1008b2986],
12	patients	NNS	O	patient	prep_in	4	SENT_981	[p24l1058t2904r1412b3010],
13	with	IN	O	with	_	0	SENT_981	[p24l1466t2904r1668b2986],
14	extensive	JJ	O	extensive	amod	15	SENT_981	[p24l1720t2904r2151b2986],
15	stage	NN	O	stage	prep_with	4	SENT_981	[p24l197t3032r428b3126],
16	small	JJ	O	small	amod	19	SENT_981	[p24l457t3020r701b3102],
17	cell	NN	O	cell	nn	19	SENT_981	[p24l725t3020r888b3102],
18	lung	NN	O	lung	nn	19	SENT_981	[p24l911t3020r1112b3126],
19	cancer	NN	O	cancer	dep	15	SENT_981	[p24l1138t3046r1452b3102],
20	.	.	O	.	_	0	SENT_981	[p24l1138t3046r1452b3102],

1	Proc	NNP	O	Proc	_	0	SENT_982	[p24l1480t3023r1719b3102],
2	.	.	O	.	_	0	SENT_982	[p24l1480t3023r1719b3102],

1	Am	NNP	O	Am	_	0	SENT_983	[p24l1745t3022r1923b3102],
2	.	.	O	.	_	0	SENT_983	[p24l1745t3022r1923b3102],

1	Soc	NN	O	soc	_	0	SENT_984	[p24l1958t3022r2139b3102],
2	.	.	O	.	_	0	SENT_984	[p24l1958t3022r2139b3102],

1	Clin	NNP	O	Clin	_	0	SENT_985	[p24l199t3136r406b3218],
2	.	.	O	.	_	0	SENT_985	[p24l199t3136r406b3218],

1	Oncol	NN	O	oncol	_	0	SENT_986	[p24l453t3136r746b3218],
2	.	.	O	.	_	0	SENT_986	[p24l453t3136r746b3218],

1	132326	CD	NUMBER	132326	number	2	SENT_987	[p24l798t3136r1103b3216],
2	(	CD	NUMBER	(	_	0	SENT_987	[p24l1138t3136r1484b3235],
3	Abstr	NNP	O	Abstr	dep	2	SENT_987	[p24l1138t3136r1484b3235],
4	.	.	O	.	_	0	SENT_987	[p24l1138t3136r1484b3235],
5	)	NN	O	)	dep	2	SENT_987	[p24l1138t3136r1484b3235],

1	Smyth	NNP	PERSON	Smyth	nn	2	SENT_988	[p24l197t3252r492b3357],
2	JF	NNP	O	JF	_	0	SENT_988	[p24l533t3254r654b3348],
3	,	,	O	,	_	0	SENT_988	[p24l533t3254r654b3348],
4	Smith	NNP	PERSON	Smith	nn	5	SENT_988	[p24l703t3252r973b3334],
5	IE	NN	O	ie	appos	2	SENT_988	[p24l1011t3254r1143b3348],
6	,	,	O	,	_	0	SENT_988	[p24l1011t3254r1143b3348],
7	Sessa	NNP	PERSON	Sessa	nn	8	SENT_988	[p24l1191t3252r1444b3334],
8	C	NNP	O	C	appos	2	SENT_988	[p24l1484t3252r1581b3348],
9	,	,	O	,	_	0	SENT_988	[p24l1484t3252r1581b3348],
10	et	FW	O	et	nn	11	SENT_988	[p24l1627t3264r1709b3333],
11	al.	FW	O	al.	appos	2	SENT_988	[p24l1748t3252r1850b3333],
12	1994	CD	DATE	1994	dep	11	SENT_988	[p24l1905t3252r2144b3334],
13	.	.	O	.	_	0	SENT_988	[p24l1905t3252r2144b3334],

1	Activity	NN	O	activity	_	0	SENT_989	[p24l193t3369r567b3475],
2	of	IN	O	of	_	0	SENT_989	[p24l610t3369r710b3451],
3	docetaxel	NN	O	docetaxel	nn	6	SENT_989	[p24l744t3370r1182b3451],
4	(	CD	NUMBER	(	num	6	SENT_989	[p24l1227t3371r1696b3470],
5	Taxotere	NNP	O	Taxotere	nn	6	SENT_989	[p24l1227t3371r1696b3470],
6	)	NN	O	)	prep_of	1	SENT_989	[p24l1227t3371r1696b3470],
7	in	IN	O	in	_	0	SENT_989	[p24l1738t3370r1827b3449],
8	smallcell	NN	O	smallcell	nn	10	SENT_989	[p24l1870t3370r2148b3451, p24l195t3485r358b3567],
9	lung	NN	O	lung	nn	10	SENT_989	[p24l431t3485r631b3591],
10	cancer	NN	O	cancer	prep_in	1	SENT_989	[p24l706t3511r1022b3567],
11	.	.	O	.	_	0	SENT_989	[p24l706t3511r1022b3567],

1	Eur	NNP	O	Eur	_	0	SENT_990	[p24l1100t3488r1276b3567],
2	.	.	O	.	_	0	SENT_990	[p24l1100t3488r1276b3567],

1	J.	NNP	O	J.	nn	3	SENT_991	[p24l1356t3488r1426b3567],
2	Cancer	NNP	O	Cancer	nn	3	SENT_991	[p24l1517t3487r1853b3567],
3	30A	NNP	O	30A	_	0	SENT_991	[p24l1926t3486r2143b3567],
4	:	:	O	:	_	0	SENT_991	[p24l1926t3486r2143b3567],
5	105	CD	NUMBER	105	number	6	SENT_991	[p24l204t3601r358b3683],
6	8-60	CD	NUMBER	8-60	dep	3	SENT_991	[p24l371t3601r593b3683],

1	Gelmon	JJ	O	gelmon	amod	2	SENT_992	[p25l195t24r563b106],
2	KA	NN	O	ka	_	0	SENT_992	[p25l600t26r788b120],
3	,	,	O	,	_	0	SENT_992	[p25l600t26r788b120],
4	Murray	NNP	PERSON	Murray	nn	5	SENT_992	[p25l826t27r1170b130],
5	N	NNP	O	N	appos	2	SENT_992	[p25l1206t27r1313b120],
6	,	,	O	,	_	0	SENT_992	[p25l1206t27r1313b120],
7	Melosky	NNP	PERSON	Melosky	nn	8	SENT_992	[p25l1352t24r1754b130],
8	B	NNP	PERSON	B	appos	2	SENT_992	[p25l1788t27r1888b120],
9	,	,	O	,	_	0	SENT_992	[p25l1788t27r1888b120],
10	et	FW	O	et	nn	11	SENT_992	[p25l1928t37r2010b106],
11	al.	FW	O	al.	appos	2	SENT_992	[p25l2045t24r2146b106],
12	1996	CD	DATE	1996	dep	11	SENT_992	[p25l204t140r443b224],
13	.	.	O	.	_	0	SENT_992	[p25l204t140r443b224],

1	Phase	NN	O	phase	nn	3	SENT_993	[p25l495t141r762b222],
2	I/II	NN	O	i/ii	nn	3	SENT_993	[p25l809t142r952b222],
3	study	NN	O	study	_	0	SENT_993	[p25l1002t141r1245b246],
4	of	IN	O	of	_	0	SENT_993	[p25l1292t140r1391b222],
5	biweekly	JJ	SET	biweekly	amod	11	SENT_993	[p25l1426t141r1848b246],
6	pac1i	NN	O	pac1us	nn	11	SENT_993	[p25l1891t141r2148b246],
7	—	NN	O	—	nn	11	SENT_993	[p25l1891t141r2148b246],
8	taxel	NN	O	taxel	nn	11	SENT_993	[p25l193t256r415b338],
9	(	CD	NUMBER	(	num	11	SENT_993	[p25l443t256r769b357],
10	Taxol	NN	O	taxol	nn	11	SENT_993	[p25l443t256r769b357],
11	)	NN	O	)	prep_of	3	SENT_993	[p25l443t256r769b357],
12	and	CC	O	and	_	0	SENT_993	[p25l800t256r963b338],
13	cisplatin	NN	O	cisplatin	conj_and	11	SENT_993	[p25l987t256r1372b362],
14	in	IN	O	in	_	0	SENT_993	[p25l1396t256r1484b336],
15	non	JJ	O	non	amod	20	SENT_993	[p25l1506t256r1965b338],
16	—	JJ	O	—	amod	20	SENT_993	[p25l1506t256r1965b338],
17	small	JJ	O	small	amod	20	SENT_993	[p25l1506t256r1965b338],
18	cell	NN	O	cell	nn	20	SENT_993	[p25l1989t256r2152b338],
19	lung	NN	O	lung	nn	20	SENT_993	[p25l193t372r394b478],
20	cancer	NN	O	cancer	prep_in	3	SENT_993	[p25l444t398r757b454],
21	.	.	O	.	_	0	SENT_993	[p25l444t398r757b454],

1	Proc	NNP	O	Proc	_	0	SENT_994	[p25l809t375r1048b454],
2	.	.	O	.	_	0	SENT_994	[p25l809t375r1048b454],

1	Am	NNP	O	Am	_	0	SENT_995	[p25l1098t374r1275b454],
2	.	.	O	.	_	0	SENT_995	[p25l1098t374r1275b454],

1	Soc	NN	O	soc	_	0	SENT_996	[p25l1334t374r1515b454],
2	.	.	O	.	_	0	SENT_996	[p25l1334t374r1515b454],

1	Clin	NNP	O	Clin	_	0	SENT_997	[p25l1579t372r1785b454],
2	.	.	O	.	_	0	SENT_997	[p25l1579t372r1785b454],

1	Oncol	NN	O	oncol	_	0	SENT_998	[p25l1848t372r2141b454],
2	.	.	O	.	_	0	SENT_998	[p25l1848t372r2141b454],

1	15:405	CD	NUMBER	15:405	_	0	SENT_999	[p25l204t488r505b570],

1	Belli	NNP	PERSON	Belli	nn	2	SENT_1000	[p25l193t605r413b687],
2	L	NNP	PERSON	L	_	0	SENT_1000	[p25l445t607r538b701],
3	,	,	O	,	_	0	SENT_1000	[p25l445t607r538b701],
4	Le	NNP	ORGANIZATION	Le	nn	6	SENT_1000	[p25l574t607r694b686],
5	Chavalier	NNP	ORGANIZATION	Chavalier	nn	6	SENT_1000	[p25l727t605r1173b687],
6	T	NN	ORGANIZATION	t	appos	2	SENT_1000	[p25l1203t607r1285b701],
7	,	,	O	,	_	0	SENT_1000	[p25l1203t607r1285b701],
8	Gottfried	NNP	PERSON	Gottfried	nn	9	SENT_1000	[p25l1321t605r1740b687],
9	M	NNP	O	M	appos	2	SENT_1000	[p25l1769t607r1895b701],
10	,	,	O	,	_	0	SENT_1000	[p25l1769t607r1895b701],
11	et	FW	O	et	nn	12	SENT_1000	[p25l1931t617r2013b686],
12	a1	FW	O	a1	appos	2	SENT_1000	[p25l2045t605r2146b686],
13	.	.	O	.	_	0	SENT_1000	[p25l2045t605r2146b686],

1	1995	CD	DATE	1995	_	0	SENT_1001	[p25l204t723r443b806],
2	.	.	O	.	_	0	SENT_1001	[p25l204t723r443b806],

1	Phase	NN	O	phase	_	0	SENT_1002	[p25l488t723r755b804],
2	I-II	CD	NUMBER	i-ii	num	3	SENT_1002	[p25l795t725r947b802],
3	trial	NN	O	trial	dep	1	SENT_1002	[p25l983t722r1165b804],
4	of	IN	O	of	_	0	SENT_1002	[p25l1204t722r1304b804],
5	paclitaxel	NN	O	paclitaxel	nn	8	SENT_1002	[p25l1334t722r1780b828],
6	(	CD	NUMBER	(	num	8	SENT_1002	[p25l1821t723r2148b823],
7	Taxol	NN	O	taxol	nn	8	SENT_1002	[p25l1821t723r2148b823],
8	)	NN	O	)	prep_of	3	SENT_1002	[p25l1821t723r2148b823],
9	and	CC	O	and	_	0	SENT_1002	[p25l195t838r359b920],
10	cisplatin	NN	O	cisplatin	conj_and	3	SENT_1002	[p25l413t838r799b944],
11	in	IN	O	in	_	0	SENT_1002	[p25l852t838r940b918],
12	previously	RB	DATE	previously	advmod	13	SENT_1002	[p25l990t838r1474b944],
13	untreated	JJ	O	untreated	amod	16	SENT_1002	[p25l1527t838r1954b920],
14	advanced	JJ	O	advanced	amod	16	SENT_1002	[p25l2010t838r2148b920, p25l194t954r520b1035],
15	non	JJ	O	non	amod	16	SENT_1002	[p25l566t954r1024b1035],
16	—	NN	O	—	prep_in	10	SENT_1002	[p25l566t954r1024b1035],
17	small	JJ	O	small	amod	20	SENT_1002	[p25l566t954r1024b1035],
18	cell	NN	O	cell	nn	20	SENT_1002	[p25l1074t954r1238b1035],
19	lung	NN	O	lung	nn	20	SENT_1002	[p25l1286t954r1486b1059],
20	cancer	NN	O	cancer	dep	10	SENT_1002	[p25l1536t980r1850b1035],
21	.	.	O	.	_	0	SENT_1002	[p25l1536t980r1850b1035],

1	Proc	NNP	O	Proc	_	0	SENT_1003	[p25l1902t957r2139b1035],
2	.	.	O	.	_	0	SENT_1003	[p25l1902t957r2139b1035],

1	Am	NNP	O	Am	_	0	SENT_1004	[p25l185t1073r363b1151],
2	.	.	O	.	_	0	SENT_1004	[p25l185t1073r363b1151],

1	Soc	NN	O	soc	_	0	SENT_1005	[p25l406t1073r588b1153],
2	.	.	O	.	_	0	SENT_1005	[p25l406t1073r588b1153],

1	Clin	NNP	O	Clin	_	0	SENT_1006	[p25l635t1071r842b1153],
2	.	.	O	.	_	0	SENT_1006	[p25l635t1071r842b1153],

1	Oncol	NN	O	oncol	_	0	SENT_1007	[p25l889t1071r1182b1153],
2	.	.	O	.	_	0	SENT_1007	[p25l889t1071r1182b1153],

1	142350	CD	NUMBER	142350	number	2	SENT_1008	[p25l1235t1071r1540b1153],
2	(	CD	NUMBER	(	_	0	SENT_1008	[p25l1574t1071r1920b1170],
3	Abstr	NNP	O	Abstr	dep	2	SENT_1008	[p25l1574t1071r1920b1170],
4	.	.	O	.	_	0	SENT_1008	[p25l1574t1071r1920b1170],
5	)	NN	O	)	dep	2	SENT_1008	[p25l1574t1071r1920b1170],

1	Cole	NNP	O	Cole	nn	2	SENT_1009	[p25l195t1189r408b1270],
2	JT	NNP	O	JT	_	0	SENT_1009	[p25l455t1191r584b1284],
3	,	,	O	,	_	0	SENT_1009	[p25l455t1191r584b1284],
4	Gralla	NNP	PERSON	Gralla	nn	5	SENT_1009	[p25l636t1189r922b1270],
5	RJ	NN	PERSON	rj	appos	2	SENT_1009	[p25l967t1191r1112b1285],
6	,	,	O	,	_	0	SENT_1009	[p25l967t1191r1112b1285],
7	Marques	NNP	PERSON	Marques	nn	8	SENT_1009	[p25l1161t1191r1561b1294],
8	CB	NNP	PERSON	CB	appos	2	SENT_1009	[p25l1611t1189r1785b1284],
9	,	,	O	,	_	0	SENT_1009	[p25l1611t1189r1785b1284],
10	Ritten	NNP	O	Ritten	appos	2	SENT_1009	[p25l1836t1189r2148b1270],
11	—	CD	NUMBER	—	num	13	SENT_1009	[p25l1836t1189r2148b1270],
12	berg	NN	O	berg	nn	13	SENT_1009	[p25l192t1304r394b1410],
13	CN	NN	O	cn	dep	10	SENT_1009	[p25l420t1305r600b1386],
14	.	.	O	.	_	0	SENT_1009	[p25l420t1305r600b1386],

1	1995	CD	DATE	1995	_	0	SENT_1010	[p25l640t1304r880b1386],
2	.	.	O	.	_	0	SENT_1010	[p25l640t1304r880b1386],

1	Phase	NN	O	phase	nn	3	SENT_1011	[p25l910t1304r1177b1386],
2	I-11	NN	MISC	i-11	nn	3	SENT_1011	[p25l1203t1306r1355b1384],
3	study	NN	O	study	_	0	SENT_1011	[p25l1382t1304r1623b1410],
4	of	IN	O	of	_	0	SENT_1011	[p25l1649t1304r1749b1386],
5	cisplatin	NN	O	cisplatin	prep_of	3	SENT_1011	[p25l1766t1304r2152b1410],
6	+	CC	O	+	_	0	SENT_1011	[p25l195t1439r255b1500],
7	docetaxel	NN	O	docetaxel	prep_of	3	SENT_1011	[p25l312t1420r750b1500],
8	(	CD	NUMBER	(	num	9	SENT_1011	[p25l809t1420r1278b1519],
9	Taxotere	NNP	O	Taxotere	dep	3	SENT_1011	[p25l809t1420r1278b1519],
10	)	CD	NUMBER	)	num	9	SENT_1011	[p25l809t1420r1278b1519],
11	in	IN	O	in	_	0	SENT_1011	[p25l1335t1420r1423b1500],
12	non	JJ	O	non	amod	17	SENT_1011	[p25l1476t1420r1934b1500],
13	—	JJ	O	—	amod	17	SENT_1011	[p25l1476t1420r1934b1500],
14	small	JJ	O	small	amod	17	SENT_1011	[p25l1476t1420r1934b1500],
15	cell	NN	O	cell	nn	17	SENT_1011	[p25l1989t1420r2151b1500],
16	lung	NN	O	lung	nn	17	SENT_1011	[p25l193t1536r394b1642],
17	cancer	NN	O	cancer	prep_in	9	SENT_1011	[p25l444t1562r757b1618],
18	.	.	O	.	_	0	SENT_1011	[p25l444t1562r757b1618],

1	Proc	NNP	O	Proc	_	0	SENT_1012	[p25l809t1539r1048b1618],
2	.	.	O	.	_	0	SENT_1012	[p25l809t1539r1048b1618],

1	Am	NNP	O	Am	_	0	SENT_1013	[p25l1098t1538r1275b1618],
2	.	.	O	.	_	0	SENT_1013	[p25l1098t1538r1275b1618],

1	Soc	NN	O	soc	_	0	SENT_1014	[p25l1333t1538r1515b1618],
2	.	.	O	.	_	0	SENT_1014	[p25l1333t1538r1515b1618],

1	Clin	NNP	O	Clin	_	0	SENT_1015	[p25l1579t1536r1785b1618],
2	.	.	O	.	_	0	SENT_1015	[p25l1579t1536r1785b1618],

1	Oncol	NN	O	oncol	_	0	SENT_1016	[p25l1848t1536r2141b1618],
2	.	.	O	.	_	0	SENT_1016	[p25l1848t1536r2141b1618],

1	14:357	CD	NUMBER	14:357	number	2	SENT_1017	[p25l204t1652r506b1734],
2	(	CD	NUMBER	(	_	0	SENT_1017	[p25l546t1652r891b1751],
3	Abstr	NNP	O	Abstr	dep	2	SENT_1017	[p25l546t1652r891b1751],
4	.	.	O	.	_	0	SENT_1017	[p25l546t1652r891b1751],
5	)	NN	O	)	dep	2	SENT_1017	[p25l546t1652r891b1751],

1	Zalcberg	NNP	O	Zalcberg	nn	2	SENT_1018	[p25l192t1768r598b1874],
2	JR	NNP	O	JR	_	0	SENT_1018	[p25l622t1770r767b1864],
3	,	,	O	,	_	0	SENT_1018	[p25l622t1770r767b1864],
4	Bishop	NNP	PERSON	Bishop	nn	6	SENT_1018	[p25l795t1768r1118b1874],
5	J	NNP	PERSON	J	nn	6	SENT_1018	[p25l1142t1770r1184b1850],
6	F	NN	PERSON	f	appos	2	SENT_1018	[p25l1187t1770r1264b1864],
7	,	,	O	,	_	0	SENT_1018	[p25l1187t1770r1264b1864],
8	Millward	NNP	PERSON	Millward	nn	9	SENT_1018	[p25l1292t1768r1719b1850],
9	MJ	NNP	PERSON	MJ	appos	2	SENT_1018	[p25l1740t1770r1911b1864],
10	,	,	O	,	_	0	SENT_1018	[p25l1740t1770r1911b1864],
11	et	FW	O	et	nn	12	SENT_1018	[p25l1940t1780r2021b1850],
12	al.	FW	O	al.	appos	2	SENT_1018	[p25l2045t1768r2146b1850],
13	1995	CD	DATE	1995	dep	12	SENT_1018	[p25l204t1884r443b1966],
14	.	.	O	.	_	0	SENT_1018	[p25l204t1884r443b1966],

1	Preliminary	JJ	O	preliminary	amod	2	SENT_1019	[p25l481t1884r1022b1990],
2	results	NNS	O	result	nsubj	8	SENT_1019	[p25l1053t1884r1349b1966],
3	of	IN	O	of	_	0	SENT_1019	[p25l1384t1884r1484b1966],
4	the	DT	O	the	det	6	SENT_1019	[p25l1508t1884r1644b1966],
5	first	JJ	ORDINAL	first	amod	6	SENT_1019	[p25l1677t1884r1862b1966],
6	phase	NN	O	phase	prep_of	2	SENT_1019	[p25l1890t1884r2151b1990],
7	II	CD	NUMBER	ii	num	8	SENT_1019	[p25l193t2003r267b2081],
8	trial	NN	O	trial	_	0	SENT_1019	[p25l319t2000r502b2082],
9	of	IN	O	of	_	0	SENT_1019	[p25l556t2000r656b2082],
10	docetaxel	NN	O	docetaxel	prep_of	8	SENT_1019	[p25l699t2000r1137b2082],
11	in	IN	O	in	_	0	SENT_1019	[p25l1189t2000r1276b2081],
12	combination	NN	O	combination	prep_in	10	SENT_1019	[p25l1327t2000r1899b2082],
13	with	IN	O	with	_	0	SENT_1019	[p25l1951t2000r2153b2082],
14	cisplatin	NN	O	cisplatin	prep_with	8	SENT_1019	[p25l195t2117r580b2222],
15	in	IN	O	in	_	0	SENT_1019	[p25l622t2117r710b2198],
16	patients	NNS	O	patient	prep_in	14	SENT_1019	[p25l748t2117r1102b2222],
17	with	IN	O	with	_	0	SENT_1019	[p25l1146t2117r1348b2199],
18	metastatic	JJ	O	metastatic	prep_with	16	SENT_1019	[p25l1388t2117r1850b2198],
19	or	CC	O	or	_	0	SENT_1019	[p25l1895t2143r1989b2198],
20	locally	RB	O	locally	advmod	21	SENT_1019	[p25l2027t2117r2148b2198, p25l195t2236r415b2341],
21	advanced	VBD	O	advance	conj_or	8	SENT_1019	[p25l448t2236r881b2317],
22	non	JJ	O	non	amod	23	SENT_1019	[p25l912t2236r1370b2317],
23	—	JJ	O	—	amod	27	SENT_1019	[p25l912t2236r1370b2317],
24	small	JJ	O	small	amod	27	SENT_1019	[p25l912t2236r1370b2317],
25	cell	NN	O	cell	nn	27	SENT_1019	[p25l1403t2236r1566b2317],
26	lung	NN	O	lung	nn	27	SENT_1019	[p25l1597t2236r1798b2341],
27	cancer	NN	O	cancer	dobj	21	SENT_1019	[p25l1832t2261r2144b2317],
28	.	.	O	.	_	0	SENT_1019	[p25l1832t2261r2144b2317],

1	Proc	NNP	O	Proc	_	0	SENT_1020	[p25l192t2355r429b2434],
2	.	.	O	.	_	0	SENT_1020	[p25l192t2355r429b2434],

1	Am	NNP	O	Am	_	0	SENT_1021	[p25l457t2354r633b2434],
2	.	.	O	.	_	0	SENT_1021	[p25l457t2354r633b2434],

1	Soc	NN	O	soc	_	0	SENT_1022	[p25l668t2354r849b2434],
2	.	.	O	.	_	0	SENT_1022	[p25l668t2354r849b2434],

1	Clin	NNP	O	Clin	_	0	SENT_1023	[p25l889t2352r1095b2434],
2	.	.	O	.	_	0	SENT_1023	[p25l889t2352r1095b2434],

1	Oncol	NN	O	oncol	_	0	SENT_1024	[p25l1133t2352r1426b2434],
2	.	.	O	.	_	0	SENT_1024	[p25l1133t2352r1426b2434],

1	142351	CD	NUMBER	142351	number	2	SENT_1025	[p25l1470t2352r1766b2434],
2	(	CD	NUMBER	(	_	0	SENT_1025	[p25l1803t2352r2148b2453],
3	Abstr	NNP	O	Abstr	dep	2	SENT_1025	[p25l1803t2352r2148b2453],
4	.	.	O	.	_	0	SENT_1025	[p25l1803t2352r2148b2453],
5	)	NN	O	)	dep	2	SENT_1025	[p25l1803t2352r2148b2453],

1	Bonomi	NNP	PERSON	Bonomi	nn	2	SENT_1026	[p25l193t2468r563b2549],
2	P	NN	O	p	_	0	SENT_1026	[p25l607t2470r678b2564],
3	,	,	O	,	_	0	SENT_1026	[p25l607t2470r678b2564],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_1026	[p25l729t2468r932b2548],
5	K	NNP	PERSON	K	appos	2	SENT_1026	[p25l974t2470r1079b2564],
6	,	,	O	,	_	0	SENT_1026	[p25l974t2470r1079b2564],
7	Chang	NNP	PERSON	Chang	nn	8	SENT_1026	[p25l1128t2468r1424b2573],
8	D	NNP	PERSON	D	appos	2	SENT_1026	[p25l1468t2470r1574b2564],
9	,	,	O	,	_	0	SENT_1026	[p25l1468t2470r1574b2564],
10	Johnson	NNP	PERSON	Johnson	nn	11	SENT_1026	[p25l1621t2468r1999b2550],
11	D.	NNP	O	D.	appos	2	SENT_1026	[p25l2041t2470r2146b2549],
12	1996	CD	DATE	1996	dep	11	SENT_1026	[p25l204t2585r443b2668],
13	.	.	O	.	_	0	SENT_1026	[p25l204t2585r443b2668],

1	Phase	NN	O	phase	nn	3	SENT_1027	[p25l486t2585r753b2667],
2	III	CD	NUMBER	iii	num	3	SENT_1027	[p25l791t2588r903b2665],
3	trial	NN	O	trial	_	0	SENT_1027	[p25l940t2585r1123b2667],
4	comparing	VBG	O	compare	partmod	3	SENT_1027	[p25l1159t2585r1647b2691],
5	etoposide	NN	O	etoposide	dobj	4	SENT_1027	[p25l1686t2585r2148b2691],
6	,	,	O	,	_	0	SENT_1027	[p25l1686t2585r2148b2691],
7	cisplatin	NN	O	cisplatin	appos	5	SENT_1027	[p25l195t2703r605b2808],
8	,	,	O	,	_	0	SENT_1027	[p25l195t2703r605b2808],
9	versus	CC	O	versus	_	0	SENT_1027	[p25l678t2728r968b2784],
10	taxol	NN	O	taxol	dobj	4	SENT_1027	[p25l1039t2703r1267b2784],
11	with	IN	O	with	_	0	SENT_1027	[p25l1335t2703r1536b2784],
12	cisplatin	NN	O	cisplatin	prep_with	10	SENT_1027	[p25l1605t2703r2148b2808],
13	.	.	O	.	_	0	SENT_1027	[p25l1605t2703r2148b2808],

1	—	NN	O	—	_	0	SENT_1028	[p25l1605t2703r2148b2808],
2	.	.	O	.	_	0	SENT_1028	[p25l1605t2703r2148b2808],

1	G	NN	O	g	nn	2	SENT_1029	[p25l1605t2703r2148b2808],
2	CSF	NN	O	csf	_	0	SENT_1029	[p25l195t2818r398b2900],
3	versus	CC	O	versus	prep	2	SENT_1029	[p25l469t2844r759b2900],
4	taxol-cisplatin	NN	O	taxol-cisplatin	dep	3	SENT_1029	[p25l835t2818r1489b2924],
5	in	IN	O	in	_	0	SENT_1029	[p25l1560t2818r1648b2898],
6	advanced	JJ	O	advanced	amod	8	SENT_1029	[p25l1720t2818r2153b2900],
7	non	JJ	O	non	amod	8	SENT_1029	[p25l193t2934r651b3015],
8	—	NN	O	—	prep_in	2	SENT_1029	[p25l193t2934r651b3015],
9	small	JJ	O	small	amod	12	SENT_1029	[p25l193t2934r651b3015],
10	cell	NN	O	cell	nn	12	SENT_1029	[p25l680t2934r842b3015],
11	lung	NN	O	lung	nn	12	SENT_1029	[p25l868t2934r1069b3039],
12	cancer	NN	O	cancer	dep	8	SENT_1029	[p25l1098t2960r1412b3015],
13	.	.	O	.	_	0	SENT_1029	[p25l1098t2960r1412b3015],

1	An	DT	O	a	det	7	SENT_1030	[p25l1445t2934r1583b3014],
2	Eastern	NNP	ORGANIZATION	Eastern	nn	7	SENT_1030	[p25l1611t2936r1954b3015],
3	Cooperative	NNP	ORGANIZATION	Cooperative	nn	7	SENT_1030	[p25l1982t2934r2148b3016, p25l195t3051r619b3157],
4	Oncology	NNP	ORGANIZATION	Oncology	nn	7	SENT_1030	[p25l669t3051r1119b3157],
5	Group	NNP	ORGANIZATION	Group	nn	7	SENT_1030	[p25l1168t3052r1457b3157],
6	(	CD	NUMBER	(	num	7	SENT_1030	[p25l1510t3052r1890b3152],
7	ECOG	NNP	O	ECOG	_	0	SENT_1030	[p25l1510t3052r1890b3152],
8	)	CD	NUMBER	)	num	9	SENT_1030	[p25l1510t3052r1890b3152],
9	trial	NN	O	trial	dep	7	SENT_1030	[p25l1940t3051r2146b3133],
10	.	.	O	.	_	0	SENT_1030	[p25l1940t3051r2146b3133],

1	Proc	NNP	O	Proc	_	0	SENT_1031	[p25l192t3170r430b3247],
2	.	.	O	.	_	0	SENT_1031	[p25l192t3170r430b3247],

1	Am	NNP	O	Am	_	0	SENT_1032	[p25l457t3169r634b3247],
2	.	.	O	.	_	0	SENT_1032	[p25l457t3169r634b3247],

1	Soc	NN	O	soc	_	0	SENT_1033	[p25l668t3169r849b3249],
2	.	.	O	.	_	0	SENT_1033	[p25l668t3169r849b3249],

1	Clin	NNP	O	Clin	_	0	SENT_1034	[p25l889t3167r1095b3249],
2	.	.	O	.	_	0	SENT_1034	[p25l889t3167r1095b3249],

1	Oncol	NN	O	oncol	_	0	SENT_1035	[p25l1133t3167r1426b3249],
2	.	.	O	.	_	0	SENT_1035	[p25l1133t3167r1426b3249],

1	151382	CD	NUMBER	151382	number	2	SENT_1036	[p25l1470t3167r1775b3249],
2	(	CD	NUMBER	(	_	0	SENT_1036	[p25l1803t3167r2148b3266],
3	Abstr	NNP	O	Abstr	dep	2	SENT_1036	[p25l1803t3167r2148b3266],
4	.	.	O	.	_	0	SENT_1036	[p25l1803t3167r2148b3266],
5	)	NN	O	)	dep	2	SENT_1036	[p25l1803t3167r2148b3266],

1	Langer	NNP	O	Langer	nn	2	SENT_1037	[p25l193t3285r520b3389],
2	CJ	NNP	O	CJ	_	0	SENT_1037	[p25l558t3284r701b3379],
3	,	,	O	,	_	0	SENT_1037	[p25l558t3284r701b3379],
4	Leighton	NNP	PERSON	Leighton	nn	5	SENT_1037	[p25l742t3283r1156b3389],
5	JC	NNP	PERSON	JC	appos	2	SENT_1037	[p25l1192t3284r1337b3379],
6	,	,	O	,	_	0	SENT_1037	[p25l1192t3284r1337b3379],
7	Comis	NNP	ORGANIZATION	Comis	nn	8	SENT_1037	[p25l1379t3283r1674b3365],
8	RL	NNP	ORGANIZATION	RL	appos	2	SENT_1037	[p25l1714t3285r1884b3379],
9	,	,	O	,	_	0	SENT_1037	[p25l1714t3285r1884b3379],
10	et	FW	O	et	nn	11	SENT_1037	[p25l1926t3295r2008b3365],
11	al.	FW	O	al.	appos	2	SENT_1037	[p25l2045t3283r2146b3365],
12	1995	CD	DATE	1995	dep	11	SENT_1037	[p25l204t3399r443b3481],
13	.	.	O	.	_	0	SENT_1037	[p25l204t3399r443b3481],

1	Paclitaxel	NN	O	paclitaxel	_	0	SENT_1038	[p25l483t3399r934b3481],
2	and	CC	O	and	_	0	SENT_1038	[p25l969t3399r1132b3481],
3	carboplatin	NN	O	carboplatin	conj_and	1	SENT_1038	[p25l1163t3399r1677b3505],
4	in	IN	O	in	_	0	SENT_1038	[p25l1708t3399r1796b3479],
5	combination	NN	O	combination	prep_in	1	SENT_1038	[p25l1829t3399r2148b3481, p25l193t3516r479b3596],
6	in	IN	O	in	_	0	SENT_1038	[p25l525t3516r612b3596],
7	the	DT	O	the	det	8	SENT_1038	[p25l659t3516r795b3596],
8	treatment	NN	O	treatment	prep_in	1	SENT_1038	[p25l842t3528r1278b3596],
9	of	IN	O	of	_	0	SENT_1038	[p25l1323t3516r1423b3596],
10	advanced	JJ	O	advanced	amod	11	SENT_1038	[p25l1464t3516r1897b3596],
11	nonsmall-cell	JJ	O	nonsmall-cell	prep_of	8	SENT_1038	[p25l1942t3542r2148b3596, p25l197t3632r645b3713],

1	lung	NN	O	lung	nn	2	SENT_1039	[p25l682t3632r882b3737],
2	cancer	NN	O	cancer	_	0	SENT_1039	[p25l922t3658r1245b3713],
3	:	:	O	:	_	0	SENT_1039	[p25l922t3658r1245b3713],
4	a	DT	O	a	det	7	SENT_1039	[p25l1292t3658r1339b3713],
5	phase	NN	O	phase	nn	7	SENT_1039	[p25l1374t3632r1635b3737],
6	II	CD	NUMBER	ii	num	7	SENT_1039	[p25l1673t3634r1747b3713],
7	toxicity	NN	O	toxicity	dep	2	SENT_1039	[p25l1783t3632r2146b3737],
8	,	,	O	,	_	0	SENT_1039	[p25l1783t3632r2146b3737],

1	997.48:353	CD	NUMBER	997.48:353	num	2	SENT_1040	[p26l7t2999r65b3538],
2	—	NN	O	—	_	0	SENT_1040	[p26l7t2999r65b3538],
3	374	CD	NUMBER	374	num	2	SENT_1040	[p26l7t2999r65b3538],
4	.	.	O	.	_	0	SENT_1040	[p26l7t2999r65b3538],

1	Downloaded	VBN	O	download	_	0	SENT_1041	[p26l7t2552r65b2972],
2	from	IN	O	from	_	0	SENT_1041	[p26l7t2370r64b2530],
3	www.annualreviews.org	NN	O	www.annualreviews.org	nn	6	SENT_1041	[p26l7t1544r82b2348],
4	Wisconsin	NNP	LOCATION	Wisconsin	nn	6	SENT_1041	[p26l90t3178r147b3527],
5	—	NNP	O	—	nn	6	SENT_1041	[p26l125t3133r130b3154],
6	Madison	NNP	O	Madison	prep_from	1	SENT_1041	[p26l90t2820r147b3108],
7	on	IN	O	on	_	0	SENT_1041	[p26l108t2717r147b2797],
8	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_1041	[p26l89t2387r147b2695],
9	.	.	O	.	_	0	SENT_1041	[p26l89t2387r147b2695],

1	For	IN	O	for	_	0	SENT_1042	[p26l91t2246r147b2360],
2	personal	JJ	O	personal	amod	3	SENT_1042	[p26l90t1947r165b2225],
3	use	NN	O	use	pobj	1	SENT_1042	[p26l108t1817r147b1925],
4	only	RB	O	only	advmod	3	SENT_1042	[p26l90t1632r165b1792],
5	.	.	O	.	_	0	SENT_1042	[p26l90t1632r165b1792],

1	374	CD	NUMBER	374	_	0	SENT_1043	[p26l605t144r739b208],
2	ROWIN	NNP	O	ROWIN	dep	1	SENT_1043	[p26l834t144r1147b208],
3	SKY	NNS	O	sky	dep	1	SENT_1043	[p26l1151t144r1331b208],

1	response	NN	O	response	_	0	SENT_1044	[p26l756t366r1061b423],
2	,	,	O	,	_	0	SENT_1044	[p26l756t366r1061b423],
3	and	CC	O	and	dep	1	SENT_1044	[p26l1107t349r1223b406],
4	survival	NN	O	survival	dep	1	SENT_1044	[p26l1268t349r1526b406],
5	analysis	NN	O	analysis	dep	4	SENT_1044	[p26l1570t349r1847b423],
6	.	.	O	.	_	0	SENT_1044	[p26l1570t349r1847b423],

1	J.	NNP	PERSON	J.	nn	2	SENT_1045	[p26l1891t351r1940b407],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1045	[p26l1995t349r2141b407],
3	.	.	O	.	_	0	SENT_1045	[p26l1995t349r2141b407],

1	Oncol	NN	O	oncol	_	0	SENT_1046	[p26l761t429r968b487],
2	.	.	O	.	_	0	SENT_1046	[p26l761t429r968b487],

1	l3	NN	O	l3	_	0	SENT_1047	[p26l1006t429r1387b487],
2	:	:	O	:	_	0	SENT_1047	[p26l1006t429r1387b487],
3	l860	CD	NUMBER	l860	dep	1	SENT_1047	[p26l1006t429r1387b487],
4	—	CD	NUMBER	—	number	5	SENT_1047	[p26l1006t429r1387b487],
5	70	CD	NUMBER	70	dep	3	SENT_1047	[p26l1006t429r1387b487],

1	95	CD	NUMBER	95	_	0	SENT_1048	[p26l623t511r719b569],
2	.	.	O	.	_	0	SENT_1048	[p26l623t511r719b569],

1	Choi	NNP	PERSON	Choi	nn	2	SENT_1049	[p26l758t511r914b569],
2	H	NNP	PERSON	H	_	0	SENT_1049	[p26l939t512r1015b579],
3	,	,	O	,	_	0	SENT_1049	[p26l939t512r1015b579],
4	Akerley	NNP	PERSON	Akerley	nn	5	SENT_1049	[p26l1042t511r1304b585],
5	W	NNP	O	W	appos	2	SENT_1049	[p26l1329t512r1415b579],
6	,	,	O	,	_	0	SENT_1049	[p26l1329t512r1415b579],
7	Safran	NNP	PERSON	Safran	nn	8	SENT_1049	[p26l1445t511r1656b569],
8	H	NNP	PERSON	H	appos	2	SENT_1049	[p26l1680t512r1755b579],
9	,	,	O	,	_	0	SENT_1049	[p26l1680t512r1755b579],
10	et	FW	O	et	nn	11	SENT_1049	[p26l1783t519r1841b568],
11	al.	FW	O	al.	appos	2	SENT_1049	[p26l1866t511r1938b568],
12	1994	CD	DATE	1994	dep	11	SENT_1049	[p26l1975t511r2145b569],
13	.	.	O	.	_	0	SENT_1049	[p26l1975t511r2145b569],

1	Phase	NN	O	phase	_	0	SENT_1050	[p26l757t592r947b651],
2	I	CD	NUMBER	i	num	3	SENT_1050	[p26l965t594r991b650],
3	trial	NN	O	trial	dep	1	SENT_1050	[p26l1009t592r1138b651],
4	of	IN	O	of	_	0	SENT_1050	[p26l1157t592r1228b651],
5	outpatient	JJ	O	outpatient	amod	7	SENT_1050	[p26l1240t592r1566b668],
6	weekly	JJ	SET	weekly	amod	7	SENT_1050	[p26l1582t592r1816b668],
7	paclitaxel	NN	O	paclitaxel	prep_of	3	SENT_1050	[p26l1833t592r2151b668],
8	and	CC	O	and	_	0	SENT_1050	[p26l758t674r875b731],
9	concurrent	JJ	O	concurrent	amod	11	SENT_1050	[p26l914t682r1263b731],
10	radiation	NN	O	radiation	nn	11	SENT_1050	[p26l1301t674r1591b731],
11	therapy	NN	O	therapy	dep	1	SENT_1050	[p26l1630t674r1874b748],
12	for	IN	O	for	_	0	SENT_1050	[p26l1914t674r2008b731],
13	advanced	JJ	O	advanced	amod	15	SENT_1050	[p26l2049t674r2147b731, p26l757t756r988b813],
14	non	JJ	O	non	amod	15	SENT_1050	[p26l1011t756r1336b813],
15	—	NN	O	—	prep_for	11	SENT_1050	[p26l1011t756r1336b813],
16	small	JJ	O	small	amod	19	SENT_1050	[p26l1011t756r1336b813],
17	cell	NN	O	cell	nn	19	SENT_1050	[p26l1359t756r1475b813],
18	lung	NN	O	lung	nn	19	SENT_1050	[p26l1497t756r1640b830],
19	cancer	NN	O	cancer	dep	11	SENT_1050	[p26l1663t773r1886b813],
20	.	.	O	.	_	0	SENT_1050	[p26l1663t773r1886b813],

1	J.	NNP	PERSON	J.	nn	2	SENT_1051	[p26l1911t758r1960b814],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1051	[p26l1994t756r2141b814],
3	.	.	O	.	_	0	SENT_1051	[p26l1994t756r2141b814],

1	Oncol	NN	O	oncol	_	0	SENT_1052	[p26l761t838r968b897],
2	.	.	O	.	_	0	SENT_1052	[p26l761t838r968b897],

1	l2	NN	O	l2	_	0	SENT_1053	[p26l1006t838r1386b896],
2	:2682	CD	NUMBER	:2682	number	3	SENT_1053	[p26l1006t838r1386b896],
3	—	CD	NUMBER	—	dep	1	SENT_1053	[p26l1006t838r1386b896],
4	86	CD	NUMBER	86	dep	3	SENT_1053	[p26l1006t838r1386b896],

1	96	CD	NUMBER	96	_	0	SENT_1054	[p26l623t919r719b978],
2	.	.	O	.	_	0	SENT_1054	[p26l623t919r719b978],

1	Forastiere	NNP	O	Forastiere	nn	2	SENT_1055	[p26l757t919r1084b977],
2	AA	NNP	O	AA	_	0	SENT_1055	[p26l1098t920r1232b988],
3	,	,	O	,	_	0	SENT_1055	[p26l1098t920r1232b988],
4	Neuberg	NNP	ORGANIZATION	Neuberg	nn	5	SENT_1055	[p26l1250t919r1530b994],
5	D	NNP	ORGANIZATION	D	appos	2	SENT_1055	[p26l1545t921r1620b988],
6	,	,	O	,	_	0	SENT_1055	[p26l1545t921r1620b988],
7	Taylor	NNP	ORGANIZATION	Taylor	nn	8	SENT_1055	[p26l1637t919r1850b994],
8	SG	NNP	ORGANIZATION	SG	appos	2	SENT_1055	[p26l1864t920r1983b988],
9	,	,	O	,	_	0	SENT_1055	[p26l1864t920r1983b988],
10	et	FW	O	et	nn	11	SENT_1055	[p26l2001t928r2059b977],
11	al.	FW	O	al.	appos	2	SENT_1055	[p26l2074t919r2146b977],
12	1993	CD	DATE	1993	dep	11	SENT_1055	[p26l765t1001r935b1059],
13	.	.	O	.	_	0	SENT_1055	[p26l765t1001r935b1059],

1	Phase	NN	O	phase	_	0	SENT_1056	[p26l974t1001r1164b1058],
2	II	CD	NUMBER	ii	num	3	SENT_1056	[p26l1198t1002r1251b1058],
3	evaluation	NN	O	evaluation	dep	1	SENT_1056	[p26l1285t1001r1624b1058],
4	of	IN	O	of	_	0	SENT_1056	[p26l1658t1001r1729b1058],
5	taxol	NN	O	taxol	prep_of	3	SENT_1056	[p26l1756t1001r1918b1058],
6	in	IN	O	in	_	0	SENT_1056	[p26l1951t1001r2013b1058],
7	advanced	JJ	O	advanced	prep_in	5	SENT_1056	[p26l2049t1001r2147b1058, p26l757t1081r989b1139],

1	head	NN	O	head	nn	4	SENT_1057	[p26l1019t1081r1174b1139],
2	and	CC	O	and	_	0	SENT_1057	[p26l1205t1081r1320b1139],
3	neck	NN	O	neck	nn	4	SENT_1057	[p26l1350t1081r1506b1139],
4	cancer	NN	O	cancer	_	0	SENT_1057	[p26l1534t1099r1764b1139],
5	:	:	O	:	_	0	SENT_1057	[p26l1534t1099r1764b1139],
6	an	DT	O	a	det	7	SENT_1057	[p26l1800t1099r1874b1139],
7	Eastern	NNP	MISC	Eastern	dep	4	SENT_1057	[p26l1905t1083r2149b1139],

1	Cooperative	NNP	O	Cooperative	nn	4	SENT_1058	[p26l758t1163r1155b1237],
2	Oncology	NNP	O	Oncology	nn	4	SENT_1058	[p26l1254t1163r1574b1237],
3	Group	NNP	O	Group	nn	4	SENT_1058	[p26l1672t1163r1878b1237],
4	Trial	NNP	O	Trial	_	0	SENT_1058	[p26l1976t1163r2145b1220],
5	.	.	O	.	_	0	SENT_1058	[p26l1976t1163r2145b1220],

1	Monogic	NNP	O	Monogic	nn	4	SENT_1059	[p26l754t1247r1024b1319],
2	Natl.	NNP	O	Natl.	nn	4	SENT_1059	[p26l1050t1245r1203b1303],
3	Cancer	NNP	O	Cancer	nn	4	SENT_1059	[p26l1238t1246r1476b1303],
4	Inst	NNP	O	Inst	_	0	SENT_1059	[p26l1494t1247r1630b1303],
5	.	.	O	.	_	0	SENT_1059	[p26l1494t1247r1630b1303],

1	l5	NN	O	l5	_	0	SENT_1060	[p26l1667t1245r2007b1303],
2	:	:	O	:	_	0	SENT_1060	[p26l1667t1245r2007b1303],
3	l8l	NN	O	l8l	dep	1	SENT_1060	[p26l1667t1245r2007b1303],
4	—	CD	NUMBER	—	number	5	SENT_1060	[p26l1667t1245r2007b1303],
5	84	CD	NUMBER	84	dep	3	SENT_1060	[p26l1667t1245r2007b1303],

1	97	CD	NUMBER	97	_	0	SENT_1061	[p26l623t1327r719b1385],
2	.	.	O	.	_	0	SENT_1061	[p26l623t1327r719b1385],

1	Au	NN	O	au	nn	2	SENT_1062	[p26l757t1327r855b1384],
2	E	NN	O	e	_	0	SENT_1062	[p26l874t1328r940b1395],
3	,	,	O	,	_	0	SENT_1062	[p26l874t1328r940b1395],
4	Ang	NNP	O	Ang	nn	5	SENT_1062	[p26l960t1327r1099b1402],
5	PT	NN	O	pt	appos	2	SENT_1062	[p26l1118t1328r1222b1395],
6	,	,	O	,	_	0	SENT_1062	[p26l1118t1328r1222b1395],
7	Chua	NNP	O	Chua	nn	8	SENT_1062	[p26l1244t1326r1416b1385],
8	EJ	NNP	O	EJ	appos	5	SENT_1062	[p26l1431t1328r1529b1385],
9	.	.	O	.	_	0	SENT_1062	[p26l1431t1328r1529b1385],

1	1996	CD	DATE	1996	_	0	SENT_1063	[p26l1558t1326r1728b1385],
2	.	.	O	.	_	0	SENT_1063	[p26l1558t1326r1728b1385],

1	Paclitaxel	NN	O	paclitaxel	_	0	SENT_1064	[p26l1750t1326r2070b1384],
2	in	IN	O	in	_	0	SENT_1064	[p26l2087t1326r2150b1383],
3	metastatic	JJ	O	metastatic	amod	5	SENT_1064	[p26l757t1408r1086b1465],
4	nasopharyngeal	NN	O	nasopharyngeal	nn	5	SENT_1064	[p26l1136t1408r1649b1482],
5	cancer	NN	O	cancer	prep_in	1	SENT_1064	[p26l1698t1426r1921b1465],
6	.	.	O	.	_	0	SENT_1064	[p26l1698t1426r1921b1465],

1	Proc	NNP	O	Proc	_	0	SENT_1065	[p26l1972t1410r2142b1465],
2	.	.	O	.	_	0	SENT_1065	[p26l1972t1410r2142b1465],

1	Am	NNP	O	Am	_	0	SENT_1066	[p26l751t1492r878b1548],
2	.	.	O	.	_	0	SENT_1066	[p26l751t1492r878b1548],

1	Soc	NN	O	soc	_	0	SENT_1067	[p26l908t1492r1037b1549],
2	.	.	O	.	_	0	SENT_1067	[p26l908t1492r1037b1549],

1	Clin	NNP	O	Clin	_	0	SENT_1068	[p26l1072t1491r1218b1549],
2	.	.	O	.	_	0	SENT_1068	[p26l1072t1491r1218b1549],

1	Oncol	NN	O	oncol	_	0	SENT_1069	[p26l1252t1491r1460b1549],
2	.	.	O	.	_	0	SENT_1069	[p26l1252t1491r1460b1549],

1	l5	NN	O	l5	_	0	SENT_1070	[p26l1497t1491r1714b1549],
2	:332	CD	NUMBER	:332	number	3	SENT_1070	[p26l1497t1491r1714b1549],
3	(	CD	NUMBER	(	dep	1	SENT_1070	[p26l1739t1491r1985b1562],
4	Abstr	NNP	O	Abstr	nn	6	SENT_1070	[p26l1739t1491r1985b1562],
5	.	.	O	.	_	0	SENT_1070	[p26l1739t1491r1985b1562],
6	)	NN	O	)	dep	3	SENT_1070	[p26l1739t1491r1985b1562],

1	98	CD	NUMBER	98	_	0	SENT_1071	[p26l623t1574r719b1632],
2	.	.	O	.	_	0	SENT_1071	[p26l623t1574r719b1632],

1	Catimel	NNP	O	Catimel	nn	2	SENT_1072	[p26l758t1574r1015b1631],
2	G	NNP	O	G	_	0	SENT_1072	[p26l1047t1574r1120b1642],
3	,	,	O	,	_	0	SENT_1072	[p26l1047t1574r1120b1642],
4	Verweij	NNP	O	Verweij	nn	5	SENT_1072	[p26l1154t1574r1402b1649],
5	J	NNP	O	J	appos	2	SENT_1072	[p26l1436t1575r1484b1642],
6	,	,	O	,	_	0	SENT_1072	[p26l1436t1575r1484b1642],
7	Mattijssen	NNP	O	Mattijssen	nn	8	SENT_1072	[p26l1518t1574r1858b1649],
8	V	NNP	O	V	appos	2	SENT_1072	[p26l1888t1575r1951b1641],
9	,	,	O	,	_	0	SENT_1072	[p26l1888t1575r1951b1641],
10	et	FW	O	et	nn	11	SENT_1072	[p26l1986t1582r2043b1631],
11	al.	FW	O	al.	appos	2	SENT_1072	[p26l2074t1574r2146b1631],
12	1994	CD	DATE	1994	dep	11	SENT_1072	[p26l765t1657r935b1715],
13	.	.	O	.	_	0	SENT_1072	[p26l765t1657r935b1715],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_1073	[p26l960t1656r1292b1714],
2	(	CD	NUMBER	(	num	1	SENT_1073	[p26l1314t1657r1667b1727],
3	TaXotere	NNP	O	TaXotere	dep	1	SENT_1073	[p26l1314t1657r1667b1727],
4	)	CD	NUMBER	)	num	3	SENT_1073	[p26l1314t1657r1667b1727],
5	:	:	O	:	_	0	SENT_1073	[p26l1314t1657r1667b1727],
6	an	DT	O	a	det	8	SENT_1073	[p26l1693t1674r1768b1714],
7	active	JJ	O	active	amod	8	SENT_1073	[p26l1790t1656r1981b1714],
8	drug	NN	O	drug	dep	1	SENT_1073	[p26l2002t1656r2148b1731],
9	for	IN	O	for	_	0	SENT_1073	[p26l757t1739r853b1796],
10	the	DT	O	the	det	11	SENT_1073	[p26l872t1739r969b1796],
11	treatment	NN	O	treatment	prep_for	8	SENT_1073	[p26l990t1747r1299b1796],
12	of	IN	O	of	_	0	SENT_1073	[p26l1319t1739r1390b1796],
13	patients	NNS	O	patient	prep_of	11	SENT_1073	[p26l1404t1739r1655b1814],
14	with	IN	O	with	_	0	SENT_1073	[p26l1678t1739r1821b1796],
15	advanced	JJ	O	advanced	amod	18	SENT_1073	[p26l1843t1739r2151b1796],
16	squamous	JJ	O	squamous	amod	18	SENT_1073	[p26l760t1839r1081b1896],
17	cell	NN	O	cell	nn	18	SENT_1073	[p26l1114t1821r1231b1879],
18	carcinoma	NN	O	carcinoma	prep_with	13	SENT_1073	[p26l1259t1821r1600b1879],
19	of	IN	O	of	_	0	SENT_1073	[p26l1629t1821r1700b1879],
20	the	DT	O	the	det	21	SENT_1073	[p26l1723t1821r1820b1879],
21	head	NN	O	head	prep_of	18	SENT_1073	[p26l1849t1821r2005b1879],
22	and	CC	O	and	_	0	SENT_1073	[p26l2034t1821r2150b1879],
23	neck	NN	O	neck	prep_of	18	SENT_1073	[p26l757t1905r926b1962],
24	.	.	O	.	_	0	SENT_1073	[p26l757t1905r926b1962],

1	Ann	NNP	PERSON	Ann	_	0	SENT_1074	[p26l947t1905r1096b1962],
2	.	.	O	.	_	0	SENT_1074	[p26l947t1905r1096b1962],

1	Oncol	NN	O	oncol	_	0	SENT_1075	[p26l1130t1905r1338b1963],
2	.	.	O	.	_	0	SENT_1075	[p26l1130t1905r1338b1963],

1	5:533	CD	NUMBER	5:533	_	0	SENT_1076	[p26l1368t1904r1672b1962],
2	—	CD	NUMBER	—	num	3	SENT_1076	[p26l1368t1904r1672b1962],
3	37	CD	NUMBER	37	dep	1	SENT_1076	[p26l1368t1904r1672b1962],

1	99	CD	NUMBER	99	_	0	SENT_1077	[p26l623t1988r719b2045],
2	.	.	O	.	_	0	SENT_1077	[p26l623t1988r719b2045],

1	Dreyfuss	NNP	PERSON	Dreyfuss	nn	2	SENT_1078	[p26l757t1987r1050b2062],
2	A	NNP	O	A	_	0	SENT_1078	[p26l1069t1988r1144b2055],
3	,	,	O	,	_	0	SENT_1078	[p26l1069t1988r1144b2055],
4	Clark	NNP	PERSON	Clark	nn	5	SENT_1078	[p26l1165t1987r1346b2045],
5	J	NNP	PERSON	J	appos	2	SENT_1078	[p26l1360t1989r1408b2055],
6	,	,	O	,	_	0	SENT_1078	[p26l1360t1989r1408b2055],
7	Norris	NNP	PERSON	Norris	nn	8	SENT_1078	[p26l1428t1987r1634b2045],
8	CN	NN	O	cn	appos	2	SENT_1078	[p26l1652t1988r1782b2055],
9	,	,	O	,	_	0	SENT_1078	[p26l1652t1988r1782b2055],
10	et	FW	O	et	nn	11	SENT_1078	[p26l1801t1996r1859b2045],
11	al.	FW	O	al.	appos	2	SENT_1078	[p26l1875t1987r1947b2045],
12	1996	CD	DATE	1996	dep	11	SENT_1078	[p26l1975t1987r2145b2046],
13	.	.	O	.	_	0	SENT_1078	[p26l1975t1987r2145b2046],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_1079	[p26l757t2069r1088b2127],
2	(	CD	NUMBER	(	num	1	SENT_1079	[p26l1161t2070r1515b2140],
3	TaXotere	NNP	O	TaXotere	dep	1	SENT_1079	[p26l1161t2070r1515b2140],
4	)	CD	NUMBER	)	num	3	SENT_1079	[p26l1161t2070r1515b2140],
5	:	:	O	:	_	0	SENT_1079	[p26l1161t2070r1515b2140],
6	an	DT	O	a	det	8	SENT_1079	[p26l1592t2087r1666b2127],
7	active	JJ	O	active	amod	8	SENT_1079	[p26l1739t2069r1930b2127],
8	drug	NN	O	drug	dep	1	SENT_1079	[p26l2002t2069r2148b2144],
9	against	IN	O	against	_	0	SENT_1079	[p26l759t2152r989b2227],
10	squamous	JJ	O	squamous	amod	12	SENT_1079	[p26l1034t2170r1355b2227],
11	cell	NN	O	cell	nn	12	SENT_1079	[p26l1402t2152r1517b2210],
12	carcinoma	NN	O	carcinoma	prep_against	8	SENT_1079	[p26l1560t2152r1901b2210],
13	of	IN	O	of	_	0	SENT_1079	[p26l1944t2152r2015b2210],
14	the	DT	O	the	det	15	SENT_1079	[p26l2051t2152r2149b2210],
15	head	NN	O	head	prep_of	12	SENT_1079	[p26l757t2234r911b2292],
16	and	CC	O	and	_	0	SENT_1079	[p26l933t2234r1049b2292],
17	neck	NN	O	neck	prep_of	12	SENT_1079	[p26l1068t2234r1239b2292],
18	.	.	O	.	_	0	SENT_1079	[p26l1068t2234r1239b2292],

1	J.	NNP	PERSON	J.	nn	2	SENT_1080	[p26l1262t2237r1311b2293],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1080	[p26l1344t2234r1491b2293],
3	.	.	O	.	_	0	SENT_1080	[p26l1344t2234r1491b2293],

1	Oncol	NN	O	oncol	_	0	SENT_1081	[p26l1523t2234r1731b2293],
2	.	.	O	.	_	0	SENT_1081	[p26l1523t2234r1731b2293],

1	l4	NN	O	l4	_	0	SENT_1082	[p26l1768t2234r2146b2293],
2	:	:	O	:	_	0	SENT_1082	[p26l1768t2234r2146b2293],
3	l672	NN	O	l672	nn	4	SENT_1082	[p26l1768t2234r2146b2293],
4	—	NN	O	—	dep	1	SENT_1082	[p26l1768t2234r2146b2293],
5	78	CD	NUMBER	78	dep	4	SENT_1082	[p26l1768t2234r2146b2293],

1	loO	NN	O	loo	_	0	SENT_1083	[p26l611t2318r1051b2376],
2	.	.	O	.	_	0	SENT_1083	[p26l611t2318r1051b2376],

1	Bedikian	JJ	MISC	bedikian	amod	2	SENT_1084	[p26l611t2318r1051b2376],
2	AY	NN	MISC	ay	_	0	SENT_1084	[p26l1080t2319r1196b2386],
3	,	,	O	,	_	0	SENT_1084	[p26l1080t2319r1196b2386],
4	Weiss	NNP	PERSON	Weiss	nn	5	SENT_1084	[p26l1227t2318r1418b2376],
5	GR	NN	O	gr	appos	2	SENT_1084	[p26l1451t2318r1579b2386],
6	,	,	O	,	_	0	SENT_1084	[p26l1451t2318r1579b2386],
7	Legha	NNP	O	Legha	nn	8	SENT_1084	[p26l1611t2318r1816b2392],
8	SS	NNP	O	SS	appos	2	SENT_1084	[p26l1848t2318r1953b2386],
9	,	,	O	,	_	0	SENT_1084	[p26l1848t2318r1953b2386],
10	et	FW	O	et	nn	11	SENT_1084	[p26l1986t2326r2044b2376],
11	al.	FW	O	al.	appos	2	SENT_1084	[p26l2074t2318r2146b2376],
12	1995	CD	DATE	1995	dep	11	SENT_1084	[p26l765t2399r935b2458],
13	.	.	O	.	_	0	SENT_1084	[p26l765t2399r935b2458],

1	Phase	NN	O	phase	nn	3	SENT_1085	[p26l960t2400r1150b2458],
2	II	CD	NUMBER	ii	num	3	SENT_1085	[p26l1172t2401r1225b2457],
3	trial	NN	O	trial	_	0	SENT_1085	[p26l1246t2399r1375b2458],
4	of	IN	O	of	_	0	SENT_1085	[p26l1397t2399r1468b2458],
5	docetaxel	NN	O	docetaxel	prep_of	3	SENT_1085	[p26l1484t2399r1796b2458],
6	in	IN	O	in	_	0	SENT_1085	[p26l1816t2399r1878b2457],
7	patients	NNS	O	patient	prep_in	3	SENT_1085	[p26l1896t2399r2147b2474],
8	with	IN	O	with	_	0	SENT_1085	[p26l758t2482r901b2540],
9	advanced	JJ	O	advanced	amod	11	SENT_1085	[p26l939t2482r1247b2540],
10	cutaneous	JJ	O	cutaneous	amod	11	SENT_1085	[p26l1282t2491r1605b2540],
11	melanoma	NN	O	melanoma	prep_with	7	SENT_1085	[p26l1643t2482r1985b2540],
12	previously	RB	DATE	previously	advmod	13	SENT_1085	[p26l2018t2501r2147b2557, p26l757t2565r996b2640],
13	untreated	JJ	O	untreated	amod	11	SENT_1085	[p26l1040t2565r1344b2623],
14	with	IN	O	with	_	0	SENT_1085	[p26l1387t2565r1531b2623],
15	chemotherapy	NN	O	chemotherapy	prep_with	3	SENT_1085	[p26l1574t2565r2047b2640],
16	.	.	O	.	_	0	SENT_1085	[p26l1574t2565r2047b2640],

1	J.	NNP	PERSON	J.	nn	2	SENT_1086	[p26l2092t2568r2141b2624],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1086	[p26l761t2648r908b2707],
3	.	.	O	.	_	0	SENT_1086	[p26l761t2648r908b2707],

1	Oncol	NN	O	oncol	_	0	SENT_1087	[p26l942t2648r1150b2707],
2	.	.	O	.	_	0	SENT_1087	[p26l942t2648r1150b2707],

1	l3	NN	O	l3	_	0	SENT_1088	[p26l1187t2648r1567b2707],
2	:	:	O	:	_	0	SENT_1088	[p26l1187t2648r1567b2707],
3	l895	CD	NUMBER	l895	dep	1	SENT_1088	[p26l1187t2648r1567b2707],
4	—	CD	NUMBER	—	number	5	SENT_1088	[p26l1187t2648r1567b2707],
5	99	CD	NUMBER	99	dep	3	SENT_1088	[p26l1187t2648r1567b2707],

1	lOl	NN	O	lol	_	0	SENT_1089	[p26l611t2730r1016b2789],
2	.	.	O	.	_	0	SENT_1089	[p26l611t2730r1016b2789],

1	Aamdal	JJ	O	aamdal	amod	2	SENT_1090	[p26l611t2730r1016b2789],
2	S	NN	O	s	_	0	SENT_1090	[p26l1045t2731r1104b2799],
3	,	,	O	,	_	0	SENT_1090	[p26l1045t2731r1104b2799],
4	Wolff	NNP	PERSON	Wolff	appos	2	SENT_1090	[p26l1134t2730r1326b2789],
5	1	CD	NUMBER	1	num	4	SENT_1090	[p26l1348t2732r1391b2799],
6	,	,	O	,	_	0	SENT_1090	[p26l1348t2732r1391b2799],
7	Kaplan	NNP	PERSON	Kaplan	nn	8	SENT_1090	[p26l1423t2730r1658b2805],
8	S	NNP	O	S	appos	2	SENT_1090	[p26l1687t2731r1747b2799],
9	,	,	O	,	_	0	SENT_1090	[p26l1687t2731r1747b2799],
10	et	FW	O	et	nn	11	SENT_1090	[p26l1778t2739r1836b2788],
11	al.	FW	O	al.	appos	2	SENT_1090	[p26l1864t2730r1936b2788],
12	1994	CD	DATE	1994	dep	11	SENT_1090	[p26l1975t2731r2145b2789],
13	.	.	O	.	_	0	SENT_1090	[p26l1975t2731r2145b2789],

1	Docetaxel	NNP	O	Docetaxel	nn	3	SENT_1091	[p26l757t2813r1088b2870],
2	(	NNP	O	(	nn	3	SENT_1091	[p26l1126t2813r1460b2884],
3	Taxotere	NNP	O	Taxotere	_	0	SENT_1091	[p26l1126t2813r1460b2884],
4	)	NN	O	)	dep	3	SENT_1091	[p26l1126t2813r1460b2884],
5	in	IN	O	in	_	0	SENT_1091	[p26l1498t2813r1560b2870],
6	advanced	JJ	O	advanced	amod	8	SENT_1091	[p26l1596t2813r1904b2870],
7	malignant	JJ	O	malignant	amod	8	SENT_1091	[p26l1938t2813r2147b2888, p26l757t2904r897b2953],
8	melanoma	NN	O	melanoma	prep_in	4	SENT_1091	[p26l937t2895r1294b2953],
9	:	:	O	:	_	0	SENT_1091	[p26l937t2895r1294b2953],
10	a	DT	O	a	det	13	SENT_1091	[p26l1340t2913r1374b2953],
11	phase	NN	O	phase	nn	13	SENT_1091	[p26l1412t2896r1598b2970],
12	II	CD	NUMBER	ii	num	13	SENT_1091	[p26l1637t2897r1690b2952],
13	study	NN	O	study	dep	4	SENT_1091	[p26l1733t2895r1905b2970],
14	of	IN	O	of	_	0	SENT_1091	[p26l1946t2895r2017b2953],
15	the	DT	O	the	det	17	SENT_1091	[p26l2051t2895r2148b2953],
16	EORTC	NNP	O	EORTC	nn	17	SENT_1091	[p26l757t2979r1018b3036],
17	Early	NNP	O	Early	prep_of	13	SENT_1091	[p26l1035t2979r1211b3054],
18	Clinical	JJ	O	clinical	amod	19	SENT_1091	[p26l1228t2979r1484b3036],
19	Trials	NNPS	O	Trials	dep	3	SENT_1091	[p26l1500t2979r1684b3036],
20	Group	NNP	O	Group	dep	19	SENT_1091	[p26l1703t2979r1926b3054],
21	.	.	O	.	_	0	SENT_1091	[p26l1703t2979r1926b3054],

1	Eur	NNP	O	Eur	_	0	SENT_1092	[p26l1945t2981r2070b3036],
2	.	.	O	.	_	0	SENT_1092	[p26l1945t2981r2070b3036],

1	J.	NNP	O	J.	nn	3	SENT_1093	[p26l2092t2981r2141b3037],
2	Cancer	NNP	O	Cancer	nn	3	SENT_1093	[p26l761t3062r1000b3119],
3	30A	NNP	O	30A	_	0	SENT_1093	[p26l1022t3062r1176b3119],
4	:	:	O	:	_	0	SENT_1093	[p26l1022t3062r1176b3119],
5	1061-64	CD	NUMBER	1061-64	dep	3	SENT_1093	[p26l1192t3061r1468b3119],

1	l02	NN	O	l02	_	0	SENT_1094	[p26l611t3143r973b3201],
2	.	.	O	.	_	0	SENT_1094	[p26l611t3143r973b3201],

1	G1antz	NNP	O	G1antz	nn	2	SENT_1095	[p26l611t3143r973b3201],
2	MJ	NNP	O	MJ	_	0	SENT_1095	[p26l1014t3144r1135b3211],
3	,	,	O	,	_	0	SENT_1095	[p26l1014t3144r1135b3211],
4	Choy	NNP	PERSON	Choy	nn	5	SENT_1095	[p26l1181t3143r1355b3217],
5	H	NNP	PERSON	H	appos	2	SENT_1095	[p26l1396t3144r1470b3211],
6	,	,	O	,	_	0	SENT_1095	[p26l1396t3144r1470b3211],
7	Keams	NNP	ORGANIZATION	Keams	nn	8	SENT_1095	[p26l1516t3145r1744b3201],
8	CM	NN	ORGANIZATION	cm	appos	2	SENT_1095	[p26l1787t3144r1930b3211],
9	,	,	O	,	_	0	SENT_1095	[p26l1787t3144r1930b3211],
10	et	FW	O	et	nn	11	SENT_1095	[p26l1975t3151r2033b3201],
11	al.	FW	O	al.	appos	2	SENT_1095	[p26l2074t3143r2146b3201],
12	1996	CD	DATE	1996	dep	11	SENT_1095	[p26l765t3226r935b3285],
13	.	.	O	.	_	0	SENT_1095	[p26l765t3226r935b3285],

1	Phase	NN	O	phase	nn	3	SENT_1096	[p26l971t3226r1162b3284],
2	I	CD	NUMBER	i	num	3	SENT_1096	[p26l1195t3228r1220b3283],
3	study	NN	O	study	_	0	SENT_1096	[p26l1255t3226r1427b3301],
4	of	IN	O	of	_	0	SENT_1096	[p26l1461t3226r1532b3284],
5	weekly	JJ	SET	weekly	amod	7	SENT_1096	[p26l1559t3226r1793b3301],
6	outpatient	NN	O	outpatient	nn	7	SENT_1096	[p26l1826t3226r2151b3301],
7	paclitaxel	NN	O	paclitaxel	prep_of	3	SENT_1096	[p26l756t3309r1073b3383],
8	and	CC	O	and	_	0	SENT_1096	[p26l1113t3309r1230b3366],
9	concurrent	JJ	O	concurrent	amod	11	SENT_1096	[p26l1266t3317r1615b3366],
10	cranial	JJ	O	cranial	amod	11	SENT_1096	[p26l1653t3309r1873b3366],
11	irradiation	NN	O	irradiation	prep_of	3	SENT_1096	[p26l1911t3309r2147b3366, p26l757t3391r882b3449],
12	in	IN	O	in	_	0	SENT_1096	[p26l916t3391r978b3448],
13	adults	NNS	O	adult	prep_in	3	SENT_1096	[p26l1013t3391r1203b3449],
14	with	IN	O	with	_	0	SENT_1096	[p26l1240t3391r1383b3449],
15	astrocytomas	NNS	O	astrocytoma	prep_with	13	SENT_1096	[p26l1418t3400r1864b3466],
16	.	.	O	.	_	0	SENT_1096	[p26l1418t3400r1864b3466],

1	J.	NNP	PERSON	J.	nn	2	SENT_1097	[p26l1899t3393r1949b3450],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1097	[p26l1995t3391r2141b3450],
3	.	.	O	.	_	0	SENT_1097	[p26l1995t3391r2141b3450],

1	Oncol	NN	O	oncol	_	0	SENT_1098	[p26l761t3474r968b3532],
2	.	.	O	.	_	0	SENT_1098	[p26l761t3474r968b3532],

1	l4	NN	O	l4	_	0	SENT_1099	[p26l1006t3473r1304b3532],
2	:600	CD	NUMBER	:600	number	3	SENT_1099	[p26l1006t3473r1304b3532],
3	—	CD	NUMBER	—	dep	1	SENT_1099	[p26l1006t3473r1304b3532],
4	9	CD	NUMBER	9	dep	3	SENT_1099	[p26l1006t3473r1304b3532],

1	103	CD	NUMBER	103	_	0	SENT_1100	[p27l610t22r1144b80],
2	.	.	O	.	_	0	SENT_1100	[p27l610t22r1144b80],

1	Abbruzzese	NNP	PERSON	Abbruzzese	nn	2	SENT_1101	[p27l610t22r1144b80],
2	JL	NNP	O	JL	_	0	SENT_1101	[p27l1171t24r1269b91],
3	,	,	O	,	_	0	SENT_1101	[p27l1171t24r1269b91],
4	Evans	NNP	PERSON	Evans	nn	5	SENT_1101	[p27l1300t24r1497b80],
5	D	NNP	O	D	appos	2	SENT_1101	[p27l1527t24r1602b91],
6	,	,	O	,	_	0	SENT_1101	[p27l1527t24r1602b91],
7	Gravel	NNP	O	Gravel	nn	8	SENT_1101	[p27l1635t22r1855b80],
8	D	NNP	O	D	appos	2	SENT_1101	[p27l1882t24r1957b91],
9	,	,	O	,	_	0	SENT_1101	[p27l1882t24r1957b91],
10	et	FW	O	et	nn	11	SENT_1101	[p27l1988t31r2046b80],
11	al.	FW	O	al.	appos	2	SENT_1101	[p27l2074t22r2146b80],
12	1995	CD	DATE	1995	dep	11	SENT_1101	[p27l765t106r935b164],
13	.	.	O	.	_	0	SENT_1101	[p27l765t106r935b164],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_1102	[p27l961t105r1310b174],
2	,	,	O	,	_	0	SENT_1102	[p27l961t105r1310b174],
3	a	DT	O	a	det	6	SENT_1102	[p27l1336t124r1370b163],
4	potentially	RB	O	potentially	advmod	5	SENT_1102	[p27l1389t105r1736b180],
5	active	JJ	O	active	amod	6	SENT_1102	[p27l1761t105r1952b163],
6	agent	NN	O	agent	appos	1	SENT_1102	[p27l1976t114r2151b180],
7	for	IN	O	for	_	0	SENT_1102	[p27l757t188r853b246],
8	patients	NNS	O	patient	prep_for	6	SENT_1102	[p27l897t188r1148b263],
9	with	IN	O	with	_	0	SENT_1102	[p27l1198t188r1341b246],
10	pancreatic	JJ	O	pancreatic	amod	13	SENT_1102	[p27l1387t188r1721b263],
11	adenocarci	JJ	O	adenocarci	amod	13	SENT_1102	[p27l1770t188r2147b246],
12	—	NN	O	—	nn	13	SENT_1102	[p27l1770t188r2147b246],
13	noma	NN	O	noma	prep_with	8	SENT_1102	[p27l757t289r954b329],
14	.	.	O	.	_	0	SENT_1102	[p27l757t289r954b329],

1	Proc	NNP	O	Proc	_	0	SENT_1103	[p27l981t273r1151b329],
2	.	.	O	.	_	0	SENT_1103	[p27l981t273r1151b329],

1	Am	NNP	O	Am	_	0	SENT_1104	[p27l1178t272r1304b329],
2	.	.	O	.	_	0	SENT_1104	[p27l1178t272r1304b329],

1	Soc	NN	O	soc	_	0	SENT_1105	[p27l1336t272r1465b329],
2	.	.	O	.	_	0	SENT_1105	[p27l1336t272r1465b329],

1	Clin	NNP	O	Clin	_	0	SENT_1106	[p27l1502t270r1648b329],
2	.	.	O	.	_	0	SENT_1106	[p27l1502t270r1648b329],

1	Oncol	NN	O	oncol	_	0	SENT_1107	[p27l1684t270r1892b329],
2	.	.	O	.	_	0	SENT_1107	[p27l1684t270r1892b329],

1	14:221	CD	NUMBER	14:221	_	0	SENT_1108	[p27l1931t271r2142b329],

1	(	NN	O	(	nn	2	SENT_1109	[p27l760t353r1005b424],
2	Abstr	NN	O	abstr	_	0	SENT_1109	[p27l760t353r1005b424],
3	.	.	O	.	_	0	SENT_1109	[p27l760t353r1005b424],
4	)	SYM	O	)	dep	2	SENT_1109	[p27l760t353r1005b424],

1	104	CD	NUMBER	104	_	0	SENT_1110	[p27l610t436r740b494],
2	.	.	O	.	_	0	SENT_1110	[p27l610t436r740b494],

1	Ducreux	NN	O	ducreux	nn	2	SENT_1111	[p27l757t437r1038b494],
2	M	NN	O	m	_	0	SENT_1111	[p27l1054t437r1144b504],
3	,	,	O	,	_	0	SENT_1111	[p27l1054t437r1144b504],
4	Adenis	NNP	O	Adenis	nn	5	SENT_1111	[p27l1164t435r1392b494],
5	A	NNP	O	A	appos	2	SENT_1111	[p27l1410t436r1485b504],
6	,	,	O	,	_	0	SENT_1111	[p27l1410t436r1485b504],
7	Blanc	NNP	PERSON	Blanc	nn	8	SENT_1111	[p27l1506t436r1694b494],
8	C	NNP	O	C	appos	2	SENT_1111	[p27l1712t436r1781b504],
9	,	,	O	,	_	0	SENT_1111	[p27l1712t436r1781b504],
10	et	FW	O	et	nn	11	SENT_1111	[p27l1801t445r1859b494],
11	al.	FW	O	al.	appos	2	SENT_1111	[p27l1875t435r1947b494],
12	1994	CD	DATE	1994	dep	11	SENT_1111	[p27l1975t436r2145b495],
13	.	.	O	.	_	0	SENT_1111	[p27l1975t436r2145b495],

1	Phase	NN	O	phase	nn	3	SENT_1112	[p27l757t518r947b576],
2	II	CD	NUMBER	ii	num	3	SENT_1112	[p27l981t520r1034b575],
3	study	NN	O	study	_	0	SENT_1112	[p27l1070t518r1242b593],
4	of	IN	O	of	_	0	SENT_1112	[p27l1278t518r1349b576],
5	docetaxel	NN	O	docetaxel	prep_of	3	SENT_1112	[p27l1376t518r1687b576],
6	in	IN	O	in	_	0	SENT_1112	[p27l1720t518r1782b575],
7	pancreatic	JJ	O	pancreatic	amod	8	SENT_1112	[p27l1813t518r2147b593],
8	adenocarcinoma	NN	O	adenocarcinoma	prep_in	3	SENT_1112	[p27l759t601r1309b659],
9	.	.	O	.	_	0	SENT_1112	[p27l759t601r1309b659],

1	Ann	NNP	PERSON	Ann	_	0	SENT_1113	[p27l1333t602r1482b659],
2	.	.	O	.	_	0	SENT_1113	[p27l1333t602r1482b659],

1	Oncol	NN	O	oncol	_	0	SENT_1114	[p27l1518t601r1726b660],
2	.	.	O	.	_	0	SENT_1114	[p27l1518t601r1726b660],

1	5	CD	NUMBER	5	num	2	SENT_1115	[p27l1759t601r2031b676],
2	(	CD	NUMBER	(	_	0	SENT_1115	[p27l1759t601r2031b676],
3	Supp1	NN	O	supp1	dep	2	SENT_1115	[p27l1759t601r2031b676],
4	.	.	O	.	_	0	SENT_1115	[p27l1759t601r2031b676],

1	8	CD	NUMBER	8	num	2	SENT_1116	[p27l2064t602r2144b673],
2	)	NN	O	)	_	0	SENT_1116	[p27l2064t602r2144b673],
3	:	:	O	:	_	0	SENT_1116	[p27l2064t602r2144b673],
4	406	CD	NUMBER	406	number	5	SENT_1116	[p27l757t683r877b741],
5	(	CD	NUMBER	(	dep	2	SENT_1116	[p27l903t683r1149b755],
6	Abstr	NNP	O	Abstr	nn	8	SENT_1116	[p27l903t683r1149b755],
7	.	.	O	.	_	0	SENT_1116	[p27l903t683r1149b755],
8	)	NN	O	)	dep	5	SENT_1116	[p27l903t683r1149b755],

1	105	CD	NUMBER	105	_	0	SENT_1117	[p27l610t766r973b825],
2	.	.	O	.	_	0	SENT_1117	[p27l610t766r973b825],

1	Sulkes	NNP	O	Sulkes	nn	2	SENT_1118	[p27l610t766r973b825],
2	A	NNP	O	A	_	0	SENT_1118	[p27l1007t767r1082b835],
3	,	,	O	,	_	0	SENT_1118	[p27l1007t767r1082b835],
4	Smyth	NNP	PERSON	Smyth	nn	5	SENT_1118	[p27l1120t766r1331b842],
5	J	NNP	PERSON	J	appos	2	SENT_1118	[p27l1362t768r1411b835],
6	,	,	O	,	_	0	SENT_1118	[p27l1362t768r1411b835],
7	Sessa	NNP	PERSON	Sessa	nn	8	SENT_1118	[p27l1449t767r1630b825],
8	C	NNP	O	C	appos	2	SENT_1118	[p27l1662t767r1732b835],
9	,	,	O	,	_	0	SENT_1118	[p27l1662t767r1732b835],
10	et	FW	O	et	nn	11	SENT_1118	[p27l1769t775r1826b825],
11	al.	FW	O	al.	appos	2	SENT_1118	[p27l1859t766r1930b825],
12	1994	CD	DATE	1994	dep	11	SENT_1118	[p27l1975t767r2145b826],
13	.	.	O	.	_	0	SENT_1118	[p27l1975t767r2145b826],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_1119	[p27l757t848r1088b905],
2	in	IN	O	in	_	0	SENT_1119	[p27l1118t848r1180b905],
3	advanced	JJ	O	advanced	amod	5	SENT_1119	[p27l1211t848r1519b905],
4	gastric	JJ	O	gastric	amod	5	SENT_1119	[p27l1549t848r1763b922],
5	cancer	NN	O	cancer	prep_in	1	SENT_1119	[p27l1796t866r2026b905],
6	:	:	O	:	_	0	SENT_1119	[p27l1796t866r2026b905],
7	results	NNS	O	result	dep	1	SENT_1119	[p27l2059t866r2147b905, p27l760t930r904b988],
8	of	IN	O	of	_	0	SENT_1119	[p27l921t930r993b988],
9	a	DT	O	a	det	10	SENT_1119	[p27l1003t948r1037b988],
10	phase	NN	O	phase	prep_of	7	SENT_1119	[p27l1050t930r1236b1005],
11	II	CD	NUMBER	ii	num	13	SENT_1119	[p27l1250t931r1303b987],
12	clinical	JJ	O	clinical	amod	13	SENT_1119	[p27l1319t930r1557b988],
13	trial	NN	O	trial	dep	7	SENT_1119	[p27l1570t930r1715b988],
14	.	.	O	.	_	0	SENT_1119	[p27l1570t930r1715b988],

1	Br	NN	O	br	nsubj	2	SENT_1120	[p27l1732t932r1817b988],
2	J	NN	O	j	_	0	SENT_1120	[p27l1837t932r1879b989],
3	.	.	O	.	_	0	SENT_1120	[p27l1877t978r1886b988],

1	Cancer	NN	O	cancer	_	0	SENT_1121	[p27l1913t931r2152b989],
2	702380-84	CD	NUMBER	702380-84	num	1	SENT_1121	[p27l758t1012r1104b1069],

1	106	CD	NUMBER	106	_	0	SENT_1122	[p27l611t1093r969b1167],
2	.	.	O	.	_	0	SENT_1122	[p27l611t1093r969b1167],

1	Einzig	NNP	PERSON	Einzig	nn	2	SENT_1123	[p27l611t1093r969b1167],
2	A	NNP	O	A	_	0	SENT_1123	[p27l999t1093r1074b1161],
3	,	,	O	,	_	0	SENT_1123	[p27l999t1093r1074b1161],
4	Lipsitz	NNP	PERSON	Lipsitz	nn	5	SENT_1123	[p27l1107t1093r1332b1167],
5	S	NNP	O	S	appos	2	SENT_1123	[p27l1365t1093r1424b1161],
6	,	,	O	,	_	0	SENT_1123	[p27l1365t1093r1424b1161],
7	Wiernik	NNP	O	Wiernik	nn	8	SENT_1123	[p27l1458t1093r1723b1150],
8	PH	NNP	O	PH	appos	2	SENT_1123	[p27l1751t1094r1872b1161],
9	,	,	O	,	_	0	SENT_1123	[p27l1751t1094r1872b1161],
10	Benson	NNP	ORGANIZATION	Benson	nn	11	SENT_1123	[p27l1905t1094r2150b1150],
11	AB	NNP	ORGANIZATION	AB	appos	2	SENT_1123	[p27l757t1176r886b1234],
12	.	.	O	.	_	0	SENT_1123	[p27l757t1176r886b1234],

1	1995	CD	DATE	1995	_	0	SENT_1124	[p27l939t1175r1110b1235],
2	.	.	O	.	_	0	SENT_1124	[p27l939t1175r1110b1235],

1	Phase	NN	O	phase	nn	3	SENT_1125	[p27l1157t1175r1346b1234],
2	II	CD	NUMBER	ii	num	3	SENT_1125	[p27l1389t1177r1442b1233],
3	trial	NN	O	trial	_	0	SENT_1125	[p27l1484t1175r1614b1234],
4	of	IN	O	of	_	0	SENT_1125	[p27l1656t1175r1728b1234],
5	Taxotere	NNP	O	Taxotere	prep_of	3	SENT_1125	[p27l1763t1177r2047b1234],
6	in	IN	O	in	_	0	SENT_1125	[p27l2088t1175r2150b1233],
7	patients	NNS	O	patient	prep_in	3	SENT_1125	[p27l756t1258r1008b1333],
8	with	IN	O	with	_	0	SENT_1125	[p27l1032t1258r1175b1316],
9	adenocarcinoma	NN	O	adenocarcinoma	prep_with	7	SENT_1125	[p27l1200t1258r1735b1316],
10	of	IN	O	of	_	0	SENT_1125	[p27l1757t1258r1828b1316],
11	the	DT	O	the	det	14	SENT_1125	[p27l1844t1258r1942b1316],
12	upper	JJ	O	upper	amod	14	SENT_1125	[p27l1965t1276r2152b1333],
13	gastrointestinal	JJ	O	gastrointestinal	amod	14	SENT_1125	[p27l758t1339r1255b1415],
14	tract	NN	O	tract	prep_of	9	SENT_1125	[p27l1290t1348r1436b1397],
15	previously	RB	DATE	previously	advmod	16	SENT_1125	[p27l1468t1339r1811b1414],
16	untreated	JJ	O	untreated	amod	14	SENT_1125	[p27l1846t1339r2151b1397],
17	with	IN	O	with	_	0	SENT_1125	[p27l758t1421r901b1478],
18	cytotoxic	JJ	O	cytotoxic	amod	19	SENT_1125	[p27l926t1421r1226b1495],
19	chemotherapy	NN	O	chemotherapy	prep_with	3	SENT_1125	[p27l1253t1421r1726b1495],
20	.	.	O	.	_	0	SENT_1125	[p27l1253t1421r1726b1495],

1	The	DT	O	the	det	5	SENT_1126	[p27l1755t1421r1880b1478],
2	Eastem	NNP	ORGANIZATION	Eastem	nn	5	SENT_1126	[p27l1905t1422r2150b1478],
3	Cooperative	NNP	ORGANIZATION	Cooperative	nn	5	SENT_1126	[p27l758t1502r1155b1578],
4	Oncology	NNP	ORGANIZATION	Oncology	nn	5	SENT_1126	[p27l1181t1502r1501b1578],
5	Group	NNP	ORGANIZATION	Group	_	0	SENT_1126	[p27l1527t1503r1733b1578],
6	(	CD	NUMBER	(	num	7	SENT_1126	[p27l1761t1503r2033b1574],
7	ECOG	NN	O	ecog	dep	5	SENT_1126	[p27l1761t1503r2033b1574],
8	)	CD	NUMBER	)	num	9	SENT_1126	[p27l1761t1503r2033b1574],
9	reAnnu	NN	O	reannu	dep	7	SENT_1126	[p27l2059t1521r2147b1561, p27l7t440r64b639],
10	.	.	O	.	_	0	SENT_1126	[p27l2059t1521r2147b1561, p27l7t440r64b639],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1127	[p27l8t266r64b413],
2	Med	NNP	O	Med	_	0	SENT_1127	[p27l7t73r64b240],
3	.	.	O	.	_	0	SENT_1127	[p27l7t73r64b240],

1	1	CD	NUMBER	1	_	0	SENT_1128	[p27l7t15r64b39],

1	by	IN	O	by	_	0	SENT_1129	[p27l90t474r165b555],
2	University	NNP	O	University	pobj	1	SENT_1129	[p27l89t104r165b450],
3	of	IN	O	of	_	0	SENT_1129	[p27l90t9r147b80],
4	sults	NNS	O	sult	prep_of	2	SENT_1129	[p27l214t1836r439b1915],
5	.	.	O	.	_	0	SENT_1129	[p27l214t1836r439b1915],

1	Proc	NNP	O	Proc	_	0	SENT_1130	[p27l486t1838r721b1915],
2	.	.	O	.	_	0	SENT_1130	[p27l486t1838r721b1915],

1	Am	NNP	O	Am	_	0	SENT_1131	[p27l766t1836r942b1915],
2	.	.	O	.	_	0	SENT_1131	[p27l766t1836r942b1915],

1	Soc	NN	O	soc	_	0	SENT_1132	[p27l993t1836r1173b1917],
2	.	.	O	.	_	0	SENT_1132	[p27l993t1836r1173b1917],

1	Clin	NNP	O	Clin	_	0	SENT_1133	[p27l1231t1836r1436b1917],
2	.	.	O	.	_	0	SENT_1133	[p27l1231t1836r1436b1917],

1	Oncol	NN	O	oncol	_	0	SENT_1134	[p27l1493t1836r1782b1917],
2	.	.	O	.	_	0	SENT_1134	[p27l1493t1836r1782b1917],

1	142191	CD	NUMBER	142191	_	0	SENT_1135	[p27l1844t1836r2136b1917],

1	(	NN	O	(	nn	2	SENT_1136	[p27l214t1950r556b2050],
2	Abstr	NN	O	abstr	_	0	SENT_1136	[p27l214t1950r556b2050],
3	.	.	O	.	_	0	SENT_1136	[p27l214t1950r556b2050],
4	)	SYM	O	)	dep	2	SENT_1136	[p27l214t1950r556b2050],

1	107	CD	NUMBER	107	_	0	SENT_1137	[p27l6t2066r497b2145],
2	.	.	O	.	_	0	SENT_1137	[p27l6t2066r497b2145],

1	Hudes	NNP	PERSON	Hudes	nn	2	SENT_1138	[p27l6t2066r497b2145],
2	GR	NN	O	gr	_	0	SENT_1138	[p27l540t2066r718b2160],
3	,	,	O	,	_	0	SENT_1138	[p27l540t2066r718b2160],
4	Obasaju	NNP	PERSON	Obasaju	nn	5	SENT_1138	[p27l761t2066r1131b2169],
5	C	NNP	O	C	appos	2	SENT_1138	[p27l1169t2066r1266b2160],
6	,	,	O	,	_	0	SENT_1138	[p27l1169t2066r1266b2160],
7	Chapman	NNP	PERSON	Chapman	nn	8	SENT_1138	[p27l1308t2066r1743b2169],
8	A	NNP	O	A	appos	2	SENT_1138	[p27l1777t2066r1881b2160],
9	,	,	O	,	_	0	SENT_1138	[p27l1777t2066r1881b2160],
10	et	FW	O	et	nn	11	SENT_1138	[p27l1924t2078r2003b2145],
11	al.	FW	O	al.	appos	2	SENT_1138	[p27l2041t2066r2141b2145],
12	1995	CD	DATE	1995	dep	11	SENT_1138	[p27l221t2181r458b2264],
13	.	.	O	.	_	0	SENT_1138	[p27l221t2181r458b2264],

1	Phase	NN	O	phase	nn	3	SENT_1139	[p27l509t2181r773b2262],
2	I	CD	NUMBER	i	num	3	SENT_1139	[p27l817t2184r852b2260],
3	study	NN	O	study	_	0	SENT_1139	[p27l900t2181r1139b2286],
4	of	IN	O	of	_	0	SENT_1139	[p27l1184t2181r1283b2262],
5	estramustine	NN	O	estramustine	prep_of	3	SENT_1139	[p27l1319t2181r1915b2262],
6	:	:	O	:	_	0	SENT_1139	[p27l1319t2181r1915b2262],
7	preliminary	JJ	O	preliminary	amod	8	SENT_1139	[p27l1963t2207r2143b2286, p27l211t2296r592b2399],
8	activity	NN	O	activity	dep	3	SENT_1139	[p27l676t2296r1011b2399],
9	in	IN	O	in	_	0	SENT_1139	[p27l1091t2296r1178b2375],
10	hormone-refractory	JJ	O	hormone-refractory	amod	12	SENT_1139	[p27l1255t2296r2146b2399],
11	prostate	NN	O	prostate	nn	12	SENT_1139	[p27l209t2425r570b2516],
12	cancer	NN	O	cancer	prep_in	8	SENT_1139	[p27l604t2437r914b2492],
13	.	.	O	.	_	0	SENT_1139	[p27l604t2437r914b2492],

1	Sem	NNP	O	Sem	_	0	SENT_1140	[p27l955t2414r1161b2493],
2	.	.	O	.	_	0	SENT_1140	[p27l955t2414r1161b2493],

1	Oncol	NN	O	oncol	_	0	SENT_1141	[p27l1212t2412r1500b2493],
2	.	.	O	.	_	0	SENT_1141	[p27l1212t2412r1500b2493],

1	22	CD	NUMBER	22	num	2	SENT_1142	[p27l1546t2412r1983b2516],
2	(	CD	NUMBER	(	_	0	SENT_1142	[p27l1546t2412r1983b2516],
3	Supp1	NN	O	supp1	dep	2	SENT_1142	[p27l1546t2412r1983b2516],
4	.	.	O	.	_	0	SENT_1142	[p27l1546t2412r1983b2516],

1	6	CD	NUMBER	6	num	2	SENT_1143	[p27l2025t2411r2139b2511],
2	)	NN	O	)	_	0	SENT_1143	[p27l2025t2411r2139b2511],
3	:	:	O	:	_	0	SENT_1143	[p27l2025t2411r2139b2511],
4	6-11	CD	NUMBER	6-11	dep	2	SENT_1143	[p27l213t2525r421b2606],

1	108	CD	NUMBER	108	_	0	SENT_1144	[p27l6t2643r187b2722],
2	.	.	O	.	_	0	SENT_1144	[p27l6t2643r187b2722],

1	McGuire	NNP	PERSON	McGuire	nn	2	SENT_1145	[p27l211t2641r620b2722],
2	WP	NNP	O	WP	_	0	SENT_1145	[p27l649t2644r828b2736],
3	,	,	O	,	_	0	SENT_1145	[p27l649t2644r828b2736],
4	Blessing	NN	O	blessing	nn	6	SENT_1145	[p27l862t2641r1252b2746],
5	J	NN	O	j	nn	6	SENT_1145	[p27l1281t2644r1323b2722],
6	A	NN	O	a	appos	2	SENT_1145	[p27l1326t2643r1430b2736],
7	,	,	O	,	_	0	SENT_1145	[p27l1326t2643r1430b2736],
8	Moore	NNP	PERSON	Moore	nn	9	SENT_1145	[p27l1462t2644r1765b2722],
9	D	NNP	O	D	appos	2	SENT_1145	[p27l1793t2644r1898b2736],
10	,	,	O	,	_	0	SENT_1145	[p27l1793t2644r1898b2736],
11	et	FW	O	et	nn	12	SENT_1145	[p27l1932t2654r2013b2722],
12	al.	FW	O	al.	appos	2	SENT_1145	[p27l2041t2641r2141b2722],
13	1996	CD	DATE	1996	dep	12	SENT_1145	[p27l221t2756r458b2837],
14	.	.	O	.	_	0	SENT_1145	[p27l221t2756r458b2837],

1	Paclitaxel	NN	O	paclitaxel	nsubj	2	SENT_1146	[p27l514t2756r959b2835],
2	has	VBZ	O	have	_	0	SENT_1146	[p27l1007t2756r1154b2835],
3	moderate	JJ	O	moderate	amod	4	SENT_1146	[p27l1205t2756r1628b2835],
4	activity	NN	O	activity	dobj	2	SENT_1146	[p27l1677t2756r2012b2859],
5	in	IN	O	in	_	0	SENT_1146	[p27l2061t2756r2148b2835],
6	squamous	JJ	O	squamous	amod	8	SENT_1146	[p27l214t2896r663b2975],
7	cervix	NN	O	cervix	nn	8	SENT_1146	[p27l726t2872r1009b2951],
8	cancer	NN	O	cancer	prep_in	4	SENT_1146	[p27l1069t2896r1390b2951],
9	:	:	O	:	_	0	SENT_1146	[p27l1069t2896r1390b2951],
10	a	DT	O	a	det	14	SENT_1146	[p27l1459t2896r1507b2951],
11	Gynecologic	JJ	O	gynecologic	amod	14	SENT_1146	[p27l1567t2872r2144b2975],
12	Oncology	NNP	O	Oncology	nn	14	SENT_1146	[p27l213t2986r657b3091],
13	Group	NNP	O	Group	nn	14	SENT_1146	[p27l688t2987r973b3091],
14	Study	NNP	O	Study	dep	4	SENT_1146	[p27l1005t2986r1280b3091],
15	.	.	O	.	_	0	SENT_1146	[p27l1005t2986r1280b3091],

1	J.	NNP	PERSON	J.	nn	2	SENT_1147	[p27l1312t2989r1381b3067],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1147	[p27l1426t2986r1631b3067],
3	.	.	O	.	_	0	SENT_1147	[p27l1426t2986r1631b3067],

1	Oncol	NN	O	oncol	_	0	SENT_1148	[p27l1674t2986r1964b3067],
2	.	.	O	.	_	0	SENT_1148	[p27l1674t2986r1964b3067],

1	14	CD	NUMBER	14	_	0	SENT_1149	[p27l2015t2987r2138b3067],
2	:	:	O	:	_	0	SENT_1149	[p27l2015t2987r2138b3067],
3	792-95	CD	NUMBER	792-95	dep	1	SENT_1149	[p27l211t3101r545b3184],

1	109	CD	NUMBER	109	_	0	SENT_1150	[p28l6t25r187b106],
2	.	.	O	.	_	0	SENT_1150	[p28l6t25r187b106],

1	Levy	NNP	ORGANIZATION	Levy	nn	2	SENT_1151	[p28l211t26r442b128],
2	T	NN	ORGANIZATION	t	_	0	SENT_1151	[p28l481t26r563b118],
3	,	,	O	,	_	0	SENT_1151	[p28l481t26r563b118],
4	Kudelka	NNP	ORGANIZATION	Kudelka	nn	5	SENT_1151	[p28l607t23r990b104],
5	AP	NNP	ORGANIZATION	AP	appos	2	SENT_1151	[p28l1028t25r1181b118],
6	,	,	O	,	_	0	SENT_1151	[p28l1028t25r1181b118],
7	Verschraegen	NNP	O	Verschraegen	nn	8	SENT_1151	[p28l1224t23r1838b128],
8	CF	NN	O	cf	appos	2	SENT_1151	[p28l1875t25r2024b118],
9	,	,	O	,	_	0	SENT_1151	[p28l1875t25r2024b118],
10	et	FW	O	et	nn	11	SENT_1151	[p28l2068t36r2149b104],
11	al.	FW	O	al.	appos	2	SENT_1151	[p28l213t138r313b217],
12	1996	CD	DATE	1996	dep	11	SENT_1151	[p28l378t138r614b219],
13	.	.	O	.	_	0	SENT_1151	[p28l378t138r614b219],

1	Advanced	NNP	O	Advanced	nn	4	SENT_1152	[p28l669t138r1131b219],
2	squamous	JJ	O	squamous	amod	4	SENT_1152	[p28l1181t163r1628b241],
3	cell	NN	O	cell	nn	4	SENT_1152	[p28l1681t138r1841b217],
4	carcinoma	NN	O	carcinoma	dep	21	SENT_1152	[p28l1891t138r2143b217, p28l211t279r463b332],
5	of	IN	O	of	_	0	SENT_1152	[p28l518t253r616b332],
6	the	DT	O	the	det	7	SENT_1152	[p28l661t253r795b332],
7	cervix	NN	O	cervix	prep_of	4	SENT_1152	[p28l852t253r1157b334],
8	:	:	O	:	_	0	SENT_1152	[p28l852t253r1157b334],
9	a	DT	O	a	det	13	SENT_1152	[p28l1219t279r1266b332],
10	phase	NN	O	phase	nn	13	SENT_1152	[p28l1317t253r1574b356],
11	II	CD	NUMBER	ii	num	13	SENT_1152	[p28l1629t255r1738b363],
12	“	NN	O	“	nn	13	SENT_1152	[p28l1629t255r1738b363],
13	study	NN	O	study	dep	7	SENT_1152	[p28l1760t253r2000b356],
14	of	IN	O	of	_	0	SENT_1152	[p28l2055t253r2153b332],
15	docetaxel	NN	O	docetaxel	nn	18	SENT_1152	[p28l211t370r646b450],
16	(	CD	NUMBER	(	num	18	SENT_1152	[p28l700t370r1164b469],
17	Taxotere	NNP	O	Taxotere	nn	18	SENT_1152	[p28l700t370r1164b469],
18	)	NN	O	)	prep_of	13	SENT_1152	[p28l700t370r1164b469],
19	100	CD	NUMBER	100	num	20	SENT_1152	[p28l1229t370r1385b450],
20	mg/m	NN	O	mg/m	dep	21	SENT_1152	[p28l1438t365r1741b474],
21	‘	CD	NUMBER	‘	dep	27	SENT_1152	[p28l1438t365r1741b474],
22	intravenously	RB	O	intravenously	advmod	21	SENT_1152	[p28l1794t370r2143b450, p28l211t484r511b589],
23	over	IN	O	over	_	0	SENT_1152	[p28l554t510r756b565],
24	1H	NN	O	1h	prep_over	21	SENT_1152	[p28l805t486r932b563],
25	every	DT	SET	every	det	27	SENT_1152	[p28l974t510r1224b589],
26	21	CD	SET	21	num	27	SENT_1152	[p28l1265t486r1366b563],
27	days	NNS	NUMBER	day	dep	31	SENT_1152	[p28l1417t484r1647b589],
28	:	:	O	:	_	0	SENT_1152	[p28l1417t484r1647b589],
29	a	DT	O	a	det	31	SENT_1152	[p28l1696t510r1745b565],
30	preliminary	JJ	O	preliminary	amod	31	SENT_1152	[p28l1781t484r2143b589, p28l211t625r411b702],
31	report	NN	O	report	_	0	SENT_1152	[p28l461t611r752b702],
32	.	.	O	.	_	0	SENT_1152	[p28l461t611r752b702],

1	Proc	NNP	O	Proc	_	0	SENT_1153	[p28l809t602r1043b678],
2	.	.	O	.	_	0	SENT_1153	[p28l809t602r1043b678],

1	Am	NNP	O	Am	_	0	SENT_1154	[p28l1097t600r1271b678],
2	.	.	O	.	_	0	SENT_1154	[p28l1097t600r1271b678],

1	Soc	NN	O	soc	_	0	SENT_1155	[p28l1333t601r1512b680],
2	.	.	O	.	_	0	SENT_1155	[p28l1333t601r1512b680],

1	Clin	NNP	O	Clin	_	0	SENT_1156	[p28l1577t599r1783b680],
2	.	.	O	.	_	0	SENT_1156	[p28l1577t599r1783b680],

1	Oncol	NN	O	oncol	_	0	SENT_1157	[p28l1846t599r2136b680],
2	.	.	O	.	_	0	SENT_1157	[p28l1846t599r2136b680],

1	15:293	CD	NUMBER	15:293	number	2	SENT_1158	[p28l221t714r518b797],
2	(	CD	NUMBER	(	_	0	SENT_1158	[p28l559t715r900b814],
3	Abstr	NNP	O	Abstr	dep	2	SENT_1158	[p28l559t715r900b814],
4	.	.	O	.	_	0	SENT_1158	[p28l559t715r900b814],
5	)	NN	O	)	dep	2	SENT_1158	[p28l559t715r900b814],

1	110	CD	NUMBER	110	_	0	SENT_1159	[p28l6t831r187b910],
2	.	.	O	.	_	0	SENT_1159	[p28l6t831r187b910],

1	Wilson	NNP	PERSON	Wilson	nn	2	SENT_1160	[p28l209t831r533b910],
2	HW	NNP	O	HW	_	0	SENT_1160	[p28l568t832r768b925],
3	,	,	O	,	_	0	SENT_1160	[p28l568t832r768b925],
4	Chabner	NNP	PERSON	Chabner	nn	5	SENT_1160	[p28l807t831r1193b910],
5	BA	NN	O	ba	appos	2	SENT_1160	[p28l1224t831r1405b925],
6	,	,	O	,	_	0	SENT_1160	[p28l1224t831r1405b925],
7	Bryant	NNP	PERSON	Bryant	nn	8	SENT_1160	[p28l1443t833r1752b934],
8	G	NNP	O	G	appos	2	SENT_1160	[p28l1784t831r1886b924],
9	,	,	O	,	_	0	SENT_1160	[p28l1784t831r1886b924],
10	et	FW	O	et	nn	11	SENT_1160	[p28l1927t843r2007b910],
11	a1	FW	O	a1	appos	2	SENT_1160	[p28l2041t831r2141b910],
12	.	.	O	.	_	0	SENT_1160	[p28l2041t831r2141b910],

1	1995	CD	DATE	1995	_	0	SENT_1161	[p28l221t945r458b1026],
2	.	.	O	.	_	0	SENT_1161	[p28l221t945r458b1026],

1	Phase	NN	O	phase	nn	3	SENT_1162	[p28l516t945r780b1026],
2	II	CD	NUMBER	ii	num	3	SENT_1162	[p28l833t947r906b1024],
3	study	NN	O	study	nsubj	7	SENT_1162	[p28l961t945r1200b1050],
4	of	IN	O	of	_	0	SENT_1162	[p28l1255t945r1354b1026],
5	paclitaxel	NN	O	paclitaxel	prep_of	3	SENT_1162	[p28l1395t945r1836b1050],
6	in	IN	O	in	prep	5	SENT_1162	[p28l1886t945r1972b1024],
7	relapsed	VBN	O	relapse	_	0	SENT_1162	[p28l2020t971r2143b1026, p28l211t1060r502b1165],
8	non	JJ	O	non	acomp	7	SENT_1162	[p28l540t1060r1217b1165],
9	.	.	O	.	_	0	SENT_1162	[p28l540t1060r1217b1165],

1	—	NN	O	—	_	0	SENT_1163	[p28l540t1060r1217b1165],
2	.	.	O	.	_	0	SENT_1163	[p28l540t1060r1217b1165],

1	Hodgkin	NN	PERSON	hodgkin	poss	3	SENT_1164	[p28l540t1060r1217b1165],
2	’s	POS	O	’s	_	0	SENT_1164	[p28l540t1060r1217b1165],
3	lymphoma	NN	O	lymphoma	_	0	SENT_1164	[p28l1259t1060r1767b1165],
4	.	.	O	.	_	0	SENT_1164	[p28l1259t1060r1767b1165],

1	J.	NNP	PERSON	J.	nn	2	SENT_1165	[p28l1806t1063r1874b1141],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1165	[p28l1931t1060r2134b1141],
3	.	.	O	.	_	0	SENT_1165	[p28l1931t1060r2134b1141],

1	Oncol	NN	O	oncol	_	0	SENT_1166	[p28l216t1174r504b1255],
2	.	.	O	.	_	0	SENT_1166	[p28l216t1174r504b1255],

1	131381-86	CD	NUMBER	131381-86	_	0	SENT_1167	[p28l557t1174r1028b1255],

1	111	CD	NUMBER	111	_	0	SENT_1168	[p28l6t1290r187b1369],
2	.	.	O	.	_	0	SENT_1168	[p28l6t1290r187b1369],

1	Younes	NNPS	MISC	Younes	nn	2	SENT_1169	[p28l211t1292r542b1369],
2	A	NNP	MISC	A	_	0	SENT_1169	[p28l573t1290r677b1384],
3	,	,	O	,	_	0	SENT_1169	[p28l573t1290r677b1384],
4	Sarris	NNP	PERSON	Sarris	nn	5	SENT_1169	[p28l711t1290r969b1371],
5	A	NNP	O	A	appos	2	SENT_1169	[p28l1000t1290r1104b1384],
6	,	,	O	,	_	0	SENT_1169	[p28l1000t1290r1104b1384],
7	Melnyk	NNP	PERSON	Melnyk	nn	8	SENT_1169	[p28l1136t1290r1490b1393],
8	A	NNP	O	A	appos	2	SENT_1169	[p28l1515t1290r1619b1385],
9	,	,	O	,	_	0	SENT_1169	[p28l1515t1290r1619b1385],
10	et	FW	O	et	nn	11	SENT_1169	[p28l1653t1302r1733b1369],
11	al.	FW	O	al.	appos	2	SENT_1169	[p28l1760t1290r1860b1369],
12	1995	CD	DATE	1995	dep	11	SENT_1169	[p28l1903t1290r2113b1371],
13	.	.	O	.	_	0	SENT_1169	[p28l2127t1357r2140b1369],

1	Three-hour	JJ	DURATION	three-hour	amod	3	SENT_1170	[p28l211t1405r723b1486],
2	paclitaxel	NN	O	paclitaxel	nn	3	SENT_1170	[p28l766t1405r1207b1510],
3	infusion	NN	O	infusion	nsubj	9	SENT_1170	[p28l1250t1405r1621b1486],
4	in	IN	O	in	_	0	SENT_1170	[p28l1665t1405r1752b1484],
5	patients	NNS	O	patient	pobj	4	SENT_1170	[p28l1794t1405r2143b1510],
6	with	IN	O	with	_	0	SENT_1170	[p28l211t1520r411b1601],
7	refractory	JJ	O	refractory	prep_with	4	SENT_1170	[p28l545t1520r993b1625],
8	and	CC	O	and	_	0	SENT_1170	[p28l1131t1520r1293b1601],
9	relapsed	VBD	O	relapse	conj_and	4	SENT_1170	[p28l1426t1520r1805b1625],
10	nonHodgkin	JJ	O	nonhodgkin	poss	12	SENT_1170	[p28l1939t1546r2143b1601, p28l211t1635r680b1738],
11	’s	POS	O	’s	_	0	SENT_1170	[p28l1939t1546r2143b1601, p28l211t1635r680b1738],
12	lymphoma	NN	O	lymphoma	dobj	9	SENT_1170	[p28l771t1635r1278b1738],
13	.	.	O	.	_	0	SENT_1170	[p28l771t1635r1278b1738],

1	J.	NNP	PERSON	J.	nn	2	SENT_1171	[p28l1367t1638r1435b1716],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1171	[p28l1539t1635r1743b1716],
3	.	.	O	.	_	0	SENT_1171	[p28l1539t1635r1743b1716],

1	Oncol	NN	O	oncol	_	0	SENT_1172	[p28l1846t1635r2136b1716],
2	.	.	O	.	_	0	SENT_1172	[p28l1846t1635r2136b1716],

1	132583-87	CD	NUMBER	132583-87	_	0	SENT_1173	[p28l221t1749r690b1830],

1	112	CD	NUMBER	112	_	0	SENT_1174	[p28l6t1867r430b1947],
2	.	.	O	.	_	0	SENT_1174	[p28l6t1867r430b1947],

1	Roth	NNP	ORGANIZATION	Roth	nn	2	SENT_1175	[p28l6t1867r430b1947],
2	BJ	NNP	ORGANIZATION	BJ	_	0	SENT_1175	[p28l487t1869r630b1962],
3	,	,	O	,	_	0	SENT_1175	[p28l487t1869r630b1962],
4	Dreicer	NNP	PERSON	Dreicer	nn	5	SENT_1175	[p28l692t1867r1033b1947],
5	R	NNP	PERSON	R	appos	2	SENT_1175	[p28l1088t1869r1186b1961],
6	,	,	O	,	_	0	SENT_1175	[p28l1088t1869r1186b1961],
7	Einhorn	NNP	ORGANIZATION	Einhorn	nn	8	SENT_1175	[p28l1245t1867r1611b1947],
8	LH	NNP	ORGANIZATION	LH	appos	2	SENT_1175	[p28l1667t1869r1841b1962],
9	,	,	O	,	_	0	SENT_1175	[p28l1667t1869r1841b1962],
10	et	FW	O	et	nn	11	SENT_1175	[p28l1903t1879r1983b1947],
11	al.	FW	O	al.	appos	2	SENT_1175	[p28l2041t1867r2141b1947],
12	1994	CD	DATE	1994	dep	11	SENT_1175	[p28l221t1982r458b2062],
13	.	.	O	.	_	0	SENT_1175	[p28l221t1982r458b2062],

1	Significant	JJ	O	significant	amod	2	SENT_1176	[p28l514t1981r1009b2086],
2	activity	NN	O	activity	_	0	SENT_1176	[p28l1057t1981r1390b2086],
3	of	IN	O	of	_	0	SENT_1176	[p28l1438t1981r1536b2062],
4	paclitaxel	NN	O	paclitaxel	prep_of	2	SENT_1176	[p28l1574t1981r2015b2086],
5	in	IN	O	in	_	0	SENT_1176	[p28l2061t1981r2148b2060],
6	advanced	JJ	O	advanced	amod	7	SENT_1176	[p28l213t2096r640b2175],
7	transitiona1	NN	O	transitiona1	prep_in	4	SENT_1176	[p28l664t2096r1374b2175],
8	—	CD	NUMBER	—	num	10	SENT_1176	[p28l664t2096r1374b2175],
9	ce11	NN	O	ce11	nn	10	SENT_1176	[p28l664t2096r1374b2175],
10	carcinoma	NN	O	carcinoma	dep	2	SENT_1176	[p28l1398t2096r1872b2175],
11	of	IN	O	of	_	0	SENT_1176	[p28l1895t2096r1993b2175],
12	the	DT	O	the	det	13	SENT_1176	[p28l2010t2096r2146b2175],
13	urothelium	NN	O	urothelium	prep_of	10	SENT_1176	[p28l209t2211r731b2292],
14	:	:	O	:	_	0	SENT_1176	[p28l209t2211r731b2292],
15	a	DT	O	a	det	18	SENT_1176	[p28l771t2237r819b2292],
16	phase	NN	O	phase	nn	18	SENT_1176	[p28l847t2211r1104b2316],
17	II	CD	NUMBER	ii	num	18	SENT_1176	[p28l1136t2214r1211b2290],
18	study	NN	O	study	dep	2	SENT_1176	[p28l1245t2211r1485b2316],
19	of	IN	O	of	_	0	SENT_1176	[p28l1517t2211r1616b2292],
20	the	DT	O	the	det	24	SENT_1176	[p28l1639t2211r1774b2292],
21	Eastern	NNP	ORGANIZATION	Eastern	nn	24	SENT_1176	[p28l1806t2214r2148b2292],
22	Cooperative	NNP	ORGANIZATION	Cooperative	nn	24	SENT_1176	[p28l211t2327r764b2430],
23	Oncology	NNP	ORGANIZATION	Oncology	nn	24	SENT_1176	[p28l797t2327r1240b2430],
24	Group	NNP	ORGANIZATION	Group	prep_of	18	SENT_1176	[p28l1272t2327r1581b2430],
25	.	.	O	.	_	0	SENT_1176	[p28l1272t2327r1581b2430],

1	J.	NNP	PERSON	J.	nn	2	SENT_1177	[p28l1612t2329r1681b2406],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1177	[p28l1726t2327r1931b2408],
3	.	.	O	.	_	0	SENT_1177	[p28l1726t2327r1931b2408],

1	Oncol	NN	O	oncol	_	0	SENT_1178	[p28l1975t2328r2141b2408, p28l212t2440r366b2521],
2	.	.	O	.	_	0	SENT_1178	[p28l1975t2328r2141b2408, p28l212t2440r366b2521],

1	12:2264	CD	NUMBER	12:2264	_	0	SENT_1179	[p28l418t2440r947b2521],
2	—	CD	NUMBER	—	num	3	SENT_1179	[p28l418t2440r947b2521],
3	70	CD	NUMBER	70	dep	1	SENT_1179	[p28l418t2440r947b2521],

1	113	CD	NUMBER	113	_	0	SENT_1180	[p28l6t2557r187b2637],
2	.	.	O	.	_	0	SENT_1180	[p28l6t2557r187b2637],

1	Ajani	JJ	O	ajani	amod	2	SENT_1181	[p28l211t2556r461b2661],
2	JA	NN	O	ja	_	0	SENT_1181	[p28l485t2557r633b2651],
3	,	,	O	,	_	0	SENT_1181	[p28l485t2557r633b2651],
4	Ilson	NN	PERSON	ilson	nn	5	SENT_1181	[p28l661t2556r886b2637],
5	D	NN	PERSON	d	appos	2	SENT_1181	[p28l909t2558r1013b2651],
6	,	,	O	,	_	0	SENT_1181	[p28l909t2558r1013b2651],
7	Daugherty	NNP	PERSON	Daugherty	nn	8	SENT_1181	[p28l1041t2556r1519b2661],
8	L	NNP	PERSON	L	appos	2	SENT_1181	[p28l1543t2558r1634b2651],
9	,	,	O	,	_	0	SENT_1181	[p28l1543t2558r1634b2651],
10	et	FW	O	et	nn	11	SENT_1181	[p28l1662t2568r1743b2637],
11	al.	FW	O	al.	appos	2	SENT_1181	[p28l1764t2556r1864b2637],
12	1994	CD	DATE	1994	dep	11	SENT_1181	[p28l1903t2557r2139b2637],
13	.	.	O	.	_	0	SENT_1181	[p28l1903t2557r2139b2637],

1	Activity	NN	O	activity	_	0	SENT_1182	[p28l211t2671r580b2776],
2	of	IN	O	of	_	0	SENT_1182	[p28l609t2671r707b2752],
3	taxol	NN	O	taxol	prep_of	1	SENT_1182	[p28l726t2671r950b2752],
4	in	IN	O	in	_	0	SENT_1182	[p28l976t2671r1063b2750],
5	patients	NNS	O	patient	prep_in	1	SENT_1182	[p28l1088t2671r1436b2776],
6	with	IN	O	with	_	0	SENT_1182	[p28l1467t2671r1666b2752],
7	squamous	JJ	O	squamous	amod	9	SENT_1182	[p28l1696t2697r2143b2776],
8	cell	NN	O	cell	nn	9	SENT_1182	[p28l211t2786r373b2865],
9	carcinoma	NN	O	carcinoma	prep_with	5	SENT_1182	[p28l407t2786r880b2865],
10	and	CC	O	and	_	0	SENT_1182	[p28l914t2786r1076b2865],
11	adenocarcinoma	NN	O	adenocarcinoma	prep_with	5	SENT_1182	[p28l1109t2786r1853b2865],
12	of	IN	O	of	_	0	SENT_1182	[p28l1887t2786r1986b2865],
13	the	DT	O	the	det	14	SENT_1182	[p28l2010t2786r2146b2865],
14	esophagus	NN	O	esophagus	prep_of	1	SENT_1182	[p28l211t2900r706b3004],
15	.	.	O	.	_	0	SENT_1182	[p28l211t2900r706b3004],

1	J.	NNP	O	J.	nn	4	SENT_1183	[p28l745t2904r814b2981],
2	Natl.	NNP	O	Natl.	nn	4	SENT_1183	[p28l857t2900r1071b2980],
3	Cancer	NNP	O	Cancer	nn	4	SENT_1183	[p28l1124t2902r1457b2982],
4	Inst	NNP	O	Inst	_	0	SENT_1183	[p28l1485t2904r1674b2980],
5	.	.	O	.	_	0	SENT_1183	[p28l1485t2904r1674b2980],

1	862108691	CD	NUMBER	862108691	_	0	SENT_1184	[p28l1724t2899r2148b2980, p28l212t3017r313b3096],

1	114	CD	NUMBER	114	_	0	SENT_1185	[p28l6t3131r540b3210],
2	.	.	O	.	_	0	SENT_1185	[p28l6t3131r540b3210],

1	Motzer	NNP	PERSON	Motzer	nn	2	SENT_1186	[p28l6t3131r540b3210],
2	R	NNP	PERSON	R	_	0	SENT_1186	[p28l586t3133r683b3225],
3	,	,	O	,	_	0	SENT_1186	[p28l586t3133r683b3225],
4	Bajorin	NNP	PERSON	Bajorin	nn	8	SENT_1186	[p28l736t3131r1074b3234],
5	D	NNP	PERSON	D	nn	8	SENT_1186	[p28l1122t3133r1226b3225],
6	,	,	O	,	_	0	SENT_1186	[p28l1122t3133r1226b3225],
7	Schwartz	NNP	PERSON	Schwartz	appos	8	SENT_1186	[p28l1283t3131r1700b3210],
8	L.	NNP	O	L.	appos	2	SENT_1186	[p28l1749t3133r1839b3210],
9	1994	CD	DATE	1994	num	8	SENT_1186	[p28l1903t3131r2139b3212],
10	.	.	O	.	_	0	SENT_1186	[p28l1903t3131r2139b3212],

1	Phase	NN	O	phase	nn	3	SENT_1187	[p28l211t3246r475b3325],
2	II	CD	NUMBER	ii	num	3	SENT_1187	[p28l504t3248r576b3325],
3	trial	NN	O	trial	nsubj	6	SENT_1187	[p28l604t3246r783b3325],
4	of	IN	O	of	_	0	SENT_1187	[p28l812t3246r911b3325],
5	paclitaxel	NN	O	paclitaxel	prep_of	3	SENT_1187	[p28l929t3246r1369b3349],
6	shows	VBZ	O	show	_	0	SENT_1187	[p28l1401t3246r1676b3327],
7	antitumor	NN	O	antitumor	nn	8	SENT_1187	[p28l1710t3246r2148b3325],
8	activity	NN	O	activity	dobj	6	SENT_1187	[p28l213t3362r547b3465],
9	in	IN	O	in	_	0	SENT_1187	[p28l583t3362r671b3440],
10	patients	NNS	O	patient	prep_in	6	SENT_1187	[p28l705t3362r1054b3465],
11	with	IN	O	with	prep	10	SENT_1187	[p28l1093t3362r1292b3441],
12	previously	RB	DATE	previously	pcomp	11	SENT_1187	[p28l1326t3362r1803b3465],
13	treated	VBN	O	treat	partmod	10	SENT_1187	[p28l1839t3362r2148b3441],
14	germ	NN	O	germ	nn	16	SENT_1187	[p28l211t3502r445b3581],
15	cell	NN	O	cell	nn	16	SENT_1187	[p28l473t3476r633b3557],
16	tumors	NNS	O	tumor	dobj	13	SENT_1187	[p28l659t3488r997b3557],
17	.	.	O	.	_	0	SENT_1187	[p28l659t3488r997b3557],

1	J.	NNP	PERSON	J.	nn	2	SENT_1188	[p28l1029t3479r1097b3557],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1188	[p28l1141t3476r1347b3557],
3	.	.	O	.	_	0	SENT_1188	[p28l1141t3476r1347b3557],

1	Oncol	NN	O	oncol	_	0	SENT_1189	[p28l1390t3476r1679b3557],
2	.	.	O	.	_	0	SENT_1189	[p28l1390t3476r1679b3557],

1	12:2277	CD	NUMBER	12:2277	_	0	SENT_1190	[p28l1729t3477r2148b3557],
2	—	CD	NUMBER	—	num	3	SENT_1190	[p28l1729t3477r2148b3557],
3	83	CD	NUMBER	83	dep	1	SENT_1190	[p28l215t3590r316b3671],

1	115	CD	NUMBER	115	_	0	SENT_1191	[p28l6t3706r340b3787],
2	.	.	O	.	_	0	SENT_1191	[p28l6t3706r340b3787],

1	De	NNP	O	De	nn	3	SENT_1192	[p28l6t3706r340b3787],
2	Wit	NN	O	wit	nn	3	SENT_1192	[p28l380t3706r547b3787],
3	R	NN	O	r	_	0	SENT_1192	[p28l583t3709r682b3801],
4	,	,	O	,	_	0	SENT_1192	[p28l583t3709r682b3801],
5	Stoter	NNP	O	Stoter	nn	6	SENT_1192	[p28l728t3707r998b3787],
6	G	NNP	O	G	appos	3	SENT_1192	[p28l1036t3707r1138b3801],
7	,	,	O	,	_	0	SENT_1192	[p28l1036t3707r1138b3801],
8	Blanc	NNP	PERSON	Blanc	nn	9	SENT_1192	[p28l1183t3706r1443b3787],
9	C	NNP	O	C	appos	3	SENT_1192	[p28l1486t3708r1583b3801],
10	,	,	O	,	_	0	SENT_1192	[p28l1486t3708r1583b3801],
11	et	FW	O	et	nn	12	SENT_1192	[p28l1627t3719r1708b3787],
12	al.	FW	O	al.	appos	3	SENT_1192	[p28l1748t3706r1848b3787],
13	1994	CD	DATE	1994	dep	12	SENT_1192	[p28l1903t3707r2139b3789],
14	.	.	O	.	_	0	SENT_1192	[p28l1903t3707r2139b3789],

1	Phase	NN	O	phase	_	0	SENT_1193	[p29l211t17r475b96],
2	II	CD	NUMBER	ii	num	3	SENT_1193	[p29l563t19r637b96],
3	study	NN	O	study	dep	1	SENT_1193	[p29l728t17r968b120],
4	of	IN	O	of	_	0	SENT_1193	[p29l1058t17r1157b96],
5	first-line	JJ	O	first-line	amod	6	SENT_1193	[p29l1236t17r1623b96],
6	docetaxel	NN	O	docetaxel	prep_of	3	SENT_1193	[p29l1713t17r2148b96],
7	(	CD	NUMBER	(	num	8	SENT_1193	[p29l214t133r678b232],
8	Taxotere	NNP	O	Taxotere	dep	1	SENT_1193	[p29l214t133r678b232],
9	)	CD	NUMBER	)	num	8	SENT_1193	[p29l214t133r678b232],
10	in	IN	O	in	_	0	SENT_1193	[p29l774t132r861b211],
11	patients	NNS	O	patient	prep_in	8	SENT_1193	[p29l950t132r1300b237],
12	with	IN	O	with	_	0	SENT_1193	[p29l1396t132r1595b213],
13	metastatic	JJ	O	metastatic	amod	15	SENT_1193	[p29l1688t132r2145b213],
14	urothelial	JJ	O	urothelial	amod	15	SENT_1193	[p29l209t247r642b328],
15	cancer	NN	O	cancer	prep_with	11	SENT_1193	[p29l678t273r987b328],
16	.	.	O	.	_	0	SENT_1193	[p29l678t273r987b328],

1	Ann	NNP	PERSON	Ann	_	0	SENT_1194	[p29l1017t249r1224b328],
2	.	.	O	.	_	0	SENT_1194	[p29l1017t249r1224b328],

1	Oncol	NN	O	oncol	_	0	SENT_1195	[p29l1271t247r1562b328],
2	.	.	O	.	_	0	SENT_1195	[p29l1271t247r1562b328],

1	5	CD	NUMBER	5	num	2	SENT_1196	[p29l1605t247r1984b352],
2	(	CD	NUMBER	(	_	0	SENT_1196	[p29l1605t247r1984b352],
3	Suppl	NNP	O	Suppl	dep	2	SENT_1196	[p29l1605t247r1984b352],
4	.	.	O	.	_	0	SENT_1196	[p29l1605t247r1984b352],

1	8	CD	NUMBER	8	num	2	SENT_1197	[p29l2027t248r2138b345],
2	)	NN	O	)	_	0	SENT_1197	[p29l2027t248r2138b345],
3	:	:	O	:	_	0	SENT_1197	[p29l2027t248r2138b345],
4	67	CD	NUMBER	67	number	5	SENT_1197	[p29l213t362r318b443],
5	(	CD	NUMBER	(	dep	2	SENT_1197	[p29l357t362r699b462],
6	Abstr	NNP	PERSON	Abstr	nn	8	SENT_1197	[p29l357t362r699b462],
7	.	.	O	.	_	0	SENT_1197	[p29l357t362r699b462],
8	)	NN	O	)	dep	5	SENT_1197	[p29l357t362r699b462],

1	116	CD	NUMBER	116	_	0	SENT_1198	[p29l6t478r187b559],
2	.	.	O	.	_	0	SENT_1198	[p29l6t478r187b559],

1	Van	NNP	O	Van	nn	3	SENT_1199	[p29l211t504r373b557],
2	Hoesel	NNP	O	Hoesel	nn	3	SENT_1199	[p29l407t478r723b557],
3	QGCM	NNP	O	QGCM	_	0	SENT_1199	[p29l757t478r1121b578],
4	,	,	O	,	_	0	SENT_1199	[p29l757t478r1121b578],
5	Verweij	NNP	PERSON	Verweij	nn	9	SENT_1199	[p29l1157t478r1504b581],
6	J	NNP	PERSON	J	nn	9	SENT_1199	[p29l1543t480r1609b573],
7	,	,	O	,	_	0	SENT_1199	[p29l1543t480r1609b573],
8	Catimel	NNP	O	Catimel	appos	9	SENT_1199	[p29l1648t478r2005b559],
9	G.	NNP	O	G.	appos	3	SENT_1199	[p29l2039t478r2139b559],
10	1994	CD	DATE	1994	num	9	SENT_1199	[p29l221t594r458b675],
11	.	.	O	.	_	0	SENT_1199	[p29l221t594r458b675],

1	Phase	NN	O	phase	_	0	SENT_1200	[p29l557t594r821b673],
2	II	CD	NUMBER	ii	num	3	SENT_1200	[p29l917t596r990b672],
3	study	NN	O	study	dep	1	SENT_1200	[p29l1088t594r1326b697],
4	with	IN	O	with	_	0	SENT_1200	[p29l1421t594r1621b673],
5	docetaxel	NN	O	docetaxel	prep_with	3	SENT_1200	[p29l1713t594r2148b673],
6	(	CD	NUMBER	(	num	5	SENT_1200	[p29l214t709r678b808],
7	Taxotere	NNP	O	Taxotere	dep	1	SENT_1200	[p29l214t709r678b808],
8	)	CD	NUMBER	)	num	7	SENT_1200	[p29l214t709r678b808],
9	in	IN	O	in	_	0	SENT_1200	[p29l711t708r797b787],
10	advanced	JJ	O	advanced	amod	13	SENT_1200	[p29l828t708r1257b789],
11	soft	JJ	O	soft	amod	13	SENT_1200	[p29l1288t708r1455b789],
12	tissue	NN	O	tissue	nn	13	SENT_1200	[p29l1481t708r1738b789],
13	sarcoma	NN	O	sarcoma	prep_in	7	SENT_1200	[p29l1771t734r2148b789],
14	of	IN	O	of	_	0	SENT_1200	[p29l212t823r311b903],
15	the	DT	O	the	det	16	SENT_1200	[p29l335t823r470b903],
16	adult	NN	O	adult	prep_of	13	SENT_1200	[p29l504t823r747b903],
17	.	.	O	.	_	0	SENT_1200	[p29l504t823r747b903],

1	Ann	NNP	PERSON	Ann	_	0	SENT_1201	[p29l776t824r983b903],
2	.	.	O	.	_	0	SENT_1201	[p29l776t824r983b903],

1	Oncol	NN	O	oncol	_	0	SENT_1202	[p29l1031t823r1319b904],
2	.	.	O	.	_	0	SENT_1202	[p29l1031t823r1319b904],

1	52539-42	CD	NUMBER	52539-42	_	0	SENT_1203	[p29l1362t823r1786b904],

1	1	CD	NUMBER	1	num	2	SENT_1204	[p29l6t941r39b1018],
2	17	CD	NUMBER	17	_	0	SENT_1204	[p29l64t941r187b1020],
3	.	.	O	.	_	0	SENT_1204	[p29l64t941r187b1020],

1	Gill	NNP	PERSON	Gill	nn	2	SENT_1205	[p29l213t939r384b1020],
2	PS	NNP	O	PS	_	0	SENT_1205	[p29l409t940r558b1034],
3	,	,	O	,	_	0	SENT_1205	[p29l409t940r558b1034],
4	Tulpule	NNP	MISC	Tulpule	nn	5	SENT_1205	[p29l588t939r935b1044],
5	A	NNP	MISC	A	appos	2	SENT_1205	[p29l959t940r1064b1034],
6	,	,	O	,	_	0	SENT_1205	[p29l959t940r1064b1034],
7	Reynolds	NNP	ORGANIZATION	Reynolds	nn	8	SENT_1205	[p29l1093t939r1517b1044],
8	T	NN	ORGANIZATION	t	appos	2	SENT_1205	[p29l1546t942r1628b1034],
9	,	,	O	,	_	0	SENT_1205	[p29l1546t942r1628b1034],
10	et	FW	O	et	nn	11	SENT_1205	[p29l1658t952r1739b1020],
11	al.	FW	O	al.	appos	2	SENT_1205	[p29l1764t939r1864b1020],
12	1996	CD	DATE	1996	dep	11	SENT_1205	[p29l1903t939r2141b1022],
13	.	.	O	.	_	0	SENT_1205	[p29l1903t939r2141b1022],

1	Paclitaxel	NN	O	paclitaxel	nn	4	SENT_1206	[p29l211t1055r658b1135],
2	(	CD	NUMBER	(	num	4	SENT_1206	[p29l709t1055r1033b1154],
3	Taxol	NN	O	taxol	nn	4	SENT_1206	[p29l709t1055r1033b1154],
4	)	NN	O	)	_	0	SENT_1206	[p29l709t1055r1033b1154],
5	in	IN	O	in	_	0	SENT_1206	[p29l1084t1054r1171b1134],
6	the	DT	O	the	det	7	SENT_1206	[p29l1219t1055r1354b1135],
7	treatment	NN	O	treatment	prep_in	4	SENT_1206	[p29l1405t1067r1836b1135],
8	of	IN	O	of	_	0	SENT_1206	[p29l1882t1054r1981b1135],
9	relapsed	VBN	O	relapse	prepc_of	7	SENT_1206	[p29l2020t1080r2143b1135, p29l211t1170r502b1275],
10	or	CC	O	or	_	0	SENT_1206	[p29l531t1196r625b1251],
11	refractory	JJ	O	refractory	amod	12	SENT_1206	[p29l649t1170r1097b1275],
12	AIDs	NNS	MISC	aid	prep_in	4	SENT_1206	[p29l1126t1170r1721b1251],
13	—	RB	O	—	advmod	17	SENT_1206	[p29l1126t1170r1721b1251],
14	related	JJ	O	related	amod	15	SENT_1206	[p29l1126t1170r1721b1251],
15	Kaposi	NN	PERSON	kaposus	poss	17	SENT_1206	[p29l1751t1170r2141b1275],
16	’s	POS	O	’s	_	0	SENT_1206	[p29l1751t1170r2141b1275],
17	sarcoma	NN	O	sarcoma	rcmod	12	SENT_1206	[p29l214t1309r613b1364],
18	.	.	O	.	_	0	SENT_1206	[p29l214t1309r613b1364],

1	Proc	NNP	O	Proc	_	0	SENT_1207	[p29l659t1287r893b1364],
2	.	.	O	.	_	0	SENT_1207	[p29l659t1287r893b1364],

1	Am	NNP	O	Am	_	0	SENT_1208	[p29l937t1285r1112b1364],
2	.	.	O	.	_	0	SENT_1208	[p29l937t1285r1112b1364],

1	Soc	NN	O	soc	_	0	SENT_1209	[p29l1165t1285r1345b1365],
2	.	.	O	.	_	0	SENT_1209	[p29l1165t1285r1345b1365],

1	Clin	NNP	O	Clin	_	0	SENT_1210	[p29l1402t1284r1607b1365],
2	.	.	O	.	_	0	SENT_1210	[p29l1402t1284r1607b1365],

1	Oncol	NN	O	oncol	_	0	SENT_1211	[p29l1663t1284r1953b1365],
2	.	.	O	.	_	0	SENT_1211	[p29l1663t1284r1953b1365],

1	15	CD	NUMBER	15	_	0	SENT_1212	[p29l2015t1284r2138b1365],
2	:	:	O	:	_	0	SENT_1212	[p29l2015t1284r2138b1365],

1	306	CD	NUMBER	306	number	2	SENT_1213	[p29l213t1400r377b1481],
2	(	CD	NUMBER	(	_	0	SENT_1213	[p29l414t1400r756b1500],
3	Abstr	NNP	O	Abstr	dep	2	SENT_1213	[p29l414t1400r756b1500],
4	.	.	O	.	_	0	SENT_1213	[p29l414t1400r756b1500],
5	)	NN	O	)	dep	2	SENT_1213	[p29l414t1400r756b1500],

